GeneSymbol,Chromosome,Start,ReferenceAllele,AlternateAllele,ClinicalSignificance,PhenotypeList,Assembly,Type
ZNF592,15,84799209,na,na,Uncertain significance,Galloway-Mowat syndrome 1,GRCh38,single nucleotide variant
FOXRED1,11,126275389,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19|not provided|Leigh syndrome|FOXRED1-related disorder",GRCh38,single nucleotide variant
FOXRED1,11,126277517,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19",GRCh38,single nucleotide variant
NUBPL,14,31562125,na,na,Conflicting classifications of pathogenicity,"not provided|Inborn genetic diseases|Mitochondrial complex 1 deficiency, nuclear type 21|not specified",GRCh38,single nucleotide variant
HFE,6,26092913,na,na,"Pathogenic/Pathogenic, low penetrance; other; risk factor",Hemochromatosis type 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary hemochromatosis|Porphyrinuria;Cutaneous photosensitivity|Cardiomyopathy|7 conditions|Bronze diabetes|HFE-related disorder|Inborn genetic diseases|6 conditions|Juvenile hemochromatosis,GRCh38,single nucleotide variant
HFE,6,26090951,na,na,Conflicting classifications of pathogenicity; other,Hemochromatosis type 1|not provided|not specified|Hereditary hemochromatosis|Bronze diabetes|Cardiomyopathy|6 conditions|Cystic fibrosis|Variegate porphyria|See cases,GRCh38,single nucleotide variant
HFE,6,26090957,na,na,Conflicting classifications of pathogenicity,Hemochromatosis type 1|Hereditary hemochromatosis|not provided|6 conditions|6 conditions|not specified|HFE-related disorder,GRCh38,single nucleotide variant
HFE,6,26091078,na,na,Uncertain significance,Hemochromatosis type 1|Hereditary hemochromatosis,GRCh38,single nucleotide variant
HFE,6,26091041,na,na,Uncertain significance,Hemochromatosis type 1|not specified,GRCh38,single nucleotide variant
HFE,6,26093008,na,na,Benign,HFE INTRONIC POLYMORPHISM|not provided,GRCh38,single nucleotide variant
HFE,6,26090921,na,na,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not provided,GRCh38,single nucleotide variant
HFE,6,26090939,na,na,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not specified,GRCh38,single nucleotide variant
HFE,6,26091354,na,na,Uncertain significance,Hemochromatosis type 1|not specified,GRCh38,single nucleotide variant
HFE,6,26093215,na,na,Pathogenic,Hemochromatosis type 1,GRCh38,single nucleotide variant
HFE,6,26092916,na,na,Pathogenic/Likely pathogenic,Hemochromatosis type 1|Hereditary hemochromatosis|not provided|Incidental Discovery,GRCh38,single nucleotide variant
WDR35,2,19989284,na,na,Pathogenic,Cranioectodermal dysplasia 2,GRCh38,single nucleotide variant
WDR35,2,19945787,na,na,Pathogenic,Cranioectodermal dysplasia 2,GRCh38,single nucleotide variant
WDR35,2,19933469,na,na,Likely pathogenic,Cranioectodermal dysplasia 2|not provided,GRCh38,single nucleotide variant
ABHD12,20,25302322,na,na,Pathogenic,PHARC syndrome|not provided,GRCh38,single nucleotide variant
ZNF513,2,27378156,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 58|not provided,GRCh38,single nucleotide variant
HOGA1,10,97611535,na,na,Pathogenic,Primary hyperoxaluria type 3|not provided,GRCh38,single nucleotide variant
HOGA1,10,97598852,na,na,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided|HOGA1-related disorder,GRCh38,single nucleotide variant
HOGA1,10,97600167,na,na,Pathogenic,Primary hyperoxaluria type 3,GRCh38,single nucleotide variant
HOGA1,10,97584912,na,na,Pathogenic,Primary hyperoxaluria type 3|not provided,GRCh38,single nucleotide variant
HOGA1,10,97601925,na,na,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided,GRCh38,single nucleotide variant
FAM161A,2,61840319,na,na,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|not provided|Autosomal recessive retinitis pigmentosa,GRCh38,single nucleotide variant
FAM161A,2,61839695,na,na,Pathogenic,Retinitis pigmentosa 28|not provided|Cone-rod dystrophy|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
FAM161A,2,61839437,na,na,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
FAM161A,2,61836075,na,na,Pathogenic,Retinitis pigmentosa 28|not provided,GRCh38,single nucleotide variant
WDR62,19,36084678,na,na,Uncertain significance,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations|not provided|Autosomal recessive primary microcephaly|Inborn genetic diseases",GRCh38,single nucleotide variant
WDR62,19,36067415,na,na,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",GRCh38,single nucleotide variant
WDR62,19,36083099,na,na,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",GRCh38,single nucleotide variant
WDPCP,2,63492941,na,na,Pathogenic,Bardet-Biedl syndrome 15,GRCh38,single nucleotide variant
WDPCP,2,63437430,na,na,risk factor,"Bardet-Biedl syndrome 12, modifier of",GRCh38,single nucleotide variant
WDPCP,2,63487491,na,na,risk factor,"Meckel syndrome, type 6, modifier of",GRCh38,single nucleotide variant
TBC1D24,16,2496587,na,na,Pathogenic,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24",GRCh38,single nucleotide variant
TBC1D24,16,2500822,na,na,Conflicting classifications of pathogenicity,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24|DOORS syndrome|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
TBC1D24,16,2496899,na,na,Pathogenic,Familial infantile myoclonic epilepsy,GRCh38,single nucleotide variant
XPNPEP3,22,40924482,na,na,Pathogenic,Nephronophthisis-like nephropathy 1,GRCh38,single nucleotide variant
CEP152,15,48793359,na,na,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|CEP152-related disorder|not provided|Microcephaly 9, primary, autosomal recessive;Seckel syndrome 5",GRCh38,single nucleotide variant
CEP152,15,48756289,na,na,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|not provided",GRCh38,single nucleotide variant
SDCCAG8,1,243305133,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 16|Senior-Loken syndrome 7|Bardet-Biedl syndrome|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7|SDCCAG8-related disorder,GRCh38,single nucleotide variant
SDCCAG8,1,243304716,na,na,Pathogenic,Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7,GRCh38,single nucleotide variant
OPN1SW,7,128775556,na,na,Likely benign,Blue color blindness|not provided,GRCh38,single nucleotide variant
OPN1SW,7,128774545,na,na,Uncertain significance,Blue color blindness|not provided,GRCh38,single nucleotide variant
OPN1SW,7,128773786,na,na,Uncertain significance,Blue color blindness|not provided,GRCh38,single nucleotide variant
UROD,1,45014803,na,na,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45014803,na,na,Pathogenic,Hepatoerythropoietic porphyria|Porphyria cutanea tarda|Familial porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45014071,na,na,Pathogenic,Familial porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45013933,na,na,Uncertain significance,Hepatoerythropoietic porphyria|not provided,GRCh38,single nucleotide variant
UROD,1,45014835,na,na,Pathogenic,Hepatoerythropoietic porphyria,GRCh38,single nucleotide variant
UROD,1,45013187,na,na,Pathogenic,Hepatoerythropoietic porphyria|not provided,GRCh38,single nucleotide variant
UROD,1,45014996,na,na,Conflicting classifications of pathogenicity,Hepatoerythropoietic porphyria|Sporadic porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45015006,na,na,Likely pathogenic,Familial porphyria cutanea tarda|not provided|UROD-related disorder,GRCh38,single nucleotide variant
UROD,1,45013928,na,na,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45014017,na,na,Pathogenic,Familial porphyria cutanea tarda,GRCh38,single nucleotide variant
UROD,1,45014976,na,na,Pathogenic,Familial porphyria cutanea tarda|not provided,GRCh38,single nucleotide variant
UROD,1,45015389,na,na,Conflicting classifications of pathogenicity,Familial porphyria cutanea tarda,GRCh38,single nucleotide variant
LIPA,10,89225168,na,na,Pathogenic,Wolman disease|Lysosomal acid lipase deficiency|Cholesteryl ester storage disease,GRCh38,single nucleotide variant
LIPA,10,89223710,na,na,Pathogenic,Lysosomal acid lipase deficiency|Cholesteryl ester storage disease|not provided|Wolman disease|Cholesteryl ester storage disease;Wolman disease,GRCh38,single nucleotide variant
LIPA,10,89222510,na,na,Pathogenic,Wolman disease,GRCh38,single nucleotide variant
LIPA,10,89245776,na,na,Pathogenic,Wolman disease,GRCh38,single nucleotide variant
HPSE2,10,98482733,na,na,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|not provided,GRCh38,single nucleotide variant
HPSE2,10,98490103,na,na,Pathogenic,Urofacial syndrome type 1|not provided,GRCh38,single nucleotide variant
HPSE2,10,99144391,na,na,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|Congenital anomaly of kidney and urinary tract|not provided,GRCh38,single nucleotide variant
ASAH1,8,18061724,na,na,Pathogenic,Farber lipogranulomatosis,GRCh38,single nucleotide variant
ASAH1,8,18064501,na,na,Likely pathogenic,Farber lipogranulomatosis|not provided,GRCh38,single nucleotide variant
ASAH1,8,18075559,na,na,Pathogenic/Likely pathogenic,Farber lipogranulomatosis|not provided,GRCh38,single nucleotide variant
ASAH1,8,18059424,na,na,Pathogenic,Farber lipogranulomatosis,GRCh38,single nucleotide variant
ASAH1,8,18062383,na,na,Pathogenic,Farber lipogranulomatosis,GRCh38,single nucleotide variant
TCN2,22,30615623,na,na,Benign,TCN2 POLYMORPHISM|not specified|Transcobalamin II deficiency|not provided,GRCh38,single nucleotide variant
TCN2,22,30613044,na,na,Pathogenic,Transcobalamin II deficiency,GRCh38,single nucleotide variant
TCN2,22,30615125,na,na,Pathogenic,Transcobalamin II deficiency,GRCh38,single nucleotide variant
PCARE,2,29073503,na,na,Pathogenic,Retinitis pigmentosa 54,GRCh38,single nucleotide variant
PCARE,2,29073661,na,na,Uncertain significance,Retinitis pigmentosa 54|not provided,GRCh38,single nucleotide variant
PCARE,2,29073706,na,na,Pathogenic,Retinitis pigmentosa 54|Retinitis pigmentosa,GRCh38,single nucleotide variant
MIR2861,9,127785950,na,na,association,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,GRCh38,single nucleotide variant
TMEM127,2,96254117,na,na,Pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma",GRCh38,single nucleotide variant
TMEM127,2,96254050,na,na,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma",GRCh38,single nucleotide variant
TMEM127,2,96254998,na,na,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|not provided",GRCh38,single nucleotide variant
VIPAS39,14,77444311,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",GRCh38,single nucleotide variant
VIPAS39,14,77442636,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",GRCh38,single nucleotide variant
VIPAS39,14,77435885,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",GRCh38,single nucleotide variant
VIPAS39,14,77454101,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",GRCh38,single nucleotide variant
CBS,21,43062988,na,na,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder",GRCh38,single nucleotide variant
CBS,21,43066260,na,na,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",GRCh38,single nucleotide variant
CBS,21,43066353,na,na,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|Classic homocystinuria|CBS-related disorder|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
CBS,21,43063074,na,na,Pathogenic,"Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|not provided|Intellectual disability|Homocystinuria|Connective tissue disorder|See cases|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection",GRCh38,single nucleotide variant
CBS,21,43066279,na,na,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",GRCh38,single nucleotide variant
CBS,21,43066264,na,na,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|CBS-related disorder",GRCh38,single nucleotide variant
CBS,21,43059299,na,na,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",GRCh38,single nucleotide variant
CBS,21,43053920,na,na,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",GRCh38,single nucleotide variant
CBS,21,43063931,na,na,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
CBS,21,43058862,na,na,Pathogenic/Likely pathogenic,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
CBS,21,43065645,na,na,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria",GRCh38,single nucleotide variant
CBS,21,43058970,na,na,Pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
CBS,21,43058927,na,na,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria",GRCh38,single nucleotide variant
CBS,21,43058215,na,na,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified",GRCh38,single nucleotide variant
CBS,21,43060528,na,na,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
CBS,21,43065481,na,na,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|not provided|Homocystinuria|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder",GRCh38,single nucleotide variant
TPRN,9,137199473,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 79|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
SLC52A3,20,765564,na,na,Pathogenic,Brown-Vialetto-van Laere syndrome 1,GRCh38,single nucleotide variant
SLC52A3,20,765381,na,na,Uncertain significance,Brown-Vialetto-van Laere syndrome 1,GRCh38,single nucleotide variant
SLC52A3,20,763901,na,na,Pathogenic,Brown-Vialetto-van Laere syndrome 1,GRCh38,single nucleotide variant
SLC52A3,20,765669,na,na,Conflicting classifications of pathogenicity,Brown-Vialetto-van Laere syndrome 1|not provided|Progressive bulbar palsy of childhood,GRCh38,single nucleotide variant
SLC52A3,20,761198,na,na,Uncertain significance,Brown-Vialetto-van Laere syndrome 1|not specified,GRCh38,single nucleotide variant
SLC52A3,20,765693,na,na,Pathogenic,Brown-Vialetto-van Laere syndrome 1,GRCh38,single nucleotide variant
OAT,10,124412169,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124398076,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
OAT,10,124412009,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124408887,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124408601,na,na,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Hyperornithinemia,GRCh38,single nucleotide variant
OAT,10,124405545,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124403019,na,na,Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124403015,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124398057,na,na,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,GRCh38,single nucleotide variant
OAT,10,124398012,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124397951,na,na,Benign,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124400875,na,na,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Retinal dystrophy|not specified,GRCh38,single nucleotide variant
OAT,10,124403835,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124400865,na,na,Benign,Ornithine aminotransferase deficiency|not provided|not specified,GRCh38,single nucleotide variant
OAT,10,124401746,na,na,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124412010,na,na,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|not specified,GRCh38,single nucleotide variant
OAT,10,124401785,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124405534,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124403847,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,GRCh38,single nucleotide variant
OAT,10,124403820,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124400941,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided,GRCh38,single nucleotide variant
OAT,10,124398090,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124398082,na,na,Uncertain significance,Ornithine aminotransferase deficiency|not specified,GRCh38,single nucleotide variant
OAT,10,124398061,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124405457,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124402930,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
OAT,10,124397986,na,na,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,GRCh38,single nucleotide variant
OAT,10,124405551,na,na,Pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124403003,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124403892,na,na,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency|Hyperornithinemia,GRCh38,single nucleotide variant
OAT,10,124408897,na,na,Uncertain significance,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
OAT,10,124405488,na,na,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,GRCh38,single nucleotide variant
DPYS,8,104428071,na,na,Pathogenic,Dihydropyrimidinase deficiency|not provided,GRCh38,single nucleotide variant
DPYS,8,104392924,na,na,Pathogenic,Dihydropyrimidinase deficiency,GRCh38,single nucleotide variant
DPYS,8,104427994,na,na,Pathogenic/Likely pathogenic,Dihydropyrimidinase deficiency|not provided,GRCh38,single nucleotide variant
DPYS,8,104424247,na,na,Pathogenic,Dihydropyrimidinase deficiency,GRCh38,single nucleotide variant
SH3PXD2B,5,172422445,na,na,Likely pathogenic,Frank-Ter Haar syndrome,GRCh38,single nucleotide variant
SH3PXD2B,5,172422498,na,na,Pathogenic,Frank-Ter Haar syndrome,GRCh38,single nucleotide variant
GRXCR1,4,43020345,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 25|not provided,GRCh38,single nucleotide variant
GRXCR1,4,42963153,na,na,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,GRCh38,single nucleotide variant
GRXCR1,4,42893495,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 25|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
GRXCR1,4,42962919,na,na,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,GRCh38,single nucleotide variant
TMEM216,11,61393965,na,na,Pathogenic,"Joubert syndrome 2|Joubert syndrome|Inborn genetic diseases|TMEM216-related disorder|Meckel syndrome, type 2|not provided|Joubert syndrome 2;Meckel syndrome, type 2",GRCh38,single nucleotide variant
TMEM216,11,61393965,na,na,Pathogenic/Likely pathogenic,"Joubert syndrome 2|Meckel syndrome, type 2|Joubert syndrome|Joubert syndrome 2;Meckel syndrome, type 2",GRCh38,single nucleotide variant
TMEM216,11,61397885,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",GRCh38,single nucleotide variant
TMEM216,11,61397774,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",GRCh38,single nucleotide variant
USB1,16,58017332,na,na,Pathogenic,Poikiloderma with neutropenia,GRCh38,single nucleotide variant
USB1,16,58014325,na,na,Pathogenic,Poikiloderma with neutropenia,GRCh38,single nucleotide variant
KCNJ18,17,21703847,na,na,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",GRCh38,single nucleotide variant
KCNJ18,17,21703400,na,na,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",GRCh38,single nucleotide variant
KCNJ18,17,21703883,na,na,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",GRCh38,single nucleotide variant
PEPD,19,33401862,na,na,Pathogenic,Prolidase deficiency|not provided,GRCh38,single nucleotide variant
PEPD,19,33464060,na,na,Likely pathogenic,Prolidase deficiency|not provided,GRCh38,single nucleotide variant
PEPD,19,33401855,na,na,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,GRCh38,single nucleotide variant
PEPD,19,33387892,na,na,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,GRCh38,single nucleotide variant
PEPD,19,33411697,na,na,Pathogenic,Prolidase deficiency|not provided,GRCh38,single nucleotide variant
PEPD,19,33388000,na,na,Pathogenic,Prolidase deficiency,GRCh38,single nucleotide variant
PEPD,19,33464006,na,na,Pathogenic,Prolidase deficiency,GRCh38,single nucleotide variant
AGA,4,177438764,na,na,Pathogenic,"Aspartylglucosaminuria, finnish type|Aspartylglucosaminuria",GRCh38,single nucleotide variant
AGA,4,177433250,na,na,Pathogenic,Aspartylglucosaminuria,GRCh38,single nucleotide variant
AGA,4,177433238,na,na,Likely pathogenic,Aspartylglucosaminuria,GRCh38,single nucleotide variant
AGA,4,177440375,na,na,Likely pathogenic,Aspartylglucosaminuria,GRCh38,single nucleotide variant
AGA,4,177439668,na,na,Pathogenic/Likely pathogenic,Aspartylglucosaminuria|not provided|Autism,GRCh38,single nucleotide variant
AGA,4,177433213,na,na,Pathogenic,Aspartylglucosaminuria,GRCh38,single nucleotide variant
AGA,4,177440340,na,na,Pathogenic,Aspartylglucosaminuria,GRCh38,single nucleotide variant
CYB5A,18,74263479,na,na,Pathogenic,Methemoglobinemia type 4,GRCh38,single nucleotide variant
WDR72,15,53615858,na,na,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3,GRCh38,single nucleotide variant
WDR72,15,53609531,na,na,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3|not provided,GRCh38,single nucleotide variant
CYB5R3,22,42628233,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",GRCh38,single nucleotide variant
CYB5R3,22,42631431,na,na,Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|CYB5R3-related disorder",GRCh38,single nucleotide variant
CYB5R3,22,42628169,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",GRCh38,single nucleotide variant
CYB5R3,22,42630899,na,na,Uncertain significance,"METHEMOGLOBINEMIA, TYPE I|not provided",GRCh38,single nucleotide variant
CYB5R3,22,42619946,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",GRCh38,single nucleotide variant
CYB5R3,22,42628144,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",GRCh38,single nucleotide variant
CYB5R3,22,42623867,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",GRCh38,single nucleotide variant
CYB5R3,22,42627327,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",GRCh38,single nucleotide variant
CYB5R3,22,42628265,na,na,Benign,CYB5R3 POLYMORPHISM|not provided|not specified,GRCh38,single nucleotide variant
CYB5R3,22,42627690,na,na,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE II|Deficiency of cytochrome-b5 reductase|not provided",GRCh38,single nucleotide variant
CYB5R3,22,42631386,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",GRCh38,single nucleotide variant
CYB5R3,22,42630986,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided",GRCh38,single nucleotide variant
CYB5R3,22,42627674,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided|Deficiency of cytochrome-b5 reductase",GRCh38,single nucleotide variant
CYB5R3,22,42627326,na,na,Pathogenic,"METHEMOGLOBINEMIA, TYPE I|Hereditary methemoglobinemia",GRCh38,single nucleotide variant
CYB5R3,22,42619804,na,na,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|Deficiency of cytochrome-b5 reductase",GRCh38,single nucleotide variant
CYB5R3,22,42623803,na,na,Conflicting classifications of pathogenicity,"METHEMOGLOBINEMIA, TYPE I|Deficiency of cytochrome-b5 reductase|not provided",GRCh38,single nucleotide variant
XPC,3,14158882,na,na,Benign/Likely benign,"Xeroderma pigmentosum, group C|not specified|not provided|Xeroderma pigmentosum|XPC-related disorder",GRCh38,single nucleotide variant
XPC,3,14156333,na,na,Pathogenic,"Xeroderma pigmentosum, group C",GRCh38,single nucleotide variant
XPC,3,14158148,na,na,Pathogenic,"Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided",GRCh38,single nucleotide variant
XPC,3,14168389,na,na,Pathogenic,"Xeroderma pigmentosum, group C",GRCh38,single nucleotide variant
XPC,3,14168404,na,na,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group C|not provided",GRCh38,single nucleotide variant
DNAAF1,16,84159744,na,na,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
DNAAF1,16,84159725,na,na,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
DNAAF1,16,84154748,na,na,Pathogenic,Primary ciliary dyskinesia 13|Kartagener syndrome,GRCh38,single nucleotide variant
RBM20,10,110812310,na,na,Pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1A|RBM20-related disorder,GRCh38,single nucleotide variant
RBM20,10,110812298,na,na,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
RBM20,10,110812303,na,na,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Cardiovascular phenotype|Primary familial dilated cardiomyopathy|not provided|Primary dilated cardiomyopathy,GRCh38,single nucleotide variant
RBM20,10,110812304,na,na,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|not provided|Primary familial dilated cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|RBM20-related disorder,GRCh38,single nucleotide variant
RBM20,10,110812306,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
KLHDC8B,3,49171662,na,na,Likely benign,Classic Hodgkin lymphoma|not provided,GRCh38,single nucleotide variant
SERPINF2,17,1754289,na,na,Pathogenic,Alpha-2-plasmin inhibitor deficiency,GRCh38,single nucleotide variant
CANT1,17,78993858,na,na,Pathogenic/Likely pathogenic,Desbuquois dysplasia 1|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
CANT1,17,78993857,na,na,Likely pathogenic,Desbuquois dysplasia 1,GRCh38,single nucleotide variant
CANT1,17,78997249,na,na,Conflicting classifications of pathogenicity,"Desbuquois dysplasia 1|Desbuquois dysplasia 1;Epiphyseal dysplasia, multiple, 7",GRCh38,single nucleotide variant
CANT1,17,78993860,na,na,Likely pathogenic,Desbuquois dysplasia 1|CANT1-related disorder,GRCh38,single nucleotide variant
VWF,12,6018535,na,na,Pathogenic,Von Willebrand disease type 2A|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|VWF-related disorder|von Willebrand disorder,GRCh38,single nucleotide variant
VWF,12,6018629,na,na,Pathogenic,Von Willebrand disease type 2A|not provided|not specified|Hereditary von Willebrand disease|Inborn genetic diseases|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6018598,na,na,Likely pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6019479,na,na,Pathogenic,Von Willebrand disease type 2B|not provided,GRCh38,single nucleotide variant
VWF,12,6019502,na,na,Pathogenic,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|Abnormality of coagulation|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3,GRCh38,single nucleotide variant
VWF,12,6019496,na,na,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease,GRCh38,single nucleotide variant
VWF,12,6019472,na,na,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3,GRCh38,single nucleotide variant
VWF,12,6019396,na,na,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease|VWF-related disorder,GRCh38,single nucleotide variant
VWF,12,6018581,na,na,Uncertain significance,Von Willebrand disease type 2A|not provided,GRCh38,single nucleotide variant
VWF,12,6019222,na,na,Uncertain significance,Abnormality of coagulation|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1|VWF-related disorder|not specified|von Willebrand disease type 2|von Willebrand disease type 1;von Willebrand disease type 3,GRCh38,single nucleotide variant
VWF,12,6044361,na,na,Pathogenic,von Willebrand disease type 2N|not provided|Abnormal bleeding|Hereditary von Willebrand disease|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6036488,na,na,Pathogenic,von Willebrand disease type 2N|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1;von Willebrand disease type 3;von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6034812,na,na,Pathogenic,von Willebrand disease type 2N|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3|von Willebrand disease type 2|von Willebrand disease type 3|Abnormality of coagulation|VWF-related disorder|Abnormal bleeding;Thrombocytopenia|von Willebrand disorder,GRCh38,single nucleotide variant
VWF,12,6018443,na,na,Pathogenic,von Willebrand disease type 3|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|VWF-related disorder,GRCh38,single nucleotide variant
VWF,12,6013544,na,na,Pathogenic,von Willebrand disease type 1|von Willebrand disease type 3|not provided|Abnormality of blood and blood-forming tissues|Hereditary von Willebrand disease|VWF-related disorder|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,5969337,na,na,Pathogenic,von Willebrand disease type 3|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1|von Willebrand disorder,GRCh38,single nucleotide variant
VWF,12,6019448,na,na,Pathogenic,von Willebrand disease type 2M|not provided|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6019604,na,na,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,GRCh38,single nucleotide variant
VWF,12,6019478,na,na,Pathogenic,Von Willebrand disease type 2B|not provided,GRCh38,single nucleotide variant
VWF,12,6018877,na,na,Pathogenic,Von Willebrand disease type 2A|not provided,GRCh38,single nucleotide variant
VWF,12,6057930,na,na,Pathogenic,Von Willebrand disease type 2A|not provided,GRCh38,single nucleotide variant
VWF,12,5949140,na,na,Pathogenic,Von Willebrand disease type 2A|not provided,GRCh38,single nucleotide variant
VWF,12,6021960,na,na,Pathogenic,von Willebrand disease type 1|von Willebrand factor Vicenza|not provided|Reduced quantity of Von Willebrand factor;Reduced von Willebrand factor activity|Hereditary von Willebrand disease|VWF-related disorder,GRCh38,single nucleotide variant
VWF,12,6022833,na,na,Pathogenic,von Willebrand disease type 1|not provided|von Willebrand disease type 2|Von Willebrand disease type 2A,GRCh38,single nucleotide variant
VWF,12,6018667,na,na,Conflicting classifications of pathogenicity; risk factor,|not provided|Inborn genetic diseases|von Willebrand disease type 1|Thrombocytopenia|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3|Thrombus|VWF-related disorder|von Willebrand disorder,GRCh38,single nucleotide variant
VWF,12,6019564,na,na,Likely pathogenic,von Willebrand disease type 2M|not provided,GRCh38,single nucleotide variant
VWF,12,6044349,na,na,Pathogenic,von Willebrand disease type 2N|not provided,GRCh38,single nucleotide variant
VWF,12,6044322,na,na,Likely pathogenic,von Willebrand disease type 2N|not provided,GRCh38,single nucleotide variant
VWF,12,6019621,na,na,Conflicting classifications of pathogenicity,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 1|Thrombocytopenia|VWF-related disorder|von Willebrand disease type 1;von Willebrand disease type 3,GRCh38,single nucleotide variant
VWF,12,5981988,na,na,Pathogenic,von Willebrand disease type 3|not provided,GRCh38,single nucleotide variant
VWF,12,6072369,na,na,Pathogenic,von Willebrand disease type 2N|not provided,GRCh38,single nucleotide variant
VWF,12,6025624,na,na,Pathogenic,von Willebrand disease type 2N|not provided,GRCh38,single nucleotide variant
VWF,12,6057995,na,na,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,GRCh38,single nucleotide variant
TSPAN12,7,120788801,na,na,Pathogenic,Exudative vitreoretinopathy 5,GRCh38,single nucleotide variant
TSPAN12,7,120806599,na,na,Uncertain significance,Exudative vitreoretinopathy 5|not provided,GRCh38,single nucleotide variant
TSPAN12,7,120810512,na,na,Pathogenic,Exudative vitreoretinopathy 5,GRCh38,single nucleotide variant
TSPAN12,7,120815787,na,na,Uncertain significance,Exudative vitreoretinopathy 5|not provided,GRCh38,single nucleotide variant
NEXN,1,77942756,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1CC|Dilated cardiomyopathy 1S|not provided|Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC|Cardiovascular phenotype|Primary dilated cardiomyopathy|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy 20,GRCh38,single nucleotide variant
NEXN,1,77942632,na,na,Uncertain significance,Dilated cardiomyopathy 1CC|Cardiovascular phenotype,GRCh38,single nucleotide variant
RETREG1,5,16477736,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",GRCh38,single nucleotide variant
RETREG1,5,16565788,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",GRCh38,single nucleotide variant
NF1,17,31334883,na,na,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31334933,na,na,Pathogenic,"Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31258500,na,na,Pathogenic,"Neurofibromatosis, type 1|Neurofibroma;Cafe au lait spots, multiple;Optic nerve glioma;Axillary freckling|not provided|Neurofibromatosis, type 1;Juvenile myelomonocytic leukemia;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Pheochromocytoma|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype|Café-au-lait macules with pulmonary stenosis",GRCh38,single nucleotide variant
NF1,17,31337430,na,na,Pathogenic,"Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31337514,na,na,Pathogenic,"Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31334927,na,na,Pathogenic,"Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Juvenile myelomonocytic leukemia;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal|not provided|Neurofibromatosis, type 1;Tibial pseudarthrosis|Juvenile myelomonocytic leukemia|NF1-related disorder|Neurofibromatosis-Noonan syndrome|Neoplasm|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31249093,na,na,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Juvenile myelomonocytic leukemia;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal",GRCh38,single nucleotide variant
NF1,17,31230383,na,na,Pathogenic,"Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1;Tibial pseudarthrosis|Hereditary cancer-predisposing syndrome|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype|NF1-related disorder",GRCh38,single nucleotide variant
NF1,17,31230373,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
NF1,17,31258406,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31261810,na,na,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
NF1,17,31221842,na,na,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31235729,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31214524,na,na,Pathogenic,"Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Tibial pseudarthrosis|not provided|Rhabdomyosarcoma|Abnormality of the skin|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1;Juvenile myelomonocytic leukemia;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal|NF1-related disorder|Neurofibromatosis-Noonan syndrome",GRCh38,single nucleotide variant
NF1,17,31214581,na,na,Pathogenic,"Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31201486,na,na,Pathogenic,"Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
NF1,17,31249030,na,na,Pathogenic,"Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
NF1,17,31336750,na,na,Uncertain significance,"Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31336328,na,na,Pathogenic,"Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|not provided|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype|Juvenile myelomonocytic leukemia",GRCh38,single nucleotide variant
NF1,17,31235623,na,na,Pathogenic,"Neurofibromatosis, type 1|Inborn genetic diseases|not provided|Juvenile myelomonocytic leukemia|NF1-related disorder|Neoplasm",GRCh38,single nucleotide variant
NF1,17,31201044,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1;Juvenile myelomonocytic leukemia;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal|not provided",GRCh38,single nucleotide variant
NF1,17,31343138,na,na,Likely pathogenic,"Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome;Cardiovascular phenotype",GRCh38,single nucleotide variant
NF1,17,31235630,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
NF1,17,31330459,na,na,Pathogenic,"Neurofibromatosis, type 1|Neoplasm",GRCh38,single nucleotide variant
NF1,17,31229146,na,na,Pathogenic,"Neurofibromatosis, type 1",GRCh38,single nucleotide variant
NF1,17,31261858,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",GRCh38,single nucleotide variant
CTSA,20,45898068,na,na,Likely pathogenic,"Galactosialidosis, late infantile|Combined deficiency of sialidase AND beta galactosidase|not provided",GRCh38,single nucleotide variant
CTSA,20,45893314,na,na,Pathogenic,"Galactosialidosis, adult|Combined deficiency of sialidase AND beta galactosidase",GRCh38,single nucleotide variant
CTSA,20,45891714,na,na,Pathogenic/Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,GRCh38,single nucleotide variant
CTSA,20,45891761,na,na,Pathogenic,Combined deficiency of sialidase AND beta galactosidase,GRCh38,single nucleotide variant
CTSA,20,45891990,na,na,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,GRCh38,single nucleotide variant
CTSA,20,45897736,na,na,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase|not provided,GRCh38,single nucleotide variant
CTSA,20,45894040,na,na,Pathogenic,"Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, late infantile",GRCh38,single nucleotide variant
CTSA,20,45892434,na,na,Uncertain significance,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",GRCh38,single nucleotide variant
CTSA,20,45894002,na,na,Pathogenic,"Galactosialidosis, early infantile",GRCh38,single nucleotide variant
CTSA,20,45898065,na,na,Conflicting classifications of pathogenicity,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",GRCh38,single nucleotide variant
CTSA,20,45897769,na,na,Pathogenic,"Galactosialidosis, late infantile",GRCh38,single nucleotide variant
CTSA,20,45898107,na,na,Pathogenic,"Galactosialidosis, late infantile",GRCh38,single nucleotide variant
CTSA,20,45894081,na,na,Pathogenic,"Galactosialidosis, late infantile",GRCh38,single nucleotide variant
GM2A,5,151266899,na,na,Pathogenic,"Tay-Sachs disease, variant AB",GRCh38,single nucleotide variant
GM2A,5,151267375,na,na,Pathogenic,"Tay-Sachs disease, variant AB",GRCh38,single nucleotide variant
GM2A,5,151259833,na,na,Pathogenic,"Tay-Sachs disease, variant AB",GRCh38,single nucleotide variant
LOXHD1,18,46572125,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 77|not provided|LOXHD1-related disorder,GRCh38,single nucleotide variant
INPP5E,9,136429731,na,na,Pathogenic,MORM syndrome|MORM syndrome;Joubert syndrome 1,GRCh38,single nucleotide variant
INPP5E,9,136431830,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Joubert syndrome 1;MORM syndrome,GRCh38,single nucleotide variant
INPP5E,9,136430391,na,na,Likely pathogenic,Joubert syndrome 1|Joubert syndrome and related disorders,GRCh38,single nucleotide variant
INPP5E,9,136432562,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Retinal dystrophy|not provided|INPP5E-related disorder|not specified|Joubert syndrome 1;MORM syndrome,GRCh38,single nucleotide variant
INPP5E,9,136433182,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|16 conditions|not provided|Inborn genetic diseases|Joubert syndrome and related disorders|INPP5E-related disorder|Joubert syndrome 1;MORM syndrome,GRCh38,single nucleotide variant
SDHAF2,11,61437820,na,na,Pathogenic,Paragangliomas 2|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma,GRCh38,single nucleotide variant
TAT,16,71576247,na,na,Pathogenic,Tyrosinemia type II|not provided,GRCh38,single nucleotide variant
TAT,16,71572224,na,na,Pathogenic,Tyrosinemia type II,GRCh38,single nucleotide variant
TAT,16,71568260,na,na,Pathogenic,Tyrosinemia type II,GRCh38,single nucleotide variant
TAT,16,71569894,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
TAT,16,71576031,na,na,Pathogenic,Tyrosinemia type II,GRCh38,single nucleotide variant
UROC1,3,126498141,na,na,Pathogenic,Urocanate hydratase deficiency,GRCh38,single nucleotide variant
UROC1,3,126510712,na,na,Pathogenic,Urocanate hydratase deficiency,GRCh38,single nucleotide variant
TMEM126A,11,85654139,na,na,Pathogenic,"Autosomal recessive optic atrophy, OPA7 type|not provided|TMEM126A-related disorder",GRCh38,single nucleotide variant
RNASET2,6,166931061,na,na,Pathogenic,Cystic leukoencephalopathy without megalencephaly,GRCh38,single nucleotide variant
RNASET2,6,166943091,na,na,Pathogenic,Cystic leukoencephalopathy without megalencephaly,GRCh38,single nucleotide variant
RNASET2,6,166931044,na,na,Uncertain significance,Cystic leukoencephalopathy without megalencephaly,GRCh38,single nucleotide variant
PGAM2,7,44065297,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease type X|not provided|PGAM2-related disorder,GRCh38,single nucleotide variant
PGAM2,7,44065264,na,na,Conflicting classifications of pathogenicity,Glycogen storage disease type X,GRCh38,single nucleotide variant
PGAM2,7,44065262,na,na,Uncertain significance,Glycogen storage disease type X|not provided,GRCh38,single nucleotide variant
PGAM2,7,44065240,na,na,Conflicting classifications of pathogenicity,Glycogen storage disease type X|not provided,GRCh38,single nucleotide variant
NDUFAF3,3,49022497,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",GRCh38,single nucleotide variant
NDUFAF3,3,49022903,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",GRCh38,single nucleotide variant
NDUFAF3,3,49022146,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18|not provided",GRCh38,single nucleotide variant
TUBB1,20,59024379,na,na,Conflicting classifications of pathogenicity,"Macrothrombocytopenia, isolated, 1, autosomal dominant|Macrothrombocytopenia|not provided",GRCh38,single nucleotide variant
TUBB2B,6,3225575,na,na,Pathogenic,Complex cortical dysplasia with other brain malformations 7,GRCh38,single nucleotide variant
TUBB2B,6,3225406,na,na,Pathogenic,Complex cortical dysplasia with other brain malformations 7,GRCh38,single nucleotide variant
TUBB2B,6,3225296,na,na,Pathogenic,Complex cortical dysplasia with other brain malformations 7,GRCh38,single nucleotide variant
SDHAF1,19,35995443,na,na,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",GRCh38,single nucleotide variant
SDHAF1,19,35995438,na,na,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",GRCh38,single nucleotide variant
COQ9,16,57459583,na,na,Pathogenic,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome|not provided,GRCh38,single nucleotide variant
DPYD,1,97450058,na,na,drug response,"Dihydropyrimidine dehydrogenase deficiency|Fluorouracil response|not provided|Hirschsprung disease, susceptibility to, 1|tegafur response - Toxicity|fluorouracil response - Toxicity|fluorouracil response - Other|capecitabine response - Toxicity|Inborn genetic diseases|DPYD-related disorder",GRCh38,single nucleotide variant
DPYD,1,97079133,na,na,Pathogenic,Fluorouracil response,GRCh38,single nucleotide variant
DPYD,1,97883329,na,na,drug response,Dihydropyrimidine dehydrogenase deficiency|fluorouracil response - Toxicity|not provided|capecitabine response - Toxicity|not specified,GRCh38,single nucleotide variant
DPYD,1,97098598,na,na,Uncertain significance,Dihydropyrimidine dehydrogenase deficiency|not specified,GRCh38,single nucleotide variant
BCAM,19,44812188,na,na,Benign,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)|not provided,GRCh38,single nucleotide variant
BCAM,19,44819487,na,na,Benign,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b)|LuLu phenotype;BLOOD GROUP--LUTHERAN SYSTEM|BCAM-related disorder|not provided,GRCh38,single nucleotide variant
BCAM,19,44813527,na,na,Pathogenic,BLOOD GROUP--LUTHERAN NULL,GRCh38,single nucleotide variant
BCAM,19,44813547,na,na,Pathogenic,BLOOD GROUP--LUTHERAN NULL,GRCh38,single nucleotide variant
BCAM,19,44812319,na,na,Pathogenic,BLOOD GROUP--LUTHERAN NULL,GRCh38,single nucleotide variant
DUOXA2,15,45117274,na,na,Pathogenic/Likely pathogenic,Thyroglobulin synthesis defect|Inborn genetic diseases|Familial thyroid dyshormonogenesis,GRCh38,single nucleotide variant
CCBE1,18,59480228,na,na,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,GRCh38,single nucleotide variant
CCBE1,18,59469568,na,na,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,GRCh38,single nucleotide variant
CCBE1,18,59438119,na,na,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,GRCh38,single nucleotide variant
CCBE1,18,59466820,na,na,Conflicting classifications of pathogenicity,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided|not specified|CCBE1-related disorder,GRCh38,single nucleotide variant
CCBE1,18,59466772,na,na,Likely pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,GRCh38,single nucleotide variant
CPOX,3,98585622,na,na,Uncertain significance,Coproporphyria|Hereditary coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98581407,na,na,Pathogenic,Coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98581474,na,na,Pathogenic/Likely pathogenic,Harderoporphyria|not provided|Harderoporphyria;Hereditary coproporphyria|CPOX-related hereditary coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98588783,na,na,Pathogenic,Coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98581404,na,na,Uncertain significance,Harderoporphyria|not provided,GRCh38,single nucleotide variant
CPOX,3,98593420,na,na,Pathogenic,Coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98580709,na,na,Conflicting classifications of pathogenicity,Coproporphyria|Hereditary coproporphyria|not provided,GRCh38,single nucleotide variant
CPOX,3,98591089,na,na,Pathogenic,Coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98585631,na,na,Pathogenic,Coproporphyria,GRCh38,single nucleotide variant
CPOX,3,98588831,na,na,Pathogenic,-,GRCh38,single nucleotide variant
ALDOB,9,101427574,na,na,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
ALDOB,9,101427498,na,na,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|Inborn genetic diseases|See cases|ALDOB-related disorder,GRCh38,single nucleotide variant
ALDOB,9,101425532,na,na,Pathogenic/Likely pathogenic,Hereditary fructosuria,GRCh38,single nucleotide variant
ALDOB,9,101421899,na,na,Pathogenic,Hereditary fructosuria|not provided|ALDOB-related disorder,GRCh38,single nucleotide variant
ALDOB,9,101430878,na,na,Pathogenic/Likely pathogenic,Hereditary fructosuria,GRCh38,single nucleotide variant
ALDOB,9,101429901,na,na,Pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
ALDOB,9,101425628,na,na,Pathogenic/Likely pathogenic,Hereditary fructosuria,GRCh38,single nucleotide variant
ALDOB,9,101427580,na,na,Uncertain significance,Hereditary fructosuria|not specified,GRCh38,single nucleotide variant
PTS,11,112226517,na,na,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,GRCh38,single nucleotide variant
PTS,11,112226489,na,na,Likely pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency",GRCh38,single nucleotide variant
PTS,11,112228665,na,na,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided|PTS-related disorder,GRCh38,single nucleotide variant
PTS,11,112233178,na,na,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency|GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided,GRCh38,single nucleotide variant
PTS,11,112230210,na,na,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,GRCh38,single nucleotide variant
PTS,11,112228649,na,na,Pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",GRCh38,single nucleotide variant
PTS,11,112233464,na,na,Conflicting classifications of pathogenicity,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|not specified|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency",GRCh38,single nucleotide variant
PTS,11,112233205,na,na,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,GRCh38,single nucleotide variant
PTS,11,112228271,na,na,Uncertain significance,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided,GRCh38,single nucleotide variant
QDPR,4,17511987,na,na,Pathogenic/Likely pathogenic,Dihydropteridine reductase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,GRCh38,single nucleotide variant
QDPR,4,17501833,na,na,Pathogenic,Dihydropteridine reductase deficiency,GRCh38,single nucleotide variant
QDPR,4,17509363,na,na,Pathogenic,Dihydropteridine reductase deficiency,GRCh38,single nucleotide variant
QDPR,4,17492769,na,na,Pathogenic,Dihydropteridine reductase deficiency,GRCh38,single nucleotide variant
QDPR,4,17492328,na,na,Pathogenic,Dihydropteridine reductase deficiency|not provided,GRCh38,single nucleotide variant
QDPR,4,17504404,na,na,Pathogenic,Dihydropteridine reductase deficiency,GRCh38,single nucleotide variant
RFX6,6,116877954,na,na,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,GRCh38,single nucleotide variant
RFX6,6,116877784,na,na,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|Diabetes mellitus,GRCh38,single nucleotide variant
RFX6,6,116895209,na,na,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,GRCh38,single nucleotide variant
RFX6,6,116895184,na,na,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,GRCh38,single nucleotide variant
RFX6,6,116882404,na,na,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|RFX6-related disorder,GRCh38,single nucleotide variant
RSPH4A,6,116617083,na,na,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia|Respiratory ciliopathies including non-CF bronchiectasis,GRCh38,single nucleotide variant
RSPH4A,6,116616948,na,na,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
RSPH4A,6,116628175,na,na,Pathogenic/Likely pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
ANK1,8,41672445,na,na,Pathogenic,Hereditary spherocytosis type 1,GRCh38,single nucleotide variant
ANK1,8,41797646,na,na,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not specified|not provided",GRCh38,single nucleotide variant
ANK1,8,41668498,na,na,Pathogenic,Hereditary spherocytosis type 1|not provided,GRCh38,single nucleotide variant
ANK1,8,41661923,na,na,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 1|not provided|ANK1-related disorder,GRCh38,single nucleotide variant
ANK1,8,41797691,na,na,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|not provided",GRCh38,single nucleotide variant
ANK1,8,41708992,na,na,Pathogenic/Likely pathogenic,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not provided",GRCh38,single nucleotide variant
FBN2,5,128335544,na,na,Likely pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128395182,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128328823,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128335592,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128334870,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128344385,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128338980,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
FBN2,5,128335543,na,na,Pathogenic,Congenital contractural arachnodactyly,GRCh38,single nucleotide variant
DNAAF2,14,49635127,na,na,Pathogenic,Primary ciliary dyskinesia 10|Kartagener syndrome,GRCh38,single nucleotide variant
DCAF17,2,171480198,na,na,Pathogenic,Woodhouse-Sakati syndrome,GRCh38,single nucleotide variant
DCAF17,2,171473981,na,na,Pathogenic,Woodhouse-Sakati syndrome,GRCh38,single nucleotide variant
EYS,6,64436244,na,na,Pathogenic,Retinitis pigmentosa 25|not provided,GRCh38,single nucleotide variant
EYS,6,63720626,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 25|not provided|Retinal dystrophy|Retinitis pigmentosa|EYS-related disorder,GRCh38,single nucleotide variant
TMEM70,8,73981153,na,na,Pathogenic/Likely pathogenic,Mitochondrial complex V (ATP synthase) deficiency nuclear type 2|not provided|See cases|TMEM70-related disorder|Neurodevelopmental disorder,GRCh38,single nucleotide variant
LRTOMT,11,72106094,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63|Rare genetic deafness,GRCh38,single nucleotide variant
LRTOMT,11,72106165,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,GRCh38,single nucleotide variant
LRTOMT,11,72106180,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,GRCh38,single nucleotide variant
LRTOMT,11,72106185,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,GRCh38,single nucleotide variant
NDUFAF6,8,95032093,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 17",GRCh38,single nucleotide variant
FECH,18,57580104,na,na,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not specified|not provided",GRCh38,single nucleotide variant
FECH,18,57559148,na,na,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided",GRCh38,single nucleotide variant
FECH,18,57580222,na,na,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided|Jaundice;Erythema|not specified",GRCh38,single nucleotide variant
FECH,18,57550734,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1",GRCh38,single nucleotide variant
FECH,18,57554259,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1",GRCh38,single nucleotide variant
FECH,18,57551312,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",GRCh38,single nucleotide variant
FECH,18,57551367,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1",GRCh38,single nucleotide variant
FECH,18,57573244,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",GRCh38,single nucleotide variant
FECH,18,57573240,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1",GRCh38,single nucleotide variant
FECH,18,57551317,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",GRCh38,single nucleotide variant
FECH,18,57580062,na,na,Pathogenic,"Protoporphyria, erythropoietic, 1",GRCh38,single nucleotide variant
FECH,18,57550760,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
FECH,18,57571588,na,na,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|Jaundice;Erythema|not provided|Autosomal erythropoietic protoporphyria|not specified",GRCh38,single nucleotide variant
SLC29A3,10,71362459,na,na,Pathogenic,H syndrome|not provided,GRCh38,single nucleotide variant
SLC29A3,10,71362510,na,na,Pathogenic/Likely pathogenic,H syndrome|not provided,GRCh38,single nucleotide variant
SLC29A3,10,71362489,na,na,Pathogenic,H syndrome|not provided,GRCh38,single nucleotide variant
SLC29A3,10,71344255,na,na,Likely pathogenic,H syndrome,GRCh38,single nucleotide variant
SLC29A3,10,71362526,na,na,Pathogenic,H syndrome|SLC29A3-related disorder,GRCh38,single nucleotide variant
NDUFAF5,20,13801652,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16|not provided|Mitochondrial complex I deficiency",GRCh38,single nucleotide variant
NDUFAF5,20,13794939,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16",GRCh38,single nucleotide variant
KNG1,3,186727258,na,na,Pathogenic,"KININOGEN DEFICIENCY, TOTAL|High molecular weight kininogen deficiency",GRCh38,single nucleotide variant
PAH,12,102840399,na,na,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|Pituitary hormone deficiency, combined, 2|PAH-related disorder",GRCh38,single nucleotide variant
PAH,12,102840493,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Inborn genetic diseases|See cases,GRCh38,single nucleotide variant
PAH,12,102846932,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102844424,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852819,na,na,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder|Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis",GRCh38,single nucleotide variant
PAH,12,102894756,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852875,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102894826,na,na,Pathogenic/Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102852903,na,na,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1|See cases",GRCh38,single nucleotide variant
PAH,12,102917130,na,na,Pathogenic,Phenylketonuria|Hyperphenylalaninemia|not provided,GRCh38,single nucleotide variant
PAH,12,102866632,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102852930,na,na,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|Hyperphenylalaninemia|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102852815,na,na,Likely pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102855231,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852929,na,na,Pathogenic/Likely pathogenic,Phenylketonuria|Inborn genetic diseases|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102840477,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102840474,na,na,Pathogenic,Hyperphenylalaninemia|Phenylketonuria|not provided|See cases|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102866664,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102843777,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852843,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102852839,na,na,Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852814,na,na,Pathogenic,Phenylketonuria|not provided|Hyperphenylalaninemia,GRCh38,single nucleotide variant
PAH,12,102852893,na,na,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102843648,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852881,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852828,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102912842,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
PAH,12,102843790,na,na,Pathogenic,Phenylketonuria|not provided|Hyperphenylalaninemia|Inborn genetic diseases,GRCh38,single nucleotide variant
PAH,12,102912816,na,na,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102855180,na,na,Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852876,na,na,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1",GRCh38,single nucleotide variant
PAH,12,102840492,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Hyperphenylalaninemia,GRCh38,single nucleotide variant
PAH,12,102851703,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102852813,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102844356,na,na,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102846899,na,na,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|See cases,GRCh38,single nucleotide variant
PAH,12,102840472,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102846948,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,GRCh38,single nucleotide variant
PAH,12,102843683,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102852926,na,na,Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102917128,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102843782,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102844404,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,GRCh38,single nucleotide variant
PAH,12,102843676,na,na,Pathogenic,Phenylketonuria|Hyperphenylalaninemia|not provided|PAH-related disorder|Mild hyperphenylalaninemia,GRCh38,single nucleotide variant
PAH,12,102843769,na,na,Pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102894794,na,na,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|PAH-related disorder|not specified,GRCh38,single nucleotide variant
PAH,12,102843706,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Marfanoid habitus and intellectual disability|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Inborn genetic diseases|PAH-related disorder,GRCh38,single nucleotide variant
PAH,12,102912823,na,na,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
PAH,12,102912819,na,na,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,GRCh38,single nucleotide variant
PAH,12,102855315,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Inborn genetic diseases|See cases,GRCh38,single nucleotide variant
PAH,12,102852923,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases,GRCh38,single nucleotide variant
PAH,12,102844333,na,na,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,GRCh38,single nucleotide variant
PAH,12,102840495,na,na,Likely pathogenic,Phenylketonuria|not provided,GRCh38,single nucleotide variant
PAH,12,102894893,na,na,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|See cases|Inborn genetic diseases,GRCh38,single nucleotide variant
PAH,12,102894860,na,na,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,GRCh38,single nucleotide variant
CILK1,6,53016099,na,na,Pathogenic,Endocrine-cerebro-osteodysplasia syndrome,GRCh38,single nucleotide variant
FASTKD2,2,206774264,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Combined oxidative phosphorylation deficiency 44",GRCh38,single nucleotide variant
F5,1,169549811,na,na,drug response,"Budd-Chiari syndrome, susceptibility to|Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 1|Factor V deficiency|Thrombophilia due to activated protein C resistance|not specified|Inborn genetic diseases|Factor V deficiency;Thrombophilia due to activated protein C resistance|hormonal contraceptives for systemic use response - Toxicity|Congenital factor V deficiency|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|Budd-Chiari syndrome;Congenital factor V deficiency;Ischemic stroke;Pregnancy loss, recurrent, susceptibility to, 1;Thrombophilia due to activated protein C resistance|not provided",GRCh38,single nucleotide variant
F5,1,169555300,na,na,Conflicting classifications of pathogenicity,Factor V Hong Kong|not provided|Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,GRCh38,single nucleotide variant
F5,1,169555299,na,na,Conflicting classifications of pathogenicity,Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,GRCh38,single nucleotide variant
F5,1,169560701,na,na,Pathogenic,Thrombophilia due to activated protein C resistance,GRCh38,single nucleotide variant
F5,1,169530805,na,na,Pathogenic/Likely pathogenic,Factor V deficiency|Congenital factor V deficiency|not provided,GRCh38,single nucleotide variant
F5,1,169542689,na,na,Pathogenic,Factor V deficiency,GRCh38,single nucleotide variant
F5,1,169541609,na,na,Pathogenic,Factor V deficiency,GRCh38,single nucleotide variant
F5,1,169518453,na,na,Likely pathogenic,Factor V deficiency,GRCh38,single nucleotide variant
F5,1,169552693,na,na,Pathogenic,Thrombophilia due to activated protein C resistance,GRCh38,single nucleotide variant
PROC,2,127428602,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",GRCh38,single nucleotide variant
PROC,2,127428892,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127426180,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|not provided",GRCh38,single nucleotide variant
PROC,2,127428462,na,na,Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|not provided",GRCh38,single nucleotide variant
PROC,2,127426178,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127428485,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|Hereditary thrombophilia due to congenital protein C deficiency",GRCh38,single nucleotide variant
PROC,2,127428587,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",GRCh38,single nucleotide variant
PROC,2,127421397,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|PROC-related disorder|not provided",GRCh38,single nucleotide variant
PROC,2,127421438,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Abnormal thrombosis|Cerebral palsy|PROC-related disorder",GRCh38,single nucleotide variant
PROC,2,127428560,na,na,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|PROC-related disorder",GRCh38,single nucleotide variant
PROC,2,127428426,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",GRCh38,single nucleotide variant
PROC,2,127426207,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|PROC-related disorder",GRCh38,single nucleotide variant
PROC,2,127426208,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant;Thrombophilia due to protein C deficiency, autosomal recessive|not provided",GRCh38,single nucleotide variant
PROC,2,127428374,na,na,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Thromboembolism|not provided",GRCh38,single nucleotide variant
PROC,2,127426236,na,na,Uncertain significance,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity",GRCh38,single nucleotide variant
PROC,2,127426227,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127427219,na,na,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Deep venous thrombosis|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127428895,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",GRCh38,single nucleotide variant
PROC,2,127428575,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Inborn genetic diseases|not provided",GRCh38,single nucleotide variant
PROC,2,127418425,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127423319,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROC,2,127428495,na,na,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",GRCh38,single nucleotide variant
FUCA1,1,23845837,na,na,Pathogenic,Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23848671,na,na,Pathogenic,Fucosidosis|not provided,GRCh38,single nucleotide variant
FUCA1,1,23854359,na,na,Pathogenic,Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23868043,na,na,Pathogenic,Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23848649,na,na,Pathogenic,Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23863148,na,na,Pathogenic,Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23854472,na,na,Benign,FU1/FU2 POLYMORPHISM|not provided|Fucosidosis,GRCh38,single nucleotide variant
FUCA1,1,23846105,na,na,Likely pathogenic,Fucosidosis,GRCh38,single nucleotide variant
ADAMTSL2,9,133540625,na,na,Pathogenic,Geleophysic dysplasia 1,GRCh38,single nucleotide variant
ADAMTSL2,9,133539799,na,na,Likely pathogenic,"Geleophysic dysplasia 1|Lethal short-limb skeletal dysplasia, Al Gazali type",GRCh38,single nucleotide variant
ADAMTSL2,9,133539801,na,na,Conflicting classifications of pathogenicity,Geleophysic dysplasia 1|not provided|Geleophysic dysplasia,GRCh38,single nucleotide variant
ADAMTSL2,9,133570346,na,na,Pathogenic,Geleophysic dysplasia 1,GRCh38,single nucleotide variant
ADAMTSL2,9,133570501,na,na,Pathogenic,Geleophysic dysplasia 1,GRCh38,single nucleotide variant
GALNS,16,88836222,na,na,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
GALNS,16,88841001,na,na,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
GALNS,16,88824853,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88818029,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
GALNS,16,88841077,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided",GRCh38,single nucleotide variant
GALNS,16,88818072,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
GALNS,16,88841936,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88835335,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",GRCh38,single nucleotide variant
GALNS,16,88835240,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88832099,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88837703,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",GRCh38,single nucleotide variant
GALNS,16,88842745,na,na,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
GALNS,16,88835794,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88832065,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",GRCh38,single nucleotide variant
GALNS,16,88842772,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",GRCh38,single nucleotide variant
ZFP57,6,29673328,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 1",GRCh38,single nucleotide variant
ZFP57,6,29672739,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 1",GRCh38,single nucleotide variant
ZFP57,6,29673368,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 1",GRCh38,single nucleotide variant
ZFP57,6,29673282,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 1",GRCh38,single nucleotide variant
NAT2,8,18400593,na,na,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,GRCh38,single nucleotide variant
NAT2,8,18400344,na,na,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,GRCh38,single nucleotide variant
NAT2,8,18400806,na,na,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,GRCh38,single nucleotide variant
NAT2,8,18400860,na,na,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,GRCh38,single nucleotide variant
NAT2,8,18400194,na,na,Likely benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,GRCh38,single nucleotide variant
TPCN2,11,69078931,na,na,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",GRCh38,single nucleotide variant
TPCN2,11,69087895,na,na,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",GRCh38,single nucleotide variant
UQCRQ,5,132867015,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 4|not provided,GRCh38,single nucleotide variant
RBM28,7,128330896,na,na,Pathogenic,ANE syndrome,GRCh38,single nucleotide variant
TMEM43,3,14141665,na,na,Pathogenic,Arrhythmogenic right ventricular dysplasia 5|Arrhythmogenic right ventricular cardiomyopathy|not provided|Familial isolated arrhythmogenic right ventricular dysplasia|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Primary dilated cardiomyopathy,GRCh38,single nucleotide variant
RNF212,4,1101493,na,na,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,GRCh38,single nucleotide variant
RNF212,4,1084399,na,na,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,GRCh38,single nucleotide variant
IYD,6,150389474,na,na,Likely pathogenic,Iodotyrosine deiodination defect|IYD-related disorder,GRCh38,single nucleotide variant
IYD,6,150389520,na,na,Likely pathogenic,Iodotyrosine deiodination defect,GRCh38,single nucleotide variant
IYD,6,150394226,na,na,Pathogenic/Likely pathogenic,Iodotyrosine deiodination defect,GRCh38,single nucleotide variant
CC2D2A,4,15550981,na,na,Pathogenic,Joubert syndrome 9,GRCh38,single nucleotide variant
CC2D2A,4,15537074,na,na,Pathogenic,"Meckel syndrome, type 6|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|not provided",GRCh38,single nucleotide variant
CC2D2A,4,15567752,na,na,Conflicting classifications of pathogenicity,Joubert syndrome 9|not provided|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome,GRCh38,single nucleotide variant
CC2D2A,4,15599614,na,na,Pathogenic/Likely pathogenic,"Joubert syndrome 9|not provided|COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",GRCh38,single nucleotide variant
CC2D2A,4,15559183,na,na,Pathogenic,"Joubert syndrome 9|not provided|Inborn genetic diseases|Meckel-Gruber syndrome;Joubert syndrome|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",GRCh38,single nucleotide variant
CC2D2A,4,15563485,na,na,Pathogenic,"COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 9/15, digenic|not provided|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|See cases|Inborn genetic diseases|Meckel syndrome, type 6;COACH syndrome 2;Joubert syndrome 9",GRCh38,single nucleotide variant
CC2D2A,4,15567735,na,na,Conflicting classifications of pathogenicity,"COACH syndrome 2|not provided|Joubert syndrome 9|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",GRCh38,single nucleotide variant
ZFYVE26,14,67782840,na,na,Pathogenic,Hereditary spastic paraplegia 15|Spastic paraplegia|not provided,GRCh38,single nucleotide variant
ZFYVE26,14,67769731,na,na,Pathogenic,Hereditary spastic paraplegia 15,GRCh38,single nucleotide variant
ZFYVE26,14,67802241,na,na,Pathogenic,Hereditary spastic paraplegia 15,GRCh38,single nucleotide variant
GIGYF2,2,232747740,na,na,Uncertain significance,"Parkinson disease 11, autosomal dominant, susceptibility to|not specified|not provided|GIGYF2-related disorder",GRCh38,single nucleotide variant
GIGYF2,2,232794835,na,na,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
GIGYF2,2,232809731,na,na,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
GIGYF2,2,232790817,na,na,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
GIGYF2,2,232791426,na,na,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
TRAPPC9,8,140397625,na,na,Pathogenic,"Intellectual disability, autosomal recessive 13|Abnormality of the nervous system|not provided",GRCh38,single nucleotide variant
TRAPPC9,8,140360131,na,na,Pathogenic/Likely pathogenic,"Intellectual disability, autosomal recessive 13|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
MMADHC,2,149570089,na,na,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Methylmalonic aciduria and homocystinuria type cblD,GRCh38,single nucleotide variant
MMADHC,2,149575775,na,na,Pathogenic,Homocystinuria-megaloblastic anemia cblD type,GRCh38,single nucleotide variant
MMADHC,2,149570119,na,na,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Cobalamin C disease|Methylmalonic aciduria and homocystinuria type cblD|See cases,GRCh38,single nucleotide variant
MMADHC,2,149579643,na,na,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,GRCh38,single nucleotide variant
MMADHC,2,149570117,na,na,Pathogenic/Likely pathogenic,Methylmalonic aciduria and homocystinuria type cblD|not provided,GRCh38,single nucleotide variant
FAM83H,8,143728488,na,na,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728269,na,na,Pathogenic,"FAM83H-related disorder|Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728218,na,na,Pathogenic,"Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728570,na,na,Pathogenic,"Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728081,na,na,Pathogenic,"Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143727432,na,na,Pathogenic/Likely pathogenic,"Amelogenesis imperfecta, hypocalcification type|not provided|Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728053,na,na,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728601,na,na,Pathogenic,"Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143727381,na,na,Pathogenic,"Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
FAM83H,8,143728082,na,na,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",GRCh38,single nucleotide variant
ISCU,12,108564313,na,na,Likely pathogenic,Hereditary myopathy with lactic acidosis due to ISCU deficiency|not provided,GRCh38,single nucleotide variant
SLC16A12,10,89438899,na,na,Pathogenic,Juvenile cataract-microcornea-renal glucosuria syndrome,GRCh38,single nucleotide variant
RFT1,3,53123791,na,na,Pathogenic/Likely pathogenic,RFT1-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
GPD1L,3,32159096,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 2|Brugada syndrome|not provided|not specified|Death in infancy|Cardiovascular phenotype|Brugada syndrome (shorter-than-normal QT interval)|Long QT syndrome|GPD1L-related disorder,GRCh38,single nucleotide variant
GPD1L,3,32138608,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,GRCh38,single nucleotide variant
GPD1L,3,32140231,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 2|SUDDEN INFANT DEATH SYNDROME|Primary familial hypertrophic cardiomyopathy;Long QT syndrome|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Brugada syndrome|GPD1L-related disorder,GRCh38,single nucleotide variant
GPD1L,3,32159074,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,GRCh38,single nucleotide variant
NDUFAF4,6,96896790,na,na,Pathogenic,Mitochondrial complex I deficiency,GRCh38,single nucleotide variant
NKX2-6,8,23702906,na,na,Likely pathogenic,Persistent truncus arteriosus|Conotruncal heart malformations,GRCh38,single nucleotide variant
LMF1,16,869982,na,na,Pathogenic,"Lipase deficiency, combined|not provided",GRCh38,single nucleotide variant
APC,5,112827199,na,na,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
APC,5,112819272,na,na,Benign,Gardner syndrome|Hereditary cancer-predisposing syndrome|not specified|Familial adenomatous polyposis 1|APC-Associated Polyposis Disorders|not provided|Classic or attenuated familial adenomatous polyposis,GRCh38,single nucleotide variant
APC,5,112815564,na,na,Pathogenic/Likely pathogenic,"Familial adenomatous polyposis 1|Gardner syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Classic or attenuated familial adenomatous polyposis|Neoplasm",GRCh38,single nucleotide variant
APC,5,112815499,na,na,Pathogenic,Gardner syndrome|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112837732,na,na,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112839606,na,na,Pathogenic,Carcinoma of colon|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112838953,na,na,Uncertain significance,Gastric cancer|Classic or attenuated familial adenomatous polyposis|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112838793,na,na,Pathogenic,Gastric cancer|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112828001,na,na,Pathogenic,Familial adenomatous polyposis 1|Brain tumor-polyposis syndrome 2|Hereditary cancer-predisposing syndrome|Carcinoma of colon|not provided,GRCh38,single nucleotide variant
APC,5,112828889,na,na,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|not provided|Familial multiple polyposis syndrome|Neoplasm of stomach;Carcinoma of colon;Familial adenomatous polyposis 1;Hepatocellular carcinoma;Desmoid disease, hereditary|Gastric cancer",GRCh38,single nucleotide variant
APC,5,112828919,na,na,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Familial multiple polyposis syndrome|Neoplasm|Classic or attenuated familial adenomatous polyposis,GRCh38,single nucleotide variant
APC,5,112838399,na,na,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Neoplasm of stomach;Carcinoma of colon;Familial adenomatous polyposis 1;Hepatocellular carcinoma;Desmoid disease, hereditary",GRCh38,single nucleotide variant
APC,5,112775676,na,na,Pathogenic,Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112780901,na,na,Pathogenic,Familial adenomatous polyposis 1|Brain tumor-polyposis syndrome 2|not provided|not specified|Hereditary cancer-predisposing syndrome|6 conditions,GRCh38,single nucleotide variant
APC,5,112839777,na,na,Pathogenic,Hepatoblastoma,GRCh38,single nucleotide variant
APC,5,112839514,na,na,Conflicting classifications of pathogenicity; association; risk factor,"|Breast cancer, susceptibility to|not specified|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial multiple polyposis syndrome|Carcinoma of colon|Colorectal cancer|Colorectal cancer, susceptibility to|Breast carcinoma|Familial colorectal cancer|APC-Associated Polyposis Disorders|Diffuse midline glioma, H3 K27-altered",GRCh38,single nucleotide variant
APC,5,112827194,na,na,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Familial multiple polyposis syndrome|Carcinoma of colon|APC-Associated Polyposis Disorders,GRCh38,single nucleotide variant
APC,5,112827157,na,na,Pathogenic,Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112839543,na,na,Benign/Likely benign,Familial adenomatous polyposis 1|not provided|not specified|APC-Associated Polyposis Disorders|Hereditary cancer-predisposing syndrome|Carcinoma of colon,GRCh38,single nucleotide variant
APC,5,112837687,na,na,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
APC,5,112775628,na,na,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
APC,5,112780880,na,na,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,GRCh38,single nucleotide variant
KCTD7,7,66633425,na,na,Pathogenic,Progressive myoclonic epilepsy type 3,GRCh38,single nucleotide variant
ATP6V0A2,12,123754537,na,na,Pathogenic,Cutis laxa with osteodystrophy|ALG9 congenital disorder of glycosylation,GRCh38,single nucleotide variant
ATP6V0A2,12,123718692,na,na,Pathogenic,Cutis laxa with osteodystrophy|not provided|Cutis laxa|ALG9 congenital disorder of glycosylation|Wrinkly skin syndrome;Cutis laxa with osteodystrophy,GRCh38,single nucleotide variant
SART3,12,108530286,na,na,Uncertain significance,"Porokeratosis 3, disseminated superficial actinic type",GRCh38,single nucleotide variant
SLC46A1,17,28402322,na,na,Pathogenic,Congenital defect of folate absorption|not provided|Inborn genetic diseases|SLC46A1-related disorder,GRCh38,single nucleotide variant
SLC46A1,17,28405360,na,na,Pathogenic,Congenital defect of folate absorption|not provided,GRCh38,single nucleotide variant
SLC46A1,17,28404743,na,na,Pathogenic,Congenital defect of folate absorption|not provided,GRCh38,single nucleotide variant
SLC46A1,17,28402277,na,na,Pathogenic,Congenital defect of folate absorption|not provided,GRCh38,single nucleotide variant
SLC46A1,17,28405360,na,na,Pathogenic,Congenital defect of folate absorption|not provided,GRCh38,single nucleotide variant
UBIAD1,1,11273836,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11274060,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11273886,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11274055,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11285809,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11273866,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11274042,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11285670,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
UBIAD1,1,11285822,na,na,Pathogenic,Schnyder crystalline corneal dystrophy,GRCh38,single nucleotide variant
MIR96,7,129774757,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,GRCh38,single nucleotide variant
MIR96,7,129774756,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,GRCh38,single nucleotide variant
FBP1,9,94609998,na,na,Pathogenic/Likely pathogenic,Fructose-biphosphatase deficiency,GRCh38,single nucleotide variant
FBP1,9,94609958,na,na,Pathogenic,Fructose-biphosphatase deficiency,GRCh38,single nucleotide variant
FBP1,9,94639223,na,na,Pathogenic,Fructose-biphosphatase deficiency,GRCh38,single nucleotide variant
FBP1,9,94606939,na,na,Pathogenic,Fructose-biphosphatase deficiency,GRCh38,single nucleotide variant
FBP1,9,94603547,na,na,Pathogenic,Fructose-biphosphatase deficiency,GRCh38,single nucleotide variant
UPK3A,22,45295673,na,na,Uncertain significance,Congenital anomalies of kidney and urinary tract 1|Renal hypodysplasia/aplasia 1|UPK3A-related disorder|not provided,GRCh38,single nucleotide variant
UPK3A,22,45295826,na,na,Uncertain significance,Renal hypodysplasia/aplasia 1|UPK3A-related disorder,GRCh38,single nucleotide variant
UPK3A,22,45293214,na,na,Uncertain significance,Congenital anomalies of kidney and urinary tract 1,GRCh38,single nucleotide variant
NCR3,6,31593133,na,na,Pathogenic; risk factor,"Malaria, mild, susceptibility to|Malaria, severe, susceptibility to",GRCh38,single nucleotide variant
ARSB,5,78969095,na,na,Uncertain significance,"Mucopolysaccharidosis, type vi, intermediate|Mucopolysaccharidosis type 6",GRCh38,single nucleotide variant
ARSB,5,78969156,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",GRCh38,single nucleotide variant
ARSB,5,78955486,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, type vi, mild|Mucopolysaccharidosis type 6",GRCh38,single nucleotide variant
ARSB,5,78781974,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSB,5,78985034,na,na,Conflicting classifications of pathogenicity,not provided|Mucopolysaccharidosis type 6|not specified,GRCh38,single nucleotide variant
ARSB,5,78984965,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,GRCh38,single nucleotide variant
ARSB,5,78964477,na,na,Pathogenic,Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy|ARSB-related disorder,GRCh38,single nucleotide variant
ARSB,5,78839391,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,GRCh38,single nucleotide variant
ARSB,5,78839427,na,na,Pathogenic,Mucopolysaccharidosis type 6,GRCh38,single nucleotide variant
ARSB,5,78839434,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6,GRCh38,single nucleotide variant
FOXD3,1,63322420,na,na,risk factor,"Autoimmune disease, susceptibility to, 1",GRCh38,single nucleotide variant
EMG1,12,6974427,na,na,Pathogenic,Bowen-Conradi syndrome,GRCh38,single nucleotide variant
RARS2,6,87569512,na,na,Pathogenic,Pontocerebellar hypoplasia type 6|not provided,GRCh38,single nucleotide variant
CISD2,4,102885221,na,na,Pathogenic,Wolfram syndrome 2,GRCh38,single nucleotide variant
GUSB,7,65960997,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,GRCh38,single nucleotide variant
GUSB,7,65974626,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis,GRCh38,single nucleotide variant
GUSB,7,65979477,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,GRCh38,single nucleotide variant
GUSB,7,65974923,na,na,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7|not provided,GRCh38,single nucleotide variant
GUSB,7,65961022,na,na,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65979866,na,na,Pathogenic,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65967900,na,na,Uncertain significance,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65967863,na,na,Pathogenic,Mucopolysaccharidosis type 7|not provided,GRCh38,single nucleotide variant
GUSB,7,65967767,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65964382,na,na,Likely pathogenic,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65974348,na,na,Pathogenic,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65979782,na,na,Pathogenic,Mucopolysaccharidosis type 7|not provided|Mucopolysaccharidosis type 6|GUSB-related disorder,GRCh38,single nucleotide variant
GUSB,7,65974934,na,na,Pathogenic,Mucopolysaccharidosis type 7,GRCh38,single nucleotide variant
GUSB,7,65960972,na,na,Likely pathogenic,Mucopolysaccharidosis type 7|not provided|GUSB-related disorder,GRCh38,single nucleotide variant
GUSB,7,65974701,na,na,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis|not provided,GRCh38,single nucleotide variant
CYP4F22,19,15549170,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 5|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
CYP4F22,19,15549173,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 5,GRCh38,single nucleotide variant
CYP4F22,19,15540506,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 5|Lamellar ichthyosis,GRCh38,single nucleotide variant
CA2,8,85480760,na,na,Benign/Likely benign,CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis|not provided,GRCh38,single nucleotide variant
CA2,8,85465289,na,na,Pathogenic,CARBONIC ANHYDRASE II VARIANT,GRCh38,single nucleotide variant
CA2,8,85480713,na,na,Pathogenic,CARBONIC ANHYDRASE II VARIANT,GRCh38,single nucleotide variant
CA2,8,85473779,na,na,Pathogenic,Osteopetrosis with renal tubular acidosis,GRCh38,single nucleotide variant
CA2,8,85477119,na,na,Pathogenic,Osteopetrosis with renal tubular acidosis,GRCh38,single nucleotide variant
CA2,8,85465357,na,na,Pathogenic,Osteopetrosis with renal tubular acidosis,GRCh38,single nucleotide variant
PLEKHM1,17,45477899,na,na,Pathogenic,Autosomal recessive osteopetrosis 6,GRCh38,single nucleotide variant
GLB1,3,33072644,na,na,Conflicting classifications of pathogenicity,"Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33016819,na,na,Pathogenic,"Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2",GRCh38,single nucleotide variant
GLB1,3,33058221,na,na,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GLB1-related disorder|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",GRCh38,single nucleotide variant
GLB1,3,33072637,na,na,Pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33068849,na,na,Pathogenic,"Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33051766,na,na,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33016818,na,na,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis",GRCh38,single nucleotide variant
GLB1,3,33051979,na,na,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",GRCh38,single nucleotide variant
GLB1,3,33016743,na,na,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",GRCh38,single nucleotide variant
GLB1,3,33014263,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33072544,na,na,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|Inborn genetic diseases|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",GRCh38,single nucleotide variant
GLB1,3,33068969,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33016744,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33058200,na,na,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2|Inborn genetic diseases",GRCh38,single nucleotide variant
GLB1,3,33018482,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Spondyloepiphyseal dysplasia|GM1 gangliosidosis",GRCh38,single nucleotide variant
GLB1,3,33046137,na,na,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Spastic ataxia",GRCh38,single nucleotide variant
GLB1,3,33014292,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis type 3|GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33021576,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",GRCh38,single nucleotide variant
GLB1,3,33072587,na,na,Pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3",GRCh38,single nucleotide variant
GLB1,3,33072613,na,na,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|not provided|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GLB1-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
GLB1,3,33014312,na,na,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis|GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2",GRCh38,single nucleotide variant
GLB1,3,32997308,na,na,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement",GRCh38,single nucleotide variant
GLB1,3,32997307,na,na,Pathogenic/Likely pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2",GRCh38,single nucleotide variant
DOCK8,9,336714,na,na,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency|,GRCh38,single nucleotide variant
OCA2,15,27955157,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",GRCh38,single nucleotide variant
OCA2,15,27983407,na,na,Conflicting classifications of pathogenicity,Tyrosinase-positive oculocutaneous albinism|not specified|not provided|OCA2-related disorder,GRCh38,single nucleotide variant
OCA2,15,27985101,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|Inborn genetic diseases|OCA2-related disorder|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|See cases|Albinism or congenital nystagmus",GRCh38,single nucleotide variant
OCA2,15,27871170,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|Tyrosinase-positive oculocutaneous albinism;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",GRCh38,single nucleotide variant
OCA2,15,28014819,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",GRCh38,single nucleotide variant
OCA2,15,27926169,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism",GRCh38,single nucleotide variant
OCA2,15,27983383,na,na,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism|OCA2-related disorder",GRCh38,single nucleotide variant
OCA2,15,28014907,na,na,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|not provided",GRCh38,single nucleotide variant
OCA2,15,27985172,na,na,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|not provided",GRCh38,single nucleotide variant
OCA2,15,27989601,na,na,Uncertain significance,Tyrosinase-positive oculocutaneous albinism,GRCh38,single nucleotide variant
LCA5,6,79493636,na,na,Pathogenic,Leber congenital amaurosis 5|Inborn genetic diseases|not provided|Retinal dystrophy|Leber congenital amaurosis,GRCh38,single nucleotide variant
FANCI,15,89315319,na,na,Conflicting classifications of pathogenicity,Fanconi anemia complementation group I|Fanconi anemia,GRCh38,single nucleotide variant
FANCI;POLG,15,89315318,na,na,Pathogenic,Fanconi anemia complementation group I|not provided|Fanconi anemia|FANCI-related disorder,GRCh38,single nucleotide variant
RNF135,17,30997289,na,na,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",GRCh38,single nucleotide variant
RNF135,17,30998749,na,na,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",GRCh38,single nucleotide variant
ARMS2,10,122454932,na,na,Benign,Age related macular degeneration 8|not provided|ARMS2-related disorder,GRCh38,single nucleotide variant
NHEJ1,2,219158194,na,na,Conflicting classifications of pathogenicity,Cernunnos-XLF deficiency|not provided,GRCh38,single nucleotide variant
NHEJ1,2,219157495,na,na,Pathogenic,Cernunnos-XLF deficiency,GRCh38,single nucleotide variant
NHEJ1,2,219146736,na,na,Pathogenic,not provided|Cernunnos-XLF deficiency,GRCh38,single nucleotide variant
CDKAL1,6,20660803,na,na,Uncertain significance,Type 2 diabetes mellitus,GRCh38,single nucleotide variant
CDKAL1,6,20679478,na,na,Uncertain significance,Type 2 diabetes mellitus,GRCh38,single nucleotide variant
IFT80,3,160377485,na,na,Pathogenic,Asphyxiating thoracic dystrophy 2,GRCh38,single nucleotide variant
IFT80,3,160268535,na,na,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 2|Jeune thoracic dystrophy|not provided,GRCh38,single nucleotide variant
XPA,9,97689600,na,na,Likely pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum,GRCh38,single nucleotide variant
XPA,9,97675579,na,na,Pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum|not provided,GRCh38,single nucleotide variant
XPA,9,97684977,na,na,Pathogenic,Xeroderma pigmentosum group A|not provided|Xeroderma pigmentosum,GRCh38,single nucleotide variant
XPA,9,97689575,na,na,Pathogenic,Xeroderma pigmentosum group A,GRCh38,single nucleotide variant
XPA,9,97697119,na,na,Pathogenic,Xeroderma pigmentosum group A,GRCh38,single nucleotide variant
SLC30A8,8,117172544,na,na,Benign; risk factor,"Diabetes mellitus type 2, susceptibility to|SLC30A8-related disorder",GRCh38,single nucleotide variant
MFSD8,4,127930752,na,na,Likely pathogenic,Neuronal ceroid lipofuscinosis 7,GRCh38,single nucleotide variant
MFSD8,4,127921588,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 7,GRCh38,single nucleotide variant
MFSD8,4,127930787,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,GRCh38,single nucleotide variant
MFSD8,4,127943829,na,na,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
MFSD8,4,127921639,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,GRCh38,single nucleotide variant
MFSD8,4,127930800,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Late-infantile neuronal ceroid lipofuscinosis|Inborn genetic diseases,GRCh38,single nucleotide variant
KLHL7,7,23140775,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided,GRCh38,single nucleotide variant
KLHL7,7,23140784,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
KLHL7,7,23140783,na,na,Pathogenic,Retinitis pigmentosa 42|Retinal dystrophy,GRCh38,single nucleotide variant
FGD4,12,32598566,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4H|not provided|Charcot-Marie-Tooth disease type 4,GRCh38,single nucleotide variant
FGD4,12,32625774,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H,GRCh38,single nucleotide variant
FGD4,12,32602217,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
FGD4,12,32601410,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease type 4,GRCh38,single nucleotide variant
FGD4,12,32633547,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
PLEKHG5,1,6469444,na,na,Conflicting classifications of pathogenicity,"Neuronopathy, distal hereditary motor, autosomal recessive 4|Hereditary motor neuron disease",GRCh38,single nucleotide variant
MTMR14,3,9684627,na,na,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",GRCh38,single nucleotide variant
MTMR14,3,9689034,na,na,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",GRCh38,single nucleotide variant
FAM20C,7,255869,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,255939,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,259870,na,na,Uncertain significance,Lethal osteosclerotic bone dysplasia|not provided,GRCh38,single nucleotide variant
FAM20C,7,248312,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,255912,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,257003,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,246512,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
FAM20C,7,258645,na,na,Pathogenic,Lethal osteosclerotic bone dysplasia,GRCh38,single nucleotide variant
SETBP1,18,44951952,na,na,Pathogenic/Likely pathogenic,"Schinzel-Giedion syndrome|not provided|Intellectual disability, autosomal dominant 29|Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita|SETBP1-related disorder",GRCh38,single nucleotide variant
SETBP1,18,44951942,na,na,Pathogenic,"Schinzel-Giedion syndrome|Schinzel-Giedion syndrome;Intellectual disability, autosomal dominant 29|not provided|Intellectual disability, autosomal dominant 29|SETBP1-related disorder",GRCh38,single nucleotide variant
SETBP1,18,44951943,na,na,Pathogenic,Schinzel-Giedion syndrome,GRCh38,single nucleotide variant
SETBP1,18,44951949,na,na,Pathogenic,Schinzel-Giedion syndrome,GRCh38,single nucleotide variant
SETBP1,18,44951948,na,na,Pathogenic,Schinzel-Giedion syndrome|not provided|SETBP1-related disorder,GRCh38,single nucleotide variant
G6PC3,17,44075760,na,na,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency|not provided,GRCh38,single nucleotide variant
G6PC3,17,44075328,na,na,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,GRCh38,single nucleotide variant
G6PC3,17,44071106,na,na,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,GRCh38,single nucleotide variant
G6PC3,17,44075786,na,na,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,GRCh38,single nucleotide variant
G6PC3,17,44074700,na,na,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,GRCh38,single nucleotide variant
FA2H,16,74718987,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 35|not provided,GRCh38,single nucleotide variant
FA2H,16,74774653,na,na,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 35,GRCh38,single nucleotide variant
OBSL1,2,219568188,na,na,Pathogenic,3M syndrome 2|not provided,GRCh38,single nucleotide variant
OBSL1,2,219567787,na,na,Pathogenic,3M syndrome 2,GRCh38,single nucleotide variant
INF2,14,104703343,na,na,Pathogenic,Focal segmental glomerulosclerosis 5|INF2-related disorder,GRCh38,single nucleotide variant
INF2,14,104703440,na,na,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|not provided|Inborn genetic diseases|Focal segmental glomerulosclerosis 5;Charcot-Marie-Tooth disease dominant intermediate E|Kidney disorder|Charcot-Marie-Tooth disease dominant intermediate E,GRCh38,single nucleotide variant
INF2,14,104703439,na,na,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E,GRCh38,single nucleotide variant
INF2,14,104703428,na,na,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Kidney disorder,GRCh38,single nucleotide variant
INF2,14,104701490,na,na,Pathogenic,Focal segmental glomerulosclerosis 5,GRCh38,single nucleotide variant
FTO,16,53873837,na,na,Pathogenic,"Lethal polymalformative syndrome, Boissel type",GRCh38,single nucleotide variant
YARS2,12,32755719,na,na,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided",GRCh38,single nucleotide variant
DARS2,1,173857643,na,na,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,GRCh38,single nucleotide variant
DARS2,1,173838206,na,na,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,GRCh38,single nucleotide variant
DARS2,1,173838207,na,na,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,GRCh38,single nucleotide variant
DARS2,1,173831593,na,na,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|See cases|not provided|DARS2-related disorder,GRCh38,single nucleotide variant
DARS2,1,173831632,na,na,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|Dysmetria;Gait ataxia;Gait imbalance|10 conditions|Inborn genetic diseases,GRCh38,single nucleotide variant
DARS2,1,173826692,na,na,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,GRCh38,single nucleotide variant
DARS2,1,173833419,na,na,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,GRCh38,single nucleotide variant
DARS2,1,173850408,na,na,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,GRCh38,single nucleotide variant
DARS2,1,173857604,na,na,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,GRCh38,single nucleotide variant
DARS2,1,173857644,na,na,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,GRCh38,single nucleotide variant
RPGRIP1L,16,53686512,na,na,Pathogenic,Joubert syndrome 7|RPGRIP1L-related disorder|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|not provided,GRCh38,single nucleotide variant
RPGRIP1L,16,53652844,na,na,Pathogenic,"Joubert syndrome 7|not provided|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3|Joubert syndrome|Joubert syndrome and related disorders|RPGRIP1L-related disorder",GRCh38,single nucleotide variant
RPGRIP1L,16,53686452,na,na,Pathogenic,"Joubert syndrome 7|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|Joubert syndrome and related disorders|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",GRCh38,single nucleotide variant
RPGRIP1L,16,53652604,na,na,Pathogenic,Joubert syndrome 7,GRCh38,single nucleotide variant
RPGRIP1L,16,53692201,na,na,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",GRCh38,single nucleotide variant
RPGRIP1L,16,53671580,na,na,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",GRCh38,single nucleotide variant
RPGRIP1L,16,53645694,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 5|not provided|Meckel-Gruber syndrome;Joubert syndrome|COACH syndrome 1;Joubert syndrome 7;Meckel syndrome, type 5|RPGRIP1L-related disorder|Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3|Meckel-Gruber syndrome",GRCh38,single nucleotide variant
RPGRIP1L,16,53652637,na,na,Pathogenic/Likely pathogenic,"Joubert syndrome 7|Meckel syndrome, type 5;COACH syndrome 1;Joubert syndrome 7|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|not provided|Abnormality of prenatal development or birth|Meckel syndrome, type 5;Joubert syndrome 7;COACH syndrome 3",GRCh38,single nucleotide variant
RPGRIP1L,16,53686524,na,na,Benign,"Retinitis pigmentosa in ciliopathies, modifier of|not specified|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 5|not provided|Joubert syndrome 7|Nephronophthisis 8|Focal segmental glomerulosclerosis|Meckel syndrome, type 5;Joubert syndrome 7;COACH syndrome 3",GRCh38,single nucleotide variant
RPGRIP1L,16,53645895,na,na,Pathogenic,"COACH syndrome 3|Joubert syndrome 7|not provided|Joubert syndrome|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",GRCh38,single nucleotide variant
RPGRIP1L,16,53652712,na,na,Pathogenic,COACH syndrome 3|Joubert syndrome 7,GRCh38,single nucleotide variant
PSAT1,9,78304842,na,na,Pathogenic,PSAT deficiency|not provided|Neu-Laxova syndrome 2,GRCh38,single nucleotide variant
NOBOX,7,144399847,na,na,Conflicting classifications of pathogenicity,Premature ovarian failure 5|Genetic non-acquired premature ovarian failure|not provided,GRCh38,single nucleotide variant
ZFAT,8,134597964,na,na,risk factor,"Autoimmune thyroid disease, susceptibility to, 3",GRCh38,single nucleotide variant
CHMP4B,20,33850969,na,na,Pathogenic,Cataract 31 multiple types,GRCh38,single nucleotide variant
CHMP4B,20,33851064,na,na,Pathogenic,Cataract 31 multiple types,GRCh38,single nucleotide variant
FLVCR2,14,75641008,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
FLVCR2,14,75639419,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
FLVCR2,14,75579445,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
FLVCR2,14,75624639,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
FLVCR2,14,75633653,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
FLVCR2,14,75641062,na,na,Pathogenic,Fowler syndrome,GRCh38,single nucleotide variant
AGL,1,99851058,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,GRCh38,single nucleotide variant
AGL,1,99881329,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|Glycogen storage disease IIIa,GRCh38,single nucleotide variant
AGL,1,99916398,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|AGL-related disorder,GRCh38,single nucleotide variant
AGL,1,99880047,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III,GRCh38,single nucleotide variant
AGL,1,99916492,na,na,Pathogenic,Glycogen storage disease IIIa,GRCh38,single nucleotide variant
AGL,1,99915491,na,na,Conflicting classifications of pathogenicity,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,GRCh38,single nucleotide variant
AGL,1,99875394,na,na,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,GRCh38,single nucleotide variant
AGL,1,99900712,na,na,Pathogenic,Glycogen storage disease IIIc,GRCh38,single nucleotide variant
AGL,1,99913557,na,na,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,GRCh38,single nucleotide variant
SPG11,15,44573652,na,na,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11;Amyotrophic lateral sclerosis type 5,GRCh38,single nucleotide variant
SPG11,15,44663530,na,na,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5|not provided,GRCh38,single nucleotide variant
SPG11,15,44660431,na,na,Pathogenic,Hereditary spastic paraplegia 11|not provided|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
SPG11,15,44563302,na,na,Pathogenic,Hereditary spastic paraplegia 11,GRCh38,single nucleotide variant
SPG11,15,44584057,na,na,Pathogenic,Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X;Amyotrophic lateral sclerosis type 5,GRCh38,single nucleotide variant
SLC25A38,3,39391513,na,na,Pathogenic,Sideroblastic anemia 2|not provided,GRCh38,single nucleotide variant
SLC25A38,3,39391956,na,na,Conflicting classifications of pathogenicity,Sideroblastic anemia 2|not provided,GRCh38,single nucleotide variant
SLC25A38,3,39391440,na,na,Pathogenic,Sideroblastic anemia 2,GRCh38,single nucleotide variant
SLC25A38,3,39394574,na,na,Pathogenic,Sideroblastic anemia 2,GRCh38,single nucleotide variant
SLC35D1,1,67009112,na,na,Pathogenic,Schneckenbecken dysplasia,GRCh38,single nucleotide variant
SLC35D1,1,67047264,na,na,Pathogenic,Schneckenbecken dysplasia,GRCh38,single nucleotide variant
SLC35D1,1,67052776,na,na,Pathogenic,Schneckenbecken dysplasia,GRCh38,single nucleotide variant
SLC35D1,1,67052009,na,na,Pathogenic,Schneckenbecken dysplasia,GRCh38,single nucleotide variant
SLC35D1,1,67053821,na,na,Pathogenic,Schneckenbecken dysplasia,GRCh38,single nucleotide variant
ATG16L1,2,233274722,na,na,Benign,"Inflammatory bowel disease 10, susceptibility to|not specified|not provided|ATG16L1-related disorder",GRCh38,single nucleotide variant
DOLK,9,128947009,na,na,Pathogenic,DK1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
DOLK,9,128945982,na,na,Pathogenic,DK1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
STRA6,15,74190889,na,na,Likely pathogenic,Matthew-Wood syndrome|not provided,GRCh38,single nucleotide variant
STRA6,15,74180121,na,na,Uncertain significance,Matthew-Wood syndrome|not provided,GRCh38,single nucleotide variant
STRA6,15,74180153,na,na,Pathogenic,Matthew-Wood syndrome,GRCh38,single nucleotide variant
STRA6,15,74196145,na,na,Pathogenic,Matthew-Wood syndrome,GRCh38,single nucleotide variant
STRA6,15,74189244,na,na,Uncertain significance,Matthew-Wood syndrome|STRA6-related disorder,GRCh38,single nucleotide variant
STRA6,15,74202199,na,na,Pathogenic,Matthew-Wood syndrome,GRCh38,single nucleotide variant
HYLS1;PUS3,11,125900000,na,na,Pathogenic,Hydrolethalus syndrome|Hydrolethalus syndrome 1|not provided,GRCh38,single nucleotide variant
HIBCH,2,190294639,na,na,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,GRCh38,single nucleotide variant
HIBCH,2,190290425,na,na,Conflicting classifications of pathogenicity,3-hydroxyisobutyryl-CoA hydrolase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
HIBCH,2,190296956,na,na,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,GRCh38,single nucleotide variant
BBS12,4,122742955,na,na,Pathogenic,"Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|Abnormal cardiovascular system morphology;Visual impairment;Polydactyly, postaxial, type A1;Inability to walk|not provided|Bardet-Biedl syndrome 1",GRCh38,single nucleotide variant
BBS12,4,122742757,na,na,Likely pathogenic,Bardet-Biedl syndrome 12|Retinal dystrophy|Bardet-Biedl syndrome|not provided,GRCh38,single nucleotide variant
PFKM,12,48140872,na,na,Pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48133313,na,na,Pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48130393,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48142041,na,na,Uncertain significance,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48130393,na,na,Pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48132913,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
PFKM,12,48145096,na,na,Pathogenic,"Glycogen storage disease, type VII",GRCh38,single nucleotide variant
WASHC5,8,125056817,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 8|Ritscher-Schinzel syndrome;Hereditary spastic paraplegia 8|Hereditary spastic paraplegia|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
WASHC5,8,125057574,na,na,Pathogenic,Hereditary spastic paraplegia 8|Ritscher-Schinzel syndrome;Hereditary spastic paraplegia 8,GRCh38,single nucleotide variant
WASHC5,8,125061192,na,na,Pathogenic,Hereditary spastic paraplegia 8,GRCh38,single nucleotide variant
F12,5,177402372,na,na,Pathogenic,FACTOR XII (WASHINGTON D.C.),GRCh38,single nucleotide variant
F12,5,177403994,na,na,Pathogenic,FACTOR XII (LOCARNO),GRCh38,single nucleotide variant
F12,5,177402460,na,na,Conflicting classifications of pathogenicity,Factor XII deficiency disease|F12-related disorder|not provided|Hereditary angioedema type 3,GRCh38,single nucleotide variant
F12,5,177409531,na,na,Benign,F12 POLYMORPHISM|Hereditary angioedema type 3|not specified|Factor XII deficiency disease|not provided,GRCh38,single nucleotide variant
F12,5,177406019,na,na,Uncertain significance,Hereditary angioedema type 3|Factor XII deficiency disease,GRCh38,single nucleotide variant
F12,5,177404231,na,na,Pathogenic,Hereditary angioedema type 3|not provided|Hereditary angioneurotic edema|Hereditary angioedema type 3;Factor XII deficiency disease,GRCh38,single nucleotide variant
F12,5,177404231,na,na,Pathogenic,Hereditary angioedema type 3|Angioedema;Hyperbilirubinemia;Urticaria;Hypertensive disorder|Factor XII deficiency disease,GRCh38,single nucleotide variant
CYP11B1,8,142875012,na,na,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder,GRCh38,single nucleotide variant
CYP11B1,8,142876242,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,GRCh38,single nucleotide variant
CYP11B1,8,142875712,na,na,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided,GRCh38,single nucleotide variant
CYP11B1,8,142879080,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,GRCh38,single nucleotide variant
CYP11B1,8,142877221,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,GRCh38,single nucleotide variant
CYP11B1,8,142875877,na,na,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,GRCh38,single nucleotide variant
CYP11B1,8,142879690,na,na,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,GRCh38,single nucleotide variant
CYP11B1,8,142874953,na,na,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,GRCh38,single nucleotide variant
CYP11B1,8,142877007,na,na,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
CYP11B1,8,142875086,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase,GRCh38,single nucleotide variant
CYP11B1,8,142879146,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,GRCh38,single nucleotide variant
CYP11B1,8,142875730,na,na,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,GRCh38,single nucleotide variant
PRCD,17,76540146,na,na,Uncertain significance,Retinitis pigmentosa 36|not provided,GRCh38,single nucleotide variant
ARHGAP9,12,57476372,na,na,Uncertain significance,"Coronary artery spasm 3, susceptibility to",GRCh38,single nucleotide variant
RSPO4,20,968024,na,na,Pathogenic,Anonychia,GRCh38,single nucleotide variant
RSPO4,20,967264,na,na,Pathogenic,Anonychia,GRCh38,single nucleotide variant
RSPO4,20,967230,na,na,Pathogenic,Anonychia,GRCh38,single nucleotide variant
RSPO4,20,968000,na,na,Pathogenic,Anonychia,GRCh38,single nucleotide variant
MARVELD2,5,69432526,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 49,GRCh38,single nucleotide variant
MARVELD2,5,69433088,na,na,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Ear malformation|Autosomal recessive nonsyndromic hearing loss 49,GRCh38,single nucleotide variant
PDSS2,6,107210483,na,na,Pathogenic,"Coenzyme Q10 deficiency, primary, 3",GRCh38,single nucleotide variant
PDSS2,6,107154674,na,na,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 3|not provided|Nephrotic syndrome|not specified",GRCh38,single nucleotide variant
MAT1A,10,80274639,na,na,Likely pathogenic,Hepatic methionine adenosyltransferase deficiency,GRCh38,single nucleotide variant
MAT1A,10,80285517,na,na,Uncertain significance,Hepatic methionine adenosyltransferase deficiency,GRCh38,single nucleotide variant
MAT1A,10,80274535,na,na,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,GRCh38,single nucleotide variant
MAT1A,10,80275054,na,na,Pathogenic,Hepatic methionine adenosyltransferase deficiency,GRCh38,single nucleotide variant
MAT1A,10,80275177,na,na,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,GRCh38,single nucleotide variant
MAT1A,10,80275178,na,na,Pathogenic,Hepatic methionine adenosyltransferase deficiency|MAT1A-related disorder,GRCh38,single nucleotide variant
MAT1A,10,80274599,na,na,Conflicting classifications of pathogenicity,Hepatic methionine adenosyltransferase deficiency|not specified|not provided,GRCh38,single nucleotide variant
WWC1,5,168418786,na,na,association,Memory quantitative trait locus,GRCh38,single nucleotide variant
HYCC1,7,22991060,na,na,Pathogenic,Hypomyelination and Congenital Cataract,GRCh38,single nucleotide variant
HYCC1,7,22977340,na,na,Likely pathogenic,Hypomyelination and Congenital Cataract,GRCh38,single nucleotide variant
HYCC1,7,22978444,na,na,Pathogenic,Hypomyelination and Congenital Cataract,GRCh38,single nucleotide variant
ATP13A2,1,16996381,na,na,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|not provided,GRCh38,single nucleotide variant
ATP13A2,1,16996008,na,na,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|See cases|Neurodegeneration with brain iron accumulation,GRCh38,single nucleotide variant
SEC23B,20,18515695,na,na,Pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder|See cases",GRCh38,single nucleotide variant
SEC23B,20,18510875,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder",GRCh38,single nucleotide variant
SEC23B,20,18543095,na,na,Conflicting classifications of pathogenicity,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",GRCh38,single nucleotide variant
SEC23B,20,18525888,na,na,Pathogenic,"Congenital dyserythropoietic anemia, type II|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II|not provided",GRCh38,single nucleotide variant
SEC23B,20,18526508,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II|not provided",GRCh38,single nucleotide variant
SEC23B,20,18524980,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",GRCh38,single nucleotide variant
SEC23A,14,39067256,na,na,Pathogenic,Craniolenticulosutural dysplasia,GRCh38,single nucleotide variant
SAMD9,7,93101615,na,na,Pathogenic,Normophosphatemic familial tumoral calcinosis|not provided,GRCh38,single nucleotide variant
HGSNAT,8,43159045,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Inborn genetic diseases|not provided",GRCh38,single nucleotide variant
HGSNAT,8,43173740,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinal dystrophy|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Sanfilippo syndrome",GRCh38,single nucleotide variant
HGSNAT,8,43178184,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-C",GRCh38,single nucleotide variant
HGSNAT,8,43193824,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Inborn genetic diseases",GRCh38,single nucleotide variant
HGSNAT,8,43158921,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Sanfilippo syndrome|not provided",GRCh38,single nucleotide variant
HGSNAT,8,43182162,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis|Sanfilippo syndrome|not provided|Retinal dystrophy",GRCh38,single nucleotide variant
HGSNAT,8,43197682,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",GRCh38,single nucleotide variant
LAMTOR2,1,156058394,na,na,Uncertain significance,Primary immunodeficiency syndrome due to p14 deficiency|not provided,GRCh38,single nucleotide variant
RAX2,19,3770916,na,na,Uncertain significance,Age related macular degeneration 6|not provided,GRCh38,single nucleotide variant
RAX2,19,3770767,na,na,Pathogenic,Cone-rod dystrophy 11,GRCh38,single nucleotide variant
PALB2,16,23634893,na,na,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 5",GRCh38,single nucleotide variant
PALB2,16,23603471,na,na,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Inherited breast cancer and ovarian cancer|PALB2-related disorder",GRCh38,single nucleotide variant
PALB2,16,23623003,na,na,Pathogenic,"Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5",GRCh38,single nucleotide variant
P3H1,1,42757782,na,na,Pathogenic,Osteogenesis imperfecta type 8|not provided|Osteogenesis imperfecta|P3H1-related disorder,GRCh38,single nucleotide variant
P3H1,1,42752536,na,na,Pathogenic,Osteogenesis imperfecta type 8,GRCh38,single nucleotide variant
P3H1,1,42750250,na,na,Pathogenic,Osteogenesis imperfecta type 8,GRCh38,single nucleotide variant
P3H1,1,42755616,na,na,Pathogenic,Osteogenesis imperfecta type 8|not provided,GRCh38,single nucleotide variant
P3H1,1,42747254,na,na,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 8|not provided,GRCh38,single nucleotide variant
RNASEH2C,11,65720385,na,na,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 3|not provided|Abnormality of the nervous system|Aicardi Goutieres syndrome,GRCh38,single nucleotide variant
RNASEH2C,11,65720085,na,na,Uncertain significance,Aicardi-Goutieres syndrome 3|not provided|not specified,GRCh38,single nucleotide variant
RNASEH2B,13,50945445,na,na,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|Abnormality of the nervous system|Cerebral palsy|Aicardi Goutieres syndrome|not provided|Inborn genetic diseases|Autism spectrum disorder|RNASEH2B-related disorder,GRCh38,single nucleotide variant
RNASEH2B,13,50945470,na,na,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|not provided,GRCh38,single nucleotide variant
B3GLCT,13,31269278,na,na,Pathogenic,Peters plus syndrome|B3GLCT-related disorder|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
B3GLCT,13,31247104,na,na,Pathogenic,Peters plus syndrome,GRCh38,single nucleotide variant
B3GLCT,13,31317679,na,na,Pathogenic,Peters plus syndrome,GRCh38,single nucleotide variant
BANK1,4,101829919,na,na,Uncertain significance,Variant of unknown significance,GRCh38,single nucleotide variant
GALNT12,9,98807701,na,na,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",GRCh38,single nucleotide variant
GALNT12,9,98845990,na,na,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not specified|not provided",GRCh38,single nucleotide variant
GALNT12,9,98837121,na,na,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",GRCh38,single nucleotide variant
DOK7,4,3485545,na,na,Likely pathogenic,Congenital myasthenic syndrome 10|not provided,GRCh38,single nucleotide variant
DOK7,4,3485607,na,na,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,GRCh38,single nucleotide variant
DOK7,4,3463505,na,na,Pathogenic,Congenital myasthenic syndrome 10,GRCh38,single nucleotide variant
ORAI1,12,121627018,na,na,Pathogenic,Combined immunodeficiency due to ORAI1 deficiency,GRCh38,single nucleotide variant
PIGV,1,26795056,na,na,Pathogenic/Likely pathogenic,Hyperphosphatasia with intellectual disability syndrome 1|Inborn genetic diseases|not provided|Hyperphosphatasia-intellectual disability syndrome|PIGV-related disorder,GRCh38,single nucleotide variant
PIGV,1,26795188,na,na,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,GRCh38,single nucleotide variant
PIGV,1,26794800,na,na,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,GRCh38,single nucleotide variant
PIGV,1,26795056,na,na,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,GRCh38,single nucleotide variant
PIGM,1,160032009,na,na,Pathogenic,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,GRCh38,single nucleotide variant
ZFYVE27,10,97749494,na,na,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 33|not specified|Spastic tetraparesis|Spastic paraplegia|not provided,GRCh38,single nucleotide variant
TRMU,22,46335792,na,na,Benign/Likely benign,"Deafness, mitochondrial, modifier of|not specified|not provided|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness",GRCh38,single nucleotide variant
TRMU,22,46337925,na,na,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|not provided|TRMU-related disorder|Aminoglycoside-induced deafness|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness,GRCh38,single nucleotide variant
TRMU,22,46353809,na,na,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,GRCh38,single nucleotide variant
TRMU,22,46335766,na,na,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,GRCh38,single nucleotide variant
PJVK,2,178456149,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59|not provided|Ear malformation,GRCh38,single nucleotide variant
PJVK,2,178453570,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,GRCh38,single nucleotide variant
PJVK,2,178456101,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 59|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
SLC4A11,20,3228684,na,na,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,GRCh38,single nucleotide variant
SLC4A11,20,3230258,na,na,Pathogenic/Likely pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome,GRCh38,single nucleotide variant
SLC4A11,20,3230587,na,na,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,GRCh38,single nucleotide variant
SLC4A11,20,3229430,na,na,Pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",GRCh38,single nucleotide variant
SLC4A11,20,3228260,na,na,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,GRCh38,single nucleotide variant
SLC4A11,20,3228259,na,na,Pathogenic/Likely pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",GRCh38,single nucleotide variant
SLC4A11,20,3230515,na,na,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,GRCh38,single nucleotide variant
SLC4A11,20,3228299,na,na,Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",GRCh38,single nucleotide variant
SLC4A11,20,3228337,na,na,Pathogenic/Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|not provided|Corneal dystrophy, Fuchs endothelial, 4;Corneal dystrophy-perceptive deafness syndrome;Congenital hereditary endothelial dystrophy of cornea|Congenital hereditary endothelial dystrophy of cornea",GRCh38,single nucleotide variant
SLC4A11,20,3233937,na,na,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,GRCh38,single nucleotide variant
SLC4A11,20,3228952,na,na,Pathogenic,"Corneal dystrophy, Fuchs endothelial, 4",GRCh38,single nucleotide variant
SLC4A11,20,3228687,na,na,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 4|not specified|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",GRCh38,single nucleotide variant
SLC4A11,20,3230954,na,na,Uncertain significance,"Corneal dystrophy, Fuchs endothelial, 4|not specified|not provided",GRCh38,single nucleotide variant
MED25,19,49830790,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B2|Charcot-Marie-Tooth disease|not provided|not specified|Charcot-Marie-Tooth disease type 2|Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome|Tip-toe gait|MED25-related disorder,GRCh38,single nucleotide variant
CCDC28B,1,32204044,na,na,Uncertain significance,"Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome|CCDC28B-related disorder",GRCh38,single nucleotide variant
CCT5,5,10256063,na,na,Uncertain significance,Hereditary sensory and autonomic neuropathy with spastic paraplegia|not provided|CCT5-related disorder,GRCh38,single nucleotide variant
BBS10,12,76348258,na,na,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,GRCh38,single nucleotide variant
BBS10,12,76347054,na,na,Pathogenic,Bardet-Biedl syndrome 10|not provided|Bardet-Biedl syndrome|Retinal dystrophy,GRCh38,single nucleotide variant
BBS10,12,76348327,na,na,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,GRCh38,single nucleotide variant
CEP290,12,88077263,na,na,Pathogenic/Likely pathogenic,"Joubert syndrome 5|not provided|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Meckel-Gruber syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis|Meckel syndrome, type 4|Senior-Loken syndrome 6;Joubert syndrome 5|COG7 congenital disorder of glycosylation|Abnormality of the nervous system|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Joubert syndrome 5|Leber congenital amaurosis 10|CEP290-related disorder",GRCh38,single nucleotide variant
CEP290,12,88141287,na,na,Pathogenic,Joubert syndrome 5|not provided|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Nephronophthisis,GRCh38,single nucleotide variant
CEP290,12,88101183,na,na,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 10|not provided|Joubert syndrome 1|Intellectual disability|Meckel-Gruber syndrome;Nephronophthisis;Joubert syndrome|Retinitis pigmentosa|CEP290-related disorder|Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5;Bardet-Biedl syndrome 14;Meckel syndrome, type 4|Retinal dystrophy|Joubert syndrome 5|Bardet-Biedl syndrome 14|Leber congenital amaurosis",GRCh38,single nucleotide variant
CEP290,12,88111320,na,na,Pathogenic,Leber congenital amaurosis 10|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 14,GRCh38,single nucleotide variant
CEP290,12,88083936,na,na,Pathogenic,"Joubert syndrome 5|Leber congenital amaurosis 10|not provided|not specified|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Retinal dystrophy|Blindness|Nystagmus;Central hypotonia;Molar tooth sign on MRI|Senior-Loken syndrome 6|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|CEP290-related ciliopathy|Bardet-Biedl syndrome 14|CEP290-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
CEP290,12,88130324,na,na,Pathogenic,"Meckel syndrome, type 4|Polycystic kidney disease;Severe hydrocephalus;Encephalocele|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Leber congenital amaurosis 10|not provided|Retinal dystrophy|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Bardet-Biedl syndrome 14|CEP290-related disorder",GRCh38,single nucleotide variant
CEP290,12,88077227,na,na,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 14|Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis 10",GRCh38,single nucleotide variant
VANGL1,1,115664171,na,na,Uncertain significance,Caudal regression sequence|not provided,GRCh38,single nucleotide variant
VANGL1,1,115682372,na,na,Likely pathogenic,"Neural tube defects, susceptibility to|not provided",GRCh38,single nucleotide variant
VANGL1,1,115683980,na,na,risk factor,"Neural tube defects, susceptibility to",GRCh38,single nucleotide variant
ADAMTSL4,1,150556974,na,na,Pathogenic,"Ectopia lentis 2, isolated, autosomal recessive|not provided",GRCh38,single nucleotide variant
SIAE,11,124647396,na,na,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided",GRCh38,single nucleotide variant
SIAE,11,124649754,na,na,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|not specified|SIAE-related disorder",GRCh38,single nucleotide variant
SIAE,11,124660768,na,na,Benign,"Autoimmune disease, susceptibility to, 6|not provided",GRCh38,single nucleotide variant
SIAE,11,124638651,na,na,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|not specified",GRCh38,single nucleotide variant
ALDH5A1,6,24528167,na,na,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,GRCh38,single nucleotide variant
ALDH5A1,6,24511869,na,na,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,GRCh38,single nucleotide variant
ALDH5A1,6,24504871,na,na,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ALDH5A1,6,24528057,na,na,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ALDH5A1,6,24528049,na,na,Pathogenic/Likely pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
CLDN19,1,42740005,na,na,Pathogenic/Likely pathogenic,Renal hypomagnesemia 5 with ocular involvement|not provided|CLDN19-related disorder,GRCh38,single nucleotide variant
CLDN19,1,42739895,na,na,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,GRCh38,single nucleotide variant
CLDN19,1,42738540,na,na,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,GRCh38,single nucleotide variant
EHBP1,2,62904596,na,na,Uncertain significance,"Prostate cancer, hereditary, 12|EHBP1-related disorder",GRCh38,single nucleotide variant
TMEM67,8,93780872,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",GRCh38,single nucleotide variant
TMEM67,8,93782456,na,na,Pathogenic,"Meckel syndrome, type 3",GRCh38,single nucleotide variant
TMEM67,8,93791320,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",GRCh38,single nucleotide variant
TMEM67,8,93791282,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 6|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome and related disorders|6 conditions,GRCh38,single nucleotide variant
TMEM67,8,93804883,na,na,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,GRCh38,single nucleotide variant
TMEM67,8,93765648,na,na,Conflicting classifications of pathogenicity,"Joubert syndrome 6|Meckel syndrome, type 3|not provided|Meckel-Gruber syndrome;Joubert syndrome|TMEM67-related disorder|Joubert syndrome and related disorders",GRCh38,single nucleotide variant
TMEM67,8,93793256,na,na,Pathogenic/Likely pathogenic,Meckel-Gruber syndrome;Joubert syndrome|not provided,GRCh38,single nucleotide variant
TMEM67,8,93797329,na,na,Pathogenic,COACH syndrome 1|Joubert syndrome 6,GRCh38,single nucleotide variant
TMEM67,8,93765617,na,na,Pathogenic,"Joubert syndrome 6|Meckel syndrome, type 3|TMEM67-related disorder|Meckel-Gruber syndrome;Joubert syndrome|not provided|RHYNS syndrome|Joubert syndrome and related disorders|6 conditions|Inborn genetic diseases",GRCh38,single nucleotide variant
TMEM67,8,93780962,na,na,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 14, modifier of|Nephronophthisis|Joubert syndrome 6|RHYNS syndrome|not provided|Meckel-Gruber syndrome;Joubert syndrome|COACH syndrome 1|TMEM67-related disorder|Meckel syndrome, type 3|Nephronophthisis 11|6 conditions|not specified",GRCh38,single nucleotide variant
TMEM67,8,93808898,na,na,Pathogenic/Likely pathogenic,"COACH syndrome 1|Joubert syndrome 6|6 conditions|Meckel syndrome, type 3|Meckel-Gruber syndrome;Joubert syndrome|not provided|Joubert syndrome and related disorders|TMEM67-related disorder|Joubert syndrome 6;COACH syndrome 1;RHYNS syndrome;Nephronophthisis 11",GRCh38,single nucleotide variant
TMEM67,8,93808957,na,na,Pathogenic,COACH syndrome 1|Joubert syndrome 6,GRCh38,single nucleotide variant
TMEM67,8,93755871,na,na,Pathogenic,COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,GRCh38,single nucleotide variant
TMEM67,8,93795503,na,na,Pathogenic/Likely pathogenic,COACH syndrome 1|Joubert syndrome 6|not provided|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,GRCh38,single nucleotide variant
TMEM67,8,93808861,na,na,Pathogenic,Nephronophthisis 11|Joubert syndrome 6,GRCh38,single nucleotide variant
TMEM67,8,93795970,na,na,Pathogenic/Likely pathogenic,"Joubert syndrome 6|Nephronophthisis 11|Nephronophthisis|Meckel-Gruber syndrome;Joubert syndrome|Inborn genetic diseases|14 conditions|TMEM67-related disorder|not provided|Oligohydramnios;Joubert syndrome;Renal cyst|Nephronophthisis 11;Joubert syndrome 6;Bardet-Biedl syndrome 14;COACH syndrome 1;Meckel syndrome, type 3|RHYNS syndrome|6 conditions|Nephronophthisis 11;Joubert syndrome 6;RHYNS syndrome;COACH syndrome 1",GRCh38,single nucleotide variant
TMEM67,8,93780747,na,na,Pathogenic,Nephronophthisis 11,GRCh38,single nucleotide variant
TMEM67,8,93808861,na,na,Pathogenic,Joubert syndrome 6|Nephronophthisis 11,GRCh38,single nucleotide variant
TMEM67,8,93755044,na,na,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,GRCh38,single nucleotide variant
TMEM67,8,93780633,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 6|Nephronophthisis|Meckel-Gruber syndrome;Joubert syndrome|not provided|6 conditions|TMEM67-related disorder|Joubert syndrome and related disorders,GRCh38,single nucleotide variant
MKS1,17,58219149,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28",GRCh38,single nucleotide variant
MKS1,17,58210658,na,na,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|MKS1-related disorder",GRCh38,single nucleotide variant
MKS1,17,58216088,na,na,Conflicting classifications of pathogenicity,"Meckel syndrome, type 1|Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|Inborn genetic diseases|not provided|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|MKS1-related disorder",GRCh38,single nucleotide variant
MKS1,17,58206479,na,na,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 13|Hypotonia;Nystagmus;Polydactyly|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|Joubert syndrome 28|MKS1-related disorder|Meckel syndrome, type 1|Bardet-Biedl syndrome",GRCh38,single nucleotide variant
SPATA7,14,88416794,na,na,Pathogenic/Likely pathogenic,Leber congenital amaurosis 3|SPATA7-related disorder|not provided|Leber congenital amaurosis|Retinal dystrophy,GRCh38,single nucleotide variant
SPATA7,14,88437565,na,na,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 3|not provided|Retinitis pigmentosa 94, variable age at onset|Leber congenital amaurosis|Retinal dystrophy",GRCh38,single nucleotide variant
TMPRSS6,22,37073531,na,na,Pathogenic,Iron-refractory iron deficiency anemia,GRCh38,single nucleotide variant
TMPRSS6,22,37069072,na,na,Pathogenic,Iron-refractory iron deficiency anemia,GRCh38,single nucleotide variant
TMPRSS6,22,37075180,na,na,Pathogenic/Likely pathogenic,Iron-refractory iron deficiency anemia|not provided,GRCh38,single nucleotide variant
TMPRSS6,22,37073553,na,na,Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|TMPRSS6-related disorder,GRCh38,single nucleotide variant
TMPRSS6,22,37084775,na,na,Likely pathogenic,Iron-refractory iron deficiency anemia|not provided|TMPRSS6-related disorder,GRCh38,single nucleotide variant
TMPRSS6,22,37084339,na,na,Pathogenic,Iron-refractory iron deficiency anemia,GRCh38,single nucleotide variant
TMPRSS6,22,37070557,na,na,Pathogenic/Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|not provided,GRCh38,single nucleotide variant
TMPRSS6,22,37098426,na,na,Pathogenic,Iron-refractory iron deficiency anemia,GRCh38,single nucleotide variant
SPATA16,3,173019486,na,na,Likely benign,Globozoospermia|not provided,GRCh38,single nucleotide variant
SI,3,165019732,na,na,Uncertain significance,Sucrase-isomaltase deficiency|not provided,GRCh38,single nucleotide variant
SI,3,165060026,na,na,Pathogenic,Sucrase-isomaltase deficiency,GRCh38,single nucleotide variant
SI,3,165069101,na,na,Pathogenic,Sucrase-isomaltase deficiency,GRCh38,single nucleotide variant
SI,3,165046869,na,na,Pathogenic,Sucrase-isomaltase deficiency,GRCh38,single nucleotide variant
SI,3,165017621,na,na,Pathogenic,Sucrase-isomaltase deficiency,GRCh38,single nucleotide variant
SI,3,164983015,na,na,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,GRCh38,single nucleotide variant
SI,3,165046998,na,na,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,GRCh38,single nucleotide variant
SI,3,165021265,na,na,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|Inborn genetic diseases|not provided|SI-related disorder,GRCh38,single nucleotide variant
SLC24A4,14,92307319,na,na,association,"SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR",GRCh38,single nucleotide variant
MMACHC,1,45508282,na,na,Pathogenic/Likely pathogenic,Cobalamin C disease|Disorders of Intracellular Cobalamin Metabolism,GRCh38,single nucleotide variant
MMACHC,1,45508329,na,na,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria and homocystinuria type cblD|cblC type of combined methylmalonic aciduria and homocystinuria|Abnormality of metabolism/homeostasis|Disorders of Intracellular Cobalamin Metabolism,GRCh38,single nucleotide variant
MMACHC,1,45508266,na,na,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Disorders of Intracellular Cobalamin Metabolism|MMACHC-related disorder,GRCh38,single nucleotide variant
MMACHC,1,45508848,na,na,Pathogenic,Cobalamin C disease|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Inborn genetic diseases|Methylmalonic acidemia with homocystinuria cblC|MMACHC-related disorder|Disorders of Intracellular Cobalamin Metabolism,GRCh38,single nucleotide variant
SLC34A3,9,137234241,na,na,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|not provided,GRCh38,single nucleotide variant
SLC34A3,9,137234634,na,na,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease,GRCh38,single nucleotide variant
SLC34A3,9,137233722,na,na,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,GRCh38,single nucleotide variant
SLC34A3,9,137233234,na,na,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,GRCh38,single nucleotide variant
SLC34A3,9,137236018,na,na,Pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder,GRCh38,single nucleotide variant
SLC34A3,9,137233404,na,na,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|SLC34A3-related disorder|not provided|not specified,GRCh38,single nucleotide variant
COQ2,4,83269882,na,na,Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided",GRCh38,single nucleotide variant
COQ2,4,83273598,na,na,Pathogenic/Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Multiple system atrophy 1, susceptibility to;Coenzyme Q10 deficiency, primary, 1",GRCh38,single nucleotide variant
COQ2,4,83273505,na,na,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Inborn genetic diseases|Nephrotic syndrome",GRCh38,single nucleotide variant
COQ2,4,83279081,na,na,Pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|Multiple system atrophy 1, susceptibility to;Coenzyme Q10 deficiency, primary, 1",GRCh38,single nucleotide variant
HMBS,11,119085067,na,na,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",GRCh38,single nucleotide variant
HMBS,11,119088298,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119085067,na,na,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",GRCh38,single nucleotide variant
HMBS,11,119089991,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119091414,na,na,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",GRCh38,single nucleotide variant
HMBS,11,119091432,na,na,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",GRCh38,single nucleotide variant
HMBS,11,119090230,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119090213,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119092486,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119091507,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119088638,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119088647,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119091413,na,na,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",GRCh38,single nucleotide variant
HMBS,11,119091414,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119089084,na,na,Uncertain significance,Acute intermittent porphyria|not provided|not specified,GRCh38,single nucleotide variant
HMBS,11,119089216,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119091515,na,na,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",GRCh38,single nucleotide variant
HMBS,11,119089747,na,na,Pathogenic/Likely pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119091412,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119091444,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119092419,na,na,Conflicting classifications of pathogenicity,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119092491,na,na,Likely pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119092500,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119092506,na,na,Uncertain significance,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119092507,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119092518,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119092524,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119093109,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119089273,na,na,Pathogenic,Acute intermittent porphyria,GRCh38,single nucleotide variant
HMBS,11,119092159,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119092958,na,na,Pathogenic,Acute intermittent porphyria|not provided,GRCh38,single nucleotide variant
HMBS,11,119085034,na,na,Uncertain significance,"Porphyria, acute intermittent, nonerythroid variant|not provided",GRCh38,single nucleotide variant
HMBS,11,119089248,na,na,Pathogenic,"Encephalopathy, porphyria-related",GRCh38,single nucleotide variant
HMBS,11,119090212,na,na,Pathogenic,Acute intermittent porphyria|not provided|HMBS-related disorder,GRCh38,single nucleotide variant
SLC24A5,15,48134287,na,na,association,"Skin/hair/eye pigmentation, variation in, 4",GRCh38,single nucleotide variant
NEK8,17,28738721,na,na,Pathogenic,Nephronophthisis 9,GRCh38,single nucleotide variant
TRIOBP,22,37723595,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,GRCh38,single nucleotide variant
TRIOBP,22,37724297,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
TRIOBP,22,37723445,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28,GRCh38,single nucleotide variant
TRIOBP,22,37724918,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,GRCh38,single nucleotide variant
TRIOBP,22,37725758,na,na,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 28,GRCh38,single nucleotide variant
TRIOBP,22,37725905,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,GRCh38,single nucleotide variant
ACOX1,17,75953563,na,na,Pathogenic,Acyl-CoA oxidase deficiency,GRCh38,single nucleotide variant
ACOX1,17,75957465,na,na,Pathogenic,Acyl-CoA oxidase deficiency,GRCh38,single nucleotide variant
ACOX1,17,75953469,na,na,Pathogenic,Acyl-CoA oxidase deficiency,GRCh38,single nucleotide variant
ACOX1,17,75957555,na,na,Pathogenic,Acyl-CoA oxidase deficiency|not provided|Acyl-CoA oxidase deficiency;Mitchell syndrome,GRCh38,single nucleotide variant
PKLR,1,155295457,na,na,Uncertain significance,Pyruvate kinase deficiency of red cells|not provided,GRCh38,single nucleotide variant
PKLR,1,155293556,na,na,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,GRCh38,single nucleotide variant
PKLR,1,155293446,na,na,Pathogenic,Pyruvate kinase deficiency of red cells,GRCh38,single nucleotide variant
PKLR,1,155293177,na,na,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,GRCh38,single nucleotide variant
PKLR,1,155291845,na,na,Pathogenic,Pyruvate kinase deficiency of red cells|not provided|PKLR-related disorder,GRCh38,single nucleotide variant
PKLR,1,155300271,na,na,Affects,Pyruvate kinase hyperactivity,GRCh38,single nucleotide variant
PKLR,1,155291918,na,na,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|Pyruvate kinase hyperactivity;Pyruvate kinase deficiency of red cells|not provided|Pyruvate kinase hyperactivity|See cases|PKLR-related disorder,GRCh38,single nucleotide variant
PKLR,1,155295555,na,na,Pathogenic,Pyruvate kinase deficiency of red cells,GRCh38,single nucleotide variant
PKLR,1,155301478,na,na,Pathogenic,Pyruvate kinase deficiency of red cells,GRCh38,single nucleotide variant
PKLR,1,155293295,na,na,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,GRCh38,single nucleotide variant
PKLR,1,155293438,na,na,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|Pyruvate kinase deficiency of red cells;Pyruvate kinase hyperactivity|not provided,GRCh38,single nucleotide variant
LPL,8,19954185,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954222,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|LPL-related disorder",GRCh38,single nucleotide variant
LPL,8,19951916,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",GRCh38,single nucleotide variant
LPL,8,19955876,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19951768,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954279,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",GRCh38,single nucleotide variant
LPL,8,19954271,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954240,na,na,Conflicting classifications of pathogenicity,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
LPL,8,19955874,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype",GRCh38,single nucleotide variant
LPL,8,19951819,na,na,Pathogenic,"Hyperlipoproteinemia, type I|not provided",GRCh38,single nucleotide variant
LPL,8,19953386,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954126,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19962213,na,na,Benign,"Hyperlipoproteinemia, type I|Cardiovascular phenotype|not provided|not specified|LPL-related disorder|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19948341,na,na,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19951783,na,na,Pathogenic,"Hyperlipoproteinemia, type I|Cardiovascular phenotype",GRCh38,single nucleotide variant
LPL,8,19960988,na,na,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19955894,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19951856,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19951791,na,na,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19939529,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19959322,na,na,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19954174,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19951825,na,na,Pathogenic,"Hyperlipoproteinemia, type I|not provided",GRCh38,single nucleotide variant
LPL,8,19954243,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954199,na,na,Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",GRCh38,single nucleotide variant
LPL,8,19955873,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|LPL-related disorder|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19939214,na,na,Uncertain significance,"Hyperlipidemia, familial combined, susceptibility to|not specified",GRCh38,single nucleotide variant
LPL,8,19956018,na,na,Conflicting classifications of pathogenicity,"Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, susceptibility to|Hyperlipoproteinemia, type I|not specified|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
LPL,8,19960935,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19948197,na,na,Benign/Likely benign; other,"Hyperlipidemia, familial combined, susceptibility to|Coronary heart disease|not specified|Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",GRCh38,single nucleotide variant
LPL,8,19962126,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19954333,na,na,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",GRCh38,single nucleotide variant
LPL,8,19956052,na,na,Pathogenic,"Hyperlipoproteinemia, type I|LIPOPROTEIN LIPASE (OLBIA)",GRCh38,single nucleotide variant
LPL,8,19955863,na,na,Pathogenic,"Hyperlipoproteinemia, type I",GRCh38,single nucleotide variant
LPL,8,19961928,na,na,Benign,High density lipoprotein cholesterol level quantitative trait locus 11|not provided,GRCh38,single nucleotide variant
NAGLU,17,42544027,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|not provided|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",GRCh38,single nucleotide variant
NAGLU,17,42543882,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",GRCh38,single nucleotide variant
NAGLU,17,42541074,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",GRCh38,single nucleotide variant
NAGLU,17,42543934,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",GRCh38,single nucleotide variant
NAGLU,17,42543933,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",GRCh38,single nucleotide variant
NAGLU,17,42543568,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided|Mucopolysaccharidosis",GRCh38,single nucleotide variant
NAGLU,17,42543699,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",GRCh38,single nucleotide variant
NAGLU,17,42543700,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",GRCh38,single nucleotide variant
NAGLU,17,42536414,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",GRCh38,single nucleotide variant
NAGLU,17,42541127,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B|NAGLU-related disorder",GRCh38,single nucleotide variant
NAGLU,17,42543450,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",GRCh38,single nucleotide variant
NAGLU,17,42538691,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",GRCh38,single nucleotide variant
HPD,12,121849726,na,na,Likely pathogenic,Tyrosinemia type III|Hawkinsinuria;Tyrosinemia type III,GRCh38,single nucleotide variant
HPD,12,121846919,na,na,Pathogenic,Tyrosinemia type III,GRCh38,single nucleotide variant
HPD,12,121847211,na,na,Pathogenic,Tyrosinemia type III,GRCh38,single nucleotide variant
HPD,12,121839998,na,na,Conflicting classifications of pathogenicity,Tyrosinemia type III|Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria|not provided|not specified|HPD-related disorder,GRCh38,single nucleotide variant
HPD,12,121857429,na,na,Benign,Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria,GRCh38,single nucleotide variant
SLITRK1,13,83878728,na,na,Pathogenic,Tourette syndrome,GRCh38,single nucleotide variant
WDR36,5,111119021,na,na,Benign/Likely benign,"Glaucoma 1, open angle, G|not specified|not provided",GRCh38,single nucleotide variant
WDR36,5,111104342,na,na,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, G|not provided",GRCh38,single nucleotide variant
WDR36,5,111106140,na,na,Benign/Likely benign,"Glaucoma 1, open angle, G|not provided|Usher syndrome type 2C|WDR36-related disorder",GRCh38,single nucleotide variant
WDR36,5,111110280,na,na,Uncertain significance,"Glaucoma 1, open angle, G|not specified|not provided",GRCh38,single nucleotide variant
NLRP7,19,54940930,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54934488,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54938096,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54938095,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54930571,na,na,Likely pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54939525,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54938095,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54939626,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NLRP7,19,54938222,na,na,Pathogenic,"Hydatidiform mole, recurrent, 1",GRCh38,single nucleotide variant
NDUFAF2,5,61073136,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 10|Inborn genetic diseases|Leigh syndrome|not specified|Mitochondrial complex I deficiency, nuclear type 1|not provided",GRCh38,single nucleotide variant
NLRP12,19,53810809,na,na,Conflicting classifications of pathogenicity,Familial cold autoinflammatory syndrome 2|not provided|Autoinflammatory syndrome,GRCh38,single nucleotide variant
FANCM,14,45173065,na,na,Uncertain significance,"Fanconi anemia, complementation group M",GRCh38,single nucleotide variant
NECTIN4,1,161076355,na,na,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,GRCh38,single nucleotide variant
NECTIN4,1,161077629,na,na,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,GRCh38,single nucleotide variant
RSPO1,1,37616483,na,na,Pathogenic,Palmoplantar hyperkeratosis and true hermaphroditism,GRCh38,single nucleotide variant
GLRX5,14,95535383,na,na,Pathogenic,Sideroblastic anemia 3,GRCh38,single nucleotide variant
L2HGDH,14,50269164,na,na,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,GRCh38,single nucleotide variant
L2HGDH,14,50269162,na,na,Pathogenic,L-2-hydroxyglutaric aciduria,GRCh38,single nucleotide variant
L2HGDH,14,50302994,na,na,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|L2HGDH-related disorder,GRCh38,single nucleotide variant
L2HGDH,14,50302132,na,na,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,GRCh38,single nucleotide variant
CUL7,6,43038949,na,na,Pathogenic,3M syndrome 1|not provided,GRCh38,single nucleotide variant
CUL7,6,43038891,na,na,Pathogenic/Likely pathogenic,3M syndrome 1|3-M syndrome|not provided,GRCh38,single nucleotide variant
CUL7,6,43049665,na,na,Pathogenic,3M syndrome 1,GRCh38,single nucleotide variant
ACADL,2,210195326,na,na,Benign,not provided,GRCh38,single nucleotide variant
ACADVL,17,7223238,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ACADVL,17,7224966,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ACADVL,17,7223199,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADVL,17,7220519,na,na,Benign,Very long chain acyl-CoA dehydrogenase deficiency|not specified|not provided,GRCh38,single nucleotide variant
ACADVL,17,7224007,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|ACADVL-related disorder,GRCh38,single nucleotide variant
ACADVL,17,7223707,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADVL,17,7223984,na,na,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|Rhabdomyolysis;Abnormal circulating enzyme concentration,GRCh38,single nucleotide variant
PLEKHG4,16,67280029,na,na,Uncertain significance,Spinocerebellar ataxia type 31,GRCh38,single nucleotide variant
ALDH3A2,17,19656535,na,na,Pathogenic,Sjögren-Larsson syndrome,GRCh38,single nucleotide variant
ALDH3A2,17,19663335,na,na,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,GRCh38,single nucleotide variant
ALDH3A2,17,19657862,na,na,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,GRCh38,single nucleotide variant
ALDH3A2,17,19664997,na,na,Pathogenic,Sjögren-Larsson syndrome|not provided,GRCh38,single nucleotide variant
THAP1,8,42839212,na,na,Uncertain significance,Torsion dystonia 6,GRCh38,single nucleotide variant
THAP1,8,42839187,na,na,Uncertain significance,Torsion dystonia 6|not provided,GRCh38,single nucleotide variant
THAP1,8,42843070,na,na,Pathogenic,Torsion dystonia 6,GRCh38,single nucleotide variant
CHMP2B,3,87253421,na,na,Uncertain significance,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,GRCh38,single nucleotide variant
CHMP2B,3,87253798,na,na,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,GRCh38,single nucleotide variant
CHMP2B,3,87253472,na,na,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,GRCh38,single nucleotide variant
CYP27B1,12,57766073,na,na,Likely pathogenic,"Vitamin D-dependent rickets, type 1|Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57766019,na,na,Likely pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57764510,na,na,Pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57764169,na,na,Uncertain significance,"Vitamin D-dependent rickets, type 1A|not provided",GRCh38,single nucleotide variant
CYP27B1,12,57764755,na,na,Pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57765296,na,na,Pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57763798,na,na,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",GRCh38,single nucleotide variant
CYP27B1,12,57764147,na,na,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1|not provided|Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57766006,na,na,Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",GRCh38,single nucleotide variant
CYP27B1,12,57764148,na,na,Pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57764487,na,na,Pathogenic,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
CYP27B1,12,57765320,na,na,Uncertain significance,"Vitamin D-dependent rickets, type 1A",GRCh38,single nucleotide variant
MANBA,4,102689573,na,na,Pathogenic/Likely pathogenic,Beta-D-mannosidosis|not provided,GRCh38,single nucleotide variant
MANBA,4,102650702,na,na,Pathogenic,Beta-D-mannosidosis,GRCh38,single nucleotide variant
MANBA,4,102657873,na,na,Pathogenic,Beta-D-mannosidosis,GRCh38,single nucleotide variant
MANBA,4,102723865,na,na,Pathogenic,Beta-D-mannosidosis,GRCh38,single nucleotide variant
MANBA,4,102726614,na,na,Pathogenic,Beta-D-mannosidosis,GRCh38,single nucleotide variant
MANBA,4,102669004,na,na,Pathogenic,Beta-D-mannosidosis,GRCh38,single nucleotide variant
MAN2B1,19,12665750,na,na,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase,GRCh38,single nucleotide variant
MAN2B1,19,12649418,na,na,Pathogenic,Deficiency of alpha-mannosidase,GRCh38,single nucleotide variant
MAN2B1,19,12652376,na,na,Likely pathogenic,Deficiency of alpha-mannosidase,GRCh38,single nucleotide variant
MAN2B1,19,12649932,na,na,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
MAN2B1,19,12658470,na,na,Uncertain significance,Deficiency of alpha-mannosidase,GRCh38,single nucleotide variant
HAL,12,95992778,na,na,Affects,Histidinemia,GRCh38,single nucleotide variant
HAL,12,95992772,na,na,Affects,Histidinemia,GRCh38,single nucleotide variant
HAL,12,95990472,na,na,Affects,Histidinemia,GRCh38,single nucleotide variant
HAL,12,95987153,na,na,Affects,Histidinemia,GRCh38,single nucleotide variant
NDUFA13,19,19516253,na,na,Pathogenic,Hurthle cell carcinoma of thyroid,GRCh38,single nucleotide variant
LHFPL5,6,35806050,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 67,GRCh38,single nucleotide variant
LHFPL5,6,35814627,na,na,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 67|not provided|LHFPL5-related disorder,GRCh38,single nucleotide variant
PIKFYVE,2,208326119,na,na,Pathogenic,Fleck corneal dystrophy,GRCh38,single nucleotide variant
PIKFYVE,2,208325773,na,na,Pathogenic,Fleck corneal dystrophy,GRCh38,single nucleotide variant
ERCC6,10,49500673,na,na,Pathogenic,Cockayne syndrome type 2|not provided,GRCh38,single nucleotide variant
ERCC6,10,49478437,na,na,Pathogenic,DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome type 2|ERCC6-related disorder|not provided|Cerebrooculofacioskeletal syndrome 1|7 conditions,GRCh38,single nucleotide variant
ERCC6,10,49524073,na,na,Pathogenic,Cockayne syndrome type 2|Cockayne syndrome type 2;DE SANCTIS-CACCHIONE SYNDROME;Cerebrooculofacioskeletal syndrome 1|7 conditions|not provided|7 conditions,GRCh38,single nucleotide variant
ERCC6,10,49470676,na,na,Conflicting classifications of pathogenicity,Cockayne syndrome type 2|not specified|Cerebrooculofacioskeletal syndrome 1|Age related macular degeneration 5|not provided|DE SANCTIS-CACCHIONE SYNDROME,GRCh38,single nucleotide variant
ERCC6,10,49532736,na,na,Pathogenic,UV-sensitive syndrome 1|Cockayne syndrome type 2|not provided|Cockayne syndrome,GRCh38,single nucleotide variant
ERCC6,10,49539493,na,na,Benign,"LUNG CANCER, SUSCEPTIBILITY TO|Age related macular degeneration 5|not provided",GRCh38,single nucleotide variant
ERCC6,10,49482809,na,na,Pathogenic/Likely pathogenic,Cerebrooculofacioskeletal syndrome 1|not provided|ERCC6-related disorder|DE SANCTIS-CACCHIONE SYNDROME|7 conditions|Cockayne syndrome type 2,GRCh38,single nucleotide variant
ERCC6,10,49471085,na,na,Uncertain significance,Cerebrooculofacioskeletal syndrome 1|not specified,GRCh38,single nucleotide variant
ERCC6,10,49478386,na,na,Pathogenic,Cerebrooculofacioskeletal syndrome 1,GRCh38,single nucleotide variant
ERCC8,5,60890964,na,na,Pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,GRCh38,single nucleotide variant
NDUFAF2;ERCC8,5,60944972,na,na,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome|Cockayne syndrome type 1;UV-sensitive syndrome 2,GRCh38,single nucleotide variant
ERCC8,5,60904794,na,na,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,GRCh38,single nucleotide variant
ERCC8,5,60902446,na,na,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome type 1;UV-sensitive syndrome 2,GRCh38,single nucleotide variant
STOX1,10,68882104,na,na,risk factor,Preeclampsia/eclampsia 4,GRCh38,single nucleotide variant
STOX1,10,68885620,na,na,Benign,Preeclampsia/eclampsia 4|not specified|not provided,GRCh38,single nucleotide variant
FIG4,6,109715133,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4J|not provided|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis type 11|Amyotrophic lateral sclerosis|Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome|Yunis-Varon syndrome|Bilateral parasagittal parieto-occipital polymicrogyria|Inborn genetic diseases|FIG4-related disorder|Amyotrophic lateral sclerosis type 11;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome;Bilateral parasagittal parieto-occipital polymicrogyria,GRCh38,single nucleotide variant
FIG4,6,109735199,na,na,Pathogenic/Likely pathogenic,Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4J|not provided|Amyotrophic lateral sclerosis|Charcot-Marie-Tooth disease type 4|FIG4-related disorder,GRCh38,single nucleotide variant
FIG4,6,109715168,na,na,Uncertain significance,Amyotrophic lateral sclerosis type 11|Amyotrophic lateral sclerosis,GRCh38,single nucleotide variant
NIPAL4,5,157463303,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
NIPAL4,5,157468728,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Autosomal recessive congenital ichthyosis|Lamellar ichthyosis,GRCh38,single nucleotide variant
NIPAL4,5,157471818,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 6,GRCh38,single nucleotide variant
KIFBP,10,68989100,na,na,Pathogenic,Goldberg-Shprintzen syndrome,GRCh38,single nucleotide variant
KIFBP,10,68989082,na,na,Pathogenic,Goldberg-Shprintzen syndrome,GRCh38,single nucleotide variant
ESCO2,8,27799658,na,na,Likely pathogenic,Roberts-SC phocomelia syndrome|not provided,GRCh38,single nucleotide variant
ESCO2,8,27776813,na,na,Pathogenic,Roberts-SC phocomelia syndrome|not provided|Roberts syndrome|Roberts-SC phocomelia syndrome;Juberg-Hayward syndrome,GRCh38,single nucleotide variant
ESCO2,8,27791968,na,na,Pathogenic,Roberts-SC phocomelia syndrome|not provided,GRCh38,single nucleotide variant
ESCO2,8,27776912,na,na,Pathogenic,Roberts-SC phocomelia syndrome|not provided,GRCh38,single nucleotide variant
CBLIF,11,59845386,na,na,Benign,"Intrinsic factor deficiency, congenital, susceptibility to|Hereditary intrinsic factor deficiency|not provided",GRCh38,single nucleotide variant
CBLIF,11,59844056,na,na,Pathogenic,Hereditary intrinsic factor deficiency,GRCh38,single nucleotide variant
CBLIF,11,59843998,na,na,Likely pathogenic,Hereditary intrinsic factor deficiency,GRCh38,single nucleotide variant
DBH,9,133635393,na,na,association,Dopamine beta-hydroxylase polymorphism,GRCh38,single nucleotide variant
DBH,9,133636712,na,na,Pathogenic,Orthostatic hypotension 1|not provided,GRCh38,single nucleotide variant
DBH,9,133639848,na,na,Uncertain significance,Orthostatic hypotension 1,GRCh38,single nucleotide variant
DBH,9,133636672,na,na,Uncertain significance,Orthostatic hypotension 1,GRCh38,single nucleotide variant
MSH2,2,47475130,na,na,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided,GRCh38,single nucleotide variant
MSH2,2,47429881,na,na,Pathogenic,Lynch syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|Carcinoma of colon|Mismatch repair cancer syndrome 1;Muir-Torré syndrome;Lynch syndrome 1|Gastric cancer,GRCh38,single nucleotide variant
MSH2,2,47475180,na,na,Pathogenic,Lynch syndrome 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer,GRCh38,single nucleotide variant
MSH2,2,47475066,na,na,Pathogenic,Muir-Torré syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1,GRCh38,single nucleotide variant
MSH2,2,47466718,na,na,Likely pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary nonpolyposis colon cancer,GRCh38,single nucleotide variant
MSH2,2,47416318,na,na,Benign,MSH2 POLYMORPHISM|Lynch syndrome|not provided|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|not specified|Carcinoma of colon|Breast carcinoma|Hereditary nonpolyposis colorectal neoplasms,GRCh38,single nucleotide variant
MSH2,2,47475171,na,na,Pathogenic,Lynch syndrome|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Mismatch repair cancer syndrome 1;Muir-Torré syndrome;Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon,GRCh38,single nucleotide variant
SLC25A22,11,792429,na,na,Pathogenic/Likely pathogenic,"Early myoclonic encephalopathy|Developmental and epileptic encephalopathy|Developmental and epileptic encephalopathy, 3",GRCh38,single nucleotide variant
SLC25A22,11,792340,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 3",GRCh38,single nucleotide variant
CYP17A1,10,102835374,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|CYP17A1-related disorder",GRCh38,single nucleotide variant
CYP17A1,10,102834074,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Breast cancer, susceptibility to|not provided|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102832626,na,na,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not provided",GRCh38,single nucleotide variant
CYP17A1,10,102837076,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",GRCh38,single nucleotide variant
CYP17A1,10,102831503,na,na,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102832610,na,na,Pathogenic,"17,20-lyase deficiency, isolated|Deficiency of steroid 17-alpha-monooxygenase|not provided",GRCh38,single nucleotide variant
CYP17A1,10,102832577,na,na,Pathogenic/Likely pathogenic,"17,20-lyase deficiency, isolated|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",GRCh38,single nucleotide variant
CYP17A1,10,102837311,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided",GRCh38,single nucleotide variant
CYP17A1,10,102835249,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",GRCh38,single nucleotide variant
CYP17A1,10,102837084,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",GRCh38,single nucleotide variant
CYP17A1,10,102835350,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",GRCh38,single nucleotide variant
CYP17A1,10,102835343,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",GRCh38,single nucleotide variant
CYP17A1,10,102832611,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",GRCh38,single nucleotide variant
CYP17A1,10,102832566,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia|CYP17A1-related disorder",GRCh38,single nucleotide variant
CYP17A1,10,102831535,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102832665,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",GRCh38,single nucleotide variant
CYP17A1,10,102830946,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102834850,na,na,Uncertain significance,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not specified|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102837281,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",GRCh38,single nucleotide variant
CYP17A1,10,102837075,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",GRCh38,single nucleotide variant
CYP17A1,10,102835316,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102830982,na,na,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|CYP17A1-related disorder|Deficiency of steroid 17-alpha-monooxygenase",GRCh38,single nucleotide variant
CYP17A1,10,102830871,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",GRCh38,single nucleotide variant
CYP17A1,10,102835016,na,na,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",GRCh38,single nucleotide variant
SPRED1,15,38322382,na,na,Pathogenic,Legius syndrome|not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|Neurodevelopmental delay,GRCh38,single nucleotide variant
SPRED1,15,38299410,na,na,Pathogenic,Legius syndrome|not provided,GRCh38,single nucleotide variant
SPRED1,15,38324810,na,na,Pathogenic,Legius syndrome,GRCh38,single nucleotide variant
SPRED1,15,38349482,na,na,Pathogenic,Legius syndrome,GRCh38,single nucleotide variant
SPRED1,15,38299530,na,na,Pathogenic,Legius syndrome|not provided,GRCh38,single nucleotide variant
SPRED1,15,38349476,na,na,Pathogenic,Legius syndrome,GRCh38,single nucleotide variant
SPRED1,15,38351113,na,na,Pathogenic,Legius syndrome,GRCh38,single nucleotide variant
SPRED1,15,38299471,na,na,Pathogenic,Legius syndrome,GRCh38,single nucleotide variant
CPAP,13,24884083,na,na,Pathogenic,"Microcephaly 6, primary, autosomal recessive",GRCh38,single nucleotide variant
RAB3GAP2,1,220164733,na,na,Pathogenic,Martsolf syndrome|Martsolf syndrome 1,GRCh38,single nucleotide variant
CRBN,3,3150939,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, autosomal recessive 2|not provided",GRCh38,single nucleotide variant
LIPI,21,14189302,na,na,Benign,Hypertriglyceridemia 1|not provided,GRCh38,single nucleotide variant
GPSM2,1,108897592,na,na,Pathogenic,"Chudley-McCullough syndrome|Hearing loss, autosomal recessive|Breast-ovarian cancer, familial, susceptibility to, 2",GRCh38,single nucleotide variant
LPAR6,13,48411961,na,na,Likely pathogenic,Hypotrichosis 8,GRCh38,single nucleotide variant
LPAR6,13,48411862,na,na,Pathogenic/Likely pathogenic,"Wooly hair, autosomal recessive 1, with or without hypotrichosis|Hypotrichosis 8",GRCh38,single nucleotide variant
LPAR6,13,48411988,na,na,Likely pathogenic,Hypotrichosis 8,GRCh38,single nucleotide variant
LPAR6,13,48411859,na,na,Pathogenic/Likely pathogenic,Hypotrichosis 8,GRCh38,single nucleotide variant
IQCB1,3,121781772,na,na,Pathogenic,Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|not provided|Renal dysplasia and retinal aplasia|IQCB1-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
IQCB1,3,121790133,na,na,Pathogenic,Senior-Loken syndrome 5,GRCh38,single nucleotide variant
MRPS16,10,73250935,na,na,Uncertain significance,Combined oxidative phosphorylation defect type 2|not provided,GRCh38,single nucleotide variant
MRAP,21,32299078,na,na,Pathogenic,Glucocorticoid deficiency 2,GRCh38,single nucleotide variant
MRAP,21,32299078,na,na,Pathogenic,Glucocorticoid deficiency 2,GRCh38,single nucleotide variant
MRAP,21,32299078,na,na,Pathogenic,Glucocorticoid deficiency 2,GRCh38,single nucleotide variant
MRAP,21,32298974,na,na,Pathogenic,Glucocorticoid deficiency 2|Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MPLKIP,7,40133169,na,na,Pathogenic/Likely pathogenic,"Trichothiodystrophy 4, nonphotosensitive|not provided",GRCh38,single nucleotide variant
SUGCT,7,40459197,na,na,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency|not provided|SUGCT-related disorder,GRCh38,single nucleotide variant
SUGCT,7,40237664,na,na,Pathogenic,Glutaryl-CoA oxidase deficiency,GRCh38,single nucleotide variant
SUGCT,7,40188569,na,na,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency,GRCh38,single nucleotide variant
D2HGDH,2,241767734,na,na,Pathogenic,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
D2HGDH,2,241742524,na,na,Pathogenic,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
D2HGDH,2,241741010,na,na,Pathogenic,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
D2HGDH,2,241744707,na,na,Pathogenic,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
D2HGDH,2,241767718,na,na,Pathogenic,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
D2HGDH,2,241751371,na,na,Uncertain significance,D-2-hydroxyglutaric aciduria 1,GRCh38,single nucleotide variant
REEP1,2,86254816,na,na,Pathogenic,Hereditary spastic paraplegia 31,GRCh38,single nucleotide variant
REEP1,2,86217057,na,na,Conflicting classifications of pathogenicity,"Hereditary spastic paraplegia 31|Neuronopathy, distal hereditary motor, type 5B|not provided|Hereditary spastic paraplegia|Inborn genetic diseases|REEP1-related disorder|not specified",GRCh38,single nucleotide variant
REEP1,2,86282216,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 31|not provided|Spastic paraplegia|Hereditary spastic paraplegia|Inborn genetic diseases,GRCh38,single nucleotide variant
REEP1,2,86252037,na,na,Pathogenic,Hereditary spastic paraplegia 31|Hereditary spastic paraplegia|not provided,GRCh38,single nucleotide variant
PDCD10,3,167695606,na,na,Pathogenic,Cerebral cavernous malformation 3,GRCh38,single nucleotide variant
PDCD10,3,167687317,na,na,Pathogenic,Cerebral cavernous malformation 3,GRCh38,single nucleotide variant
POU6F2,7,39339703,na,na,Pathogenic,Wilms tumor 5,GRCh38,single nucleotide variant
POU6F2,7,38978015,na,na,Pathogenic,Wilms tumor 5,GRCh38,single nucleotide variant
PNPLA2,11,822494,na,na,Pathogenic,Neutral lipid storage myopathy,GRCh38,single nucleotide variant
PNPLA2,11,823801,na,na,Pathogenic,Neutral lipid storage myopathy,GRCh38,single nucleotide variant
MMUT,6,49459415,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|not provided",GRCh38,single nucleotide variant
MMUT,6,49459154,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia",GRCh38,single nucleotide variant
MMUT,6,49451668,na,na,Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",GRCh38,single nucleotide variant
MMUT,6,49459189,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder",GRCh38,single nucleotide variant
MMUT,6,49431831,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",GRCh38,single nucleotide variant
MMUT,6,49459118,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency",GRCh38,single nucleotide variant
MMUT,6,49440295,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|MMUT-related disorder",GRCh38,single nucleotide variant
MMUT,6,49435473,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",GRCh38,single nucleotide variant
MMUT,6,49457789,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",GRCh38,single nucleotide variant
MMUT,6,49459145,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder|not specified",GRCh38,single nucleotide variant
MMUT,6,49457801,na,na,Pathogenic/Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic acidemia",GRCh38,single nucleotide variant
MMUT,6,49436515,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE",GRCh38,single nucleotide variant
MMUT,6,49441840,na,na,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",GRCh38,single nucleotide variant
KRT75,12,52433824,na,na,Benign; risk factor,not provided|Pseudofolliculitis barbae|KRT75-related disorder,GRCh38,single nucleotide variant
PNKD,2,218270561,na,na,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal dyskinesia;Episodic hemiplegia;Paroxysmal dystonia|not provided|Paroxysmal nonkinesigenic dyskinesia,GRCh38,single nucleotide variant
PNKD,2,218270555,na,na,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia,GRCh38,single nucleotide variant
PNKD,2,218271410,na,na,Conflicting classifications of pathogenicity,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia|not provided,GRCh38,single nucleotide variant
BTD,3,15645451,na,na,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,GRCh38,single nucleotide variant
BTD,3,15645468,na,na,Pathogenic,Biotinidase deficiency|Inborn genetic diseases|not provided|BTD-related disorder,GRCh38,single nucleotide variant
BTD,3,15635479,na,na,Pathogenic/Likely pathogenic,Biotinidase deficiency|BTD-related disorder,GRCh38,single nucleotide variant
BTD,3,15645186,na,na,Conflicting classifications of pathogenicity,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,GRCh38,single nucleotide variant
BTD,3,15644611,na,na,Pathogenic,Biotinidase deficiency|not provided,GRCh38,single nucleotide variant
BTD,3,15645224,na,na,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Intellectual disability|Inborn genetic diseases|BTD-related disorder,GRCh38,single nucleotide variant
BTD,3,15645322,na,na,Conflicting classifications of pathogenicity,Biotinidase deficiency|not specified|not provided,GRCh38,single nucleotide variant
BTD,3,15645063,na,na,Conflicting classifications of pathogenicity; other,Biotinidase deficiency|not provided,GRCh38,single nucleotide variant
BTD,3,15635614,na,na,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided,GRCh38,single nucleotide variant
HLCS,21,36936735,na,na,Pathogenic,Holocarboxylase synthetase deficiency,GRCh38,single nucleotide variant
HLCS,21,36759811,na,na,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,GRCh38,single nucleotide variant
HLCS,21,36765170,na,na,Pathogenic,Holocarboxylase synthetase deficiency,GRCh38,single nucleotide variant
HLCS,21,36759781,na,na,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency,GRCh38,single nucleotide variant
HLCS,21,36765044,na,na,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,GRCh38,single nucleotide variant
HLCS,21,36767213,na,na,Pathogenic,Holocarboxylase synthetase deficiency|not provided,GRCh38,single nucleotide variant
HLCS,21,36936798,na,na,Pathogenic,Holocarboxylase synthetase deficiency,GRCh38,single nucleotide variant
ERMAP,1,42830851,na,na,Likely benign,"SCIANNA BLOOD GROUP SYSTEM, SC:-1,2|not specified",GRCh38,single nucleotide variant
ERMAP,1,42830860,na,na,Affects,RADIN BLOOD GROUP ANTIGEN,GRCh38,single nucleotide variant
ERMAP,1,42830821,na,na,Affects,Antigen in Scianna blood group system,GRCh38,single nucleotide variant
MCCC2,5,71599672,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,GRCh38,single nucleotide variant
MCCC2,5,71602586,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,GRCh38,single nucleotide variant
MCCC2,5,71635176,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Autism spectrum disorder|Methylcrotonyl-CoA carboxylase deficiency,GRCh38,single nucleotide variant
MCCC2,5,71602621,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Methylcrotonyl-CoA carboxylase deficiency,GRCh38,single nucleotide variant
MCCC2,5,71632185,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided,GRCh38,single nucleotide variant
MCCC2,5,71649189,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,GRCh38,single nucleotide variant
MCCC2,5,71604413,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,GRCh38,single nucleotide variant
MCCC2,5,71634977,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,GRCh38,single nucleotide variant
MCCC2,5,71652755,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,GRCh38,single nucleotide variant
MCCC1,3,183045522,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
MCCC1,3,183041679,na,na,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
MCCC1,3,183037218,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,GRCh38,single nucleotide variant
MCCC1,3,183039093,na,na,Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,GRCh38,single nucleotide variant
MCCC1,3,183034068,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,GRCh38,single nucleotide variant
MCCC1,3,183037432,na,na,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,GRCh38,single nucleotide variant
LRRK2,12,40310434,na,na,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,GRCh38,single nucleotide variant
LRRK2,12,40321114,na,na,Pathogenic,Autosomal dominant Parkinson disease 8,GRCh38,single nucleotide variant
LRRK2,12,40310434,na,na,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,GRCh38,single nucleotide variant
LRRK2,12,40299125,na,na,Pathogenic,Autosomal dominant Parkinson disease 8,GRCh38,single nucleotide variant
LRRK2,12,40340400,na,na,Pathogenic/Likely pathogenic; risk factor,"Autosomal dominant Parkinson disease 8|not provided|Inborn genetic diseases|Young-onset Parkinson disease|Parkinson disease|Parkinson disease, late-onset|LRRK2-related disorder",GRCh38,single nucleotide variant
LRRK2,12,40340404,na,na,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,GRCh38,single nucleotide variant
LRRK2,12,40310435,na,na,Pathogenic/Likely pathogenic,Autosomal dominant Parkinson disease 8,GRCh38,single nucleotide variant
LRRK2,12,40363526,na,na,Conflicting classifications of pathogenicity; risk factor,Autosomal dominant Parkinson disease 8|Parkinson disease|not provided,GRCh38,single nucleotide variant
ADAMTS10,19,8601029,na,na,Pathogenic,Weill-Marchesani syndrome 1|not provided,GRCh38,single nucleotide variant
ADAMTS10,19,8596306,na,na,Pathogenic,Weill-Marchesani syndrome 1,GRCh38,single nucleotide variant
ADAMTS10,19,8600927,na,na,Likely pathogenic,Weill-Marchesani syndrome 1|not provided,GRCh38,single nucleotide variant
ADAMTS10,19,8605638,na,na,Uncertain significance,Weill-Marchesani syndrome 1|not provided,GRCh38,single nucleotide variant
ADAMTS10,19,8597075,na,na,Pathogenic,Weill-Marchesani syndrome 1,GRCh38,single nucleotide variant
ADAMTS10,19,8592797,na,na,Pathogenic,Weill-Marchesani syndrome 1,GRCh38,single nucleotide variant
ADAMTS10,19,8589302,na,na,Pathogenic,Weill-Marchesani syndrome 1,GRCh38,single nucleotide variant
DNAJC19,3,180987023,na,na,Pathogenic,3-methylglutaconic aciduria type 5|DNAJC19-related disorder,GRCh38,single nucleotide variant
CABP4,11,67456191,na,na,Conflicting classifications of pathogenicity,"Cone-rod synaptic disorder, congenital nonprogressive|not provided",GRCh38,single nucleotide variant
ADA,20,44626579,na,na,Benign,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",GRCh38,single nucleotide variant
ADA,20,44626517,na,na,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44626516,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA,20,44623053,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",GRCh38,single nucleotide variant
ADA,20,44621082,na,na,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|ADA-related disorder|not provided",GRCh38,single nucleotide variant
ADA,20,44620391,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|ADA-related disorder",GRCh38,single nucleotide variant
ADA,20,44621103,na,na,Conflicting classifications of pathogenicity,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA,20,44626592,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",GRCh38,single nucleotide variant
ADA,20,44625601,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",GRCh38,single nucleotide variant
ADA,20,44622612,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44626498,na,na,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA;PKIG,20,44623054,na,na,Likely pathogenic,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA,20,44623042,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",GRCh38,single nucleotide variant
ADA,20,44623039,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder",GRCh38,single nucleotide variant
ADA,20,44626601,na,na,Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44625581,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease|not provided",GRCh38,single nucleotide variant
ADA,20,44621121,na,na,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA,20,44620435,na,na,Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44651586,na,na,Benign,"Adenosine deaminase 2 allozyme|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",GRCh38,single nucleotide variant
ADA,20,44651574,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44626597,na,na,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44625593,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
ADA,20,44622911,na,na,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44626528,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
ADA,20,44619862,na,na,Uncertain significance,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",GRCh38,single nucleotide variant
ADA,20,44625580,na,na,Pathogenic/Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
FREM2,13,38859591,na,na,Pathogenic,Fraser syndrome 2,GRCh38,single nucleotide variant
FREM2,13,38784703,na,na,Uncertain significance,Fraser syndrome 2|Fraser syndrome 2;Isolated cryptophthalmia,GRCh38,single nucleotide variant
FREM1,9,14824929,na,na,Uncertain significance,BNAR syndrome|not provided|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome|Oculotrichoanal syndrome,GRCh38,single nucleotide variant
FREM1,9,14784494,na,na,Uncertain significance,BNAR syndrome|not provided|Oculotrichoanal syndrome|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome,GRCh38,single nucleotide variant
ARL13B,3,94003764,na,na,Pathogenic,Joubert syndrome 8,GRCh38,single nucleotide variant
ARL13B,3,94003774,na,na,Pathogenic,Joubert syndrome 8,GRCh38,single nucleotide variant
ARL13B,3,94036663,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 8|Joubert syndrome and related disorders,GRCh38,single nucleotide variant
PITPNM3,17,6468237,na,na,Conflicting classifications of pathogenicity,Cone-rod dystrophy 5|not specified|not provided|Retinitis pigmentosa|Retinal dystrophy|PITPNM3-related disorder,GRCh38,single nucleotide variant
ATPAF2,17,18028276,na,na,Pathogenic,"Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1",GRCh38,single nucleotide variant
UNC13D,17,75836338,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome,GRCh38,single nucleotide variant
UNC13D,17,75840317,na,na,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome|UNC13D-related disorder,GRCh38,single nucleotide variant
UNC13D,17,75840506,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided,GRCh38,single nucleotide variant
UNC13D,17,75836662,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|Familial hemophagocytic lymphohistiocytosis,GRCh38,single nucleotide variant
UNC13D,17,75831153,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,GRCh38,single nucleotide variant
SGCG,13,23324513,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided,GRCh38,single nucleotide variant
SGCG,13,23324452,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
AHI1,6,135457594,na,na,Pathogenic,Joubert syndrome 3|Joubert syndrome,GRCh38,single nucleotide variant
AHI1,6,135455775,na,na,Pathogenic,Joubert syndrome 3|Joubert syndrome,GRCh38,single nucleotide variant
AHI1,6,135455750,na,na,Pathogenic/Likely pathogenic,Joubert syndrome 3|Global developmental delay;Typical Joubert syndrome MRI findings,GRCh38,single nucleotide variant
AHI1,6,135447022,na,na,Pathogenic,Joubert syndrome 3|not provided|Rod-cone dystrophy|Joubert syndrome,GRCh38,single nucleotide variant
AHI1,6,135433125,na,na,Conflicting classifications of pathogenicity,Joubert syndrome 3|Joubert syndrome|Joubert syndrome with ocular defect|not provided|AHI1-related disorder,GRCh38,single nucleotide variant
SLC6A19,5,1212338,na,na,Pathogenic/Likely pathogenic,Neutral 1 amino acid transport defect|not provided|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not specified|SLC6A19-related disorder,GRCh38,single nucleotide variant
SLC6A19,5,1213517,na,na,Pathogenic,Neutral 1 amino acid transport defect|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not provided,GRCh38,single nucleotide variant
SLC6A19,5,1216785,na,na,Benign,"Iminoglycinuria, digenic|Hyperglycinuria|not specified|Neutral 1 amino acid transport defect|not provided",GRCh38,single nucleotide variant
CHD7,8,60822627,na,na,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|See cases,GRCh38,single nucleotide variant
CHD7,8,60830569,na,na,Pathogenic,CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60850506,na,na,Pathogenic,CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60855993,na,na,Pathogenic,CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60836105,na,na,Pathogenic,CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60777762,na,na,Uncertain significance,"Scoliosis, isolated, susceptibility to, 3",GRCh38,single nucleotide variant
CHD7,8,60853047,na,na,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided,GRCh38,single nucleotide variant
CHD7,8,60816389,na,na,Pathogenic,CHARGE syndrome|HYPOGONADOTROPIC HYPOGONADISM 5 WITHOUT ANOSMIA,GRCh38,single nucleotide variant
CHD7,8,60801598,na,na,Pathogenic,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60816506,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 5 with or without anosmia|not provided|Childhood onset hearing loss|CHARGE syndrome|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|Inborn genetic diseases,GRCh38,single nucleotide variant
CHD7,8,60741596,na,na,Benign,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,GRCh38,single nucleotide variant
CHD7,8,60841997,na,na,Pathogenic,CHARGE syndrome|not provided,GRCh38,single nucleotide variant
PPARGC1B,5,149832680,na,na,Benign,PPARGC1B polymorphism|not provided,GRCh38,single nucleotide variant
ARL6,3,97788004,na,na,Pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Retinal dystrophy,GRCh38,single nucleotide variant
ARL6,3,97791797,na,na,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1",GRCh38,single nucleotide variant
ARL6,3,97768199,na,na,Pathogenic,Bardet-Biedl syndrome 3|Retinitis pigmentosa|Retinitis pigmentosa 55;Bardet-Biedl syndrome 3|not provided|Bardet-Biedl syndrome 1;Retinitis pigmentosa 55;Bardet-Biedl syndrome 3,GRCh38,single nucleotide variant
ARL6,3,97791800,na,na,Pathogenic,Bardet-Biedl syndrome 3,GRCh38,single nucleotide variant
ARL6,3,97768199,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1|Retinal dystrophy,GRCh38,single nucleotide variant
ARL6,3,97784966,na,na,Likely pathogenic,Retinitis pigmentosa 55|Autosomal recessive retinitis pigmentosa,GRCh38,single nucleotide variant
RDH12,14,67729209,na,na,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RDH12,14,67727097,na,na,Pathogenic,Leber congenital amaurosis 13,GRCh38,single nucleotide variant
RDH12,14,67724550,na,na,Pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|Retinal dystrophy,GRCh38,single nucleotide variant
RDH12,14,67724588,na,na,Pathogenic,Leber congenital amaurosis 13|Leber congenital amaurosis|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RDH12,14,67726086,na,na,Pathogenic,Leber congenital amaurosis 13|not provided|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
RDH12,14,67726983,na,na,Pathogenic,Leber congenital amaurosis 13,GRCh38,single nucleotide variant
RDH12,14,67729220,na,na,Pathogenic,Leber congenital amaurosis 13,GRCh38,single nucleotide variant
RDH12,14,67726983,na,na,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RDH12,14,67725206,na,na,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|Retinal dystrophy|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
RDH12,14,67727055,na,na,Pathogenic,Leber congenital amaurosis 13,GRCh38,single nucleotide variant
RDH12,14,67724556,na,na,Likely pathogenic,Leber congenital amaurosis 13,GRCh38,single nucleotide variant
RDH12,14,67727191,na,na,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa,GRCh38,single nucleotide variant
RDH12,14,67726996,na,na,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|See cases|Retinal dystrophy,GRCh38,single nucleotide variant
RDH12,14,67726084,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 53|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|RDH12-related disorder,GRCh38,single nucleotide variant
SUMO4;TAB2,6,149400554,na,na,Benign,Type 1 diabetes mellitus 5|not specified|not provided,GRCh38,single nucleotide variant
EFHC1,6,52438563,na,na,Benign,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|Juvenile myoclonic epilepsy|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1",GRCh38,single nucleotide variant
EFHC1,6,52452799,na,na,Conflicting classifications of pathogenicity,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|not provided|Absence seizure|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",GRCh38,single nucleotide variant
EFHC1,6,52452742,na,na,Uncertain significance,"Myoclonic epilepsy, juvenile, susceptibility to, 1|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",GRCh38,single nucleotide variant
EFHC1,6,52454128,na,na,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",GRCh38,single nucleotide variant
EFHC1,6,52424111,na,na,Benign/Likely benign,"not specified|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1|EFHC1-related disorder",GRCh38,single nucleotide variant
EFHC1,6,52438538,na,na,risk factor,Absence seizure,GRCh38,single nucleotide variant
EFHC1,6,52454147,na,na,risk factor,Absence seizure,GRCh38,single nucleotide variant
EFHC1,6,52454254,na,na,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",GRCh38,single nucleotide variant
GJC2,1,228158615,na,na,Pathogenic,Hypomyelinating leukodystrophy 2|See cases,GRCh38,single nucleotide variant
GJC2,1,228158026,na,na,Likely pathogenic,Hypomyelinating leukodystrophy 2,GRCh38,single nucleotide variant
GJC2,1,228158476,na,na,Pathogenic,Hypomyelinating leukodystrophy 2|not provided,GRCh38,single nucleotide variant
GJC2,1,228158572,na,na,Pathogenic,Hypomyelinating leukodystrophy 2,GRCh38,single nucleotide variant
GJC2,1,228157866,na,na,Pathogenic,Hereditary spastic paraplegia 44,GRCh38,single nucleotide variant
GJC2,1,228157901,na,na,Pathogenic,Lymphatic malformation 3,GRCh38,single nucleotide variant
GJC2,1,228158536,na,na,Pathogenic,Lymphatic malformation 3,GRCh38,single nucleotide variant
GCDH,19,12896940,na,na,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided",GRCh38,single nucleotide variant
GCDH,19,12899486,na,na,Pathogenic,"Glutaric aciduria, type 1|not provided",GRCh38,single nucleotide variant
GCDH,19,12896934,na,na,Pathogenic,"Glutaric aciduria, type 1|not provided",GRCh38,single nucleotide variant
GCDH,19,12899471,na,na,Likely pathogenic,"Glutaric aciduria, type 1",GRCh38,single nucleotide variant
GCDH,19,12897824,na,na,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided|Abnormality of metabolism/homeostasis|Inborn genetic diseases|Primary ciliary dyskinesia 29",GRCh38,single nucleotide variant
GCDH,19,12897713,na,na,Pathogenic,"Glutaric aciduria, type 1|not provided",GRCh38,single nucleotide variant
GCDH;KLF1;LOC117125594,19,12891400,na,na,Pathogenic,"Glutaric aciduria, type 1|FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6;Congenital dyserythropoietic anemia type 4;BLOOD GROUP--LUTHERAN INHIBITOR",GRCh38,single nucleotide variant
GCDH,19,12897818,na,na,Pathogenic,"Glutaric aciduria, type 1|not provided|GCDH-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
GCDH,19,12896249,na,na,Pathogenic,"Glutaric aciduria, type 1|not provided",GRCh38,single nucleotide variant
GSDME,7,24706382,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,GRCh38,single nucleotide variant
GSDME,7,24706180,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,GRCh38,single nucleotide variant
PC,11,66851944,na,na,Pathogenic,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
PC,11,66850918,na,na,Pathogenic,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
PC,11,66871368,na,na,Pathogenic,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
PC,11,66863791,na,na,Likely pathogenic,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
PC,11,66871335,na,na,Conflicting classifications of pathogenicity,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
PC,11,66852516,na,na,Pathogenic,Pyruvate carboxylase deficiency,GRCh38,single nucleotide variant
GTF2H5,6,158192107,na,na,Pathogenic/Likely pathogenic,"Trichothiodystrophy 3, photosensitive|not provided",GRCh38,single nucleotide variant
GTF2H5,6,158192003,na,na,Pathogenic,"Trichothiodystrophy 3, photosensitive",GRCh38,single nucleotide variant
ANKK1,11,113400106,na,na,Benign,Taq1A POLYMORPHISM|not specified|ANKK1-related disorder|Schizophrenia|not provided,GRCh38,single nucleotide variant
MED13L,12,116019846,na,na,Uncertain significance,"Transposition of the great arteries, dextro-looped|Impaired intellectual development and distinctive facial features with cardiac defects|Cardiac anomalies - developmental delay - facial dysmorphism syndrome",GRCh38,single nucleotide variant
MED13L,12,115975287,na,na,Uncertain significance,"Transposition of the great arteries, dextro-looped",GRCh38,single nucleotide variant
MED13L,12,115969097,na,na,Uncertain significance,"Transposition of the great arteries, dextro-looped",GRCh38,single nucleotide variant
DLAT,11,112061088,na,na,Conflicting classifications of pathogenicity,Pyruvate dehydrogenase E2 deficiency,GRCh38,single nucleotide variant
PDHX,11,34960519,na,na,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,GRCh38,single nucleotide variant
PDHX,11,34984569,na,na,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,GRCh38,single nucleotide variant
PDHX,11,34966740,na,na,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,GRCh38,single nucleotide variant
TSEN54,17,75522000,na,na,Pathogenic,Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 4|Inborn genetic diseases|Olivopontocerebellar hypoplasia|Global developmental delay;Microcephaly|not provided|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|Amblyopia;Global developmental delay;Hypertonia|Congenital cerebellar hypoplasia|Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4;Methylmalonic aciduria and homocystinuria type cblD|Intellectual disability|TSEN54 Pontocerebellar Hypoplasia|Pontocerebellar hypoplasia type 2;Pontocerebellar hypoplasia type 4|Pontoneocerebellar hypoplasia|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4|TSEN54-related disorder,GRCh38,single nucleotide variant
TSEN54,17,75521817,na,na,Pathogenic/Likely pathogenic,Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|not provided,GRCh38,single nucleotide variant
TSEN54,17,75522108,na,na,Pathogenic,Pontocerebellar hypoplasia type 4,GRCh38,single nucleotide variant
TSEN34,19,54191536,na,na,Pathogenic,Pontocerebellar hypoplasia type 2C,GRCh38,single nucleotide variant
TSEN2,3,12516627,na,na,Conflicting classifications of pathogenicity,Pontocerebellar hypoplasia type 2B|Pontoneocerebellar hypoplasia|not provided,GRCh38,single nucleotide variant
C1QTNF5,11,119339574,na,na,Pathogenic/Likely pathogenic,Late-onset retinal degeneration|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
ALG3,3,184245559,na,na,Pathogenic,ALG3-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG3,3,184248776,na,na,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
ALG3,3,184245291,na,na,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
ALG3,3,184245798,na,na,Uncertain significance,ALG3-congenital disorder of glycosylation|not specified,GRCh38,single nucleotide variant
ALG3,3,184245333,na,na,Pathogenic,ALG3-congenital disorder of glycosylation,GRCh38,single nucleotide variant
SLC39A13,11,47410315,na,na,Conflicting classifications of pathogenicity,"Ehlers-Danlos syndrome, spondylocheirodysplastic type|not provided",GRCh38,single nucleotide variant
CYP2R1,11,14885847,na,na,Pathogenic/Likely pathogenic,"Vitamin D hydroxylation-deficient rickets, type 1B|not provided|Vitamin D-dependent rickets, type 1|CYP2R1-related disorder",GRCh38,single nucleotide variant
DNAAF4,15,55498332,na,na,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided",GRCh38,single nucleotide variant
DNAAF4,15,55430684,na,na,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided|Primary ciliary dyskinesia 25",GRCh38,single nucleotide variant
NIPBL,5,36953698,na,na,Pathogenic/Likely pathogenic,Cornelia de Lange syndrome 1|not provided,GRCh38,single nucleotide variant
NIPBL,5,37057211,na,na,Pathogenic,Cornelia de Lange syndrome 1,GRCh38,single nucleotide variant
NIPBL,5,37020615,na,na,Pathogenic,Cornelia de Lange syndrome 1,GRCh38,single nucleotide variant
NIPBL,5,37002734,na,na,Pathogenic,Cornelia de Lange syndrome 1,GRCh38,single nucleotide variant
NIPBL,5,37063789,na,na,Pathogenic,Cornelia de Lange syndrome 1,GRCh38,single nucleotide variant
NIPBL,5,37014728,na,na,Pathogenic,Cornelia de Lange syndrome 1,GRCh38,single nucleotide variant
PEX26,22,18079935,na,na,Pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder|not provided|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|PEX26-related disorder,GRCh38,single nucleotide variant
PEX26,22,18079908,na,na,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B,GRCh38,single nucleotide variant
PEX26,22,18078378,na,na,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|not provided|Peroxisome biogenesis disorder 7B;Peroxisome biogenesis disorder 7A (Zellweger),GRCh38,single nucleotide variant
PEX26,22,18078510,na,na,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PEX26,22,18078607,na,na,Pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
ANO5,11,22250793,na,na,Pathogenic,Gnathodiaphyseal dysplasia|not provided,GRCh38,single nucleotide variant
ANO5,11,22250793,na,na,Pathogenic,Gnathodiaphyseal dysplasia|not provided,GRCh38,single nucleotide variant
ANO5,11,22255485,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|ANO5-related disorder,GRCh38,single nucleotide variant
ANO5,11,22236206,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|ANO5-related disorder|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3|Hereditary fructosuria|Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
ANO5,11,22274605,na,na,Pathogenic,Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|Autosomal recessive limb-girdle muscular dystrophy|ANO5 Muscle Disease,GRCh38,single nucleotide variant
SEC63,6,107929466,na,na,Pathogenic,Polycystic liver disease 2,GRCh38,single nucleotide variant
SEC63,6,107908926,na,na,Pathogenic,Polycystic liver disease 2|not provided,GRCh38,single nucleotide variant
CASP12,11,104892390,na,na,Likely benign,not specified|CASP12-related disorder|not provided,GRCh38,single nucleotide variant
ROBO3,11,124871062,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124875145,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124875150,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124872919,na,na,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124870650,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124865591,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124868837,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124874910,na,na,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124870035,na,na,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
ROBO3,11,124875581,na,na,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",GRCh38,single nucleotide variant
CYP4V2,4,186191953,na,na,Uncertain significance,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CYP4V2,4,186196007,na,na,Pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CYP4V2,4,186210586,na,na,Conflicting classifications of pathogenicity,Bietti crystalline corneoretinal dystrophy|not provided,GRCh38,single nucleotide variant
CYP4V2,4,186192004,na,na,Pathogenic,Bietti crystalline corneoretinal dystrophy,GRCh38,single nucleotide variant
CYP4V2,4,186208863,na,na,Pathogenic/Likely pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
NPSR1,7,34778501,na,na,Benign,"Asthma-related traits, susceptibility to, 2",GRCh38,single nucleotide variant
RP1L1,8,10623069,na,na,Pathogenic/Likely pathogenic,Occult macular dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 88|Optic atrophy,GRCh38,single nucleotide variant
RP1L1,8,10611220,na,na,Uncertain significance,Occult macular dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
MYH14,19,50210385,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,GRCh38,single nucleotide variant
MYH14,19,50271424,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 4A|not provided,GRCh38,single nucleotide variant
MYH14,19,50259210,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,GRCh38,single nucleotide variant
MYH14,19,50244277,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not specified|not provided|Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,GRCh38,single nucleotide variant
MYH14,19,50210724,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not provided|MYH14-related disorder,GRCh38,single nucleotide variant
VPS33B,15,90999963,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided",GRCh38,single nucleotide variant
VPS33B,15,91002143,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided|VPS33B-related disorder|Arthrogryposis, renal dysfunction, and cholestasis 1;Keratoderma-ichthyosis-deafness syndrome, autosomal recessive;Cholestasis, progressive familial intrahepatic, 12",GRCh38,single nucleotide variant
VPS33B,15,91022161,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",GRCh38,single nucleotide variant
VPS33B,15,91006949,na,na,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",GRCh38,single nucleotide variant
HMCN1,1,186178506,na,na,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO|Age related macular degeneration 1|not provided",GRCh38,single nucleotide variant
VKORC1,16,31091334,na,na,Likely pathogenic,"Vitamin K-dependent clotting factors, combined deficiency of, type 2|Hereditary combined deficiency of vitamin K-dependent clotting factors",GRCh38,single nucleotide variant
VKORC1,16,31094645,na,na,Pathogenic,Warfarin response,GRCh38,single nucleotide variant
VKORC1,16,31094596,na,na,Pathogenic,Warfarin response,GRCh38,single nucleotide variant
VKORC1,16,31094558,na,na,Pathogenic,Warfarin response,GRCh38,single nucleotide variant
VKORC1,16,31091243,na,na,drug response,Warfarin response,GRCh38,single nucleotide variant
VKORC1,16,31096368,na,na,drug response,Warfarin response|not specified|not provided|phenprocoumon response - Toxicity|phenprocoumon response - Dosage|warfarin response - Toxicity|warfarin response - Dosage|VKORC1-related disorder|Venous thromboembolism|acenocoumarol response - Dosage|warfarin response - Efficacy|See cases|Thrombus,GRCh38,single nucleotide variant
VKORC1,16,31094624,na,na,drug response,"Warfarin response|Thrombus|Vitamin K-dependent clotting factors, combined deficiency of, type 2|warfarin response - Dosage|not provided|not specified|VKORC1-related disorder",GRCh38,single nucleotide variant
VHL,3,10149871,na,na,Pathogenic,Papillary renal cell carcinoma type 1|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
VHL,3,10149823,na,na,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Pheochromocytoma|Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10149804,na,na,Pathogenic,Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial infantile myasthenia|Von Hippel-Lindau syndrome;Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10149822,na,na,Pathogenic/Likely pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10149822,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
VHL,3,10142110,na,na,Pathogenic,Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
VHL,3,10146578,na,na,Pathogenic,Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
VHL,3,10142181,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
VHL,3,10142139,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|VHL-related disorder,GRCh38,single nucleotide variant
VHL,3,10149819,na,na,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,GRCh38,single nucleotide variant
VHL,3,10149885,na,na,Uncertain significance,Von Hippel-Lindau syndrome|Pheochromocytoma|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Au-Kline syndrome|VHL-related disorder,GRCh38,single nucleotide variant
VHL,3,10142038,na,na,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,GRCh38,single nucleotide variant
VHL,3,10142035,na,na,Uncertain significance,Pheochromocytoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,GRCh38,single nucleotide variant
VHL,3,10142181,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10146561,na,na,Pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
VHL,3,10146549,na,na,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10149811,na,na,Likely pathogenic,RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
VHL,3,10149921,na,na,Conflicting classifications of pathogenicity,Chuvash polycythemia|Von Hippel-Lindau syndrome|not provided|not specified|Acute leukemia of ambiguous lineage|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Pheochromocytoma;Nonpapillary renal cell carcinoma;Von Hippel-Lindau syndrome;Chuvash polycythemia|Nonpapillary renal cell carcinoma|VHL-related disorder,GRCh38,single nucleotide variant
VHL,3,10142088,na,na,Benign,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Enchondromatosis|Chuvash polycythemia|Hepatoblastoma,GRCh38,single nucleotide variant
VHL,3,10149897,na,na,Conflicting classifications of pathogenicity,Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
VHL,3,10149894,na,na,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10142097,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
VHL,3,10142124,na,na,Pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|Chuvash polycythemia,GRCh38,single nucleotide variant
VHL,3,10149814,na,na,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
NCF2,1,183574509,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
NCF2,1,183577661,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",GRCh38,single nucleotide variant
NCF2,1,183577598,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",GRCh38,single nucleotide variant
NCF2,1,183577667,na,na,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",GRCh38,single nucleotide variant
NCF2,1,183574605,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",GRCh38,single nucleotide variant
NCF2,1,183586922,na,na,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified",GRCh38,single nucleotide variant
NCF2,1,183563302,na,na,Benign/Likely benign,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided",GRCh38,single nucleotide variant
NCF1,7,74777319,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1|not provided",GRCh38,single nucleotide variant
NCF1,7,74779298,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",GRCh38,single nucleotide variant
NCF1,7,74779360,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",GRCh38,single nucleotide variant
NCF1,7,74783061,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",GRCh38,single nucleotide variant
CYBA,16,88646773,na,na,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",GRCh38,single nucleotide variant
CYBA,16,88646131,na,na,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",GRCh38,single nucleotide variant
CYBA,16,88643474,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",GRCh38,single nucleotide variant
CYBA,16,88646761,na,na,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not specified",GRCh38,single nucleotide variant
CYBA,16,88646754,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",GRCh38,single nucleotide variant
CYBA,16,88646828,na,na,Benign,"CYBA POLYMORPHISM|not specified|Very early onset inflammatory bowel disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease|not provided",GRCh38,single nucleotide variant
CYBA,16,88651007,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",GRCh38,single nucleotide variant
CYBA,16,88648103,na,na,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease|not provided",GRCh38,single nucleotide variant
CYBA,16,88643568,na,na,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",GRCh38,single nucleotide variant
MFN2,1,11992660,na,na,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Inborn genetic diseases|Neuropathy, hereditary motor and sensory, type 6A",GRCh38,single nucleotide variant
MFN2,1,12011510,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided|Charcot-Marie-Tooth disease type 2A2;Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not specified|Charcot-Marie-Tooth disease|Inborn genetic diseases|MFN2-related disorder",GRCh38,single nucleotide variant
MFN2,1,11992606,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2,GRCh38,single nucleotide variant
MFN2,1,12001423,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Neuropathy, hereditary motor and sensory, type 6A|Charcot-Marie-Tooth disease type 2A2;Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;",GRCh38,single nucleotide variant
MFN2,1,11999030,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
MFN2,1,11992584,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2A2,GRCh38,single nucleotide variant
MFN2,1,12002014,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided,GRCh38,single nucleotide variant
MFN2,1,11997315,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2,GRCh38,single nucleotide variant
MFN2,1,11992659,na,na,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|14 conditions|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Neuropathy, hereditary motor and sensory, type 6A",GRCh38,single nucleotide variant
MFN2,1,12001411,na,na,Conflicting classifications of pathogenicity,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
MFN2,1,12002033,na,na,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 2,GRCh38,single nucleotide variant
MFN2,1,11998787,na,na,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
MFN2,1,12009641,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not provided|Charcot-Marie-Tooth disease type 2A2|MFN2-related disorder|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|Peripheral axonal neuropathy|Neuropathy, hereditary motor and sensory, type 6A|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2A2;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Charcot-Marie-Tooth disease type 2A2;Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Charcot-Marie-Tooth disease, type 2A;Hereditary motor and sensory neuropathy with optic atrophy|Multiple symmetric lipomatosis|Tip-toe gait",GRCh38,single nucleotide variant
MFN2,1,11992689,na,na,Pathogenic,"Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease|Neuropathy, hereditary motor and sensory, type 6A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease type 2A2;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;",GRCh38,single nucleotide variant
MFN2,1,12004835,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2A2|not specified|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|Tip-toe gait|Retinal dystrophy|Optic atrophy,GRCh38,single nucleotide variant
PRICKLE1,12,42469523,na,na,Pathogenic/Likely pathogenic,"Epilepsy, progressive myoclonic, 1B|not provided",GRCh38,single nucleotide variant
SETX,9,132327511,na,na,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases|not provided|SETX-related disorder",GRCh38,single nucleotide variant
SETX,9,132328996,na,na,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",GRCh38,single nucleotide variant
SETX,9,132281483,na,na,Uncertain significance,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",GRCh38,single nucleotide variant
SETX,9,132331293,na,na,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|SETX-related disorder",GRCh38,single nucleotide variant
SETX,9,132330432,na,na,Pathogenic,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4|not provided|Distal spinal muscular atrophy|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",GRCh38,single nucleotide variant
SETX,9,132349421,na,na,Likely pathogenic,Amyotrophic lateral sclerosis type 4|Distal spinal muscular atrophy|not provided,GRCh38,single nucleotide variant
SETX,9,132283403,na,na,Likely pathogenic,Amyotrophic lateral sclerosis type 4|Distal spinal muscular atrophy|not provided,GRCh38,single nucleotide variant
SETX,9,132296909,na,na,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided",GRCh38,single nucleotide variant
SETX,9,132329791,na,na,Benign/Likely benign,"not provided|Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Hereditary spastic paraplegia|Amyotrophic lateral sclerosis type 4",GRCh38,single nucleotide variant
SETX,9,132334624,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
SETX,9,132296907,na,na,Conflicting classifications of pathogenicity,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4",GRCh38,single nucleotide variant
SETX,9,132331123,na,na,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",GRCh38,single nucleotide variant
PYGM,11,64759751,na,na,Pathogenic,"Glycogen storage disease, type V|not provided|Inborn genetic diseases|Tip-toe gait|See cases",GRCh38,single nucleotide variant
PYGM,11,64757826,na,na,Pathogenic,"Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
PYGM,11,64752064,na,na,Pathogenic,"Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64751331,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64750557,na,na,Conflicting classifications of pathogenicity,"Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
PYGM,11,64753931,na,na,Pathogenic,"Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64750497,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided|PYGM-related disorder|Tip-toe gait",GRCh38,single nucleotide variant
PYGM,11,64751966,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
PYGM,11,64759898,na,na,Pathogenic,"Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
PYGM,11,64752071,na,na,Pathogenic,"Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64746796,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
PYGM,11,64751597,na,na,Pathogenic,"Glycogen storage disease, type V|See cases",GRCh38,single nucleotide variant
PYGM,11,64751970,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64756159,na,na,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V",GRCh38,single nucleotide variant
PYGM,11,64758375,na,na,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V|not provided",GRCh38,single nucleotide variant
ETHE1,19,43511455,na,na,Pathogenic,Ethylmalonic encephalopathy|not provided,GRCh38,single nucleotide variant
ETHE1,19,43527175,na,na,Pathogenic,Ethylmalonic encephalopathy|not provided,GRCh38,single nucleotide variant
SYNE2,14,64210033,na,na,Benign/Likely benign,"Emery-Dreifuss muscular dystrophy 5, autosomal dominant|not specified|not provided|SYNE2-related disorder",GRCh38,single nucleotide variant
SYNE1,6,152321898,na,na,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|SYNE1-related disorder|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",GRCh38,single nucleotide variant
SYNE1,6,152381320,na,na,Pathogenic,"Autosomal recessive ataxia, Beauce type|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",GRCh38,single nucleotide variant
SYNE1,6,152201838,na,na,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided",GRCh38,single nucleotide variant
SYNE1,6,152213737,na,na,Pathogenic,"Autosomal recessive ataxia, Beauce type",GRCh38,single nucleotide variant
SYNE1,6,152151987,na,na,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",GRCh38,single nucleotide variant
SYNE1,6,152141290,na,na,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",GRCh38,single nucleotide variant
SYNE1,6,152140027,na,na,Conflicting classifications of pathogenicity,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Autosomal recessive ataxia, Beauce type|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Intellectual disability|not specified|Autosomal recessive ataxia, Beauce type;Arthrogryposis multiplex congenita 3, myogenic type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",GRCh38,single nucleotide variant
SYNE1,6,152151692,na,na,Pathogenic,"Arthrogryposis multiplex congenita 3, myogenic type",GRCh38,single nucleotide variant
CHST14,15,40471851,na,na,Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",GRCh38,single nucleotide variant
CHST14,15,40472091,na,na,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|not provided|Ehlers-Danlos syndrome, musculocontractural type 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
CHST14,15,40472055,na,na,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",GRCh38,single nucleotide variant
CHST14,15,40471418,na,na,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",GRCh38,single nucleotide variant
CHST14,15,40472079,na,na,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",GRCh38,single nucleotide variant
MCEE,2,71124445,na,na,Pathogenic,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency|not provided|Inborn genetic diseases|Methylmalonic acidemia|MCEE-related disorder,GRCh38,single nucleotide variant
PLCE1,10,94132444,na,na,Pathogenic,"Nephrotic syndrome, type 3|not provided",GRCh38,single nucleotide variant
PLCE1,10,94254256,na,na,Pathogenic,"Nephrotic syndrome, type 3",GRCh38,single nucleotide variant
PLCE1,10,94283840,na,na,Pathogenic,"Nephrotic syndrome, type 3",GRCh38,single nucleotide variant
PLCE1,10,94304583,na,na,Pathogenic,"Nephrotic syndrome, type 3",GRCh38,single nucleotide variant
PLCE1,10,94270547,na,na,Pathogenic,"Nephrotic syndrome, type 3",GRCh38,single nucleotide variant
USH2A,1,216364958,na,na,Pathogenic,Usher syndrome type 2A,GRCh38,single nucleotide variant
USH2A,1,216325492,na,na,Pathogenic,Usher syndrome type 2A|not provided|Usher syndrome|Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome type 2A;Retinitis pigmentosa 39,GRCh38,single nucleotide variant
USH2A,1,216247118,na,na,Pathogenic,Retinitis pigmentosa 39|Usher syndrome type 2A|not provided|Retinal dystrophy|Usher syndrome|Retinitis pigmentosa|USH2A-related disorder|Autosomal recessive retinitis pigmentosa|Inborn genetic diseases|Usher syndrome type 2A;Retinitis pigmentosa 39|Ear malformation|See cases,GRCh38,single nucleotide variant
USH2A,1,215728232,na,na,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|Congenital sensorineural hearing impairment|Retinitis pigmentosa|Hearing impairment|Rare genetic deafness;Usher syndrome|Usher syndrome type 2|Usher syndrome type 2A;Retinitis pigmentosa 39|Usher syndrome type 3A|not provided|Retinal dystrophy|USH2A-related disorder|Usher syndrome|See cases,GRCh38,single nucleotide variant
USH2A,1,216325499,na,na,Pathogenic,Usher syndrome type 2A|not provided|Pigmentary retinopathy;Retinal pigment epithelial atrophy;Rod-cone dystrophy;Blindness;Abnormal macular morphology|Rare genetic deafness|Usher syndrome type 2|Usher syndrome type 2A;Retinitis pigmentosa 39|Retinitis pigmentosa 39|Retinal dystrophy,GRCh38,single nucleotide variant
USH2A,1,216324240,na,na,Pathogenic,Usher syndrome type 2A|not provided|USH2A-related disorder|Usher syndrome|Rare genetic deafness|Retinitis pigmentosa 39|Retinal dystrophy|Usher syndrome type 2A;Retinitis pigmentosa 39,GRCh38,single nucleotide variant
USH2A,1,216247185,na,na,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|not provided|Usher syndrome type 2|Rare genetic deafness,GRCh38,single nucleotide variant
USH2A,1,215671085,na,na,Likely pathogenic,Retinitis pigmentosa 39|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
SLC9A9,3,143493701,na,na,risk factor,"Autism, susceptibility to, 16",GRCh38,single nucleotide variant
CERKL,2,181558617,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 26|Retinitis pigmentosa|not provided|Retinal dystrophy|Cone dystrophy;Retinal pigment epithelial atrophy|Cone-rod dystrophy|See cases|CERKL-related disorder|CERKL-related retinopathy,GRCh38,single nucleotide variant
HJV,1,146018399,na,na,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1|not provided|Juvenile hemochromatosis,GRCh38,single nucleotide variant
HJV,1,146018382,na,na,Pathogenic/Likely pathogenic,Hemochromatosis type 2A|not provided,GRCh38,single nucleotide variant
HJV,1,146018693,na,na,Conflicting classifications of pathogenicity,Hemochromatosis type 2A|not provided|not specified,GRCh38,single nucleotide variant
HJV,1,146018516,na,na,Pathogenic,Hemochromatosis type 2A|not provided,GRCh38,single nucleotide variant
HJV,1,146019594,na,na,Pathogenic,Hemochromatosis type 2A|not provided,GRCh38,single nucleotide variant
HJV,1,146019530,na,na,Pathogenic,Hemochromatosis type 2A|not provided|HJV-related disorder,GRCh38,single nucleotide variant
HJV,1,146018395,na,na,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1,GRCh38,single nucleotide variant
HJV,1,146019672,na,na,Pathogenic,Hemochromatosis type 2A|not provided,GRCh38,single nucleotide variant
BCKDHA,19,41424582,na,na,Pathogenic/Likely pathogenic,Maple syrup urine disease type 1A|not provided|Maple syrup urine disease|Inborn genetic diseases,GRCh38,single nucleotide variant
BCKDHA,19,41422643,na,na,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
BCKDHA,19,41424496,na,na,Pathogenic/Likely pathogenic,Maple syrup urine disease,GRCh38,single nucleotide variant
BCKDHA,19,41422310,na,na,Conflicting classifications of pathogenicity,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
BCKDHA,19,41422262,na,na,Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
BCKDHA,19,41422704,na,na,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
BCKDHA,19,41422309,na,na,Conflicting classifications of pathogenicity,Maple syrup urine disease|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
SLC36A2,5,151343594,na,na,Conflicting classifications of pathogenicity,Hyperglycinuria|Iminoglycinuria|not provided|not specified,GRCh38,single nucleotide variant
SLC36A2,5,151347296,na,na,Uncertain significance,Hyperglycinuria|Iminoglycinuria,GRCh38,single nucleotide variant
ARG1,6,131583810,na,na,Pathogenic,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131583808,na,na,Pathogenic,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131581278,na,na,Pathogenic,Arginase deficiency|not provided,GRCh38,single nucleotide variant
ARG1,6,131583392,na,na,Pathogenic,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131573314,na,na,Pathogenic/Likely pathogenic,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131581326,na,na,Uncertain significance,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131573340,na,na,Pathogenic/Likely pathogenic,Arginase deficiency,GRCh38,single nucleotide variant
ARG1,6,131576666,na,na,Pathogenic,Arginase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ASL,7,66082443,na,na,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,GRCh38,single nucleotide variant
ASL,7,66089114,na,na,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided,GRCh38,single nucleotide variant
ASL,7,66092566,na,na,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,GRCh38,single nucleotide variant
ASL,7,66086751,na,na,Pathogenic,Argininosuccinate lyase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ASL,7,66092078,na,na,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided|ASL-related disorder,GRCh38,single nucleotide variant
PINK1,1,20644639,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20644526,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20649054,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20639952,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20645640,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided,GRCh38,single nucleotide variant
PINK1,1,20644549,na,na,Uncertain significance,Autosomal recessive early-onset Parkinson disease 6|not provided,GRCh38,single nucleotide variant
PINK1,1,20644651,na,na,Pathogenic/Likely pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20638104,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20649109,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided|PINK1-related disorder,GRCh38,single nucleotide variant
PINK1,1,20649034,na,na,risk factor,Parkinson disease 6,GRCh38,single nucleotide variant
PINK1,1,20648577,na,na,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",GRCh38,single nucleotide variant
CPS1,2,210590234,na,na,Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",GRCh38,single nucleotide variant
CPS1,2,210600636,na,na,Pathogenic/Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",GRCh38,single nucleotide variant
CPS1,2,210573301,na,na,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",GRCh38,single nucleotide variant
CPS1,2,210591893,na,na,Pathogenic,"Congenital hyperammonemia, type I",GRCh38,single nucleotide variant
CPS1,2,210640045,na,na,Likely pathogenic,"Congenital hyperammonemia, type I",GRCh38,single nucleotide variant
CPS1,2,210608527,na,na,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",GRCh38,single nucleotide variant
NAGS,17,44006584,na,na,Pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
NAGS,17,44006527,na,na,Pathogenic/Likely pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
NAGS,17,44006157,na,na,Pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
NAGS,17,44007611,na,na,Likely pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
NAGS,17,44007772,na,na,Pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
NAGS,17,44007621,na,na,Pathogenic,"Hyperammonemia, type III",GRCh38,single nucleotide variant
IGF2BP2,3,185793899,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
KIF21A,12,39332405,na,na,Pathogenic,"Congenital fibrosis of extraocular muscles type 1|Fibrosis of extraocular muscles, congenital, 3b|not provided|KIF21A-related disorder",GRCh38,single nucleotide variant
KIF21A,12,39332404,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b|Congenital fibrosis of extraocular muscles type 1|not provided|Abnormality of eye movement",GRCh38,single nucleotide variant
KIF21A,12,39332236,na,na,Pathogenic,Congenital fibrosis of extraocular muscles type 1,GRCh38,single nucleotide variant
KIF21A,12,39358326,na,na,Pathogenic,Congenital fibrosis of extraocular muscles type 1,GRCh38,single nucleotide variant
KIF21A,12,39332608,na,na,Pathogenic,Congenital fibrosis of extraocular muscles type 1,GRCh38,single nucleotide variant
KIF21A,12,39332607,na,na,Pathogenic,Congenital fibrosis of extraocular muscles type 1|Inborn genetic diseases,GRCh38,single nucleotide variant
KIF21A,12,39332606,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b",GRCh38,single nucleotide variant
NEU1,6,31859838,na,na,Pathogenic,Sialidosis type 1,GRCh38,single nucleotide variant
NEU1,6,31862079,na,na,Pathogenic,Sialidosis type 2,GRCh38,single nucleotide variant
NEU1,6,31860458,na,na,Pathogenic,Sialidosis type 2|not provided,GRCh38,single nucleotide variant
NEU1,6,31859879,na,na,Likely pathogenic,Sialidosis type 2|not provided,GRCh38,single nucleotide variant
NEU1,6,31860588,na,na,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided|Sialidosis|NEU1-related disorder,GRCh38,single nucleotide variant
NEU1,6,31860510,na,na,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided,GRCh38,single nucleotide variant
NEU1,6,31862690,na,na,Pathogenic,Sialidosis type 2|not provided,GRCh38,single nucleotide variant
NEU1,6,31862112,na,na,Pathogenic,Sialidosis type 2|not provided,GRCh38,single nucleotide variant
NEU1,6,31860519,na,na,Pathogenic,Sialidosis type 2,GRCh38,single nucleotide variant
NEU1,6,31860117,na,na,Pathogenic,Sialidosis type 1,GRCh38,single nucleotide variant
NEU1,6,31860041,na,na,Pathogenic,Sialidosis type 2|not provided,GRCh38,single nucleotide variant
NEU1,6,31860563,na,na,Pathogenic,Sialidosis type 2,GRCh38,single nucleotide variant
NEU1,6,31860170,na,na,Likely pathogenic,Sialidosis type 2|not provided|Sialidosis,GRCh38,single nucleotide variant
NEU1,6,31862708,na,na,Pathogenic,Sialidosis type 2|not provided|NEU1-related disorder,GRCh38,single nucleotide variant
SCN4B,11,118141265,na,na,Pathogenic,Long QT syndrome 10,GRCh38,single nucleotide variant
KRT74,12,52573334,na,na,Pathogenic,Autosomal dominant wooly hair|not provided,GRCh38,single nucleotide variant
ADSL,22,40365000,na,na,Pathogenic,Adenylosuccinate lyase deficiency,GRCh38,single nucleotide variant
ADSL,22,40364965,na,na,Pathogenic,Adenylosuccinate lyase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ADSL,22,40349976,na,na,Pathogenic,Adenylosuccinate lyase deficiency,GRCh38,single nucleotide variant
ADSL,22,40364952,na,na,Pathogenic,Adenylosuccinate lyase deficiency,GRCh38,single nucleotide variant
ADSL,22,40358950,na,na,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided,GRCh38,single nucleotide variant
ADSL,22,40360436,na,na,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided|ADSL-related disorder,GRCh38,single nucleotide variant
ADSL,22,40359279,na,na,Pathogenic,Adenylosuccinate lyase deficiency,GRCh38,single nucleotide variant
MASTL,10,27161130,na,na,Uncertain significance,Thrombocytopenia 2,GRCh38,single nucleotide variant
SCN3B,11,123653773,na,na,Conflicting classifications of pathogenicity,"Brugada syndrome 7|not provided|Brugada syndrome|Cardiovascular phenotype|Atrial fibrillation, familial, 16|not specified",GRCh38,single nucleotide variant
EXT2,11,44108226,na,na,Pathogenic,"Exostoses, multiple, type 2|not provided|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
EXT2,11,44171743,na,na,Pathogenic,"Exostoses, multiple, type 2",GRCh38,single nucleotide variant
EXT2,11,44114237,na,na,Pathogenic,"Exostoses, multiple, type 2|Seizures-scoliosis-macrocephaly syndrome|not provided|Exostoses, multiple, type 2;Seizures-scoliosis-macrocephaly syndrome",GRCh38,single nucleotide variant
EXT2,11,44114224,na,na,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|not provided",GRCh38,single nucleotide variant
EXT2,11,44124817,na,na,Pathogenic,"Exostoses, multiple, type 2",GRCh38,single nucleotide variant
EXT2,11,44124787,na,na,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder",GRCh38,single nucleotide variant
SH3TC2,5,149028146,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4,GRCh38,single nucleotide variant
SH3TC2,5,149041619,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
SH3TC2,5,149026903,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease type 4|not provided,GRCh38,single nucleotide variant
SH3TC2,5,149026872,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 4C|Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|SH3TC2-related disorder|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C|Inborn genetic diseases|Tip-toe gait",GRCh38,single nucleotide variant
SH3TC2,5,149010272,na,na,Pathogenic,"Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C",GRCh38,single nucleotide variant
SH3TC2,5,149042718,na,na,Conflicting classifications of pathogenicity,"Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4C|7 conditions|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|Tip-toe gait|not specified|Inborn genetic diseases",GRCh38,single nucleotide variant
UNC93B1,11,67998359,na,na,risk factor,"Herpes simplex encephalitis, susceptibility to, 1",GRCh38,single nucleotide variant
CDK5RAP2,9,120550852,na,na,Pathogenic,"Microcephaly 3, primary, autosomal recessive",GRCh38,single nucleotide variant
CDK5RAP2,9,120419975,na,na,Pathogenic,"Microcephaly 3, primary, autosomal recessive",GRCh38,single nucleotide variant
EXT1,8,117837145,na,na,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|Exostoses, multiple, type 1;Chondrosarcoma",GRCh38,single nucleotide variant
EXT1,8,117837148,na,na,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|not provided",GRCh38,single nucleotide variant
EXT1,8,118110690,na,na,Pathogenic/Likely pathogenic,"Exostoses, multiple, type 1|not provided",GRCh38,single nucleotide variant
EXT1,8,117837146,na,na,Pathogenic/Likely pathogenic,"Multiple congenital exostosis|not provided|Exostoses, multiple, type 1|Inborn genetic diseases|EXT1-related disorder|Exostoses, multiple, type 1;Chondrosarcoma",GRCh38,single nucleotide variant
EXT1,8,118110084,na,na,Pathogenic,"Exostoses, multiple, type 1|Multiple congenital exostosis",GRCh38,single nucleotide variant
CACNA2D4,12,1844466,na,na,Conflicting classifications of pathogenicity,Retinal cone dystrophy 4|not provided|not specified|CACNA2D4-related disorder,GRCh38,single nucleotide variant
SEMA3E,7,83367806,na,na,Conflicting classifications of pathogenicity,CHARGE syndrome|not specified|Hypogonadotropic hypogonadism 5 with or without anosmia,GRCh38,single nucleotide variant
SOX9,17,72122870,na,na,Pathogenic,Camptomelic dysplasia,GRCh38,single nucleotide variant
SOX9,17,72124177,na,na,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia|not provided|Connective tissue disorder,GRCh38,single nucleotide variant
SOX9,17,72122804,na,na,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Camptomelic dysplasia,GRCh38,single nucleotide variant
SOX9,17,72122780,na,na,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA,GRCh38,single nucleotide variant
SOX9,17,72121618,na,na,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Inborn genetic diseases,GRCh38,single nucleotide variant
SOX9,17,72122749,na,na,Pathogenic,Camptomelic dysplasia,GRCh38,single nucleotide variant
SOX9,17,72122759,na,na,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia,GRCh38,single nucleotide variant
SATB2,2,199349159,na,na,Pathogenic,Chromosome 2q32-q33 deletion syndrome|not provided|Intellectual disability|Cleft palate|SATB2-related disorder,GRCh38,single nucleotide variant
NIPA1,15,22786790,na,na,Pathogenic,Hereditary spastic paraplegia 6|not provided,GRCh38,single nucleotide variant
NIPA1,15,22812252,na,na,Pathogenic,Hereditary spastic paraplegia 6,GRCh38,single nucleotide variant
NIPA1,15,22812252,na,na,Pathogenic,Hereditary spastic paraplegia 6|Hereditary spastic paraplegia|not provided|Spastic paraplegia,GRCh38,single nucleotide variant
NSMF,9,137449656,na,na,risk factor,Hypogonadotropic hypogonadism 9 with or without anosmia,GRCh38,single nucleotide variant
ARHGEF10,8,1882669,na,na,no classifications from unflagged records,Autosomal dominant slowed nerve conduction velocity,GRCh38,single nucleotide variant
TTC8,14,88841196,na,na,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 8|Bardet-Biedl syndrome|Retinitis pigmentosa 51|Truncal obesity;Postaxial foot polydactyly;Intellectual disability, moderate|Retinal dystrophy|TTC8-related disorder|Retinitis pigmentosa 51;Bardet-Biedl syndrome 8|not provided",GRCh38,single nucleotide variant
TTC8,14,88843851,na,na,Pathogenic,Bardet-Biedl syndrome 8|not provided,GRCh38,single nucleotide variant
TTC8,14,88833691,na,na,Likely pathogenic,Retinitis pigmentosa 51|Retinal dystrophy,GRCh38,single nucleotide variant
XYLT2,17,50360095,na,na,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Spondylo-ocular syndrome|not provided|Osteogenesis imperfecta",GRCh38,single nucleotide variant
XYLT1,16,17470454,na,na,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Desbuquois dysplasia 1|Desbuquois dysplasia 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Desbuquois dysplasia 2",GRCh38,single nucleotide variant
PUS1,12,131932301,na,na,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1|not provided",GRCh38,single nucleotide variant
PUS1,12,131941405,na,na,Pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1",GRCh38,single nucleotide variant
MEFV,16,3243407,na,na,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|Inborn genetic diseases|Recurrent fever",GRCh38,single nucleotide variant
MEFV,16,3243405,na,na,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant",GRCh38,single nucleotide variant
MEFV,16,3243310,na,na,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|not provided|Inborn genetic diseases|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",GRCh38,single nucleotide variant
MEFV,16,3254626,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|Familial Mediterranean fever, autosomal dominant|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Inborn genetic diseases|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|See cases|Autoinflammatory syndrome|Systemic lupus erythematosus",GRCh38,single nucleotide variant
MEFV,16,3254567,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|not specified|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant;Acute febrile neutrophilic dermatosis",GRCh38,single nucleotide variant
MEFV,16,3254268,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|not specified|not provided",GRCh38,single nucleotide variant
MEFV,16,3247166,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|not specified|Autoinflammatory syndrome|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant;Acute febrile neutrophilic dermatosis",GRCh38,single nucleotide variant
MEFV,16,3243403,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Inborn genetic diseases|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|6 conditions|not specified|Familial Mediterranean fever, autosomal dominant|Heart, malformation of;Renal insufficiency;Abnormal cardiovascular system morphology|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",GRCh38,single nucleotide variant
MEFV,16,3243257,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|not specified|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|Autoinflammatory syndrome|Inborn genetic diseases",GRCh38,single nucleotide variant
MEFV,16,3243205,na,na,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
MEFV,16,3243447,na,na,Pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",GRCh38,single nucleotide variant
MEFV,16,3249586,na,na,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not provided|not specified|Autoinflammatory syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
MEFV,16,3249468,na,na,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
MEFV,16,3243529,na,na,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant",GRCh38,single nucleotide variant
MEFV,16,3254625,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant;Acute febrile neutrophilic dermatosis|Acute febrile neutrophilic dermatosis|Familial Mediterranean fever, autosomal dominant",GRCh38,single nucleotide variant
MEFV,16,3247171,na,na,Conflicting classifications of pathogenicity,"Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|not provided|Acute febrile neutrophilic dermatosis",GRCh38,single nucleotide variant
ALG8,11,78127438,na,na,Pathogenic,ALG8 congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG8,11,78127393,na,na,Pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,GRCh38,single nucleotide variant
ALG8,11,78114262,na,na,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,GRCh38,single nucleotide variant
ALG8,11,78112724,na,na,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,GRCh38,single nucleotide variant
CLN5,13,76992176,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
CLN5,13,77000580,na,na,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not specified,GRCh38,single nucleotide variant
CLN5,13,76995077,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not provided,GRCh38,single nucleotide variant
CLN5,13,77000799,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
CLN5,13,76995119,na,na,Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
CLN5,13,77000866,na,na,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|not provided|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
PALLD,4,168878306,na,na,Conflicting classifications of pathogenicity,"Pancreatic cancer, susceptibility to, 1|Pancreatic adenocarcinoma|not specified|PALLD-related disorder",GRCh38,single nucleotide variant
APOC4-APOC2;APOC2,19,44949172,na,na,Benign/Likely benign,APOLIPOPROTEIN C-II (AFRICAN)|not provided|Familial apolipoprotein C-II deficiency|Cardiovascular phenotype|not specified,GRCh38,single nucleotide variant
APOC2,19,44948822,na,na,Likely pathogenic,APOLIPOPROTEIN C-II (PADOVA)|Familial apolipoprotein C-II deficiency|not provided,GRCh38,single nucleotide variant
APOC2,19,44948534,na,na,Pathogenic,APOLIPOPROTEIN C-II (HAMBURG)|Familial apolipoprotein C-II deficiency,GRCh38,single nucleotide variant
APOC2,19,44948479,na,na,Pathogenic,APOLIPOPROTEIN C-II (PARIS)|Familial apolipoprotein C-II deficiency,GRCh38,single nucleotide variant
APOC2,19,44948822,na,na,Pathogenic,APOLIPOPROTEIN C-II (BARI)|Familial apolipoprotein C-II deficiency,GRCh38,single nucleotide variant
APOC2,19,44948767,na,na,Conflicting classifications of pathogenicity,Apolipoprotein c-ii variant|Familial apolipoprotein C-II deficiency|not provided|Cardiovascular phenotype|APOC2-related disorder|not specified,GRCh38,single nucleotide variant
APOC2,19,44948823,na,na,Benign/Likely benign,APOLIPOPROTEIN C-II (SAN FRANCISCO)|Familial apolipoprotein C-II deficiency|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
APOC2,19,44948787,na,na,Pathogenic,Familial apolipoprotein C-II deficiency|APOLIPOPROTEIN C-II (WAKAYAMA),GRCh38,single nucleotide variant
APOC2,19,44949198,na,na,Pathogenic,APOLIPOPROTEIN C-II (AUCKLAND)|Familial apolipoprotein C-II deficiency,GRCh38,single nucleotide variant
NHLRC1,6,18122531,na,na,Pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,GRCh38,single nucleotide variant
NHLRC1,6,18122402,na,na,Pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided|NHLRC1-related disorder,GRCh38,single nucleotide variant
NHLRC1,6,18121814,na,na,Pathogenic,Myoclonic epilepsy of Lafora 2,GRCh38,single nucleotide variant
NHLRC1,6,18122014,na,na,Likely pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,GRCh38,single nucleotide variant
NHLRC1,6,18121684,na,na,Pathogenic,Myoclonic epilepsy of Lafora 2,GRCh38,single nucleotide variant
ETFA,15,76286463,na,na,Pathogenic/Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ETFA,15,76274431,na,na,Pathogenic,Glutaric acidemia IIa|not provided|Multiple acyl-CoA dehydrogenase deficiency|ETFA-related disorder,GRCh38,single nucleotide variant
ETFA,15,76292436,na,na,Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ANTXR2,4,79983878,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ANTXR2,4,79983915,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ANTXR2,4,80055996,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ANTXR2,4,80008576,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ANTXR2,4,80036011,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ANTXR2,4,80054342,na,na,Pathogenic,Hyaline fibromatosis syndrome,GRCh38,single nucleotide variant
ASPA,17,3499000,na,na,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
ASPA,17,3483520,na,na,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",GRCh38,single nucleotide variant
ASPA,17,3499060,na,na,Pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|Inborn genetic diseases",GRCh38,single nucleotide variant
ASPA,17,3494369,na,na,Pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",GRCh38,single nucleotide variant
ASPA,17,3494408,na,na,Pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|ASPA-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
ASPA,17,3494407,na,na,Pathogenic,Spongy degeneration of central nervous system,GRCh38,single nucleotide variant
ASPA,17,3476230,na,na,Likely pathogenic,Spongy degeneration of central nervous system,GRCh38,single nucleotide variant
ASPA,17,3498892,na,na,Pathogenic/Likely pathogenic,Spongy degeneration of central nervous system,GRCh38,single nucleotide variant
ASPA,17,3476371,na,na,Pathogenic/Likely pathogenic,"Mild Canavan disease|Spongy degeneration of central nervous system|not provided|Inborn genetic diseases|Canavan Disease, Familial Form",GRCh38,single nucleotide variant
HSPB8,12,119187080,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A",GRCh38,single nucleotide variant
HSPB8,12,119187078,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A|Charcot-Marie-Tooth disease axonal type 2L|not provided",GRCh38,single nucleotide variant
HSPB8,12,119187080,na,na,Pathogenic,Charcot-Marie-Tooth disease axonal type 2L|Charcot-Marie-Tooth disease|not provided,GRCh38,single nucleotide variant
NPC1L1,7,44540234,na,na,drug response,Ezetimibe response,GRCh38,single nucleotide variant
NPC1L1,7,44516100,na,na,Likely benign,Ezetimibe response|not specified|not provided,GRCh38,single nucleotide variant
SIL1,5,139026800,na,na,Pathogenic,Marinesco-Sjögren syndrome,GRCh38,single nucleotide variant
SIL1,5,139026799,na,na,Likely pathogenic,Marinesco-Sjögren syndrome,GRCh38,single nucleotide variant
SIL1,5,139050960,na,na,Pathogenic,Marinesco-Sjögren syndrome,GRCh38,single nucleotide variant
SIL1,5,138951170,na,na,Pathogenic,Marinesco-Sjögren syndrome,GRCh38,single nucleotide variant
SIL1,5,138947191,na,na,Pathogenic,Marinesco-Sjögren syndrome|not provided,GRCh38,single nucleotide variant
SIL1,5,138947133,na,na,Pathogenic,Marinesco-Sjögren syndrome,GRCh38,single nucleotide variant
NPHP3,3,132713165,na,na,Pathogenic,Nephronophthisis 3,GRCh38,single nucleotide variant
NPHP3,3,132704341,na,na,Pathogenic,Nephronophthisis 3|not provided|NPHP3-related Meckel-like syndrome|Nephronophthisis|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,GRCh38,single nucleotide variant
NPHP3,3,132700348,na,na,Pathogenic,NPHP3-related Meckel-like syndrome|not provided|Nephronophthisis|NPHP3-related disorder,GRCh38,single nucleotide variant
NPHP3,3,132688857,na,na,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|NPHP3-related Meckel-like syndrome;Renal-hepatic-pancreatic dysplasia 1;Nephronophthisis 3|not specified,GRCh38,single nucleotide variant
NPHP3,3,132684784,na,na,Pathogenic,Renal-hepatic-pancreatic dysplasia 1|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,GRCh38,single nucleotide variant
NPHP3,3,132699348,na,na,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|Nephronophthisis|not provided|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,GRCh38,single nucleotide variant
NPHP3,3,132696798,na,na,Pathogenic,Nephronophthisis 3|Nephronophthisis|NPHP3-related Meckel-like syndrome|not provided|NPHP3-related Meckel-like syndrome;Nephronophthisis 3;Renal-hepatic-pancreatic dysplasia 1|NPHP3-related disorder|Joubert syndrome and related disorders,GRCh38,single nucleotide variant
TPP1,11,6616057,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|TPP1-related disorder,GRCh38,single nucleotide variant
TPP1,11,6616056,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|TPP1-related disorder|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,GRCh38,single nucleotide variant
TPP1,11,6617040,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|not provided|Neuronal ceroid lipofuscinosis 2;Autosomal recessive spinocerebellar ataxia 7|Abnormality of the nervous system|TPP1-related disorder,GRCh38,single nucleotide variant
TPP1,11,6617154,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|Autosomal recessive spinocerebellar ataxia 7|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|TPP1-related disorder,GRCh38,single nucleotide variant
TPP1,11,6615256,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,GRCh38,single nucleotide variant
TPP1,11,6617046,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,GRCh38,single nucleotide variant
TPP1,11,6616696,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,GRCh38,single nucleotide variant
TPP1,11,6616690,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,GRCh38,single nucleotide variant
TPP1,11,6616513,na,na,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis 2;Autosomal recessive spinocerebellar ataxia 7,GRCh38,single nucleotide variant
GORAB,1,170539515,na,na,Pathogenic,Geroderma osteodysplastica|not provided|GORAB-related disorder,GRCh38,single nucleotide variant
GORAB,1,170552136,na,na,Pathogenic/Likely pathogenic,Geroderma osteodysplastica|not provided,GRCh38,single nucleotide variant
GORAB,1,170544850,na,na,Pathogenic,Geroderma osteodysplastica,GRCh38,single nucleotide variant
COX4I2,20,31644800,na,na,Uncertain significance,Pancreatic insufficiency-anemia-hyperostosis syndrome|not provided,GRCh38,single nucleotide variant
BBS9,7,33367863,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|not provided|Bardet-Biedl syndrome|BBS9-related disorder,GRCh38,single nucleotide variant
BBS9,7,33383668,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome|Nephronophthisis 4,GRCh38,single nucleotide variant
BBS9,7,33177570,na,na,Likely pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9,GRCh38,single nucleotide variant
BBS9,7,33336487,na,na,Pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9|not provided|BBS9-related disorder,GRCh38,single nucleotide variant
BBS9,7,33177592,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
SUMF1,3,4362193,na,na,Pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4376365,na,na,Pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4362224,na,na,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,GRCh38,single nucleotide variant
SUMF1,3,4362223,na,na,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,GRCh38,single nucleotide variant
SUMF1,3,4376338,na,na,Pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4417132,na,na,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,GRCh38,single nucleotide variant
SUMF1,3,4449322,na,na,Pathogenic,Multiple sulfatase deficiency|not provided,GRCh38,single nucleotide variant
SUMF1,3,4467244,na,na,Likely pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4362236,na,na,Pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4362227,na,na,Pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4418082,na,na,Likely pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
SUMF1,3,4467245,na,na,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency,GRCh38,single nucleotide variant
CCM2,7,45064493,na,na,Pathogenic,Cerebral cavernous malformation 2|not provided,GRCh38,single nucleotide variant
CCM2,7,45000334,na,na,Pathogenic,Cerebral cavernous malformation 2|not provided,GRCh38,single nucleotide variant
CCM2,7,45064002,na,na,Pathogenic,Cerebral cavernous malformation 2,GRCh38,single nucleotide variant
CCM2,7,45068563,na,na,Pathogenic,Cerebral cavernous malformation 2,GRCh38,single nucleotide variant
WHRN,9,114403982,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 31|not provided|Usher syndrome|Usher syndrome type 2D;Autosomal recessive nonsyndromic hearing loss 31,GRCh38,single nucleotide variant
WHRN,9,114504495,na,na,Pathogenic,Usher syndrome type 2D,GRCh38,single nucleotide variant
WHRN,9,114478552,na,na,Pathogenic,Usher syndrome type 2D,GRCh38,single nucleotide variant
A4GALT,22,42693404,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
A4GALT,22,42693200,na,na,Uncertain significance,p phenotype|not provided,GRCh38,single nucleotide variant
A4GALT,22,42693169,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
A4GALT,22,42693392,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
ALG2,9,99218792,na,na,Pathogenic,ALG2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
CACNA1H,16,1195503,na,na,risk factor,"Epilepsy, childhood absence, susceptibility to, 6",GRCh38,single nucleotide variant
CACNA1H,16,1200296,na,na,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Epilepsy, childhood absence, susceptibility to, 6;Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",GRCh38,single nucleotide variant
CACNA1H,16,1205153,na,na,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",GRCh38,single nucleotide variant
CACNA1H,16,1204325,na,na,Likely benign,"Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|Hyperaldosteronism, familial, type IV;Epilepsy, childhood absence, susceptibility to, 6",GRCh38,single nucleotide variant
CACNA1H,16,1202303,na,na,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|not provided|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",GRCh38,single nucleotide variant
CACNA1H,16,1206126,na,na,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|not provided|Epilepsy, childhood absence, susceptibility to, 6|CACNA1H-related disorder|not specified",GRCh38,single nucleotide variant
FERMT3,11,64223046,na,na,Pathogenic,Leukocyte adhesion deficiency 3,GRCh38,single nucleotide variant
FERMT3,11,64207412,na,na,Pathogenic,Leukocyte adhesion deficiency 3|Leukocyte adhesion deficiency,GRCh38,single nucleotide variant
FERMT3,11,64223094,na,na,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 3,GRCh38,single nucleotide variant
FERMT3,11,64211648,na,na,Pathogenic,Leukocyte adhesion deficiency 3,GRCh38,single nucleotide variant
FERMT3,11,64220649,na,na,Pathogenic,Leukocyte adhesion deficiency 3,GRCh38,single nucleotide variant
FERMT1,20,6115809,na,na,Pathogenic,Kindler syndrome,GRCh38,single nucleotide variant
FERMT1,20,6107594,na,na,Pathogenic,Kindler syndrome|not provided,GRCh38,single nucleotide variant
FERMT1,20,6107570,na,na,Pathogenic,Kindler syndrome|not provided|FERMT1-related disorder,GRCh38,single nucleotide variant
FERMT1,20,6097619,na,na,Pathogenic,Kindler syndrome|not provided,GRCh38,single nucleotide variant
DSG4,18,31390712,na,na,Pathogenic,Hypotrichosis 6,GRCh38,single nucleotide variant
DSG4,18,31386820,na,na,Pathogenic,Hypotrichosis 6,GRCh38,single nucleotide variant
DSG4,18,31391193,na,na,Pathogenic,Hypotrichosis 6,GRCh38,single nucleotide variant
DSG4,18,31392200,na,na,Likely pathogenic,Hypotrichosis 6,GRCh38,single nucleotide variant
BEST1,11,61955749,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided,GRCh38,single nucleotide variant
BEST1,11,61955723,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61959526,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61951893,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided,GRCh38,single nucleotide variant
BEST1,11,61957429,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61951822,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided,GRCh38,single nucleotide variant
BEST1,11,61951831,na,na,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61955825,na,na,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61958159,na,na,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Autosomal dominant vitreoretinochoroidopathy|Vitelliform macular dystrophy 1,GRCh38,single nucleotide variant
BEST1,11,61951946,na,na,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Vitelliform macular dystrophy 2;Autosomal recessive bestrophinopathy|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61955892,na,na,Pathogenic/Likely pathogenic,Autosomal recessive bestrophinopathy|Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Stargardt disease|BEST1-related disorder|BEST1-related dominant retinopathy,GRCh38,single nucleotide variant
BEST1,11,61956960,na,na,Pathogenic,Autosomal recessive bestrophinopathy|not provided|Retinal dystrophy|Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Vitelliform macular dystrophy 2;Autosomal recessive bestrophinopathy,GRCh38,single nucleotide variant
BEST1,11,61959892,na,na,Pathogenic,Autosomal recessive bestrophinopathy,GRCh38,single nucleotide variant
BEST1,11,61951928,na,na,Pathogenic/Likely pathogenic,Autosomal recessive bestrophinopathy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61955726,na,na,Pathogenic,Autosomal dominant vitreoretinochoroidopathy|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
BEST1,11,61958146,na,na,Likely pathogenic,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2|not provided",GRCh38,single nucleotide variant
BEST1,11,61957457,na,na,Uncertain significance,Autosomal dominant vitreoretinochoroidopathy|not provided,GRCh38,single nucleotide variant
BEST1,11,61956976,na,na,Pathogenic,Retinitis pigmentosa 50|not provided,GRCh38,single nucleotide variant
BEST1,11,61957432,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|not provided|Retinal dystrophy|Retinitis pigmentosa,GRCh38,single nucleotide variant
BEST1,11,61957430,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 50|Vitelliform macular dystrophy 2|not provided,GRCh38,single nucleotide variant
BEST1,11,61955888,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
BEST1,11,61957454,na,na,Pathogenic,Autosomal dominant vitreoretinochoroidopathy,GRCh38,single nucleotide variant
LEMD3,12,65170053,na,na,Pathogenic,Osteopoikilosis,GRCh38,single nucleotide variant
LEMD3,12,65216025,na,na,Pathogenic,Melorheostosis with osteopoikilosis|not provided,GRCh38,single nucleotide variant
LEMD3,12,65245931,na,na,Pathogenic,Dermatofibrosis lenticularis disseminata,GRCh38,single nucleotide variant
LEMD3,12,65239970,na,na,Pathogenic,"Melorheostosis with osteopoikilosis|Dermatofibrosis lenticularis disseminata, isolated|not provided",GRCh38,single nucleotide variant
LEMD3,12,65171119,na,na,Pathogenic,"Dermatofibrosis lenticularis disseminata, isolated",GRCh38,single nucleotide variant
GNPTAB,12,101780152,na,na,Likely pathogenic,"Mucolipidosis III alpha/beta, atypical|Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis",GRCh38,single nucleotide variant
GNPTAB,12,101770085,na,na,Pathogenic,Pseudo-Hurler polydystrophy,GRCh38,single nucleotide variant
GNPTAB,12,101789951,na,na,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy,GRCh38,single nucleotide variant
GNPTAB,12,101753409,na,na,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|GNPTAB-related disorder,GRCh38,single nucleotide variant
GNPTAB,12,101760106,na,na,Pathogenic,Mucolipidosis type II,GRCh38,single nucleotide variant
GNPTAB,12,101764236,na,na,Pathogenic,Mucolipidosis type II|Pseudo-Hurler polydystrophy;Mucolipidosis type II,GRCh38,single nucleotide variant
GNPTAB,12,101764201,na,na,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis|Mucolipidosis type II|not provided|GNPTAB-related disorder,GRCh38,single nucleotide variant
GNPTAB,12,101757571,na,na,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|Pseudo-Hurler polydystrophy,GRCh38,single nucleotide variant
GNPTAB,12,101757566,na,na,Pathogenic,"Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided",GRCh38,single nucleotide variant
GNPTAB,12,101830666,na,na,Pathogenic,"Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A",GRCh38,single nucleotide variant
GNPTAB,12,101770185,na,na,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II,GRCh38,single nucleotide variant
GBE1,3,81642991,na,na,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",GRCh38,single nucleotide variant
GBE1,3,81642787,na,na,Pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|not provided|GBE1-related disorder|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease|Adult polyglucosan body disease",GRCh38,single nucleotide variant
GBE1,3,81648876,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease",GRCh38,single nucleotide variant
GBE1,3,81578000,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Inborn genetic diseases|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",GRCh38,single nucleotide variant
GBE1,3,81646403,na,na,Conflicting classifications of pathogenicity,"Glycogen storage disease IV, classic hepatic|not provided|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease|not specified",GRCh38,single nucleotide variant
GBE1,3,81577973,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Adult polyglucosan body disease;Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GBE1,3,81577972,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, combined hepatic and myopathic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",GRCh38,single nucleotide variant
GBE1,3,81761374,na,na,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",GRCh38,single nucleotide variant
GBE1,3,81537080,na,na,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",GRCh38,single nucleotide variant
GBE1,3,81536940,na,na,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GBE1,3,81535246,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body disease;Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GBE1,3,81646466,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|not provided|Adult polyglucosan body disease;Glycogen storage disease, type IV|GBE1-related disorder",GRCh38,single nucleotide variant
GBE1,3,81642989,na,na,Conflicting classifications of pathogenicity,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Adult polyglucosan body disease|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GBE1,3,81648851,na,na,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GBE1,3,81537071,na,na,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",GRCh38,single nucleotide variant
GNPTG,16,1362053,na,na,Pathogenic,GNPTG-mucolipidosis|not provided,GRCh38,single nucleotide variant
GNPTG,16,1361954,na,na,Pathogenic/Likely pathogenic,GNPTG-mucolipidosis|not provided,GRCh38,single nucleotide variant
CLN8,8,1771124,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis 8 northern epilepsy variant;Neuronal ceroid lipofuscinosis 8,GRCh38,single nucleotide variant
CLN8,8,1780495,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 8|not provided|Neuronal ceroid lipofuscinosis,GRCh38,single nucleotide variant
CLN8,8,1780316,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis|not provided|Neuronal ceroid lipofuscinosis 8;Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|CLN8-related disorder,GRCh38,single nucleotide variant
CLN8,8,1771142,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 8,GRCh38,single nucleotide variant
FRAS1,4,78481962,na,na,Pathogenic,Fraser syndrome 1|not provided,GRCh38,single nucleotide variant
FRAS1,4,78496859,na,na,Pathogenic,Fraser syndrome 1,GRCh38,single nucleotide variant
FRAS1,4,78387525,na,na,Pathogenic,Fraser syndrome 1,GRCh38,single nucleotide variant
FRAS1,4,78407804,na,na,Pathogenic,Fraser syndrome 1,GRCh38,single nucleotide variant
FRAS1,4,78472331,na,na,Pathogenic,Fraser syndrome 1|not provided,GRCh38,single nucleotide variant
ZNF365,10,62655424,na,na,Benign,"Nephrolithiasis, uric acid, susceptibility to|not provided",GRCh38,single nucleotide variant
VPS13B,8,99717219,na,na,Pathogenic,Cohen syndrome,GRCh38,single nucleotide variant
VPS13B,8,99720973,na,na,Pathogenic,Cohen syndrome|not provided,GRCh38,single nucleotide variant
VPS13B,8,99820031,na,na,Conflicting classifications of pathogenicity,Cohen syndrome|not specified|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
VPS13B,8,99511275,na,na,Pathogenic,Cohen syndrome,GRCh38,single nucleotide variant
VPS13B,8,99384294,na,na,Pathogenic,Cohen syndrome|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
VPS13B,8,99784394,na,na,Pathogenic/Likely pathogenic,Cohen syndrome,GRCh38,single nucleotide variant
VPS13B,8,99854202,na,na,Pathogenic/Likely pathogenic,Cohen syndrome,GRCh38,single nucleotide variant
VPS13B,8,99818473,na,na,Uncertain significance,Cohen syndrome|not provided|Inborn genetic diseases|VPS13B-related disorder,GRCh38,single nucleotide variant
ACAT1,11,108146334,na,na,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108139009,na,na,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108146200,na,na,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,GRCh38,single nucleotide variant
ACAT1,11,108146361,na,na,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108121608,na,na,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108146332,na,na,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108141688,na,na,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,GRCh38,single nucleotide variant
ACAT1,11,108134260,na,na,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108142545,na,na,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108144039,na,na,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,GRCh38,single nucleotide variant
ACAT1,11,108135240,na,na,Conflicting classifications of pathogenicity,Deficiency of acetyl-CoA acetyltransferase|not specified,GRCh38,single nucleotide variant
CNNM4,2,96761706,na,na,Pathogenic/Likely pathogenic,Jalili syndrome,GRCh38,single nucleotide variant
CNNM4,2,96761970,na,na,Pathogenic,Jalili syndrome,GRCh38,single nucleotide variant
CNNM4,2,96799065,na,na,Pathogenic,Jalili syndrome|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CNNM4,2,96761598,na,na,Pathogenic,Jalili syndrome,GRCh38,single nucleotide variant
CNNM4,2,96809338,na,na,Pathogenic/Likely pathogenic,Jalili syndrome|not provided,GRCh38,single nucleotide variant
ABCA12,2,214986563,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 4A,GRCh38,single nucleotide variant
ABCA12,2,214986566,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,GRCh38,single nucleotide variant
ABCA12,2,214978830,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B|not provided,GRCh38,single nucleotide variant
ABCA12,2,214982225,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|ABCA12-related disorder|Lamellar ichthyosis,GRCh38,single nucleotide variant
ABCA12,2,214980608,na,na,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,GRCh38,single nucleotide variant
ABCA12,2,214948607,na,na,Benign/Likely benign,Autosomal recessive congenital ichthyosis 4B|Congenital ichthyosis of skin|not specified|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B|not provided,GRCh38,single nucleotide variant
ABCA12,2,214953891,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 4B|Autosomal recessive congenital ichthyosis 4A|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
ABCA12,2,214990791,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 4B,GRCh38,single nucleotide variant
MCFD2,2,46909018,na,na,Likely pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2|Factor V and factor VIII, combined deficiency of, type 1|MCFD2-related disorder",GRCh38,single nucleotide variant
MCFD2,2,46907809,na,na,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",GRCh38,single nucleotide variant
MCFD2,2,46905517,na,na,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",GRCh38,single nucleotide variant
MCFD2,2,46905497,na,na,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",GRCh38,single nucleotide variant
MCFD2,2,46907878,na,na,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",GRCh38,single nucleotide variant
PCSK9,1,55044016,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",GRCh38,single nucleotide variant
PCSK9,1,55052400,na,na,Pathogenic,"Hypercholesterolemia, autosomal dominant, 3",GRCh38,single nucleotide variant
PCSK9,1,55057454,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",GRCh38,single nucleotide variant
PCSK9,1,55046549,na,na,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|not provided|Familial hypercholesterolemia|Hypercholesterolemia, autosomal dominant, 3|not specified|Cardiovascular phenotype",GRCh38,single nucleotide variant
PCSK9,1,55063542,na,na,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypocholesterolemia|Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not provided|not specified|Cardiovascular phenotype|PCSK9-related disorder",GRCh38,single nucleotide variant
PCSK9,1,55039974,na,na,Benign/Likely benign,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Hypocholesterolemia|not specified|not provided|Hypobetalipoproteinemia|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
HSD3B7,16,30986205,na,na,Likely pathogenic,Congenital bile acid synthesis defect 1,GRCh38,single nucleotide variant
HSD3B7,16,30986612,na,na,Pathogenic,Congenital bile acid synthesis defect 1|not provided,GRCh38,single nucleotide variant
KIRREL3,11,126562850,na,na,Uncertain significance,"Intellectual disability, autosomal dominant 4",GRCh38,single nucleotide variant
KIRREL3,11,126446877,na,na,Likely benign,"Intellectual disability, autosomal dominant 4|not provided|KIRREL3-related disorder",GRCh38,single nucleotide variant
KIRREL3,11,126424726,na,na,Uncertain significance,"Intellectual disability, autosomal dominant 4|not provided",GRCh38,single nucleotide variant
ITGA2B,17,44375697,na,na,Benign,BAK PLATELET-SPECIFIC ANTIGEN|not specified|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided,GRCh38,single nucleotide variant
ITGA2B,17,44380004,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16,GRCh38,single nucleotide variant
ITGA2B,17,44375719,na,na,Likely pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,GRCh38,single nucleotide variant
ITGA2B,17,44384567,na,na,Likely pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,GRCh38,single nucleotide variant
ITGA2B,17,44380385,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,GRCh38,single nucleotide variant
ITGA2B,17,44383630,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,GRCh38,single nucleotide variant
ITGA2B,17,44383640,na,na,Pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,GRCh38,single nucleotide variant
ITGA2B,17,44379780,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|ITGA2B-related disorder,GRCh38,single nucleotide variant
ITGA2B,17,44385193,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16|not provided,GRCh38,single nucleotide variant
ITGA2B,17,44374732,na,na,Uncertain significance,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not specified,GRCh38,single nucleotide variant
ITGA2B,17,44379689,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,GRCh38,single nucleotide variant
TAS2R38,7,141973545,na,na,drug response,Phenylthiocarbamide tasting,GRCh38,single nucleotide variant
TAS2R38,7,141972905,na,na,Benign,Phenylthiocarbamide tasting|not provided,GRCh38,single nucleotide variant
TAS2R38,7,141972804,na,na,drug response,Phenylthiocarbamide tasting,GRCh38,single nucleotide variant
TJP2,9,69216367,na,na,Pathogenic/Likely pathogenic,"Hypercholanemia, familial 1|Cholestasis, progressive familial intrahepatic, 4|not provided",GRCh38,single nucleotide variant
SBF2,11,9847015,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4B2,GRCh38,single nucleotide variant
SBF2,11,9832290,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2,GRCh38,single nucleotide variant
SBF2,11,9968482,na,na,Pathogenic,Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2|not provided,GRCh38,single nucleotide variant
USH1G,17,74922931,na,na,Pathogenic,Usher syndrome type 1G,GRCh38,single nucleotide variant
USH1G,17,74922961,na,na,Pathogenic,Usher syndrome type 1G|not provided,GRCh38,single nucleotide variant
SECISBP2,9,89348095,na,na,Conflicting classifications of pathogenicity,"Thyroid hormone metabolism, abnormal 1|SECISBP2-related disorder",GRCh38,single nucleotide variant
SECISBP2,9,89341356,na,na,Pathogenic,"Thyroid hormone metabolism, abnormal 1",GRCh38,single nucleotide variant
SECISBP2,9,89338609,na,na,Pathogenic,"Thyroid hormone metabolism, abnormal 1",GRCh38,single nucleotide variant
SAR1B,5,134621002,na,na,Pathogenic,Chylomicron retention disease,GRCh38,single nucleotide variant
SAR1B,5,134608443,na,na,Pathogenic/Likely pathogenic,Chylomicron retention disease|not provided,GRCh38,single nucleotide variant
SAR1B,5,134607010,na,na,Likely pathogenic,Chylomicron retention disease|SAR1B-related disorder,GRCh38,single nucleotide variant
SAR1B,5,134608504,na,na,Pathogenic,Chylomicron retention disease,GRCh38,single nucleotide variant
SAR1B,5,134608488,na,na,Pathogenic,Chylomicron retention disease,GRCh38,single nucleotide variant
SAR1B,5,134606993,na,na,Pathogenic,Chylomicron retention disease,GRCh38,single nucleotide variant
CLCF1,11,67365493,na,na,Pathogenic,Cold-induced sweating syndrome 2,GRCh38,single nucleotide variant
CLCF1,11,67365224,na,na,Pathogenic,Cold-induced sweating syndrome 2,GRCh38,single nucleotide variant
GNS,12,64737039,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-D|not provided",GRCh38,single nucleotide variant
GNS,12,64728988,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",GRCh38,single nucleotide variant
CTH,1,70415987,na,na,Conflicting classifications of pathogenicity,Cystathioninuria|not provided|CTH-related disorder,GRCh38,single nucleotide variant
CTH,1,70430388,na,na,Pathogenic,Cystathioninuria,GRCh38,single nucleotide variant
CTH,1,70439117,na,na,Benign,Homocysteine level elevated|Cystathioninuria|not provided|CTH-related disorder,GRCh38,single nucleotide variant
OSTM1,6,108049248,na,na,Pathogenic,Autosomal recessive osteopetrosis 5,GRCh38,single nucleotide variant
OSTM1,6,108074616,na,na,Pathogenic,Autosomal recessive osteopetrosis 5,GRCh38,single nucleotide variant
RAI1,17,17798371,na,na,Benign,Smith-Magenis syndrome|not provided,GRCh38,single nucleotide variant
RAI1,17,17797633,na,na,Pathogenic,Smith-Magenis syndrome,GRCh38,single nucleotide variant
XDH,2,31386525,na,na,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1|Xanthinuria type II,GRCh38,single nucleotide variant
XDH,2,31397718,na,na,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1,GRCh38,single nucleotide variant
NPC1,18,23539823,na,na,Pathogenic,"Niemann-Pick disease, type C1",GRCh38,single nucleotide variant
NPC1,18,23536811,na,na,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC1,18,23535479,na,na,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C|not provided",GRCh38,single nucleotide variant
NPC1,18,23538609,na,na,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type D|Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC1,18,23539941,na,na,Pathogenic,"Niemann-Pick disease, type C1, adult form",GRCh38,single nucleotide variant
NPC1,18,23535683,na,na,Pathogenic,"Niemann-Pick disease, type C1, juvenile form|Niemann-Pick disease, type C1",GRCh38,single nucleotide variant
NPC1,18,23533470,na,na,Pathogenic,"Niemann-Pick disease, type C1, juvenile form",GRCh38,single nucleotide variant
NPC1,18,23538564,na,na,Pathogenic,"Niemann-Pick disease, type C1|not provided|6 conditions|Niemann-Pick disease, type C|NPC1-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
NPC1,18,23536736,na,na,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C|Inborn genetic diseases|Sphingomyelin/cholesterol lipidosis|NPC1-related disorder",GRCh38,single nucleotide variant
NPC1,18,23539393,na,na,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1",GRCh38,single nucleotide variant
NPC1,18,23538609,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C|not provided",GRCh38,single nucleotide variant
NPC1,18,23556436,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC1,18,23539418,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|NPC1-related disorder",GRCh38,single nucleotide variant
NPC1,18,23536814,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided",GRCh38,single nucleotide variant
NPC1,18,23534445,na,na,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC1,18,23561461,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
NPC1,18,23538651,na,na,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC1,18,23568949,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
APBB1;SMPD1,11,6394204,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B;Niemann-Pick disease, type A|not provided|Inborn genetic diseases|SMPD1-related disorder",GRCh38,single nucleotide variant
SMPD1,11,6394446,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",GRCh38,single nucleotide variant
SMPD1,11,6393667,na,na,Pathogenic,"Niemann-Pick disease, type B",GRCh38,single nucleotide variant
SMPD1,11,6391853,na,na,Pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",GRCh38,single nucleotide variant
SMPD1,11,6393276,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis",GRCh38,single nucleotide variant
SMPD1,11,6391795,na,na,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type B|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type A",GRCh38,single nucleotide variant
SMPD1,11,6393278,na,na,Likely pathogenic,"Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B",GRCh38,single nucleotide variant
SMPD1,11,6391976,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided|Niemann-Pick disease, type B|Niemann-Pick disease, type B;Niemann-Pick disease, type A",GRCh38,single nucleotide variant
SMPD1,11,6393301,na,na,Pathogenic,"Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|not provided",GRCh38,single nucleotide variant
SMPD1,11,6393620,na,na,Pathogenic,"Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type B;Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided",GRCh38,single nucleotide variant
SMPD1,11,6393680,na,na,Pathogenic,"Niemann-Pick disease, type B|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided|not specified|Sphingomyelin/cholesterol lipidosis",GRCh38,single nucleotide variant
SMPD1,11,6391945,na,na,Pathogenic,"Niemann-Pick disease, type B|Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|Inborn genetic diseases|not specified|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not provided",GRCh38,single nucleotide variant
SMPD1,11,6394006,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not specified|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B;Niemann-Pick disease, type A",GRCh38,single nucleotide variant
SMPD1,11,6393961,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type B;Niemann-Pick disease, type A|Niemann-Pick disease, type A",GRCh38,single nucleotide variant
KRT9,17,41571506,na,na,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Palmoplantar keratoderma|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571478,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571512,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571510,na,na,Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571505,na,na,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Inborn genetic diseases|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571524,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571511,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571490,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571515,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571523,na,na,Uncertain significance,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571482,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571515,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KRT9,17,41571511,na,na,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",GRCh38,single nucleotide variant
KCNV2,9,2718166,na,na,Pathogenic/Likely pathogenic,Cone dystrophy with supernormal rod response|not provided|KCNV2-related disorder,GRCh38,single nucleotide variant
KCNV2,9,2718655,na,na,Pathogenic,Cone dystrophy with supernormal rod response,GRCh38,single nucleotide variant
KCNV2,9,2729465,na,na,Pathogenic,Cone dystrophy with supernormal rod response,GRCh38,single nucleotide variant
KCNV2,9,2718506,na,na,Pathogenic,Cone dystrophy with supernormal rod response,GRCh38,single nucleotide variant
BBS7,4,121847473,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 7|not provided|Bardet-Biedl syndrome|BBS7-related disorder|Retinal dystrophy,GRCh38,single nucleotide variant
BBS7,4,121854790,na,na,Pathogenic,"Bardet-Biedl syndrome 1/7, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 7|BBS7-related disorder",GRCh38,single nucleotide variant
ATM,11,108309110,na,na,Pathogenic,Ataxia - telangiectasia variant|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Ataxia-telangiectasia syndrome|ATM-related disorder|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related cancer predisposition|Familial colorectal cancer type X,GRCh38,single nucleotide variant
ATM,11,108345804,na,na,Pathogenic/Likely pathogenic,Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Familial cancer of breast|not provided,GRCh38,single nucleotide variant
ATM,11,108329202,na,na,Pathogenic,"Ataxia - telangiectasia variant|T-cell prolymphocytic leukemia|Breast cancer, susceptibility to|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Ataxia-telangiectasia syndrome|Breast neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related disorder|Inherited breast cancer and ovarian cancer|NICE approved PARP inhibitor treatment",GRCh38,single nucleotide variant
ATM,11,108227806,na,na,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome;Familial cancer of breast|not provided|Familial cancer of breast|See cases|ATM-related disorder,GRCh38,single nucleotide variant
ATM,11,108299752,na,na,Uncertain significance,T-cell prolymphocytic leukemia|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
ATM,11,108272572,na,na,Benign,B-cell non-Hodgkin lymphoma|not specified|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108333925,na,na,Likely pathogenic,Ataxia-telangiectasia without immunodeficiency|not provided,GRCh38,single nucleotide variant
ATM,11,108365476,na,na,Pathogenic,Ataxia-telangiectasia without immunodeficiency|not provided|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Familial cancer of breast|Familial cancer of breast;Ataxia-telangiectasia syndrome|Malignant tumor of urinary bladder|ATM-related cancer predisposition,GRCh38,single nucleotide variant
ATM,11,108281168,na,na,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of pancreas|ATM-related cancer predisposition|Breast and/or ovarian cancer|Familial cancer of breast|Ataxia-telangiectasia syndrome;Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108330233,na,na,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Carcinoma of pancreas|Familial cancer of breast|Neoplasm|Tip-toe gait|See cases|Hereditary breast ovarian cancer syndrome|ATM-related cancer predisposition,GRCh38,single nucleotide variant
ATM,11,108248927,na,na,Benign,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Familial cancer of breast|Malignant tumor of breast|Familial cancer of breast;Ataxia-telangiectasia syndrome|Breast and/or ovarian cancer,GRCh38,single nucleotide variant
ATM,11,108329199,na,na,Uncertain significance,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
ATM,11,108287687,na,na,Pathogenic,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108301779,na,na,Pathogenic,T-cell prolymphocytic leukemia|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108256340,na,na,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Ataxia-telangiectasia syndrome;Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108334988,na,na,Likely pathogenic,Ataxia - telangiectasia variant|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108235839,na,na,Pathogenic/Likely pathogenic,Ataxia - telangiectasia variant|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Familial cancer of breast,GRCh38,single nucleotide variant
ATM,11,108227849,na,na,Benign,"Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome|not specified|not provided|Ataxia-telangiectasia syndrome|Tip-toe gait|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|Familial cancer of breast",GRCh38,single nucleotide variant
ARSA,22,50625049,na,na,Benign; other,ARYLSULFATASE A PSEUDODEFICIENCY|Metachromatic leukodystrophy|not provided|not specified,GRCh38,single nucleotide variant
ARSA,22,50625988,na,na,Benign/Likely benign; other,"Metachromatic leukodystrophy|not provided|not specified|Metachromatic leukodystrophy, juvenile type",GRCh38,single nucleotide variant
ARSA,22,50627165,na,na,Pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided|Neurodevelopmental disorder|Intellectual disability|Inborn genetic diseases|See cases|ARSA-related disorder",GRCh38,single nucleotide variant
ARSA,22,50625392,na,na,Pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type||Metachromatic leukodystrophy|not provided|Intellectual disability|ARSA-related disorder|See cases",GRCh38,single nucleotide variant
ARSA,22,50627329,na,na,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50627338,na,na,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, late infantile form|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50626976,na,na,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
ARSA,22,50625578,na,na,Pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50626202,na,na,Conflicting classifications of pathogenicity,"Metachromatic leukodystrophy, late infantile form|Metachromatic leukodystrophy|PSEUDOARYLSULFATASE A DEFICIENCY|not provided|Abnormality of the nervous system",GRCh38,single nucleotide variant
ARSA,22,50627368,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50627261,na,na,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided|Inborn genetic diseases|ARSA-related disorder,GRCh38,single nucleotide variant
ARSA,22,50627218,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50627051,na,na,Likely pathogenic,Metachromatic leukodystrophy,GRCh38,single nucleotide variant
ARSA,22,50627048,na,na,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,GRCh38,single nucleotide variant
ARSA,22,50627012,na,na,Uncertain significance,Metachromatic leukodystrophy,GRCh38,single nucleotide variant
ARSA,22,50627007,na,na,Conflicting classifications of pathogenicity,ARYLSULFATASE A PSEUDODEFICIENCY|not specified|not provided|Metachromatic leukodystrophy|Intellectual disability,GRCh38,single nucleotide variant
ARSA,22,50626877,na,na,Pathogenic,Metachromatic leukodystrophy|not provided,GRCh38,single nucleotide variant
ARSA,22,50626841,na,na,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,GRCh38,single nucleotide variant
ARSA,22,50626748,na,na,Uncertain significance,Metachromatic leukodystrophy|not specified,GRCh38,single nucleotide variant
ARSA,22,50626709,na,na,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy|Metachromatic leukodystrophy, juvenile type",GRCh38,single nucleotide variant
ARSA,22,50626706,na,na,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50626618,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|ARSA-related disorder",GRCh38,single nucleotide variant
ARSA,22,50626265,na,na,Pathogenic,Metachromatic leukodystrophy|Spastic ataxia|not provided,GRCh38,single nucleotide variant
ARSA,22,50626243,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50626154,na,na,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,GRCh38,single nucleotide variant
ARSA,22,50626033,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|Leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50625675,na,na,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50625674,na,na,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50625653,na,na,Pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE|not provided|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50625639,na,na,Pathogenic/Likely pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE|Metachromatic leukodystrophy|not provided",GRCh38,single nucleotide variant
ARSA,22,50625615,na,na,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,GRCh38,single nucleotide variant
ARSA,22,50625443,na,na,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50625213,na,na,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,GRCh38,single nucleotide variant
ARSA,22,50627221,na,na,Pathogenic,"Metachromatic leukodystrophy, adult type",GRCh38,single nucleotide variant
ARSA,22,50626271,na,na,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|ARSA-related disorder",GRCh38,single nucleotide variant
ARSA,22,50626682,na,na,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50625446,na,na,Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy",GRCh38,single nucleotide variant
ARSA,22,50626228,na,na,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided",GRCh38,single nucleotide variant
ARSA,22,50625396,na,na,Pathogenic,"Metachromatic leukodystrophy, juvenile type",GRCh38,single nucleotide variant
MMAB,12,109561068,na,na,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblB type|Methylmalonic acidemia|not provided|Inborn genetic diseases|MMAB-related disorder",GRCh38,single nucleotide variant
EPM2A,6,145627691,na,na,Pathogenic,Lafora disease|not provided|Progressive myoclonic epilepsy|Myoclonic epilepsy of Lafora 1|Inborn genetic diseases|EPM2A-related disorder,GRCh38,single nucleotide variant
EPM2A,6,145627577,na,na,Pathogenic/Likely pathogenic,not provided|Progressive myoclonic epilepsy|Lafora disease|Myoclonic epilepsy of Lafora 1,GRCh38,single nucleotide variant
EPM2A,6,145686276,na,na,Pathogenic/Likely pathogenic,Progressive myoclonic epilepsy|Lafora disease|Myoclonic epilepsy of Lafora 1,GRCh38,single nucleotide variant
EPM2A,6,145635451,na,na,Likely pathogenic,Lafora disease|Progressive myoclonic epilepsy|not provided|Myoclonic epilepsy of Lafora 1,GRCh38,single nucleotide variant
EPM2A,6,145735405,na,na,Pathogenic/Likely pathogenic,not provided|Myoclonic epilepsy of Lafora 1|Progressive myoclonic epilepsy|Lafora disease,GRCh38,single nucleotide variant
IL23R,1,67240275,na,na,Benign,"Inflammatory bowel disease 17, protection against|Psoriasis, protection against|not provided",GRCh38,single nucleotide variant
SLC17A8,12,100396373,na,na,Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 25|not provided,GRCh38,single nucleotide variant
LRPPRC,2,43974244,na,na,Pathogenic,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type|not provided|LRPPRC-related disorder",GRCh38,single nucleotide variant
KCNQ1,11,2570682,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2570715,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2572981,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNQ1,11,2583448,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNQ1,11,2570719,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia,GRCh38,single nucleotide variant
KCNQ1,11,2572089,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNQ1,11,2572882,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNQ1,11,2583535,na,na,Pathogenic,"Long QT syndrome 1/2, digenic|Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia",GRCh38,single nucleotide variant
KCNQ1,11,2583535,na,na,Pathogenic,Long QT syndrome 1|not provided|Long QT syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNQ1,11,2585213,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiac arrhythmia,GRCh38,single nucleotide variant
KCNQ1,11,2583453,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2776032,na,na,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia,GRCh38,single nucleotide variant
KCNQ1,11,2572979,na,na,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2572963,na,na,Conflicting classifications of pathogenicity,"Long QT syndrome 1|not provided|not specified|Long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Cardiac arrhythmia",GRCh38,single nucleotide variant
KCNQ1,11,2768881,na,na,Pathogenic,"Long QT syndrome 1, recessive|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 1|Congenital long QT syndrome|not specified|KCNQ1-related disorder|Cardiac arrhythmia|Jervell and Lange-Nielsen syndrome 1|Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1;Long QT syndrome 1",GRCh38,single nucleotide variant
KCNQ1,11,2768902,na,na,Pathogenic/Likely pathogenic,"Long QT syndrome 1, recessive|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome",GRCh38,single nucleotide variant
KCNQ1,11,2583434,na,na,Pathogenic,Long QT syndrome 1|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2583545,na,na,Pathogenic,Long QT syndrome 1|Long QT syndrome|not provided|Long QT syndrome 2|Cardiovascular phenotype|Beckwith-Wiedemann syndrome|Congenital long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2778003,na,na,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 1|KCNQ1-related disorder,GRCh38,single nucleotide variant
KCNQ1,11,2778009,na,na,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome|Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1|Cardiac arrhythmia,GRCh38,single nucleotide variant
KCNQ1,11,2445448,na,na,Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2777990,na,na,Conflicting classifications of pathogenicity,"Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1|Congenital long QT syndrome|not provided|Short QT syndrome type 2;Atrial fibrillation, familial, 3;Long QT syndrome 1;Beckwith-Wiedemann syndrome;Jervell and Lange-Nielsen syndrome 1|Long QT syndrome|KCNQ1-related disorder|Short QT syndrome type 2;Atrial fibrillation, familial, 3;Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype",GRCh38,single nucleotide variant
KCNQ1,11,2527959,na,na,Pathogenic,"Atrial fibrillation, familial, 3|Atrial fibrillation",GRCh38,single nucleotide variant
KCNQ1,11,2572870,na,na,Pathogenic,"Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome|not specified|Short QT syndrome type 2;Long QT syndrome 1;Atrial fibrillation, familial, 3;Beckwith-Wiedemann syndrome;Jervell and Lange-Nielsen syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",GRCh38,single nucleotide variant
KCNQ1,11,2572871,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|KCNQ1-related disorder,GRCh38,single nucleotide variant
KCNQ1,11,2572984,na,na,Uncertain significance,Short QT syndrome type 2|Short QT syndrome|Long QT syndrome,GRCh38,single nucleotide variant
KCNQ1,11,2572057,na,na,Pathogenic,"Long QT syndrome 1/2, digenic|Congenital long QT syndrome",GRCh38,single nucleotide variant
ADAMTS17,15,100281258,na,na,Pathogenic,"Weill-Marchesani 4 syndrome, recessive",GRCh38,single nucleotide variant
ADAMTS17,15,100132006,na,na,Pathogenic/Likely pathogenic,"Weill-Marchesani 4 syndrome, recessive|not provided",GRCh38,single nucleotide variant
MMAA,4,145639422,na,na,Pathogenic,"Methylmalonic aciduria, cblA type|Methylmalonic acidemia",GRCh38,single nucleotide variant
MMAA,4,145646043,na,na,Pathogenic,"Methylmalonic aciduria, cblA type",GRCh38,single nucleotide variant
MMAA,4,145639572,na,na,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblA type|not provided|Methylmalonic acidemia|See cases|MMAA-related disorder",GRCh38,single nucleotide variant
APCDD1,18,10455007,na,na,Pathogenic,Hypotrichosis 1,GRCh38,single nucleotide variant
TPH2,12,72031544,na,na,risk factor,"Unipolar depression, susceptibility to",GRCh38,single nucleotide variant
TPH2,12,71979053,na,na,risk factor,"Attention deficit-hyperactivity disorder, susceptibility to, 7",GRCh38,single nucleotide variant
TPH2,12,71972526,na,na,Uncertain significance,"Bipolar affective disorder, susceptibility to|Tryptophan 5-monooxygenase deficiency|Attention deficit-hyperactivity disorder, susceptibility to, 7;Major depressive disorder",GRCh38,single nucleotide variant
HGD,3,120644405,na,na,Pathogenic,Alkaptonuria,GRCh38,single nucleotide variant
HGD,3,120638562,na,na,Pathogenic,Alkaptonuria,GRCh38,single nucleotide variant
HGD,3,120638471,na,na,Uncertain significance,Alkaptonuria,GRCh38,single nucleotide variant
HGD,3,120647041,na,na,Pathogenic,Alkaptonuria|not provided,GRCh38,single nucleotide variant
HGD,3,120675864,na,na,Pathogenic,Alkaptonuria|HGD-related disorder|not provided,GRCh38,single nucleotide variant
HGD,3,120633223,na,na,Likely pathogenic,Alkaptonuria,GRCh38,single nucleotide variant
HGD,3,120633233,na,na,Pathogenic,Alkaptonuria|not provided|See cases,GRCh38,single nucleotide variant
HGD,3,120641660,na,na,Pathogenic/Likely pathogenic,Alkaptonuria,GRCh38,single nucleotide variant
CDAN1,15,42726390,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",GRCh38,single nucleotide variant
CDAN1,15,42725550,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",GRCh38,single nucleotide variant
CDAN1,15,42731275,na,na,Likely pathogenic,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a",GRCh38,single nucleotide variant
CDAN1,15,42730757,na,na,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",GRCh38,single nucleotide variant
CDAN1,15,42729066,na,na,Pathogenic,"Congenital dyserythropoietic anemia, type I",GRCh38,single nucleotide variant
CDAN1,15,42731206,na,na,Uncertain significance,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a|not provided|not specified",GRCh38,single nucleotide variant
DYM,18,49430347,na,na,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,GRCh38,single nucleotide variant
DYM,18,49378592,na,na,Pathogenic/Likely pathogenic,Dyggve-Melchior-Clausen syndrome|Dyggve-Melchior-Clausen syndrome;Smith-McCort dysplasia 1|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
DYM,18,49257065,na,na,Pathogenic,Dyggve-Melchior-Clausen syndrome,GRCh38,single nucleotide variant
DYM,18,49379693,na,na,Pathogenic,Smith-McCort dysplasia 1|not provided|DYM-related disorder,GRCh38,single nucleotide variant
DYM,18,49258494,na,na,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,GRCh38,single nucleotide variant
DYM,18,49363235,na,na,Pathogenic,Dyggve-Melchior-Clausen syndrome,GRCh38,single nucleotide variant
DYM,18,49118866,na,na,Pathogenic,Smith-McCort dysplasia 1,GRCh38,single nucleotide variant
UTP4,16,69165386,na,na,Conflicting classifications of pathogenicity,Hereditary North American Indian childhood cirrhosis|not provided|UTP4-related disorder,GRCh38,single nucleotide variant
SBDS,7,66994210,na,na,Pathogenic/Likely pathogenic,"Shwachman-Diamond syndrome 1|Aplastic anemia, susceptibility to|not provided|not specified|Inborn genetic diseases|Microcephaly;Splenomegaly;Agenesis of permanent teeth;Deeply set eye;Short stature|Shwachman syndrome|Aplastic anemia|SBDS-related disorder|Aplastic anemia;Shwachman-Diamond syndrome 1",GRCh38,single nucleotide variant
SBDS,7,66995394,na,na,Uncertain significance,Shwachman-Diamond syndrome 1,GRCh38,single nucleotide variant
FKTN,9,105596631,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1X",GRCh38,single nucleotide variant
FKTN,9,105604372,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4",GRCh38,single nucleotide variant
FKTN,9,105601325,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Dilated cardiomyopathy 1X",GRCh38,single nucleotide variant
FKTN,9,105617968,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Autosomal recessive limb-girdle muscular dystrophy type 2M|Dilated cardiomyopathy 1X|Cardiovascular phenotype",GRCh38,single nucleotide variant
FKTN,9,105619962,na,na,Pathogenic,Dilated cardiomyopathy 1X,GRCh38,single nucleotide variant
FKTN,9,105604381,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1X|not provided|Walker-Warburg congenital muscular dystrophy,GRCh38,single nucleotide variant
FKTN,9,105604218,na,na,Benign/Likely benign,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not specified|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
FKTN,9,105601319,na,na,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy",GRCh38,single nucleotide variant
FKTN,9,105604354,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X|Walker-Warburg congenital muscular dystrophy",GRCh38,single nucleotide variant
FKTN,9,105620001,na,na,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Autosomal recessive limb-girdle muscular dystrophy type 2M",GRCh38,single nucleotide variant
FKTN,9,105617967,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X",GRCh38,single nucleotide variant
POMT2,14,77278849,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77298688,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77278764,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|POMT2-related disorder",GRCh38,single nucleotide variant
POMT2,14,77277452,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77278820,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",GRCh38,single nucleotide variant
POMT2,14,77277387,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77288777,na,na,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",GRCh38,single nucleotide variant
POMT2,14,77291380,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",GRCh38,single nucleotide variant
POMT2,14,77302898,na,na,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77301169,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",GRCh38,single nucleotide variant
POMT2,14,77302940,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2N|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Intellectual disability|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Autosomal recessive limb-girdle muscular dystrophy",GRCh38,single nucleotide variant
POMT2,14,77277386,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2N,GRCh38,single nucleotide variant
POMT2,14,77296223,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|not provided|POMT2-related disorder",GRCh38,single nucleotide variant
POMT2,14,77320429,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
POMT2,14,77285646,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",GRCh38,single nucleotide variant
POMT2,14,77285520,na,na,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",GRCh38,single nucleotide variant
PDSS1,10,26735477,na,na,Pathogenic,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,GRCh38,single nucleotide variant
POMT1,9,131506217,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Autosomal recessive limb-girdle muscular dystrophy",GRCh38,single nucleotide variant
POMT1,9,131510401,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Abnormality of the musculature|not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K",GRCh38,single nucleotide variant
POMT1,9,131520175,na,na,Uncertain significance,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",GRCh38,single nucleotide variant
POMT1,9,131509801,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2K|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Abnormality of the nervous system|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",GRCh38,single nucleotide variant
POMT1,9,131506184,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",GRCh38,single nucleotide variant
POMT1,9,131518945,na,na,Pathogenic,"not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",GRCh38,single nucleotide variant
POMT1,9,131521351,na,na,Conflicting classifications of pathogenicity,"not provided|not specified|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy",GRCh38,single nucleotide variant
POMT1,9,131522160,na,na,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",GRCh38,single nucleotide variant
POMT1,9,131513332,na,na,Pathogenic,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",GRCh38,single nucleotide variant
NME8,7,37888306,na,na,Uncertain significance,Primary ciliary dyskinesia 6|Primary ciliary dyskinesia|NME8-related disorder,GRCh38,single nucleotide variant
NME8,7,37862001,na,na,Benign/Likely benign,Primary ciliary dyskinesia 6|not specified|not provided|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
MC2R,18,13885298,na,na,Pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,GRCh38,single nucleotide variant
MC2R,18,13884918,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MC2R,18,13885159,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MC2R,18,13885137,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MC2R,18,13885200,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MC2R,18,13884767,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
MC2R,18,13885110,na,na,Pathogenic/Likely pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,GRCh38,single nucleotide variant
MC2R,18,13884758,na,na,Pathogenic,Glucocorticoid deficiency 1,GRCh38,single nucleotide variant
CDC73,1,193122203,na,na,Pathogenic,Hyperparathyroidism 2 with jaw tumors,GRCh38,single nucleotide variant
CDC73,1,193122225,na,na,Pathogenic,Hyperparathyroidism 2 with jaw tumors|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma,GRCh38,single nucleotide variant
CDC73,1,193122328,na,na,Pathogenic,Parathyroid carcinoma,GRCh38,single nucleotide variant
CDC73,1,193125171,na,na,Likely pathogenic,Hyperparathyroidism 1|Parathyroid carcinoma,GRCh38,single nucleotide variant
CDC73,1,193125142,na,na,Pathogenic,Parathyroid carcinoma,GRCh38,single nucleotide variant
CDC73,1,193122332,na,na,Pathogenic/Likely pathogenic,"Hyperparathyroidism 1|Parathyroid adenoma, somatic|Parathyroid carcinoma|not provided|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma;Hyperparathyroidism 2 with jaw tumors;Hyperparathyroidism 1",GRCh38,single nucleotide variant
CDC73,1,193130173,na,na,Pathogenic,Hyperparathyroidism 2 with jaw tumors,GRCh38,single nucleotide variant
NF2,22,29671905,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29636877,na,na,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 2|Acoustic neuroma|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NF2,22,29636805,na,na,Pathogenic,"Meningioma|not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NF2,22,29681468,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29681477,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29655621,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29661313,na,na,Pathogenic,"Neurofibromatosis, type 2|not provided",GRCh38,single nucleotide variant
NF2,22,29668405,na,na,Pathogenic,"Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NF2,22,29671847,na,na,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NF2,22,29673365,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29674882,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29674891,na,na,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NF2,22,29681443,na,na,Pathogenic,"Neurofibromatosis, type 2",GRCh38,single nucleotide variant
NF2,22,29636821,na,na,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 2|Acoustic neuroma",GRCh38,single nucleotide variant
LIPH,3,185534860,na,na,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis",GRCh38,single nucleotide variant
AIRE,21,44289773,na,na,Pathogenic,"not provided|Polyglandular autoimmune syndrome, type 1|Inborn genetic diseases|AIRE-related disorder",GRCh38,single nucleotide variant
AIRE,21,44286671,na,na,Likely pathogenic,"Polyglandular autoimmune syndrome, type 1",GRCh38,single nucleotide variant
AIRE,21,44287085,na,na,Pathogenic,"not provided|Polyglandular autoimmune syndrome, type 1",GRCh38,single nucleotide variant
AIRE,21,44289686,na,na,not provided,"Autoimmune polyglandular syndrome type 1, autosomal dominant",GRCh38,single nucleotide variant
AIRE,21,44286007,na,na,Pathogenic,"Polyglandular autoimmune syndrome, type 1|not provided",GRCh38,single nucleotide variant
AIRE,21,44286663,na,na,Pathogenic,"Polyglandular autoimmune syndrome, type 1",GRCh38,single nucleotide variant
SALL4,20,51790529,na,na,Pathogenic,Duane-radial ray syndrome,GRCh38,single nucleotide variant
SALL4,20,51789010,na,na,Pathogenic/Likely pathogenic,Duane-radial ray syndrome|not provided,GRCh38,single nucleotide variant
SALL4,20,51791960,na,na,Pathogenic,Duane-radial ray syndrome,GRCh38,single nucleotide variant
SALL4,20,51790634,na,na,Pathogenic,Duane-radial ray syndrome,GRCh38,single nucleotide variant
SALL4,20,51788890,na,na,Likely pathogenic,Duane-radial ray syndrome|not provided,GRCh38,single nucleotide variant
SALL4,20,51788940,na,na,Pathogenic,Duane-radial ray syndrome,GRCh38,single nucleotide variant
GABBR2,9,98578034,na,na,Benign,Epileptic encephalopathy|not provided,GRCh38,single nucleotide variant
RP9,7,33096550,na,na,Uncertain significance,Retinitis pigmentosa 9|not provided,GRCh38,single nucleotide variant
RP9,7,33095391,na,na,Uncertain significance,Retinitis pigmentosa 9|Retinitis pigmentosa,GRCh38,single nucleotide variant
SRD5A2,2,31526225,na,na,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
SRD5A2,2,31580737,na,na,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|Abnormality of the genitourinary system,GRCh38,single nucleotide variant
SRD5A2,2,31533704,na,na,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,GRCh38,single nucleotide variant
SRD5A2,2,31531371,na,na,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|not provided,GRCh38,single nucleotide variant
SRD5A2,2,31529326,na,na,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,GRCh38,single nucleotide variant
SRD5A2,2,31529323,na,na,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
SRD5A2,2,31529419,na,na,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|SRD5A2-related disorder,GRCh38,single nucleotide variant
SRD5A2,2,31529313,na,na,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
SRD5A2,2,31580756,na,na,Benign,SRD5A2 POLYMORPHISM|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder,GRCh38,single nucleotide variant
SRD5A2,2,31529370,na,na,Conflicting classifications of pathogenicity,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not specified,GRCh38,single nucleotide variant
SRD5A2,2,31529414,na,na,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,GRCh38,single nucleotide variant
SRD5A2,2,31580823,na,na,Pathogenic,Micropenis,GRCh38,single nucleotide variant
SRD5A2,2,31529325,na,na,Pathogenic/Likely pathogenic,Micropenis|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|Autism spectrum disorder,GRCh38,single nucleotide variant
PRPF3,1,150344216,na,na,Pathogenic,Retinitis pigmentosa 18|Retinal dystrophy|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
PRPF3,1,150344212,na,na,Pathogenic,Retinitis pigmentosa 18|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
PRPF3,1,150344201,na,na,Pathogenic,Retinitis pigmentosa 18,GRCh38,single nucleotide variant
PRPF8,17,1650884,na,na,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
PRPF8,17,1650884,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|Retinal dystrophy,GRCh38,single nucleotide variant
PRPF8,17,1650881,na,na,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
PRPF8,17,1650909,na,na,Likely pathogenic,Retinitis pigmentosa 13|not provided,GRCh38,single nucleotide variant
PRPF8,17,1650898,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|not provided,GRCh38,single nucleotide variant
SEMA4A,1,156162993,na,na,Uncertain significance,Cone-rod dystrophy 10|Retinitis pigmentosa 35|not provided,GRCh38,single nucleotide variant
SEMA4A,1,156163009,na,na,Pathogenic,Cone-rod dystrophy 10|Retinitis pigmentosa 35,GRCh38,single nucleotide variant
SEMA4A,1,156176849,na,na,Benign/Likely benign,"Retinitis pigmentosa 35|not specified|Cone-rod dystrophy 10|Retinitis Pigmentosa, Recessive|Retinitis pigmentosa|not provided|Retinal dystrophy|Retinitis pigmentosa 35;Cone-rod dystrophy 10",GRCh38,single nucleotide variant
FLCN,17,17215228,na,na,Pathogenic,Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial spontaneous pneumothorax|FLCN-related disorder|Birt-Hogg-Dube syndrome 1,GRCh38,single nucleotide variant
FLCN,17,17227902,na,na,Uncertain significance,Carcinoma of colon|Birt-Hogg-Dube syndrome,GRCh38,single nucleotide variant
FLCN,17,17215284,na,na,Conflicting classifications of pathogenicity,Carcinoma of colon|not provided|not specified|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dube syndrome|Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome 1;17p11.2 microduplication syndrome;Familial spontaneous pneumothorax;Colorectal cancer;Nonpapillary renal cell carcinoma,GRCh38,single nucleotide variant
EVC2,4,5640789,na,na,Pathogenic,Ellis-van Creveld syndrome|Short-rib thoracic dysplasia 6 with or without polydactyly|not provided|Ellis-van Creveld syndrome;Curry-Hall syndrome,GRCh38,single nucleotide variant
EVC2,4,5628590,na,na,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,GRCh38,single nucleotide variant
EVC2,4,5681282,na,na,Pathogenic,Ellis-van Creveld syndrome,GRCh38,single nucleotide variant
EVC2,4,5576247,na,na,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
EVC2,4,5584832,na,na,Uncertain significance,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,GRCh38,single nucleotide variant
TMIE,3,46709155,na,na,Conflicting classifications of pathogenicity,"Autosomal recessive nonsyndromic hearing loss 6|Hearing loss, autosomal recessive|not provided|Sensorineural hearing loss disorder",GRCh38,single nucleotide variant
TMIE,3,46709164,na,na,Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 6|not provided|Sensorineural hearing loss disorder|Hearing impairment|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
TMIE,3,46709188,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,GRCh38,single nucleotide variant
TMIE,3,46705866,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,GRCh38,single nucleotide variant
IRF5,7,128938247,na,na,Uncertain significance,"Systemic lupus erythematosus, susceptibility to, 10|Rheumatoid arthritis|Systemic lupus erythematosus",GRCh38,single nucleotide variant
IRF5,7,128949373,na,na,risk factor,"Systemic lupus erythematosus, susceptibility to, 10",GRCh38,single nucleotide variant
IRF5,7,128948946,na,na,risk factor,"Systemic lupus erythematosus, association with susceptibility to, 10",GRCh38,single nucleotide variant
NPHP4,1,5887403,na,na,Pathogenic,Nephronophthisis 4|Nephronophthisis,GRCh38,single nucleotide variant
NPHP4,1,5887394,na,na,Pathogenic,Nephronophthisis 4|Nephronophthisis,GRCh38,single nucleotide variant
NPHP4,1,5904716,na,na,Pathogenic,"Nephronophthisis 4|Infertility disorder;Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)|Nephronophthisis",GRCh38,single nucleotide variant
NPHP4,1,5874946,na,na,Pathogenic,Nephronophthisis 4,GRCh38,single nucleotide variant
NPHP4,1,5887436,na,na,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis,GRCh38,single nucleotide variant
NPHP4,1,5904788,na,na,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis|Nephronophthisis 4,GRCh38,single nucleotide variant
CARD9,9,136370362,na,na,Pathogenic,Predisposition to invasive fungal disease due to CARD9 deficiency,GRCh38,single nucleotide variant
ALOXE3,17,8109238,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 3,GRCh38,single nucleotide variant
ALOXE3,17,8112177,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 3|not provided|ALOXE3-related disorder|Autosomal recessive congenital ichthyosis 3;Autosomal recessive congenital ichthyosis 2,GRCh38,single nucleotide variant
ALOXE3,17,8110211,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 3,GRCh38,single nucleotide variant
ALOXE3,17,8112168,na,na,Benign/Likely benign,Autosomal recessive congenital ichthyosis 3|not provided|not specified,GRCh38,single nucleotide variant
IRF6,1,209796453,na,na,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",GRCh38,single nucleotide variant
IRF6,1,209789669,na,na,Likely pathogenic,Popliteal pterygium syndrome|not provided,GRCh38,single nucleotide variant
IRF6,1,209796477,na,na,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|IRF6-related condition",GRCh38,single nucleotide variant
IRF6,1,209796476,na,na,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome 1",GRCh38,single nucleotide variant
IRF6,1,209801409,na,na,Pathogenic,Van der Woude syndrome 1,GRCh38,single nucleotide variant
IRF6,1,209801398,na,na,Pathogenic/Likely pathogenic,"Van der Woude syndrome 1|Cleft palate|not provided|Orofacial cleft 6, susceptibility to;Popliteal pterygium syndrome;Van der Woude syndrome 1|IRF6-related condition",GRCh38,single nucleotide variant
IRF6,1,209789709,na,na,Pathogenic,Van der Woude syndrome 1,GRCh38,single nucleotide variant
IRF6,1,209788626,na,na,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",GRCh38,single nucleotide variant
IRF6,1,209801280,na,na,Conflicting classifications of pathogenicity,"Van der Woude syndrome 1|not provided|Popliteal pterygium syndrome;Van der Woude syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome",GRCh38,single nucleotide variant
IRF6,1,209788638,na,na,Pathogenic,Van der Woude syndrome 1,GRCh38,single nucleotide variant
IRF6,1,209790539,na,na,Pathogenic,Van der Woude syndrome 1|Popliteal pterygium syndrome,GRCh38,single nucleotide variant
TDP1,14,89993420,na,na,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1|not provided",GRCh38,single nucleotide variant
PTF1A,10,23193805,na,na,Pathogenic,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,GRCh38,single nucleotide variant
CRELD1,3,9943452,na,na,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",GRCh38,single nucleotide variant
CRELD1,3,9943399,na,na,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",GRCh38,single nucleotide variant
CRELD1,3,9937624,na,na,Conflicting classifications of pathogenicity,"Atrioventricular septal defect, partial, with heterotaxy syndrome|not provided|Atrioventricular septal defect, susceptibility to, 2",GRCh38,single nucleotide variant
CRELD1,3,9940873,na,na,risk factor,"Atrioventricular septal defect, susceptibility to, 2",GRCh38,single nucleotide variant
CRELD1,3,9944556,na,na,risk factor,"Atrioventricular septal defect, susceptibility to, 2",GRCh38,single nucleotide variant
DTNBP1,6,15627391,na,na,Pathogenic,Hermansky-Pudlak syndrome 7|not provided,GRCh38,single nucleotide variant
ALG12,22,49910479,na,na,Likely pathogenic,ALG12-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG12,22,49913480,na,na,Conflicting classifications of pathogenicity,ALG12-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG12,22,49910466,na,na,Pathogenic/Likely pathogenic,ALG12-congenital disorder of glycosylation|ALG12-related disorder|not provided,GRCh38,single nucleotide variant
ALG12,22,49910602,na,na,Likely pathogenic,ALG12-congenital disorder of glycosylation|not provided|ALG12-related disorder,GRCh38,single nucleotide variant
ALG12,22,49910085,na,na,Pathogenic,ALG12-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG12,22,49904063,na,na,Pathogenic,ALG12-congenital disorder of glycosylation,GRCh38,single nucleotide variant
FANCA,16,89810716,na,na,Pathogenic,Fanconi anemia complementation group A,GRCh38,single nucleotide variant
PROKR2,20,5302677,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified|not provided|Infertility disorder|Hypogonadotropic hypogonadism,GRCh38,single nucleotide variant
PROKR2,20,5302566,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified,GRCh38,single nucleotide variant
PROKR2,20,5314116,na,na,Conflicting classifications of pathogenicity,not provided|Hypogonadotropic hypogonadism 3 with or without anosmia|not specified|PROKR2-related disorder|Amenorrhea|Hypogonadism with anosmia|Male infertility with azoospermia or oligozoospermia due to single gene mutation,GRCh38,single nucleotide variant
PROKR2,20,5302226,na,na,Pathogenic,Hypogonadotropic hypogonadism 3 with or without anosmia,GRCh38,single nucleotide variant
MCPH1,8,6409330,na,na,Pathogenic,"Microcephaly 1, primary, autosomal recessive|not provided",GRCh38,single nucleotide variant
PAX6,11,31794120,na,na,Pathogenic,Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31800808,na,na,Pathogenic,Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31790835,na,na,Pathogenic,"Cataracts, congenital, with late-onset corneal dystrophy|Aniridia 1",GRCh38,single nucleotide variant
PAX6,11,31802769,na,na,Pathogenic/Likely pathogenic,"Aniridia 1|ANTERIOR SEGMENT DYSGENESIS 5, PETERS ANOMALY SUBTYPE|Coloboma, ocular, autosomal dominant",GRCh38,single nucleotide variant
PAX6,11,31801611,na,na,Pathogenic,Aniridia 1|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31790710,na,na,Pathogenic,Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31794705,na,na,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
PAX6,11,31794079,na,na,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis|Irido-corneo-trabecular dysgenesis,GRCh38,single nucleotide variant
PAX6,11,31790862,na,na,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis,GRCh38,single nucleotide variant
PAX6,11,31793555,na,na,Pathogenic,Autosomal dominant keratitis,GRCh38,single nucleotide variant
PAX6,11,31800832,na,na,Pathogenic,Foveal hypoplasia 1|Aniridia 1|Irido-corneo-trabecular dysgenesis;Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31800837,na,na,Likely pathogenic,"Aniridia, atypical|Irido-corneo-trabecular dysgenesis;Aniridia 1|PAX6-related ocular dysgenesis",GRCh38,single nucleotide variant
PAX6,11,31801727,na,na,Pathogenic,Foveal hypoplasia 1 with cataract|Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31801893,na,na,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 5, MULTIPLE SUBTYPES|Foveal hypoplasia 1 with or without anterior segment anomalies",GRCh38,single nucleotide variant
PAX6,11,31789935,na,na,Pathogenic/Likely pathogenic,Aniridia 1|not provided|Nystagmus;Hypertelorism;Visual impairment|8 conditions|Irido-corneo-trabecular dysgenesis;Aniridia 1|Foveal hypoplasia 1,GRCh38,single nucleotide variant
PAX6,11,31801716,na,na,Pathogenic,Coloboma of optic nerve,GRCh38,single nucleotide variant
PAX6,11,31794699,na,na,Pathogenic,Isolated optic nerve hypoplasia|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31793795,na,na,Pathogenic,"Coloboma, ocular, autosomal dominant",GRCh38,single nucleotide variant
PAX6,11,31790722,na,na,Pathogenic,"Optic nerve aplasia, bilateral",GRCh38,single nucleotide variant
PAX6,11,31806397,na,na,Likely pathogenic,Foveal hypoplasia 1,GRCh38,single nucleotide variant
PAX6,11,31794072,na,na,Pathogenic,Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31801561,na,na,Pathogenic/Likely pathogenic,Aniridia 1|not provided,GRCh38,single nucleotide variant
PAX6,11,31810826,na,na,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1,GRCh38,single nucleotide variant
PAX6,11,31793797,na,na,Pathogenic,Aniridia 1,GRCh38,single nucleotide variant
WT1,11,32391966,na,na,Pathogenic,Frasier syndrome,GRCh38,single nucleotide variant
WT1,11,32392020,na,na,Pathogenic/Likely pathogenic,"Drash syndrome|Meacham syndrome|Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Steroid-resistant nephrotic syndrome;Nephrotic range proteinuria|Kidney disorder|Wilms tumor 1|WT1-related disorder|6 conditions",GRCh38,single nucleotide variant
WT1,11,32392704,na,na,Pathogenic,"Drash syndrome|not provided|Wilms tumor 1;Drash syndrome;Frasier syndrome;Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4|Wilms tumor 1|8 conditions",GRCh38,single nucleotide variant
WT1,11,32392013,na,na,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,GRCh38,single nucleotide variant
WT1,11,32392014,na,na,Pathogenic,"Drash syndrome|Nephrotic syndrome, type 4|not provided",GRCh38,single nucleotide variant
WT1,11,32392019,na,na,Pathogenic,Drash syndrome|WT1-related disorder,GRCh38,single nucleotide variant
WT1,11,32396313,na,na,Pathogenic,Drash syndrome,GRCh38,single nucleotide variant
WT1,11,32391967,na,na,Pathogenic,"Drash syndrome|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|Nephrotic syndrome, type 4|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Wilms tumor 1|WT1-related disorder|6 conditions",GRCh38,single nucleotide variant
WT1,11,32392032,na,na,Pathogenic,Wilms tumor 1|Frasier syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Focal segmental glomerulosclerosis|6 conditions,GRCh38,single nucleotide variant
WT1,11,32392672,na,na,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome",GRCh38,single nucleotide variant
WT1,11,32392723,na,na,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,GRCh38,single nucleotide variant
WT1,11,32392717,na,na,Pathogenic,Drash syndrome|Wilms tumor 1|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|8 conditions|not provided|6 conditions,GRCh38,single nucleotide variant
WT1,11,32392682,na,na,Pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,GRCh38,single nucleotide variant
WT1,11,32400025,na,na,Pathogenic,Mesothelioma,GRCh38,single nucleotide variant
WT1,11,32391968,na,na,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic range proteinuria|Wilms tumor 1|WT1-related disorder|6 conditions",GRCh38,single nucleotide variant
WT1,11,32392053,na,na,Pathogenic,"Nephrotic syndrome, type 4",GRCh38,single nucleotide variant
WT1,11,32392026,na,na,Pathogenic,Frasier syndrome,GRCh38,single nucleotide variant
WT1,11,32392705,na,na,Pathogenic,"Meacham syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4",GRCh38,single nucleotide variant
WT1,11,32434815,na,na,Pathogenic,Wilms tumor 1,GRCh38,single nucleotide variant
NPHP1,2,110129185,na,na,Pathogenic/Likely pathogenic,Nephronophthisis 1|Nephronophthisis|Joubert syndrome with renal defect|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1,GRCh38,single nucleotide variant
NPHP1,2,110201484,na,na,Pathogenic,Nephronophthisis 1|Nephronophthisis,GRCh38,single nucleotide variant
NPHP1,2,110163048,na,na,Pathogenic,Nephronophthisis 1|not provided|Nephronophthisis|NPHP1-related disorder|Joubert syndrome with renal defect|Inborn genetic diseases|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1|Retinal dystrophy,GRCh38,single nucleotide variant
SLC22A12,11,64593747,na,na,Pathogenic,Dalmatian hypouricemia|not provided|SLC22A12-related disorder,GRCh38,single nucleotide variant
SLC22A12,11,64593548,na,na,Likely pathogenic,Dalmatian hypouricemia|not provided,GRCh38,single nucleotide variant
SLC22A12,11,64598579,na,na,Pathogenic,Dalmatian hypouricemia,GRCh38,single nucleotide variant
SLC22A12,11,64599858,na,na,Pathogenic,Dalmatian hypouricemia,GRCh38,single nucleotide variant
SLC22A12,11,64591825,na,na,Pathogenic,Dalmatian hypouricemia|Familial renal hypouricemia|not provided,GRCh38,single nucleotide variant
SLC22A12,11,64599687,na,na,Pathogenic,Dalmatian hypouricemia,GRCh38,single nucleotide variant
MTHFR,1,11800251,na,na,Pathogenic,Abnormality of metabolism/homeostasis|Homocystinuria due to methylene tetrahydrofolate reductase deficiency,GRCh38,single nucleotide variant
MTHFR,1,11801166,na,na,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect|Neural tube defects, folate-sensitive|not provided",GRCh38,single nucleotide variant
MTHFR,1,11796321,na,na,drug response,"MTHFR THERMOLABILE POLYMORPHISM|not provided|Gastrointestinal stromal tumor|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive|not specified|methotrexate response - Toxicity|See cases|Thrombophilia due to thrombin defect",GRCh38,single nucleotide variant
MTHFR,1,11794419,na,na,Benign/Likely benign; other,"Schizophrenia, susceptibility to|MTHFR THERMOLABILE POLYMORPHISM|Neural tube defects, folate-sensitive|Gastrointestinal stromal tumor|not provided|not specified|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Thrombophilia due to thrombin defect;Schizophrenia|MTHFR-related disorder",GRCh38,single nucleotide variant
MTHFR,1,11795158,na,na,Likely pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,GRCh38,single nucleotide variant
MTHFR,1,11795114,na,na,Pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,GRCh38,single nucleotide variant
MTHFR,1,11791216,na,na,Uncertain significance,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,GRCh38,single nucleotide variant
MTHFR,1,11794766,na,na,Conflicting classifications of pathogenicity,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|not provided|Neural tube defects, folate-sensitive",GRCh38,single nucleotide variant
MTHFR,1,11795161,na,na,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect",GRCh38,single nucleotide variant
HYAL1,3,50302155,na,na,Uncertain significance,Deficiency of hyaluronoglucosaminidase,GRCh38,single nucleotide variant
SLC39A4,8,144415438,na,na,Pathogenic,Hereditary acrodermatitis enteropathica,GRCh38,single nucleotide variant
SLC39A4,8,144415295,na,na,Pathogenic/Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided|SLC39A4-related disorder,GRCh38,single nucleotide variant
SLC39A4,8,144413288,na,na,Pathogenic,Hereditary acrodermatitis enteropathica,GRCh38,single nucleotide variant
SLC39A4,8,144414291,na,na,Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided,GRCh38,single nucleotide variant
SLC39A4,8,144415966,na,na,Pathogenic,Hereditary acrodermatitis enteropathica,GRCh38,single nucleotide variant
SLC39A4,8,144414422,na,na,Pathogenic,Hereditary acrodermatitis enteropathica,GRCh38,single nucleotide variant
SLC39A4,8,144416001,na,na,Pathogenic,Hereditary acrodermatitis enteropathica|not provided,GRCh38,single nucleotide variant
SLC39A4,8,144414792,na,na,Pathogenic,Hereditary acrodermatitis enteropathica,GRCh38,single nucleotide variant
IMPG2,3,101275694,na,na,Pathogenic,Retinitis pigmentosa 56|Retinitis pigmentosa,GRCh38,single nucleotide variant
IMPG2,3,101243615,na,na,Pathogenic,Retinitis pigmentosa 56|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
IMPG2,3,101242820,na,na,Pathogenic,Retinitis pigmentosa 56|Macular dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
IMPG2,3,101304277,na,na,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 5|not provided|Retinitis pigmentosa|Retinitis pigmentosa 56|Retinal dystrophy,GRCh38,single nucleotide variant
CLN3,16,28482500,na,na,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|Retinal dystrophy|Neuronal ceroid lipofuscinosis|early onset and severe retinal dystrophy|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
CLN3,16,28486427,na,na,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|not provided|Neuronal ceroid lipofuscinosis",GRCh38,single nucleotide variant
ABCC11,16,48224287,na,na,Benign,"APOCRINE GLAND SECRETION, VARIATION IN|Axillary odor|Colostrum secretion|not provided",GRCh38,single nucleotide variant
OTOA,16,21710105,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 22|not provided,GRCh38,single nucleotide variant
IVD,15,40405952,na,na,Pathogenic,"Isovaleric acidemia, type I",GRCh38,single nucleotide variant
IVD,15,40411600,na,na,Pathogenic/Likely pathogenic,"Isovaleric acidemia, type I|not provided|Isovaleryl-CoA dehydrogenase deficiency",GRCh38,single nucleotide variant
IVD,15,40407639,na,na,Pathogenic/Likely pathogenic,Isovaleryl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
IVD,15,40415454,na,na,Pathogenic,Isovaleryl-CoA dehydrogenase deficiency|not provided|Inborn genetic diseases|IVD-related disorder,GRCh38,single nucleotide variant
SUFU,10,102504196,na,na,Uncertain significance,Medulloblastoma|not provided,GRCh38,single nucleotide variant
SUFU,10,102599545,na,na,Pathogenic,not provided|Basal cell nevus syndrome 2|SUFU-related disorder|Gorlin syndrome;Medulloblastoma|Medulloblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TRPM6,9,74802138,na,na,Pathogenic,Intestinal hypomagnesemia 1,GRCh38,single nucleotide variant
TRPM6,9,74801897,na,na,Pathogenic,Intestinal hypomagnesemia 1,GRCh38,single nucleotide variant
TRPM6,9,74812322,na,na,Pathogenic,Intestinal hypomagnesemia 1,GRCh38,single nucleotide variant
TRPM6,9,74842330,na,na,Pathogenic/Likely pathogenic,Intestinal hypomagnesemia 1|not provided,GRCh38,single nucleotide variant
TRPM6,9,74821664,na,na,Pathogenic,Intestinal hypomagnesemia 1,GRCh38,single nucleotide variant
TRPM6,9,74840146,na,na,Pathogenic,Intestinal hypomagnesemia 1,GRCh38,single nucleotide variant
ACADM,1,75761161,na,na,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Epileptic spasm|See cases|Inborn genetic diseases|ACADM-related disorder,GRCh38,single nucleotide variant
ACADM,1,75749509,na,na,Pathogenic/Likely pathogenic,not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency|ACADM-related disorder,GRCh38,single nucleotide variant
ACADM,1,75761300,na,na,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADM,1,75749440,na,na,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADM,1,75734850,na,na,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,GRCh38,single nucleotide variant
ACADM,1,75740094,na,na,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ACADM,1,75740088,na,na,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADM,1,75749552,na,na,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,GRCh38,single nucleotide variant
ACADM,1,75732724,na,na,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ACADM,1,75749444,na,na,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
ACADM,1,75733603,na,na,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,GRCh38,single nucleotide variant
PROK2,3,71784959,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|PROK2-related disorder,GRCh38,single nucleotide variant
PROK2,3,71781472,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|not provided|PROK2-related disorder,GRCh38,single nucleotide variant
EHMT1,9,137818100,na,na,Pathogenic/Likely pathogenic,Kleefstra syndrome 1|not provided,GRCh38,single nucleotide variant
EHMT1,9,137814468,na,na,Pathogenic,Kleefstra syndrome 1,GRCh38,single nucleotide variant
EHMT1,9,137743418,na,na,Pathogenic,Kleefstra syndrome 1,GRCh38,single nucleotide variant
GALT,9,34647879,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder,GRCh38,single nucleotide variant
GALT,9,34649502,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not provided,GRCh38,single nucleotide variant
GALT,9,34647136,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,GRCh38,single nucleotide variant
GALT,9,34647190,na,na,Benign,GALT POLYMORPHISM,GRCh38,single nucleotide variant
GALT,9,34649445,na,na,Conflicting classifications of pathogenicity; other,"GALT POLYMORPHISM (DUARTE, D2)|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder",GRCh38,single nucleotide variant
GALT,9,34648170,na,na,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
GALT,9,34647227,na,na,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,GRCh38,single nucleotide variant
GALT,9,34648119,na,na,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,GRCh38,single nucleotide variant
GALT,9,34649462,na,na,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,GRCh38,single nucleotide variant
GALT,9,34647858,na,na,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Inborn genetic diseases|Galactosemia|See cases|GALT-related disorder,GRCh38,single nucleotide variant
GALT,9,34648154,na,na,Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,GRCh38,single nucleotide variant
GALT,9,34648421,na,na,Benign; other,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|not specified|Galactosemia,GRCh38,single nucleotide variant
GALT,9,34649032,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,GRCh38,single nucleotide variant
GALT,9,34648376,na,na,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not provided,GRCh38,single nucleotide variant
GALT,9,34649502,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia,GRCh38,single nucleotide variant
GALT,9,34648349,na,na,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,GRCh38,single nucleotide variant
MPO,17,58272835,na,na,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency|MPO-related disorder,GRCh38,single nucleotide variant
MPO,17,58279553,na,na,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency,GRCh38,single nucleotide variant
LPO;MPO,17,58279141,na,na,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder,GRCh38,single nucleotide variant
MPO,17,58278036,na,na,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided,GRCh38,single nucleotide variant
MPO,17,58272825,na,na,Pathogenic,Myeloperoxidase deficiency,GRCh38,single nucleotide variant
LPO;MPO,17,58270865,na,na,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder|not specified|Myeloperoxidase deficiency;Alzheimer disease type 1,GRCh38,single nucleotide variant
MPO,17,58281401,na,na,protective; risk factor,"Lung cancer, protection against, in smokers|",GRCh38,single nucleotide variant
MPO,17,58273534,na,na,Pathogenic,Myeloperoxidase deficiency,GRCh38,single nucleotide variant
MPO,17,58273540,na,na,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|MPO-related disorder,GRCh38,single nucleotide variant
COQ8A,1,226985332,na,na,Conflicting classifications of pathogenicity,Autosomal recessive ataxia due to ubiquinone deficiency|See cases|Abnormality of the nervous system|not provided,GRCh38,single nucleotide variant
COQ8A,1,226965719,na,na,Pathogenic/Likely pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,GRCh38,single nucleotide variant
COQ8A,1,226982111,na,na,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,GRCh38,single nucleotide variant
COQ8A,1,226982111,na,na,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,GRCh38,single nucleotide variant
COQ8A,1,226984237,na,na,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,GRCh38,single nucleotide variant
COQ8A,1,226984910,na,na,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,GRCh38,single nucleotide variant
COQ8A,1,226982947,na,na,Benign/Likely benign,Autosomal recessive ataxia due to ubiquinone deficiency|not specified|not provided|Joubert syndrome 17|Coenzyme Q10 deficiency,GRCh38,single nucleotide variant
COQ8A,1,226985326,na,na,Uncertain significance,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,GRCh38,single nucleotide variant
COG8,16,69331067,na,na,Pathogenic,COG8-congenital disorder of glycosylation,GRCh38,single nucleotide variant
COG8,16,69334520,na,na,Pathogenic,COG8-congenital disorder of glycosylation,GRCh38,single nucleotide variant
COG7,16,23452822,na,na,Pathogenic,COG7 congenital disorder of glycosylation,GRCh38,single nucleotide variant
COG7,16,23445968,na,na,Likely pathogenic,COG7 congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
COG4,16,70481397,na,na,Pathogenic/Likely pathogenic,COG4-congenital disorder of glycosylation|See cases|not provided,GRCh38,single nucleotide variant
COG1,17,73200026,na,na,Pathogenic,COG1 congenital disorder of glycosylation|Nephrotic syndrome,GRCh38,single nucleotide variant
LCAT,16,67942686,na,na,Pathogenic,LCAT deficiency,GRCh38,single nucleotide variant
LCAT,16,67940276,na,na,Pathogenic,LCAT deficiency,GRCh38,single nucleotide variant
LCAT,16,67940471,na,na,Pathogenic,LCAT deficiency,GRCh38,single nucleotide variant
LCAT,16,67942754,na,na,Pathogenic,Fish-eye disease|not provided|LCAT-related disorder|Fish-eye disease;Norum disease,GRCh38,single nucleotide variant
LCAT,16,67944001,na,na,Pathogenic,Fish-eye disease|Fish-eye disease;Norum disease|not provided,GRCh38,single nucleotide variant
LCAT,16,67940115,na,na,Uncertain significance,Fish-eye disease|Fish-eye disease;Norum disease,GRCh38,single nucleotide variant
LCAT,16,67940400,na,na,Pathogenic,LCAT deficiency,GRCh38,single nucleotide variant
LCAT,16,67942413,na,na,Pathogenic,LCAT deficiency,GRCh38,single nucleotide variant
LCAT,16,67942939,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
LCAT,16,67942719,na,na,Likely pathogenic,LCAT deficiency|not provided,GRCh38,single nucleotide variant
LCAT,16,67940193,na,na,Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,GRCh38,single nucleotide variant
LCAT,16,67942967,na,na,Pathogenic/Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,GRCh38,single nucleotide variant
LCAT,16,67942731,na,na,Pathogenic,Fish-eye disease,GRCh38,single nucleotide variant
LCAT,16,67942609,na,na,Pathogenic,Fish-eye disease,GRCh38,single nucleotide variant
GALE,1,23797128,na,na,Likely pathogenic,"UDPglucose-4-epimerase deficiency|UDPglucose-4-epimerase deficiency;Thrombocytopenia 13, syndromic",GRCh38,single nucleotide variant
GALE,1,23798907,na,na,Conflicting classifications of pathogenicity,"UDPglucose-4-epimerase deficiency|not provided|not specified|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency",GRCh38,single nucleotide variant
GALE,1,23798199,na,na,Pathogenic,UDPglucose-4-epimerase deficiency,GRCh38,single nucleotide variant
GALE,1,23798160,na,na,Uncertain significance,UDPglucose-4-epimerase deficiency,GRCh38,single nucleotide variant
GALE,1,23796722,na,na,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not specified|not provided|GALE-related disorder,GRCh38,single nucleotide variant
GALE,1,23796202,na,na,Pathogenic,UDPglucose-4-epimerase deficiency,GRCh38,single nucleotide variant
GALE,1,23796183,na,na,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not provided|GALE-related disorder,GRCh38,single nucleotide variant
GALE,1,23798188,na,na,Pathogenic/Likely pathogenic,"UDPglucose-4-epimerase deficiency|Galactosemia III, severe|not provided|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency|Inborn genetic diseases",GRCh38,single nucleotide variant
LDLR,19,11100252,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11102732,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11105436,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11116201,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11120382,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11105587,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11105588,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|Homozygous familial hypercholesterolemia|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11107484,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder",GRCh38,single nucleotide variant
LDLR;MIR6886,19,11113376,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|Homozygous familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11113382,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11113743,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11116144,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11116153,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11120425,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|See cases|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11120436,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11129562,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided",GRCh38,single nucleotide variant
LDLR,19,11129606,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Cardiovascular phenotype|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11105576,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11105429,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11105470,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11105599,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11113388,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11129654,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11113293,na,na,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
LDLR,19,11102787,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|See cases",GRCh38,single nucleotide variant
LDLR,19,11116197,na,na,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not specified|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11105602,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",GRCh38,single nucleotide variant
LDLR,19,11105457,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11106652,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|not provided|Cardiovascular phenotype|Hypercholesterolemia",GRCh38,single nucleotide variant
LDLR,19,11100286,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11100292,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 1",GRCh38,single nucleotide variant
LDLR,19,11105232,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 1",GRCh38,single nucleotide variant
LDLR,19,11120523,na,na,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype|LDLR-related disorder",GRCh38,single nucleotide variant
LDLR,19,11113307,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",GRCh38,single nucleotide variant
LDLR,19,11105527,na,na,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ALG9,11,111836179,na,na,Uncertain significance,ALG9 congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG9,11,111853415,na,na,Likely pathogenic,ALG9 congenital disorder of glycosylation|ALG9-related disorder|Gillessen-Kaesbach-Nishimura syndrome;ALG9 congenital disorder of glycosylation,GRCh38,single nucleotide variant
UROS,10,125815061,na,na,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,GRCh38,single nucleotide variant
UROS,10,125815120,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125815081,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125815094,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125788983,na,na,Conflicting classifications of pathogenicity,Cutaneous porphyria|not provided|UROS-related disorder,GRCh38,single nucleotide variant
UROS,10,125816490,na,na,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,GRCh38,single nucleotide variant
UROS,10,125815034,na,na,Uncertain significance,Cutaneous porphyria|not provided,GRCh38,single nucleotide variant
UROS,10,125794978,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125815035,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125794978,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125823205,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125816708,na,na,Pathogenic,Cutaneous porphyria|not provided,GRCh38,single nucleotide variant
UROS,10,125816718,na,na,Pathogenic,Cutaneous porphyria|not provided,GRCh38,single nucleotide variant
UROS,10,125816722,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
UROS,10,125788993,na,na,Pathogenic,Cutaneous porphyria|not provided,GRCh38,single nucleotide variant
UROS,10,125816436,na,na,Pathogenic/Likely pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,GRCh38,single nucleotide variant
UROS,10,125788923,na,na,Pathogenic,Cutaneous porphyria,GRCh38,single nucleotide variant
TRPM4,19,49157885,na,na,Likely pathogenic,Progressive familial heart block type IB|TRPM4-related disorder,GRCh38,single nucleotide variant
TYR,11,89178195,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Albinism|Oculocutaneous albinism|Inborn genetic diseases|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1",GRCh38,single nucleotide variant
TYR,11,89191205,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism type 1A|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|TYR-related disorder|Albinism or congenital nystagmus",GRCh38,single nucleotide variant
TYR,11,89227904,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89227933,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Nonsyndromic Oculocutaneous Albinism|Inborn genetic diseases|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89178183,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1B|See cases|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Albinism or congenital nystagmus|TYR-related disorder|Oculocutaneous albinism",GRCh38,single nucleotide variant
TYR,11,89284805,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism type 1A|Oculocutaneous albinism|Inborn genetic diseases|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Hearing impairment|Abnormality of the skin|TYR-related disorder|Albinism or congenital nystagmus|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89178528,na,na,Conflicting classifications of pathogenicity,"SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1A|not provided|not specified|Oculocutaneous albinism|Albinism or congenital nystagmus|Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89284793,na,na,Conflicting classifications of pathogenicity; other,"Oculocutaneous albinism type 1B|Temperature-sensitive oculocutaneous albinism type 1|Melanoma, cutaneous malignant, susceptibility to, 8|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Skin/hair/eye pigmentation 3, blue/green eyes|Oculocutaneous albinism type 1A|not provided|not specified|Autosomal recessive ocular albinism|6 conditions|Malignant tumor of breast|Oculocutaneous albinism type 1|Albinism or congenital nystagmus",GRCh38,single nucleotide variant
TYR,11,89178218,na,na,Pathogenic,Oculocutaneous albinism type 1A|not provided|8 conditions,GRCh38,single nucleotide variant
TYR,11,89284853,na,na,Pathogenic,"Temperature-sensitive oculocutaneous albinism type 1|not provided|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89177755,na,na,Benign,Oculocutaneous albinism type 1A|not provided,GRCh38,single nucleotide variant
TYR,11,89178486,na,na,Pathogenic,Oculocutaneous albinism type 1A|not provided,GRCh38,single nucleotide variant
TYR,11,89227932,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89178078,na,na,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,GRCh38,single nucleotide variant
TYR,11,89178117,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",GRCh38,single nucleotide variant
TYR,11,89178569,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",GRCh38,single nucleotide variant
TYR,11,89284843,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Albinism or congenital nystagmus",GRCh38,single nucleotide variant
TYR,11,89178014,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",GRCh38,single nucleotide variant
TYR,11,89178093,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|Oculocutaneous albinism type 1B|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Inborn genetic diseases|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89178602,na,na,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1B|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89191278,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|See cases|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89227898,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89284797,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",GRCh38,single nucleotide variant
TYR,11,89284924,na,na,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",GRCh38,single nucleotide variant
TYR,11,89284930,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",GRCh38,single nucleotide variant
TYR,11,89178660,na,na,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,GRCh38,single nucleotide variant
TYR,11,89178599,na,na,Uncertain significance,Oculocutaneous albinism type 1A|not provided|not specified,GRCh38,single nucleotide variant
TYR,11,89177954,na,na,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Hypopigmentation of the skin;Iris transillumination defect;Hypopigmentation of hair;Horizontal nystagmus|Myopia;Albinism;Nystagmus|Oculocutaneous albinism type 1A|6 conditions|Abnormality of the skin|Oculocutaneous albinism type 1B;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1A|TYR-related disorder|Oculocutaneous albinism",GRCh38,single nucleotide variant
LYST,1,235805826,na,na,Pathogenic/Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome|not provided",GRCh38,single nucleotide variant
LYST,1,235830270,na,na,Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",GRCh38,single nucleotide variant
LYST,1,235806051,na,na,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome|not provided",GRCh38,single nucleotide variant
LYST,1,235788701,na,na,Uncertain significance,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",GRCh38,single nucleotide variant
LYST,1,235766204,na,na,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",GRCh38,single nucleotide variant
GALC,14,87963392,na,na,Pathogenic,Galactosylceramide beta-galactosidase deficiency,GRCh38,single nucleotide variant
SUOX,12,56004039,na,na,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency,GRCh38,single nucleotide variant
SUOX,12,56004183,na,na,Uncertain significance,Sulfite oxidase deficiency,GRCh38,single nucleotide variant
SUOX,12,56004978,na,na,Likely pathogenic,Sulfite oxidase deficiency|Sulfocysteinuria,GRCh38,single nucleotide variant
ACADS,12,120727115,na,na,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases|ACADS-related disorder,GRCh38,single nucleotide variant
ACADS,12,120737094,na,na,Pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ACADS,12,120737049,na,na,Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACADS,12,120737893,na,na,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|ACADS-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
ACADS,12,120739356,na,na,Pathogenic/Likely pathogenic,not provided|Deficiency of butyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACADS,12,120737875,na,na,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not provided|not specified,GRCh38,single nucleotide variant
ACADS,12,120738280,na,na,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not specified|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ACADS,12,120737043,na,na,Uncertain significance,Deficiency of butyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACADS,12,120737939,na,na,Conflicting classifications of pathogenicity,Deficiency of butyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACADS,12,120738859,na,na,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACADS,12,120739168,na,na,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACADS,12,120739347,na,na,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
IRAK4,12,43778238,na,na,Pathogenic,Immunodeficiency 67|not provided|IRAK4-related disorder,GRCh38,single nucleotide variant
IRAK4,12,43786398,na,na,Pathogenic,Immunodeficiency 67,GRCh38,single nucleotide variant
IRAK4,12,43784244,na,na,Likely pathogenic,"Immunodeficiency 67|Invasive pneumococcal disease, recurrent isolated",GRCh38,single nucleotide variant
ATP7B,13,51944145,na,na,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ATP7B,13,51937583,na,na,Pathogenic/Likely pathogenic,Wilson disease|not provided,GRCh38,single nucleotide variant
ATP7B,13,51965034,na,na,Pathogenic,Wilson disease|not provided|Developmental and epileptic encephalopathy 93,GRCh38,single nucleotide variant
ATP7B,13,51950116,na,na,Pathogenic/Likely pathogenic,Wilson disease|not provided,GRCh38,single nucleotide variant
ATP7B,13,51958333,na,na,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,GRCh38,single nucleotide variant
ATP7B,13,51958373,na,na,Pathogenic/Likely pathogenic,Wilson disease,GRCh38,single nucleotide variant
ATP7B,13,51949700,na,na,Pathogenic,Wilson disease|not provided,GRCh38,single nucleotide variant
ATP7B,13,51949772,na,na,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ATP7B,13,51937570,na,na,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,GRCh38,single nucleotide variant
ATP7B,13,51946438,na,na,Pathogenic,Wilson disease|not provided|ATP7B-related disorder,GRCh38,single nucleotide variant
ATP7B,13,51958369,na,na,Pathogenic/Likely pathogenic,Wilson disease,GRCh38,single nucleotide variant
ATP7B,13,51961849,na,na,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,GRCh38,single nucleotide variant
ATP7B,13,51941194,na,na,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ATP7B,13,51974355,na,na,Pathogenic/Likely pathogenic,Wilson disease|not provided,GRCh38,single nucleotide variant
ATP7B,13,51958543,na,na,Pathogenic,Wilson disease|not provided,GRCh38,single nucleotide variant
ATP7B,13,51960198,na,na,Pathogenic/Likely pathogenic,Wilson disease,GRCh38,single nucleotide variant
PHGDH,1,119743906,na,na,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|See cases|PHGDH-related disorder|Neu-Laxova syndrome 1,GRCh38,single nucleotide variant
PHGDH,1,119742870,na,na,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1,GRCh38,single nucleotide variant
PHGDH,1,119726897,na,na,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|not provided,GRCh38,single nucleotide variant
PHGDH,1,119741817,na,na,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|not provided|Neu-Laxova syndrome 1,GRCh38,single nucleotide variant
PHGDH,1,119735432,na,na,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1|not provided|not specified,GRCh38,single nucleotide variant
HEXB,5,74689390,na,na,Benign,HEXB POLYMORPHISM|not specified|Sandhoff disease|not provided,GRCh38,single nucleotide variant
HEXB,5,74718921,na,na,Uncertain significance,"Sandhoff disease, juvenile form|Sandhoff disease|not specified|not provided",GRCh38,single nucleotide variant
HEXB,5,74718804,na,na,Pathogenic/Likely pathogenic,"Sandhoff disease, adult form|Sandhoff disease, juvenile form|not provided|Sandhoff disease|Inborn genetic diseases|HEXB-related disorder|See cases",GRCh38,single nucleotide variant
HEXB,5,74720648,na,na,Pathogenic,"Sandhoff disease, adult form|Sandhoff disease",GRCh38,single nucleotide variant
HEXB,5,74721131,na,na,Likely benign; other,"HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM|not provided|Sandhoff disease",GRCh38,single nucleotide variant
HEXB,5,74685445,na,na,Benign,"Sandhoff disease, infantile form|Sandhoff disease",GRCh38,single nucleotide variant
HEXB,5,74720644,na,na,Pathogenic/Likely pathogenic,"Sandhoff disease, chronic|Sandhoff disease|not provided",GRCh38,single nucleotide variant
HEXB,5,74715695,na,na,Pathogenic,"Sandhoff disease, infantile form",GRCh38,single nucleotide variant
HEXB,5,74713584,na,na,Pathogenic,"Sandhoff disease|Sandhoff disease, infantile form|not provided",GRCh38,single nucleotide variant
HEXA,15,72346234,na,na,Pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72345528,na,na,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
HEXA,15,72356524,na,na,Pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72345461,na,na,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, juvenile|Tay-Sachs disease|not provided",GRCh38,single nucleotide variant
HEXA,15,72353105,na,na,Pathogenic/Likely pathogenic,"Hexa, dn allele|Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease|Inborn genetic diseases|Global developmental delay|HEXA-related disorder",GRCh38,single nucleotide variant
HEXA,15,72353106,na,na,Pathogenic,"Tay-Sachs disease, B1 variant|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72350518,na,na,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, adult|Tay-Sachs disease|not provided|Gm2-gangliosidosis, late onset|Inborn genetic diseases|HEXA-related disorder",GRCh38,single nucleotide variant
HEXA,15,72345476,na,na,Pathogenic,"Gm2-gangliosidosis, juvenile|Inborn genetic diseases|Tay-Sachs disease|not provided",GRCh38,single nucleotide variant
HEXA,15,72353129,na,na,Pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72346597,na,na,Pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72350574,na,na,Pathogenic/Likely pathogenic,"Tay-sachs disease, juvenile|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72355562,na,na,Pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72346680,na,na,Pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72345462,na,na,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, chronic|not provided|Tay-Sachs disease|not specified",GRCh38,single nucleotide variant
HEXA,15,72351176,na,na,Pathogenic/Likely pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72375895,na,na,Pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72353105,na,na,Likely pathogenic,Tay-Sachs disease|not provided,GRCh38,single nucleotide variant
HEXA,15,72375972,na,na,Pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72345477,na,na,Pathogenic,"GM2-gangliosidosis, adult-onset|Tay-Sachs disease|Inborn genetic diseases",GRCh38,single nucleotide variant
HEXA,15,72348134,na,na,Likely pathogenic,"Gm2-gangliosidosis, variant b1|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72345519,na,na,Uncertain significance,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72353098,na,na,Affects,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72348047,na,na,Pathogenic/Likely pathogenic,Tay-Sachs disease|not provided|Inborn genetic diseases|HEXA-related disorder,GRCh38,single nucleotide variant
HEXA,15,72350584,na,na,Benign/Likely benign; other,"Beta-hexosaminidase a, pseudodeficiency of|not specified|not provided|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72351231,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
HEXA,15,72350551,na,na,Pathogenic/Likely pathogenic,"Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72353130,na,na,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
HEXA,15,72351215,na,na,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, late onset|not provided|not specified|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72351132,na,na,Pathogenic,"Tay-sachs disease, juvenile/adult|Tay-Sachs disease|not provided",GRCh38,single nucleotide variant
HEXA,15,72351173,na,na,Affects,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72355591,na,na,Pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72351194,na,na,Conflicting classifications of pathogenicity,Tay-Sachs disease|not specified|not provided,GRCh38,single nucleotide variant
HEXA,15,72349163,na,na,Conflicting classifications of pathogenicity,"Tay-Sachs disease|Tay-Sachs disease;Tay-Sachs disease, variant AB",GRCh38,single nucleotide variant
HEXA,15,72346296,na,na,Likely pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72375857,na,na,Affects,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72346681,na,na,Pathogenic,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72350517,na,na,Pathogenic,Tay-Sachs disease|HEXA-related disorder,GRCh38,single nucleotide variant
HEXA,15,72353100,na,na,Likely pathogenic,"Gm2-gangliosidosis, late onset|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72345550,na,na,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, subacute|Tay-Sachs disease",GRCh38,single nucleotide variant
HEXA,15,72346305,na,na,Uncertain significance; Affects,Tay-Sachs disease,GRCh38,single nucleotide variant
HEXA,15,72349093,na,na,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, subacute|Tay-Sachs disease|not provided",GRCh38,single nucleotide variant
SERPING1,11,57614450,na,na,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,GRCh38,single nucleotide variant
SERPING1,11,57614475,na,na,Conflicting classifications of pathogenicity,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|Hereditary angioedema type 1|not provided|Hereditary angioedema type 1;C1 inhibitor deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
SERPING1,11,57614474,na,na,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided|Hereditary angioedema type 1,GRCh38,single nucleotide variant
SERPING1,11,57614474,na,na,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided,GRCh38,single nucleotide variant
SERPING1,11,57611937,na,na,Pathogenic,Hereditary angioedema type 1,GRCh38,single nucleotide variant
SERPING1,11,57614439,na,na,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,GRCh38,single nucleotide variant
SERPING1,11,57614472,na,na,Uncertain significance,"Complement component 4, partial deficiency of, due to dysfunctional c1 inhibitor|not provided",GRCh38,single nucleotide variant
SERPING1,11,57597582,na,na,Pathogenic,Hereditary angioedema type 1,GRCh38,single nucleotide variant
SERPING1,11,57602081,na,na,Pathogenic,Hereditary angioedema type 1,GRCh38,single nucleotide variant
GCLC,6,53507001,na,na,Pathogenic,Gamma-glutamylcysteine synthetase deficiency,GRCh38,single nucleotide variant
TCOF1,5,150374288,na,na,Pathogenic,Treacher Collins syndrome 1,GRCh38,single nucleotide variant
TCOF1,5,150361196,na,na,Likely pathogenic,Treacher Collins syndrome 1|not provided,GRCh38,single nucleotide variant
TCOF1,5,150388004,na,na,Pathogenic,Treacher Collins syndrome 1,GRCh38,single nucleotide variant
ALMS1,2,73490339,na,na,Pathogenic,Alstrom syndrome,GRCh38,single nucleotide variant
ALMS1,2,73572866,na,na,Pathogenic,Alstrom syndrome,GRCh38,single nucleotide variant
ALMS1,2,73490120,na,na,Pathogenic,Alstrom syndrome|not provided,GRCh38,single nucleotide variant
FXN,9,69053193,na,na,Pathogenic,Friedreich ataxia,GRCh38,single nucleotide variant
FXN,9,69064936,na,na,Pathogenic,Friedreich ataxia,GRCh38,single nucleotide variant
FXN,9,69065013,na,na,Pathogenic,Friedreich ataxia|Friedreich ataxia 1,GRCh38,single nucleotide variant
FXN,9,69064942,na,na,Conflicting classifications of pathogenicity,Friedreich ataxia|not provided,GRCh38,single nucleotide variant
FXN,9,69035785,na,na,Pathogenic,Friedreich ataxia|not provided|Friedreich ataxia 1,GRCh38,single nucleotide variant
FXN,9,69072646,na,na,Likely pathogenic,Friedreich ataxia,GRCh38,single nucleotide variant
POMGNT1,1,46192307,na,na,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46190473,na,na,Pathogenic/Likely pathogenic,"Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy",GRCh38,single nucleotide variant
POMGNT1,1,46192159,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46192397,na,na,Pathogenic/Likely pathogenic,"not provided|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Retinitis pigmentosa 76|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O|Retinal dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy|Autosomal recessive limb-girdle muscular dystrophy",GRCh38,single nucleotide variant
POMGNT1,1,46193873,na,na,Pathogenic/Likely pathogenic,"Muscle eye brain disease|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy",GRCh38,single nucleotide variant
POMGNT1,1,46197018,na,na,Pathogenic,"Retinitis pigmentosa 76|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46192212,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46189973,na,na,Conflicting classifications of pathogenicity,"Autosomal recessive limb-girdle muscular dystrophy type 2O|Muscle eye brain disease|not specified|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Congenital Muscular Dystrophy, alpha-dystroglycan related|Retinitis pigmentosa 76|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Structural eye disease",GRCh38,single nucleotide variant
POMGNT1,1,46189539,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46194843,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
POMGNT1,1,46192168,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|not provided|Muscle eye brain disease|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy|POMGNT1-related disorder|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",GRCh38,single nucleotide variant
COG5,7,107258398,na,na,Pathogenic,COG5-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALDH4A1,1,18877498,na,na,Conflicting classifications of pathogenicity,Hyperprolinemia type 2,GRCh38,single nucleotide variant
PRODH,22,18918386,na,na,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|not specified|Schizophrenia 4;Proline dehydrogenase deficiency,GRCh38,single nucleotide variant
PRODH,22,18922389,na,na,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|not specified|Proline dehydrogenase deficiency;Schizophrenia 4,GRCh38,single nucleotide variant
PRODH,22,18918421,na,na,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|not provided|Inborn genetic diseases|not specified|Proline dehydrogenase deficiency;Schizophrenia 4,GRCh38,single nucleotide variant
PRODH,22,18918380,na,na,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|Inborn genetic diseases|not provided|Schizophrenia 4;Proline dehydrogenase deficiency,GRCh38,single nucleotide variant
PRODH,22,18913491,na,na,Benign,Proline dehydrogenase deficiency|Schizophrenia 4|not provided,GRCh38,single nucleotide variant
PRODH,22,18918451,na,na,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|Proline dehydrogenase deficiency;Schizophrenia 4|not specified,GRCh38,single nucleotide variant
PRODH,22,18913492,na,na,Pathogenic,Proline dehydrogenase deficiency,GRCh38,single nucleotide variant
PRODH,22,18918346,na,na,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Schizophrenia 4;Proline dehydrogenase deficiency,GRCh38,single nucleotide variant
MYO3A,10,26168729,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,GRCh38,single nucleotide variant
MYO3A,10,26120664,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,GRCh38,single nucleotide variant
MYO3A,10,26024020,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,GRCh38,single nucleotide variant
FTCD,21,46151945,na,na,Uncertain significance,Glutamate formiminotransferase deficiency,GRCh38,single nucleotide variant
FTCD,21,46150129,na,na,Uncertain significance,Glutamate formiminotransferase deficiency,GRCh38,single nucleotide variant
GAA,17,80104857,na,na,Benign/Likely benign; other,"Acid alpha-glucosidase, allele 2|not provided|not specified|Glycogen storage disease, type II|Cardiovascular phenotype",GRCh38,single nucleotide variant
GAA,17,80107894,na,na,Pathogenic,"Glycogen storage disease type II, infantile|not provided|Glycogen storage disease, type II",GRCh38,single nucleotide variant
GAA,17,80110950,na,na,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided",GRCh38,single nucleotide variant
GAA,17,80112914,na,na,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",GRCh38,single nucleotide variant
GAA,17,80113350,na,na,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",GRCh38,single nucleotide variant
GAA,17,80107837,na,na,Likely pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II",GRCh38,single nucleotide variant
GAA,17,80104542,na,na,Pathogenic,"Glycogen storage disease, type II|GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Myopathy|Glycogen storage disease due to acid maltase deficiency, late-onset|See cases|Cardiovascular phenotype|Glycogen storage disease, type IV|GAA-related disorder",GRCh38,single nucleotide variant
GAA,17,80112922,na,na,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided|Cardiovascular phenotype|GAA-related disorder",GRCh38,single nucleotide variant
GAA,17,80113242,na,na,Benign; other,"Acid alpha-glucosidase, allele 4|not specified|not provided|Glycogen storage disease, type II|Cardiovascular phenotype",GRCh38,single nucleotide variant
GAA,17,80111023,na,na,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Glycogen storage disease, type II",GRCh38,single nucleotide variant
GAA,17,80118271,na,na,Pathogenic,"Glycogen storage disease, type II|not provided|GAA-related disorder|Cardiovascular phenotype",GRCh38,single nucleotide variant
GAA,17,80107574,na,na,Uncertain significance,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|GAA-related disorder|not specified|not provided",GRCh38,single nucleotide variant
GAA,17,80107818,na,na,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",GRCh38,single nucleotide variant
ST14,11,130209734,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 11,GRCh38,single nucleotide variant
ST14,11,130159982,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 11,GRCh38,single nucleotide variant
TPO,2,1487841,na,na,Pathogenic,Deficiency of iodide peroxidase|not provided,GRCh38,single nucleotide variant
TPO,2,1484596,na,na,Pathogenic,Deficiency of iodide peroxidase,GRCh38,single nucleotide variant
TPO,2,1484614,na,na,Pathogenic,Deficiency of iodide peroxidase|not provided,GRCh38,single nucleotide variant
TPO,2,1487991,na,na,Pathogenic,Deficiency of iodide peroxidase,GRCh38,single nucleotide variant
TPO,2,1503956,na,na,Pathogenic,Deficiency of iodide peroxidase|not provided,GRCh38,single nucleotide variant
TPO,2,1493976,na,na,Pathogenic,Deficiency of iodide peroxidase|not provided,GRCh38,single nucleotide variant
TPO,2,1496059,na,na,Uncertain significance,Deficiency of iodide peroxidase|not specified,GRCh38,single nucleotide variant
TPO,2,1494011,na,na,Pathogenic/Likely pathogenic,Deficiency of iodide peroxidase|not provided,GRCh38,single nucleotide variant
MLYCD,16,83907018,na,na,Pathogenic,Deficiency of malonyl-CoA decarboxylase|not provided,GRCh38,single nucleotide variant
MLYCD,16,83914942,na,na,Pathogenic,Deficiency of malonyl-CoA decarboxylase,GRCh38,single nucleotide variant
MLYCD,16,83899152,na,na,Conflicting classifications of pathogenicity,Deficiency of malonyl-CoA decarboxylase|not provided,GRCh38,single nucleotide variant
MLYCD,16,83899263,na,na,Pathogenic,Deficiency of malonyl-CoA decarboxylase,GRCh38,single nucleotide variant
DUOX2,15,45108887,na,na,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
DUOX2,15,45106217,na,na,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,GRCh38,single nucleotide variant
DUOX2,15,45104176,na,na,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|Genetic transient congenital hypothyroidism;Familial thyroid dyshormonogenesis,GRCh38,single nucleotide variant
DUOX2,15,45109895,na,na,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|DUOX2-related disorder|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,GRCh38,single nucleotide variant
SAMHD1,20,36930760,na,na,Likely pathogenic,Aicardi-Goutieres syndrome 5,GRCh38,single nucleotide variant
SAMHD1,20,36935105,na,na,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,GRCh38,single nucleotide variant
SAMHD1,20,36935048,na,na,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Chilblain lupus 2;Aicardi-Goutieres syndrome 5,GRCh38,single nucleotide variant
SAMHD1,20,36935093,na,na,Pathogenic,Aicardi-Goutieres syndrome 5,GRCh38,single nucleotide variant
SAMHD1,20,36897926,na,na,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,GRCh38,single nucleotide variant
SAMHD1,20,36935170,na,na,Pathogenic,Aicardi-Goutieres syndrome 5,GRCh38,single nucleotide variant
SAMHD1,20,36919456,na,na,Uncertain significance,Aicardi-Goutieres syndrome 5|not specified,GRCh38,single nucleotide variant
TLL1,4,165995090,na,na,Pathogenic,Atrial septal defect 6,GRCh38,single nucleotide variant
TLL1,4,166003471,na,na,Uncertain significance,Atrial septal defect 6|not provided,GRCh38,single nucleotide variant
TLL1,4,166060066,na,na,Pathogenic,Atrial septal defect 6,GRCh38,single nucleotide variant
CLN6,15,68214373,na,na,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",GRCh38,single nucleotide variant
CLN6,15,68211793,na,na,Conflicting classifications of pathogenicity,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)|not provided",GRCh38,single nucleotide variant
CLN6,15,68209639,na,na,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",GRCh38,single nucleotide variant
CLN6,15,68211258,na,na,Uncertain significance,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis",GRCh38,single nucleotide variant
SLC26A2,5,149980428,na,na,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4|SLC26A2-related disorder|Sulfate transporter-related osteochondrodysplasia|not provided|Inborn genetic diseases|Atelosteogenesis type II;Multiple epiphyseal dysplasia type 4;Diastrophic dysplasia;Achondrogenesis, type IB|3MC syndrome 2|Connective tissue disorder|Achondrogenesis, type IB",GRCh38,single nucleotide variant
SLC26A2,5,149980357,na,na,Conflicting classifications of pathogenicity,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Osteochondrodysplasia",GRCh38,single nucleotide variant
SLC26A2,5,149981737,na,na,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Achondrogenesis, type IB",GRCh38,single nucleotide variant
SLC26A2,5,149978184,na,na,Pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|not provided|Diastrophic dysplasia;Atelosteogenesis type II;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Atelosteogenesis type II|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder|3MC syndrome 2",GRCh38,single nucleotide variant
SLC26A2,5,149980866,na,na,Pathogenic/Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4",GRCh38,single nucleotide variant
SLC26A2,5,149981626,na,na,Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",GRCh38,single nucleotide variant
SLC26A2,5,149980954,na,na,Pathogenic,"Diastrophic dysplasia, broad bone-platyspondylic variant|Diastrophic dysplasia",GRCh38,single nucleotide variant
SLC26A2,5,149960981,na,na,Pathogenic,"Diastrophic dysplasia|Sulfate transporter-related osteochondrodysplasia|Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|not provided|SLC26A2-related disorder|3MC syndrome 2|Achondrogenesis, type IB",GRCh38,single nucleotide variant
SLC26A2,5,149981550,na,na,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 4|not provided|Diastrophic dysplasia|Atelosteogenesis type II|Diastrophic dysplasia;Atelosteogenesis type II;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Achondrogenesis, type IB|Connective tissue disorder|3MC syndrome 2|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder",GRCh38,single nucleotide variant
SLC26A2,5,149981128,na,na,Pathogenic,"De la Chapelle dysplasia|Diastrophic dysplasia|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",GRCh38,single nucleotide variant
SLC26A2,5,149978050,na,na,Uncertain significance,Diastrophic dysplasia|not specified,GRCh38,single nucleotide variant
TMC1,9,72816161,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 36|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
TMC1,9,72694578,na,na,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Rare genetic deafness|Hearing loss, autosomal recessive|not provided|Autosomal dominant nonsyndromic hearing loss 36|Autosomal dominant nonsyndromic hearing loss 36;Autosomal recessive nonsyndromic hearing loss 7",GRCh38,single nucleotide variant
TMC1,9,72821038,na,na,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 7|not provided|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
TMC1,9,72816161,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 36,GRCh38,single nucleotide variant
TMC1,9,72648665,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 7,GRCh38,single nucleotide variant
TMC1,9,72792329,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
PKHD1,6,52083201,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive polycystic kidney disease|Colorectal cancer, protection against|not provided|Oligohydramnios;Polycystic kidney disease;Periportal fibrosis|Polycystic kidney disease|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4|PKHD1-related disorder|Inborn genetic diseases|See cases",GRCh38,single nucleotide variant
PKHD1,6,52024819,na,na,Pathogenic,Autosomal recessive polycystic kidney disease,GRCh38,single nucleotide variant
PKHD1,6,51748563,na,na,Uncertain significance,Autosomal recessive polycystic kidney disease|not provided|not specified,GRCh38,single nucleotide variant
PKHD1,6,52024589,na,na,Conflicting classifications of pathogenicity,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4|See cases|PKHD1-related disorder,GRCh38,single nucleotide variant
PKHD1,6,51847871,na,na,Pathogenic,Autosomal recessive polycystic kidney disease|Polycystic kidney disease 4|not provided|PKHD1-related disorder,GRCh38,single nucleotide variant
PKHD1,6,51659468,na,na,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|Inborn genetic diseases|Polycystic kidney disease 4|PKHD1-related disorder,GRCh38,single nucleotide variant
PKHD1,6,52058349,na,na,Pathogenic,Autosomal recessive polycystic kidney disease|not provided|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4,GRCh38,single nucleotide variant
PKHD1,6,51659714,na,na,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4,GRCh38,single nucleotide variant
EIF2B4,2,27366880,na,na,Likely pathogenic,Leukoencephalopathy with vanishing white matter 4|Vanishing white matter disease,GRCh38,single nucleotide variant
EIF2B4,2,27366830,na,na,Conflicting classifications of pathogenicity,Leukoencephalopathy with vanishing white matter 4|not provided,GRCh38,single nucleotide variant
EIF2B4,2,27366758,na,na,Pathogenic,Leukoencephalopathy with vanishing white matter 4,GRCh38,single nucleotide variant
EIF2B4,2,27368047,na,na,Pathogenic,Leukoencephalopathy with vanishing white matter 4,GRCh38,single nucleotide variant
EIF2B4,2,27364579,na,na,Pathogenic,Leukoencephalopathy with vanishing white matter 4,GRCh38,single nucleotide variant
EIF2B4,2,27364507,na,na,Pathogenic/Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 4,GRCh38,single nucleotide variant
EIF2B1,12,123630396,na,na,Conflicting classifications of pathogenicity,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 1,GRCh38,single nucleotide variant
EIF2B1,12,123624792,na,na,Uncertain significance,Vanishing white matter disease|not provided,GRCh38,single nucleotide variant
HPS4,22,26457923,na,na,Pathogenic,Hermansky-Pudlak syndrome 4|not provided,GRCh38,single nucleotide variant
HPS4,22,26470774,na,na,Pathogenic,Hermansky-Pudlak syndrome 4,GRCh38,single nucleotide variant
HPS4,22,26468571,na,na,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 4|not provided|Hermansky-Pudlak syndrome|See cases,GRCh38,single nucleotide variant
HPS4,22,26472391,na,na,Pathogenic,Hermansky-Pudlak syndrome 4,GRCh38,single nucleotide variant
HPS4,22,26468556,na,na,Pathogenic,Hermansky-Pudlak syndrome 4,GRCh38,single nucleotide variant
NSD1,5,177209709,na,na,Pathogenic,Sotos syndrome|not provided,GRCh38,single nucleotide variant
NSD1,5,177283929,na,na,Pathogenic,not provided|Sotos syndrome,GRCh38,single nucleotide variant
NSD1,5,177292124,na,na,Pathogenic,Sotos syndrome,GRCh38,single nucleotide variant
NSD1,5,177293916,na,na,Pathogenic,Sotos syndrome,GRCh38,single nucleotide variant
NSD1,5,177238273,na,na,Pathogenic,not provided|Sotos syndrome,GRCh38,single nucleotide variant
NSD1,5,177293973,na,na,Pathogenic/Likely pathogenic,not provided|Sotos syndrome,GRCh38,single nucleotide variant
UPB1,22,24500105,na,na,Pathogenic/Likely pathogenic,Deficiency of beta-ureidopropionase|not provided|UPB1-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
UPB1,22,24500256,na,na,Conflicting classifications of pathogenicity,Deficiency of beta-ureidopropionase|not provided|not specified,GRCh38,single nucleotide variant
UPB1,22,24500211,na,na,Uncertain significance,Deficiency of beta-ureidopropionase,GRCh38,single nucleotide variant
GP1BA,17,4933681,na,na,Pathogenic,"Bernard-Soulier syndrome, type A1",GRCh38,single nucleotide variant
GP1BA,17,4933350,na,na,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease,GRCh38,single nucleotide variant
GP1BA,17,4932821,na,na,Likely pathogenic,"Bernard-Soulier syndrome, type A2, autosomal dominant|Macrothrombocytopenia",GRCh38,single nucleotide variant
GP1BA,17,4933367,na,na,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease|Thrombocytopenia|Impaired ristocetin-induced platelet aggregation|not provided,GRCh38,single nucleotide variant
GP1BA,17,4933119,na,na,Pathogenic,"Bernard-Soulier syndrome, type A1|Bernard-Soulier syndrome, type A2, autosomal dominant|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",GRCh38,single nucleotide variant
GP1BA,17,4934224,na,na,Pathogenic/Likely pathogenic,"Bernard-Soulier syndrome, type A1|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",GRCh38,single nucleotide variant
RXFP2,13,31777398,na,na,Conflicting classifications of pathogenicity,Cryptorchidism|not provided,GRCh38,single nucleotide variant
GFM1,3,158646896,na,na,Likely pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,GRCh38,single nucleotide variant
GFM1,3,158645686,na,na,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,GRCh38,single nucleotide variant
GFM1,3,158665443,na,na,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,GRCh38,single nucleotide variant
NLRP1,17,5582047,na,na,Benign,"Vitiligo-associated multiple autoimmune disease susceptibility 1|Respiratory papillomatosis, juvenile recurrent, congenital|not provided|Autoinflammation with arthritis and dyskeratosis|Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome|not specified",GRCh38,single nucleotide variant
TMPRSS15,21,18312975,na,na,Pathogenic,Enterokinase deficiency|not provided,GRCh38,single nucleotide variant
TMPRSS15,21,18281139,na,na,Pathogenic,Enterokinase deficiency|not provided,GRCh38,single nucleotide variant
TMPRSS15,21,18359856,na,na,Pathogenic,Enterokinase deficiency,GRCh38,single nucleotide variant
RIMS1,6,72251007,na,na,Conflicting classifications of pathogenicity,Cone-rod dystrophy 7|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
GNMT,6,42960916,na,na,Pathogenic,Glycine N-methyltransferase deficiency,GRCh38,single nucleotide variant
GNMT,6,42963149,na,na,Uncertain significance,Glycine N-methyltransferase deficiency|not provided,GRCh38,single nucleotide variant
SMARCAL1,2,216478216,na,na,Pathogenic,Schimke immuno-osseous dysplasia|9 conditions|Nephrotic syndrome|not provided,GRCh38,single nucleotide variant
SMARCAL1,2,216414753,na,na,Pathogenic,Schimke immuno-osseous dysplasia,GRCh38,single nucleotide variant
SMARCAL1,2,216414804,na,na,Pathogenic,Schimke immuno-osseous dysplasia,GRCh38,single nucleotide variant
SMARCAL1,2,216435495,na,na,Pathogenic,Schimke immuno-osseous dysplasia,GRCh38,single nucleotide variant
SMARCAL1,2,216450927,na,na,Pathogenic/Likely pathogenic,Schimke immuno-osseous dysplasia,GRCh38,single nucleotide variant
SMARCAL1,2,216447063,na,na,Conflicting classifications of pathogenicity,Schimke immuno-osseous dysplasia|Nephrotic syndrome,GRCh38,single nucleotide variant
SMARCAL1,2,216475315,na,na,Pathogenic,Schimke immuno-osseous dysplasia,GRCh38,single nucleotide variant
TREX1,3,48466996,na,na,Pathogenic/Likely pathogenic,"Aicardi-Goutieres syndrome 1|Systemic lupus erythematosus, susceptibility to|not provided|Inborn genetic diseases|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Inborn genetic diseases|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Chilblain lupus 1;Aicardi-Goutieres syndrome 1|TREX1-related disorder|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Systemic lupus erythematosus",GRCh38,single nucleotide variant
TREX1,3,48467145,na,na,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 1|not provided|TREX1-related disorder|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1,GRCh38,single nucleotide variant
TREX1,3,48467257,na,na,Pathogenic,Aicardi-Goutieres syndrome 1|not provided,GRCh38,single nucleotide variant
TREX1,3,48467253,na,na,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",GRCh38,single nucleotide variant
TREX1,3,48466707,na,na,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|not provided|Chilblain lupus|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",GRCh38,single nucleotide variant
EDARADD,1,236482455,na,na,Likely pathogenic,"Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant",GRCh38,single nucleotide variant
EDARADD,1,236482366,na,na,Pathogenic,"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
GDAP1,8,74350553,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4A,GRCh38,single nucleotide variant
GDAP1,8,74362940,na,na,Pathogenic,"Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|not provided|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",GRCh38,single nucleotide variant
GDAP1,8,74360308,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4A|not provided,GRCh38,single nucleotide variant
GDAP1,8,74361886,na,na,Pathogenic,"Neuropathy, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease type 4A|not provided|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2K",GRCh38,single nucleotide variant
GDAP1,8,74364134,na,na,Pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|not provided|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",GRCh38,single nucleotide variant
GDAP1,8,74360184,na,na,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K|Inborn genetic diseases",GRCh38,single nucleotide variant
GDAP1,8,74360295,na,na,Pathogenic,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
GDAP1,8,74364005,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Sensory neuropathy;Peripheral axonal neuropathy;Elevated circulating alkaline phosphatase concentration;Elevated circulating creatine kinase concentration;Polyneuropathy|Charcot-Marie-Tooth disease|not provided|GDAP1-related disorder|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",GRCh38,single nucleotide variant
GDAP1,8,74363011,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A,GRCh38,single nucleotide variant
GDAP1,8,74363051,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A",GRCh38,single nucleotide variant
GDAP1,8,74364009,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,GRCh38,single nucleotide variant
GDAP1,8,74363037,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,GRCh38,single nucleotide variant
PAX3,2,222297150,na,na,Pathogenic,Waardenburg syndrome type 1,GRCh38,single nucleotide variant
PAX3,2,222297057,na,na,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|not provided,GRCh38,single nucleotide variant
PAX3,2,222297048,na,na,Pathogenic,Waardenburg syndrome type 3|Waardenburg syndrome type 1|not provided,GRCh38,single nucleotide variant
PAX3,2,222297158,na,na,Likely pathogenic,Craniofacial-deafness-hand syndrome|not provided,GRCh38,single nucleotide variant
PAX3,2,222297160,na,na,Pathogenic,Waardenburg syndrome type 3,GRCh38,single nucleotide variant
PAX3,2,222297031,na,na,Pathogenic,Waardenburg syndrome type 3,GRCh38,single nucleotide variant
PAX3,2,222297132,na,na,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|Waardenburg syndrome|not provided,GRCh38,single nucleotide variant
FKRP,19,46756376,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy|not provided",GRCh38,single nucleotide variant
FKRP,19,46756604,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I",GRCh38,single nucleotide variant
FKRP,19,46756793,na,na,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy",GRCh38,single nucleotide variant
FKRP,19,46756276,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy|Autosomal recessive limb-girdle muscular dystrophy|8 conditions|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Myopathy|FKRP-related disorder|Neuronopathy, distal hereditary motor, type 2B|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Nizon-Isidor syndrome|Myopathy caused by variation in FKRP|FKRP-related muscular dystrophy-dystroglycanopathy",GRCh38,single nucleotide variant
FKRP,19,46756936,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|not provided|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
FKRP,19,46756396,na,na,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Walker-Warburg congenital muscular dystrophy,GRCh38,single nucleotide variant
FKRP,19,46756113,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",GRCh38,single nucleotide variant
FKRP,19,46756814,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Walker-Warburg congenital muscular dystrophy|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",GRCh38,single nucleotide variant
FKRP,19,46756663,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",GRCh38,single nucleotide variant
FKRP,19,46755610,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
FKRP,19,46755685,na,na,Conflicting classifications of pathogenicity,Autosomal recessive limb-girdle muscular dystrophy type 2I|not specified|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype,GRCh38,single nucleotide variant
FKRP,19,46756214,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I,GRCh38,single nucleotide variant
FKRP,19,46755850,na,na,Uncertain significance,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy,GRCh38,single nucleotide variant
FKRP,19,46756349,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",GRCh38,single nucleotide variant
FKRP,19,46756369,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Walker-Warburg congenital muscular dystrophy|FKRP-related disorder|Autosomal recessive limb-girdle muscular dystrophy",GRCh38,single nucleotide variant
FKRP,19,46756403,na,na,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",GRCh38,single nucleotide variant
FKRP,19,46756837,na,na,Pathogenic/Likely pathogenic,"Muscular dystrophy|Walker-Warburg congenital muscular dystrophy|not provided|Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Muscular dystrophy-dystroglycanopathy type B5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",GRCh38,single nucleotide variant
ENAM,4,70635895,na,na,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,GRCh38,single nucleotide variant
ENAM,4,70631882,na,na,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,GRCh38,single nucleotide variant
OPA3,19,45553912,na,na,Pathogenic,3-Methylglutaconic aciduria type 3|not provided|3-Methylglutaconic aciduria type 3;Optic atrophy 3,GRCh38,single nucleotide variant
OPA3,19,45553777,na,na,Pathogenic,Optic atrophy 3,GRCh38,single nucleotide variant
OPA3,19,45553741,na,na,Pathogenic,Optic atrophy 3|not provided|3-Methylglutaconic aciduria type 3;Optic atrophy 3,GRCh38,single nucleotide variant
MYLK2,20,31820333,na,na,Conflicting classifications of pathogenicity,"Cardiomyopathy, hypertrophic, midventricular, digenic|Hypertrophic cardiomyopathy 1|not provided|not specified",GRCh38,single nucleotide variant
MYLK2,20,31820357,na,na,Benign/Likely benign,"Cardiomyopathy, hypertrophic, midventricular, digenic|not specified|Hypertrophic cardiomyopathy 1|not provided|Cardiomyopathy|MYLK2-related disorder",GRCh38,single nucleotide variant
LZTS1,8,20255097,na,na,Pathogenic,"Esophageal squamous cell carcinoma, somatic",GRCh38,single nucleotide variant
LZTS1,8,20253576,na,na,Pathogenic,"Esophageal squamous cell carcinoma, somatic",GRCh38,single nucleotide variant
MYO5B,18,49963032,na,na,Uncertain significance,Congenital microvillous atrophy|not specified,GRCh38,single nucleotide variant
MYO5B,18,50036982,na,na,Pathogenic,Congenital microvillous atrophy,GRCh38,single nucleotide variant
MYO5B,18,49974547,na,na,Pathogenic,Congenital microvillous atrophy|not provided,GRCh38,single nucleotide variant
MYO5B,18,49936289,na,na,Conflicting classifications of pathogenicity,Congenital microvillous atrophy|not provided,GRCh38,single nucleotide variant
MYO5B,18,49936276,na,na,Pathogenic,Congenital microvillous atrophy|not provided,GRCh38,single nucleotide variant
SCGB3A2,5,147878599,na,na,risk factor,Inherited susceptibility to asthma,GRCh38,single nucleotide variant
CYP27A1,2,218814716,na,na,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,GRCh38,single nucleotide variant
CYP27A1,2,218814186,na,na,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability|Cardiovascular phenotype|CYP27A1-related disorder,GRCh38,single nucleotide variant
CYP27A1,2,218812923,na,na,Pathogenic,Cholestanol storage disease|not provided,GRCh38,single nucleotide variant
CYP27A1,2,218812750,na,na,Pathogenic,Cholestanol storage disease|not provided,GRCh38,single nucleotide variant
CYP27A1,2,218814702,na,na,Pathogenic,Cholestanol storage disease|CYP27A1-related disorder|not provided,GRCh38,single nucleotide variant
CYP27A1,2,218814701,na,na,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,GRCh38,single nucleotide variant
CYP27A1,2,218814409,na,na,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability,GRCh38,single nucleotide variant
CYP27A1,2,218814186,na,na,Pathogenic/Likely pathogenic,Cholestanol storage disease,GRCh38,single nucleotide variant
CYP27A1,2,218814459,na,na,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,GRCh38,single nucleotide variant
CYP27A1,2,218809755,na,na,Pathogenic,Cholestanol storage disease,GRCh38,single nucleotide variant
CYP27A1,2,218813095,na,na,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,GRCh38,single nucleotide variant
CYP27A1,2,218814716,na,na,Conflicting classifications of pathogenicity,Cholestanol storage disease|not provided,GRCh38,single nucleotide variant
MLPH,2,237493529,na,na,Likely pathogenic,Griscelli syndrome type 3,GRCh38,single nucleotide variant
SLC25A19,17,75278265,na,na,Pathogenic,Amish lethal microcephaly,GRCh38,single nucleotide variant
ZMPSTE24,1,40285988,na,na,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,GRCh38,single nucleotide variant
ZMPSTE24,1,40258392,na,na,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,GRCh38,single nucleotide variant
ZMPSTE24,1,40272009,na,na,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,GRCh38,single nucleotide variant
ZMPSTE24,1,40271981,na,na,Pathogenic,Lethal tight skin contracture syndrome|not provided,GRCh38,single nucleotide variant
ITPKC,19,40718299,na,na,Conflicting classifications of pathogenicity,ITPKC-related disorder|Reclassified - variant of unknown significance,GRCh38,single nucleotide variant
NOP10,15,34342063,na,na,Pathogenic,"Dyskeratosis congenita, autosomal recessive 1",GRCh38,single nucleotide variant
NHP2,5,178149760,na,na,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",GRCh38,single nucleotide variant
NHP2,5,178149799,na,na,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",GRCh38,single nucleotide variant
NHP2,5,178149715,na,na,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1|not provided",GRCh38,single nucleotide variant
HAMP,19,35284953,na,na,Pathogenic,Hemochromatosis type 2B,GRCh38,single nucleotide variant
HAMP,19,35284999,na,na,Benign/Likely benign,"Hemochromatosis, type 2a, modifier of|Hereditary hemochromatosis|not specified|Hemochromatosis type 1|Hemochromatosis type 2B|not provided|HAMP-related disorder",GRCh38,single nucleotide variant
HAMP,19,35282553,na,na,Pathogenic/Likely pathogenic,Hemochromatosis type 2B|Hereditary hemochromatosis,GRCh38,single nucleotide variant
GBA1,1,155235252,na,na,Pathogenic; risk factor,"Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I|Dementia, Lewy body, susceptibility to|Gaucher disease|not provided|Gaucher disease perinatal lethal|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|Hypomimic face;Movement disorder;Parkinsonian disorder;Resting tremor;Thoracolumbar scoliosis|7 conditions|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|GBA1-related disorder|Lewy body dementia|not specified",GRCh38,single nucleotide variant
GBA1,1,155235708,na,na,Pathogenic,Gaucher disease type II,GRCh38,single nucleotide variant
GBA1,1,155235843,na,na,Pathogenic/Likely pathogenic; risk factor,"Dementia, Lewy body, susceptibility to|Gaucher disease type I|Parkinson disease, late-onset|not provided|Gaucher disease|7 conditions|Rigidity;Akinesia|Gaucher disease perinatal lethal|Lewy body dementia|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|Abnormal bleeding;Thrombocytopenia|Parkinson disease|GBA1-related disorder|not specified|Lewy body dementia;Parkinson disease, late-onset",GRCh38,single nucleotide variant
GBA1,1,155238629,na,na,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I|Gaucher disease|not provided|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,GRCh38,single nucleotide variant
GBA1,1,155235772,na,na,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease type III|Gaucher disease|7 conditions|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|not provided|Parkinson disease, late-onset",GRCh38,single nucleotide variant
GBA1,1,155235727,na,na,Pathogenic/Likely pathogenic,"Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease perinatal lethal|Gaucher disease|not provided|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|7 conditions|Parkinson disease, late-onset|not specified",GRCh38,single nucleotide variant
GBA1,1,155235726,na,na,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease|Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155235196,na,na,Pathogenic,"Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease|not provided|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|not specified|GBA1-related disorder",GRCh38,single nucleotide variant
GBA1,1,155239939,na,na,Pathogenic,Gaucher disease type I|Gaucher disease|not provided,GRCh38,single nucleotide variant
GBA1,1,155237576,na,na,Pathogenic/Likely pathogenic,"Gaucher disease type I|not provided|Parkinson disease, late-onset|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type III;Gaucher disease type I;Gaucher disease type II|Gaucher disease|7 conditions",GRCh38,single nucleotide variant
GBA1,1,155238570,na,na,Uncertain significance,not provided|Gaucher disease|not specified|Gaucher disease perinatal lethal,GRCh38,single nucleotide variant
GBA1,1,155238519,na,na,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided,GRCh38,single nucleotide variant
GBA1,1,155238141,na,na,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease type II|Gaucher disease type I|Gaucher disease|not provided|not specified|Lewy body dementia|7 conditions,GRCh38,single nucleotide variant
GBA1,1,155235760,na,na,Pathogenic,Gaucher disease perinatal lethal,GRCh38,single nucleotide variant
GBA1,1,155237357,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155236384,na,na,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|7 conditions,GRCh38,single nucleotide variant
GBA1,1,155238624,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155238144,na,na,Uncertain significance,Gaucher disease type I|Gaucher disease|not provided,GRCh38,single nucleotide variant
GBA1,1,155235057,na,na,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided|not specified,GRCh38,single nucleotide variant
GBA1,1,155235002,na,na,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease|7 conditions|not provided|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|Parkinson disease, late-onset|not specified",GRCh38,single nucleotide variant
GBA1,1,155240033,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155238215,na,na,Pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|not provided|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|Gaucher disease type II|7 conditions,GRCh38,single nucleotide variant
GBA1,1,155237577,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155236426,na,na,Uncertain significance,Gaucher disease type I|not specified,GRCh38,single nucleotide variant
GBA1,1,155236416,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155236379,na,na,Likely pathogenic,Gaucher disease type II|not provided|Gaucher disease|7 conditions|Gaucher disease perinatal lethal,GRCh38,single nucleotide variant
GBA1,1,155236328,na,na,Pathogenic,Gaucher disease type II,GRCh38,single nucleotide variant
GBA1,1,155236261,na,na,Likely pathogenic,Gaucher disease type I|not provided,GRCh38,single nucleotide variant
GBA1,1,155239934,na,na,Pathogenic,"Gaucher disease type I|Gaucher disease|not provided|7 conditions|See cases|Parkinson disease, late-onset|Lewy body dementia",GRCh38,single nucleotide variant
GBA1,1,155236295,na,na,Pathogenic,Gaucher disease type III,GRCh38,single nucleotide variant
GBA1,1,155235750,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155236420,na,na,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|not provided,GRCh38,single nucleotide variant
GBA1,1,155236277,na,na,Pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I|not provided|Gaucher disease|7 conditions,GRCh38,single nucleotide variant
GBA1,1,155235823,na,na,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Abnormal bleeding;Thrombocytopenia|7 conditions|not provided,GRCh38,single nucleotide variant
GBA1,1,155237453,na,na,Pathogenic,"Gaucher disease perinatal lethal|not provided|Gaucher disease|Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I|Parkinson disease, late-onset|7 conditions|GBA1-related disorder|Gaucher disease type I",GRCh38,single nucleotide variant
GBA1,1,155238596,na,na,Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease,GRCh38,single nucleotide variant
GBA1,1,155239716,na,na,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|not provided,GRCh38,single nucleotide variant
GBA1,1,155237470,na,na,Pathogenic,Gaucher disease perinatal lethal,GRCh38,single nucleotide variant
GBA1,1,155235841,na,na,Pathogenic,Gaucher disease type I,GRCh38,single nucleotide variant
GBA1,1,155235101,na,na,Pathogenic,Gaucher disease perinatal lethal,GRCh38,single nucleotide variant
GBA1,1,155237458,na,na,Conflicting classifications of pathogenicity; other,not provided|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III|Gaucher disease type I|Gaucher disease perinatal lethal|Gaucher disease|not specified|GBA1-related disorder,GRCh38,single nucleotide variant
GBA1,1,155235256,na,na,Conflicting classifications of pathogenicity,"Parkinson disease, late-onset|not provided|7 conditions|not specified|Gaucher disease",GRCh38,single nucleotide variant
EIF2B2,14,75005906,na,na,Pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 2|Leukoencephalopathy with vanishing white matter 1|not provided|See cases|EIF2B2-related disorder,GRCh38,single nucleotide variant
EIF2B2,14,75009079,na,na,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2,GRCh38,single nucleotide variant
EIF2B2,14,75004850,na,na,Pathogenic/Likely pathogenic,Leukoencephalopathy with vanishing white matter 2|not provided,GRCh38,single nucleotide variant
EIF2B2,14,75004815,na,na,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 2,GRCh38,single nucleotide variant
HTRA2;LOXL3,2,74532698,na,na,Benign/Likely benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided",GRCh38,single nucleotide variant
HTRA2,2,74530427,na,na,Benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided|Parkinson disease 13, autosomal dominant, susceptibility to;3-methylglutaconic aciduria type 8",GRCh38,single nucleotide variant
ATL1,14,50613343,na,na,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 3A|not provided|Spastic paraplegia|Neuropathy, hereditary sensory, type 1D;Hereditary spastic paraplegia 3A|Hereditary spastic paraplegia",GRCh38,single nucleotide variant
ATL1,14,50614425,na,na,Pathogenic,Hereditary spastic paraplegia 3A,GRCh38,single nucleotide variant
ATL1,14,50614422,na,na,Pathogenic,Hereditary spastic paraplegia 3A,GRCh38,single nucleotide variant
ATL1,14,50613278,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|not provided,GRCh38,single nucleotide variant
ATL1,14,50628133,na,na,Pathogenic,Hereditary spastic paraplegia 3A,GRCh38,single nucleotide variant
ATL1,14,50628154,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
ATL1,14,50591587,na,na,Pathogenic,Hereditary spastic paraplegia 3A,GRCh38,single nucleotide variant
EGLN1,1,231374041,na,na,Conflicting classifications of pathogenicity,"Erythrocytosis, familial, 3|not specified",GRCh38,single nucleotide variant
EGLN1,1,231370598,na,na,Pathogenic,"Erythrocytosis, familial, 3",GRCh38,single nucleotide variant
EGLN1,1,231370589,na,na,Pathogenic,"Erythrocytosis, familial, 3",GRCh38,single nucleotide variant
PRPF31,19,54123867,na,na,Pathogenic,Retinitis pigmentosa 11,GRCh38,single nucleotide variant
PRPF31,19,54123563,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 11|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
PRPF31,19,54123802,na,na,Pathogenic,Retinitis pigmentosa 11,GRCh38,single nucleotide variant
PRPF31,19,54130024,na,na,Pathogenic,Retinitis pigmentosa 11|not provided,GRCh38,single nucleotide variant
DHCR24,1,54852372,na,na,Likely pathogenic,Desmosterolosis,GRCh38,single nucleotide variant
DHCR24,1,54865442,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
DHCR24,1,54875134,na,na,Likely pathogenic,Desmosterolosis,GRCh38,single nucleotide variant
NLRP3,1,247424765,na,na,Pathogenic/Likely pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome|Keratitis fugax hereditaria;Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Autoinflammatory syndrome",GRCh38,single nucleotide variant
NLRP3,1,247424041,na,na,Conflicting classifications of pathogenicity,"Familial cold autoinflammatory syndrome 1|Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|not provided|Familial cold autoinflammatory syndrome|not specified|Cryopyrin associated periodic syndrome|Hearing loss, autosomal dominant 34, with or without inflammation|Kidney disorder|Keratitis fugax hereditaria;Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Autoinflammatory syndrome|NLRP3-related disorder|Chronic infantile neurological, cutaneous and articular syndrome",GRCh38,single nucleotide variant
NLRP3,1,247425329,na,na,Likely pathogenic,Familial cold autoinflammatory syndrome 1|Autoinflammatory syndrome,GRCh38,single nucleotide variant
NLRP3,1,247424504,na,na,Pathogenic/Likely pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome,GRCh38,single nucleotide variant
NLRP3,1,247424227,na,na,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome|Autoinflammatory syndrome|NLRP3-related disorder,GRCh38,single nucleotide variant
NLRP3,1,247425154,na,na,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1,GRCh38,single nucleotide variant
NLRP3,1,247425167,na,na,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",GRCh38,single nucleotide variant
NLRP3,1,247424356,na,na,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome",GRCh38,single nucleotide variant
NLRP3,1,247424375,na,na,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",GRCh38,single nucleotide variant
NLRP3,1,247424507,na,na,Pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|not specified|Cryopyrin associated periodic syndrome|Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Chronic infantile neurological, cutaneous and articular syndrome;Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness|NLRP3-related disorder",GRCh38,single nucleotide variant
BSND,1,54999187,na,na,Pathogenic,Bartter disease type 4A|not provided,GRCh38,single nucleotide variant
BSND,1,54999208,na,na,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,GRCh38,single nucleotide variant
BSND,1,54999189,na,na,Pathogenic/Likely pathogenic,Bartter disease type 4A|not provided|Bartter syndrome,GRCh38,single nucleotide variant
BSND,1,54999214,na,na,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,GRCh38,single nucleotide variant
BSND,1,54999209,na,na,Pathogenic,Bartter disease type 4A,GRCh38,single nucleotide variant
BSND,1,54999325,na,na,Pathogenic/Likely pathogenic,"Bartter disease type 4A|not provided|Bartter syndrome|BSND-related disorder|Bartter syndrome type 4|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
BSND,1,54999221,na,na,Pathogenic,"Sensorineural deafness with mild renal dysfunction|Bartter disease type 4A|Hearing loss, autosomal recessive|not provided|Bartter syndrome",GRCh38,single nucleotide variant
BSND,1,54999196,na,na,Pathogenic,Sensorineural deafness with mild renal dysfunction|Hearing impairment|not provided|Bartter disease type 4A,GRCh38,single nucleotide variant
ANTXR1,2,69152193,na,na,risk factor,Capillary infantile hemangioma,GRCh38,single nucleotide variant
CLRN1,3,150928107,na,na,Pathogenic/Likely pathogenic,Usher syndrome type 3|not provided|Hearing impairment|Retinitis pigmentosa|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A;Retinitis pigmentosa,GRCh38,single nucleotide variant
CLRN1,3,150941656,na,na,Likely pathogenic,Usher syndrome type 3|not provided,GRCh38,single nucleotide variant
CLRN1;CLRN1-AS1,3,150972565,na,na,Pathogenic/Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa|not provided|Usher syndrome type 3A|not specified|Retinal dystrophy|Retinitis pigmentosa;Usher syndrome type 3A|Retinitis pigmentosa 61;Usher syndrome type 3A|Retinitis pigmentosa 61,GRCh38,single nucleotide variant
CLRN1,3,150928186,na,na,Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa 61,GRCh38,single nucleotide variant
CLRN1,3,150972520,na,na,Pathogenic,Usher syndrome type 3|Retinitis pigmentosa|Rare genetic deafness|CLRN1-related disorder|Usher syndrome type 3A|not provided|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,GRCh38,single nucleotide variant
CLRN1,3,150972591,na,na,Conflicting classifications of pathogenicity,Usher syndrome type 3|not provided|Usher syndrome type 3A|Usher syndrome|CLRN1-related disorder|Retinal dystrophy|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,GRCh38,single nucleotide variant
APOA5,11,116790676,na,na,Conflicting classifications of pathogenicity,Hypertriglyceridemia 1|Cardiovascular phenotype|not provided|not specified,GRCh38,single nucleotide variant
APOA5,11,116791691,na,na,Benign/Likely benign,Hypertriglyceridemia 1|Cardiovascular phenotype|Familial type 5 hyperlipoproteinemia;Hypertriglyceridemia 1|not provided|not specified,GRCh38,single nucleotide variant
APOA5,11,116790814,na,na,Pathogenic,Familial type 5 hyperlipoproteinemia,GRCh38,single nucleotide variant
ALS2,2,201754672,na,na,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,GRCh38,single nucleotide variant
ALS2,2,201726854,na,na,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,GRCh38,single nucleotide variant
ALS2,2,201761524,na,na,Likely pathogenic,Infantile-onset ascending hereditary spastic paralysis|not provided,GRCh38,single nucleotide variant
ALS2,2,201726868,na,na,Pathogenic,Juvenile primary lateral sclerosis,GRCh38,single nucleotide variant
ALS2,2,201744285,na,na,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,GRCh38,single nucleotide variant
ESPN,1,6451926,na,na,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",GRCh38,single nucleotide variant
ESPN,1,6452001,na,na,Uncertain significance,"Deafness, without vestibular involvement, autosomal dominant|not provided|Autosomal recessive nonsyndromic hearing loss 36;Usher syndrome, type 1M",GRCh38,single nucleotide variant
ESPN,1,6452092,na,na,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",GRCh38,single nucleotide variant
APTX,9,32984784,na,na,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",GRCh38,single nucleotide variant
APTX,9,32974544,na,na,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",GRCh38,single nucleotide variant
APTX,9,32984799,na,na,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",GRCh38,single nucleotide variant
APTX,9,32973653,na,na,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",GRCh38,single nucleotide variant
APTX,9,32974495,na,na,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia|not provided|Inborn genetic diseases|APTX-related disorder",GRCh38,single nucleotide variant
APTX,9,32984733,na,na,Likely pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",GRCh38,single nucleotide variant
PSTPIP1,15,77032304,na,na,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,GRCh38,single nucleotide variant
PSTPIP1,15,77031225,na,na,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided|PSTPIP1-related disorder,GRCh38,single nucleotide variant
SIX6,14,60509891,na,na,Uncertain significance,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,GRCh38,single nucleotide variant
EIF2B3,1,44881722,na,na,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 3,GRCh38,single nucleotide variant
EIF2B3,1,44978349,na,na,Pathogenic,Vanishing white matter disease|not provided|EIF2B3-related disorder|Leukoencephalopathy with vanishing white matter 3,GRCh38,single nucleotide variant
EIF2B3,1,44875634,na,na,Pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 3|not provided,GRCh38,single nucleotide variant
CTNS,17,3655055,na,na,Pathogenic,Nephropathic cystinosis,GRCh38,single nucleotide variant
CTNS,17,3655305,na,na,Pathogenic,Nephropathic cystinosis|not provided|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis|CTNS-related disorder,GRCh38,single nucleotide variant
CTNS,17,3656531,na,na,Likely pathogenic,Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases,GRCh38,single nucleotide variant
CTNS,17,3647506,na,na,Benign/Likely benign,"Cystinosis, atypical nephropathic|Ocular cystinosis|Nephropathic cystinosis|not provided|not specified|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|CTNS-related disorder|Cystinosis",GRCh38,single nucleotide variant
CTNS,17,3659855,na,na,Pathogenic,Ocular cystinosis,GRCh38,single nucleotide variant
CTNS,17,3656703,na,na,Pathogenic/Likely pathogenic,Ocular cystinosis|Nephropathic cystinosis|not provided|Inborn genetic diseases;Juvenile nephropathic cystinosis;Ocular cystinosis|Nephropathic cystinosis;Juvenile nephropathic cystinosis;Ocular cystinosis|Cystinosis,GRCh38,single nucleotide variant
CTNS,17,3636418,na,na,Pathogenic,Ocular cystinosis,GRCh38,single nucleotide variant
CTNS,17,3660280,na,na,Pathogenic,Nephropathic cystinosis|not provided|Ocular cystinosis;Juvenile nephropathic cystinosis;Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|CTNS-related disorder|Cystinosis,GRCh38,single nucleotide variant
CTNS,17,3659974,na,na,Pathogenic,Juvenile nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|Nephropathic cystinosis,GRCh38,single nucleotide variant
CTNS,17,3655101,na,na,Pathogenic,"Cystinosis, atypical nephropathic",GRCh38,single nucleotide variant
CTNS,17,3655307,na,na,Pathogenic/Likely pathogenic,"Juvenile nephropathic cystinosis|Cystinosis, atypical nephropathic|Nephropathic cystinosis|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|not provided|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis",GRCh38,single nucleotide variant
WNT10A,2,218890304,na,na,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",GRCh38,single nucleotide variant
WNT10A,2,218882368,na,na,Pathogenic,"Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome|Tooth agenesis, selective, 4|Inborn genetic diseases|not provided|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|WNT10A-related disorder|Ectodermal dysplasia|not specified",GRCh38,single nucleotide variant
WNT10A,2,218890289,na,na,Conflicting classifications of pathogenicity,"Odonto-onycho-dermal dysplasia|Inborn genetic diseases|Hypohidrotic ectodermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|Tooth agenesis|Ectodermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome|Ectodermal dysplasia WNT10A related|WNT10A-related disorder|See cases",GRCh38,single nucleotide variant
WNT10A,2,218889990,na,na,Pathogenic/Likely pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome;Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",GRCh38,single nucleotide variant
WNT10A,2,218893145,na,na,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",GRCh38,single nucleotide variant
WNT10A,2,218881022,na,na,Pathogenic,Odonto-onycho-dermal dysplasia,GRCh38,single nucleotide variant
CLEC7A,12,10118488,na,na,Benign/Likely benign,"Familial chronic mucocutaneous candidiasis|Aspergillosis, susceptibility to|not specified|Aspergillosis, susceptibility to;Familial chronic mucocutaneous candidiasis|CLEC7A-related disorder|not provided",GRCh38,single nucleotide variant
TIRAP,11,126292948,na,na,Benign,"Invasive pneumococcal disease, protection against|Malaria, resistance to|Mycobacterium tuberculosis, protection against|Bacteremia, susceptibility|not provided|not specified|Malaria, susceptibility to;Mycobacterium tuberculosis, susceptibility to;Bacteremia, susceptibility to, 1",GRCh38,single nucleotide variant
DICER1,14,95096172,na,na,Likely pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition,GRCh38,single nucleotide variant
DICER1,14,95117624,na,na,Pathogenic,Pleuropulmonary blastoma|Hereditary cancer-predisposing syndrome|DICER1-related tumor predisposition|not provided,GRCh38,single nucleotide variant
DICER1,14,95106198,na,na,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
DICER1,14,95116575,na,na,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
MFRP,11,119345538,na,na,Pathogenic,Nanophthalmos 2|not provided|Isolated microphthalmia 5,GRCh38,single nucleotide variant
MFRP,11,119345516,na,na,Pathogenic,Nanophthalmos 2,GRCh38,single nucleotide variant
NT5C3A,7,33021317,na,na,Pathogenic/Likely pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided,GRCh38,single nucleotide variant
NT5C3A,7,33017501,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
NT5C3A,7,33015871,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
NT5C3A,7,33017487,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
NT5C3A,7,33015871,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
NT5C3A,7,33017461,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
NT5C3A,7,33015741,na,na,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,GRCh38,single nucleotide variant
SELENON,1,25809096,na,na,Pathogenic,Eichsfeld type congenital muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25812790,na,na,Pathogenic,Eichsfeld type congenital muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25800231,na,na,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|Congenital myopathy with fiber type disproportion|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25813890,na,na,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|SEPN1-related disorder|Muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25812763,na,na,Likely pathogenic,Eichsfeld type congenital muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25812789,na,na,Pathogenic,Eichsfeld type congenital muscular dystrophy,GRCh38,single nucleotide variant
SELENON,1,25809753,na,na,Pathogenic/Likely pathogenic,"Congenital myopathy with fiber type disproportion|Eichsfeld type congenital muscular dystrophy|not provided|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy|SEPN1-related disorder|Congenital myopathy 4A, autosomal dominant;Eichsfeld type congenital muscular dystrophy|SELENON-related myopathy",GRCh38,single nucleotide variant
SLC45A2,5,33964017,na,na,Pathogenic,Oculocutaneous albinism type 4,GRCh38,single nucleotide variant
SLC45A2,5,33951628,na,na,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 4|not provided|SLC45A2-related disorder|SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;Oculocutaneous albinism type 4",GRCh38,single nucleotide variant
SLC45A2,5,33944784,na,na,Conflicting classifications of pathogenicity,Oculocutaneous albinism type 4|not provided|not specified,GRCh38,single nucleotide variant
SLC45A2,5,33982329,na,na,Pathogenic,Oculocutaneous albinism type 4|not provided,GRCh38,single nucleotide variant
SLC45A2,5,33963765,na,na,Benign/Likely benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|not provided|Oculocutaneous albinism type 4|SLC45A2-related disorder",GRCh38,single nucleotide variant
SLC45A2,5,33951588,na,na,Benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|Malignant melanoma of skin|not provided",GRCh38,single nucleotide variant
WFS1,4,6301966,na,na,Conflicting classifications of pathogenicity,Wolfram syndrome 1|not provided,GRCh38,single nucleotide variant
WFS1,4,6301879,na,na,Pathogenic/Likely pathogenic,Wolfram syndrome 1|not provided|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus,GRCh38,single nucleotide variant
WFS1,4,6301739,na,na,Pathogenic,Wolfram syndrome 1|not provided,GRCh38,single nucleotide variant
WFS1,4,6301306,na,na,Pathogenic/Likely pathogenic,Wolfram syndrome 1|Wolfram syndrome 1;Wolfram-like syndrome|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|WFS1-related disorder,GRCh38,single nucleotide variant
WFS1,4,6289132,na,na,Pathogenic,Wolfram syndrome 1|not provided,GRCh38,single nucleotide variant
WFS1,4,6291961,na,na,Pathogenic,Wolfram syndrome 1,GRCh38,single nucleotide variant
WFS1,4,6302250,na,na,Pathogenic,Wolfram syndrome 1,GRCh38,single nucleotide variant
WFS1,4,6301941,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness,GRCh38,single nucleotide variant
WFS1,4,6302281,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Inborn genetic diseases|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus|Wolfram syndrome 1,GRCh38,single nucleotide variant
WFS1,4,6301891,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not specified|not provided,GRCh38,single nucleotide variant
WFS1,4,6302287,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not provided,GRCh38,single nucleotide variant
WFS1,4,6301696,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 6,GRCh38,single nucleotide variant
WFS1,4,6302385,na,na,Pathogenic/Likely pathogenic,Wolfram-like syndrome|Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness|Wolfram syndrome 1|Nonsyndromic genetic hearing loss|Autosomal dominant nonsyndromic hearing loss|See cases|Retinal dystrophy,GRCh38,single nucleotide variant
WFS1,4,6291188,na,na,Benign,Type 2 diabetes mellitus|WFS1-Related Spectrum Disorders|not specified|Autosomal dominant nonsyndromic hearing loss 6|not provided|Wolfram syndrome 1|Wolfram syndrome,GRCh38,single nucleotide variant
WFS1,4,6293966,na,na,Benign,"Diabetes mellitus, noninsulin-dependent, association with|not provided|Wolfram syndrome|Wolfram syndrome 1|Type 2 diabetes mellitus|not specified",GRCh38,single nucleotide variant
WFS1,4,6302371,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 6|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|Optic atrophy|WFS1-related disorder,GRCh38,single nucleotide variant
BHLHE41,12,26122364,na,na,Affects,"Short sleep, familial natural, 1",GRCh38,single nucleotide variant
BSCL2,11,62694594,na,na,Pathogenic,"Congenital generalized lipodystrophy type 2|Inborn genetic diseases|Neuronopathy, distal hereditary motor, type 5C|Berardinelli-Seip congenital lipodystrophy",GRCh38,single nucleotide variant
BSCL2,11,62694567,na,na,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,GRCh38,single nucleotide variant
BSCL2,11,62692413,na,na,Pathogenic,"Congenital generalized lipodystrophy type 2|Severe neurodegenerative syndrome with lipodystrophy;Hereditary spastic paraplegia 17;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2",GRCh38,single nucleotide variant
BSCL2,11,62692371,na,na,Uncertain significance,"Congenital generalized lipodystrophy type 2|Hereditary spastic paraplegia|Berardinelli-Seip congenital lipodystrophy|Hereditary spastic paraplegia 17;Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C",GRCh38,single nucleotide variant
BSCL2,11,62691424,na,na,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,GRCh38,single nucleotide variant
BSCL2;HNRNPUL2-BSCL2,11,62702499,na,na,Pathogenic,"Hereditary spastic paraplegia 17|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease type 2|not specified|not provided|Neuronopathy, distal hereditary motor, type 5C|Hereditary spastic paraplegia|Peripheral neuropathy|Inborn genetic diseases|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17",GRCh38,single nucleotide variant
BSCL2,11,62702493,na,na,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 17|Hereditary spastic paraplegia 17;Neuronopathy, distal hereditary motor, type 5A|not provided|Charcot-Marie-Tooth disease type 2|Abnormal central motor function|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C|BSCL2-related disorder",GRCh38,single nucleotide variant
BSCL2,11,62691132,na,na,Pathogenic,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,GRCh38,single nucleotide variant
BSCL2,11,62692671,na,na,Pathogenic,Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy,GRCh38,single nucleotide variant
PANK2,20,3918695,na,na,Pathogenic,"Pigmentary pallidal degeneration|Inborn genetic diseases|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Retinitis pigmentosa|Pigmentary pallidal degeneration;Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency",GRCh38,single nucleotide variant
PANK2,20,3889670,na,na,Pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
PANK2,20,3908087,na,na,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided,GRCh38,single nucleotide variant
PANK2,20,3908153,na,na,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
PANK2,20,3912634,na,na,Likely pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
PANK2,20,3910646,na,na,Pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
PANK2,20,3907997,na,na,Conflicting classifications of pathogenicity,Pigmentary pallidal degeneration|not specified,GRCh38,single nucleotide variant
PANK2,20,3908129,na,na,Uncertain significance,not provided|Pigmentary pallidal degeneration|not specified,GRCh38,single nucleotide variant
MIR103A2;MIR103B2;PANK2,20,3918717,na,na,Pathogenic,"Pigmentary pallidal degeneration|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Inborn genetic diseases|PANK2-related disorder",GRCh38,single nucleotide variant
PANK2,20,3916955,na,na,Pathogenic,Pigmentary pallidal degeneration|Dystonic disorder,GRCh38,single nucleotide variant
PANK2,20,3912532,na,na,Pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
PANK2,20,3916926,na,na,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
PANK2,20,3889633,na,na,Pathogenic,Pigmentary pallidal degeneration,GRCh38,single nucleotide variant
SLC19A3,2,227702251,na,na,Pathogenic/Likely pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
SLC19A3,2,227688216,na,na,Pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases|Thiamine metabolism dysfunction syndrome 2 (biotin/thiamine-responsive basal ganglia disease type),GRCh38,single nucleotide variant
SLC19A3,2,227702189,na,na,Pathogenic,Biotin-responsive basal ganglia disease,GRCh38,single nucleotide variant
SLC19A3,2,227698757,na,na,Pathogenic,Biotin-responsive basal ganglia disease,GRCh38,single nucleotide variant
BBS2,16,56514574,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2,GRCh38,single nucleotide variant
BBS2,16,56519791,na,na,Pathogenic/Likely pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder",GRCh38,single nucleotide variant
BBS2,16,56514623,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|not provided,GRCh38,single nucleotide variant
BBS2,16,56502790,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Retinal dystrophy|BBS2-related disorder|Retinitis pigmentosa 74,GRCh38,single nucleotide variant
BBS2,16,56502454,na,na,Pathogenic/Likely pathogenic,"Bardet-biedl syndrome 2/4, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Retinal dystrophy|Autosomal recessive retinitis pigmentosa",GRCh38,single nucleotide variant
BBS2,16,56514589,na,na,Benign,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome",GRCh38,single nucleotide variant
BBS2,16,56514487,na,na,Pathogenic,"Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Retinitis pigmentosa 74|Retinitis pigmentosa|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder|not provided",GRCh38,single nucleotide variant
BBS2,16,56496982,na,na,Pathogenic,Bardet-Biedl syndrome 2|BBS2-related disorder|Retinitis pigmentosa 74|Retinitis pigmentosa|Retinal dystrophy|Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Inborn genetic diseases,GRCh38,single nucleotide variant
BBS2,16,56514681,na,na,Pathogenic,Bardet-Biedl syndrome 2,GRCh38,single nucleotide variant
BBS2,16,56506191,na,na,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Retinal dystrophy|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74",GRCh38,single nucleotide variant
BBS2,16,56511214,na,na,Pathogenic,Bardet-Biedl syndrome 2,GRCh38,single nucleotide variant
SLC2A10,20,46725546,na,na,Pathogenic,Arterial tortuosity syndrome|not provided,GRCh38,single nucleotide variant
SLC2A10,20,46725279,na,na,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|SLC2A10-related disorder,GRCh38,single nucleotide variant
SLC2A10,20,46726312,na,na,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
SLC2A10,20,46725430,na,na,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided,GRCh38,single nucleotide variant
RAB23,6,57194817,na,na,Pathogenic,RAB23-related Carpenter syndrome|not provided|Carpenter syndrome|Inborn genetic diseases|RAB23-related disorder,GRCh38,single nucleotide variant
SLC2A9,4,9964756,na,na,association,"Uric acid concentration, serum, quantitative trait locus 2",GRCh38,single nucleotide variant
SLC2A9,4,9992591,na,na,association,"Uric acid concentration, serum, quantitative trait locus 2",GRCh38,single nucleotide variant
SLC2A9,4,9933120,na,na,association,"Uric acid concentration, serum, quantitative trait locus 2",GRCh38,single nucleotide variant
SLC2A9,4,9890687,na,na,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",GRCh38,single nucleotide variant
SLC2A9,4,9980681,na,na,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",GRCh38,single nucleotide variant
SLC2A9,4,9887623,na,na,Pathogenic,"Hypouricemia, renal, 2",GRCh38,single nucleotide variant
SLURP1,8,142741802,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142741169,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142741199,na,na,Pathogenic,Acroerythrokeratoderma|not provided,GRCh38,single nucleotide variant
SLURP1,8,142741199,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142742385,na,na,Likely pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142742343,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142741226,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
SLURP1,8,142741159,na,na,Pathogenic,Acroerythrokeratoderma,GRCh38,single nucleotide variant
HPS3,3,149145547,na,na,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome|HPS3-related disorder,GRCh38,single nucleotide variant
HPS3,3,149157533,na,na,Pathogenic,Hermansky-Pudlak syndrome 3,GRCh38,single nucleotide variant
HPS3,3,149163840,na,na,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,GRCh38,single nucleotide variant
HPS3,3,149163950,na,na,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided,GRCh38,single nucleotide variant
HPS3,3,149150624,na,na,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,GRCh38,single nucleotide variant
PIP5K1C,19,3653454,na,na,Pathogenic,Lethal congenital contracture syndrome 3,GRCh38,single nucleotide variant
TWNK,10,100989823,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",GRCh38,single nucleotide variant
TWNK,10,100989285,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease|not provided",GRCh38,single nucleotide variant
TWNK,10,100989822,na,na,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3;Infantile onset spinocerebellar ataxia;Perrault syndrome 5;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",GRCh38,single nucleotide variant
TWNK,10,100989154,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",GRCh38,single nucleotide variant
TWNK,10,100989271,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",GRCh38,single nucleotide variant
TWNK,10,100989352,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease",GRCh38,single nucleotide variant
TWNK,10,100989211,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Infantile onset spinocerebellar ataxia",GRCh38,single nucleotide variant
TWNK,10,100989316,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",GRCh38,single nucleotide variant
TWNK,10,100989165,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",GRCh38,single nucleotide variant
TWNK,10,100989770,na,na,Pathogenic,Infantile onset spinocerebellar ataxia,GRCh38,single nucleotide variant
TWNK,10,100990474,na,na,Pathogenic/Likely pathogenic,Infantile onset spinocerebellar ataxia|not provided,GRCh38,single nucleotide variant
TWNK,10,100989118,na,na,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",GRCh38,single nucleotide variant
TWNK,10,100989330,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",GRCh38,single nucleotide variant
TWNK,10,100989162,na,na,Pathogenic,Infantile onset spinocerebellar ataxia|See cases,GRCh38,single nucleotide variant
TBX20,7,35248766,na,na,Uncertain significance,Atrial septal defect 4|Cardiovascular phenotype|not provided,GRCh38,single nucleotide variant
TBX20,7,35245020,na,na,Pathogenic,Atrial septal defect 4,GRCh38,single nucleotide variant
TBX20,7,35249968,na,na,Pathogenic,Atrial septal defect 4,GRCh38,single nucleotide variant
IFT122,3,129481546,na,na,Pathogenic,Cranioectodermal dysplasia 1,GRCh38,single nucleotide variant
IFT122,3,129476463,na,na,Likely pathogenic,Cranioectodermal dysplasia 1,GRCh38,single nucleotide variant
IFT122,3,129461309,na,na,Uncertain significance,Cranioectodermal dysplasia 1,GRCh38,single nucleotide variant
IFT122,3,129440351,na,na,Pathogenic,Cranioectodermal dysplasia 1,GRCh38,single nucleotide variant
CD96,3,111585362,na,na,Pathogenic,C syndrome,GRCh38,single nucleotide variant
RNASEH2A,19,12806782,na,na,Pathogenic,Aicardi-Goutieres syndrome 4,GRCh38,single nucleotide variant
ALX3,1,110061565,na,na,Pathogenic,Frontorhiny,GRCh38,single nucleotide variant
ALX3,1,110061550,na,na,Pathogenic,Frontorhiny,GRCh38,single nucleotide variant
ALX3,1,110064679,na,na,Pathogenic,Frontorhiny,GRCh38,single nucleotide variant
ALX3,1,110064634,na,na,Uncertain significance,Frontorhiny|not provided,GRCh38,single nucleotide variant
ALX3,1,110064638,na,na,Pathogenic,Frontorhiny,GRCh38,single nucleotide variant
ALX3,1,110064595,na,na,Pathogenic,Frontorhiny,GRCh38,single nucleotide variant
BTNL2,6,32396039,na,na,risk factor,"Sarcoidosis, susceptibility to, 2",GRCh38,single nucleotide variant
HAX1,1,154275165,na,na,Pathogenic,Kostmann syndrome,GRCh38,single nucleotide variant
HAX1,1,154273538,na,na,Pathogenic,Kostmann syndrome|not provided,GRCh38,single nucleotide variant
KIF1B,1,10258602,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2A1,GRCh38,single nucleotide variant
KIF1B,1,10297206,na,na,risk factor,"Neuroblastoma, susceptibility to, 1",GRCh38,single nucleotide variant
KIF1B,1,10324838,na,na,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Charcot-Marie-Tooth disease type 2|Neuroblastoma|Charcot-Marie-Tooth disease|Malignant tumor of breast|not provided|Neuroblastoma, susceptibility to, 1;Charcot-Marie-Tooth disease type 2A1|not specified|KIF1B-related disorder",GRCh38,single nucleotide variant
KIF1B,1,10345943,na,na,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Neuroblastoma|Charcot-Marie-Tooth disease type 2|not specified",GRCh38,single nucleotide variant
KIF1B,1,10365476,na,na,Uncertain significance,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED|Charcot-Marie-Tooth disease type 2|not specified",GRCh38,single nucleotide variant
PDP1,8,93922336,na,na,Pathogenic,Pyruvate dehydrogenase phosphatase deficiency,GRCh38,single nucleotide variant
DCLRE1C,10,14945110,na,na,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency|Severe combined immunodeficiency disease|DCLRE1C-related disorder,GRCh38,single nucleotide variant
DCLRE1C,10,14926842,na,na,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,GRCh38,single nucleotide variant
DCLRE1C,10,14928015,na,na,Likely pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,GRCh38,single nucleotide variant
DCLRE1C,10,14936537,na,na,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis,GRCh38,single nucleotide variant
DCLRE1C,10,14934461,na,na,Pathogenic,Athabaskan severe combined immunodeficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis,GRCh38,single nucleotide variant
DCLRE1C,10,14953908,na,na,Pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency,GRCh38,single nucleotide variant
DCLRE1C,10,14954009,na,na,Uncertain significance,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency,GRCh38,single nucleotide variant
UBR1,15,43082648,na,na,Pathogenic,Johanson-Blizzard syndrome,GRCh38,single nucleotide variant
UBR1,15,43032566,na,na,Pathogenic,Johanson-Blizzard syndrome,GRCh38,single nucleotide variant
UBR1,15,43048394,na,na,Pathogenic,Johanson-Blizzard syndrome,GRCh38,single nucleotide variant
UBR1,15,43022697,na,na,Pathogenic,Johanson-Blizzard syndrome,GRCh38,single nucleotide variant
VPS13A,9,77205394,na,na,Pathogenic,Chorea-acanthocytosis,GRCh38,single nucleotide variant
VPS13A,9,77213240,na,na,Pathogenic,Chorea-acanthocytosis|not provided,GRCh38,single nucleotide variant
VPS13A,9,77358438,na,na,Pathogenic,Chorea-acanthocytosis,GRCh38,single nucleotide variant
NOD2,16,50722629,na,na,Conflicting classifications of pathogenicity; association,"not specified|Blau syndrome|Yao syndrome|not provided|Autoinflammatory syndrome|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Blau syndrome;Yao syndrome|Inflammatory bowel disease 1;Blau syndrome;Yao syndrome|Blau syndrome;Regional enteritis",GRCh38,single nucleotide variant
NOD2,16,50712015,na,na,Conflicting classifications of pathogenicity; association,Blau syndrome|not specified|Yao syndrome|Crohn disease|not provided|Blau syndrome;Regional enteritis|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome|Autoinflammatory syndrome,GRCh38,single nucleotide variant
NOD2,16,50710912,na,na,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,GRCh38,single nucleotide variant
NOD2,16,50711316,na,na,Pathogenic,Blau syndrome,GRCh38,single nucleotide variant
NOD2,16,50710911,na,na,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,GRCh38,single nucleotide variant
NOD2,16,50722863,na,na,Conflicting classifications of pathogenicity,Blau syndrome|Yao syndrome|Autoinflammatory syndrome|not provided|Inflammatory bowel disease 1|Regional enteritis;Blau syndrome,GRCh38,single nucleotide variant
NOD2,16,50711398,na,na,Pathogenic,Blau syndrome,GRCh38,single nucleotide variant
NOD2,16,50711057,na,na,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,GRCh38,single nucleotide variant
NOD2,16,50711745,na,na,Conflicting classifications of pathogenicity,"Blau syndrome|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Yao syndrome;Blau syndrome|Inflammatory bowel disease 1|Regional enteritis;Blau syndrome|not provided",GRCh38,single nucleotide variant
NOD2,16,50711058,na,na,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,GRCh38,single nucleotide variant
DPM3,1,155139987,na,na,Pathogenic,DPM3-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PCNT,21,46346146,na,na,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,GRCh38,single nucleotide variant
PCNT,21,46411840,na,na,Pathogenic/Likely pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,GRCh38,single nucleotide variant
PCNT,21,46367083,na,na,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,GRCh38,single nucleotide variant
PCNT,21,46435904,na,na,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,GRCh38,single nucleotide variant
ANGPTL4,19,8364439,na,na,association,Plasma triglyceride level quantitative trait locus,GRCh38,single nucleotide variant
MLC1,22,50068488,na,na,Conflicting classifications of pathogenicity,Megalencephalic leukoencephalopathy with subcortical cysts 1,GRCh38,single nucleotide variant
MLC1,22,50080387,na,na,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,GRCh38,single nucleotide variant
MLC1,22,50064200,na,na,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,GRCh38,single nucleotide variant
MLC1,22,50079918,na,na,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,GRCh38,single nucleotide variant
MLC1,22,50079919,na,na,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,GRCh38,single nucleotide variant
MLC1,22,50080391,na,na,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|Megalencephalic leukoencephalopathy with subcortical cysts|not provided,GRCh38,single nucleotide variant
MLC1,22,50084727,na,na,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,GRCh38,single nucleotide variant
ALG1,16,5078789,na,na,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Finnish congenital nephrotic syndrome|Encephalopathy|ALG12-congenital disorder of glycosylation,GRCh38,single nucleotide variant
ALG1,16,5081009,na,na,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ALG1,16,5075447,na,na,Pathogenic,ALG1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
LDB3,10,86687163,na,na,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|not provided|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,GRCh38,single nucleotide variant
LDB3,10,86687218,na,na,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|Neuromuscular disease|Myofibrillar myopathy|not provided|Cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1C|LDB3-related disorder,GRCh38,single nucleotide variant
LDB3,10,86699324,na,na,Uncertain significance,Myofibrillar myopathy 4|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 1C|Primary familial dilated cardiomyopathy|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,GRCh38,single nucleotide variant
LDB3,10,86706669,na,na,Uncertain significance,Dilated cardiomyopathy 1C|not provided|Myofibrillar myopathy 4,GRCh38,single nucleotide variant
LDB3,10,86681680,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|not provided|Familial hypertrophic cardiomyopathy 24|Cardiovascular phenotype|Myofibrillar myopathy 4|Dilated cardiomyopathy 1A|Cardiomyopathy|Dilated cardiomyopathy 1C;Myofibrillar myopathy 4,GRCh38,single nucleotide variant
LDB3,10,86681731,na,na,Uncertain significance,Dilated cardiomyopathy 1C|Cardiovascular phenotype|Myofibrillar myopathy 4,GRCh38,single nucleotide variant
LDB3,10,86687073,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|Primary dilated cardiomyopathy|Myofibrillar myopathy 4|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
LDB3,10,86687107,na,na,Uncertain significance,Dilated cardiomyopathy 1C|Cardiomyopathy,GRCh38,single nucleotide variant
LDB3,10,86726175,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|Left ventricular noncompaction 3|not provided|Myofibrillar myopathy 4|Cardiovascular phenotype|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,GRCh38,single nucleotide variant
BRIP1,17,61859862,na,na,Conflicting classifications of pathogenicity,"Hereditary cancer-predisposing syndrome|Breast cancer, early-onset|Fanconi anemia complementation group J;Familial cancer of breast|BRIP1-related disorder|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|not specified|Fanconi anemia complementation group J|not provided|Ovarian cancer|Hereditary breast ovarian cancer syndrome",GRCh38,single nucleotide variant
BRIP1,17,61808488,na,na,Uncertain significance,"Breast cancer, early-onset|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J;Familial cancer of breast|not specified",GRCh38,single nucleotide variant
BRIP1,17,61716051,na,na,Pathogenic,"Fanconi anemia complementation group J;Familial cancer of breast|Fanconi anemia complementation group J|Esophageal atresia/tracheoesophageal fistula;Fanconi anemia complementation group J;Familial cancer of breast|BRIP1-related disorder|Familial cancer of breast|Malignant tumor of breast|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia|Breast cancer, early-onset|Inherited ovarian cancer (without breast cancer)|BRIP1-related disorder;Fanconi anemia complementation group J|Breast and/or ovarian cancer|Ovarian cancer|Gastric cancer|Breast-ovarian cancer, familial, susceptibility to, 1",GRCh38,single nucleotide variant
SLC35C1,11,45806240,na,na,Likely pathogenic,Leukocyte adhesion deficiency type II,GRCh38,single nucleotide variant
SLC35C1,11,45811163,na,na,Pathogenic,Leukocyte adhesion deficiency type II,GRCh38,single nucleotide variant
KCNK9,8,139618677,na,na,Pathogenic,Birk-Barel syndrome|not provided,GRCh38,single nucleotide variant
DMGDH,5,79055859,na,na,Likely pathogenic,Dimethylglycine dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HERC2,15,28285036,na,na,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",GRCh38,single nucleotide variant
HERC2,15,28268218,na,na,Affects,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",GRCh38,single nucleotide variant
HERC2,15,28120472,na,na,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",GRCh38,single nucleotide variant
TMC8,17,78134966,na,na,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 2|Epidermodysplasia verruciformis",GRCh38,single nucleotide variant
TMC6,17,78125876,na,na,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis|not provided",GRCh38,single nucleotide variant
TMC6,17,78119382,na,na,risk factor,"Epidermodysplasia verruciformis, susceptibility to, 1",GRCh38,single nucleotide variant
TMC6,17,78124671,na,na,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",GRCh38,single nucleotide variant
TMC6,17,78124181,na,na,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",GRCh38,single nucleotide variant
NUP62,19,49908636,na,na,Pathogenic,Infantile bilateral striatal necrosis,GRCh38,single nucleotide variant
MRPS22,3,139350183,na,na,Pathogenic/Likely pathogenic,Hypotonia with lactic acidemia and hyperammonemia|not provided|Ovarian dysgenesis 7;Hypotonia with lactic acidemia and hyperammonemia,GRCh38,single nucleotide variant
ZEB2,2,144399542,na,na,Pathogenic,Mowat-Wilson syndrome,GRCh38,single nucleotide variant
ZEB2,2,144399104,na,na,Pathogenic,Mowat-Wilson syndrome|not provided,GRCh38,single nucleotide variant
ZEB2,2,144398632,na,na,Pathogenic,Mowat-Wilson syndrome,GRCh38,single nucleotide variant
ZEB2,2,144517420,na,na,Uncertain significance,Mowat-Wilson syndrome,GRCh38,single nucleotide variant
ZEB2,2,144389740,na,na,Pathogenic,Mowat-Wilson syndrome,GRCh38,single nucleotide variant
AMN,14,102923789,na,na,Likely pathogenic,Imerslund-Grasbeck syndrome type 2|Imerslund-Grasbeck syndrome,GRCh38,single nucleotide variant
BCO1,16,81264677,na,na,Uncertain significance,Hereditary hypercarotenemia and vitamin A deficiency|not specified|BCO1-related disorder,GRCh38,single nucleotide variant
LDLRAP1,1,25543763,na,na,Pathogenic,"Hypercholesterolemia, familial, 4",GRCh38,single nucleotide variant
LDLRAP1,1,25557214,na,na,Pathogenic,"Hypercholesterolemia, familial, 4|Cardiovascular phenotype|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLRAP1,1,25563142,na,na,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia|not specified",GRCh38,single nucleotide variant
LDLRAP1,1,25553921,na,na,Pathogenic,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia",GRCh38,single nucleotide variant
LDLRAP1,1,25557269,na,na,Likely pathogenic,"Hypercholesterolemia, familial, 4|not provided",GRCh38,single nucleotide variant
SOST,17,43758672,na,na,Pathogenic,Sclerosteosis 1|not provided,GRCh38,single nucleotide variant
SOST,17,43758519,na,na,not provided,Sclerosteosis 1,GRCh38,single nucleotide variant
SOST,17,43755612,na,na,Pathogenic,Sclerosteosis 1,GRCh38,single nucleotide variant
SOST,17,43755608,na,na,Pathogenic,Sclerosteosis 1,GRCh38,single nucleotide variant
PRX,19,40395495,na,na,Pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease|PRX-related disorder,GRCh38,single nucleotide variant
PRX,19,40397250,na,na,Pathogenic/Likely pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Peripheral neuropathy|Inborn genetic diseases,GRCh38,single nucleotide variant
PRX,19,40397766,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided,GRCh38,single nucleotide variant
PRX,19,40396207,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
PRX,19,40395144,na,na,Pathogenic/Likely pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4,GRCh38,single nucleotide variant
SPTLC2,14,77555331,na,na,Pathogenic/Likely pathogenic,"Neuropathy, hereditary sensory and autonomic, type 1C|not provided",GRCh38,single nucleotide variant
SPTLC2,14,77555401,na,na,Conflicting classifications of pathogenicity,"Neuropathy, hereditary sensory and autonomic, type 1C",GRCh38,single nucleotide variant
SPTLC2,14,77518097,na,na,Pathogenic,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE",GRCh38,single nucleotide variant
SPTLC1,9,92080045,na,na,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease|Inborn genetic diseases|not provided",GRCh38,single nucleotide variant
SPTLC1,9,92068095,na,na,Pathogenic/Likely pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|not provided|SPTLC1-related disorder|Neuropathy, hereditary sensory and autonomic, type 1A|Inborn genetic diseases",GRCh38,single nucleotide variant
SPTLC1,9,92038342,na,na,Benign/Likely benign,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A|not provided|Inborn genetic diseases|not specified",GRCh38,single nucleotide variant
SPTLC1,9,92080044,na,na,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Sensorimotor neuropathy|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A|not provided",GRCh38,single nucleotide variant
SPTLC1,9,92047261,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type IA, severe|Neuropathy, hereditary sensory and autonomic, type 1A",GRCh38,single nucleotide variant
SPTLC1,9,92047198,na,na,Uncertain significance,"Neuropathy, hereditary sensory and autonomic, type 1A|Hereditary sensory and autonomic neuropathy type 1",GRCh38,single nucleotide variant
VAPB,20,58418318,na,na,Pathogenic,"Amyotrophic lateral sclerosis type 8|not provided|Adult-onset proximal spinal muscular atrophy, autosomal dominant;Amyotrophic lateral sclerosis type 8|Adult-onset proximal spinal muscular atrophy, autosomal dominant",GRCh38,single nucleotide variant
TRPM7,15,50586433,na,na,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to|Juvenile amyotrophic lateral sclerosis|not provided|TRPM7-related disorder",GRCh38,single nucleotide variant
FBXO7,22,32493269,na,na,Pathogenic,Parkinsonian-pyramidal syndrome,GRCh38,single nucleotide variant
FBXO7,22,32498453,na,na,Pathogenic,Parkinsonian-pyramidal syndrome|not provided,GRCh38,single nucleotide variant
FBXO7,22,32493282,na,na,Pathogenic,Parkinsonian-pyramidal syndrome,GRCh38,single nucleotide variant
FBXO7,22,32475067,na,na,Pathogenic/Likely pathogenic,Parkinsonian-pyramidal syndrome,GRCh38,single nucleotide variant
SLC26A4,7,107702023,na,na,Pathogenic,Pendred syndrome,GRCh38,single nucleotide variant
SLC26A4,7,107695984,na,na,Pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Deafness|Hearing impairment,GRCh38,single nucleotide variant
SLC26A4,7,107675051,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 4|Hearing impairment|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107690220,na,na,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107683538,na,na,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107690125,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107674970,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|not provided|Rare genetic deafness|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107689156,na,na,Pathogenic; Affects,Autosomal recessive nonsyndromic hearing loss 4,GRCh38,single nucleotide variant
SLC26A4,7,107689166,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,GRCh38,single nucleotide variant
SLC26A4,7,107710132,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107710126,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Rare genetic deafness|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided,GRCh38,single nucleotide variant
SLC26A4,7,107672255,na,na,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,GRCh38,single nucleotide variant
SLC26A4,7,107694473,na,na,Pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,GRCh38,single nucleotide variant
SLC26A4,7,107674326,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 4|not provided,GRCh38,single nucleotide variant
SLC26A4,7,107689049,na,na,Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,GRCh38,single nucleotide variant
SLC26A4,7,107672230,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,GRCh38,single nucleotide variant
SLC26A4,7,107672245,na,na,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided|Rare genetic deafness|Hearing impairment|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107698085,na,na,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,GRCh38,single nucleotide variant
SLC26A4,7,107660756,na,na,Uncertain significance,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided|not specified|Hearing impairment,GRCh38,single nucleotide variant
SLC26A4,7,107661726,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Pendred syndrome|Wolff-Parkinson-White pattern|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC26A4,7,107683453,na,na,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided|Pendred syndrome|Rare genetic deafness|Hearing loss, autosomal recessive|SLC26A4-related disorder",GRCh38,single nucleotide variant
SLC26A4,7,107696035,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided,GRCh38,single nucleotide variant
SLC26A4,7,107689054,na,na,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Pendred syndrome|not provided|Rare genetic deafness|SLC26A4-related disorder,GRCh38,single nucleotide variant
SLC6A20,3,45772602,na,na,Benign,Hyperglycinuria|not provided|SLC6A20-related disorder,GRCh38,single nucleotide variant
PNKP,19,49862424,na,na,Pathogenic,"Microcephaly, seizures, and developmental delay|not provided|Developmental and epileptic encephalopathy, 12|Abnormality of the nervous system",GRCh38,single nucleotide variant
PNKP,19,49864376,na,na,Pathogenic,"Microcephaly, seizures, and developmental delay",GRCh38,single nucleotide variant
CLDN14,21,36461442,na,na,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 29|Hearing impairment|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
CLDN14,21,36461395,na,na,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 29|not provided,GRCh38,single nucleotide variant
FOXL2,3,138946068,na,na,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",GRCh38,single nucleotide variant
FOXL2,3,138946566,na,na,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",GRCh38,single nucleotide variant
FOXL2,3,138945901,na,na,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",GRCh38,single nucleotide variant
FOXL2,3,138946472,na,na,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|FOXL2-related disorder",GRCh38,single nucleotide variant
FOXL2,3,138946428,na,na,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",GRCh38,single nucleotide variant
FOXL2,3,138946137,na,na,Pathogenic,"Blepharophimosis, ptosis, and epicanthus inversus syndrome",GRCh38,single nucleotide variant
FOXL2,3,138945951,na,na,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|not provided|Blepharophimosis, ptosis, and epicanthus inversus syndrome",GRCh38,single nucleotide variant
FOXL2,3,138946163,na,na,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|Blepharophimosis, ptosis, and epicanthus inversus syndrome|See cases|not provided",GRCh38,single nucleotide variant
HSD17B3,9,96240885,na,na,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HSD17B3,9,96240877,na,na,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,GRCh38,single nucleotide variant
HSD17B3,9,96254906,na,na,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided|Pseudohermaphroditism,GRCh38,single nucleotide variant
HSD17B3,9,96244393,na,na,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Inborn genetic diseases|Pseudohermaphroditism|not provided,GRCh38,single nucleotide variant
HSD17B3,9,96254907,na,na,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|not provided,GRCh38,single nucleotide variant
HSD17B3,9,96244395,na,na,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HSD17B3,9,96298451,na,na,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,GRCh38,single nucleotide variant
HSD17B3,9,96251482,na,na,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HSD17B3,9,96240777,na,na,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency,GRCh38,single nucleotide variant
RTN4R,22,20242778,na,na,risk factor,"Schizophrenia, susceptibility to",GRCh38,single nucleotide variant
RTN4R,22,20242546,na,na,risk factor,"Schizophrenia, susceptibility to",GRCh38,single nucleotide variant
RETN,19,7670411,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to|HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO",GRCh38,single nucleotide variant
FGF20,8,16992890,na,na,Benign,"Parkinson disease, late-onset|not provided",GRCh38,single nucleotide variant
AIP,11,67483198,na,na,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
AIP,11,67490037,na,na,Uncertain significance,Somatotroph adenoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
AIP,11,67490910,na,na,Pathogenic,Somatotroph adenoma|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
AIP,11,67490804,na,na,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|not provided,GRCh38,single nucleotide variant
AIP,11,67490911,na,na,Conflicting classifications of pathogenicity,Pituitary dependent hypercortisolism|not specified|Somatotroph adenoma|not provided|Hereditary cancer-predisposing syndrome|Dopamine agonists response|AIP-related disorder,GRCh38,single nucleotide variant
AIP,11,67483222,na,na,Pathogenic,Somatotroph adenoma,GRCh38,single nucleotide variant
CD244,1,160837925,na,na,risk factor,Rheumatoid arthritis,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791771,na,na,Pathogenic,Polydactyly of a triphalangeal thumb,GRCh38,single nucleotide variant
ZRS;LMBR1,7,156791472,na,na,Pathogenic,"Tibia, hypoplasia or aplasia of, with polydactyly",GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791571,na,na,Pathogenic,Polydactyly of a triphalangeal thumb,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791547,na,na,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791137,na,na,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791255,na,na,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791581,na,na,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,GRCh38,single nucleotide variant
LMBR1;ZRS,7,156791480,na,na,Uncertain significance,Polydactyly of a triphalangeal thumb|not provided,GRCh38,single nucleotide variant
LPIN2,18,2922173,na,na,Pathogenic/Likely pathogenic,Majeed syndrome|not provided|Autoinflammatory syndrome,GRCh38,single nucleotide variant
LPIN1,2,11773666,na,na,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",GRCh38,single nucleotide variant
LPIN1,2,11783834,na,na,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",GRCh38,single nucleotide variant
LPIN1,2,11819590,na,na,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",GRCh38,single nucleotide variant
LPIN1,2,11785078,na,na,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",GRCh38,single nucleotide variant
CDH23,10,71739772,na,na,Pathogenic,"Usher syndrome type 1D|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types",GRCh38,single nucleotide variant
CDH23,10,71779316,na,na,Pathogenic,"Usher syndrome type 1D|not provided|Retinal dystrophy|Usher syndrome type 1|Childhood onset hearing loss|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D|Rare genetic deafness|Usher syndrome|Autosomal recessive nonsyndromic hearing loss 12|Inborn genetic diseases|Pituitary adenoma 5, multiple types|CDH23-related disorder",GRCh38,single nucleotide variant
CDH23,10,71799634,na,na,Pathogenic,"Usher syndrome type 1D|Rare genetic deafness|not provided|Pituitary adenoma 5, multiple types",GRCh38,single nucleotide variant
CDH23,10,71791215,na,na,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types",GRCh38,single nucleotide variant
CDH23,10,71793532,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Pituitary adenoma 5, multiple types|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1|Usher syndrome",GRCh38,single nucleotide variant
CDH23,10,71732151,na,na,Pathogenic,"Usher syndrome type 1D|not provided|Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
CDH23,10,71793370,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Rare genetic deafness|not provided|Usher syndrome type 2A;Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1|Usher syndrome type 1D;Pituitary adenoma 5, multiple types;Autosomal recessive nonsyndromic hearing loss 12|Pituitary adenoma 5, multiple types|Usher syndrome|CDH23-related disorder|Retinal dystrophy|Usher syndrome type 1D",GRCh38,single nucleotide variant
CDH23,10,71732292,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types|Usher syndrome|Usher syndrome type 1D",GRCh38,single nucleotide variant
CDH23,10,71785051,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome,GRCh38,single nucleotide variant
CDH23,10,71812822,na,na,Uncertain significance,"USHER SYNDROME, TYPE ID/F, DIGENIC|not specified|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",GRCh38,single nucleotide variant
CDH23,10,71730514,na,na,Benign,"Usher syndrome type 1D|not specified|Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome|Usher syndrome type 1|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",GRCh38,single nucleotide variant
CDH23,10,71570884,na,na,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1D|not provided|Usher syndrome type 1|Nonsyndromic genetic hearing loss|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Pituitary adenoma 5, multiple types",GRCh38,single nucleotide variant
CDH23,10,71615573,na,na,Uncertain significance,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Pituitary adenoma 5, multiple types|Nonsyndromic genetic hearing loss|Usher syndrome",GRCh38,single nucleotide variant
PCDH15,10,53857265,na,na,Pathogenic,Usher syndrome type 1F,GRCh38,single nucleotide variant
PCDH15,10,54664256,na,na,Pathogenic,Usher syndrome type 1F|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 23|not provided|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23,GRCh38,single nucleotide variant
PCDH15,10,54317414,na,na,Pathogenic,Usher syndrome type 1F|Usher syndrome type 1G|Usher syndrome type 1|not provided|Rare genetic deafness|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23|Usher syndrome type 1D|Autosomal recessive nonsyndromic hearing loss 23|PCDH15-related disorder,GRCh38,single nucleotide variant
PCDH15,10,54317362,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 23,GRCh38,single nucleotide variant
PCDH15,10,54369194,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 23|Rare genetic deafness|Usher syndrome type 1F,GRCh38,single nucleotide variant
PCDH15,10,54090041,na,na,Pathogenic,Usher syndrome type 1F,GRCh38,single nucleotide variant
ELOVL4,6,79916743,na,na,Pathogenic/Likely pathogenic,Stargardt disease 3|not provided,GRCh38,single nucleotide variant
TMPRSS3,21,42383062,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8|Hearing impairment|not provided,GRCh38,single nucleotide variant
TMPRSS3,21,42375852,na,na,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 8|Ear malformation|not provided,GRCh38,single nucleotide variant
TMPRSS3,21,42383168,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8,GRCh38,single nucleotide variant
CRTAP,3,33119323,na,na,Likely pathogenic,Osteogenesis imperfecta type 7|CRTAP-related disorder,GRCh38,single nucleotide variant
CRTAP,3,33114549,na,na,Pathogenic,Osteogenesis imperfecta type 7,GRCh38,single nucleotide variant
CRTAP,3,33129971,na,na,Pathogenic,Osteogenesis imperfecta type 7|not provided,GRCh38,single nucleotide variant
CRTAP,3,33114080,na,na,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 7|Osteogenesis imperfecta,GRCh38,single nucleotide variant
DNAI2,17,74310164,na,na,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,GRCh38,single nucleotide variant
DNAI2,17,74286974,na,na,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,GRCh38,single nucleotide variant
DNAI2,17,74299780,na,na,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,GRCh38,single nucleotide variant
ASPM,1,197101490,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive",GRCh38,single nucleotide variant
ASPM,1,197093168,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided|Inborn genetic diseases|Autosomal recessive primary microcephaly",GRCh38,single nucleotide variant
ASPM,1,197117876,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",GRCh38,single nucleotide variant
ASPM,1,197144049,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive",GRCh38,single nucleotide variant
ASPM,1,197103062,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive",GRCh38,single nucleotide variant
ASPM,1,197133380,na,na,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",GRCh38,single nucleotide variant
ABCG8,2,43872094,na,na,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 1;Gallbladder disease 4|ABCG8-related disorder,GRCh38,single nucleotide variant
ABCG8,2,43875377,na,na,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|ABCG8-related disorder|Early-onset coronary artery disease,GRCh38,single nucleotide variant
ABCG8,2,43877865,na,na,Conflicting classifications of pathogenicity,not provided|Sitosterolemia 1|Sitosterolemia|ABCG8-related disorder|Cardiovascular phenotype,GRCh38,single nucleotide variant
ABCG8,2,43852692,na,na,Conflicting classifications of pathogenicity,Sitosterolemia 1|not provided|ABCG8-related disorder|Cardiovascular phenotype,GRCh38,single nucleotide variant
ABCG8,2,43873809,na,na,Pathogenic/Likely pathogenic,Sitosterolemia|Sitosterolemia 1|not provided|Cardiovascular phenotype|ABCG8-related disorder,GRCh38,single nucleotide variant
ABCG8,2,43877591,na,na,Pathogenic,Sitosterolemia 1,GRCh38,single nucleotide variant
ABCG8,2,43852483,na,na,Pathogenic,Sitosterolemia 1,GRCh38,single nucleotide variant
ABCG5;ABCG8,2,43839108,na,na,Benign/Likely benign; association,Gallbladder disease 4|not specified|Sitosterolemia|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 2|ABCG8-related disorder|not provided,GRCh38,single nucleotide variant
ABCG5,2,43824015,na,na,Pathogenic/Likely pathogenic,Sitosterolemia 2|Sitosterolemia|not provided,GRCh38,single nucleotide variant
ABCG5,2,43826429,na,na,Pathogenic,Sitosterolemia 2|ABCG5-related disorder,GRCh38,single nucleotide variant
ABCG5,2,43823981,na,na,Pathogenic,Sitosterolemia 2,GRCh38,single nucleotide variant
ABCG5,2,43823981,na,na,Pathogenic,Sitosterolemia 2,GRCh38,single nucleotide variant
ABCG5,2,43824071,na,na,Pathogenic/Likely pathogenic,Sitosterolemia 2|Sitosterolemia|not provided|Cardiovascular phenotype|ABCG5-related disorder,GRCh38,single nucleotide variant
ABCG5,2,43837870,na,na,Pathogenic,Sitosterolemia 2,GRCh38,single nucleotide variant
RPGRIP1,14,21294785,na,na,Pathogenic,Leber congenital amaurosis 6|Leber congenital amaurosis,GRCh38,single nucleotide variant
RPGRIP1,14,21325943,na,na,Likely pathogenic,Cone-rod dystrophy 13|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RPGRIP1,14,21321881,na,na,Benign/Likely benign,Cone-rod dystrophy 13|not provided|not specified|Leber congenital amaurosis 6|Leber congenital amaurosis 1|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,GRCh38,single nucleotide variant
RPGRIP1,14,21343037,na,na,Benign/Likely benign,Leber congenital amaurosis 6|not specified|not provided|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,GRCh38,single nucleotide variant
ADIPOQ,3,186854303,na,na,Pathogenic,Adiponectin deficiency,GRCh38,single nucleotide variant
PRKCH,14,61457521,na,na,risk factor,"Cerebral infarction, susceptibility to",GRCh38,single nucleotide variant
TRPV4,12,109792407,na,na,Pathogenic,Brachyrachia (short spine dysplasia)|Skeletal dysplasia|not provided|Charcot-Marie-Tooth disease axonal type 2C,GRCh38,single nucleotide variant
TRPV4,12,109792396,na,na,Pathogenic/Likely pathogenic,Brachyrachia (short spine dysplasia)|Neuromuscular disease;Skeletal dysplasia|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C|not provided|Metatropic dysplasia|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
TRPV4,12,109792695,na,na,Pathogenic/Likely pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Parastremmatic dwarfism|Neuromuscular disease;Skeletal dysplasia|not provided|Charcot-Marie-Tooth disease axonal type 2C|Metatropic dysplasia|Neuronopathy, distal hereditary motor, autosomal dominant 8|Inborn genetic diseases",GRCh38,single nucleotide variant
TRPV4,12,109798768,na,na,Pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia",GRCh38,single nucleotide variant
TRPV4,12,109788462,na,na,Uncertain significance,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C",GRCh38,single nucleotide variant
TRPV4,12,109798775,na,na,Pathogenic,Metatropic dysplasia|Skeletal dysplasia,GRCh38,single nucleotide variant
TRPV4,12,109784378,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, Maroteaux type|Metatropic dysplasia|Skeletal dysplasia|Parastremmatic dwarfism|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2C|Spondylometaphyseal dysplasia, Kozlowski type|not provided",GRCh38,single nucleotide variant
TRPV4,12,109798823,na,na,Pathogenic/Likely pathogenic,"Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C|Neuronopathy, distal hereditary motor, autosomal dominant 8|not provided|Neuronopathy, distal hereditary motor, autosomal dominant|Neuromuscular disease|Inborn genetic diseases|TRPV4-related disorder|TRPV4-Associated Disorders|Neuronopathy, distal hereditary motor, autosomal dominant 8;Scapuloperoneal spinal muscular atrophy",GRCh38,single nucleotide variant
TRPV4,12,109800665,na,na,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, autosomal dominant 8|Charcot-Marie-Tooth disease axonal type 2C|Charcot-Marie-Tooth disease|Neuromuscular disease|not provided|Inborn genetic diseases|11 conditions|TRPV4-related bone disorder",GRCh38,single nucleotide variant
TRPV4,12,109798820,na,na,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|not provided|Charcot-Marie-Tooth disease|Neuromuscular disease|Neuronopathy, distal hereditary motor, autosomal dominant|TRPV4-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
TRPV4,12,109800666,na,na,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|Neuromuscular disease|Neuronopathy, distal hereditary motor, autosomal dominant 8|not provided|Hereditary motor neuron disease|Distal spinal muscular atrophy|Inborn genetic diseases",GRCh38,single nucleotide variant
TRPV4,12,109814742,na,na,Benign,"Sodium serum level quantitative trait locus 1|Neuronopathy, distal hereditary motor, autosomal dominant 8|Spondylometaphyseal dysplasia, Kozlowski type|Scapuloperoneal spinal muscular atrophy|Brachyrachia (short spine dysplasia)|Metatropic dysplasia|not specified|not provided|Charcot-Marie-Tooth disease axonal type 2C|Connective tissue disorder|Charcot-Marie-Tooth disease",GRCh38,single nucleotide variant
GJB4,1,34761663,na,na,Likely pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,GRCh38,single nucleotide variant
GJB4,1,34761665,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,GRCh38,single nucleotide variant
GJB4,1,34761507,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,GRCh38,single nucleotide variant
GJB4,1,34761289,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,GRCh38,single nucleotide variant
GJB4,1,34761319,na,na,Uncertain significance,Erythrokeratodermia variabilis et progressiva 2|not provided,GRCh38,single nucleotide variant
GJB4,1,34761820,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,GRCh38,single nucleotide variant
DHH,12,49094511,na,na,Pathogenic,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",GRCh38,single nucleotide variant
DHH,12,49091208,na,na,Pathogenic,"46,XY sex reversal 7",GRCh38,single nucleotide variant
ALX4,11,44309645,na,na,Pathogenic,Parietal foramina 2,GRCh38,single nucleotide variant
ALX4,11,44275389,na,na,Pathogenic,Parietal foramina 2,GRCh38,single nucleotide variant
ALX4,11,44275472,na,na,Pathogenic,Parietal foramina 2,GRCh38,single nucleotide variant
ALX4,11,44267585,na,na,Pathogenic,Parietal foramina 2,GRCh38,single nucleotide variant
ALX4,11,44275505,na,na,Pathogenic,Parietal foramina 2,GRCh38,single nucleotide variant
ALX4,11,44267607,na,na,Pathogenic,Frontonasal dysplasia with alopecia and genital anomaly|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
MINPP1,10,87505037,na,na,Pathogenic,"Thyroid cancer, nonmedullary, 2",GRCh38,single nucleotide variant
MINPP1,10,87508507,na,na,Pathogenic,"Thyroid cancer, nonmedullary, 2",GRCh38,single nucleotide variant
FGF23,12,4370572,na,na,Pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,GRCh38,single nucleotide variant
FGF23,12,4370564,na,na,Pathogenic/Likely pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,GRCh38,single nucleotide variant
FGF23,12,4379372,na,na,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided|Tumoral calcinosis, hyperphosphatemic, familial, 2|Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome|Tumoral calcinosis, hyperphosphatemic, familial, 2;Autosomal dominant hypophosphatemic rickets",GRCh38,single nucleotide variant
FGF23,12,4372622,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2|not provided",GRCh38,single nucleotide variant
FGF23,12,4370713,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2",GRCh38,single nucleotide variant
GAN,16,81365432,na,na,Pathogenic/Likely pathogenic,Giant axonal neuropathy 1|Inborn genetic diseases,GRCh38,single nucleotide variant
GAN,16,81365423,na,na,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81354723,na,na,Pathogenic,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81365005,na,na,Uncertain significance,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81354535,na,na,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81315156,na,na,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81365405,na,na,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
GAN,16,81354627,na,na,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,GRCh38,single nucleotide variant
AAAS,12,53309158,na,na,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,GRCh38,single nucleotide variant
AAAS,12,53307698,na,na,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|Neurodevelopmental disorder,GRCh38,single nucleotide variant
AAAS,12,53315142,na,na,Pathogenic,Glucocorticoid deficiency with achalasia,GRCh38,single nucleotide variant
AAAS,12,53321423,na,na,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|AAAS-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
AAAS,12,53309624,na,na,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Babinski sign;Spastic paraparesis;Hyperreflexia|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
AAAS,12,53308724,na,na,Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,GRCh38,single nucleotide variant
AAAS,12,53308095,na,na,Pathogenic,Achalasia-alacrima syndrome,GRCh38,single nucleotide variant
AAAS,12,53320565,na,na,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Achalasia-alacrima syndrome|not provided,GRCh38,single nucleotide variant
ARFGEF2,20,48953577,na,na,Conflicting classifications of pathogenicity,"Periventricular heterotopia with microcephaly, autosomal recessive|not specified|not provided",GRCh38,single nucleotide variant
ARFGEF2,20,48941953,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
ARHGAP26,5,143041855,na,na,Pathogenic,Juvenile myelomonocytic leukemia,GRCh38,single nucleotide variant
ELAC2,17,13011692,na,na,Benign,"Prostate cancer, hereditary, 2|not provided|not specified|Combined oxidative phosphorylation defect type 17|Combined oxidative phosphorylation defect type 17;Prostate cancer, hereditary, 2",GRCh38,single nucleotide variant
ELAC2,17,12996585,na,na,Benign/Likely benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17|not specified|not provided|Prostate cancer, hereditary, 2;Combined oxidative phosphorylation defect type 17",GRCh38,single nucleotide variant
ELAC2,17,12992957,na,na,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 2|not provided|Combined oxidative phosphorylation defect type 17|Inborn genetic diseases",GRCh38,single nucleotide variant
ELAC2,17,12995006,na,na,Benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17",GRCh38,single nucleotide variant
GAD1,2,170818626,na,na,Uncertain significance,Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,GRCh38,single nucleotide variant
GHRL,3,10289835,na,na,risk factor,"Metabolic syndrome, susceptibility to|Obesity",GRCh38,single nucleotide variant
GHRL,3,10289773,na,na,Conflicting classifications of pathogenicity,"Metabolic syndrome, susceptibility to|Obesity, age at onset of|not provided|Obesity|Inherited obesity",GRCh38,single nucleotide variant
GHRL,3,10286769,na,na,Benign,Obesity|not provided,GRCh38,single nucleotide variant
CYP3A5,7,99672916,na,na,association; drug response; risk factor,"Hypertension, salt-sensitive essential, susceptibility to|refractory myasthenia gravis|Tacrolimus response",GRCh38,single nucleotide variant
FOXP2,7,114662075,na,na,Pathogenic/Likely pathogenic,Childhood apraxia of speech|FOXP2-related disorder,GRCh38,single nucleotide variant
FOXP2,7,114642616,na,na,Pathogenic,Childhood apraxia of speech|not provided|Inborn genetic diseases|See cases,GRCh38,single nucleotide variant
CHST6,16,75479308,na,na,Pathogenic,Macular corneal dystrophy,GRCh38,single nucleotide variant
CHST6,16,75479220,na,na,Pathogenic,Macular corneal dystrophy,GRCh38,single nucleotide variant
CHST6,16,75479230,na,na,Pathogenic,"Macular corneal dystrophy, type II|Macular corneal dystrophy|not provided|CHST6-related disorder",GRCh38,single nucleotide variant
CHST6,16,75479525,na,na,Pathogenic,Macular corneal dystrophy,GRCh38,single nucleotide variant
CHST6,16,75479500,na,na,Pathogenic,Macular corneal dystrophy,GRCh38,single nucleotide variant
CHST6,16,75479002,na,na,Conflicting classifications of pathogenicity,Macular corneal dystrophy,GRCh38,single nucleotide variant
CHST6,16,75479552,na,na,Pathogenic,"Macular corneal dystrophy, type II",GRCh38,single nucleotide variant
OPA1,3,193637980,na,na,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,GRCh38,single nucleotide variant
OPA1,3,193642764,na,na,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,GRCh38,single nucleotide variant
OPA1,3,193637280,na,na,Pathogenic/Likely pathogenic,"Autosomal dominant optic atrophy classic form|not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Retinal dystrophy",GRCh38,single nucleotide variant
OPA1,3,193643005,na,na,Pathogenic,Autosomal dominant optic atrophy classic form|not provided|OPA1-related optic atrophy with or without extraocular features|Optic atrophy,GRCh38,single nucleotide variant
OPA1,3,193637285,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
OPA1,3,193648109,na,na,Pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy",GRCh38,single nucleotide variant
OPA1,3,193643996,na,na,Pathogenic/Likely pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|not provided|Mitochondrial disease|Autosomal dominant optic atrophy classic form|Centronuclear myopathy|OPA1-related disorder|Optic atrophy",GRCh38,single nucleotide variant
CAPN10,2,240591757,na,na,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",GRCh38,single nucleotide variant
CAPN10,2,240603286,na,na,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",GRCh38,single nucleotide variant
CAPN10,2,240591746,na,na,risk factor,"|Type 2 diabetes mellitus 1, susceptibility to",GRCh38,single nucleotide variant
TSC1,9,132912446,na,na,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
TSC1,9,132905818,na,na,Benign,Tuberous sclerosis 1|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|Isolated focal cortical dysplasia type II|not provided|Lung lymphangioleiomyomatosis,GRCh38,single nucleotide variant
TSC1,9,132923361,na,na,Pathogenic,Lymphangiomyomatosis,GRCh38,single nucleotide variant
TSC1,9,132903665,na,na,Conflicting classifications of pathogenicity,Focal cortical dysplasia of Taylor type 2B|Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,GRCh38,single nucleotide variant
TSC1,9,132921429,na,na,Likely pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
TSC1,9,132921943,na,na,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
SERPINA10,14,94288306,na,na,Uncertain significance,"Venous thrombosis, susceptibility to|not provided",GRCh38,single nucleotide variant
CARD14;SGSH,17,80213815,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome|not provided|Inborn genetic diseases|Mucopolysaccharidosis|Neurodegeneration|SGSH-related disorder",GRCh38,single nucleotide variant
SGSH,17,80217061,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Abnormal circulating carbohydrate concentration|Mucopolysaccharidosis",GRCh38,single nucleotide variant
SGSH,17,80210663,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
SGSH,17,80214738,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-A|not specified",GRCh38,single nucleotide variant
SGSH;SLC26A11,17,80217084,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Sanfilippo syndrome|Mucopolysaccharidosis|SGSH-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
SGSH,17,80214672,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|SGSH-related disorder",GRCh38,single nucleotide variant
SGSH,17,80210622,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
SGSH,17,80210856,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|SGSH-related disorder",GRCh38,single nucleotide variant
SGSH,17,80214218,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A",GRCh38,single nucleotide variant
NDRG1,8,133258374,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease type 4|not provided,GRCh38,single nucleotide variant
NDRG1,8,133254596,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
AICDA,12,8606951,na,na,Pathogenic,Hyper-IgM syndrome type 2,GRCh38,single nucleotide variant
AICDA,12,8605439,na,na,Pathogenic,Hyper-IgM syndrome type 2|not provided,GRCh38,single nucleotide variant
AICDA,12,8605404,na,na,Uncertain significance,Hyper-IgM syndrome type 2,GRCh38,single nucleotide variant
AICDA,12,8605325,na,na,Pathogenic,Hyper-IgM syndrome type 2,GRCh38,single nucleotide variant
AICDA,12,8605227,na,na,Pathogenic,Hyper-IgM syndrome type 2|not provided,GRCh38,single nucleotide variant
AICDA,12,8604909,na,na,Pathogenic,Hyper-IgM syndrome type 2|not provided,GRCh38,single nucleotide variant
AICDA,12,8604898,na,na,Pathogenic,Hyper-IgM syndrome type 2,GRCh38,single nucleotide variant
MCOLN1,19,7526759,na,na,Pathogenic,Mucolipidosis type IV|not provided|Mucolipidosis|Mucolipidosis type IV;Lisch epithelial corneal dystrophy,GRCh38,single nucleotide variant
MCOLN1,19,7528683,na,na,Pathogenic,Mucolipidosis type IV|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
MCOLN1,19,7528920,na,na,Pathogenic/Likely pathogenic,Mucolipidosis type IV|not provided|MCOLN1-related disorder|Lisch epithelial corneal dystrophy;Mucolipidosis type IV,GRCh38,single nucleotide variant
MCOLN1,19,7526505,na,na,Pathogenic,Mucolipidosis type IV|not provided,GRCh38,single nucleotide variant
MCOLN1,19,7529173,na,na,Pathogenic/Likely pathogenic,Mucolipidosis type IV,GRCh38,single nucleotide variant
USH1C,11,17531431,na,na,Pathogenic,Usher syndrome type 1C|Usher syndrome|not provided|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|USH1C-related disorder,GRCh38,single nucleotide variant
USH1C,11,17544271,na,na,Pathogenic,Usher syndrome type 1C,GRCh38,single nucleotide variant
USH1C,11,17533268,na,na,Pathogenic,Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|not provided|Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1;Usher syndrome type 1C,GRCh38,single nucleotide variant
USH1C,11,17522779,na,na,no classifications from unflagged records,Autosomal recessive nonsyndromic hearing loss 18A,GRCh38,single nucleotide variant
USH1C,11,17509546,na,na,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 18A|not specified|not provided|Usher syndrome type 1C|Meniere disease|Optic atrophy|Retinal dystrophy|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,GRCh38,single nucleotide variant
USH1C,11,17527331,na,na,Benign/Likely benign,Usher syndrome type 1C|not specified|not provided|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,GRCh38,single nucleotide variant
ATP6V0A4,7,138715764,na,na,Pathogenic,"Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",GRCh38,single nucleotide variant
ATP6V0A4,7,138706689,na,na,Uncertain significance,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",GRCh38,single nucleotide variant
ATP6V0A4,7,138734135,na,na,Pathogenic/Likely pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",GRCh38,single nucleotide variant
ATP6V0A4,7,138733046,na,na,Benign/Likely benign,"Autosomal recessive distal renal tubular acidosis|not specified|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",GRCh38,single nucleotide variant
ATP6V0A4,7,138762435,na,na,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",GRCh38,single nucleotide variant
ATP6V0A4,7,138739541,na,na,Uncertain significance,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",GRCh38,single nucleotide variant
ATP6V0A4,7,138739606,na,na,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",GRCh38,single nucleotide variant
ATP6V0A4,7,138709633,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive distal renal tubular acidosis|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",GRCh38,single nucleotide variant
HNMT,2,138002079,na,na,Benign; risk factor,Inherited susceptibility to asthma|HNMT-related disorder,GRCh38,single nucleotide variant
WNK1,12,868046,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",GRCh38,single nucleotide variant
WNK1,12,868772,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",GRCh38,single nucleotide variant
WNK1,12,868697,na,na,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|not provided|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",GRCh38,single nucleotide variant
DISC1,1,231632793,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
HCN4,15,73324216,na,na,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",GRCh38,single nucleotide variant
HCN4,15,73325378,na,na,Uncertain significance,"Sick sinus syndrome 2, autosomal dominant|Brugada syndrome 8",GRCh38,single nucleotide variant
HCN4,15,73329725,na,na,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",GRCh38,single nucleotide variant
TOR1A,9,129818622,na,na,Benign,|Early-onset generalized limb-onset dystonia|not specified|Dystonic disorder|not provided|Arthrogryposis multiplex congenita 5;Early-onset generalized limb-onset dystonia,GRCh38,single nucleotide variant
MESP2,15,89776664,na,na,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive|not provided",GRCh38,single nucleotide variant
MESP2,15,89776730,na,na,Uncertain significance,"Spondylocostal dysostosis 2, autosomal recessive|not specified",GRCh38,single nucleotide variant
MESP2,15,89777057,na,na,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive",GRCh38,single nucleotide variant
CFC1,2,130597896,na,na,Pathogenic,"Heterotaxy, visceral, 2, autosomal",GRCh38,single nucleotide variant
ANKH,5,14713644,na,na,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|Chondrocalcinosis 2",GRCh38,single nucleotide variant
ANKH,5,14713671,na,na,Pathogenic/Likely pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided",GRCh38,single nucleotide variant
ANKH,5,14769145,na,na,Pathogenic,Chondrocalcinosis 2,GRCh38,single nucleotide variant
ANKH,5,14871458,na,na,Pathogenic,Chondrocalcinosis 2,GRCh38,single nucleotide variant
ANKH,5,14871434,na,na,Likely pathogenic,Chondrocalcinosis 2|not provided,GRCh38,single nucleotide variant
ANKH,5,14871435,na,na,Pathogenic/Likely pathogenic,Chondrocalcinosis 2|ANKH-related disorder,GRCh38,single nucleotide variant
ANKH,5,14716832,na,na,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",GRCh38,single nucleotide variant
ANKH,5,14713637,na,na,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",GRCh38,single nucleotide variant
ANKH,5,14741837,na,na,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",GRCh38,single nucleotide variant
WWOX,16,78432568,na,na,Uncertain significance,"Esophageal squamous cell carcinoma, somatic|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12",GRCh38,single nucleotide variant
SPINT2,19,38291839,na,na,Pathogenic,Congenital secretory sodium diarrhea 3,GRCh38,single nucleotide variant
SPINT2,19,38290215,na,na,Pathogenic,not provided|Congenital secretory sodium diarrhea 3,GRCh38,single nucleotide variant
SPINT2,19,38287937,na,na,Pathogenic,Congenital secretory sodium diarrhea 3,GRCh38,single nucleotide variant
SPINT2,19,38290282,na,na,Pathogenic,Congenital secretory sodium diarrhea 3,GRCh38,single nucleotide variant
SPINT2,19,38264893,na,na,Pathogenic,Congenital secretory sodium diarrhea 3,GRCh38,single nucleotide variant
MASP2,1,11046609,na,na,Conflicting classifications of pathogenicity,Immunodeficiency due to MASP-2 deficiency|not specified|not provided|MASP2-related disorder,GRCh38,single nucleotide variant
TAB2,6,149378537,na,na,Pathogenic,"Congenital heart defects, multiple types, 2",GRCh38,single nucleotide variant
TAB2,6,149378603,na,na,Uncertain significance,"Congenital heart defects, multiple types, 2|not provided",GRCh38,single nucleotide variant
TREM2,6,41161421,na,na,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,GRCh38,single nucleotide variant
TREM2,6,41158991,na,na,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,GRCh38,single nucleotide variant
TREM2,6,41159873,na,na,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,GRCh38,single nucleotide variant
TREM2,6,41161522,na,na,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,GRCh38,single nucleotide variant
TREM2,6,41161277,na,na,Pathogenic/Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|TREM2-related disorder,GRCh38,single nucleotide variant
TREM2,6,41161557,na,na,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|Inborn genetic diseases|not provided|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly,GRCh38,single nucleotide variant
FRZB,2,182834857,na,na,Benign; risk factor,FRZB-related disorder|Osteoarthritis susceptibility 1,GRCh38,single nucleotide variant
FRZB,2,182838608,na,na,Benign; risk factor,Osteoarthritis susceptibility 1|FRZB-related disorder,GRCh38,single nucleotide variant
CNGB3,8,86632768,na,na,Pathogenic,Achromatopsia 3|not provided,GRCh38,single nucleotide variant
CNGB3,8,86668055,na,na,Pathogenic,Achromatopsia 3|not provided|Retinal dystrophy|Achromatopsia,GRCh38,single nucleotide variant
CNGB3,8,86628994,na,na,Benign/Likely benign,not specified|Achromatopsia 3|Severe early-childhood-onset retinal dystrophy|not provided|Achromatopsia,GRCh38,single nucleotide variant
TARDBP,1,11022418,na,na,Pathogenic,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED;Amyotrophic lateral sclerosis type 10|not provided",GRCh38,single nucleotide variant
TARDBP,1,11022400,na,na,Pathogenic,Amyotrophic lateral sclerosis type 10,GRCh38,single nucleotide variant
TARDBP,1,11022290,na,na,Uncertain significance,Amyotrophic lateral sclerosis type 10|Inborn genetic diseases,GRCh38,single nucleotide variant
TARDBP,1,11022278,na,na,Uncertain significance,"Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",GRCh38,single nucleotide variant
TARDBP,1,11022301,na,na,Pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED;Amyotrophic lateral sclerosis type 10|TARDBP-related disorder",GRCh38,single nucleotide variant
TARDBP,1,11018836,na,na,Pathogenic,Amyotrophic lateral sclerosis type 10,GRCh38,single nucleotide variant
TARDBP,1,11022451,na,na,Pathogenic/Likely pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED;Amyotrophic lateral sclerosis type 10",GRCh38,single nucleotide variant
TARDBP,1,11022437,na,na,Pathogenic,Amyotrophic lateral sclerosis type 10,GRCh38,single nucleotide variant
TARDBP,1,11022352,na,na,Pathogenic,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED;Amyotrophic lateral sclerosis type 10|not provided",GRCh38,single nucleotide variant
TARDBP,1,11022196,na,na,Pathogenic,"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED",GRCh38,single nucleotide variant
TARDBP,1,11023351,na,na,Uncertain significance,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",GRCh38,single nucleotide variant
TRIM37,17,59079879,na,na,Pathogenic,Mulibrey nanism syndrome|not provided,GRCh38,single nucleotide variant
TRIM37,17,59084045,na,na,Conflicting classifications of pathogenicity,Mulibrey nanism syndrome|not specified,GRCh38,single nucleotide variant
TRIM37,17,59064355,na,na,Likely pathogenic,Mulibrey nanism syndrome|not provided,GRCh38,single nucleotide variant
VSX1,20,25079443,na,na,Uncertain significance,Keratoconus 1|Polymorphous corneal dystrophy,GRCh38,single nucleotide variant
VSX1,20,25079460,na,na,Conflicting classifications of pathogenicity,Posterior polymorphous corneal dystrophy 1|Polymorphous corneal dystrophy|not specified|not provided,GRCh38,single nucleotide variant
VSX1,20,25079464,na,na,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy,GRCh38,single nucleotide variant
VSX1,20,25077727,na,na,Uncertain significance,Craniofacial anomalies and anterior segment dysgenesis syndrome|not specified,GRCh38,single nucleotide variant
VSX1,20,25082047,na,na,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy|VSX1-related disorder,GRCh38,single nucleotide variant
CYLD,16,50793665,na,na,Pathogenic,Familial cylindromatosis,GRCh38,single nucleotide variant
CYLD,16,50792627,na,na,Pathogenic,Familial cylindromatosis|not specified|not provided|Brooke-Spiegler syndrome,GRCh38,single nucleotide variant
CYLD,16,50782468,na,na,Pathogenic,Familial multiple trichoepitheliomata,GRCh38,single nucleotide variant
CYLD,16,50791689,na,na,Pathogenic,Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome,GRCh38,single nucleotide variant
CYLD,16,50796443,na,na,Pathogenic,"Familial cylindromatosis|Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome|Familial cylindromatosis;Brooke-Spiegler syndrome;Trichoepithelioma, multiple familial, 1;Frontotemporal dementia and/or amyotrophic lateral sclerosis 8|not provided",GRCh38,single nucleotide variant
STX11,6,144187429,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4,GRCh38,single nucleotide variant
SPINK5,5,148120063,na,na,Pathogenic,Netherton syndrome|not provided|Ichthyosis linearis circumflexa,GRCh38,single nucleotide variant
SPINK5,5,148086403,na,na,Pathogenic,Netherton syndrome,GRCh38,single nucleotide variant
SPINK5,5,148101392,na,na,Benign,SPINK5 POLYMORPHISM|not specified|not provided|Netherton syndrome|Ichthyosis linearis circumflexa,GRCh38,single nucleotide variant
NHERF1,17,74749174,na,na,Benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not specified|not provided,GRCh38,single nucleotide variant
NHERF1,17,74762028,na,na,Conflicting classifications of pathogenicity,Hypophosphatemic nephrolithiasis/osteoporosis 2|not provided|Chronic kidney disease|NHERF1-related disorder,GRCh38,single nucleotide variant
NHERF1,17,74763436,na,na,Benign/Likely benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not specified|Nephrolithiasis;Hypophosphatemia|not provided|NHERF1-related disorder|Dominant hypophosphatemia with nephrolithiasis or osteoporosis,GRCh38,single nucleotide variant
SPTBN2,11,66713645,na,na,Pathogenic,Spinocerebellar ataxia type 5|not provided,GRCh38,single nucleotide variant
POLG2,17,64477929,na,na,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4|POLG2-related disorder|not provided",GRCh38,single nucleotide variant
HPS1,10,98417671,na,na,Likely pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome,GRCh38,single nucleotide variant
HPS1,10,98435273,na,na,Pathogenic,Hermansky-Pudlak syndrome 1|not provided,GRCh38,single nucleotide variant
HPS1,10,98435267,na,na,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome,GRCh38,single nucleotide variant
PRKAG3,2,218828561,na,na,association,SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS,GRCh38,single nucleotide variant
PDE11A,2,178014454,na,na,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 2|not provided|See cases",GRCh38,single nucleotide variant
SLC26A5,7,103421569,na,na,Benign/Likely benign,Autosomal recessive nonsyndromic hearing loss 61|not specified|not provided,GRCh38,single nucleotide variant
TBCE,1,235437471,na,na,Pathogenic,Hypoparathyroidism-retardation-dysmorphism syndrome,GRCh38,single nucleotide variant
MUTYH,1,45332803,na,na,Pathogenic/Likely pathogenic,Endometrial carcinoma|Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Gastric cancer|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder|Inherited polyposis and early onset colorectal cancer - germline testing,GRCh38,single nucleotide variant
MUTYH,1,45331556,na,na,Pathogenic/Likely pathogenic,"Endometrial cancer|Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Familial adenomatous polyposis 2;Neoplasm of stomach|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Ovarian carcinoma|Small intestine carcinoid|Pilomatrixoma;Familial adenomatous polyposis 2;Neoplasm of stomach|Colon cancer|Familial colorectal cancer|Breast carcinoma|Diffuse midline glioma, H3 K27-altered|Inherited polyposis and early onset colorectal cancer - germline testing|MUTYH-related disorder|Familial adenomatous polyposis 2;Gastric cancer",GRCh38,single nucleotide variant
MUTYH,1,45333449,na,na,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer,GRCh38,single nucleotide variant
MUTYH,1,45331220,na,na,Pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder,GRCh38,single nucleotide variant
MUTYH,1,45331530,na,na,Uncertain significance,Gastric cancer|Familial adenomatous polyposis 2,GRCh38,single nucleotide variant
MUTYH,1,45331502,na,na,Pathogenic,Gastric cancer,GRCh38,single nucleotide variant
CTDP1,18,79710825,na,na,Pathogenic,Congenital cataracts-facial dysmorphism-neuropathy syndrome|Charcot-Marie-Tooth disease|not provided,GRCh38,single nucleotide variant
TNFRSF13B,17,16948873,na,na,Conflicting classifications of pathogenicity; risk factor,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|Severe SARS-CoV-2 infection, susceptibility to|not provided|not specified|Immunodeficiency, common variable, 1;Immunodeficiency, common variable, 2|Common variable immunodeficiency|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|Immunodeficiency, common variable, 1|TNFRSF13B-related disorder|Immune deficiency, familial variable",GRCh38,single nucleotide variant
TNFRSF13B,17,16940415,na,na,Pathogenic/Likely pathogenic,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|Common variable immunodeficiency|not provided|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|See cases",GRCh38,single nucleotide variant
TNFRSF13B,17,16940352,na,na,Conflicting classifications of pathogenicity,"Immunodeficiency, common variable, 2|Common Variable Immune Deficiency, Dominant|not provided|not specified",GRCh38,single nucleotide variant
TNFRSF13B,17,16948752,na,na,Pathogenic,"Immunodeficiency, common variable, 2",GRCh38,single nucleotide variant
MKKS,20,10413265,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
MKKS,20,10413405,na,na,Pathogenic/Likely pathogenic,McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|Retinal dystrophy|Inborn genetic diseases|Nephronophthisis|Bardet-Biedl syndrome|MKKS-related disorder|Syndromic inherited retinal disease,GRCh38,single nucleotide variant
MKKS,20,10413360,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome,GRCh38,single nucleotide variant
MKKS,20,10412723,na,na,Pathogenic,Bardet-Biedl syndrome 6,GRCh38,single nucleotide variant
MKKS,20,10412685,na,na,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 6|not provided|Inborn genetic diseases|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|MKKS-related disorder|McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
MKKS,20,10413346,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|not provided,GRCh38,single nucleotide variant
MKKS,20,10413073,na,na,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",GRCh38,single nucleotide variant
MKKS,20,10405464,na,na,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",GRCh38,single nucleotide variant
MKKS,20,10412542,na,na,risk factor,"Bardet-Biedl syndrome 1, modifier of",GRCh38,single nucleotide variant
TBX21,17,47731462,na,na,Uncertain significance,"Asthma, aspirin-induced, susceptibility to|Asthma and nasal polyps|Immunodeficiency 88",GRCh38,single nucleotide variant
NEUROG3,10,69572725,na,na,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|NEUROG3-related disorder,GRCh38,single nucleotide variant
NEUROG3,10,69572766,na,na,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|not provided,GRCh38,single nucleotide variant
SLC12A6,15,34236719,na,na,Pathogenic,"Agenesis of the corpus callosum with peripheral neuropathy|See cases|not provided|Agenesis of the corpus callosum with peripheral neuropathy;Charcot-Marie-Tooth disease, axonal, IIa 2II",GRCh38,single nucleotide variant
SLC12A6,15,34243993,na,na,Pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|not provided|SLC12A6-related disorder,GRCh38,single nucleotide variant
SLC12A6,15,34257713,na,na,Conflicting classifications of pathogenicity,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease|not provided,GRCh38,single nucleotide variant
TAS2R16,7,122995119,na,na,Uncertain significance,"BETA-GLUCOPYRANOSIDE TASTING|Alcohol dependence, susceptibility to|Alcohol dependence",GRCh38,single nucleotide variant
LRAT,4,154744851,na,na,Pathogenic,"RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED|not provided",GRCh38,single nucleotide variant
CD207,2,70831747,na,na,Uncertain significance,Birbeck granule deficiency|not provided,GRCh38,single nucleotide variant
EVC,4,5793722,na,na,Pathogenic/Likely pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly,GRCh38,single nucleotide variant
EVC,4,5808274,na,na,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,GRCh38,single nucleotide variant
EVC,4,5748226,na,na,Pathogenic,Ellis-van Creveld syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly|Ellis-van Creveld syndrome;Curry-Hall syndrome,GRCh38,single nucleotide variant
EVC,4,5753797,na,na,Benign,Ellis-van Creveld syndrome|not specified|Curry-Hall syndrome;Ellis-van Creveld syndrome|Curry-Hall syndrome|not provided,GRCh38,single nucleotide variant
EVC,4,5745321,na,na,Pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|Curry-Hall syndrome,GRCh38,single nucleotide variant
KL,13,33017018,na,na,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 3|Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
ABHD5,3,43717670,na,na,Pathogenic,Triglyceride storage disease with ichthyosis,GRCh38,single nucleotide variant
ABHD5,3,43699326,na,na,Pathogenic,Triglyceride storage disease with ichthyosis,GRCh38,single nucleotide variant
ABHD5,3,43702213,na,na,Pathogenic,Triglyceride storage disease with ichthyosis,GRCh38,single nucleotide variant
ABHD5,3,43702470,na,na,Pathogenic,Triglyceride storage disease with ichthyosis,GRCh38,single nucleotide variant
ABHD5,3,43691011,na,na,Likely benign,Triglyceride storage disease with ichthyosis|not provided,GRCh38,single nucleotide variant
ABHD5,3,43717675,na,na,Pathogenic,Triglyceride storage disease with ichthyosis,GRCh38,single nucleotide variant
ACAD8,11,134258589,na,na,Uncertain significance,Deficiency of isobutyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACAD8,11,134262556,na,na,Pathogenic/Likely pathogenic,Deficiency of isobutyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACAD8,11,134261786,na,na,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
ACAD8,11,134261300,na,na,Pathogenic,Deficiency of isobutyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACAD8,11,134261338,na,na,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
NPHS2,1,179561327,na,na,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Nephrotic syndrome|Nephrotic range proteinuria|Steroid-resistant nephrotic syndrome|Chronic kidney disease|NPHS2-related disorder|See cases",GRCh38,single nucleotide variant
NPHS2,1,179561328,na,na,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome|Idiopathic nephrotic syndrome|Focal segmental glomerulosclerosis",GRCh38,single nucleotide variant
NPHS2,1,179575806,na,na,Conflicting classifications of pathogenicity,"Nephrotic syndrome, type 2|not provided|not specified|Steroid-resistant nephrotic syndrome|Focal segmental glomerulosclerosis|Finnish congenital nephrotic syndrome|NPHS2-related disorder",GRCh38,single nucleotide variant
NPHS2,1,179575591,na,na,Pathogenic,"Nephrotic syndrome, type 2",GRCh38,single nucleotide variant
NPHS2,1,179559734,na,na,Likely pathogenic,"Nephrotic syndrome, type 2",GRCh38,single nucleotide variant
NPHS2,1,179557227,na,na,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome",GRCh38,single nucleotide variant
NPHS2,1,179552605,na,na,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Inborn genetic diseases|Steroid-resistant nephrotic syndrome",GRCh38,single nucleotide variant
NPHS2,1,179557079,na,na,Conflicting classifications of pathogenicity,"|Proteinuria|Nephrotic syndrome, type 2|not provided|not specified|Focal segmental glomerulosclerosis|Inborn genetic diseases|Nephrotic syndrome|NPHS2-related disorder",GRCh38,single nucleotide variant
SYCP3,12,101729109,na,na,Pathogenic,Spermatogenic failure 4,GRCh38,single nucleotide variant
AKR1D1,7,138106621,na,na,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,GRCh38,single nucleotide variant
AKR1D1,7,138091822,na,na,Pathogenic,Congenital bile acid synthesis defect 2,GRCh38,single nucleotide variant
AKR1D1,7,138097885,na,na,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,GRCh38,single nucleotide variant
AKR1D1,7,138107506,na,na,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 2|Congenital bile acid synthesis defect,GRCh38,single nucleotide variant
TSFM,12,57796539,na,na,Pathogenic,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
TFR2,7,100633100,na,na,Pathogenic,Hemochromatosis type 3,GRCh38,single nucleotide variant
TFR2,7,100633515,na,na,Pathogenic,Hemochromatosis type 3,GRCh38,single nucleotide variant
TFR2,7,100629279,na,na,Conflicting classifications of pathogenicity,"Hemochromatosis, type 1, modifier of|Hemochromatosis type 3|not provided|Hereditary hemochromatosis|TFR2-related disorder",GRCh38,single nucleotide variant
TFR2,7,100626830,na,na,Pathogenic,Hemochromatosis type 3,GRCh38,single nucleotide variant
RRM2B,8,102212829,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,GRCh38,single nucleotide variant
RRM2B,8,102225020,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 8a|not provided,GRCh38,single nucleotide variant
RRM2B,8,102218918,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,GRCh38,single nucleotide variant
RRM2B,8,102214136,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,GRCh38,single nucleotide variant
RRM2B,8,102208210,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5|not provided|RRM2B-related mitochondrial disease",GRCh38,single nucleotide variant
RRM2B,8,102214157,na,na,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease|not provided,GRCh38,single nucleotide variant
RRM2B,8,102225011,na,na,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease|not provided|Mitochondrial DNA depletion syndrome 8a,GRCh38,single nucleotide variant
RRM2B,8,102224978,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease,GRCh38,single nucleotide variant
LTBP4,19,40613453,na,na,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",GRCh38,single nucleotide variant
LTBP4,19,40605768,na,na,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",GRCh38,single nucleotide variant
MERTK,2,112001199,na,na,Pathogenic,Retinitis pigmentosa 38|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
MERTK,2,112008466,na,na,Pathogenic,Retinitis pigmentosa 38|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
MERTK,2,112019523,na,na,Pathogenic,Retinitis pigmentosa 38|Inborn genetic diseases|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
AKAP10,17,19909228,na,na,Conflicting classifications of pathogenicity,Reclassified - variant of unknown significance|AKAP10-related disorder,GRCh38,single nucleotide variant
HOXA2,7,27101301,na,na,Pathogenic,Bilateral microtia-deafness-cleft palate syndrome,GRCh38,single nucleotide variant
CD209,19,7747847,na,na,protective; risk factor,"Susceptibility to HIV infection|Mycobacterium tuberculosis, susceptibility to|Dengue fever, protection against",GRCh38,single nucleotide variant
CD209,19,7748382,na,na,risk factor,"Mycobacterium tuberculosis, susceptibility to",GRCh38,single nucleotide variant
SLC40A1,2,189571799,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189575202,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189571759,na,na,Likely pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189565568,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189564018,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189565572,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189575193,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
SLC40A1,2,189564186,na,na,Pathogenic,Hemochromatosis type 4,GRCh38,single nucleotide variant
MAPK8IP1,11,45898159,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
ACTN4,19,38710286,na,na,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,GRCh38,single nucleotide variant
ACTN4,19,38710299,na,na,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,GRCh38,single nucleotide variant
ACTN4,19,38710307,na,na,Pathogenic,Focal segmental glomerulosclerosis 1,GRCh38,single nucleotide variant
EFEMP2,11,65871355,na,na,Pathogenic,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal recessive, type 1B",GRCh38,single nucleotide variant
EFEMP2,11,65868522,na,na,Likely pathogenic,"Cutis laxa, autosomal recessive, type 1B|Cutis laxa, autosomal recessive, type 1A",GRCh38,single nucleotide variant
NR0B2,1,26913841,na,na,Pathogenic,"Obesity, mild, early-onset",GRCh38,single nucleotide variant
NR0B2,1,26912036,na,na,Uncertain significance,"Obesity, mild, early-onset|not specified",GRCh38,single nucleotide variant
MMP20,11,102594759,na,na,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A2|not provided|MMP20-related disorder,GRCh38,single nucleotide variant
HSPB3,5,54455810,na,na,Likely benign,"Neuronopathy, distal hereditary motor, type 2C|not provided",GRCh38,single nucleotide variant
LGI1,10,93797277,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1",GRCh38,single nucleotide variant
LGI1,10,93777543,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1",GRCh38,single nucleotide variant
LGI1,10,93758280,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1|Autosomal dominant epilepsy with auditory features",GRCh38,single nucleotide variant
LGI1,10,93797082,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1",GRCh38,single nucleotide variant
LGI1,10,93777618,na,na,Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided",GRCh38,single nucleotide variant
LGI1,10,93793207,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1",GRCh38,single nucleotide variant
LGI1,10,93777592,na,na,Pathogenic/Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided|Autosomal dominant epilepsy with auditory features|LGI1-related disorder",GRCh38,single nucleotide variant
LGI1,10,93777551,na,na,Pathogenic,"Epilepsy, familial temporal lobe, 1",GRCh38,single nucleotide variant
TBX19,1,168305136,na,na,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency|not provided,GRCh38,single nucleotide variant
TBX19,1,168291339,na,na,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,GRCh38,single nucleotide variant
TBX19,1,168291213,na,na,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,GRCh38,single nucleotide variant
WRN,8,31157461,na,na,Pathogenic,Werner syndrome,GRCh38,single nucleotide variant
WRN,8,31147397,na,na,Pathogenic,Werner syndrome,GRCh38,single nucleotide variant
WRN,8,31141680,na,na,Pathogenic,Werner syndrome|not provided,GRCh38,single nucleotide variant
WRN,8,31081132,na,na,Pathogenic/Likely pathogenic,Werner syndrome|Medulloblastoma|not provided,GRCh38,single nucleotide variant
WRN,8,31150454,na,na,Pathogenic,Werner syndrome,GRCh38,single nucleotide variant
WRN,8,31090843,na,na,Pathogenic,Werner syndrome,GRCh38,single nucleotide variant
WRN,8,31064934,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
BLM,15,90769553,na,na,Conflicting classifications of pathogenicity,Bloom syndrome|not specified,GRCh38,single nucleotide variant
BLM,15,90794254,na,na,Pathogenic,Bloom syndrome,GRCh38,single nucleotide variant
KALRN,3,124055231,na,na,Benign,"Coronary heart disease, susceptibility to, 5|KALRN-related disorder",GRCh38,single nucleotide variant
TCIRG1,11,68047733,na,na,Pathogenic,Autosomal recessive osteopetrosis 1,GRCh38,single nucleotide variant
TCIRG1,11,68049081,na,na,Uncertain significance,Autosomal recessive osteopetrosis 1|not provided,GRCh38,single nucleotide variant
TCIRG1,11,68041392,na,na,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Inborn genetic diseases|Autosomal recessive osteopetrosis|TCIRG1-related disorder,GRCh38,single nucleotide variant
TCIRG1,11,68047480,na,na,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Osteopetrosis,GRCh38,single nucleotide variant
TCIRG1,11,68047672,na,na,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided,GRCh38,single nucleotide variant
FCGR2B,1,161662856,na,na,risk factor,"Systemic lupus erythematosus, susceptibility to",GRCh38,single nucleotide variant
FCGR2B,1,161674008,na,na,protective; risk factor,"Systemic lupus erythematosus, susceptibility to|Malaria, resistance to",GRCh38,single nucleotide variant
PDGFRL,8,17589479,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
AFG3L2,18,12337445,na,na,Pathogenic,Spinocerebellar ataxia type 28,GRCh38,single nucleotide variant
AFG3L2,18,12337435,na,na,Pathogenic,Spinocerebellar ataxia type 28,GRCh38,single nucleotide variant
AFG3L2,18,12337411,na,na,Pathogenic/Likely pathogenic,Spinocerebellar ataxia type 28|not provided,GRCh38,single nucleotide variant
AFG3L2,18,12353028,na,na,Pathogenic,Spinocerebellar ataxia type 28,GRCh38,single nucleotide variant
FBLN5,14,91887253,na,na,Conflicting classifications of pathogenicity,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal dominant",GRCh38,single nucleotide variant
FBLN5,14,91937148,na,na,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration|FBLN5-related disorder",GRCh38,single nucleotide variant
FBLN5,14,91937114,na,na,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",GRCh38,single nucleotide variant
FBLN5,14,91937067,na,na,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",GRCh38,single nucleotide variant
FBLN5,14,91891334,na,na,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",GRCh38,single nucleotide variant
FBLN5,14,91877621,na,na,Uncertain significance,"Macular degeneration, age-related, 3|Cutis laxa|not provided|See cases|not specified|Charcot-Marie-Tooth disease, demyelinating, IIA 1H;Cutis laxa, autosomal dominant 2;Macular degeneration, age-related, 3;Cutis laxa, autosomal recessive, type 1A|Age-related macular degeneration",GRCh38,single nucleotide variant
FBLN5,14,91877585,na,na,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",GRCh38,single nucleotide variant
FBLN5,14,91870336,na,na,Uncertain significance,"Macular degeneration, age-related, 3|Age-related macular degeneration|not provided",GRCh38,single nucleotide variant
FZD4,11,86951506,na,na,Pathogenic,"Exudative vitreoretinopathy 1|Exudative vitreoretinopathy, digenic",GRCh38,single nucleotide variant
FZD4,11,86951732,na,na,Uncertain significance,Exudative vitreoretinopathy 1|not provided,GRCh38,single nucleotide variant
FZD4,11,86951751,na,na,Pathogenic,Exudative vitreoretinopathy 1,GRCh38,single nucleotide variant
FZD4,11,86951990,na,na,Conflicting classifications of pathogenicity,Retinopathy of prematurity|not provided|FZD4-related disorder,GRCh38,single nucleotide variant
CNTNAP2,7,147877298,na,na,risk factor,"Autism, susceptibility to, 15",GRCh38,single nucleotide variant
CNTNAP2,7,146792514,na,na,risk factor,"Autism, susceptibility to, 15",GRCh38,single nucleotide variant
CNTNAP2,7,148147542,na,na,Conflicting classifications of pathogenicity,"Autism, susceptibility to, 15|not provided|Cortical dysplasia-focal epilepsy syndrome|Inborn genetic diseases",GRCh38,single nucleotide variant
CNTNAP2,7,147485934,na,na,Pathogenic,Cortical dysplasia-focal epilepsy syndrome|not provided,GRCh38,single nucleotide variant
ALG6,1,63419380,na,na,Pathogenic,ALG6-congenital disorder of glycosylation 1C|not provided|ALG6-related disorder,GRCh38,single nucleotide variant
ALG6,1,63436928,na,na,Likely pathogenic,ALG6-congenital disorder of glycosylation 1C,GRCh38,single nucleotide variant
ALG6,1,63396602,na,na,Pathogenic,ALG6-congenital disorder of glycosylation 1C,GRCh38,single nucleotide variant
ADAMTS2,5,179272926,na,na,Pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type|not provided",GRCh38,single nucleotide variant
ADAMTS2,5,179130005,na,na,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type",GRCh38,single nucleotide variant
IDH3B,20,2660912,na,na,Uncertain significance,Retinitis pigmentosa 46|not provided,GRCh38,single nucleotide variant
BLNK,10,96271349,na,na,Pathogenic,"Agammaglobulinemia 4, autosomal recessive",GRCh38,single nucleotide variant
TRIP11,14,92015729,na,na,Pathogenic,"Achondrogenesis, type IA|Odontochondrodysplasia 1",GRCh38,single nucleotide variant
TRIP11,14,92025422,na,na,Likely pathogenic,"Achondrogenesis, type IA",GRCh38,single nucleotide variant
TRIP11,14,92005874,na,na,Conflicting classifications of pathogenicity,"Achondrogenesis, type IA|not provided|Connective tissue disorder",GRCh38,single nucleotide variant
SACS,13,23336372,na,na,Pathogenic,Charlevoix-Saguenay spastic ataxia|Hereditary spastic paraplegia|not provided|Spastic paraplegia,GRCh38,single nucleotide variant
SACS,13,23331656,na,na,Pathogenic,Charlevoix-Saguenay spastic ataxia,GRCh38,single nucleotide variant
SACS,13,23338040,na,na,Pathogenic,Charlevoix-Saguenay spastic ataxia|Spastic paraplegia|SACS-related disorder,GRCh38,single nucleotide variant
SACS,13,23334134,na,na,Pathogenic,Charlevoix-Saguenay spastic ataxia,GRCh38,single nucleotide variant
SACS,13,23340715,na,na,Pathogenic,Charlevoix-Saguenay spastic ataxia,GRCh38,single nucleotide variant
AMACR,5,34007866,na,na,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 4|Alpha-methylacyl-CoA racemase deficiency|not provided|AMACR-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
AMACR,5,34005827,na,na,Pathogenic,Congenital bile acid synthesis defect 4,GRCh38,single nucleotide variant
TCAP,17,39665762,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G,GRCh38,single nucleotide variant
TCAP,17,39665865,na,na,Uncertain significance,Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
NR2E3,15,71811590,na,na,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|not provided|Retinal dystrophy|Retinitis pigmentosa|NR2E3-related disorder,GRCh38,single nucleotide variant
NR2E3,15,71811591,na,na,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|Retinal dystrophy|not provided|Goldmann-Favre syndrome|NR2E3-related disorder|Enhanced S-cone syndrome;Retinitis pigmentosa 37|Retinitis pigmentosa 37,GRCh38,single nucleotide variant
NR2E3,15,71813573,na,na,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|Goldmann-Favre syndrome|NR2E3-related disorder|Enhanced S-cone syndrome;Retinitis pigmentosa 37|Enhanced S-cone syndrome;NR2E3-related disorder|Retinitis pigmentosa 37|not provided|Retinal dystrophy|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa,GRCh38,single nucleotide variant
NR2E3,15,71811530,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 37|Retinal dystrophy|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
IRAK3,12,66203804,na,na,risk factor,"Asthma-related traits, susceptibility to, 5",GRCh38,single nucleotide variant
IRAK3,12,66209521,na,na,risk factor,"Asthma-related traits, susceptibility to, 5",GRCh38,single nucleotide variant
SP110,2,230185999,na,na,Benign,"Mycobacterium tuberculosis, susceptibility to|not specified|Hepatic veno-occlusive disease-immunodeficiency syndrome|not provided",GRCh38,single nucleotide variant
SP110,2,230210491,na,na,Uncertain significance,"Mycobacterium tuberculosis, susceptibility to",GRCh38,single nucleotide variant
KCNE3;LIPT2,11,74457316,na,na,Conflicting classifications of pathogenicity,"not provided|Periodic paralysis|Brugada syndrome 6|not specified|Cardiovascular phenotype|Syncope;Ventricular fibrillation|Cardiomyopathy|Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",GRCh38,single nucleotide variant
KCNE3,11,74457268,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 6|not provided|Brugada syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
GJB6,13,20223467,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 3B,GRCh38,single nucleotide variant
GJB6,13,20223450,na,na,Pathogenic,Hidrotic ectodermal dysplasia syndrome|Autosomal recessive nonsyndromic hearing loss 1B;Autosomal recessive nonsyndromic hearing loss 1A;Hidrotic ectodermal dysplasia syndrome;Autosomal dominant nonsyndromic hearing loss 3B|not provided|GJB6-related disorder,GRCh38,single nucleotide variant
GJB6,13,20223218,na,na,Pathogenic,Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;Autosomal recessive nonsyndromic hearing loss 1A|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;X-linked mixed hearing loss with perilymphatic gusher;Autosomal recessive nonsyndromic hearing loss 1A,GRCh38,single nucleotide variant
GJB6,13,20223371,na,na,Pathogenic,Hidrotic ectodermal dysplasia syndrome,GRCh38,single nucleotide variant
GPC6,13,93830534,na,na,Pathogenic,Autosomal recessive omodysplasia,GRCh38,single nucleotide variant
ST3GAL5,2,85844542,na,na,Pathogenic,GM3 synthase deficiency|not provided|ST3GAL5-related disorder,GRCh38,single nucleotide variant
MLH3,14,75047174,na,na,Uncertain significance,"Carcinoma of colon|Colorectal cancer, hereditary nonpolyposis, type 7|not specified",GRCh38,single nucleotide variant
MLH3,14,75049586,na,na,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",GRCh38,single nucleotide variant
MLH3,14,75048160,na,na,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7",GRCh38,single nucleotide variant
MLH3,14,75047786,na,na,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified",GRCh38,single nucleotide variant
AREL1;MLH3,14,75047435,na,na,Benign/Likely benign,"Endometrial carcinoma|Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified|Colorectal cancer;Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7",GRCh38,single nucleotide variant
MLH3,14,75017093,na,na,Conflicting classifications of pathogenicity,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified|not provided|Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7;Colorectal cancer",GRCh38,single nucleotide variant
MLH3,14,75032069,na,na,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",GRCh38,single nucleotide variant
AIPL1,17,6425781,na,na,Pathogenic,Leber congenital amaurosis 4|not provided|AIPL1-related disorder|Leber congenital amaurosis|Leber congenital amaurosis 4;Retinitis pigmentosa|Retinal dystrophy|AIPL1-related retinopathy,GRCh38,single nucleotide variant
AIPL1,17,6426684,na,na,Conflicting classifications of pathogenicity,Leber congenital amaurosis 4|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
TRPS1,8,115604916,na,na,Pathogenic,Trichorhinophalangeal dysplasia type I,GRCh38,single nucleotide variant
TRPS1,8,115604099,na,na,Pathogenic,"Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Inborn genetic diseases",GRCh38,single nucleotide variant
TRPS1,8,115587144,na,na,Pathogenic,Trichorhinophalangeal dysplasia type I|not provided|TRPS1-related disorder,GRCh38,single nucleotide variant
TRPS1,8,115418413,na,na,Pathogenic,"Trichorhinophalangeal syndrome, type III",GRCh38,single nucleotide variant
TRPS1,8,115414593,na,na,Pathogenic,Trichorhinophalangeal dysplasia type I,GRCh38,single nucleotide variant
TRPS1,8,115418391,na,na,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",GRCh38,single nucleotide variant
TRPS1,8,115418358,na,na,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Congenital anomaly of kidney and urinary tract",GRCh38,single nucleotide variant
TRPS1,8,115415015,na,na,Pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III",GRCh38,single nucleotide variant
TRPS1,8,115415014,na,na,Pathogenic/Likely pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",GRCh38,single nucleotide variant
ATP2C1,3,130963981,na,na,Pathogenic,Familial benign pemphigus,GRCh38,single nucleotide variant
ATP2C1,3,130969385,na,na,Pathogenic,Familial benign pemphigus|not provided,GRCh38,single nucleotide variant
ATP2C1,3,130963970,na,na,Pathogenic,Familial benign pemphigus,GRCh38,single nucleotide variant
ATP2C1,3,130975387,na,na,Pathogenic,Familial benign pemphigus,GRCh38,single nucleotide variant
ATP2C1,3,130980591,na,na,Pathogenic,Familial benign pemphigus,GRCh38,single nucleotide variant
ATP2C1,3,130996112,na,na,Pathogenic,Familial benign pemphigus,GRCh38,single nucleotide variant
CHEK2,22,28725099,na,na,Conflicting classifications of pathogenicity; risk factor,"CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome|not specified|Breast and colorectal cancer, susceptibility to|Familial cancer of breast|not provided|Adrenal cortex carcinoma;Gastrointestinal carcinoma|Malignant tumor of breast|Predisposition to cancer|Breast and/or ovarian cancer|TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE/COLORECTAL|Prostate cancer|Bone osteosarcoma;Familial prostate cancer;CHEK2-related cancer predisposition|CHEK2-related disorder|Bone osteosarcoma;Familial prostate cancer;Familial cancer of breast;CHEK2-related cancer predisposition|Bone osteosarcoma;Familial prostate cancer;Familial cancer of breast;Colorectal cancer;CHEK2-related cancer predisposition",GRCh38,single nucleotide variant
CHEK2,22,28725254,na,na,Likely pathogenic,CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|not provided|Malignant tumor of breast|Li-Fraumeni syndrome|Breast and/or ovarian cancer|Li-Fraumeni syndrome 1|Gastric cancer,GRCh38,single nucleotide variant
CHEK2,22,28734468,na,na,Benign/Likely benign,Bone osteosarcoma|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome,GRCh38,single nucleotide variant
CHEK2,22,28734673,na,na,Pathogenic,Bone osteosarcoma,GRCh38,single nucleotide variant
CHEK2,22,28725030,na,na,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome|Prostate cancer,GRCh38,single nucleotide variant
CHEK2,22,28725028,na,na,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not specified|Hereditary breast ovarian cancer syndrome|CHEK2-related disorder|CHEK2-related cancer predisposition",GRCh38,single nucleotide variant
CHEK2,22,28725027,na,na,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Bone osteosarcoma;Prostate cancer;Familial cancer of breast;CHEK2-related cancer predisposition|CHEK2-related cancer predisposition|not specified|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|Prostate cancer|Bone osteosarcoma;Familial prostate cancer;CHEK2-related cancer predisposition,GRCh38,single nucleotide variant
CHEK2,22,28711986,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Colorectal cancer|Prostate cancer,GRCh38,single nucleotide variant
CHEK2,22,28711986,na,na,Conflicting classifications of pathogenicity,not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|Predisposition to cancer|CHEK2-related cancer predisposition|CHEK2-related disorder|Bone osteosarcoma;Prostate cancer;Familial cancer of breast;Colorectal cancer;CHEK2-related cancer predisposition|Prostate cancer,GRCh38,single nucleotide variant
CHEK2,22,28695219,na,na,Conflicting classifications of pathogenicity,"Breast cancer, susceptibility to|Breast and colorectal cancer, susceptibility to|not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast neoplasm|Malignant tumor of breast|Bone osteosarcoma;Prostate cancer;Familial cancer of breast;CHEK2-related cancer predisposition|Hereditary breast ovarian cancer syndrome|TUMOR PREDISPOSITION SYNDROME 4, BREAST|CHEK2-related cancer risk|CHEK2-related disorder|Breast and/or ovarian cancer|Bone osteosarcoma;Familial prostate cancer;CHEK2-related cancer predisposition|CHEK2-related cancer predisposition|Inherited breast cancer and ovarian cancer",GRCh38,single nucleotide variant
DNAI1,9,34513165,na,na,Pathogenic/Likely pathogenic,Kartagener syndrome|Primary ciliary dyskinesia|DNAI1-related disorder,GRCh38,single nucleotide variant
PROM1,4,15994028,na,na,Pathogenic,Retinitis pigmentosa 41|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
PROM1,4,16013299,na,na,Pathogenic/Likely pathogenic,Stargardt disease 4|Retinal macular dystrophy type 2|Cone-rod dystrophy 12|not provided|Retinal dystrophy|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|Retinitis pigmentosa 41;Retinal macular dystrophy type 2;Cone-rod dystrophy 12;Stargardt disease 4,GRCh38,single nucleotide variant
B4GALT7,5,177607445,na,na,Pathogenic,Ehlers-Danlos syndrome progeroid type,GRCh38,single nucleotide variant
B4GALT7,5,177607505,na,na,Pathogenic,Ehlers-Danlos syndrome progeroid type,GRCh38,single nucleotide variant
B4GALT7,5,177608994,na,na,Pathogenic,"Ehlers-Danlos syndrome progeroid type|Larsen-like syndrome, B3GAT3 type|Lethal skeletal dysplasia|not provided|Ehlers-Danlos syndrome, spondylodysplastic type, 1|",GRCh38,single nucleotide variant
SLC17A5,6,73644583,na,na,Pathogenic,"Salla disease|Sialic acid storage disease, severe infantile type|not provided|Salla disease;Sialic acid storage disease, severe infantile type",GRCh38,single nucleotide variant
SLC17A5,6,73638477,na,na,Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease",GRCh38,single nucleotide variant
SLC17A5,6,73615425,na,na,Pathogenic/Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease|Salla disease;Sialic acid storage disease, severe infantile type",GRCh38,single nucleotide variant
TINF2,14,24240642,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|not provided",GRCh38,single nucleotide variant
TINF2,14,24240635,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Revesz syndrome|not provided|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 1;Revesz syndrome;Dyskeratosis congenita, autosomal dominant 3",GRCh38,single nucleotide variant
TINF2,14,24240636,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita",GRCh38,single nucleotide variant
TINF2,14,24240636,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita|not provided",GRCh38,single nucleotide variant
GALK1,17,75765043,na,na,Conflicting classifications of pathogenicity,Deficiency of galactokinase,GRCh38,single nucleotide variant
GALK1,17,75764014,na,na,Pathogenic,Deficiency of galactokinase,GRCh38,single nucleotide variant
GALK1,17,75765055,na,na,Pathogenic,Deficiency of galactokinase|not provided,GRCh38,single nucleotide variant
GALK1,17,75758091,na,na,Pathogenic,Deficiency of galactokinase,GRCh38,single nucleotide variant
GALK1,17,75763032,na,na,Conflicting classifications of pathogenicity,Deficiency of galactokinase|not specified|GALK1-related disorder,GRCh38,single nucleotide variant
CST3,20,23635330,na,na,Pathogenic,"Hereditary cerebral amyloid angiopathy, Icelandic type",GRCh38,single nucleotide variant
CST3,20,23637790,na,na,Benign,"Age related macular degeneration 11|not provided|Hereditary cerebral amyloid angiopathy, Icelandic type|not specified|Hereditary cerebral amyloid angiopathy, Icelandic type;Age related macular degeneration 11",GRCh38,single nucleotide variant
GRHPR,9,37426545,na,na,Pathogenic,"Primary hyperoxaluria, type II|not provided|Primary hyperoxaluria",GRCh38,single nucleotide variant
RAD54B,8,94391640,na,na,Benign,Non-Hodgkin lymphoma|not provided,GRCh38,single nucleotide variant
RAD54B,8,94399540,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
AGXT,2,240873995,na,na,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided",GRCh38,single nucleotide variant
AGXT,2,240868897,na,na,Benign/Likely benign,"Primary hyperoxaluria, type I|not specified|not provided",GRCh38,single nucleotide variant
AGXT,2,240869202,na,na,Pathogenic,"Primary hyperoxaluria, type I|not provided",GRCh38,single nucleotide variant
AGXT,2,240869249,na,na,Pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",GRCh38,single nucleotide variant
AGXT,2,240868986,na,na,Pathogenic,"Primary hyperoxaluria, type I|Nephrocalcinosis;Nephrolithiasis|not provided|Primary hyperoxaluria",GRCh38,single nucleotide variant
AGXT,2,240871379,na,na,Pathogenic,"Primary hyperoxaluria, type I|Primary hyperoxaluria|not provided",GRCh38,single nucleotide variant
AGXT,2,240875159,na,na,Pathogenic,"Primary hyperoxaluria, type I|Nephrocalcinosis;Nephrolithiasis|Primary hyperoxaluria|AGXT-related disorder|not provided",GRCh38,single nucleotide variant
AGXT,2,240875125,na,na,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",GRCh38,single nucleotide variant
AGXT,2,240875126,na,na,Pathogenic,"Primary hyperoxaluria, type I|not provided",GRCh38,single nucleotide variant
AGXT,2,240875166,na,na,Pathogenic,"Primary hyperoxaluria, type I|not provided",GRCh38,single nucleotide variant
AGXT,2,240871391,na,na,Pathogenic,"Primary hyperoxaluria, type I|Primary hyperoxaluria|not provided|Hyperoxaluria",GRCh38,single nucleotide variant
SPAST,2,32116199,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SPAST,2,32136898,na,na,Pathogenic,Hereditary spastic paraplegia 4|not provided,GRCh38,single nucleotide variant
SPAST,2,32141905,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|Spastic paraparesis|not provided|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
SPAST,2,32147216,na,na,Pathogenic,Hereditary spastic paraplegia 4|not provided,GRCh38,single nucleotide variant
SPAST,2,32136877,na,na,Pathogenic,Hereditary spastic paraplegia 4|Tics|not provided,GRCh38,single nucleotide variant
SPAST,2,32147259,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SPAST,2,32128483,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|not provided,GRCh38,single nucleotide variant
SPAST,2,32116145,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SPAST,2,32127006,na,na,Pathogenic,Hereditary spastic paraplegia 4|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
SPAST,2,32136964,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SPAST,2,32063962,na,na,Benign/Likely benign; other; risk factor,|not specified|Hereditary spastic paraplegia 4|not provided|Hereditary spastic paraplegia|Cerebral palsy|SPAST-related disorder,GRCh38,single nucleotide variant
SPAST,2,32063965,na,na,Conflicting classifications of pathogenicity,|not provided|Hereditary spastic paraplegia 4|Hereditary spastic paraplegia|not specified,GRCh38,single nucleotide variant
SPAST,2,32145004,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SPAST,2,32128450,na,na,Pathogenic,Hereditary spastic paraplegia 4|not provided|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
SPAST,2,32136890,na,na,Pathogenic,Hereditary spastic paraplegia 4,GRCh38,single nucleotide variant
SCO2,22,50524255,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1;Myopia 6",GRCh38,single nucleotide variant
SCO2,22,50523738,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",GRCh38,single nucleotide variant
SCO2,22,50523901,na,na,Conflicting classifications of pathogenicity,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|not provided",GRCh38,single nucleotide variant
SCO2,22,50523994,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Seizure;Severe global developmental delay|Myopia 6;Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Tip-toe gait|SCO2-related disorder",GRCh38,single nucleotide variant
SCO2,22,50524144,na,na,Pathogenic/Likely pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided",GRCh38,single nucleotide variant
SCO2,22,50524014,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",GRCh38,single nucleotide variant
SCO2,22,50524305,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",GRCh38,single nucleotide variant
LRP4,11,46893085,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
LRP4,11,46899884,na,na,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,GRCh38,single nucleotide variant
LRP4,11,46868107,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
LRP4,11,46899386,na,na,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,GRCh38,single nucleotide variant
LRP4,11,46899455,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
LRP4,11,46894784,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
LRP4,11,46894748,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
LRP4,11,46900387,na,na,Pathogenic,Cenani-Lenz syndactyly syndrome,GRCh38,single nucleotide variant
STAT5B,17,42210189,na,na,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",GRCh38,single nucleotide variant
STAT5B,17,42223478,na,na,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",GRCh38,single nucleotide variant
DLC1,8,13099462,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
RNF6,13,26215577,na,na,Pathogenic,"Esophageal squamous cell carcinoma, somatic",GRCh38,single nucleotide variant
RNF6,13,26215158,na,na,Pathogenic,"Esophageal squamous cell carcinoma, somatic",GRCh38,single nucleotide variant
RNF6,13,26215151,na,na,Pathogenic,"Esophageal squamous cell carcinoma, somatic",GRCh38,single nucleotide variant
CD2AP,6,47612492,na,na,Conflicting classifications of pathogenicity,"Focal segmental glomerulosclerosis 3|not provided|Focal segmental glomerulosclerosis 3, susceptibility to",GRCh38,single nucleotide variant
CRLF1,19,18599720,na,na,Uncertain significance,Cold-induced sweating syndrome 1|not specified,GRCh38,single nucleotide variant
CRLF1,19,18599736,na,na,Pathogenic,Cold-induced sweating syndrome 1,GRCh38,single nucleotide variant
CRLF1,19,18598767,na,na,Uncertain significance,Cold-induced sweating syndrome 1|not specified,GRCh38,single nucleotide variant
CRLF1,19,18594357,na,na,Pathogenic,Cold-induced sweating syndrome 1,GRCh38,single nucleotide variant
CRLF1,19,18596918,na,na,Pathogenic,Cold-induced sweating syndrome 1,GRCh38,single nucleotide variant
SLC34A2,4,25662818,na,na,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,GRCh38,single nucleotide variant
SLC34A2,4,25664267,na,na,Likely pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,GRCh38,single nucleotide variant
KRIT1,7,92213341,na,na,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,GRCh38,single nucleotide variant
KRIT1,7,92222870,na,na,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation|not provided|KRIT1-related disorder,GRCh38,single nucleotide variant
KRIT1,7,92234806,na,na,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,GRCh38,single nucleotide variant
KRIT1,7,92236488,na,na,Likely pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,GRCh38,single nucleotide variant
KRIT1,7,92235531,na,na,Pathogenic,not provided|Cerebral cavernous malformation 1|Cerebral cavernous malformation,GRCh38,single nucleotide variant
KRIT1,7,92234451,na,na,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,GRCh38,single nucleotide variant
CRB1,1,197434985,na,na,Pathogenic,Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis 8|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder|Retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,GRCh38,single nucleotide variant
CRB1,1,197434846,na,na,Pathogenic,Retinitis pigmentosa 12|not provided,GRCh38,single nucleotide variant
CRB1,1,197427615,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinitis pigmentosa|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Macular dystrophy|Retinal dystrophy|Leber congenital amaurosis 8|CRB1-related maculopathy|Retinitis pigmentosa-deafness syndrome|Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8;Retinitis pigmentosa 12|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder|Cone-rod dystrophy,GRCh38,single nucleotide variant
CRB1,1,197427559,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinal dystrophy|Leber congenital amaurosis 8|Pigmented paravenous retinochoroidal atrophy|Leber congenital amaurosis|Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8;Retinitis pigmentosa 12,GRCh38,single nucleotide variant
CRB1,1,197435162,na,na,Likely pathogenic,Leber congenital amaurosis 8|not provided|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,GRCh38,single nucleotide variant
CRB1,1,197442284,na,na,Pathogenic,Leber congenital amaurosis 8,GRCh38,single nucleotide variant
CRB1,1,197427726,na,na,Pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinitis pigmentosa|Leber congenital amaurosis|Leber congenital amaurosis 8|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder|Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8;Retinitis pigmentosa 12,GRCh38,single nucleotide variant
CRB1,1,197435404,na,na,Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CRB1,1,197328835,na,na,Conflicting classifications of pathogenicity,Pigmented paravenous retinochoroidal atrophy|Retinitis pigmentosa|not specified|Leber congenital amaurosis 8|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12,GRCh38,single nucleotide variant
CRB1,1,197435170,na,na,Pathogenic,Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis|Retinal dystrophy|Pigmented paravenous retinochoroidal atrophy|Early-onset retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,GRCh38,single nucleotide variant
SLC27A4,9,128345497,na,na,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Autosomal recessive congenital ichthyosis,GRCh38,single nucleotide variant
SLC27A4,9,128350311,na,na,Likely pathogenic,Ichthyosis prematurity syndrome,GRCh38,single nucleotide variant
SLC27A4,9,128345267,na,na,Pathogenic,Ichthyosis prematurity syndrome,GRCh38,single nucleotide variant
SLC27A4,9,128350335,na,na,Uncertain significance,Ichthyosis prematurity syndrome|not specified,GRCh38,single nucleotide variant
SLC27A4,9,128352659,na,na,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
SLC27A4,9,128353023,na,na,Pathogenic,Ichthyosis prematurity syndrome,GRCh38,single nucleotide variant
SLC27A4,9,128355770,na,na,Uncertain significance,Ichthyosis prematurity syndrome|not specified,GRCh38,single nucleotide variant
SLC22A4,5,132301616,na,na,risk factor,Rheumatoid arthritis,GRCh38,single nucleotide variant
SLC22A4,5,132340627,na,na,Benign,SLC22A4 POLYMORPHISM|not provided,GRCh38,single nucleotide variant
RPL11,1,23693872,na,na,Pathogenic,Diamond-Blackfan anemia 7|not provided|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
RPL11,1,23693806,na,na,Pathogenic,Diamond-Blackfan anemia 7|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
KISS1R,19,919563,na,na,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,GRCh38,single nucleotide variant
KISS1R,19,920542,na,na,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,GRCh38,single nucleotide variant
KISS1R,19,920746,na,na,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|not provided|KISS1R-related disorder|Hypogonadotropic hypogonadism,GRCh38,single nucleotide variant
KISS1R,19,918604,na,na,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,GRCh38,single nucleotide variant
KISS1R,19,920708,na,na,Conflicting classifications of pathogenicity,Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,GRCh38,single nucleotide variant
SLC6A5,11,20617755,na,na,Pathogenic,Hyperekplexia 3,GRCh38,single nucleotide variant
SLC6A5,11,20628056,na,na,Conflicting classifications of pathogenicity,Hyperekplexia 3,GRCh38,single nucleotide variant
SLC6A5,11,20638477,na,na,Pathogenic,Hyperekplexia 3,GRCh38,single nucleotide variant
SLC6A5,11,20607583,na,na,Pathogenic,Hyperekplexia 3,GRCh38,single nucleotide variant
SLC6A5,11,20630717,na,na,Pathogenic,Hyperekplexia 3,GRCh38,single nucleotide variant
SLC6A5,11,20626721,na,na,Uncertain significance,Hyperekplexia 3,GRCh38,single nucleotide variant
SGCE,7,94628303,na,na,Pathogenic,Myoclonic dystonia 11|not provided|Inborn genetic diseases|SGCE-related disorder,GRCh38,single nucleotide variant
SGCE,7,94628288,na,na,Pathogenic,Myoclonic dystonia 11|not provided|SGCE-related disorder,GRCh38,single nucleotide variant
SGCE,7,94618833,na,na,Pathogenic,Myoclonic dystonia 11,GRCh38,single nucleotide variant
SGCE,7,94598914,na,na,Pathogenic,Myoclonic dystonia 11|not provided,GRCh38,single nucleotide variant
SLC7A9,19,32862557,na,na,Pathogenic,Cystinuria,GRCh38,single nucleotide variant
SLC7A9,19,32864261,na,na,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,GRCh38,single nucleotide variant
SLC7A9,19,32862521,na,na,Conflicting classifications of pathogenicity,Cystinuria|not provided|SLC7A9-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
SLC7A9,19,32862482,na,na,Likely pathogenic,Cystinuria,GRCh38,single nucleotide variant
SLC7A9,19,32859939,na,na,Likely pathogenic,Cystinuria|not provided,GRCh38,single nucleotide variant
SLC7A9,19,32843932,na,na,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,GRCh38,single nucleotide variant
SLC7A9,19,32864733,na,na,Pathogenic,Cystinuria,GRCh38,single nucleotide variant
SLC7A9,19,32859932,na,na,Uncertain significance,Cystinuria|not provided,GRCh38,single nucleotide variant
SLC7A9,19,32862127,na,na,Conflicting classifications of pathogenicity,Cystinuria|not provided,GRCh38,single nucleotide variant
SLC7A9,19,32864206,na,na,Conflicting classifications of pathogenicity,Cystinuria|not provided,GRCh38,single nucleotide variant
TYROBP,19,35908227,na,na,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1,GRCh38,single nucleotide variant
ADAMTS13,9,133424434,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133448718,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133424452,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133426246,na,na,Pathogenic,Upshaw-Schulman syndrome|not provided,GRCh38,single nucleotide variant
ADAMTS13,9,133433478,na,na,Likely pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133454440,na,na,Pathogenic/Likely pathogenic,Upshaw-Schulman syndrome|not provided|Thrombotic thrombocytopenic purpura,GRCh38,single nucleotide variant
ADAMTS13,9,133437895,na,na,Uncertain significance,Upshaw-Schulman syndrome|not provided,GRCh38,single nucleotide variant
ADAMTS13,9,133456138,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133442504,na,na,Pathogenic,Upshaw-Schulman syndrome|not provided,GRCh38,single nucleotide variant
ADAMTS13,9,133437902,na,na,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided,GRCh38,single nucleotide variant
ADAMTS13,9,133436865,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133428750,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133436862,na,na,Benign,not specified|Upshaw-Schulman syndrome|not provided,GRCh38,single nucleotide variant
ADAMTS13,9,133436943,na,na,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided|not specified,GRCh38,single nucleotide variant
ADAMTS13,9,133425613,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133428696,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
ADAMTS13,9,133425528,na,na,Pathogenic,Upshaw-Schulman syndrome,GRCh38,single nucleotide variant
RBBP8,18,22992836,na,na,Uncertain significance,Carcinoma of pancreas|not provided,GRCh38,single nucleotide variant
ADGRG1,16,57656620,na,na,Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,GRCh38,single nucleotide variant
ADGRG1,16,57653985,na,na,Pathogenic,Bilateral frontoparietal polymicrogyria,GRCh38,single nucleotide variant
ADGRG1,16,57651247,na,na,Conflicting classifications of pathogenicity,Bilateral frontoparietal polymicrogyria|Abnormality of the nervous system|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ADGRG1,16,57656244,na,na,Likely pathogenic,Bilateral frontoparietal polymicrogyria,GRCh38,single nucleotide variant
ADGRG1,16,57661707,na,na,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,GRCh38,single nucleotide variant
ADGRG1,16,57651407,na,na,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,GRCh38,single nucleotide variant
ADGRG1,16,57651398,na,na,Pathogenic,Bilateral frontoparietal polymicrogyria,GRCh38,single nucleotide variant
MYOT,5,137870821,na,na,Pathogenic,not provided|Myofibrillar myopathy 3,GRCh38,single nucleotide variant
MYOT,5,137870815,na,na,Pathogenic/Likely pathogenic,Progressive distal muscle weakness;Progressive proximal muscle weakness|not provided|8 conditions|Myofibrillar myopathy 3,GRCh38,single nucleotide variant
MYOT,5,137870830,na,na,Pathogenic,Myofibrillar myopathy 3|not provided|Myofibrillar myopathy,GRCh38,single nucleotide variant
MYOT,5,137870830,na,na,Pathogenic/Likely pathogenic,Myofibrillar myopathy 3|not provided|MYOT-related disorder,GRCh38,single nucleotide variant
MYOT,5,137870935,na,na,Pathogenic,Myofibrillar myopathy 3,GRCh38,single nucleotide variant
MYOT,5,137870767,na,na,Pathogenic/Likely pathogenic,not provided|Myofibrillar myopathy 3,GRCh38,single nucleotide variant
GRM6,5,178986393,na,na,Pathogenic,Congenital stationary night blindness 1B|not provided|Leber congenital amaurosis|Retinal dystrophy,GRCh38,single nucleotide variant
GRM6,5,178983005,na,na,Uncertain significance,Congenital stationary night blindness 1B|not provided,GRCh38,single nucleotide variant
GRM6,5,178986132,na,na,Pathogenic,Congenital stationary night blindness 1B|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
GRM6,5,178994497,na,na,Likely pathogenic,Congenital stationary night blindness 1B|not provided,GRCh38,single nucleotide variant
GRM6,5,178994808,na,na,Likely pathogenic,Congenital stationary night blindness 1B|not provided|Congenital stationary night blindness,GRCh38,single nucleotide variant
GRM6,5,178986689,na,na,Uncertain significance,Congenital stationary night blindness 1B|not provided,GRCh38,single nucleotide variant
GRM6,5,178989075,na,na,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1B|not provided,GRCh38,single nucleotide variant
EDAR,2,108929288,na,na,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108929295,na,na,Uncertain significance,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108897182,na,na,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|not provided|Non-syndromic oligodontia|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108896995,na,na,Pathogenic/Likely pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|not provided|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108930963,na,na,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",GRCh38,single nucleotide variant
EDAR,2,108897130,na,na,Likely pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|not provided",GRCh38,single nucleotide variant
EDAR,2,108929225,na,na,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",GRCh38,single nucleotide variant
EDAR,2,108897194,na,na,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108897145,na,na,Benign,"Hair morphology 1, hair thickness|Hypohidrotic Ectodermal Dysplasia, Dominant|not specified|Hypohidrotic ectodermal dysplasia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|not provided|Non-syndromic oligodontia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",GRCh38,single nucleotide variant
EDAR,2,108910459,na,na,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia",GRCh38,single nucleotide variant
RGS9,17,65197160,na,na,Pathogenic,Bradyopsia|Leber congenital amaurosis|not provided,GRCh38,single nucleotide variant
SEPTIN9,17,77402298,na,na,Pathogenic,Amyotrophic neuralgia|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
SEPTIN9,17,77402314,na,na,Pathogenic,Amyotrophic neuralgia,GRCh38,single nucleotide variant
SEPTIN9,17,77320193,na,na,Pathogenic,Amyotrophic neuralgia,GRCh38,single nucleotide variant
MPDU1,17,7585994,na,na,Conflicting classifications of pathogenicity,MPDU1-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
MPDU1,17,7586745,na,na,Pathogenic,MPDU1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MPDU1,17,7583864,na,na,Pathogenic,MPDU1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MPDU1,17,7585997,na,na,Pathogenic,MPDU1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
RAD50,5,132618182,na,na,Pathogenic,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RAD50,5,132642364,na,na,Conflicting classifications of pathogenicity,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
EIF2AK3,2,88583430,na,na,Pathogenic,Wolcott-Rallison dysplasia|not provided,GRCh38,single nucleotide variant
EIF2AK3,2,88570873,na,na,Likely pathogenic,Wolcott-Rallison dysplasia|not provided,GRCh38,single nucleotide variant
EIF2AK3,2,88590826,na,na,Pathogenic,Wolcott-Rallison dysplasia,GRCh38,single nucleotide variant
AXIN2,17,65536345,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
AXIN2,17,65536495,na,na,Pathogenic,Oligodontia-cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
UNC119,17,28552389,na,na,Uncertain significance,not provided|Cone-rod dystrophy 24,GRCh38,single nucleotide variant
AKAP9,7,92040690,na,na,Conflicting classifications of pathogenicity,Long QT syndrome 11|not provided|Long QT syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
POLH,6,43604646,na,na,Pathogenic,Xeroderma pigmentosum variant type,GRCh38,single nucleotide variant
POLH,6,43587375,na,na,Pathogenic,Xeroderma pigmentosum variant type|not provided,GRCh38,single nucleotide variant
POLH,6,43610596,na,na,Pathogenic,Xeroderma pigmentosum variant type|not provided,GRCh38,single nucleotide variant
POLH,6,43614018,na,na,Benign/Likely benign,Xeroderma pigmentosum variant type|not provided|POLH-related disorder|Xeroderma pigmentosum|not specified,GRCh38,single nucleotide variant
POLH,6,43614181,na,na,Uncertain significance,Xeroderma pigmentosum variant type,GRCh38,single nucleotide variant
SCN4A,17,63957427,na,na,Pathogenic/Likely pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|not provided|6 conditions|Sotos syndrome|Hypokalemic periodic paralysis, type 2|SCN4A-related disorder",GRCh38,single nucleotide variant
SCN4A,17,63941508,na,na,Pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|6 conditions|not provided|7 conditions|Congenital myopathy 22A, classic",GRCh38,single nucleotide variant
SCN4A,17,63941940,na,na,Pathogenic,"Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 1|Hypokalemic periodic paralysis, type 2",GRCh38,single nucleotide variant
SCN4A,17,63941939,na,na,Pathogenic,"Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|Rhabdomyolysis|Delayed gross motor development|SCN4A-related non-dystrophic myotonia|Potassium-aggravated myotonia|SCN4A-related disorder|Congenital myasthenic syndrome 16;Familial hyperkalemic periodic paralysis;Hypokalemic periodic paralysis, type 2;Potassium-aggravated myotonia;Paramyotonia congenita of Von Eulenburg",GRCh38,single nucleotide variant
SCN4A,17,63945614,na,na,Pathogenic/Likely pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Familial hyperkalemic periodic paralysis|not provided|Focal-onset seizure|6 conditions|Inborn genetic diseases|SCN4A-related disorder|Potassium-aggravated myotonia,GRCh38,single nucleotide variant
SCN4A,17,63951866,na,na,Pathogenic/Likely pathogenic,Paramyotonia congenita/myotonia congenita|not provided|Myotonia fluctuans|Familial hyperkalemic periodic paralysis,GRCh38,single nucleotide variant
SCN4A,17,63957515,na,na,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Paramyotonia congenita of Von Eulenburg",GRCh38,single nucleotide variant
SCN4A,17,63943846,na,na,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|SCN4A-related non-dystrophic myotonia|7 conditions|Hypokalemic periodic paralysis, type 2;Paramyotonia congenita of Von Eulenburg;Familial hyperkalemic periodic paralysis;Potassium-aggravated myotonia;Congenital myopathy 22A, classic",GRCh38,single nucleotide variant
SCN4A,17,63943825,na,na,Pathogenic,"Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia|Congenital myasthenic syndrome 16|SCN4A-related disorder|SCN4A-related myopathy, autosomal recessive",GRCh38,single nucleotide variant
SCN4A,17,63941517,na,na,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2",GRCh38,single nucleotide variant
SCN4A,17,63945602,na,na,Pathogenic,"Myotonia congenita, atypical, acetazolamide-responsive|not provided|Familial hyperkalemic periodic paralysis",GRCh38,single nucleotide variant
SCN4A,17,63941984,na,na,Pathogenic,Paramyotonia congenita of Von Eulenburg|SCN4A-related non-dystrophic myotonia,GRCh38,single nucleotide variant
SCN4A,17,63943846,na,na,Pathogenic/Likely pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Familial hyperkalemic periodic paralysis;Hypokalemic periodic paralysis, type 2;Potassium-aggravated myotonia;Paramyotonia congenita of Von Eulenburg|Myotonia fluctuans|Potassium-aggravated myotonia|SCN4A-related channelopathy",GRCh38,single nucleotide variant
SCN4A,17,63944708,na,na,Pathogenic,Paramyotonia congenita of Von Eulenburg|not provided|SCN4A-related disorder|Familial hyperkalemic periodic paralysis,GRCh38,single nucleotide variant
SCN4A,17,63964587,na,na,Pathogenic,Potassium-aggravated myotonia|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia,GRCh38,single nucleotide variant
SCN4A,17,63959278,na,na,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|7 conditions|not provided",GRCh38,single nucleotide variant
SCN4A,17,63959269,na,na,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|Acetazolamide-responsive myotonia|Paramyotonia congenita of Von Eulenburg|6 conditions",GRCh38,single nucleotide variant
SCN4A,17,63959270,na,na,Pathogenic,"Hypokalemic periodic paralysis, type 2|Hypokalemic periodic paralysis, type 1|Familial hyperkalemic periodic paralysis|not provided",GRCh38,single nucleotide variant
SCN4A,17,63941957,na,na,Pathogenic,Congenital myasthenic syndrome 16|Congenital myasthenic syndrome,GRCh38,single nucleotide variant
SCN4A,17,63941915,na,na,Pathogenic,Paramyotonia congenita of Von Eulenburg,GRCh38,single nucleotide variant
SCN4A,17,63959270,na,na,Pathogenic/Likely pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|Hypokalemic periodic paralysis",GRCh38,single nucleotide variant
SCN4A,17,63945608,na,na,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
SCN4A,17,63957515,na,na,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|Abnormality of the musculature|not provided",GRCh38,single nucleotide variant
SCN4A,17,63957514,na,na,Pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Myopathy|Hypokalemic periodic paralysis, type 2|Congenital myasthenic syndrome 16|7 conditions",GRCh38,single nucleotide variant
SCN4A,17,63943846,na,na,Pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Myotonia permanens|Paramyotonia congenita of Von Eulenburg|Potassium-aggravated myotonia|6 conditions|SCN4A-related myopathy, autosomal recessive",GRCh38,single nucleotide variant
SCN4A,17,63941854,na,na,Pathogenic/Likely pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|Acetazolamide-responsive myotonia,GRCh38,single nucleotide variant
SCN4A,17,63944694,na,na,Pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Paramyotonia congenita of Von Eulenburg,GRCh38,single nucleotide variant
SCN4A,17,63957460,na,na,Pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|SCN4A-related non-dystrophic myotonia,GRCh38,single nucleotide variant
SCN4A,17,63972197,na,na,Pathogenic,Paramyotonia congenita of Von Eulenburg,GRCh38,single nucleotide variant
CLDN16,3,190404779,na,na,Pathogenic,Primary hypomagnesemia|not provided,GRCh38,single nucleotide variant
CLDN16,3,190408436,na,na,Pathogenic,Primary hypomagnesemia|not provided,GRCh38,single nucleotide variant
CLDN16,3,190404905,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190408314,na,na,Likely pathogenic,Primary hypomagnesemia|not provided,GRCh38,single nucleotide variant
CLDN16,3,190388331,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190404834,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190408416,na,na,Uncertain significance,Primary hypomagnesemia|Nephrolithiasis;Nephrocalcinosis,GRCh38,single nucleotide variant
CLDN16,3,190408419,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190408425,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190404787,na,na,Pathogenic,Primary hypomagnesemia|not provided,GRCh38,single nucleotide variant
CLDN16,3,190404786,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190404768,na,na,Pathogenic,Primary hypomagnesemia|not provided,GRCh38,single nucleotide variant
CLDN16,3,190402362,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190408384,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
CLDN16,3,190410026,na,na,Pathogenic,"HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING",GRCh38,single nucleotide variant
CLDN16,3,190409949,na,na,Pathogenic,Primary hypomagnesemia,GRCh38,single nucleotide variant
KCNMB1,5,170383792,na,na,Benign; protective,"HYPERTENSION, DIASTOLIC, RESISTANCE TO|KCNMB1-related disorder",GRCh38,single nucleotide variant
EIF2B5,3,184136687,na,na,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184144111,na,na,Pathogenic,Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184141925,na,na,Likely pathogenic,Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184137637,na,na,Pathogenic,Vanishing white matter disease|not provided|See cases|Leukoencephalopathy with vanishing white matter 5|Inborn genetic diseases|EIF2B5-related disorder,GRCh38,single nucleotide variant
EIF2B5,3,184137975,na,na,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184140499,na,na,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184137974,na,na,Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184137936,na,na,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5|Vanishing white matter disease,GRCh38,single nucleotide variant
EIF2B5,3,184140518,na,na,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184135551,na,na,Conflicting classifications of pathogenicity,not provided|not specified|Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
EIF2B5,3,184135552,na,na,Pathogenic,Leukoencephalopathy with vanishing white matter 5,GRCh38,single nucleotide variant
GYG1,3,148996406,na,na,Uncertain significance,Glycogen storage disease XV|not provided,GRCh38,single nucleotide variant
SLC19A2,1,169477478,na,na,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",GRCh38,single nucleotide variant
SLC19A2,1,169477447,na,na,Pathogenic/Likely pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",GRCh38,single nucleotide variant
SLC19A2,1,169477212,na,na,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",GRCh38,single nucleotide variant
SLC19A2,1,169468793,na,na,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",GRCh38,single nucleotide variant
SLC19A2,1,169485615,na,na,Uncertain significance,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",GRCh38,single nucleotide variant
RP1,8,54625911,na,na,Pathogenic,Retinitis pigmentosa 1|not provided|Retinal dystrophy|RP1-related disorder,GRCh38,single nucleotide variant
RP1,8,54625917,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 1|not provided,GRCh38,single nucleotide variant
RP1,8,54626835,na,na,Benign/Likely benign,not specified|Retinitis pigmentosa|Hypertriglyceridemia 1|not provided|Retinitis pigmentosa 1|Retinal dystrophy,GRCh38,single nucleotide variant
RP1,8,54625000,na,na,Benign/Likely benign,Retinitis pigmentosa 1|not specified|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
GPHN,14,66508555,na,na,Uncertain significance,Hyperekplexia|Hyperekplexia 1|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|Hyperekplexia 1;Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
HABP2,10,113588287,na,na,Conflicting classifications of pathogenicity,"Venous thromboembolism, susceptibility to|FACTOR VII-ACTIVATING PROTEASE MARBURG I POLYMORPHISM|THYROID CANCER, NONMEDULLARY, 5, SUSCEPTIBILITY TO|Factor VII Marburg I Variant Thrombophilia|not provided|Thyroid cancer, nonmedullary, 5",GRCh38,single nucleotide variant
SUCLA2,13,47988540,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",GRCh38,single nucleotide variant
SUCLA2,13,47988901,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",GRCh38,single nucleotide variant
SUCLA2,13,47954510,na,na,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria|not provided",GRCh38,single nucleotide variant
ITM2B,13,48261222,na,na,Pathogenic,ABri amyloidosis,GRCh38,single nucleotide variant
BAG3,10,119672373,na,na,Pathogenic,Myofibrillar myopathy 6|not provided|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Peripheral neuropathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
RAB27A,15,55230423,na,na,Pathogenic,Griscelli syndrome type 2,GRCh38,single nucleotide variant
RAB27A,15,55230398,na,na,Likely pathogenic,Griscelli syndrome type 2,GRCh38,single nucleotide variant
RAB27A,15,55223967,na,na,Pathogenic,Griscelli syndrome type 2,GRCh38,single nucleotide variant
RAB27A,15,55223902,na,na,Pathogenic,Griscelli syndrome type 2,GRCh38,single nucleotide variant
RAB27A,15,55224004,na,na,Pathogenic,Griscelli syndrome type 2|See cases|Multisystem inflammatory syndrome in children,GRCh38,single nucleotide variant
RAB27A,15,55228693,na,na,Conflicting classifications of pathogenicity,Griscelli syndrome type 2|not specified|not provided,GRCh38,single nucleotide variant
SLC25A15,13,40807379,na,na,Conflicting classifications of pathogenicity,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|not provided,GRCh38,single nucleotide variant
SLC25A15,13,40807376,na,na,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|SLC25A15-related disorder,GRCh38,single nucleotide variant
SLC25A15,13,40799080,na,na,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A15,13,40809585,na,na,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A15,13,40799111,na,na,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A15,13,40799213,na,na,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A15,13,40809576,na,na,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A15,13,40799096,na,na,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,GRCh38,single nucleotide variant
SLC25A13,7,96184276,na,na,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency|SLC25A13-related disorder|Late-onset citrullinemia|CITRIN DEFICIENCY, NEONATAL ONSET",GRCh38,single nucleotide variant
SLC25A13,7,96191189,na,na,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency",GRCh38,single nucleotide variant
SLC25A13,7,96170044,na,na,Pathogenic,"Citrullinemia type II|Citrin deficiency|Late-onset citrullinemia|Citrullinemia, type II, adult-onset|not provided|Neonatal intrahepatic cholestasis due to citrin deficiency",GRCh38,single nucleotide variant
SLC25A13,7,96121733,na,na,Conflicting classifications of pathogenicity,Citrullinemia type II|not provided|Citrullinemia|Neonatal intrahepatic cholestasis due to citrin deficiency|Inborn genetic diseases|Citrin deficiency,GRCh38,single nucleotide variant
PHOX2B,4,41747479,na,na,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Haddad syndrome",GRCh38,single nucleotide variant
PHOX2B,4,41747357,na,na,Pathogenic,Hirschsprung disease-ganglioneuroblastoma syndrome,GRCh38,single nucleotide variant
PHOX2B,4,41746162,na,na,Uncertain significance,"Neuroblastoma, susceptibility to, 2|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
DNM1L,12,32731118,na,na,Pathogenic,"Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1",GRCh38,single nucleotide variant
NDUFS6,5,1802376,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",GRCh38,single nucleotide variant
NDUFS6,5,1815885,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",GRCh38,single nucleotide variant
NDUFS3,11,47582140,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|Neurodevelopmental delay",GRCh38,single nucleotide variant
NDUFS3,11,47582436,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|not provided",GRCh38,single nucleotide variant
GNE,9,36234106,na,na,Pathogenic,Sialuria|Inborn genetic diseases,GRCh38,single nucleotide variant
GNE,9,36234105,na,na,Pathogenic,Sialuria|Sialuria;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36234114,na,na,Likely pathogenic,Sialuria,GRCh38,single nucleotide variant
GNE,9,36217399,na,na,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|GNE-related disorder|Sialuria|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36219927,na,na,Conflicting classifications of pathogenicity,GNE myopathy|Sialuria;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36218225,na,na,Pathogenic/Likely pathogenic,GNE myopathy|Sialuria;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36217448,na,na,Conflicting classifications of pathogenicity,GNE myopathy|not provided|GNE myopathy;Sialuria|Thrombocytopenia 12 with or without myopathy;GNE myopathy;Sialuria|GNE-related disorder|Sialuria,GRCh38,single nucleotide variant
GNE,9,36233993,na,na,Pathogenic,GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36236864,na,na,Pathogenic/Likely pathogenic,"GNE myopathy|not provided|Myopathy, autophagic vacuolar, infantile-onset|Sialuria;GNE myopathy|Sialuria;Thrombocytopenia 12 with or without myopathy;GNE myopathy",GRCh38,single nucleotide variant
GNE,9,36236928,na,na,Conflicting classifications of pathogenicity,GNE myopathy|not provided|GNE myopathy;Sialuria,GRCh38,single nucleotide variant
GNE,9,36223405,na,na,Uncertain significance,GNE myopathy|not provided,GRCh38,single nucleotide variant
GNE,9,36219940,na,na,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36218224,na,na,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|Thrombocytopenia 12 with or without myopathy|Hereditary nonpolyposis colon cancer|Sialuria;Thrombocytopenia 12 with or without myopathy;GNE myopathy,GRCh38,single nucleotide variant
GNE,9,36246136,na,na,Pathogenic,GNE myopathy,GRCh38,single nucleotide variant
TGM5,15,43260151,na,na,Pathogenic,Acral peeling skin syndrome|not provided|Inborn genetic diseases|TGM5-related disorder,GRCh38,single nucleotide variant
CHST3,10,72007942,na,na,Conflicting classifications of pathogenicity,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007807,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72008145,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007695,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007951,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007634,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007888,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007453,na,na,Uncertain significance,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72007506,na,na,Pathogenic/Likely pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations|not provided,GRCh38,single nucleotide variant
CHST3,10,72007512,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
CHST3,10,72008019,na,na,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,GRCh38,single nucleotide variant
KCNE2,21,34370503,na,na,Benign/Likely benign,"Long QT syndrome 6, acquired, susceptibility to|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|Long QT syndrome 6|not specified",GRCh38,single nucleotide variant
KCNE2,21,34370639,na,na,Conflicting classifications of pathogenicity; risk factor,Long QT syndrome 6|not provided|KCNE2-related disorder|Congenital long QT syndrome|Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype|not specified,GRCh38,single nucleotide variant
KCNE2,21,34370648,na,na,Conflicting classifications of pathogenicity,"Long QT syndrome 6|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|KCNE2-related disorder|Cardiac arrhythmia",GRCh38,single nucleotide variant
KCNE2,21,34370557,na,na,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 4|Long QT syndrome;Primary familial hypertrophic cardiomyopathy|Atrial fibrillation|Atrial fibrillation, familial, 4;Long QT syndrome 6|not provided|Long QT syndrome 6|Cardiovascular phenotype",GRCh38,single nucleotide variant
KCNE2,21,34370656,na,na,Pathogenic,"Long QT syndrome 3/6, digenic|Congenital long QT syndrome",GRCh38,single nucleotide variant
LITAF,16,11553576,na,na,Pathogenic,Charcot-Marie-Tooth disease type 1C|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
LITAF,16,11553566,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 1C|not provided,GRCh38,single nucleotide variant
LITAF,16,11553564,na,na,Pathogenic,Charcot-Marie-Tooth disease type 1C,GRCh38,single nucleotide variant
LITAF,16,11553546,na,na,Pathogenic,Charcot-Marie-Tooth disease type 1C,GRCh38,single nucleotide variant
LITAF,16,11549693,na,na,Uncertain significance,Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
RECQL4,8,144513412,na,na,Pathogenic,Rothmund-Thomson syndrome|Baller-Gerold syndrome|Rothmund-Thomson syndrome type 2|Inborn genetic diseases|not provided|Rothmund-Thomson syndrome;Baller-Gerold syndrome;Rapadilino syndrome|Hereditary cancer-predisposing syndrome|RECQL4-related disorder|Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;Rapadilino syndrome,GRCh38,single nucleotide variant
RECQL4,8,144513713,na,na,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,GRCh38,single nucleotide variant
RECQL4,8,144515243,na,na,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|not provided,GRCh38,single nucleotide variant
RECQL4,8,144513713,na,na,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,GRCh38,single nucleotide variant
RECQL4,8,144516313,na,na,Pathogenic,Rapadilino syndrome|Baller-Gerold syndrome,GRCh38,single nucleotide variant
RECQL4,8,144512319,na,na,Pathogenic,Baller-Gerold syndrome|RECQL4-related disorder|Rothmund-Thomson syndrome type 2,GRCh38,single nucleotide variant
RECQL4,8,144512326,na,na,Pathogenic/Likely pathogenic,Baller-Gerold syndrome|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
RECQL4,8,144514441,na,na,Pathogenic/Likely pathogenic,Rothmund-Thomson syndrome type 2|not provided|Baller-Gerold syndrome,GRCh38,single nucleotide variant
SNCAIP,5,122450708,na,na,Likely benign,"Parkinson disease, late-onset|Parkinson Disease, Dominant/Recessive|not provided",GRCh38,single nucleotide variant
KLK4,19,50908596,na,na,Likely pathogenic,Amelogenesis imperfecta type 2A1|not provided,GRCh38,single nucleotide variant
APOL1,22,36265860,na,na,Conflicting classifications of pathogenicity; risk factor,"Hyalinosis, Segmental Glomerular|Proteinuria|Focal segmental glomerulosclerosis|Sickled erythrocytes;Focal segmental glomerulosclerosis|Nephrotic range proteinuria|Focal segmental glomerulosclerosis;Steroid-resistant nephrotic syndrome|Glomerulonephritis|not specified|APOL1-associated kidney disease|not provided|Focal segmental glomerulosclerosis 4, susceptibility to",GRCh38,single nucleotide variant
ALOX12B,17,8076742,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 2,GRCh38,single nucleotide variant
ALOX12B,17,8073678,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 2,GRCh38,single nucleotide variant
ELP1,9,108899816,na,na,Pathogenic,Familial dysautonomia|not provided|Charcot-Marie-Tooth disease|Medulloblastoma|not specified|Medulloblastoma;Familial dysautonomia|Primary dysautonomia,GRCh38,single nucleotide variant
ELP1,9,108900303,na,na,Pathogenic/Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease|Medulloblastoma;Familial dysautonomia|not provided,GRCh38,single nucleotide variant
ELP1,9,108894062,na,na,Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
GCM2,6,10877343,na,na,Pathogenic,"Hypoparathyroidism, familial isolated, 2|not provided",GRCh38,single nucleotide variant
GCM2,6,10877296,na,na,Conflicting classifications of pathogenicity,"Hypoparathyroidism, familial isolated, 2|Hypoparathyroidism, familial isolated, 2;Hyperparathyroidism 4|Hyperparathyroidism 4",GRCh38,single nucleotide variant
SIX3,2,44942780,na,na,Pathogenic,Holoprosencephaly 2,GRCh38,single nucleotide variant
SIX3,2,44942874,na,na,Likely pathogenic,Holoprosencephaly 2,GRCh38,single nucleotide variant
SIX3,2,44942853,na,na,Pathogenic,Holoprosencephaly 2,GRCh38,single nucleotide variant
SIX3,2,44942310,na,na,Uncertain significance,Holoprosencephaly 2|Holoprosencephaly 2;Schizencephaly,GRCh38,single nucleotide variant
SIX3,2,44942443,na,na,Pathogenic,Holoprosencephaly 2|not specified,GRCh38,single nucleotide variant
CYP7B1,8,64604753,na,na,Pathogenic,Congenital bile acid synthesis defect 3|Hereditary spastic paraplegia 5A|Spastic paraplegia,GRCh38,single nucleotide variant
CYP7B1,8,64604827,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Hereditary spastic paraplegia|Spastic paraplegia,GRCh38,single nucleotide variant
CYP7B1,8,64624493,na,na,Pathogenic,Hereditary spastic paraplegia 5A,GRCh38,single nucleotide variant
CYP7B1,8,64596913,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|not provided|Spastic paraplegia|Hereditary spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3|CYP7B1-related disorder,GRCh38,single nucleotide variant
CYP7B1,8,64615894,na,na,Pathogenic,Hereditary spastic paraplegia 5A,GRCh38,single nucleotide variant
CYP7B1,8,64615716,na,na,Pathogenic,Hereditary spastic paraplegia 5A|not provided|Hereditary spastic paraplegia|Spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3,GRCh38,single nucleotide variant
CYP7B1,8,64596755,na,na,Pathogenic,Hereditary spastic paraplegia 5A,GRCh38,single nucleotide variant
CYP7B1,8,64596707,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Congenital bile acid synthesis defect 3;Hereditary spastic paraplegia 5A|CYP7B1-related disorder|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
MOCS2,5,53098667,na,na,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,GRCh38,single nucleotide variant
MOCS2,5,53107172,na,na,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,GRCh38,single nucleotide variant
MOCS2,5,53109714,na,na,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided,GRCh38,single nucleotide variant
MOCS2,5,53108643,na,na,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,GRCh38,single nucleotide variant
MOCS2,5,53098602,na,na,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided,GRCh38,single nucleotide variant
MOCS1,6,39912289,na,na,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|MOCS1-related disorder,GRCh38,single nucleotide variant
MOCS1,6,39925677,na,na,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided|MOCS1-related disorder,GRCh38,single nucleotide variant
MOCS1,6,39927362,na,na,Conflicting classifications of pathogenicity,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|Inborn genetic diseases,GRCh38,single nucleotide variant
RPS26,12,56042167,na,na,Pathogenic,Diamond-Blackfan anemia 10|Diamond-Blackfan anemia|not provided,GRCh38,single nucleotide variant
RPS26,12,56042167,na,na,Pathogenic,Diamond-Blackfan anemia 10|not provided,GRCh38,single nucleotide variant
RPS26,12,56042518,na,na,Pathogenic,Diamond-Blackfan anemia 10,GRCh38,single nucleotide variant
RPS26,12,56042170,na,na,Pathogenic,Diamond-Blackfan anemia 10,GRCh38,single nucleotide variant
ZFPM2,8,105802051,na,na,Benign/Likely benign,"Tetralogy of Fallot|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|not provided",GRCh38,single nucleotide variant
ZFPM2,8,105419192,na,na,Benign/Likely benign,"Tetralogy of Fallot|Double outlet right ventricle|Diaphragmatic hernia 3|46,XY sex reversal 9|46,XY sex reversal 3|not provided|not specified|ZFPM2-related disorder",GRCh38,single nucleotide variant
ZFPM2,8,105561395,na,na,Pathogenic/Likely pathogenic,Diaphragmatic hernia 3|not provided,GRCh38,single nucleotide variant
ZFPM2,8,105802189,na,na,Conflicting classifications of pathogenicity,"Diaphragmatic hernia 3|Double outlet right ventricle|46,XY sex reversal 3|not provided|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|ZFPM2-related disorder",GRCh38,single nucleotide variant
ZFPM2,8,105802609,na,na,Pathogenic,Diaphragmatic hernia 3,GRCh38,single nucleotide variant
SLC33A1,3,155853659,na,na,Pathogenic,Hereditary spastic paraplegia 42,GRCh38,single nucleotide variant
OTOF,2,26466723,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
OTOF,2,26495075,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|not provided,GRCh38,single nucleotide variant
OTOF,2,26476127,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,GRCh38,single nucleotide variant
OTOF,2,26460203,na,na,Pathogenic/Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|not provided",GRCh38,single nucleotide variant
OTOF,2,26477210,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|not provided|Nonsyndromic genetic hearing loss|OTOF-related disorder,GRCh38,single nucleotide variant
OTOF,2,26461756,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,GRCh38,single nucleotide variant
OTOF,2,26464868,na,na,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",GRCh38,single nucleotide variant
OTOF,2,26458074,na,na,Pathogenic,"Auditory neuropathy, autosomal recessive, 1",GRCh38,single nucleotide variant
OTOF,2,26475453,na,na,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",GRCh38,single nucleotide variant
OTOF,2,26482441,na,na,Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|not provided",GRCh38,single nucleotide variant
PTCH2,1,44823064,na,na,Pathogenic,"Basal cell carcinoma, somatic",GRCh38,single nucleotide variant
PTCH2,1,44827617,na,na,Uncertain significance,Gorlin syndrome|Basal cell nevus syndrome 1,GRCh38,single nucleotide variant
SLC25A12,2,171787637,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 39",GRCh38,single nucleotide variant
RPS7,2,3575889,na,na,Pathogenic,Diamond-Blackfan anemia 8,GRCh38,single nucleotide variant
TRPC6,11,101504634,na,na,Pathogenic,Focal segmental glomerulosclerosis 2,GRCh38,single nucleotide variant
TRPC6,11,101504541,na,na,Uncertain significance,Focal segmental glomerulosclerosis 2|not provided,GRCh38,single nucleotide variant
TRPC6,11,101504161,na,na,Pathogenic,Focal segmental glomerulosclerosis 2,GRCh38,single nucleotide variant
TRPC6,11,101453674,na,na,Pathogenic,Focal segmental glomerulosclerosis 2|not provided,GRCh38,single nucleotide variant
TRPC6,11,101453068,na,na,Pathogenic,Focal segmental glomerulosclerosis 2|Nephrotic syndrome|not provided|TRPC6-related disorder,GRCh38,single nucleotide variant
TRPC6,11,101453062,na,na,Likely pathogenic,Focal segmental glomerulosclerosis 2|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
BBS5,2,169493012,na,na,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
BBS5,2,169492912,na,na,Pathogenic,Bardet-Biedl syndrome 5,GRCh38,single nucleotide variant
BBS5,2,169487103,na,na,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
BBS5,2,169487811,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
BBS5,2,169493765,na,na,Pathogenic,Bardet-Biedl syndrome 5,GRCh38,single nucleotide variant
BCS1L,2,218662620,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,GRCh38,single nucleotide variant
BCS1L,2,218661283,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|not provided|Pili torti-deafness syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661762,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,GRCh38,single nucleotide variant
BCS1L,2,218663183,na,na,Conflicting classifications of pathogenicity,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661219,na,na,Pathogenic,GRACILE syndrome|not provided|Mitochondrial complex III deficiency nuclear type 1|BCS1L-related disorder|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome|Pili torti-deafness syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661120,na,na,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661153,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|GRACILE syndrome|BCS1L-related disorder|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;Leigh syndrome;GRACILE syndrome|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661846,na,na,Pathogenic,Pili torti-deafness syndrome|GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome|not provided|Leigh syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661848,na,na,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|Bjornstad syndrome with mild mitochondrial complex III deficiency|GRACILE syndrome|not provided|BCS1L-related disorder|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,GRCh38,single nucleotide variant
BCS1L,2,218661090,na,na,Pathogenic,Bjornstad syndrome with mild mitochondrial complex III deficiency,GRCh38,single nucleotide variant
BCS1L,2,218661135,na,na,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,GRCh38,single nucleotide variant
BCS1L,2,218661845,na,na,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|GRACILE syndrome|Pili torti-deafness syndrome|GRACILE syndrome;Pili torti-deafness syndrome;Mitochondrial complex III deficiency nuclear type 1,GRCh38,single nucleotide variant
COX15,10,99724057,na,na,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2|Inborn genetic diseases|not provided",GRCh38,single nucleotide variant
SCO1,17,10692805,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 4|not provided",GRCh38,single nucleotide variant
RPL5,1,92833452,na,na,Pathogenic,Diamond-Blackfan anemia 6|not provided|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
DIPK1A;RPL5,1,92836283,na,na,Conflicting classifications of pathogenicity,Diamond-Blackfan anemia 6|not specified|Diamond-Blackfan anemia|not provided,GRCh38,single nucleotide variant
RPL5,1,92833460,na,na,Pathogenic,Diamond-Blackfan anemia 6,GRCh38,single nucleotide variant
RPS10,6,34425219,na,na,Pathogenic,Diamond-Blackfan anemia 9,GRCh38,single nucleotide variant
RPS10,6,34421793,na,na,Pathogenic,Diamond-Blackfan anemia 9|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
YARS1,1,32810994,na,na,Pathogenic,Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
YARS1,1,32797768,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease|Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2",GRCh38,single nucleotide variant
RAD54L,1,46250097,na,na,Pathogenic,Colon adenocarcinoma,GRCh38,single nucleotide variant
RAD54L,1,46272758,na,na,Pathogenic,Non-Hodgkin lymphoma,GRCh38,single nucleotide variant
RAD54L,1,46267540,na,na,Pathogenic,Breast ductal adenocarcinoma,GRCh38,single nucleotide variant
PLA2G6,22,38112212,na,na,Pathogenic/Likely pathogenic,Infantile neuroaxonal dystrophy|not provided|Iron accumulation in brain|Autism;Seizure|Inborn genetic diseases|PLA2G6-associated neurodegeneration|Abnormality of the nervous system|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation|PLA2G6-related disorder,GRCh38,single nucleotide variant
PLA2G6,22,38120867,na,na,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Cerebellar ataxia;Congenital cerebellar hypoplasia;Global developmental delay;Developmental regression;Microcephaly|not provided|Autosomal recessive Parkinson disease 14,GRCh38,single nucleotide variant
PLA2G6,22,38132979,na,na,Conflicting classifications of pathogenicity,Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration,GRCh38,single nucleotide variant
PLA2G6,22,38115667,na,na,Pathogenic/Likely pathogenic,Karak syndrome|not provided|Neurodegeneration with brain iron accumulation|Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B,GRCh38,single nucleotide variant
PLA2G6,22,38145625,na,na,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|PLA2G6-associated neurodegeneration|not provided,GRCh38,single nucleotide variant
PLA2G6,22,38112558,na,na,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|Neurodegeneration with brain iron accumulation|Infantile neuroaxonal dystrophy|not provided,GRCh38,single nucleotide variant
PLA2G6,22,38112541,na,na,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|not provided|PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy,GRCh38,single nucleotide variant
SLC7A7,14,22813398,na,na,Pathogenic,Lysinuric protein intolerance,GRCh38,single nucleotide variant
SLC7A7,14,22775538,na,na,Pathogenic,Lysinuric protein intolerance,GRCh38,single nucleotide variant
SLC7A7,14,22813238,na,na,Uncertain significance,Lysinuric protein intolerance,GRCh38,single nucleotide variant
SLC7A7,14,22774371,na,na,Pathogenic/Likely pathogenic,Lysinuric protein intolerance,GRCh38,single nucleotide variant
SLC7A7,14,22778837,na,na,Pathogenic,Lysinuric protein intolerance|Autoinflammatory syndrome|not provided,GRCh38,single nucleotide variant
LARGE1,22,33304434,na,na,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B6|LARGE1-Related Disorders,GRCh38,single nucleotide variant
LARGE1,22,33304476,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",GRCh38,single nucleotide variant
LARGE1,22,33384205,na,na,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",GRCh38,single nucleotide variant
TRPM1,15,31041949,na,na,Pathogenic,Congenital stationary night blindness 1C,GRCh38,single nucleotide variant
TRPM1,15,31028454,na,na,Pathogenic,Congenital stationary night blindness 1C|not provided,GRCh38,single nucleotide variant
TRPM1,15,31070213,na,na,Pathogenic,Congenital stationary night blindness 1C,GRCh38,single nucleotide variant
TRPM1,15,31068010,na,na,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1C|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
TRPM1,15,31042140,na,na,Uncertain significance,Congenital stationary night blindness 1C|Retinal dystrophy,GRCh38,single nucleotide variant
VNN1,6,132714186,na,na,Benign,RECLASSIFIED - VNN1 POLYMORPHISM,GRCh38,single nucleotide variant
MTMR2,11,95845063,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4B1|Charcot-Marie-Tooth disease type 4,GRCh38,single nucleotide variant
MTMR2,11,95849841,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4B1,GRCh38,single nucleotide variant
MTMR2,11,95841652,na,na,Pathogenic,Charcot-Marie-Tooth disease type 4B1,GRCh38,single nucleotide variant
EYA4,6,133512709,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 10,GRCh38,single nucleotide variant
KCNQ4,1,40819893,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Nonsyndromic genetic hearing loss|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
KCNQ4,1,40819465,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
KCNQ4,1,40820180,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
KCNQ4,1,40819893,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,GRCh38,single nucleotide variant
KCNQ4,1,40819882,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,GRCh38,single nucleotide variant
KCNQ4,1,40819459,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,GRCh38,single nucleotide variant
KCNQ4,1,40819926,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,GRCh38,single nucleotide variant
BCL10,1,85270792,na,na,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC",GRCh38,single nucleotide variant
BCL10,1,85270792,na,na,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC|Immunodeficiency 37",GRCh38,single nucleotide variant
LRP6,12,12164494,na,na,Pathogenic,"Coronary artery disease, autosomal dominant 2|LRP6-related disorder",GRCh38,single nucleotide variant
LRP5,11,68312743,na,na,Pathogenic,Osteoporosis with pseudoglioma,GRCh38,single nucleotide variant
LRP5,11,68386582,na,na,Pathogenic,Osteoporosis with pseudoglioma|not provided|8 conditions|LRP5-related disorder,GRCh38,single nucleotide variant
LRP5,11,68413742,na,na,Pathogenic,Osteoporosis with pseudoglioma,GRCh38,single nucleotide variant
LRP5,11,68389949,na,na,Pathogenic/Likely pathogenic,Osteoporosis with pseudoglioma|not provided|6 conditions|LRP5-related disorder|Exudative vitreoretinopathy 1,GRCh38,single nucleotide variant
LRP5,11,68403606,na,na,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|Osteogenesis imperfecta,GRCh38,single nucleotide variant
LRP5,11,68406721,na,na,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|not specified|Increased bone mineral density|8 conditions|Osteogenesis imperfecta|Retinal dystrophy|6 conditions,GRCh38,single nucleotide variant
LRP5,11,68389921,na,na,Pathogenic,Osteoporosis with pseudoglioma,GRCh38,single nucleotide variant
LRP5,11,68410024,na,na,Pathogenic,Osteoporosis with pseudoglioma,GRCh38,single nucleotide variant
LRP5,11,68357673,na,na,Pathogenic/Likely pathogenic,High bone mass|Increased bone mineral density|not provided,GRCh38,single nucleotide variant
LRP5,11,68357672,na,na,Pathogenic,Autosomal dominant osteopetrosis 1,GRCh38,single nucleotide variant
LRP5,11,68363784,na,na,Pathogenic/Likely pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided|LRP5-related disorder,GRCh38,single nucleotide variant
LRP5,11,68357801,na,na,Pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided,GRCh38,single nucleotide variant
LRP5,11,68357802,na,na,Pathogenic,Worth disease,GRCh38,single nucleotide variant
LRP5,11,68363818,na,na,Pathogenic,Autosomal dominant osteopetrosis 1,GRCh38,single nucleotide variant
LRP5,11,68439918,na,na,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Inborn genetic diseases|not provided|Familial exudative vitreoretinopathy|Retinal dystrophy|Osteoporosis with pseudoglioma|Exudative vitreoretinopathy 4",GRCh38,single nucleotide variant
LRP5,11,68403607,na,na,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Inborn genetic diseases|Retinal dystrophy|not provided",GRCh38,single nucleotide variant
LRP5,11,68410076,na,na,Pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|not provided",GRCh38,single nucleotide variant
LRP5,11,68436987,na,na,Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Retinal dystrophy",GRCh38,single nucleotide variant
LRP5,11,68348188,na,na,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Osteoporosis with pseudoglioma",GRCh38,single nucleotide variant
LRP5,11,68386630,na,na,Pathogenic,"Exudative vitreoretinopathy 4, digenic|not provided|LRP5-related disorder",GRCh38,single nucleotide variant
LRP5,11,68406550,na,na,Conflicting classifications of pathogenicity,"Exudative vitreoretinopathy 4, autosomal recessive|not provided|Retinal dystrophy",GRCh38,single nucleotide variant
DPM1,20,50948650,na,na,Pathogenic,Congenital disorder of glycosylation type 1E|not provided|DPM1-related disorder,GRCh38,single nucleotide variant
TNFRSF11A,18,62358328,na,na,Pathogenic,Autosomal recessive osteopetrosis 7,GRCh38,single nucleotide variant
TNFRSF11A,18,62359956,na,na,Pathogenic,Autosomal recessive osteopetrosis 7,GRCh38,single nucleotide variant
TNFRSF11A,18,62354492,na,na,Uncertain significance,Autosomal recessive osteopetrosis 7|not provided,GRCh38,single nucleotide variant
TNFRSF11A,18,62361793,na,na,Pathogenic,Autosomal recessive osteopetrosis 7,GRCh38,single nucleotide variant
TNFRSF11A,18,62348249,na,na,Pathogenic,Autosomal recessive osteopetrosis 7,GRCh38,single nucleotide variant
AURKC,19,57234985,na,na,Pathogenic,Infertility associated with multi-tailed spermatozoa and excessive DNA,GRCh38,single nucleotide variant
WNT4,1,22120459,na,na,Pathogenic,Mullerian aplasia and hyperandrogenism,GRCh38,single nucleotide variant
WNT4,1,22121549,na,na,Pathogenic,SERKAL syndrome,GRCh38,single nucleotide variant
WNT4,1,22129682,na,na,Pathogenic,Mullerian aplasia and hyperandrogenism,GRCh38,single nucleotide variant
WNT4,1,22142888,na,na,Pathogenic,Mullerian aplasia and hyperandrogenism,GRCh38,single nucleotide variant
CILP,15,65201874,na,na,Benign; risk factor,"Lumbar disc disease, susceptibility to|CILP-related disorder",GRCh38,single nucleotide variant
RPS19,19,41869138,na,na,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
RPS19,19,41869042,na,na,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder,GRCh38,single nucleotide variant
RPS19,19,41861138,na,na,Pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
RPS19,19,41869108,na,na,Pathogenic,Diamond-Blackfan anemia 1,GRCh38,single nucleotide variant
RPS19,19,41860817,na,na,Pathogenic,not provided,GRCh38,single nucleotide variant
RPS19,19,41869722,na,na,Likely pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
ASS1,9,130452268,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130466774,na,na,Conflicting classifications of pathogenicity,Citrullinemia type I|not provided|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130470877,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130489464,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia|ASS1-related disorder,GRCh38,single nucleotide variant
ASS1,9,130494983,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130499545,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia|Inborn genetic diseases,GRCh38,single nucleotide variant
ASS1,9,130489404,na,na,Pathogenic,Citrullinemia type I|Citrullinemia|not provided,GRCh38,single nucleotide variant
ASS1,9,130452281,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia|ASS1-related disorder,GRCh38,single nucleotide variant
ASS1,9,130458482,na,na,Pathogenic,Citrullinemia type I|Citrullinemia|not provided,GRCh38,single nucleotide variant
ASS1,9,130480446,na,na,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130458549,na,na,Conflicting classifications of pathogenicity,Citrullinemia type I|not specified|not provided|Citrullinemia,GRCh38,single nucleotide variant
ASS1,9,130470873,na,na,Pathogenic,"Citrullinemia, mild|not provided|Citrullinemia type I|Citrullinemia|ASS1-related disorder",GRCh38,single nucleotide variant
ASS1,9,130494981,na,na,Pathogenic,"Citrullinemia, mild|Citrullinemia type I|not provided|Citrullinemia",GRCh38,single nucleotide variant
ASS1,9,130489422,na,na,Likely pathogenic,Citrullinemia type I|Citrullinemia,GRCh38,single nucleotide variant
FANCF,11,22625795,na,na,Pathogenic,Fanconi anemia complementation group F,GRCh38,single nucleotide variant
FANCF,11,22625484,na,na,Pathogenic,Fanconi anemia complementation group F,GRCh38,single nucleotide variant
PER2,2,238257003,na,na,Pathogenic,Advanced sleep phase syndrome 1,GRCh38,single nucleotide variant
PRKRA,2,178436264,na,na,Pathogenic/Likely pathogenic,Dystonia 16|not provided|PRKRA-related disorder,GRCh38,single nucleotide variant
PDLIM4,5,132251371,na,na,risk factor,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,GRCh38,single nucleotide variant
SCN9A,2,166277251,na,na,Pathogenic,"Primary erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",GRCh38,single nucleotide variant
SCN9A,2,166277281,na,na,Pathogenic,"Primary erythromelalgia|Acute episodes of neuropathic symptoms;Abnormality of pain sensation|SCN9A-related peripheral neuropathies associated with increased pain|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|not provided",GRCh38,single nucleotide variant
SCN9A,2,166303270,na,na,Conflicting classifications of pathogenicity,Primary erythromelalgia,GRCh38,single nucleotide variant
SCN9A,2,166226587,na,na,Pathogenic,Primary erythromelalgia,GRCh38,single nucleotide variant
SCN9A,2,166286562,na,na,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",GRCh38,single nucleotide variant
SCN9A,2,166277133,na,na,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",GRCh38,single nucleotide variant
SCN9A,2,166272731,na,na,Conflicting classifications of pathogenicity,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|not provided",GRCh38,single nucleotide variant
SCN9A,2,166228971,na,na,Pathogenic,Paroxysmal extreme pain disorder,GRCh38,single nucleotide variant
SCN9A,2,166228972,na,na,Pathogenic,Paroxysmal extreme pain disorder,GRCh38,single nucleotide variant
SCN9A,2,166228969,na,na,Pathogenic,"Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|not provided",GRCh38,single nucleotide variant
SCN9A,2,166204448,na,na,Pathogenic,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",GRCh38,single nucleotide variant
SCN9A,2,166204439,na,na,Pathogenic,Paroxysmal extreme pain disorder,GRCh38,single nucleotide variant
SCN9A,2,166303162,na,na,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|Inborn genetic diseases",GRCh38,single nucleotide variant
SCN9A,2,166293354,na,na,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|not provided",GRCh38,single nucleotide variant
SCN9A,2,166277252,na,na,Pathogenic,Primary erythromelalgia,GRCh38,single nucleotide variant
SCN9A,2,166304279,na,na,Pathogenic,Primary erythromelalgia,GRCh38,single nucleotide variant
SCN9A,2,166284506,na,na,Conflicting classifications of pathogenicity,"Generalized epilepsy with febrile seizures plus, type 7|Primary erythromelalgia;Neuropathy, hereditary sensory and autonomic, type 2A;Paroxysmal extreme pain disorder;Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Inborn genetic diseases|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",GRCh38,single nucleotide variant
SCN9A,2,166281786,na,na,Benign/Likely benign,"Generalized epilepsy with febrile seizures plus, type 7|not specified|Seizure;Hypoglycemia;Global developmental delay|not provided|Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|Inborn genetic diseases|SCN9A-related disorder",GRCh38,single nucleotide variant
SCN9A,2,166311573,na,na,Uncertain significance,"Febrile seizures, familial, 3b|not provided|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|6 conditions|Inborn genetic diseases|not specified",GRCh38,single nucleotide variant
SCN9A,2,166306531,na,na,Uncertain significance,"Febrile seizures, familial, 3b",GRCh38,single nucleotide variant
SCN9A,2,166311728,na,na,Likely benign,"Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Inherited Erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",GRCh38,single nucleotide variant
AP3B1,5,78129219,na,na,Pathogenic,Hermansky-Pudlak syndrome 2,GRCh38,single nucleotide variant
AP3B1,5,78156252,na,na,Pathogenic,Hermansky-Pudlak syndrome 2,GRCh38,single nucleotide variant
AP3B1,5,78181545,na,na,Pathogenic,Hermansky-Pudlak syndrome 2,GRCh38,single nucleotide variant
AP3B1,5,78141268,na,na,Pathogenic,Hermansky-Pudlak syndrome 2,GRCh38,single nucleotide variant
AP3B1,5,78116228,na,na,Pathogenic,Hermansky-Pudlak syndrome 2,GRCh38,single nucleotide variant
CCN6,6,112064842,na,na,Uncertain significance,Progressive pseudorheumatoid dysplasia|not specified,GRCh38,single nucleotide variant
CCN6,6,112069548,na,na,Pathogenic,Progressive pseudorheumatoid dysplasia,GRCh38,single nucleotide variant
CCN6,6,112061098,na,na,Pathogenic/Likely pathogenic,Progressive pseudorheumatoid dysplasia|See cases|not provided,GRCh38,single nucleotide variant
CCN6,6,112061174,na,na,Pathogenic,Progressive pseudorheumatoid dysplasia,GRCh38,single nucleotide variant
CCN6,6,112069555,na,na,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,GRCh38,single nucleotide variant
PDE8B,5,77349456,na,na,Pathogenic,"Pigmented nodular adrenocortical disease, primary, 3",GRCh38,single nucleotide variant
SYNGAP1,6,33432709,na,na,Pathogenic,"Intellectual disability, autosomal dominant 5",GRCh38,single nucleotide variant
SYNGAP1,6,33440787,na,na,Pathogenic,"Intellectual disability, autosomal dominant 5|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
FLNB,3,58110138,na,na,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,GRCh38,single nucleotide variant
FLNB,3,58136126,na,na,Likely pathogenic,Spondylocarpotarsal synostosis syndrome,GRCh38,single nucleotide variant
FLNB,3,58077235,na,na,Likely pathogenic,Larsen syndrome|Connective tissue disorder,GRCh38,single nucleotide variant
FLNB,3,58136063,na,na,Pathogenic,Larsen syndrome,GRCh38,single nucleotide variant
FLNB,3,58077271,na,na,Pathogenic,Atelosteogenesis type I|not provided,GRCh38,single nucleotide variant
FLNB,3,58078779,na,na,Pathogenic,Atelosteogenesis type I|Atelosteogenesis type III,GRCh38,single nucleotide variant
FLNB,3,58109627,na,na,Likely pathogenic,Atelosteogenesis type III|not specified,GRCh38,single nucleotide variant
FLNB,3,58077265,na,na,Pathogenic,Boomerang dysplasia,GRCh38,single nucleotide variant
FLNB,3,58081692,na,na,Pathogenic,Boomerang dysplasia,GRCh38,single nucleotide variant
FLNB,3,58081668,na,na,Pathogenic,Larsen syndrome|FLNB-related disorder|not provided,GRCh38,single nucleotide variant
FLNB,3,58138491,na,na,Pathogenic,Larsen syndrome|not provided|Larsen syndrome;Spondylocarpotarsal synostosis syndrome;Boomerang dysplasia;Atelosteogenesis type I;Atelosteogenesis type III,GRCh38,single nucleotide variant
FLNB,3,58148771,na,na,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,GRCh38,single nucleotide variant
FLNB,3,58146043,na,na,Pathogenic,Spondylocarpotarsal synostosis syndrome,GRCh38,single nucleotide variant
SLC22A5,5,132378380,na,na,Pathogenic,Renal carnitine transport defect|not provided,GRCh38,single nucleotide variant
SLC22A5,5,132387044,na,na,Pathogenic,Renal carnitine transport defect|not provided|SLC22A5-related disorder,GRCh38,single nucleotide variant
SLC22A5,5,132392598,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect,GRCh38,single nucleotide variant
SLC22A5,5,132384281,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,GRCh38,single nucleotide variant
SLC22A5,5,132384155,na,na,Pathogenic,not provided|Renal carnitine transport defect,GRCh38,single nucleotide variant
SLC22A5,5,132384154,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect,GRCh38,single nucleotide variant
SLC22A5,5,132389020,na,na,Pathogenic,Renal carnitine transport defect,GRCh38,single nucleotide variant
SLC22A5,5,132390833,na,na,Pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,GRCh38,single nucleotide variant
SLC22A5,5,132369975,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect,GRCh38,single nucleotide variant
SLC22A5,5,132385435,na,na,Pathogenic,not specified|Renal carnitine transport defect|not provided,GRCh38,single nucleotide variant
SLC22A5,5,132390832,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,GRCh38,single nucleotide variant
SLC22A5,5,132370015,na,na,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,GRCh38,single nucleotide variant
TSHR,14,80955786,na,na,Benign/Likely benign,"Hypothyroidism due to TSH receptor mutations|Familial hyperthyroidism due to mutations in TSH receptor|not specified|not provided|Graves disease, susceptibility to, 1",GRCh38,single nucleotide variant
TSHR,14,81143914,na,na,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",GRCh38,single nucleotide variant
TSHR,14,81143949,na,na,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic|Familial hyperthyroidism due to mutations in TSH receptor",GRCh38,single nucleotide variant
TSHR,14,81092563,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81092547,na,na,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Hypothyroidism due to TSH receptor mutations;Familial hyperthyroidism due to mutations in TSH receptor;Familial gestational hyperthyroidism|Familial gestational hyperthyroidism,GRCh38,single nucleotide variant
TSHR,14,81143416,na,na,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81143955,na,na,Pathogenic,"THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC",GRCh38,single nucleotide variant
TSHR,14,81087962,na,na,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81143695,na,na,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder,GRCh38,single nucleotide variant
TSHR,14,81143028,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81143286,na,na,Uncertain significance,Hypothyroidism due to TSH receptor mutations|not specified,GRCh38,single nucleotide variant
TSHR,14,80955802,na,na,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|Epilepsy;Developmental delay;autistic features|not provided|not specified|Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81143633,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81143228,na,na,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81143715,na,na,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder|not provided|Familial gestational hyperthyroidism,GRCh38,single nucleotide variant
TSHR,14,81139828,na,na,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",GRCh38,single nucleotide variant
TSHR,14,81143584,na,na,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81144073,na,na,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81143572,na,na,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor|not provided,GRCh38,single nucleotide variant
TSHR,14,81143945,na,na,Pathogenic,"Familial hyperthyroidism due to mutations in TSH receptor|Thyroid adenoma, hyperfunctioning, somatic",GRCh38,single nucleotide variant
TSHR,14,81139828,na,na,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81096641,na,na,Pathogenic,Familial gestational hyperthyroidism,GRCh38,single nucleotide variant
TSHR,14,81143973,na,na,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81143488,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81142986,na,na,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|not specified|not provided,GRCh38,single nucleotide variant
TSHR,14,81143349,na,na,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,GRCh38,single nucleotide variant
TSHR,14,81143856,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81143458,na,na,Pathogenic,Hypothyroidism due to TSH receptor mutations,GRCh38,single nucleotide variant
TSHR,14,81092611,na,na,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided,GRCh38,single nucleotide variant
GLE1,9,128522658,na,na,Pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Lethal congenital contractural syndrome Finnish type|not provided,GRCh38,single nucleotide variant
GLE1,9,128536414,na,na,Pathogenic/Likely pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Inborn genetic diseases|not provided|Lethal congenital contractural syndrome Finnish type|Lethal arthrogryposis-anterior horn cell disease syndrome;Lethal congenital contracture syndrome 1,GRCh38,single nucleotide variant
GLE1,9,128538058,na,na,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome,GRCh38,single nucleotide variant
GLE1,9,128541124,na,na,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome|not provided,GRCh38,single nucleotide variant
PEX16,11,45914619,na,na,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger)|not provided|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PEX16,11,45910896,na,na,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger),GRCh38,single nucleotide variant
EPAS1,2,46380281,na,na,Pathogenic,"Erythrocytosis, familial, 4",GRCh38,single nucleotide variant
EPAS1,2,46380281,na,na,Pathogenic,"Erythrocytosis, familial, 4|not provided",GRCh38,single nucleotide variant
EPAS1,2,46380275,na,na,Pathogenic,"Erythrocytosis, familial, 4",GRCh38,single nucleotide variant
SLC4A4,4,71447706,na,na,Pathogenic,Autosomal recessive proximal renal tubular acidosis,GRCh38,single nucleotide variant
SLC4A4,4,71472728,na,na,Pathogenic,Autosomal recessive proximal renal tubular acidosis,GRCh38,single nucleotide variant
SLC4A4,4,71339333,na,na,Pathogenic,Autosomal recessive proximal renal tubular acidosis,GRCh38,single nucleotide variant
DNAH11,7,21748602,na,na,Pathogenic,"Primary ciliary dyskinesia 7|CILIARY DYSKINESIA, PRIMARY, 7, WITH SITUS INVERSUS",GRCh38,single nucleotide variant
DNAH11,7,21880869,na,na,Pathogenic,Primary ciliary dyskinesia 7|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
DNAH5,5,13754203,na,na,Likely pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
DNAH5,5,13901476,na,na,Pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
GJB3,1,34784796,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,GRCh38,single nucleotide variant
GJB3,1,34784797,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|not provided,GRCh38,single nucleotide variant
GJB3,1,34785018,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,GRCh38,single nucleotide variant
GJB3,1,34785309,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 2B|Erythrokeratodermia variabilis et progressiva 1|not specified|GJB3-related disorder|not provided,GRCh38,single nucleotide variant
GJB3,1,34785300,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 2B|not specified|not provided,GRCh38,single nucleotide variant
GJB3,1,34785183,na,na,Uncertain significance,"Hearing loss, autosomal recessive",GRCh38,single nucleotide variant
GJB3,1,34784887,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,GRCh38,single nucleotide variant
GJB3,1,34784863,na,na,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|Autosomal dominant nonsyndromic hearing loss 2B,GRCh38,single nucleotide variant
GJB3,1,34785259,na,na,Pathogenic,"Deafness, digenic, GJB2/GJB3",GRCh38,single nucleotide variant
GJB3,1,34785342,na,na,Conflicting classifications of pathogenicity,"Deafness, digenic, GJB2/GJB3|Erythrokeratodermia variabilis et progressiva 1|not provided|Autosomal recessive nonsyndromic hearing loss 1A;Autosomal dominant nonsyndromic hearing loss 2B;Erythrokeratodermia variabilis et progressiva 1",GRCh38,single nucleotide variant
ALG10,12,34026832,na,na,Benign,Long QT syndrome 2,GRCh38,single nucleotide variant
KLF11,2,10048376,na,na,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 7|not provided,GRCh38,single nucleotide variant
KLF11,2,10047996,na,na,Benign/Likely benign,Maturity-onset diabetes of the young type 7|not specified|not provided|Monogenic diabetes,GRCh38,single nucleotide variant
DYNC2H1,11,103177652,na,na,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,GRCh38,single nucleotide variant
DYNC2H1,11,103304601,na,na,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy|not provided|not specified,GRCh38,single nucleotide variant
DYNC2H1,11,103220720,na,na,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy|Fetal growth restriction;Narrow chest;Bowing of the long bones|Short rib-polydactyly syndrome|DYNC2H1-related disorder,GRCh38,single nucleotide variant
DYNC2H1,11,103155476,na,na,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,GRCh38,single nucleotide variant
DYNC2H1,11,103245374,na,na,Pathogenic,Asphyxiating thoracic dystrophy 3,GRCh38,single nucleotide variant
DYNC2H1,11,103125197,na,na,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,GRCh38,single nucleotide variant
DYNC2H1,11,103185032,na,na,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy,GRCh38,single nucleotide variant
DYNC2H1,11,103209933,na,na,Pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,GRCh38,single nucleotide variant
DYNC2H1,11,103170291,na,na,Pathogenic,Asphyxiating thoracic dystrophy 3,GRCh38,single nucleotide variant
DYNC2H1,11,103163146,na,na,Pathogenic,Asphyxiating thoracic dystrophy 3,GRCh38,single nucleotide variant
DYNC2H1,11,103189761,na,na,Pathogenic,Asphyxiating thoracic dystrophy 3,GRCh38,single nucleotide variant
DYNC2H1,11,103177640,na,na,Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided,GRCh38,single nucleotide variant
SMAD9,13,36872722,na,na,Pathogenic,"Pulmonary hypertension, primary, 2",GRCh38,single nucleotide variant
KERA,12,91055542,na,na,Pathogenic,Cornea plana 2|not provided,GRCh38,single nucleotide variant
KERA,12,91055762,na,na,Pathogenic,Cornea plana 2,GRCh38,single nucleotide variant
KERA,12,91055638,na,na,Pathogenic,Cornea plana 2,GRCh38,single nucleotide variant
KERA,12,91051468,na,na,Pathogenic,Cornea plana 2,GRCh38,single nucleotide variant
PNPO,17,47946681,na,na,Pathogenic/Likely pathogenic,Pyridoxal phosphate-responsive seizures|not provided,GRCh38,single nucleotide variant
PNPO,17,47945558,na,na,Pathogenic,Pyridoxal phosphate-responsive seizures,GRCh38,single nucleotide variant
PNPO,17,47946780,na,na,Pathogenic,Pyridoxal phosphate-responsive seizures,GRCh38,single nucleotide variant
PNPO,17,47945963,na,na,Pathogenic,Pyridoxal phosphate-responsive seizures,GRCh38,single nucleotide variant
TP63,3,189864379,na,na,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Rapp-Hodgkin syndrome|8 conditions",GRCh38,single nucleotide variant
TP63,3,189864380,na,na,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Split hand-foot malformation 4",GRCh38,single nucleotide variant
TP63,3,189868620,na,na,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",GRCh38,single nucleotide variant
TP63,3,189864349,na,na,Pathogenic,Split hand-foot malformation 4,GRCh38,single nucleotide variant
TP63,3,189867905,na,na,Pathogenic,"Split hand-foot malformation 4|not provided|TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",GRCh38,single nucleotide variant
TP63,3,189867903,na,na,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|Rapp-Hodgkin syndrome|not provided|TP63-Related Spectrum Disorders",GRCh38,single nucleotide variant
TP63,3,189868615,na,na,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Inborn genetic diseases|8 conditions",GRCh38,single nucleotide variant
TP63,3,189890795,na,na,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,GRCh38,single nucleotide variant
TP63,3,189890817,na,na,Likely pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|TP63-Related Spectrum Disorders,GRCh38,single nucleotide variant
TP63,3,189789816,na,na,Pathogenic,ADULT syndrome,GRCh38,single nucleotide variant
TP63,3,189868597,na,na,Pathogenic/Likely pathogenic,ADULT syndrome|TP63-Related Spectrum Disorders|not provided,GRCh38,single nucleotide variant
TP63,3,189868639,na,na,Pathogenic,"not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",GRCh38,single nucleotide variant
TP63,3,189889478,na,na,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|Rapp-Hodgkin syndrome,GRCh38,single nucleotide variant
TP63,3,189890874,na,na,Pathogenic,Rapp-Hodgkin syndrome,GRCh38,single nucleotide variant
TP63,3,189868641,na,na,Uncertain significance,"Orofacial cleft 8|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",GRCh38,single nucleotide variant
TP63,3,189868596,na,na,Pathogenic,ADULT syndrome|not provided,GRCh38,single nucleotide variant
TP63,3,189738739,na,na,Uncertain significance,Split hand-foot malformation 4|TP63-Related Spectrum Disorders|8 conditions,GRCh38,single nucleotide variant
TP63,3,189866712,na,na,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|ADULT syndrome|not provided|TP63-Related Spectrum Disorders",GRCh38,single nucleotide variant
SMARCA4,19,11033308,na,na,Pathogenic,Rhabdoid tumor predisposition syndrome 2|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
BMPR1B,4,95129875,na,na,Likely pathogenic,Type A2 brachydactyly|not provided,GRCh38,single nucleotide variant
BMPR1B,4,95154620,na,na,Pathogenic,Type A2 brachydactyly|Acromesomelic dysplasia 3;Type A2 brachydactyly|not provided,GRCh38,single nucleotide variant
BMPR1B,4,95154621,na,na,Likely pathogenic,Type A2 brachydactyly|BMPR1B-related disorder,GRCh38,single nucleotide variant
ABCC6,16,16163078,na,na,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Arterial calcification, generalized, of infancy, 2;Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste|Cutis laxa;Papule|ABCC6-related disorder|See cases",GRCh38,single nucleotide variant
ABCC6,16,16173283,na,na,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Arterial calcification, generalized, of infancy, 2;Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste|ABCC6-related disorder|Pseudoxanthoma elasticum",GRCh38,single nucleotide variant
ABCC6,16,16163086,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",GRCh38,single nucleotide variant
ABCC6,16,16163158,na,na,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided|ABCC6-related disorder,GRCh38,single nucleotide variant
ABCC6,16,16154974,na,na,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",GRCh38,single nucleotide variant
ABCC6,16,16163110,na,na,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Abnormality of the eye|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided",GRCh38,single nucleotide variant
ABCC6,16,16157742,na,na,Benign,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Pseudoxanthoma elasticum, forme fruste|Arterial calcification, generalized, of infancy, 2|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|not specified",GRCh38,single nucleotide variant
ABCC6,16,16163087,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided|ABCC6-related disorder",GRCh38,single nucleotide variant
ABCC6,16,16163009,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|See cases|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",GRCh38,single nucleotide variant
ABCC6,16,16157810,na,na,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided",GRCh38,single nucleotide variant
ABCC6,16,16154899,na,na,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided,GRCh38,single nucleotide variant
ABCC6,16,16150606,na,na,Uncertain significance,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|not specified|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",GRCh38,single nucleotide variant
ABCC6,16,16155022,na,na,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,GRCh38,single nucleotide variant
ABCC6,16,16155010,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",GRCh38,single nucleotide variant
ABCC6,16,16154953,na,na,Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,GRCh38,single nucleotide variant
ABCC6,16,16159505,na,na,Pathogenic/Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,GRCh38,single nucleotide variant
BFSP2,3,133450432,na,na,Pathogenic,Cataract 12 multiple types|not provided,GRCh38,single nucleotide variant
KCNJ13,2,232768790,na,na,Pathogenic/Likely pathogenic,Snowflake vitreoretinal degeneration|not provided,GRCh38,single nucleotide variant
LCT,2,135807131,na,na,Pathogenic,Congenital lactase deficiency|not provided,GRCh38,single nucleotide variant
LCT,2,135829593,na,na,Pathogenic,Congenital lactase deficiency,GRCh38,single nucleotide variant
ABCB11,2,168970131,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 2|ABCB11-related disorder|See cases|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,GRCh38,single nucleotide variant
ABCB11,2,168990819,na,na,Pathogenic,"Progressive familial intrahepatic cholestasis type 2|Benign recurrent intrahepatic cholestasis type 2|not provided|Progressive familial intrahepatic cholestasis|Cholestasis, intrahepatic, of pregnancy, 3|ABCB11-related disorder|Progressive familial intrahepatic cholestasis type 2;Benign recurrent intrahepatic cholestasis type 2",GRCh38,single nucleotide variant
ABCB11,2,169014300,na,na,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2,GRCh38,single nucleotide variant
ABCB11,2,168976590,na,na,Likely pathogenic,Benign recurrent intrahepatic cholestasis type 2|not provided,GRCh38,single nucleotide variant
ABCB11,2,168932421,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,GRCh38,single nucleotide variant
RFXANK,19,19197047,na,na,Pathogenic/Likely pathogenic,MHC class II deficiency|MHC class II deficiency 2|MHC class II deficiency 3,GRCh38,single nucleotide variant
RFXANK,19,19197545,na,na,Pathogenic/Likely pathogenic,MHC class II deficiency|not provided|MHC class II deficiency 2,GRCh38,single nucleotide variant
PNPLA6,19,7556507,na,na,Pathogenic,Hereditary spastic paraplegia 39|Ataxia-hypogonadism-choroidal dystrophy syndrome,GRCh38,single nucleotide variant
PNPLA6,19,7555041,na,na,Pathogenic,Hereditary spastic paraplegia 39,GRCh38,single nucleotide variant
COCH,14,30877686,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,GRCh38,single nucleotide variant
COCH,14,30878834,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|not provided,GRCh38,single nucleotide variant
COCH,14,30878920,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Hereditary hearing loss and deafness|not provided,GRCh38,single nucleotide variant
COCH,14,30877640,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss|Rare genetic deafness|not provided|Hearing impairment,GRCh38,single nucleotide variant
COCH,14,30878897,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|not provided,GRCh38,single nucleotide variant
COCH,14,30878926,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
COCH,14,30889763,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
COCH,14,30889763,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,GRCh38,single nucleotide variant
COCH,14,30889673,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,GRCh38,single nucleotide variant
ALDH6A1,14,74065249,na,na,Pathogenic,Methylmalonate semialdehyde dehydrogenase deficiency,GRCh38,single nucleotide variant
PPP2R1B,11,111764842,na,na,Pathogenic,Lung carcinoma,GRCh38,single nucleotide variant
CPN1,10,100069757,na,na,Benign,Anaphylotoxin inactivator deficiency|not specified|not provided|CPN1-related disorder,GRCh38,single nucleotide variant
AGPAT2,9,136677537,na,na,Pathogenic,Congenital generalized lipodystrophy type 1|not provided,GRCh38,single nucleotide variant
AGPAT2,9,136674809,na,na,Pathogenic,Congenital generalized lipodystrophy type 1|Congenital generalized lipodystrophy|not provided,GRCh38,single nucleotide variant
AGPAT2,9,136673906,na,na,Pathogenic,Congenital generalized lipodystrophy type 1,GRCh38,single nucleotide variant
AGPAT2,9,136674753,na,na,Pathogenic,Congenital generalized lipodystrophy type 1,GRCh38,single nucleotide variant
AGPAT2,9,136676681,na,na,Pathogenic/Likely pathogenic,Congenital generalized lipodystrophy type 1,GRCh38,single nucleotide variant
AGPAT2,9,136676603,na,na,Pathogenic,Congenital generalized lipodystrophy type 1,GRCh38,single nucleotide variant
B3GALNT1,3,161086553,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
B3GALNT1,3,161085944,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
B3GALNT1,3,161085958,na,na,Affects,p phenotype,GRCh38,single nucleotide variant
AURKA,20,56386485,na,na,Benign,"Colon cancer, susceptibility to|not provided|AURKA-related disorder",GRCh38,single nucleotide variant
PLOD3,7,101215100,na,na,Uncertain significance,"Bone fragility with contractures, arterial rupture, and deafness|not provided",GRCh38,single nucleotide variant
AGPS,2,177493170,na,na,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,GRCh38,single nucleotide variant
AGPS,2,177461948,na,na,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,GRCh38,single nucleotide variant
AGPS,2,177499661,na,na,Pathogenic,Rhizomelic chondrodysplasia punctata type 3,GRCh38,single nucleotide variant
COLQ,3,15470613,na,na,Pathogenic,Congenital myasthenic syndrome 5,GRCh38,single nucleotide variant
COLQ,3,15475447,na,na,Pathogenic,Congenital myasthenic syndrome 5,GRCh38,single nucleotide variant
COLQ,3,15458296,na,na,Pathogenic,Congenital myasthenic syndrome 5,GRCh38,single nucleotide variant
COLQ,3,15453838,na,na,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome|COLQ-related disorder|Slow-Channel Congenital Myasthenia Syndrome,GRCh38,single nucleotide variant
COLQ,3,15458197,na,na,Pathogenic,Congenital myasthenic syndrome 5|not provided|Synaptic congenital myasthenic syndromes,GRCh38,single nucleotide variant
COLQ,3,15453826,na,na,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome,GRCh38,single nucleotide variant
COLQ,3,15466437,na,na,Pathogenic,Congenital myasthenic syndrome 5,GRCh38,single nucleotide variant
TLR5,1,223111858,na,na,protective; risk factor,"Legionnaire disease, susceptibility to|Systemic lupus erythematosus, resistance to, 1|Melioidosis, resistance to",GRCh38,single nucleotide variant
TLR5,1,223111257,na,na,Benign; risk factor,"Legionnaire disease, susceptibility to|TLR5-related disorder",GRCh38,single nucleotide variant
TLR4,9,117713024,na,na,Benign,"TLR4 POLYMORPHISM|Pericementitis|COPD, severe early onset|not provided|Susceptibility to severe coronavirus disease (COVID-19)",GRCh38,single nucleotide variant
TLR4,9,117713324,na,na,Benign,"TLR4 POLYMORPHISM|not provided|COPD, severe early onset",GRCh38,single nucleotide variant
TLR3,4,186083346,na,na,Uncertain significance,"Immunodeficiency 83, susceptibility to viral infections|Herpes simplex encephalitis, susceptibility to, 1|Immunodeficiency 83, susceptibility to viral infections;Susceptibility to HIV infection|not specified|TLR3-related disorder|not provided",GRCh38,single nucleotide variant
TLR2,4,153704936,na,na,risk factor,"Leprosy, susceptibility to, 3",GRCh38,single nucleotide variant
DYSF,2,71553071,na,na,Pathogenic,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin,GRCh38,single nucleotide variant
DYSF,2,71602794,na,na,Benign,Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|not specified|Qualitative or quantitative defects of dysferlin|Distal myopathy with anterior tibial onset|DYSF-related disorder|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
DYSF,2,71682597,na,na,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Abnormality of the musculature|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71564074,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
DYSF,2,71664443,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Miyoshi muscular dystrophy 1,GRCh38,single nucleotide variant
DYSF,2,71570300,na,na,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71570704,na,na,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin,GRCh38,single nucleotide variant
DYSF,2,71674242,na,na,Pathogenic,Distal myopathy with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|Distal myopathy with anterior tibial onset;Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
DYSF,2,71553131,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71667376,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71551073,na,na,Conflicting classifications of pathogenicity,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
DYSF,2,71590178,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71517028,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin,GRCh38,single nucleotide variant
DYSF,2,71517028,na,na,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B,GRCh38,single nucleotide variant
DYSF,2,71535019,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
PAPSS2,10,87743589,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",GRCh38,single nucleotide variant
PAPSS2,10,87709311,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",GRCh38,single nucleotide variant
PAPSS2,10,87727403,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type|not provided|Autosomal recessive brachyolmia",GRCh38,single nucleotide variant
CUBN,10,17041160,na,na,Pathogenic/Likely pathogenic,"Imerslund-Grasbeck syndrome|Imerslund-Grasbeck syndrome type 1|Proteinuria, chronic benign;Imerslund-Grasbeck syndrome type 1",GRCh38,single nucleotide variant
NOG,17,56594888,na,na,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,GRCh38,single nucleotide variant
NOG,17,56594887,na,na,Pathogenic,Proximal symphalangism 1A,GRCh38,single nucleotide variant
NOG,17,56594872,na,na,Pathogenic,Symphalangism-brachydactyly syndrome,GRCh38,single nucleotide variant
NOG,17,56594891,na,na,Pathogenic,Proximal symphalangism 1A,GRCh38,single nucleotide variant
NOG,17,56594788,na,na,Pathogenic,Proximal symphalangism 1A,GRCh38,single nucleotide variant
NOG,17,56594834,na,na,Pathogenic,Tarsal-carpal coalition syndrome,GRCh38,single nucleotide variant
NOG,17,56594327,na,na,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,GRCh38,single nucleotide variant
NOG,17,56594774,na,na,Pathogenic,Proximal symphalangism 1A,GRCh38,single nucleotide variant
NOG,17,56594609,na,na,Pathogenic,Proximal symphalangism 1A,GRCh38,single nucleotide variant
NOG,17,56594722,na,na,Pathogenic,Brachydactyly type B2,GRCh38,single nucleotide variant
NOG,17,56594326,na,na,Pathogenic,Proximal symphalangism 1A|Brachydactyly type B2|Stapes ankylosis with broad thumbs and toes|not provided,GRCh38,single nucleotide variant
NOG,17,56594551,na,na,Pathogenic,Stapes ankylosis with broad thumbs and toes|not provided,GRCh38,single nucleotide variant
NOG,17,56594837,na,na,Pathogenic,Symphalangism-brachydactyly syndrome,GRCh38,single nucleotide variant
NOG,17,56594838,na,na,Pathogenic,Symphalangism-brachydactyly syndrome,GRCh38,single nucleotide variant
NOG,17,56594326,na,na,Pathogenic,Brachydactyly type B2,GRCh38,single nucleotide variant
NDUFS2,1,161209912,na,na,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",GRCh38,single nucleotide variant
NDUFS2,1,161209915,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6",GRCh38,single nucleotide variant
NDUFS2,1,161213673,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",GRCh38,single nucleotide variant
FANCG,9,35078338,na,na,Pathogenic,Fanconi anemia complementation group G|not provided|Fanconi anemia,GRCh38,single nucleotide variant
FANCG,9,35078604,na,na,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,GRCh38,single nucleotide variant
FANCG,9,35076442,na,na,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,GRCh38,single nucleotide variant
FANCG,9,35076585,na,na,Pathogenic,Fanconi anemia complementation group G,GRCh38,single nucleotide variant
FANCG,9,35075278,na,na,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|FANCG-related disorder|not provided,GRCh38,single nucleotide variant
BAAT,9,101371179,na,na,Pathogenic,Bile acid conjugation defect 1,GRCh38,single nucleotide variant
FAAH,1,46405089,na,na,Benign/Likely benign,"FAAH POLYMORPHISM|Polysubstance abuse, susceptibility to|FAAH-related disorder|not provided",GRCh38,single nucleotide variant
SMAD7,18,48927093,na,na,risk factor,"Colorectal cancer, susceptibility to, 3",GRCh38,single nucleotide variant
STXBP1,9,127682489,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
STXBP1,9,127663314,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4|Inborn genetic diseases",GRCh38,single nucleotide variant
STXBP1,9,127676722,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4",GRCh38,single nucleotide variant
STXBP1,9,127660034,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4",GRCh38,single nucleotide variant
STXBP1,9,127675855,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4|not provided|Inborn genetic diseases|Developmental and epileptic encephalopathy|Infantile epilepsy syndrome",GRCh38,single nucleotide variant
STXBP1,9,127653797,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 4",GRCh38,single nucleotide variant
AQP7,9,33385243,na,na,Affects,GLYCEROL QUANTITATIVE TRAIT LOCUS,GRCh38,single nucleotide variant
DNMT3B,20,32807791,na,na,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,GRCh38,single nucleotide variant
DNMT3B,20,32807793,na,na,Pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",GRCh38,single nucleotide variant
DNMT3B,20,32802416,na,na,Pathogenic/Likely pathogenic,"Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Immunodeficiency-centromeric instability-facial anomalies syndrome 1",GRCh38,single nucleotide variant
DNMT3B,20,32800916,na,na,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,GRCh38,single nucleotide variant
DNMT3B,20,32800200,na,na,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Facioscapulohumeral muscular dystrophy 4, digenic;Immunodeficiency-centromeric instability-facial anomalies syndrome 1",GRCh38,single nucleotide variant
DNMT3B,20,32807751,na,na,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|not provided|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",GRCh38,single nucleotide variant
DNMT3B,20,32805343,na,na,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,GRCh38,single nucleotide variant
DNMT3B,20,32780411,na,na,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,GRCh38,single nucleotide variant
DNMT3B,20,32807860,na,na,Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",GRCh38,single nucleotide variant
DNMT3B,20,32789007,na,na,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,GRCh38,single nucleotide variant
CERS1;GDF1;UPF1,19,18869035,na,na,Pathogenic/Likely pathogenic,"Congenital heart defects, multiple types, 6|Right atrial isomerism|not provided|GDF1-RELATED DISORDERS|GDF1-related disorder|Transposition of the great arteries|Right atrial isomerism;Congenital heart defects, multiple types, 6",GRCh38,single nucleotide variant
GDF1,19,18868916,na,na,Uncertain significance,Double outlet right ventricle|GDF1-related disorder,GRCh38,single nucleotide variant
CERS1;GDF1,19,18869231,na,na,Conflicting classifications of pathogenicity,Tetralogy of Fallot|not provided|Progressive myoclonic epilepsy type 8|GDF1-related disorder,GRCh38,single nucleotide variant
OCLN,5,69509746,na,na,Pathogenic,Pseudo-TORCH syndrome 1,GRCh38,single nucleotide variant
PKP2,12,32879021,na,na,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Cardiovascular phenotype|not provided|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|Cardiac arrhythmia,GRCh38,single nucleotide variant
PKP2,12,32802499,na,na,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|PKP2-related disorder|Cardiomyopathy,GRCh38,single nucleotide variant
PKP2,12,32802557,na,na,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Cardiomyopathy|PKP2-related disorder,GRCh38,single nucleotide variant
PKP2,12,32796108,na,na,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic ventricular cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|Familial isolated arrhythmogenic right ventricular dysplasia|Sudden unexplained death,GRCh38,single nucleotide variant
BUB1B,15,40165136,na,na,Benign/Likely benign,Carcinoma of colon|not provided|not specified|Mosaic variegated aneuploidy syndrome 1|Mosaic variegated aneuploidy syndrome 1;Premature chromatid separation trait;Colorectal cancer,GRCh38,single nucleotide variant
BUB1B,15,40176672,na,na,Pathogenic/Likely pathogenic,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,GRCh38,single nucleotide variant
BUB1B,15,40212643,na,na,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,GRCh38,single nucleotide variant
BUB1B,15,40217580,na,na,Conflicting classifications of pathogenicity,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|not provided|Inborn genetic diseases|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,GRCh38,single nucleotide variant
BUB1B,15,40212554,na,na,Conflicting classifications of pathogenicity,Premature chromatid separation trait|Mosaic variegated aneuploidy syndrome 1,GRCh38,single nucleotide variant
BUB1B,15,40220641,na,na,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1;Colorectal cancer|not specified,GRCh38,single nucleotide variant
BUB1B,15,40202609,na,na,Benign/Likely benign,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,GRCh38,single nucleotide variant
BUB1B,15,40200243,na,na,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,GRCh38,single nucleotide variant
BUB1B,15,40200239,na,na,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,GRCh38,single nucleotide variant
PEX10,1,2408451,na,na,Pathogenic,"Peroxisome biogenesis disorder 6A (Zellweger)|Zellweger spectrum disorders|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|not provided|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder",GRCh38,single nucleotide variant
PEX10,1,2406526,na,na,Pathogenic,Peroxisome biogenesis disorder 6B,GRCh38,single nucleotide variant
PEX10,1,2408679,na,na,Pathogenic/Likely pathogenic,"Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 6A (Zellweger)",GRCh38,single nucleotide variant
DHCR7,11,71437944,na,na,not provided,Smith-Lemli-Opitz syndrome,GRCh38,single nucleotide variant
DHCR7,11,71442319,na,na,Conflicting classifications of pathogenicity,Smith-Lemli-Opitz syndrome|not provided|not specified,GRCh38,single nucleotide variant
DHCR7,11,71438980,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71438966,na,na,Pathogenic,Smith-Lemli-Opitz syndrome,GRCh38,single nucleotide variant
DHCR7,11,71444036,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Abnormal brain morphology|See cases,GRCh38,single nucleotide variant
DHCR7,11,71441400,na,na,Pathogenic,Smith-Lemli-Opitz syndrome,GRCh38,single nucleotide variant
DHCR7,11,71435827,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71435749,na,na,Pathogenic,Smith-Lemli-Opitz syndrome|Microcephaly|not provided|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71435593,na,na,Pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71437909,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
DHCR7,11,71437936,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71444950,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,GRCh38,single nucleotide variant
DHCR7,11,71435461,na,na,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,GRCh38,single nucleotide variant
DHCR7,11,71444952,na,na,Pathogenic/Likely pathogenic,not provided|Smith-Lemli-Opitz syndrome|Inborn genetic diseases|DHCR7-related disorder,GRCh38,single nucleotide variant
DHCR7,11,71435748,na,na,Pathogenic,Smith-Lemli-Opitz syndrome|not provided,GRCh38,single nucleotide variant
PSMA6,14,35292469,na,na,Benign; risk factor,"Myocardial infarction, susceptibility to|PSMA6-related disorder",GRCh38,single nucleotide variant
ADGRV1,5,90705508,na,na,Pathogenic,"Febrile seizures, familial, 4",GRCh38,single nucleotide variant
ADGRV1,5,90690991,na,na,Pathogenic/Likely pathogenic,"Usher syndrome type 2C|Usher syndrome|not provided|Rare genetic deafness|Febrile seizures, familial, 4;Usher syndrome type 2C",GRCh38,single nucleotide variant
ADGRV1,5,90985501,na,na,Pathogenic,Usher syndrome type 2C,GRCh38,single nucleotide variant
KIF5A,12,57569015,na,na,Pathogenic,Hereditary spastic paraplegia 10,GRCh38,single nucleotide variant
KIF5A,12,57569274,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Spastic paraplegia|Hereditary spastic paraplegia,GRCh38,single nucleotide variant
KIF5A,12,57569263,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Spastic paraplegia|KIF5A-related disorder,GRCh38,single nucleotide variant
KIF5A,12,57569648,na,na,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 10|Spastic paraplegia|not specified|not provided|KIF5A-related disorder,GRCh38,single nucleotide variant
SPG7,16,89553932,na,na,Likely pathogenic,Hereditary spastic paraplegia 7,GRCh38,single nucleotide variant
SPG7,16,89510539,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Hereditary spastic paraplegia|Proximal spinal muscular atrophy|SPG7-related disorder|Retinal dystrophy,GRCh38,single nucleotide variant
SPG7,16,89531961,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Hereditary spastic paraplegia|SPG7-related disorder|Inborn genetic diseases|Retinal dystrophy,GRCh38,single nucleotide variant
SPG7,16,89550579,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided,GRCh38,single nucleotide variant
SHOC2,10,110964362,na,na,Pathogenic,Noonan syndrome-like disorder with loose anagen hair 1|RASopathy|not provided|Inborn genetic diseases|Noonan syndrome-like disorder with loose anagen hair|Noonan syndrome|Noonan syndrome and Noonan-related syndrome|Polycystic kidney disease 4|Pectus excavatum;Noonan syndrome-like disorder with loose anagen hair 1|SHOC2-related disorder,GRCh38,single nucleotide variant
RAD51C,17,58709926,na,na,Conflicting classifications of pathogenicity,"Fanconi anemia complementation group O|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 3;Fanconi anemia complementation group O",GRCh38,single nucleotide variant
RAD51C,17,58695159,na,na,Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group O",GRCh38,single nucleotide variant
RAD51C,17,58696702,na,na,Pathogenic/Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group O|Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3",GRCh38,single nucleotide variant
CBX2,17,79783736,na,na,Pathogenic,"46,XY sex reversal 5",GRCh38,single nucleotide variant
CBX2,17,79784771,na,na,Pathogenic,"46,XY sex reversal 5",GRCh38,single nucleotide variant
DLL3,19,39507099,na,na,Uncertain significance,"Spondylocostal dysostosis 1, autosomal recessive|not provided",GRCh38,single nucleotide variant
DLL3,19,39504130,na,na,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",GRCh38,single nucleotide variant
DLL3,19,39507456,na,na,Pathogenic/Likely pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",GRCh38,single nucleotide variant
KRT85,12,52367173,na,na,Benign/Likely benign,"Ectodermal dysplasia 4, hair/nail type|not provided|not specified",GRCh38,single nucleotide variant
KRT83,12,52315936,na,na,Likely pathogenic,Monilethrix|not provided|MONILETHRIX 3,GRCh38,single nucleotide variant
PHOX2A,11,72243787,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",GRCh38,single nucleotide variant
PHOX2A,11,72240199,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",GRCh38,single nucleotide variant
PHOX2A,11,72243790,na,na,Uncertain significance,"Fibrosis of extraocular muscles, congenital, 2",GRCh38,single nucleotide variant
GNPAT,1,231265356,na,na,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,GRCh38,single nucleotide variant
GNPAT,1,231265355,na,na,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 2|Rhizomelic chondrodysplasia punctata,GRCh38,single nucleotide variant
PRKAG2,7,151576412,na,na,Pathogenic,Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy 6|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome,GRCh38,single nucleotide variant
PRKAG2,7,151568801,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not specified|not provided|Lethal congenital glycogen storage disease of heart,GRCh38,single nucleotide variant
PRKAG2,7,151568750,na,na,Likely pathogenic,Hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy|PRKAG2-related disorder,GRCh38,single nucleotide variant
PRKAG2,7,151564199,na,na,Pathogenic,Hypertrophic cardiomyopathy 6,GRCh38,single nucleotide variant
PRKAG2,7,151560611,na,na,Pathogenic,"Wolff-Parkinson-White syndrome, childhood-onset|Cardiovascular phenotype",GRCh38,single nucleotide variant
PRKAG2,7,151560610,na,na,Pathogenic,Lethal congenital glycogen storage disease of heart|Hypertrophic cardiomyopathy|not provided,GRCh38,single nucleotide variant
PRKAG2,7,151564203,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not provided|Lethal congenital glycogen storage disease of heart|Cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
PRKAG2,7,151560613,na,na,Pathogenic,Hypertrophic cardiomyopathy 6|not provided|Hypertrophic cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype,GRCh38,single nucleotide variant
PRKAG2,7,151564146,na,na,Likely pathogenic,Hypertrophic cardiomyopathy 6|not provided|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
PRKAG2,7,151560560,na,na,Uncertain significance,Hypertrophic cardiomyopathy 6|Lethal congenital glycogen storage disease of heart,GRCh38,single nucleotide variant
ALDH9A1,1,165683019,na,na,Affects,ALDH9A1*2 POLYMORPHISM,GRCh38,single nucleotide variant
ACVR2B,3,38477353,na,na,Benign/Likely benign,"Heterotaxy, visceral, 4, autosomal|not specified|not provided",GRCh38,single nucleotide variant
ACVR2B,3,38483273,na,na,Uncertain significance,"Heterotaxy, visceral, 4, autosomal|not provided",GRCh38,single nucleotide variant
CLCN7,16,1449282,na,na,Pathogenic,Autosomal recessive osteopetrosis 4,GRCh38,single nucleotide variant
CLCN7,16,1447052,na,na,Pathogenic,Autosomal recessive osteopetrosis 4,GRCh38,single nucleotide variant
CLCN7,16,1447040,na,na,Pathogenic,Autosomal recessive osteopetrosis 4,GRCh38,single nucleotide variant
CLCN7,16,1447038,na,na,Pathogenic,Autosomal dominant osteopetrosis 2|Autosomal recessive osteopetrosis 4|not provided,GRCh38,single nucleotide variant
CLCN7,16,1457295,na,na,Pathogenic,Autosomal recessive osteopetrosis 4,GRCh38,single nucleotide variant
NPHS1,19,35831358,na,na,Pathogenic,Finnish congenital nephrotic syndrome|not provided,GRCh38,single nucleotide variant
NPHS1,19,35848142,na,na,Conflicting classifications of pathogenicity,not specified|Finnish congenital nephrotic syndrome|Congenital nephrotic syndrome|Proteinuria|Focal segmental glomerulosclerosis|not provided,GRCh38,single nucleotide variant
NPHS1,19,35831056,na,na,Pathogenic,Finnish congenital nephrotic syndrome|not provided|Nephrotic syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
NPHS1,19,35849283,na,na,Pathogenic,Finnish congenital nephrotic syndrome,GRCh38,single nucleotide variant
NPHS1,19,35842421,na,na,Conflicting classifications of pathogenicity,Finnish congenital nephrotic syndrome|not provided,GRCh38,single nucleotide variant
ADAM9,8,39026811,na,na,Pathogenic,Cone-rod dystrophy 9,GRCh38,single nucleotide variant
ADAM9,8,39023177,na,na,Pathogenic,Cone-rod dystrophy 9,GRCh38,single nucleotide variant
ADAM9,8,39017298,na,na,Pathogenic,Cone-rod dystrophy 9|not provided|Cone-rod dystrophy,GRCh38,single nucleotide variant
ADAM9,8,39017211,na,na,Pathogenic,Cone-rod dystrophy 9|Cone-rod dystrophy,GRCh38,single nucleotide variant
EP300,22,41137768,na,na,Pathogenic,Carcinoma of colon|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,GRCh38,single nucleotide variant
EP300,22,41178373,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
EP300,22,41141111,na,na,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,GRCh38,single nucleotide variant
NDUFS4,5,53646371,na,na,Pathogenic,"Mitochondrial complex I deficiency|Mitochondrial complex I deficiency, nuclear type 1|Leigh syndrome|not provided",GRCh38,single nucleotide variant
NDUFS4,5,53560706,na,na,Pathogenic,"Mitochondrial complex I deficiency, nuclear type 1",GRCh38,single nucleotide variant
SDHD,11,112087910,na,na,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112087916,na,na,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112086961,na,na,Likely pathogenic,Paragangliomas 1|Pheochromocytoma,GRCh38,single nucleotide variant
SDHD,11,112086941,na,na,Conflicting classifications of pathogenicity,"Cowden syndrome 3|Paragangliomas 1|Pheochromocytoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Carney-Stratakis syndrome;Pheochromocytoma;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss|Mitochondrial complex 2 deficiency, nuclear type 3|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary pheochromocytoma-paraganglioma",GRCh38,single nucleotide variant
SDHD,11,112088939,na,na,Pathogenic/Likely pathogenic,"Pheochromocytoma|Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 1;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome|SDHD-related disorder",GRCh38,single nucleotide variant
SDHD,11,112088971,na,na,Pathogenic/Likely pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas 4|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|not provided,GRCh38,single nucleotide variant
SDHD,11,112089002,na,na,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112094831,na,na,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|not provided,GRCh38,single nucleotide variant
SDHD,11,112087899,na,na,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
SDHD,11,112087868,na,na,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|not provided|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma,GRCh38,single nucleotide variant
SDHD,11,112086910,na,na,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome|not provided,GRCh38,single nucleotide variant
SDHD,11,112094906,na,na,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided,GRCh38,single nucleotide variant
SDHD,11,112087953,na,na,Benign/Likely benign,"Carcinoid tumor of intestine|Hereditary cancer-predisposing syndrome|not specified|Pheochromocytoma|Paragangliomas 1|not provided|Carney-Stratakis syndrome|Carney-Stratakis syndrome;Pheochromocytoma;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3",GRCh38,single nucleotide variant
SDHD,11,112086908,na,na,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112087933,na,na,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112086940,na,na,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112086921,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHD,11,112094923,na,na,Uncertain significance,"Cowden syndrome 3|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|Mitochondrial complex 2 deficiency, nuclear type 3",GRCh38,single nucleotide variant
MAD1L1,7,1898251,na,na,Pathogenic,"LYMPHOMA, DIFFUSE LARGE B-CELL, SOMATIC",GRCh38,single nucleotide variant
MAD1L1,7,2225526,na,na,Benign/Likely benign,"Prostate cancer, somatic|Prostate cancer|not provided",GRCh38,single nucleotide variant
SLC37A4,11,119025299,na,na,Pathogenic,Glucose-6-phosphate transport defect|not provided,GRCh38,single nucleotide variant
SLC37A4,11,119025251,na,na,Pathogenic,Glucose-6-phosphate transport defect,GRCh38,single nucleotide variant
SLC37A4,11,119028223,na,na,Pathogenic,Glucose-6-phosphate transport defect|not provided,GRCh38,single nucleotide variant
SLC37A4,11,119028288,na,na,Pathogenic,Phosphate transport defect|Glucose-6-phosphate transport defect,GRCh38,single nucleotide variant
SLC37A4,11,119026602,na,na,Pathogenic,Glucose-6-phosphate transport defect,GRCh38,single nucleotide variant
SLC37A4,11,119029221,na,na,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Phosphate transport defect|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect",GRCh38,single nucleotide variant
SLC37A4,11,119029287,na,na,Pathogenic,"Glucose-6-phosphate transport defect|not provided|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect",GRCh38,single nucleotide variant
SLC37A4,11,119024957,na,na,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Phosphate transport defect|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect|Congenital disorder of glycosylation, type IIw",GRCh38,single nucleotide variant
SLC37A4,11,119025298,na,na,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|not provided|Congenital disorder of glycosylation, type IIw;Glucose-6-phosphate transport defect;Phosphate transport defect",GRCh38,single nucleotide variant
SLC37A4,11,119027628,na,na,Pathogenic,Glucose-6-phosphate transport defect,GRCh38,single nucleotide variant
PITX3,10,102232043,na,na,Likely pathogenic,Cataract 11 multiple types|not provided,GRCh38,single nucleotide variant
NBN,8,89964428,na,na,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
NBN,8,89978293,na,na,Conflicting classifications of pathogenicity,"Aplastic anemia|Leukemia, acute lymphoblastic, susceptibility to|Acute lymphoid leukemia|Microcephaly, normal intelligence and immunodeficiency|not specified|Hereditary cancer-predisposing syndrome|Carcinoma of colon|not provided|Hereditary breast ovarian cancer syndrome|Breast carcinoma|Hereditary cancer|NBN-related disorder|Diffuse midline glioma, H3 K27-altered|Pediatric high-grade glioma",GRCh38,single nucleotide variant
NBN,8,89958760,na,na,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|not provided|Aplastic anemia",GRCh38,single nucleotide variant
NBN,8,89971232,na,na,Conflicting classifications of pathogenicity,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome|not specified|not provided|NBN-related disorder",GRCh38,single nucleotide variant
MYO15A,17,18145935,na,na,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 3|Nonsyndromic genetic hearing loss|not provided,GRCh38,single nucleotide variant
MYO15A,17,18145929,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18151859,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18124558,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18125232,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3|not provided,GRCh38,single nucleotide variant
MYO15A,17,18154190,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18148133,na,na,Conflicting classifications of pathogenicity,"Deafness, with smith-magenis syndrome|not specified|Autosomal recessive nonsyndromic hearing loss 3|not provided|Nonsyndromic genetic hearing loss",GRCh38,single nucleotide variant
MYO15A,17,18122113,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18141104,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
MYO15A,17,18158522,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,GRCh38,single nucleotide variant
TUBB3,16,89935235,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",GRCh38,single nucleotide variant
TUBB3,16,89935355,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",GRCh38,single nucleotide variant
TUBB3,16,89935700,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",GRCh38,single nucleotide variant
TUBB3,16,89935700,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided|Complex cortical dysplasia with other brain malformations 1|TUBB3-related tubulinopathy",GRCh38,single nucleotide variant
TUBB3,16,89935679,na,na,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|Complex cortical dysplasia with other brain malformations 1|TUBB3-Releated Disorders|not provided|TUBB3-related disorder",GRCh38,single nucleotide variant
TNFRSF11B,8,118933071,na,na,Pathogenic,Hyperphosphatasemia with bone disease,GRCh38,single nucleotide variant
TNFRSF11B,8,118932982,na,na,Uncertain significance,Hyperphosphatasemia with bone disease|not provided,GRCh38,single nucleotide variant
TNFSF11,13,42606560,na,na,Pathogenic,Autosomal recessive osteopetrosis 2,GRCh38,single nucleotide variant
SLC67A1,11,2909210,na,na,Conflicting classifications of pathogenicity,"Rhabdomyosarcoma, somatic|SLC22A18-related disorder",GRCh38,single nucleotide variant
SLC22A18,11,2918030,na,na,Pathogenic,Lung carcinoma,GRCh38,single nucleotide variant
TGIF1,18,3456420,na,na,Conflicting classifications of pathogenicity,Holoprosencephaly 4|not specified,GRCh38,single nucleotide variant
TGIF1,18,3456525,na,na,Pathogenic,Holoprosencephaly 4,GRCh38,single nucleotide variant
TGIF1,18,3457572,na,na,Benign/Likely benign,Holoprosencephaly 4|not specified,GRCh38,single nucleotide variant
TGIF1,18,3457606,na,na,Uncertain significance,Holoprosencephaly 4,GRCh38,single nucleotide variant
TGIF1,18,3452156,na,na,Pathogenic,Holoprosencephaly 4,GRCh38,single nucleotide variant
TGIF1,18,3457441,na,na,Benign/Likely benign,Holoprosencephaly 4|not specified|not provided,GRCh38,single nucleotide variant
FKBP5,6,35639794,na,na,drug response; risk factor,"Antidepressant drug treatment, accelerated response to|",GRCh38,single nucleotide variant
FOXE1,9,97854108,na,na,Pathogenic,Bamforth-Lazarus syndrome,GRCh38,single nucleotide variant
FOXE1,9,97854084,na,na,Pathogenic,Bamforth-Lazarus syndrome,GRCh38,single nucleotide variant
FOXE1,9,97854218,na,na,Pathogenic,Bamforth-Lazarus syndrome,GRCh38,single nucleotide variant
MGAT2,14,49622137,na,na,Uncertain significance,MGAT2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MGAT2,14,49622053,na,na,Pathogenic,MGAT2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MGAT2,14,49622220,na,na,Pathogenic,MGAT2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MGAT2,14,49622285,na,na,Pathogenic,MGAT2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
CARTPT,5,71719903,na,na,Uncertain significance,Obesity,GRCh38,single nucleotide variant
OLR1,12,10160849,na,na,Benign; risk factor,"Myocardial infarction, susceptibility to|OLR1-related disorder",GRCh38,single nucleotide variant
OLR1,12,10159692,na,na,risk factor,"Myocardial infarction, susceptibility to",GRCh38,single nucleotide variant
LRP8,1,53247055,na,na,risk factor,"Myocardial infarction, susceptibility to, 1",GRCh38,single nucleotide variant
CDSN,6,31116972,na,na,Pathogenic,Hypotrichosis 2,GRCh38,single nucleotide variant
CDSN,6,31117017,na,na,Pathogenic,Hypotrichosis 2,GRCh38,single nucleotide variant
LFNG,7,2525301,na,na,Pathogenic,"Spondylocostal dysostosis 3, autosomal recessive|Spondylocostal dysostosis 2, autosomal recessive",GRCh38,single nucleotide variant
LMX1B,9,126693589,na,na,Pathogenic/Likely pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,GRCh38,single nucleotide variant
LMX1B,9,126693243,na,na,Pathogenic,Nail-patella syndrome|not provided,GRCh38,single nucleotide variant
LMX1B,9,126690862,na,na,Pathogenic,Nail-patella syndrome,GRCh38,single nucleotide variant
LMX1B,9,126615487,na,na,Pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,GRCh38,single nucleotide variant
LMX1B,9,126693273,na,na,Pathogenic,Nail-patella syndrome|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
LMX1B,9,126693250,na,na,Pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease|LMX1B-related disorder,GRCh38,single nucleotide variant
LMX1B,9,126693324,na,na,Pathogenic,Nail-patella syndrome,GRCh38,single nucleotide variant
LMX1B,9,126693527,na,na,Pathogenic,Nail-patella syndrome|not provided,GRCh38,single nucleotide variant
TECTA,11,121166652,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
TECTA,11,121168076,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,GRCh38,single nucleotide variant
TECTA,11,121130212,na,na,Pathogenic,"Deafness, neurosensory autosomal recessive 21|Autosomal dominant nonsyndromic hearing loss 12;Autosomal recessive nonsyndromic hearing loss 21|not provided",GRCh38,single nucleotide variant
TECTA,11,121137648,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided,GRCh38,single nucleotide variant
TECTA,11,121160301,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,GRCh38,single nucleotide variant
TECTA,11,121166703,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,GRCh38,single nucleotide variant
TECTA,11,121187894,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
TECTA,11,121168135,na,na,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,GRCh38,single nucleotide variant
TECTA,11,121166703,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,GRCh38,single nucleotide variant
TECTA,11,121165331,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,GRCh38,single nucleotide variant
SNCB,5,176626472,na,na,Pathogenic,Lewy body dementia,GRCh38,single nucleotide variant
SNCB,5,176621218,na,na,Conflicting classifications of pathogenicity,Lewy body dementia|not provided|SNCB-related disorder,GRCh38,single nucleotide variant
MTRR,5,7870860,na,na,Benign/Likely benign,"Down syndrome, susceptibility to|Neural tube defects, folate-sensitive, susceptibility to|Gastrointestinal stromal tumor|not specified|Disorders of Intracellular Cobalamin Metabolism|Methylcobalamin deficiency type cblE|not provided|Methotrexate response",GRCh38,single nucleotide variant
MTRR,5,7892815,na,na,Pathogenic/Likely pathogenic,"Methylcobalamin deficiency type cblE|Inborn genetic diseases|not provided|Neural tube defects, folate-sensitive",GRCh38,single nucleotide variant
MTRR,5,7891405,na,na,Pathogenic,"Methylcobalamin deficiency type cblE|not provided|Neural tube defects, folate-sensitive|Disorders of Intracellular Cobalamin Metabolism",GRCh38,single nucleotide variant
PRKN,6,161973317,na,na,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,GRCh38,single nucleotide variant
PRKN,6,161569357,na,na,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,GRCh38,single nucleotide variant
PRKN,6,162262692,na,na,Benign/Likely benign,Autosomal recessive juvenile Parkinson disease 2|not specified|not provided,GRCh38,single nucleotide variant
PRKN,6,161350139,na,na,Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,GRCh38,single nucleotide variant
PRKN,6,162201182,na,na,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,GRCh38,single nucleotide variant
PRKN,6,161973401,na,na,Pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,GRCh38,single nucleotide variant
PRKN,6,162443314,na,na,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,GRCh38,single nucleotide variant
PRKN,6,161785820,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive juvenile Parkinson disease 2|not provided|Young-onset Parkinson disease|Lung carcinoma;Leprosy, susceptibility to, 2;Ovarian neoplasm;Autosomal recessive juvenile Parkinson disease 2|See cases|Parkinson disease 12|Ovarian cancer;Lung cancer;Autosomal recessive juvenile Parkinson disease 2|PRKN-related disorder|Ovarian cancer",GRCh38,single nucleotide variant
PRKN,6,161973403,na,na,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian cancer|Ovarian cancer;Lung cancer;Autosomal recessive juvenile Parkinson disease 2,GRCh38,single nucleotide variant
PRKN,6,162727661,na,na,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,GRCh38,single nucleotide variant
PRKN,6,161973317,na,na,Conflicting classifications of pathogenicity,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian neoplasm|Young-onset Parkinson disease,GRCh38,single nucleotide variant
RAB3GAP1,2,135120817,na,na,Pathogenic,Warburg micro syndrome 1,GRCh38,single nucleotide variant
RAB3GAP1,2,135120919,na,na,Pathogenic,Warburg micro syndrome 1|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
RAB3GAP1,2,135150456,na,na,Pathogenic,Warburg micro syndrome 1,GRCh38,single nucleotide variant
RAB3GAP1,2,135135743,na,na,Pathogenic,Warburg micro syndrome 1,GRCh38,single nucleotide variant
RAB3GAP1,2,135133944,na,na,Pathogenic,Warburg micro syndrome 1,GRCh38,single nucleotide variant
PARK7,1,7984981,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,GRCh38,single nucleotide variant
PARK7,1,7962863,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,GRCh38,single nucleotide variant
PARK7,1,7984930,na,na,Likely benign,Autosomal recessive early-onset Parkinson disease 7,GRCh38,single nucleotide variant
PARK7,1,7965425,na,na,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,GRCh38,single nucleotide variant
PARK7,1,7984971,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
PARK7,1,7965348,na,na,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",GRCh38,single nucleotide variant
TUBA1A,12,49185576,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|Tubulinopathy|not provided|Lissencephaly,GRCh38,single nucleotide variant
TUBA1A,12,49185161,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy|not provided|Tubulinopathy-associated dysgyria|Lissencephaly,GRCh38,single nucleotide variant
TUBA1A,12,49185804,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,GRCh38,single nucleotide variant
TUBA1A,12,49185579,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,GRCh38,single nucleotide variant
TUBA1A,12,49185110,na,na,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|not provided|Tubulinopathy,GRCh38,single nucleotide variant
TUBA1A,12,49185176,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,GRCh38,single nucleotide variant
TUBA1A,12,49185102,na,na,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|not provided|Tubulinopathy,GRCh38,single nucleotide variant
TUBA1A,12,49185101,na,na,Pathogenic,Lissencephaly due to TUBA1A mutation|not provided|Tubulinopathy|Lissencephaly,GRCh38,single nucleotide variant
POU4F3,5,146340292,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15,GRCh38,single nucleotide variant
POU4F3,5,146340095,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15|not provided,GRCh38,single nucleotide variant
SORT1,1,109274968,na,na,association,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,GRCh38,single nucleotide variant
BUB1,2,110672660,na,na,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",GRCh38,single nucleotide variant
BUB1,2,110658451,na,na,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",GRCh38,single nucleotide variant
PON2,7,95405463,na,na,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,GRCh38,single nucleotide variant
PON2,7,95411704,na,na,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,GRCh38,single nucleotide variant
SERPINI1,3,167789273,na,na,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,GRCh38,single nucleotide variant
SERPINI1,3,167789282,na,na,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,GRCh38,single nucleotide variant
SERPINI1,3,167823019,na,na,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,GRCh38,single nucleotide variant
SERPINI1,3,167825265,na,na,Pathogenic/Likely pathogenic,Familial encephalopathy with neuroserpin inclusion bodies|Abnormality of the nervous system,GRCh38,single nucleotide variant
SERPINI1,3,167825264,na,na,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,GRCh38,single nucleotide variant
CISH,3,50612068,na,na,risk factor,"Tuberculosis, susceptibility to|Malaria, susceptibility to|Bacteremia, susceptibility to, 2",GRCh38,single nucleotide variant
HSF4,16,67165827,na,na,Pathogenic,Cataract 5 multiple types,GRCh38,single nucleotide variant
HSF4,16,67165841,na,na,Pathogenic,Cataract 5 multiple types,GRCh38,single nucleotide variant
HSF4,16,67164867,na,na,Pathogenic,Cataract 5 multiple types,GRCh38,single nucleotide variant
HSF4,16,67165742,na,na,Pathogenic,Cataract 5 multiple types,GRCh38,single nucleotide variant
OPTN,10,13109270,na,na,Pathogenic,"Glaucoma 1, open angle, E",GRCh38,single nucleotide variant
OPTN,10,13136766,na,na,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|not specified|not provided|Amyotrophic lateral sclerosis type 12|OPTN-related disorder",GRCh38,single nucleotide variant
OPTN,10,13110400,na,na,Benign/Likely benign,"Glaucoma, normal tension, susceptibility to|Glaucoma 1, open angle, E|Primary open angle glaucoma|not specified|Amyotrophic lateral sclerosis type 12|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma, normal tension, susceptibility to;Primary open angle glaucoma|not provided|Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma",GRCh38,single nucleotide variant
OPTN,10,13125989,na,na,Pathogenic,Amyotrophic lateral sclerosis type 12,GRCh38,single nucleotide variant
OPTN,10,13132098,na,na,Pathogenic,Amyotrophic lateral sclerosis type 12,GRCh38,single nucleotide variant
ROBO2,3,77596730,na,na,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,GRCh38,single nucleotide variant
ROBO2,3,77622378,na,na,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,GRCh38,single nucleotide variant
CFTR,7,117559548,na,na,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117530953,na,na,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,GRCh38,single nucleotide variant
CFTR,7,117530975,na,na,Pathogenic,"Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|ivacaftor response - Efficacy|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Obstructive azoospermia|Bronchiectasis with or without elevated sweat chloride 1|Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis",GRCh38,single nucleotide variant
CFTR,7,117540270,na,na,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1|not provided,GRCh38,single nucleotide variant
CFTR,7,117548795,na,na,Pathogenic,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587738,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587833,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117590360,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117587778,na,na,Pathogenic,Cystic fibrosis|not provided|Hereditary pancreatitis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587800,na,na,Pathogenic; drug response,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|ivacaftor response - Efficacy|Hereditary pancreatitis|not provided|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117587800,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117587801,na,na,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117590394,na,na,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587806,na,na,Pathogenic,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587811,na,na,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117587829,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117642484,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117559594,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|CFTR-related disorder|not provided|Obstructive azoospermia|Infertility disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117594977,na,na,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117603612,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117642566,na,na,Pathogenic,Cystic fibrosis|not provided|not specified|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117559479,na,na,Benign/Likely benign,Cystic fibrosis|not specified|CFTR-related disorder|not provided,GRCh38,single nucleotide variant
CFTR,7,117559587,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117548804,na,na,Likely pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117652915,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117652877,na,na,Pathogenic,"Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Spermatogenic failure, Y-linked, 2|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
CFTR,7,117627537,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117627774,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117540230,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117594990,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided,GRCh38,single nucleotide variant
CFTR,7,117587805,na,na,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117509123,na,na,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117627525,na,na,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117559629,na,na,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117559643,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117642593,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117540163,na,na,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Obstructive azoospermia,GRCh38,single nucleotide variant
CFTR,7,117559546,na,na,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117587833,na,na,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117592646,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117611638,na,na,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117611640,na,na,drug response,Cystic fibrosis|not specified|ivacaftor response - Efficacy|not provided|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117642594,na,na,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided,GRCh38,single nucleotide variant
CFTR,7,117611637,na,na,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117642528,na,na,Conflicting classifications of pathogenicity,Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not specified|Hereditary pancreatitis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117590400,na,na,Conflicting classifications of pathogenicity,"Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not provided|Lung disease, non-specific|not specified|Chronic sinusitis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis",GRCh38,single nucleotide variant
CFTR,7,117639961,na,na,Pathogenic,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;CFTR-related disorder|Hereditary pancreatitis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117642568,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117590440,na,na,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117540305,na,na,Conflicting classifications of pathogenicity,not specified|Cystic fibrosis|Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117540270,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117540276,na,na,Uncertain significance,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|not specified|not provided|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587755,na,na,Uncertain significance,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117592313,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117592658,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117627765,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117642437,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117509040,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117652905,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117530899,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117540270,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Cystic fibrosis;CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,GRCh38,single nucleotide variant
CFTR,7,117509140,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117642577,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117530899,na,na,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117559509,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117535285,na,na,Pathogenic; drug response,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|ivacaftor response - Efficacy|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117642483,na,na,Pathogenic; drug response,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy,GRCh38,single nucleotide variant
CFTR,7,117540243,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|not specified|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117611707,na,na,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117587820,na,na,Benign/Likely benign,Cystic fibrosis|not provided|not specified|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117530951,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117540285,na,na,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117509146,na,na,Uncertain significance,Cystic fibrosis|not provided|CFTR-related disorder|not specified,GRCh38,single nucleotide variant
CFTR,7,117587808,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117592110,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117592295,na,na,Pathogenic,not provided|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117603542,na,na,Pathogenic,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117603609,na,na,Uncertain significance,Cystic fibrosis|not provided|not specified|CFTR-related disorder|Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117603719,na,na,Uncertain significance,Cystic fibrosis|not specified,GRCh38,single nucleotide variant
CFTR,7,117611635,na,na,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117611653,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117611695,na,na,Pathogenic/Likely pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117611717,na,na,Pathogenic,Cystic fibrosis|not specified|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117627664,na,na,Pathogenic,Cystic fibrosis|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117627712,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|not specified|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117627753,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117642466,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117642472,na,na,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
CFTR,7,117652875,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117667029,na,na,Pathogenic/Likely pathogenic,Sweat chloride elevation without cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Respiratory ciliopathies including non-CF bronchiectasis|not provided,GRCh38,single nucleotide variant
CFTR,7,117587812,na,na,Uncertain significance,Cystic fibrosis|not specified,GRCh38,single nucleotide variant
CFTR,7,117479993,na,na,Pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117627502,na,na,Benign/Likely benign,Cystic fibrosis|not specified|not provided|CFTR-related disorder|Hereditary pancreatitis,GRCh38,single nucleotide variant
CFTR,7,117610521,na,na,Conflicting classifications of pathogenicity,||Cystic fibrosis|not provided|not specified|Pancreatitis|CFTR-related disorder|Infertility disorder|Obstructive azoospermia|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117480113,na,na,Pathogenic,Cystic fibrosis|not provided,GRCh38,single nucleotide variant
CFTR,7,117664780,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|not specified,GRCh38,single nucleotide variant
CFTR,7,117535318,na,na,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|not specified|CFTR-related disorder,GRCh38,single nucleotide variant
CFTR,7,117642451,na,na,Likely pathogenic,Cystic fibrosis,GRCh38,single nucleotide variant
CFTR,7,117590355,na,na,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
SDHC,1,161314408,na,na,Pathogenic,Paragangliomas 3|Gastrointestinal stromal tumor;Paragangliomas 3|not provided,GRCh38,single nucleotide variant
SDHC,1,161356841,na,na,Pathogenic/Likely pathogenic,Paragangliomas 3|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary pheochromocytoma-paraganglioma,GRCh38,single nucleotide variant
SDHC,1,161356841,na,na,Pathogenic,Gastrointestinal stromal tumor|Carney-Stratakis syndrome|Carney triad|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary pheochromocytoma-paraganglioma,GRCh38,single nucleotide variant
RPS24,10,78037230,na,na,Pathogenic,Diamond-Blackfan anemia 3,GRCh38,single nucleotide variant
RPS24,10,78035394,na,na,Pathogenic,Diamond-Blackfan anemia 3|Diamond-Blackfan anemia|not provided,GRCh38,single nucleotide variant
BLMH,17,30249058,na,na,Benign,not provided|Alzheimer disease type 1,GRCh38,single nucleotide variant
FOXC2,16,86567632,na,na,Likely pathogenic,Distichiasis-lymphedema syndrome,GRCh38,single nucleotide variant
FOXC2,16,86567709,na,na,Likely pathogenic,Distichiasis-lymphedema syndrome,GRCh38,single nucleotide variant
FOXC2,16,86567697,na,na,Pathogenic,Distichiasis-lymphedema syndrome,GRCh38,single nucleotide variant
ATP8B1,18,57695188,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis,GRCh38,single nucleotide variant
ATP8B1,18,57661207,na,na,Conflicting classifications of pathogenicity,"Progressive familial intrahepatic cholestasis type 1|not provided|Progressive familial intrahepatic cholestasis|Benign recurrent intrahepatic cholestasis type 1|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1",GRCh38,single nucleotide variant
ATP8B1,18,57695248,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 1,GRCh38,single nucleotide variant
ATP8B1,18,57669316,na,na,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|Benign recurrent intrahepatic cholestasis type 1,GRCh38,single nucleotide variant
ATP8B1,18,57669433,na,na,Pathogenic/Likely pathogenic,"Benign recurrent intrahepatic cholestasis type 1|Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1|Progressive familial intrahepatic cholestasis",GRCh38,single nucleotide variant
ATP8B1,18,57674993,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder,GRCh38,single nucleotide variant
ATP8B1,18,57654078,na,na,Pathogenic,Benign recurrent intrahepatic cholestasis type 1,GRCh38,single nucleotide variant
ATP8B1,18,57706561,na,na,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 1|Progressive familial intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis type 1|not specified|Benign recurrent intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder",GRCh38,single nucleotide variant
ATP8B1,18,57661282,na,na,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 1",GRCh38,single nucleotide variant
ATP8B1,18,57688361,na,na,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided,GRCh38,single nucleotide variant
ATP8B1,18,57674849,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 1|Benign recurrent intrahepatic cholestasis type 1|not provided|Familial intrahepatic cholestasis type 1,GRCh38,single nucleotide variant
TUFM,16,28844008,na,na,Uncertain significance,Combined oxidative phosphorylation defect type 4|not provided,GRCh38,single nucleotide variant
DNM2,19,10819992,na,na,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, dominant intermediate B, with neutropenia|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B",GRCh38,single nucleotide variant
DNM2,19,10793833,na,na,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,GRCh38,single nucleotide variant
DNM2,19,10793832,na,na,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Charcot-Marie-Tooth disease|not provided,GRCh38,single nucleotide variant
DNM2,19,10798543,na,na,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Abnormality of the musculature|not provided|DNM2-related disorder,GRCh38,single nucleotide variant
DNM2,19,10793829,na,na,Pathogenic,Autosomal dominant centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Centronuclear myopathy|Myopathy|not provided|DNM2-related disorder,GRCh38,single nucleotide variant
DNM2,19,10812315,na,na,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,GRCh38,single nucleotide variant
DNM2,19,10820017,na,na,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,GRCh38,single nucleotide variant
DNM2,19,10823862,na,na,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Autosomal dominant centronuclear myopathy|not provided|Fetal akinesia-cerebral and retinal hemorrhage syndrome;Autosomal dominant centronuclear myopathy;Charcot-Marie-Tooth disease dominant intermediate B,GRCh38,single nucleotide variant
DNM2,19,10823862,na,na,Pathogenic,Severe X-linked myotubular myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,GRCh38,single nucleotide variant
DNM2,19,10793799,na,na,Pathogenic/Likely pathogenic,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease dominant intermediate B|not provided,GRCh38,single nucleotide variant
IFNAR2,21,33241945,na,na,Benign,"Hepatitis B virus, susceptibility to|Immunodeficiency 45|not provided|not specified|Mortality risk in patients with severe coronavirus disease (COVID-19)",GRCh38,single nucleotide variant
CTSC,11,88309176,na,na,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88294509,na,na,Pathogenic,Papillon-Lefèvre syndrome,GRCh38,single nucleotide variant
CTSC,11,88300532,na,na,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88296166,na,na,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88296165,na,na,Conflicting classifications of pathogenicity,"Haim-Munk syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88337557,na,na,Likely pathogenic,"Papillon-Lefèvre syndrome|CTSC-related disorder|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88294497,na,na,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88294111,na,na,Pathogenic,Papillon-Lefèvre syndrome,GRCh38,single nucleotide variant
CTSC,11,88312493,na,na,Uncertain significance,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
CTSC,11,88294163,na,na,Pathogenic,"Periodontitis, aggressive 1",GRCh38,single nucleotide variant
CTSC,11,88294358,na,na,Pathogenic,"Periodontitis, aggressive 1|Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",GRCh38,single nucleotide variant
GATM,15,45369364,na,na,Pathogenic,Arginine:glycine amidinotransferase deficiency,GRCh38,single nucleotide variant
HCRT,17,42184503,na,na,Pathogenic,Narcolepsy 1,GRCh38,single nucleotide variant
ROR2,9,91724229,na,na,Pathogenic,Brachydactyly type B1|not provided,GRCh38,single nucleotide variant
ROR2,9,91724248,na,na,Pathogenic,Brachydactyly type B1,GRCh38,single nucleotide variant
ROR2,9,91724990,na,na,Pathogenic,Autosomal recessive Robinow syndrome,GRCh38,single nucleotide variant
ROR2,9,91737463,na,na,Likely pathogenic,Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1,GRCh38,single nucleotide variant
ROR2,9,91724334,na,na,Pathogenic,Autosomal recessive Robinow syndrome,GRCh38,single nucleotide variant
ROR2,9,91737400,na,na,Pathogenic,Autosomal recessive Robinow syndrome,GRCh38,single nucleotide variant
ROR2,9,91724247,na,na,Pathogenic,Brachydactyly type B1,GRCh38,single nucleotide variant
ROR2,9,91757380,na,na,Pathogenic,Autosomal recessive Robinow syndrome|not provided,GRCh38,single nucleotide variant
ROR2,9,91726603,na,na,Pathogenic,"Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly|Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1|not provided",GRCh38,single nucleotide variant
TERC,3,169764653,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",GRCh38,single nucleotide variant
TERC,3,169764857,na,na,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1",GRCh38,single nucleotide variant
TERC,3,169765003,na,na,Benign/Likely benign,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 1|not specified|not provided|Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2;Dyskeratosis congenita, autosomal dominant 1",GRCh38,single nucleotide variant
TERC,3,169764989,na,na,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia",GRCh38,single nucleotide variant
TERC,3,169764945,na,na,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1|Pulmonary fibrosis|not provided",GRCh38,single nucleotide variant
TERC,3,169764963,na,na,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Interstitial lung disease 2",GRCh38,single nucleotide variant
TERC,3,169764736,na,na,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2",GRCh38,single nucleotide variant
AGRP,16,67483042,na,na,Benign,"Leanness, inherited|Obesity, late-onset|AGRP-related condition|Inherited obesity",GRCh38,single nucleotide variant
HR,8,22119197,na,na,Benign,Alopecia universalis congenita|Atrichia with papular lesions|not provided|HR-related disorder,GRCh38,single nucleotide variant
HR,8,22116400,na,na,Pathogenic,Alopecia universalis congenita,GRCh38,single nucleotide variant
HR,8,22123727,na,na,Pathogenic,Atrichia with papular lesions,GRCh38,single nucleotide variant
HR,8,22115744,na,na,Pathogenic,Atrichia with papular lesions,GRCh38,single nucleotide variant
HR,8,22119227,na,na,Pathogenic,Alopecia universalis congenita,GRCh38,single nucleotide variant
HRURF,8,22130707,na,na,Pathogenic,Hypotrichosis 4,GRCh38,single nucleotide variant
HRURF,8,22130702,na,na,Pathogenic,Hypotrichosis 4,GRCh38,single nucleotide variant
HRURF,8,22130636,na,na,Pathogenic,Hypotrichosis 4,GRCh38,single nucleotide variant
HRURF,8,22130605,na,na,Pathogenic,Hypotrichosis 4,GRCh38,single nucleotide variant
RAB7A,3,128806576,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
RAB7A,3,128807627,na,na,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
RAB7A,3,128807625,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
RAB7A,3,128807614,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
APOA1;APOA1-AS,11,116837344,na,na,Pathogenic,Hereditary spastic paraplegia 50,GRCh38,single nucleotide variant
TRIM32,9,116699201,na,na,Pathogenic,Sarcotubular myopathy|Myopathy|Bardet-Biedl syndrome|not provided|TRIM32-related disorder|Retinal dystrophy|Bardet-Biedl syndrome 11,GRCh38,single nucleotide variant
TRIM32,9,116698130,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 11|Bardet-Biedl syndrome|not provided|TRIM32-related disorder,GRCh38,single nucleotide variant
TRIM32,9,116698923,na,na,Conflicting classifications of pathogenicity,Sarcotubular myopathy|not provided|Bardet-Biedl syndrome|TRIM32-related disorder|Bardet-Biedl syndrome 11;Sarcotubular myopathy|Bardet-Biedl syndrome 11,GRCh38,single nucleotide variant
SC5D,11,121303461,na,na,Pathogenic,Lathosterolosis,GRCh38,single nucleotide variant
SC5D,11,121307244,na,na,Pathogenic,Lathosterolosis,GRCh38,single nucleotide variant
SC5D,11,121303512,na,na,Pathogenic,Lathosterolosis,GRCh38,single nucleotide variant
TULP1,6,35503623,na,na,Pathogenic,not provided|Retinitis pigmentosa 14,GRCh38,single nucleotide variant
TEAD3;TULP1,6,35500005,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 14|Retinal dystrophy|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
TULP1,6,35500100,na,na,Likely pathogenic,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
TULP1,6,35503816,na,na,Pathogenic,Retinitis pigmentosa 14|Retinitis pigmentosa|Retinal dystrophy|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
TULP1,6,35500032,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,GRCh38,single nucleotide variant
TULP1,6,35509632,na,na,Pathogenic,Retinitis pigmentosa 14|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
PABPN1,14,23321504,na,na,Uncertain significance,Oculopharyngeal muscular dystrophy|PABPN1-related disorder|Oculopharyngeal muscular dystrophy 1,GRCh38,single nucleotide variant
GUCA1B,6,42185686,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 48|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
TCF4,18,55228988,na,na,Pathogenic,Pitt-Hopkins syndrome|not provided|Severe intellectual deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
TCF4,18,55228987,na,na,Pathogenic,Pitt-Hopkins syndrome|not provided,GRCh38,single nucleotide variant
TCF4,18,55254694,na,na,Pathogenic,"Pitt-Hopkins syndrome|not provided|Pitt-Hopkins syndrome;Corneal dystrophy, Fuchs endothelial, 3",GRCh38,single nucleotide variant
TCF4,18,55228993,na,na,Pathogenic,Pitt-Hopkins syndrome,GRCh38,single nucleotide variant
SCARB2,4,76166249,na,na,Pathogenic,Action myoclonus-renal failure syndrome,GRCh38,single nucleotide variant
SCARB2,4,76174276,na,na,Pathogenic,Action myoclonus-renal failure syndrome|not provided|Progressive myoclonic epilepsy,GRCh38,single nucleotide variant
SCARB2,4,76179596,na,na,Pathogenic,Action myoclonus-renal failure syndrome,GRCh38,single nucleotide variant
KCNQ2,20,63439674,na,na,Pathogenic,"Seizures, benign familial neonatal, 1|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
KCNQ2,20,63439609,na,na,Pathogenic,"Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy, 7|Inborn genetic diseases|Developmental and epileptic encephalopathy|not provided|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
KCNQ2,20,63444709,na,na,Pathogenic/Likely pathogenic,"Seizures, benign familial neonatal, 1|not provided|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|Neonatal/infantile epilepsy syndrome",GRCh38,single nucleotide variant
KCNQ2,20,63444730,na,na,Pathogenic,"not provided|Seizures, benign familial neonatal, 1|Seizures, benign familial neonatal, 1, and/or myokymia|Developmental and epileptic encephalopathy|Inborn genetic diseases|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy, 7",GRCh38,single nucleotide variant
KCNQ2,20,63413551,na,na,Pathogenic,"Seizures, benign familial neonatal, 1|Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy, 7|not provided",GRCh38,single nucleotide variant
KCNQ2,20,63442482,na,na,Pathogenic,"Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy|not provided",GRCh38,single nucleotide variant
KCNQ2,20,63444729,na,na,Pathogenic,"not provided|Seizures, benign familial neonatal, 1, and/or myokymia|Developmental and epileptic encephalopathy|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1|KCNQ2-related disorder|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
KCNQ3,8,132175457,na,na,Pathogenic,"Seizures, benign familial neonatal, 2",GRCh38,single nucleotide variant
SOX10,22,37977999,na,na,Pathogenic,Waardenburg syndrome type 4C|not provided,GRCh38,single nucleotide variant
SOX10,22,37983536,na,na,Pathogenic,Waardenburg syndrome type 4C,GRCh38,single nucleotide variant
SOX10,22,37983381,na,na,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",GRCh38,single nucleotide variant
SOX10,22,37973957,na,na,Pathogenic,PCWH syndrome,GRCh38,single nucleotide variant
SOX10,22,37974144,na,na,Pathogenic,PCWH syndrome|not provided,GRCh38,single nucleotide variant
SOX10,22,37977943,na,na,Pathogenic,Waardenburg syndrome type 4C,GRCh38,single nucleotide variant
SOX10,22,37973767,na,na,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement|Waardenburg syndrome type 4C|not provided",GRCh38,single nucleotide variant
SOX10,22,37974148,na,na,Pathogenic,PCWH syndrome,GRCh38,single nucleotide variant
SOX10,22,37978094,na,na,Pathogenic,Waardenburg syndrome type 4C|not provided,GRCh38,single nucleotide variant
SOX10,22,37974200,na,na,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",GRCh38,single nucleotide variant
SOX10,22,37978043,na,na,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",GRCh38,single nucleotide variant
TCF7L2,10,112998590,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
TCF7L2,10,113049143,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
TCF7L2,10,113047288,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
CRX,19,47836381,na,na,Pathogenic,Cone-rod dystrophy 2|not provided|Leber congenital amaurosis 7;Cone-rod dystrophy 2,GRCh38,single nucleotide variant
CRX,19,47836263,na,na,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Cone-rod dystrophy 2;Leber congenital amaurosis 7|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa,GRCh38,single nucleotide variant
CRX,19,47836264,na,na,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Retinal dystrophy|Leber congenital amaurosis 7;Cone-rod dystrophy 2|CRX-related disorder|Cone-rod dystrophy|Inborn genetic diseases,GRCh38,single nucleotide variant
CRX,19,47839335,na,na,Pathogenic/Likely pathogenic,Leber congenital amaurosis 7|not provided|Retinal dystrophy|Leber congenital amaurosis 7;Cone-rod dystrophy 2,GRCh38,single nucleotide variant
SALL1,16,51141107,na,na,Pathogenic,Townes-Brocks syndrome 1,GRCh38,single nucleotide variant
SALL1,16,51141396,na,na,Pathogenic/Likely pathogenic,Townes-Brocks syndrome 1|Townes syndrome|not provided,GRCh38,single nucleotide variant
SALL1,16,51141107,na,na,Pathogenic,Townes-Brocks syndrome 1|not provided,GRCh38,single nucleotide variant
SALL1,16,51141255,na,na,Pathogenic,Townes-Brocks-branchiootorenal-like syndrome|Townes syndrome|Townes-Brocks syndrome 1,GRCh38,single nucleotide variant
SALL1,16,51140966,na,na,Pathogenic,Townes-Brocks syndrome 1,GRCh38,single nucleotide variant
STK11,19,1221237,na,na,Pathogenic,Peutz-Jeghers syndrome,GRCh38,single nucleotide variant
STK11,19,1220372,na,na,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
STK11,19,1207163,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome|not provided,GRCh38,single nucleotide variant
STK11,19,1207113,na,na,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
STK11,19,1207082,na,na,Pathogenic,Peutz-Jeghers syndrome,GRCh38,single nucleotide variant
STK11,19,1220396,na,na,Pathogenic,Malignant tumor of testis|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
STK11,19,1220488,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
STK11,19,1207021,na,na,Pathogenic,Carcinoma of pancreas,GRCh38,single nucleotide variant
STK11,19,1220416,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|Peutz-Jeghers syndrome",GRCh38,single nucleotide variant
STK11,19,1207058,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",GRCh38,single nucleotide variant
STK11,19,1219352,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",GRCh38,single nucleotide variant
STK11,19,1220700,na,na,Pathogenic,Peutz-Jeghers syndrome,GRCh38,single nucleotide variant
STK11,19,1221216,na,na,Pathogenic,Peutz-Jeghers syndrome,GRCh38,single nucleotide variant
STK11,19,1223126,na,na,Benign/Likely benign,"Hereditary cancer-predisposing syndrome|not specified|Peutz-Jeghers syndrome|Breast and/or ovarian cancer|Malignant tumor of breast|not provided|Peutz-Jeghers syndrome;Melanoma, cutaneous malignant, susceptibility to, 1;Carcinoma of pancreas;Germ cell tumor of testis",GRCh38,single nucleotide variant
KCNJ10,1,160042339,na,na,Pathogenic,EAST syndrome|Cerebellar ataxia;Bilateral sensorineural hearing impairment;Spastic diplegia;Renal tubular dysfunction;Microcephaly,GRCh38,single nucleotide variant
KCNJ10,1,160041938,na,na,Pathogenic/Likely pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,GRCh38,single nucleotide variant
KCNJ10,1,160042115,na,na,Pathogenic,EAST syndrome,GRCh38,single nucleotide variant
KCNJ10,1,160042042,na,na,Pathogenic,EAST syndrome,GRCh38,single nucleotide variant
KCNJ10,1,160042033,na,na,Pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,GRCh38,single nucleotide variant
KCNJ10,1,160041644,na,na,Pathogenic/Likely pathogenic,EAST syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome,GRCh38,single nucleotide variant
KCNJ10,1,160042304,na,na,Pathogenic,EAST syndrome,GRCh38,single nucleotide variant
KCNJ10,1,160041952,na,na,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;EAST syndrome,GRCh38,single nucleotide variant
KCNJ10,1,160041491,na,na,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 4|EAST syndrome|not provided|not specified|KCNJ10-related disorder,GRCh38,single nucleotide variant
ECM1,1,150511784,na,na,Pathogenic,Lipid proteinosis,GRCh38,single nucleotide variant
ECM1,1,150509696,na,na,Pathogenic,Lipid proteinosis|not provided,GRCh38,single nucleotide variant
ECM1,1,150510989,na,na,Likely pathogenic,Lipid proteinosis,GRCh38,single nucleotide variant
ECM1,1,150510970,na,na,Pathogenic,Lipid proteinosis,GRCh38,single nucleotide variant
HSPB1,7,76303841,na,na,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease|not provided",GRCh38,single nucleotide variant
HSPB1,7,76303816,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
HSPB1,7,76304007,na,na,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2F|not provided",GRCh38,single nucleotide variant
HSPB1,7,76304100,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",GRCh38,single nucleotide variant
HSPB1,7,76303843,na,na,Pathogenic,Charcot-Marie-Tooth disease axonal type 2F,GRCh38,single nucleotide variant
HSPB1,7,76304099,na,na,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",GRCh38,single nucleotide variant
HSPB1,7,76303855,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|HSPB1-related axonal neuropathies|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2F;Neuronopathy, distal hereditary motor, type 2B|not provided",GRCh38,single nucleotide variant
HSPB1,7,76303007,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B",GRCh38,single nucleotide variant
HTRA1,10,122461028,na,na,risk factor,Age related macular degeneration 7|Susceptibility to neovascular type of age-related macular degeneration,GRCh38,single nucleotide variant
HTRA1,10,122508758,na,na,Pathogenic/Likely pathogenic,CARASIL syndrome|not provided|HTRA1-related cerebral small vessel disease,GRCh38,single nucleotide variant
HTRA1,10,122506817,na,na,Pathogenic/Likely pathogenic,"CARASIL syndrome|Small vessel cerebrovascular disease|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2|Personality changes;Seizure;Cognitive impairment|not provided",GRCh38,single nucleotide variant
HTRA1,10,122506802,na,na,Pathogenic,CARASIL syndrome,GRCh38,single nucleotide variant
HTRA1,10,122489603,na,na,Pathogenic,"CARASIL syndrome|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2",GRCh38,single nucleotide variant
MYD88,3,38140510,na,na,Uncertain significance,Pyogenic bacterial infections due to MyD88 deficiency,GRCh38,single nucleotide variant
MYD88,3,38138978,na,na,Pathogenic,Pyogenic bacterial infections due to MyD88 deficiency,GRCh38,single nucleotide variant
VRK1,14,96876033,na,na,Pathogenic,"not provided|Pontocerebellar hypoplasia type 1A|Abnormality of the musculature|Inborn genetic diseases|Congenital pontocerebellar hypoplasia type 1|Neuronopathy, distal hereditary motor, autosomal recessive 10|Neuronopathy, distal hereditary motor, autosomal recessive 10;Pontocerebellar hypoplasia type 1A",GRCh38,single nucleotide variant
ESRRB,14,76439682,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,GRCh38,single nucleotide variant
ESRRB,14,76491683,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,GRCh38,single nucleotide variant
KRT81,12,52287112,na,na,Pathogenic,not provided|MONILETHRIX 2,GRCh38,single nucleotide variant
KRT81,12,52287145,na,na,Likely pathogenic,not provided|MONILETHRIX 2,GRCh38,single nucleotide variant
PITX1,5,135031290,na,na,Pathogenic,Clubfoot|not provided,GRCh38,single nucleotide variant
LHX4,1,180271834,na,na,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,GRCh38,single nucleotide variant
LHX4,1,180271856,na,na,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,GRCh38,single nucleotide variant
LHX4,1,180266393,na,na,Conflicting classifications of pathogenicity,Short stature-pituitary and cerebellar defects-small sella turcica syndrome|not provided,GRCh38,single nucleotide variant
LHX4,1,180271497,na,na,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,GRCh38,single nucleotide variant
LHX4,1,180274568,na,na,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,GRCh38,single nucleotide variant
NDUFS8,11,68033147,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided|Leigh syndrome",GRCh38,single nucleotide variant
NDUFS8,11,68033216,na,na,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",GRCh38,single nucleotide variant
NDUFS8,11,68033165,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2",GRCh38,single nucleotide variant
NDUFS8,11,68036293,na,na,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",GRCh38,single nucleotide variant
NDUFA2,5,140647251,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 13",GRCh38,single nucleotide variant
PEX1,7,92501562,na,na,Pathogenic,Peroxisome biogenesis disorder|Leber congenital amaurosis|Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B;Heimler syndrome 1;Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisomal disorder|Heimler syndrome 1|Inborn genetic diseases|Retinal dystrophy|not specified|Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisome biogenesis disorder due to PEX1 defect|Zellweger spectrum disorders|PEX1-related disorder,GRCh38,single nucleotide variant
PEX1,7,92504812,na,na,Likely pathogenic,Peroxisome biogenesis disorder 1A (Zellweger)|Zellweger spectrum disorders|Heimler syndrome 1|not provided|Peroxisome biogenesis disorder 1A (Zellweger);Peroxisome biogenesis disorder 1B;Heimler syndrome 1,GRCh38,single nucleotide variant
MYO9B,19,17203024,na,na,Benign,"Celiac disease, susceptibility to, 4",GRCh38,single nucleotide variant
COX10,17,14102230,na,na,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",GRCh38,single nucleotide variant
COX10,17,14102205,na,na,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",GRCh38,single nucleotide variant
COX10,17,14159926,na,na,Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",GRCh38,single nucleotide variant
COX10,17,14206888,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3|Mitochondrial complex IV deficiency, nuclear type 1|not provided",GRCh38,single nucleotide variant
COX10,17,14206888,na,na,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",GRCh38,single nucleotide variant
COX10,17,14069607,na,na,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",GRCh38,single nucleotide variant
DIAPH1,5,141524142,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 1|Autosomal dominant nonsyndromic hearing loss 1;Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,GRCh38,single nucleotide variant
FGF10,5,44305045,na,na,Pathogenic/Likely pathogenic,Congenital absence of salivary gland|not provided,GRCh38,single nucleotide variant
FGF10,5,44388366,na,na,Pathogenic,Lacrimoauriculodentodigital syndrome 3,GRCh38,single nucleotide variant
FGF10,5,44305155,na,na,Pathogenic,Lacrimoauriculodentodigital syndrome 3,GRCh38,single nucleotide variant
FGF10,5,44310447,na,na,Pathogenic,Congenital absence of salivary gland|Lacrimoauriculodentodigital syndrome 3,GRCh38,single nucleotide variant
FGF10,5,44388443,na,na,Conflicting classifications of pathogenicity,Congenital absence of salivary gland|Levy-Hollister syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
FGF10,5,44310443,na,na,Pathogenic,Congenital absence of salivary gland,GRCh38,single nucleotide variant
KMT2D,12,49026430,na,na,Pathogenic/Likely pathogenic,Kabuki syndrome|not provided|Kabuki syndrome 1,GRCh38,single nucleotide variant
KMT2D,12,49030985,na,na,Pathogenic,Kabuki syndrome 1,GRCh38,single nucleotide variant
KMT2D,12,49022332,na,na,Pathogenic,Kabuki syndrome 1|Inborn genetic diseases|Kabuki syndrome|not provided,GRCh38,single nucleotide variant
KMT2D,12,49022301,na,na,Conflicting classifications of pathogenicity,Kabuki syndrome 1|not provided|Kabuki syndrome,GRCh38,single nucleotide variant
MATN3,2,20005953,na,na,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia,GRCh38,single nucleotide variant
MATN3,2,20006173,na,na,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 5|not provided|Spondyloepimetaphyseal dysplasia, matrilin-3 type|Multiple epiphyseal dysplasia|Inborn genetic diseases",GRCh38,single nucleotide variant
MATN3,2,20003169,na,na,Benign,"Osteoarthritis susceptibility 2|not specified|not provided|Multiple epiphyseal dysplasia type 5|Connective tissue disorder|MATN3-related disorder|Osteoarthritis susceptibility 2;Multiple epiphyseal dysplasia type 5;Spondyloepimetaphyseal dysplasia, matrilin-3 type",GRCh38,single nucleotide variant
MATN3,2,20005878,na,na,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia|not provided,GRCh38,single nucleotide variant
MATN3,2,20003167,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",GRCh38,single nucleotide variant
MATN3,2,20012423,na,na,Uncertain significance,Multiple epiphyseal dysplasia type 5|not provided|Multiple epiphyseal dysplasia,GRCh38,single nucleotide variant
MATN3,2,20006152,na,na,Pathogenic,Multiple epiphyseal dysplasia type 5,GRCh38,single nucleotide variant
SH3BP2,4,2831582,na,na,Pathogenic/Likely pathogenic,Fibrous dysplasia of jaw,GRCh38,single nucleotide variant
SH3BP2,4,2831582,na,na,Pathogenic,Fibrous dysplasia of jaw|not provided,GRCh38,single nucleotide variant
SH3BP2,4,2831582,na,na,Pathogenic,Fibrous dysplasia of jaw,GRCh38,single nucleotide variant
SH3BP2,4,2831573,na,na,Pathogenic,Fibrous dysplasia of jaw,GRCh38,single nucleotide variant
SH3BP2,4,2831573,na,na,Pathogenic,Fibrous dysplasia of jaw|not provided,GRCh38,single nucleotide variant
SH3BP2,4,2831587,na,na,Pathogenic,Fibrous dysplasia of jaw,GRCh38,single nucleotide variant
SH3BP2,4,2831588,na,na,Uncertain significance,Fibrous dysplasia of jaw,GRCh38,single nucleotide variant
LTBP2,14,74555629,na,na,Pathogenic,"Glaucoma 3, primary congenital, D|Microspherophakia|not provided|Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma",GRCh38,single nucleotide variant
LTBP2,14,74611614,na,na,Pathogenic,"Glaucoma 3, primary congenital, D",GRCh38,single nucleotide variant
LTBP3,11,65546473,na,na,Pathogenic,Brachyolmia-amelogenesis imperfecta syndrome,GRCh38,single nucleotide variant
TBX1,22,19763273,na,na,Pathogenic,Conotruncal anomaly face syndrome,GRCh38,single nucleotide variant
TBX1,22,19765921,na,na,Benign,DiGeorge syndrome|Cardiovascular phenotype|not provided,GRCh38,single nucleotide variant
TBX1,22,19764224,na,na,Pathogenic,Velocardiofacial syndrome,GRCh38,single nucleotide variant
KLF6,10,3781971,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
KLF6,10,3781907,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
KLF6,10,3781949,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
KLF6,10,3782127,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
KLF6,10,3781811,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
KLF6,10,3781852,na,na,Pathogenic,Gastric cancer,GRCh38,single nucleotide variant
RAC2,22,37232857,na,na,Pathogenic,Neutrophil immunodeficiency syndrome,GRCh38,single nucleotide variant
UCP3,11,74006202,na,na,Benign,"Obesity, severe, and type II diabetes|UCP3 POLYMORPHISM G/A|Inherited obesity|Short-rib thoracic dysplasia 13 with or without polydactyly|not provided",GRCh38,single nucleotide variant
UCP3,11,74005844,na,na,Conflicting classifications of pathogenicity,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",GRCh38,single nucleotide variant
UCP3,11,74003826,na,na,Benign,"not provided|UCP3 POLYMORPHISM, EXON 6 SPLICE DONOR JUNCTION|Morbid obesity|UCP3-related disorder",GRCh38,single nucleotide variant
UCP3,11,74006298,na,na,Uncertain significance,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",GRCh38,single nucleotide variant
PHYH,10,13283695,na,na,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|Phytanic acid storage disease",GRCh38,single nucleotide variant
PHYH,10,13295608,na,na,Pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease|not provided|Retinitis pigmentosa|PHYH-related disorder|Retinal dystrophy",GRCh38,single nucleotide variant
PHYH,10,13298236,na,na,Benign,not provided|Phytanic acid storage disease|not specified,GRCh38,single nucleotide variant
PHYH,10,13283713,na,na,Pathogenic,"REFSUM DISEASE, ADULT, 1",GRCh38,single nucleotide variant
PHYH,10,13288512,na,na,Pathogenic,"REFSUM DISEASE, ADULT, 1",GRCh38,single nucleotide variant
PHYH,10,13288428,na,na,Likely pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease",GRCh38,single nucleotide variant
PHYH,10,13283694,na,na,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Phytanic acid storage disease",GRCh38,single nucleotide variant
CLCNKA,1,16024773,na,na,Pathogenic,Bartter disease type 4B,GRCh38,single nucleotide variant
CLCNKA,1,16027432,na,na,Pathogenic,Bartter disease type 4B,GRCh38,single nucleotide variant
CLCNKB,1,16047917,na,na,Pathogenic,Bartter disease type 3|not provided,GRCh38,single nucleotide variant
CLCNKB,1,16048537,na,na,Pathogenic/Likely pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,GRCh38,single nucleotide variant
CLCNKB,1,16051724,na,na,Pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,GRCh38,single nucleotide variant
CLCNKB,1,16050593,na,na,Pathogenic,Bartter disease type 3,GRCh38,single nucleotide variant
CLCNKB,1,16051544,na,na,Pathogenic,Bartter disease type 3,GRCh38,single nucleotide variant
CLCNKB,1,16049616,na,na,Pathogenic,Bartter disease type 3|Bartter disease type 4B;Bartter disease type 3|not provided,GRCh38,single nucleotide variant
CLCNKB,1,16055508,na,na,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria|not provided|Bartter disease type 4B;Bartter disease type 3|Bartter disease type 3",GRCh38,single nucleotide variant
CLCNKB,1,16046534,na,na,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria",GRCh38,single nucleotide variant
CLCNKB,1,16055759,na,na,Pathogenic,"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS",GRCh38,single nucleotide variant
OGG1,3,9750423,na,na,Uncertain significance,Clear cell carcinoma of kidney|not provided,GRCh38,single nucleotide variant
PKP1,1,201317635,na,na,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,GRCh38,single nucleotide variant
PKP1,1,201320265,na,na,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,GRCh38,single nucleotide variant
CACNB4,2,151839238,na,na,risk factor,"Epilepsy, juvenile myoclonic, susceptibility to, 6",GRCh38,single nucleotide variant
CACNB4,2,151880879,na,na,Conflicting classifications of pathogenicity,"Episodic ataxia type 5|Epilepsy, idiopathic generalized, susceptibility to, 9|not provided|Juvenile myoclonic epilepsy|Idiopathic generalized epilepsy|CACNB4-related disorder",GRCh38,single nucleotide variant
KRT86,12,52306270,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
KRT86,12,52306272,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
KRT86,12,52306237,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
KRT86,12,52302256,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
KRT86,12,52306237,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
KRT86,12,52302269,na,na,Pathogenic,Monilethrix|not provided,GRCh38,single nucleotide variant
JAG1,20,10641459,na,na,Pathogenic,Alagille syndrome due to a JAG1 point mutation,GRCh38,single nucleotide variant
JAG1,20,10658612,na,na,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|JAG1-related disorder|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",GRCh38,single nucleotide variant
JAG1,20,10658611,na,na,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|Arteriohepatic dysplasia|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",GRCh38,single nucleotide variant
JAG1,20,10652533,na,na,Likely pathogenic,Tetralogy of Fallot|Alagille syndrome due to a JAG1 point mutation,GRCh38,single nucleotide variant
JAG1,20,10672978,na,na,Pathogenic,Alagille syndrome due to a JAG1 point mutation|Arteriohepatic dysplasia,GRCh38,single nucleotide variant
JAG1,20,10656452,na,na,Likely pathogenic,"Deafness, congenital heart defects, and posterior embryotoxon",GRCh38,single nucleotide variant
WNT10B,12,48966271,na,na,Pathogenic,Split hand-foot malformation 6|not provided,GRCh38,single nucleotide variant
GHSR,3,172447803,na,na,Conflicting classifications of pathogenicity,Short stature due to growth hormone secretagogue receptor deficiency|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
GHSR,3,172448408,na,na,Pathogenic,Short stature due to growth hormone secretagogue receptor deficiency,GRCh38,single nucleotide variant
GHSR,3,172447705,na,na,Uncertain significance,Short stature due to growth hormone secretagogue receptor deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
RAX,18,59272465,na,na,Pathogenic,Isolated microphthalmia 3,GRCh38,single nucleotide variant
RAX,18,59269470,na,na,Pathogenic,Isolated microphthalmia 3,GRCh38,single nucleotide variant
RAX,18,59269136,na,na,Pathogenic,Isolated microphthalmia 3,GRCh38,single nucleotide variant
LEFTY2,1,225937602,na,na,Uncertain significance,Left-right axis malformations,GRCh38,single nucleotide variant
LEFTY2,1,225937517,na,na,Uncertain significance,Left-right axis malformations,GRCh38,single nucleotide variant
PLOD2,3,146071386,na,na,Pathogenic,Bruck syndrome 2,GRCh38,single nucleotide variant
PLOD2,3,146071407,na,na,Pathogenic,Bruck syndrome 2,GRCh38,single nucleotide variant
PLOD2,3,146071416,na,na,Likely pathogenic,Bruck syndrome 2,GRCh38,single nucleotide variant
RFX5,1,151346200,na,na,Pathogenic,MHC class II deficiency 3,GRCh38,single nucleotide variant
RFX5,1,151343005,na,na,Likely benign,not specified|MHC class II deficiency 3,GRCh38,single nucleotide variant
RFX5,1,151344848,na,na,Pathogenic,MHC class II deficiency 3|not provided,GRCh38,single nucleotide variant
RFX5,1,151345189,na,na,Pathogenic,MHC class II deficiency 3,GRCh38,single nucleotide variant
RFX5,1,151344444,na,na,Uncertain significance,MHC class II deficiency|MHC class II deficiency 5,GRCh38,single nucleotide variant
RFXAP,13,36819520,na,na,Pathogenic,MHC class II deficiency 4,GRCh38,single nucleotide variant
HSD17B4,5,119452621,na,na,Conflicting classifications of pathogenicity,Bifunctional peroxisomal enzyme deficiency|not provided|Perrault syndrome;Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|HSD17B4-related disorder|Perrault syndrome|Perrault syndrome 1;Bifunctional peroxisomal enzyme deficiency,GRCh38,single nucleotide variant
HSD17B4,5,119509176,na,na,Pathogenic/Likely pathogenic,Bifunctional peroxisomal enzyme deficiency|not provided|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome 1|not specified,GRCh38,single nucleotide variant
HSD17B4,5,119475838,na,na,Pathogenic,Bifunctional peroxisomal enzyme deficiency,GRCh38,single nucleotide variant
WNK4,17,42787494,na,na,Pathogenic,Pseudohypoaldosteronism type 2B,GRCh38,single nucleotide variant
WNK4,17,42787485,na,na,Pathogenic,Pseudohypoaldosteronism type 2B,GRCh38,single nucleotide variant
WNK4,17,42787492,na,na,Pathogenic,Pseudohypoaldosteronism type 2B,GRCh38,single nucleotide variant
WNK4,17,42796244,na,na,Conflicting classifications of pathogenicity,Pseudohypoaldosteronism type 2B|not provided,GRCh38,single nucleotide variant
SLC5A5,19,17881961,na,na,Pathogenic,Thyroid dyshormonogenesis 1|not provided,GRCh38,single nucleotide variant
SLC5A5,19,17877840,na,na,Pathogenic,not provided|Thyroid dyshormonogenesis 1,GRCh38,single nucleotide variant
SLC5A5,19,17877823,na,na,Likely pathogenic,Thyroid dyshormonogenesis 1|not provided,GRCh38,single nucleotide variant
SLC5A5,19,17888397,na,na,Pathogenic,Thyroid dyshormonogenesis 1|not provided|SLC5A5-related disorder,GRCh38,single nucleotide variant
SLC5A5,19,17872596,na,na,Pathogenic,Thyroid dyshormonogenesis 1,GRCh38,single nucleotide variant
SLC5A5,19,17888432,na,na,Pathogenic,Thyroid dyshormonogenesis 1,GRCh38,single nucleotide variant
SLC5A5,19,17882160,na,na,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 1|Congenital hypothyroidism|not provided,GRCh38,single nucleotide variant
LIG4,13,108209531,na,na,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Multiple myeloma;DNA ligase IV deficiency,GRCh38,single nucleotide variant
LIG4,13,108208829,na,na,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Inborn genetic diseases|Multiple myeloma;DNA ligase IV deficiency|prenatal LIG4 syndrome with aqueductal stenosis|LIG4-related disorder,GRCh38,single nucleotide variant
LIG4,13,108209863,na,na,Pathogenic,DNA ligase IV deficiency,GRCh38,single nucleotide variant
LIG4,13,108210436,na,na,Pathogenic,DNA ligase IV deficiency|not provided|Severe combined immunodeficiency disease,GRCh38,single nucleotide variant
LIG4,13,108211261,na,na,Benign/Likely benign,"Multiple myeloma, resistance to|Severe combined immunodeficiency due to DCLRE1C deficiency|not specified|DNA ligase IV deficiency|not provided",GRCh38,single nucleotide variant
LIG4,13,108211243,na,na,Benign/Likely benign,"Multiple myeloma, resistance to|not specified|DNA ligase IV deficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided",GRCh38,single nucleotide variant
NR4A2,2,156332598,na,na,Uncertain significance,"Parkinson disease, late-onset",GRCh38,single nucleotide variant
NDUFS7,19,1391006,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|not provided|Leigh syndrome",GRCh38,single nucleotide variant
NDUFS7,19,1391144,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3",GRCh38,single nucleotide variant
NDUFS7,19,1386644,na,na,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|Leigh syndrome",GRCh38,single nucleotide variant
FXYD2,11,117822424,na,na,Pathogenic,Renal hypomagnesemia 2|not provided,GRCh38,single nucleotide variant
MCM6,2,135851076,na,na,association,LACTASE PERSISTENCE,GRCh38,single nucleotide variant
MCM6,2,135859184,na,na,association,LACTASE PERSISTENCE,GRCh38,single nucleotide variant
MCM6,2,135851176,na,na,association,LACTASE PERSISTENCE,GRCh38,single nucleotide variant
MCM6,2,135851081,na,na,association,LACTASE PERSISTENCE,GRCh38,single nucleotide variant
MCM6,2,135851073,na,na,association,LACTASE PERSISTENCE,GRCh38,single nucleotide variant
HESX1,3,57198277,na,na,Pathogenic,Septo-optic dysplasia sequence|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence,GRCh38,single nucleotide variant
HESX1,3,57198246,na,na,Uncertain significance,"SEPTOOPTIC DYSPLASIA, MILD|not provided|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|HESX1-related disorder|Septo-optic dysplasia sequence",GRCh38,single nucleotide variant
HESX1,3,57198214,na,na,Conflicting classifications of pathogenicity,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES|not provided|Septo-optic dysplasia sequence|Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES|Inborn genetic diseases,GRCh38,single nucleotide variant
HESX1,3,57199842,na,na,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",GRCh38,single nucleotide variant
HESX1,3,57198751,na,na,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",GRCh38,single nucleotide variant
HESX1,3,57198405,na,na,Pathogenic,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES,GRCh38,single nucleotide variant
HESX1,3,57199901,na,na,Uncertain significance,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|not provided|not specified",GRCh38,single nucleotide variant
PEX14,1,10624405,na,na,Pathogenic,Peroxisome biogenesis disorder 13A (Zellweger),GRCh38,single nucleotide variant
PEX13,2,61032028,na,na,Pathogenic,Peroxisome biogenesis disorder 11A (Zellweger),GRCh38,single nucleotide variant
PEX13,2,61048535,na,na,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 11B|not provided|Peroxisome biogenesis disorder 11A (Zellweger)|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
MSTN,2,190062219,na,na,Pathogenic,Myostatin-related muscle hypertrophy,GRCh38,single nucleotide variant
PMM2,16,8811153,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Cerebellar ataxia|Inborn genetic diseases|Congenital disorder of glycosylation|Muscular dystrophy;Cerebellar ataxia;Congenital cerebellar hypoplasia;Diabetes mellitus|6 conditions|Congenital cerebellar hypoplasia|PMM2-related disorder|Congenital disorder of glycosylation type I|Focal segmental glomerulosclerosis,GRCh38,single nucleotide variant
PMM2,16,8847731,na,na,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8811116,na,na,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8811674,na,na,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8804781,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8811088,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|PMM2-related disorder,GRCh38,single nucleotide variant
PMM2,16,8813030,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8811080,na,na,Likely pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8847753,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8847794,na,na,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided|See cases|PMM2-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
PMM2,16,8847806,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|PMM2-related disorder,GRCh38,single nucleotide variant
PMM2,16,8811126,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8847775,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,GRCh38,single nucleotide variant
PMM2,16,8797908,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8801827,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8847761,na,na,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8806398,na,na,Pathogenic,PMM2-congenital disorder of glycosylation|6 conditions|not provided|PMM2-related disorder,GRCh38,single nucleotide variant
PMM2,16,8801863,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PMM2,16,8806315,na,na,Pathogenic,PMM2-congenital disorder of glycosylation,GRCh38,single nucleotide variant
CYP1B1,2,38075207,na,na,Pathogenic,"Glaucoma 3A|not provided|Anterior segment dysgenesis 6|Congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A|Primary congenital glaucoma|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B",GRCh38,single nucleotide variant
CYP1B1,2,38071261,na,na,Pathogenic,Glaucoma 3A,GRCh38,single nucleotide variant
CYP1B1,2,38070949,na,na,Pathogenic,Glaucoma 3A|not provided|Congenital glaucoma|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A|Anterior segment dysgenesis 6|Primary congenital glaucoma,GRCh38,single nucleotide variant
CYP1B1,2,38071234,na,na,Likely pathogenic,Glaucoma 3A,GRCh38,single nucleotide variant
CYP1B1,2,38071195,na,na,Pathogenic/Likely pathogenic,Glaucoma 3A|not provided|Glaucoma of childhood|Congenital glaucoma|Primary congenital glaucoma|Anterior segment dysgenesis 6|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A,GRCh38,single nucleotide variant
CYP1B1,2,38075387,na,na,Pathogenic/Likely pathogenic,Anterior segment dysgenesis 6|Primary congenital glaucoma|Congenital glaucoma,GRCh38,single nucleotide variant
CYP1B1,2,38075218,na,na,Pathogenic/Likely pathogenic,"Irido-corneo-trabecular dysgenesis|Glaucoma 3A|CYP1B1-related disorder|not provided|Glaucoma 3A;Glaucoma 3, primary infantile, B;Anterior segment dysgenesis 6|Anterior segment dysgenesis|Anterior segment dysgenesis 6|Congenital glaucoma|Glaucoma 3A;Anterior segment dysgenesis 6",GRCh38,single nucleotide variant
CYP1B1,2,38071251,na,na,Conflicting classifications of pathogenicity,"Glaucoma, early-onset, digenic|Glaucoma 3A|Congenital ocular coloboma|Congenital glaucoma|not specified|Irido-corneo-trabecular dysgenesis;Glaucoma 3A|not provided|Myopathy, centronuclear, 5|CYP1B1-related disorder|Primary congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B|Anterior segment dysgenesis 6",GRCh38,single nucleotide variant
CYP1B1,2,38074695,na,na,Likely pathogenic,Glaucoma 3A|Primary congenital glaucoma,GRCh38,single nucleotide variant
CYP1B1,2,38071087,na,na,Likely pathogenic,"Glaucoma, primary open angle, juvenile-onset|Glaucoma 3A|Primary congenital glaucoma|Congenital glaucoma",GRCh38,single nucleotide variant
CYP1B1,2,38075148,na,na,Conflicting classifications of pathogenicity,Primary open angle glaucoma|not specified|Congenital ocular coloboma|Irido-corneo-trabecular dysgenesis|not provided|Congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis,GRCh38,single nucleotide variant
VDR,12,47879016,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47865106,na,na,Pathogenic/Likely pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47846679,na,na,Pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47846374,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47865085,na,na,Conflicting classifications of pathogenicity,Vitamin D-dependent rickets type II with alopecia|not provided,GRCh38,single nucleotide variant
VDR,12,47865175,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47857512,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47846743,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47878977,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47846444,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47846418,na,na,Uncertain significance,Vitamin D-dependent rickets type II with alopecia|not provided,GRCh38,single nucleotide variant
VDR,12,47844859,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia,GRCh38,single nucleotide variant
VDR,12,47879026,na,na,Pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,GRCh38,single nucleotide variant
VDR,12,47844994,na,na,Likely pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,GRCh38,single nucleotide variant
CASP8,2,201276908,na,na,Likely pathogenic,Autoimmune lymphoproliferative syndrome type 2B,GRCh38,single nucleotide variant
CASP8,2,201284866,na,na,Benign,"BREAST CANCER, PROTECTION AGAINST|not specified|not provided|Autoimmune lymphoproliferative syndrome type 2B",GRCh38,single nucleotide variant
CASP10,2,201208114,na,na,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,GRCh38,single nucleotide variant
CASP10,2,201209388,na,na,Pathogenic,Non-Hodgkin lymphoma,GRCh38,single nucleotide variant
CASP10,2,201205929,na,na,Pathogenic,Non-Hodgkin lymphoma|Gastric cancer,GRCh38,single nucleotide variant
CASP10,2,201187798,na,na,Uncertain significance,Gastric cancer|Autoimmune lymphoproliferative syndrome type 1|Autoimmune lymphoproliferative syndrome type 2A,GRCh38,single nucleotide variant
CASP10,2,201209363,na,na,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,GRCh38,single nucleotide variant
PEX12,17,35576171,na,na,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger),GRCh38,single nucleotide variant
PEX12,17,35577180,na,na,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger)|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PEX12,17,35575903,na,na,Pathogenic/Likely pathogenic,Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A (Zellweger)|not provided|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B,GRCh38,single nucleotide variant
PFKM,12,48131394,na,na,Pathogenic,Peroxisomal biogenesis disorder 3b,GRCh38,single nucleotide variant
PEX12,17,35577445,na,na,Pathogenic,Peroxisomal biogenesis disorder 3b,GRCh38,single nucleotide variant
PEX12,17,35575913,na,na,Conflicting classifications of pathogenicity,Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B,GRCh38,single nucleotide variant
PEX7,6,136898213,na,na,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|not provided|PEX7-related disorder|Peroxisome biogenesis disorder 9B|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease,GRCh38,single nucleotide variant
PEX7,6,136869909,na,na,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Peroxisome biogenesis disorder 9B;Phytanic acid storage disease;Rhizomelic chondrodysplasia punctata type 1|Rhizomelic chondrodysplasia punctata|PEX7-related disorder,GRCh38,single nucleotide variant
PEX7,6,136869905,na,na,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,GRCh38,single nucleotide variant
PEX7,6,136869950,na,na,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata,GRCh38,single nucleotide variant
PEX7,6,136898242,na,na,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|PEX7-related disorder|not provided|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,GRCh38,single nucleotide variant
PEX7,6,136845620,na,na,Pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1,GRCh38,single nucleotide variant
PEX7,6,136845605,na,na,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Retinal dystrophy|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|not provided|Phytanic acid storage disease|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PEX7,6,136822785,na,na,Pathogenic,Peroxisome biogenesis disorder 9B|PEX7-related disorder|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Phytanic acid storage disease;Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
PEX7,6,136822705,na,na,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,GRCh38,single nucleotide variant
GALNT3,2,165754931,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
GALNT3,2,165770217,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
GALNT3,2,165754927,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
GALNT3,2,165765058,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
GALNT3,2,165749747,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
GALNT3,2,165758862,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
GALNT3,2,165759443,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
GALNT3,2,165755015,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
GALNT3,2,165761928,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
GALNT3,2,165754626,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",GRCh38,single nucleotide variant
GALNT3,2,165749801,na,na,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",GRCh38,single nucleotide variant
OSMR,5,38925231,na,na,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",GRCh38,single nucleotide variant
OSMR,5,38923237,na,na,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",GRCh38,single nucleotide variant
ATIC,2,215344828,na,na,Conflicting classifications of pathogenicity,AICA-ribosiduria|not provided|See cases,GRCh38,single nucleotide variant
PTEN,10,87933145,na,na,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm|Malignant tumor of urinary bladder,GRCh38,single nucleotide variant
PTEN,10,87957915,na,na,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Ovarian neoplasm|Macrocephaly-autism syndrome|Abnormal cardiovascular system morphology|Cowden syndrome|PTEN-related disorder|Gastric cancer|Glioma susceptibility 2,GRCh38,single nucleotide variant
PTEN,10,87933228,na,na,Pathogenic,Lhermitte-Duclos disease|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1,GRCh38,single nucleotide variant
PTEN,10,87952135,na,na,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87933127,na,na,Pathogenic,Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|PTEN-related disorder|Neoplasm,GRCh38,single nucleotide variant
PTEN,10,87933129,na,na,Pathogenic,Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Gastric cancer,GRCh38,single nucleotide variant
PTEN,10,87933147,na,na,Pathogenic,Macrocephaly-autism syndrome|Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Abnormal cardiovascular system morphology|Glioma susceptibility 2|Rhabdomyosarcoma|Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer;Familial meningioma;Macrocephaly-autism syndrome|Gastric cancer|Neoplasm|Cowden syndrome 1;Macrocephaly-autism syndrome|Cowden syndrome 1;Familial prostate cancer;Glioma susceptibility 2;Familial meningioma;Macrocephaly-autism syndrome|PTEN-related disorder|Cowden syndrome,GRCh38,single nucleotide variant
PTEN,10,87931090,na,na,Pathogenic,Endometrial carcinoma|not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|Neoplasm,GRCh38,single nucleotide variant
PTEN,10,87933253,na,na,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided,GRCh38,single nucleotide variant
PTEN,10,87894049,na,na,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87925557,na,na,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Cowden syndrome 1;Prostate cancer;Familial meningioma;Macrocephaly-autism syndrome;Glioma susceptibility 2|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
PTEN,10,87957858,na,na,Pathogenic,Cowden syndrome 1|Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
PTEN,10,87957984,na,na,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87933148,na,na,Pathogenic,Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Ovarian neoplasm|not provided|Cowden syndrome|PTEN-related disorder,GRCh38,single nucleotide variant
PTEN,10,87952189,na,na,Likely pathogenic,"Prostate cancer, somatic|PTEN hamartoma tumor syndrome",GRCh38,single nucleotide variant
PTEN,10,87933094,na,na,Pathogenic,Lhermitte-Duclos disease|not provided,GRCh38,single nucleotide variant
PTEN,10,87961095,na,na,Pathogenic,not provided|Proteus-like syndrome|Macrocephaly-autism syndrome|PTEN-related disorder|Cowden syndrome 1|Ovarian neoplasm|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Macrocephaly-autism syndrome;Cowden syndrome|Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer;Familial meningioma;Macrocephaly-autism syndrome|Abnormality of the nervous system|Cowden syndrome 1;Macrocephaly-autism syndrome|Cowden syndrome|Neoplasm|Familial cancer of breast,GRCh38,single nucleotide variant
PTEN,10,87952258,na,na,Pathogenic,Melanoma|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|not provided|PTEN-related disorder|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87864524,na,na,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87957867,na,na,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
PTEN,10,87957919,na,na,Uncertain significance,Glioma susceptibility 2|Meningioma|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided|Macrocephaly-autism syndrome,GRCh38,single nucleotide variant
PTEN,10,87925529,na,na,Likely pathogenic,Vater association with macrocephaly and ventriculomegaly|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87933121,na,na,Pathogenic,Squamous cell carcinoma of the head and neck,GRCh38,single nucleotide variant
PTEN,10,87863705,na,na,Uncertain significance,not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|7 conditions|Hereditary cancer-predisposing syndrome|not specified|Glioma susceptibility 2,GRCh38,single nucleotide variant
PTEN,10,87863608,na,na,Uncertain significance,Cowden syndrome 1|PTEN hamartoma tumor syndrome,GRCh38,single nucleotide variant
PTEN,10,87933037,na,na,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|not provided,GRCh38,single nucleotide variant
PTEN,10,87957973,na,na,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2,GRCh38,single nucleotide variant
PTEN,10,87957940,na,na,Likely pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided,GRCh38,single nucleotide variant
PTEN,10,87933154,na,na,Pathogenic/Likely pathogenic,PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1|Glioma susceptibility 2|PTEN-related disorder,GRCh38,single nucleotide variant
NEUROD1,2,181678529,na,na,Pathogenic,Type 2 diabetes mellitus,GRCh38,single nucleotide variant
TBX4,17,61479921,na,na,Pathogenic,Coxopodopatellar syndrome,GRCh38,single nucleotide variant
TBX4,17,61456674,na,na,Pathogenic,Coxopodopatellar syndrome,GRCh38,single nucleotide variant
TBX4,17,61483470,na,na,Pathogenic,Coxopodopatellar syndrome,GRCh38,single nucleotide variant
STXBP2,19,7646322,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 5|STXBP2-related disorder|Familial hemophagocytic lymphohistiocytosis,GRCh38,single nucleotide variant
STXBP2,19,7642081,na,na,Uncertain significance,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE|not specified",GRCh38,single nucleotide variant
PTGIS,20,49511026,na,na,Pathogenic,Essential hypertension,GRCh38,single nucleotide variant
UCP2,11,73983709,na,na,risk factor,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4,GRCh38,single nucleotide variant
TGFBI,5,136056780,na,na,Pathogenic,Groenouw corneal dystrophy type I|7 conditions|Lattice corneal dystrophy Type I|not provided,GRCh38,single nucleotide variant
TGFBI,5,136056781,na,na,Pathogenic,Thiel-Behnke corneal dystrophy|not provided,GRCh38,single nucleotide variant
TGFBI,5,136046406,na,na,Pathogenic,Lattice corneal dystrophy Type I|Epithelial-stromal TGFBI dystrophy|not provided,GRCh38,single nucleotide variant
TGFBI,5,136046407,na,na,Pathogenic,Avellino corneal dystrophy|not provided|Lattice corneal dystrophy Type I,GRCh38,single nucleotide variant
TGFBI,5,136055770,na,na,Pathogenic/Likely pathogenic,"Corneal dystrophy, lattice type 3A|Corneal dystrophy|not specified|not provided|7 conditions",GRCh38,single nucleotide variant
TGFBI,5,136046407,na,na,Pathogenic,Reis-Bucklers' corneal dystrophy|Avellino corneal dystrophy|not provided,GRCh38,single nucleotide variant
TGFBI,5,136046406,na,na,Pathogenic,Groenouw corneal dystrophy type I|Epithelial-stromal TGFBI dystrophy,GRCh38,single nucleotide variant
TGFBI,5,136056754,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
TGFBI,5,136056736,na,na,Pathogenic,"Corneal dystrophy, lattice type 3A",GRCh38,single nucleotide variant
TGFBI,5,136060898,na,na,Pathogenic,Reis-Bucklers' corneal dystrophy,GRCh38,single nucleotide variant
TGFBI,5,136055795,na,na,Pathogenic,Epithelial basement membrane dystrophy,GRCh38,single nucleotide variant
TGFBI,5,136062674,na,na,Conflicting classifications of pathogenicity,Epithelial basement membrane dystrophy|Corneal dystrophy|not specified|not provided|7 conditions,GRCh38,single nucleotide variant
ABCA4,1,94051698,na,na,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|Retinitis pigmentosa|Peripheral neuropathy;Abnormal macular morphology|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa 19;Cone-rod dystrophy 3;Age-related macular degeneration|Inborn genetic diseases|Stargardt disease|Age related macular degeneration 2|ABCA4-related disorder|Retinitis pigmentosa 19|Stargardt disease 3|Retinitis pigmentosa 19;Age related macular degeneration 2;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|Retinitis pigmentosa 19;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy,GRCh38,single nucleotide variant
ABCA4,1,94047046,na,na,Conflicting classifications of pathogenicity,not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease|Retinitis pigmentosa 19|Retinal dystrophy|not specified|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|ABCA4-related disorder,GRCh38,single nucleotide variant
ABCA4,1,94043443,na,na,Uncertain significance,Severe early-childhood-onset retinal dystrophy|not provided,GRCh38,single nucleotide variant
ABCA4,1,94005509,na,na,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|Retinal dystrophy|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Stargardt disease|Age related macular degeneration 2,GRCh38,single nucleotide variant
ABCA4,1,94055133,na,na,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,GRCh38,single nucleotide variant
ABCA4,1,94001992,na,na,Conflicting classifications of pathogenicity,"Severe early-childhood-onset retinal dystrophy|not provided|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|not specified|Macular degeneration|Stargardt Disease, Recessive|Retinal dystrophy|ABCA4-related disorder|Retinitis pigmentosa|Cone dystrophy|Retinitis pigmentosa 19;Age related macular degeneration 2;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|Stargardt disease",GRCh38,single nucleotide variant
ABCA4,1,93998061,na,na,Benign/Likely benign,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Cone-Rod Dystrophy, Recessive|not specified|Macular degeneration|Retinitis Pigmentosa, Recessive|Stargardt Disease, Recessive|ABCA4-related disorder",GRCh38,single nucleotide variant
ABCA4,1,94043420,na,na,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Stargardt disease|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2,GRCh38,single nucleotide variant
ABCA4,1,94008251,na,na,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance","MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|Macular dystrophy|Age related macular degeneration 2|Stargardt disease|Retinal dystrophy|ABCA4-related disorder|Retinitis pigmentosa 19|Inborn genetic diseases|Retinitis pigmentosa 19;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|not specified|Retinitis pigmentosa|Cone dystrophy|ABCA4-related retinopathy|Retinitis pigmentosa 19;Age related macular degeneration 2;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|Syndromic retinitis pigmentosa|See cases",GRCh38,single nucleotide variant
ABCA4,1,94007731,na,na,Conflicting classifications of pathogenicity,Stargardt disease|not provided|not specified|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Vitreoretinopathy|Retinal dystrophy,GRCh38,single nucleotide variant
ABCA4,1,94007727,na,na,Pathogenic,Stargardt disease|not provided,GRCh38,single nucleotide variant
ABCA4,1,94043413,na,na,Pathogenic/Likely pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|not specified|ABCA4-related disorder|Retinitis pigmentosa 19;Age related macular degeneration 2;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|Age related macular degeneration 2|Optic atrophy|Retinitis pigmentosa 19;Cone-rod dystrophy 3,GRCh38,single nucleotide variant
ABCA4,1,94080559,na,na,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,GRCh38,single nucleotide variant
ABCA4,1,94098928,na,na,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Stargardt disease|Retinal dystrophy|Stargardt disease 3,GRCh38,single nucleotide variant
ABCA4,1,94120994,na,na,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Stargardt disease 3,GRCh38,single nucleotide variant
ABCA4,1,94063157,na,na,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3,GRCh38,single nucleotide variant
ABCA4,1,94063250,na,na,Conflicting classifications of pathogenicity,not provided|Severe early-childhood-onset retinal dystrophy|Retinal dystrophy|Stargardt disease|Macular dystrophy|not specified|Age related macular degeneration 2|ABCA4-related disorder|Retinitis pigmentosa,GRCh38,single nucleotide variant
ABCA4,1,94040048,na,na,Benign/Likely benign,"Cone-rod dystrophy 3|not provided|not specified|Cone-Rod Dystrophy, Recessive|Macular degeneration|Stargardt Disease, Recessive|Retinitis Pigmentosa, Recessive|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Retinal dystrophy",GRCh38,single nucleotide variant
ABCA4,1,94031110,na,na,Pathogenic/Likely pathogenic,"Severe early-childhood-onset retinal dystrophy|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Mandibulofacial dysostosis with mental deficiency|Stargardt disease|Retinal dystrophy|ABCA4-related disorder|Retinitis pigmentosa 19;Age related macular degeneration 2;Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3",GRCh38,single nucleotide variant
ABCA4,1,94005500,na,na,Pathogenic/Likely pathogenic,"Retinal dystrophy, early-onset severe|Retinal dystrophy|Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|Stargardt disease|Retinitis pigmentosa 19|ABCA4-related retinopathy|Leber congenital amaurosis 14|ABCA4-related disorder",GRCh38,single nucleotide variant
ABCA4,1,94015766,na,na,Pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy,GRCh38,single nucleotide variant
ABCA4,1,94008767,na,na,Pathogenic/Likely pathogenic,Stargardt disease|Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided,GRCh38,single nucleotide variant
ABCA4,1,94014665,na,na,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|not specified|Retinal dystrophy|Optic atrophy|Severe early-childhood-onset retinal dystrophy;Age related macular degeneration 2;Retinitis pigmentosa 19;Cone-rod dystrophy 3,GRCh38,single nucleotide variant
ABCA4,1,94047009,na,na,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|not specified|not provided|Stargardt Disease, Recessive|Stargardt disease|Macular degeneration|ABCA4-related disorder|Retinal dystrophy|Stargardt disease 3|ABCA4-related retinopathy",GRCh38,single nucleotide variant
PLA2G7,6,46709361,na,na,Benign,Platelet-activating factor acetylhydrolase deficiency|PLA2G7-related disorder|not provided,GRCh38,single nucleotide variant
PLA2G7,6,46711566,na,na,Benign,RECLASSIFIED - MYOC POLYMORPHISM|PLA2G7-related disorder,GRCh38,single nucleotide variant
PLA2G7,6,46705206,na,na,Benign,RECLASSIFIED - MYOC POLYMORPHISM|not provided|PLA2G7-related disorder,GRCh38,single nucleotide variant
HPGD,4,174508699,na,na,Pathogenic,"Cranioosteoarthropathy|Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|not provided",GRCh38,single nucleotide variant
HPGD,4,174493236,na,na,Likely pathogenic,Isolated congenital digital clubbing|not provided,GRCh38,single nucleotide variant
KRT12,17,40866783,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40866760,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40866784,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40866783,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40863154,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40866768,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
KRT12,17,40866801,na,na,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",GRCh38,single nucleotide variant
SNRNP200,2,96287968,na,na,Pathogenic,Retinitis pigmentosa 33|Retinal dystrophy|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
EYA1,8,71271802,na,na,Pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|not provided|Melnick-Fraser syndrome|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootic syndrome 1;Branchiootorenal syndrome 1,GRCh38,single nucleotide variant
EYA1,8,71216733,na,na,Pathogenic/Likely pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|Melnick-Fraser syndrome|Branchiooculofacial syndrome|Branchiootic syndrome 1|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootorenal syndrome 1;Branchiootic syndrome 1,GRCh38,single nucleotide variant
EYA1,8,71211215,na,na,Pathogenic,Anterior segment anomalies and cataract,GRCh38,single nucleotide variant
EYA1,8,71244656,na,na,Pathogenic,Abnormal anterior chamber morphology,GRCh38,single nucleotide variant
EYA1,8,71216776,na,na,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome with cataract|Otofaciocervical syndrome 1|Branchiootic syndrome 1|Branchiootorenal syndrome 1|not specified|Inborn genetic diseases|Melnick-Fraser syndrome,GRCh38,single nucleotide variant
EYA1,8,71215630,na,na,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|EYA1-related disorder,GRCh38,single nucleotide variant
EYA1,8,71215470,na,na,Pathogenic,Branchiootorenal syndrome 1,GRCh38,single nucleotide variant
EYA1,8,71299637,na,na,Pathogenic,Otofaciocervical syndrome 1|Melnick-Fraser syndrome,GRCh38,single nucleotide variant
EYA1,8,71244662,na,na,Pathogenic,Branchiootorenal syndrome 1|Branchiootic syndrome 1|Melnick-Fraser syndrome|not provided|EYA1-related disorder|Inborn genetic diseases|Branchiootic syndrome 1;Otofaciocervical syndrome 1;Branchiootorenal syndrome 1,GRCh38,single nucleotide variant
EYA1,8,71271753,na,na,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|not provided,GRCh38,single nucleotide variant
MYOC,1,171636131,na,na,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636349,na,na,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636331,na,na,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636338,na,na,Pathogenic,"Primary open angle glaucoma|Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636010,na,na,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636000,na,na,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided",GRCh38,single nucleotide variant
MYOC,1,171636341,na,na,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636430,na,na,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636173,na,na,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171652476,na,na,Likely benign,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided|Glaucoma|RECLASSIFIED - MYOC POLYMORPHISM",GRCh38,single nucleotide variant
MYOC,1,171636143,na,na,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636244,na,na,Uncertain significance,"GLAUCOMA 1, OPEN ANGLE, A, DIGENIC|Glaucoma of childhood|not provided",GRCh38,single nucleotide variant
MYOC,1,171652468,na,na,Likely benign,"Glaucoma 1, open angle, A|GLAUCOMA 3, PRIMARY CONGENITAL, A, DIGENIC|MYOC-related disorder|Glaucoma of childhood|not provided",GRCh38,single nucleotide variant
MYOC,1,171636706,na,na,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636686,na,na,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
MYOC,1,171636302,na,na,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",GRCh38,single nucleotide variant
SMN2,5,70076545,na,na,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, modifier of|Kugelberg-Welander disease|Spinal muscular atrophy|not specified",GRCh38,single nucleotide variant
UBE3A,15,25370865,na,na,Pathogenic,Angelman syndrome,GRCh38,single nucleotide variant
UBE3A,15,25340219,na,na,Pathogenic,Angelman syndrome,GRCh38,single nucleotide variant
UBE3A,15,25371798,na,na,Pathogenic,Angelman syndrome,GRCh38,single nucleotide variant
UBE3A,15,25371725,na,na,Likely pathogenic,Angelman syndrome,GRCh38,single nucleotide variant
TWIST1,7,19116966,na,na,Pathogenic,Saethre-Chotzen syndrome,GRCh38,single nucleotide variant
TWIST1,7,19117013,na,na,Pathogenic,Saethre-Chotzen syndrome,GRCh38,single nucleotide variant
TWIST1,7,19116954,na,na,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,GRCh38,single nucleotide variant
TWIST1,7,19116946,na,na,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,GRCh38,single nucleotide variant
TWIST1,7,19116930,na,na,Pathogenic,Saethre-Chotzen syndrome,GRCh38,single nucleotide variant
TWIST1,7,19116781,na,na,Pathogenic,Saethre-Chotzen syndrome,GRCh38,single nucleotide variant
TWIST1,7,19116856,na,na,Pathogenic/Likely pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,GRCh38,single nucleotide variant
TWIST1,7,19117240,na,na,Pathogenic,Saethre-Chotzen syndrome with eyelid anomalies|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,GRCh38,single nucleotide variant
TWIST1,7,19117111,na,na,Pathogenic,Robinow-Sorauf syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|TWIST1-related craniosynostosis,GRCh38,single nucleotide variant
TWIST1,7,19116766,na,na,Pathogenic,TWIST1-related craniosynostosis,GRCh38,single nucleotide variant
TWIST1,7,19116759,na,na,Uncertain significance,TWIST1-related craniosynostosis,GRCh38,single nucleotide variant
TBX3,12,114680878,na,na,Pathogenic,Ulnar-mammary syndrome,GRCh38,single nucleotide variant
TBX3,12,114677644,na,na,Pathogenic,Ulnar-mammary syndrome,GRCh38,single nucleotide variant
TBX5,12,114401863,na,na,Pathogenic,Holt-Oram syndrome|not provided,GRCh38,single nucleotide variant
TBX5,12,114385521,na,na,Pathogenic/Likely pathogenic,Holt-Oram syndrome|not provided|Aortic valve disease 2|Cardiovascular phenotype,GRCh38,single nucleotide variant
TBX5,12,114401830,na,na,Pathogenic,Holt-Oram syndrome,GRCh38,single nucleotide variant
TBX5,12,114385522,na,na,Pathogenic,"Holt-Oram syndrome|Heart, malformation of|Aortic valve disease 2|Cardiovascular phenotype",GRCh38,single nucleotide variant
TBX5,12,114403754,na,na,Pathogenic,Holt-Oram syndrome,GRCh38,single nucleotide variant
TBX5,12,114401907,na,na,Pathogenic,Holt-Oram syndrome,GRCh38,single nucleotide variant
TBX5,12,114398675,na,na,Pathogenic/Likely pathogenic,Holt-Oram syndrome|TBX5-related disorder,GRCh38,single nucleotide variant
SOX18,20,64049207,na,na,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,GRCh38,single nucleotide variant
SOX18,20,64049234,na,na,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,GRCh38,single nucleotide variant
SOX18,20,64048601,na,na,Likely pathogenic,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome|not provided,GRCh38,single nucleotide variant
RDH5,12,55724028,na,na,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy|RDH5-related disorder|See cases|Congenital stationary night blindness|Retinal dystrophy|Retinitis punctata albescens",GRCh38,single nucleotide variant
RDH5,12,55721402,na,na,Uncertain significance,"Fundus albipunctatus, autosomal recessive|not provided",GRCh38,single nucleotide variant
RDH5,12,55724427,na,na,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|Congenital stationary night blindness|not provided|Pigmentary retinal dystrophy",GRCh38,single nucleotide variant
RDH5,12,55724468,na,na,Pathogenic,"Pigmentary retinal dystrophy|Fundus albipunctatus, autosomal recessive|not provided",GRCh38,single nucleotide variant
RDH5,12,55721908,na,na,Pathogenic,"Fundus albipunctatus, autosomal recessive",GRCh38,single nucleotide variant
RDH5,12,55724429,na,na,Pathogenic,"Fundus albipunctatus, autosomal recessive",GRCh38,single nucleotide variant
RDH5,12,55721847,na,na,Pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy",GRCh38,single nucleotide variant
ABCA3,16,2285499,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency|not provided,GRCh38,single nucleotide variant
ABCA3,16,2326027,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,GRCh38,single nucleotide variant
ABCA3,16,2278348,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,GRCh38,single nucleotide variant
ABCA3,16,2278016,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,GRCh38,single nucleotide variant
ABCA3,16,2299442,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,GRCh38,single nucleotide variant
ABCA3,16,2277878,na,na,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,GRCh38,single nucleotide variant
ABCA3,16,2317661,na,na,Uncertain significance,Interstitial lung disease due to ABCA3 deficiency|not specified,GRCh38,single nucleotide variant
HADH,4,107990050,na,na,Likely risk allele,Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia,GRCh38,single nucleotide variant
HADH,4,108009797,na,na,Uncertain significance/Uncertain risk allele,"Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia, familial, 4|Hyperinsulinemic hypoglycemia",GRCh38,single nucleotide variant
HADH,4,108033239,na,na,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 4",GRCh38,single nucleotide variant
SMARCB1,22,23825416,na,na,Likely pathogenic,Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
SMARCB1,22,23787203,na,na,Pathogenic,SMARCB1-related schwannomatosis|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
SMARCB1,22,23803338,na,na,Pathogenic,"Schwannomatosis 1, somatic",GRCh38,single nucleotide variant
SMARCB1,22,23787261,na,na,Conflicting classifications of pathogenicity,SMARCB1-related schwannomatosis|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
IL12RB1,19,18083462,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency|not provided|IL12RB1-related disorder,GRCh38,single nucleotide variant
IL12RB1,19,18069609,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,GRCh38,single nucleotide variant
IL12RB1,19,18075812,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,GRCh38,single nucleotide variant
IL12RB1,19,18072111,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,GRCh38,single nucleotide variant
IL12RB1,19,18075857,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,GRCh38,single nucleotide variant
TFAP2B,6,50837977,na,na,Pathogenic,Char syndrome,GRCh38,single nucleotide variant
TFAP2B,6,50838051,na,na,Likely pathogenic,Char syndrome|not provided,GRCh38,single nucleotide variant
TFAP2B,6,50836165,na,na,Pathogenic,Char syndrome,GRCh38,single nucleotide variant
TFAP2B,6,50836165,na,na,Pathogenic,Char syndrome,GRCh38,single nucleotide variant
TFAP2B,6,50838007,na,na,Pathogenic/Likely pathogenic,Char syndrome|not provided,GRCh38,single nucleotide variant
TFAP2B,6,50823543,na,na,Pathogenic,Char syndrome,GRCh38,single nucleotide variant
BARD1,2,214752454,na,na,Benign/Likely benign,"Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not provided",GRCh38,single nucleotide variant
RAPSN,11,47448079,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 4C|not provided|Fetal akinesia deformation sequence 1|Myopathy|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 11|Fetal akinesia deformation sequence 2|RAPSN-related disorder|Inborn genetic diseases|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11,GRCh38,single nucleotide variant
RAPSN,11,47448924,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|not provided,GRCh38,single nucleotide variant
RAPSN,11,47441716,na,na,Pathogenic,Congenital myasthenic syndrome 11,GRCh38,single nucleotide variant
RAPSN,11,47449174,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11|Abnormality of the musculature|Fetal akinesia deformation sequence 2,GRCh38,single nucleotide variant
RAPSN,11,47441675,na,na,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|not provided|Global developmental delay|Fetal akinesia deformation sequence 2|RAPSN-related disorder|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1,GRCh38,single nucleotide variant
RAPSN,11,47448165,na,na,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome,GRCh38,single nucleotide variant
RAPSN,11,47447853,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Myopathy|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2|Fetal akinesia deformation sequence 2,GRCh38,single nucleotide variant
RAPSN,11,47448832,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|not provided|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,GRCh38,single nucleotide variant
RAPSN,11,47447859,na,na,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,GRCh38,single nucleotide variant
RAPSN,11,47447927,na,na,Pathogenic,Fetal akinesia deformation sequence 2,GRCh38,single nucleotide variant
RAPSN,11,47442780,na,na,Uncertain significance,Fetal akinesia deformation sequence 2|not specified,GRCh38,single nucleotide variant
WNT7A,3,13819120,na,na,Likely pathogenic,Schinzel phocomelia syndrome,GRCh38,single nucleotide variant
WNT7A,3,13854777,na,na,Pathogenic,Fuhrmann syndrome,GRCh38,single nucleotide variant
LMAN1,18,59338758,na,na,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",GRCh38,single nucleotide variant
LMAN1,18,59359243,na,na,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",GRCh38,single nucleotide variant
ING1,13,110719736,na,na,Pathogenic,Squamous cell carcinoma of the head and neck,GRCh38,single nucleotide variant
ING1,13,110719739,na,na,Pathogenic,Squamous cell carcinoma of the head and neck,GRCh38,single nucleotide variant
ING1,13,110719667,na,na,Pathogenic,Squamous cell carcinoma of the head and neck,GRCh38,single nucleotide variant
PRSS2,7,142774035,na,na,protective,"Pancreatitis, chronic, protection against",GRCh38,single nucleotide variant
EFEMP1,2,55871091,na,na,Pathogenic/Likely pathogenic,not provided|Doyne honeycomb retinal dystrophy|Retinal dystrophy,GRCh38,single nucleotide variant
PAFAH1B1,17,2670209,na,na,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,GRCh38,single nucleotide variant
PAFAH1B1,17,2674205,na,na,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,GRCh38,single nucleotide variant
PAFAH1B1,17,2670268,na,na,Pathogenic,Subcortical band heterotopia,GRCh38,single nucleotide variant
PAFAH1B1,17,2676553,na,na,Pathogenic,Lissencephaly due to LIS1 mutation,GRCh38,single nucleotide variant
PAFAH1B1,17,2665431,na,na,Pathogenic,Lissencephaly due to LIS1 mutation,GRCh38,single nucleotide variant
PAFAH1B1,17,2670247,na,na,Pathogenic/Likely pathogenic,Lissencephaly due to LIS1 mutation|not provided,GRCh38,single nucleotide variant
PAFAH1B1,17,2674110,na,na,Likely pathogenic,Subcortical band heterotopia|not provided,GRCh38,single nucleotide variant
PAFAH1B1,17,2638310,na,na,Pathogenic/Likely pathogenic,Subcortical band heterotopia|Lissencephaly due to LIS1 mutation|Lissencephaly|Intellectual disability|not provided,GRCh38,single nucleotide variant
PAFAH1B1,17,2674218,na,na,Pathogenic,Lissencephaly due to LIS1 mutation,GRCh38,single nucleotide variant
PITX2,4,110621255,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1,GRCh38,single nucleotide variant
PITX2,4,110621159,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1,GRCh38,single nucleotide variant
PITX2,4,110621214,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1,GRCh38,single nucleotide variant
PITX2,4,110618699,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|not provided,GRCh38,single nucleotide variant
PITX2,4,110618669,na,na,Pathogenic/Likely pathogenic,Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,GRCh38,single nucleotide variant
PITX2,4,110618542,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1,GRCh38,single nucleotide variant
PITX2,4,110621166,na,na,Pathogenic,Anterior segment dysgenesis 4|Anterior segment dysgenesis,GRCh38,single nucleotide variant
PITX2,4,110621210,na,na,Pathogenic,Anterior segment dysgenesis 4|not provided,GRCh38,single nucleotide variant
PITX2,4,110618690,na,na,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 4, PETERS ANOMALY SUBTYPE",GRCh38,single nucleotide variant
PITX2,4,110621169,na,na,Pathogenic,Axenfeld-Rieger syndrome type 1,GRCh38,single nucleotide variant
PITX2,4,110621231,na,na,Pathogenic/Likely pathogenic,Ring dermoid of cornea|Anterior segment dysgenesis|Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,GRCh38,single nucleotide variant
PROP1,5,177993032,na,na,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",GRCh38,single nucleotide variant
PROP1,5,177993041,na,na,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",GRCh38,single nucleotide variant
PROP1,5,177994185,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 2",GRCh38,single nucleotide variant
PROP1,5,177994230,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",GRCh38,single nucleotide variant
PROP1,5,177994231,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",GRCh38,single nucleotide variant
PROP1,5,177994153,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",GRCh38,single nucleotide variant
PROP1,5,177994152,na,na,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|Inborn genetic diseases|not provided|Combined pituitary hormone deficiencies, genetic form",GRCh38,single nucleotide variant
PROP1,5,177992808,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 2",GRCh38,single nucleotide variant
SQSTM1,5,179836445,na,na,Conflicting classifications of pathogenicity,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;Paget disease of bone 3|not provided|Spastic paraplegia-Paget disease of bone syndrome|Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Amyotrophic lateral sclerosis|Bone Paget disease",GRCh38,single nucleotide variant
SQSTM1,5,179833783,na,na,Pathogenic,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Myopathy, distal, with rimmed vacuoles",GRCh38,single nucleotide variant
ALX1,12,85283877,na,na,Pathogenic,Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,GRCh38,single nucleotide variant
CHI3L1,1,203186754,na,na,risk factor,"Asthma-related traits, susceptibility to, 7",GRCh38,single nucleotide variant
FGF14,13,101726785,na,na,Pathogenic,Spinocerebellar ataxia 27A,GRCh38,single nucleotide variant
SMO,7,129210500,na,na,Pathogenic,"Basal cell carcinoma, somatic",GRCh38,single nucleotide variant
SMO,7,129210997,na,na,Pathogenic,"Basal cell carcinoma, somatic",GRCh38,single nucleotide variant
PEX6,6,42974002,na,na,Likely pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PEX6,6,42968289,na,na,Pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder|Heimler syndrome 2,GRCh38,single nucleotide variant
PEX6,6,42966525,na,na,Uncertain significance,Peroxisome biogenesis disorder 4B,GRCh38,single nucleotide variant
IGFALS,16,1790800,na,na,Pathogenic,Short stature due to primary acid-labile subunit deficiency,GRCh38,single nucleotide variant
PPARG,3,12381349,na,na,Uncertain significance,Morbid obesity|not provided|CAROTID INTIMAL MEDIAL THICKNESS 1;Type 2 diabetes mellitus;Inherited obesity;PPARG-related familial partial lipodystrophy,GRCh38,single nucleotide variant
PPARG,3,12379739,na,na,Benign,-,GRCh38,single nucleotide variant
PPARG,3,12416825,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
PPARG,3,12416923,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
PPARG,3,12416831,na,na,Uncertain significance,Carcinoma of colon|PPARG-related disorder,GRCh38,single nucleotide variant
PPARG,3,12434111,na,na,Pathogenic/Likely pathogenic,PPARG-related familial partial lipodystrophy|Lipodystrophy|not provided,GRCh38,single nucleotide variant
PPARG,3,12416836,na,na,Pathogenic,PPARG-related familial partial lipodystrophy,GRCh38,single nucleotide variant
PPARG,3,12434058,na,na,Benign/Likely benign,"Glioma susceptibility 1|not specified|INSULIN RESISTANCE, DIGENIC|PPARG-related familial partial lipodystrophy|Obesity|PPARG POLYMORPHISM|not provided",GRCh38,single nucleotide variant
PPARG,3,12417048,na,na,Pathogenic,PPARG-related familial partial lipodystrophy,GRCh38,single nucleotide variant
PPARG,3,12433900,na,na,Pathogenic,PPARG-related familial partial lipodystrophy|not provided,GRCh38,single nucleotide variant
PPARG,3,12392701,na,na,Pathogenic,PPARG-related familial partial lipodystrophy,GRCh38,single nucleotide variant
PPARG,3,12392713,na,na,Pathogenic,PPARG-related familial partial lipodystrophy,GRCh38,single nucleotide variant
DAZL,3,16598169,na,na,Uncertain significance,Reclassified - variant of unknown significance,GRCh38,single nucleotide variant
MYO1A,12,57047675,na,na,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided|MYO1A-related disorder,GRCh38,single nucleotide variant
MYO1A,12,57043335,na,na,Benign/Likely benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,GRCh38,single nucleotide variant
MYO1A,12,57041441,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,GRCh38,single nucleotide variant
MYO1A,12,57037618,na,na,Benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,GRCh38,single nucleotide variant
MYO1A,12,57029584,na,na,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,GRCh38,single nucleotide variant
CX3CR1,3,39265765,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
DGUOK,2,73946776,na,na,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,GRCh38,single nucleotide variant
DGUOK,2,73946888,na,na,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",GRCh38,single nucleotide variant
DGUOK,2,73957212,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Inborn genetic diseases|not provided|DGUOK-related disorder|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",GRCh38,single nucleotide variant
DGUOK,2,73958201,na,na,Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",GRCh38,single nucleotide variant
CFL2,14,34713462,na,na,Pathogenic,Nemaline myopathy 7,GRCh38,single nucleotide variant
ABCC9,12,21801157,na,na,Pathogenic,Dilated cardiomyopathy 1O,GRCh38,single nucleotide variant
OXCT1,5,41805674,na,na,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,GRCh38,single nucleotide variant
OXCT1,5,41749579,na,na,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,GRCh38,single nucleotide variant
OXCT1,5,41862656,na,na,Benign,Succinyl-CoA acetoacetate transferase deficiency|not provided|OXCT1-related disorder,GRCh38,single nucleotide variant
OXCT1,5,41803148,na,na,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency|not provided,GRCh38,single nucleotide variant
OXCT1,5,41842690,na,na,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,GRCh38,single nucleotide variant
OXCT1,5,41842685,na,na,Uncertain significance,Succinyl-CoA acetoacetate transferase deficiency,GRCh38,single nucleotide variant
KARS1,16,75640258,na,na,Pathogenic,Charcot-Marie-Tooth disease recessive intermediate B,GRCh38,single nucleotide variant
SGCD,5,156595042,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L|Autosomal recessive limb-girdle muscular dystrophy type 2F;Dilated cardiomyopathy 1L|not provided|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
SGCD,5,156344574,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,GRCh38,single nucleotide variant
SGCD,5,156759301,na,na,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L,GRCh38,single nucleotide variant
SGCD,5,156595000,na,na,Uncertain significance,"Dilated cardiomyopathy 1L|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2F|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6, DIGENIC|not provided|Dilated cardiomyopathy 1L;Autosomal recessive limb-girdle muscular dystrophy type 2F",GRCh38,single nucleotide variant
SGCD,5,156594940,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,GRCh38,single nucleotide variant
CTRC,1,15445717,na,na,Conflicting classifications of pathogenicity; association,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis|not specified|not provided",GRCh38,single nucleotide variant
CTRC,1,15440524,na,na,Pathogenic,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis",GRCh38,single nucleotide variant
TBXT,6,166160758,na,na,risk factor,"Neural tube defects, susceptibility to",GRCh38,single nucleotide variant
CCR5,3,46373570,na,na,Benign,"CCR5 POLYMORPHISM, ORIENTAL 2|not provided",GRCh38,single nucleotide variant
CCR5,3,46373906,na,na,Benign,"CCR5 POLYMORPHISM, AFRICAN-AMERICAN|not provided",GRCh38,single nucleotide variant
CCR5,3,46373205,na,na,protective,Susceptibility to HIV infection,GRCh38,single nucleotide variant
CCR5,3,46370444,na,na,Conflicting classifications of pathogenicity; protective,"Acquired immunodeficiency syndrome, delayed progression to|CCR5 PROMOTER POLYMORPHISM|Susceptibility to HIV infection|CCR5-related disorder",GRCh38,single nucleotide variant
CCR5,3,46370771,na,na,Benign,"Human immunodeficiency virus type 1, increased perinatal transmission of|not specified",GRCh38,single nucleotide variant
CCR5,3,46373082,na,na,protective,Susceptibility to HIV infection,GRCh38,single nucleotide variant
MOGS,2,74462332,na,na,Pathogenic,MOGS-congenital disorder of glycosylation,GRCh38,single nucleotide variant
MOGS,2,74461835,na,na,Pathogenic,MOGS-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PKD1,16,2090673,na,na,Pathogenic,"Polycystic kidney disease, adult type",GRCh38,single nucleotide variant
PKD1,16,2090688,na,na,Pathogenic,"Polycystic kidney disease, adult type|not provided",GRCh38,single nucleotide variant
PKD1,16,2089957,na,na,Pathogenic,"Polycystic kidney disease, adult type|not provided",GRCh38,single nucleotide variant
PKD1,16,2091806,na,na,Pathogenic,"Polycystic kidney disease, adult type|not provided",GRCh38,single nucleotide variant
PKD1,16,2090468,na,na,Pathogenic,"Polycystic kidney disease, adult type",GRCh38,single nucleotide variant
PKD1,16,2091861,na,na,Pathogenic,"Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease",GRCh38,single nucleotide variant
PKD1,16,2090776,na,na,Pathogenic,"Polycystic kidney disease, adult type|not provided",GRCh38,single nucleotide variant
PKD1,16,2111872,na,na,Pathogenic,"Polycystic kidney disease, adult type",GRCh38,single nucleotide variant
PKD1,16,2118021,na,na,Conflicting classifications of pathogenicity,"Polycystic kidney disease, adult type|not provided|not specified|Polycystic kidney disease|PKD1-related disorder",GRCh38,single nucleotide variant
PKD1,16,2114489,na,na,Pathogenic/Likely pathogenic,"Polycystic kidney disease, adult type|Polycystic kidney disease 3 with or without polycystic liver disease|not provided|Polycystic kidney disease|PKD1-related disorder",GRCh38,single nucleotide variant
PKD1,16,2109403,na,na,Pathogenic,"Polycystic kidney disease, adult type",GRCh38,single nucleotide variant
PKD1,16,2090309,na,na,Likely pathogenic,"Polycystic kidney disease, adult type|not provided",GRCh38,single nucleotide variant
PTCH1,9,95479134,na,na,Pathogenic,Gorlin syndrome,GRCh38,single nucleotide variant
PTCH1,9,95479055,na,na,Pathogenic,Gorlin syndrome|Basal cell nevus syndrome 1,GRCh38,single nucleotide variant
PTCH1,9,95453587,na,na,Pathogenic,"Basal cell carcinoma, somatic",GRCh38,single nucleotide variant
PTCH1,9,95479038,na,na,Benign/Likely benign,"Holoprosencephaly 7|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder|Basal cell nevus syndrome 1;Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1",GRCh38,single nucleotide variant
PTCH1,9,95468818,na,na,Benign/Likely benign,"Holoprosencephaly 7|not specified|Gorlin syndrome|not provided|Hereditary cancer-predisposing syndrome|Basal cell carcinoma, susceptibility to, 1;Holoprosencephaly 7;Gorlin syndrome|Basal cell nevus syndrome 1;Basal cell carcinoma, susceptibility to, 1;Holoprosencephaly 7",GRCh38,single nucleotide variant
PTCH1,9,95467197,na,na,Benign,Holoprosencephaly 7|not specified|not provided|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder,GRCh38,single nucleotide variant
PTCH1,9,95458026,na,na,Conflicting classifications of pathogenicity,Holoprosencephaly 7|not provided|Holoprosencephaly sequence|not specified|Hereditary cancer-predisposing syndrome|Gorlin syndrome|PTCH1-related disorder,GRCh38,single nucleotide variant
PTCH1,9,95459764,na,na,Pathogenic,Holoprosencephaly 7,GRCh38,single nucleotide variant
BMPR1A,10,86917173,na,na,Pathogenic,Juvenile polyposis syndrome,GRCh38,single nucleotide variant
BMPR1A,10,86917270,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome|not provided,GRCh38,single nucleotide variant
BMPR1A,10,86919316,na,na,Likely pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,GRCh38,single nucleotide variant
BMPR1A,10,86899830,na,na,Pathogenic/Likely pathogenic,"Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided|Polyposis syndrome, hereditary mixed, 2",GRCh38,single nucleotide variant
BMPR1A,10,86919430,na,na,Pathogenic,Juvenile polyposis syndrome,GRCh38,single nucleotide variant
BMPR1A,10,86923442,na,na,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,GRCh38,single nucleotide variant
MUSK,9,110800746,na,na,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 9|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 9;Fetal akinesia deformation sequence 1|not provided|MUSK-related disorder,GRCh38,single nucleotide variant
SLC10A2,13,103051290,na,na,Uncertain significance,not provided,GRCh38,single nucleotide variant
ACVRL1,12,51916219,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51916114,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51913187,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51916180,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",GRCh38,single nucleotide variant
ACVRL1,12,51916107,na,na,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype|ACVRL1-related disorder",GRCh38,single nucleotide variant
ACVRL1,12,51916218,na,na,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51920831,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Pulmonary arterial hypertension|not specified|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51914445,na,na,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2",GRCh38,single nucleotide variant
ACVRL1,12,51915483,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|See cases|Cardiovascular phenotype",GRCh38,single nucleotide variant
ACVRL1,12,51916183,na,na,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Cardiovascular phenotype|Telangiectasia, hereditary hemorrhagic, type 2",GRCh38,single nucleotide variant
ACVRL1,12,51916219,na,na,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",GRCh38,single nucleotide variant
PLEC,8,143924012,na,na,Pathogenic,"Epidermolysis bullosa simplex, Ogna type|not provided|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q|Simplex epidermolysis bullosa_Ogna type",GRCh38,single nucleotide variant
PLEC,8,143934923,na,na,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",GRCh38,single nucleotide variant
PLEC,8,143933998,na,na,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",GRCh38,single nucleotide variant
PLEC,8,143920817,na,na,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q",GRCh38,single nucleotide variant
CCR2,3,46357717,na,na,Benign; protective,Susceptibility to HIV infection|CCR2-related disorder,GRCh38,single nucleotide variant
NODAL,10,70435629,na,na,Conflicting classifications of pathogenicity,"Heterotaxy, visceral, 5, autosomal|not provided",GRCh38,single nucleotide variant
NODAL,10,70435399,na,na,Conflicting classifications of pathogenicity,"Inborn genetic diseases|Heterotaxy, visceral, 5, autosomal|Wolff-Parkinson-White pattern|Visceral heterotaxy|NODAL-related disorder|not provided",GRCh38,single nucleotide variant
MAP2K2,19,4117552,na,na,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,GRCh38,single nucleotide variant
MAP2K2,19,4117553,na,na,Pathogenic,Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome,GRCh38,single nucleotide variant
MAP2K2,19,4110559,na,na,Pathogenic,Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 4|not provided|RASopathy|Noonan syndrome and Noonan-related syndrome|MAP2K2-related disorder|Noonan syndrome 1,GRCh38,single nucleotide variant
MAP2K2,19,4110576,na,na,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,GRCh38,single nucleotide variant
CAV3,3,8745725,na,na,Pathogenic,Rippling muscle disease 2|not provided|Long QT syndrome,GRCh38,single nucleotide variant
CAV3,3,8745577,na,na,Benign/Likely benign,"Rippling muscle disease 2|not specified|Limb-girdle muscular dystrophy|not provided|Limb-Girdle Muscular Dystrophy, Dominant|Cardiovascular phenotype|Long QT syndrome|Caveolinopathy|Long QT syndrome 1|Cardiomyopathy|Rippling muscle disease 2;Long QT syndrome 9;Elevated circulating creatine kinase concentration;Hypertrophic cardiomyopathy 1;Distal myopathy, Tateyama type",GRCh38,single nucleotide variant
CAV3,3,8745627,na,na,Conflicting classifications of pathogenicity,"Rippling muscle disease 2|not provided|not specified|Limb-girdle muscular dystrophy|Hypertrophic cardiomyopathy 1;Rippling muscle disease 2;Distal myopathy, Tateyama type;Long QT syndrome 9;Elevated circulating creatine kinase concentration|Cardiovascular phenotype|Long QT syndrome|Caveolinopathy|Cardiomyopathy|Long QT syndrome 1|CAV3-related disorder",GRCh38,single nucleotide variant
CAV3,3,8733960,na,na,Pathogenic,Rippling muscle disease 2|not provided,GRCh38,single nucleotide variant
CAV3,3,8745547,na,na,Pathogenic/Likely pathogenic,Rippling muscle disease 2|Elevated circulating creatine kinase concentration|not provided|Cardiovascular phenotype|Long QT syndrome|Myopathy with tubular aggregates,GRCh38,single nucleotide variant
CAV3,3,8745548,na,na,Likely pathogenic,Rippling muscle disease 2|not provided,GRCh38,single nucleotide variant
CAV3;SSUH2,3,8733956,na,na,Pathogenic,"Elevated circulating creatine kinase concentration|Rippling muscle disease 2|Distal myopathy, Tateyama type|not provided|Long QT syndrome|Hypertrophic cardiomyopathy 1;Rippling muscle disease 2;Distal myopathy, Tateyama type;Long QT syndrome 9;Elevated circulating creatine kinase concentration",GRCh38,single nucleotide variant
CAV3,3,8745671,na,na,Uncertain significance,Rippling muscle disease 2|not provided|Long QT syndrome|SUDDEN INFANT DEATH SYNDROME|Cardiovascular phenotype,GRCh38,single nucleotide variant
CAV3,3,8745688,na,na,Conflicting classifications of pathogenicity,"Rippling muscle disease 2, autosomal recessive|not provided|Long QT syndrome|Cardiovascular phenotype|Rippling muscle disease 2|Hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy 1;Rippling muscle disease 2;Distal myopathy, Tateyama type;Long QT syndrome 9;Elevated circulating creatine kinase concentration|Caveolinopathy",GRCh38,single nucleotide variant
CAV3,3,8733962,na,na,Uncertain significance,Elevated circulating creatine kinase concentration|Long QT syndrome|not provided,GRCh38,single nucleotide variant
CAV3,3,8745602,na,na,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not provided|Caveolinopathy,GRCh38,single nucleotide variant
CAV3,3,8733975,na,na,Pathogenic,"Distal myopathy, Tateyama type|Long QT syndrome",GRCh38,single nucleotide variant
CAV3,3,8745550,na,na,Uncertain significance,Rippling muscle disease 2|not provided,GRCh38,single nucleotide variant
CAV3,3,8745834,na,na,Pathogenic,Long QT syndrome 9|not provided,GRCh38,single nucleotide variant
CAV3,3,8745701,na,na,risk factor,"Long QT syndrome 9, acquired, susceptibility to|not provided",GRCh38,single nucleotide variant
CAV3,3,8745644,na,na,Conflicting classifications of pathogenicity,"Long QT syndrome 2/9, digenic|Long QT syndrome 9|not provided|not specified|Cardiovascular phenotype|Long QT syndrome|Long QT syndrome 1|Cardiomyopathy|Caveolinopathy|CAV3-related disorder|Hypertrophic cardiomyopathy",GRCh38,single nucleotide variant
CAV3,3,8745664,na,na,Pathogenic,Long QT syndrome 9|not provided,GRCh38,single nucleotide variant
CAV3,3,8733916,na,na,Pathogenic,Long QT syndrome 9|not provided,GRCh38,single nucleotide variant
CAV3,3,8745647,na,na,Uncertain significance,not provided|Long QT syndrome|Long QT syndrome 9,GRCh38,single nucleotide variant
BIN1,2,127076686,na,na,Pathogenic,"Myopathy, centronuclear, 2",GRCh38,single nucleotide variant
BIN1,2,127068992,na,na,Pathogenic,"Myopathy, centronuclear, 2",GRCh38,single nucleotide variant
BIN1,2,127048585,na,na,Likely pathogenic,"Myopathy, centronuclear, 2",GRCh38,single nucleotide variant
BIN1,2,127068982,na,na,Conflicting classifications of pathogenicity,"Myopathy, centronuclear, 2",GRCh38,single nucleotide variant
GAMT,19,1401418,na,na,Pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|See cases|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
GAMT,19,1398980,na,na,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|not provided,GRCh38,single nucleotide variant
GAMT,19,1401329,na,na,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome,GRCh38,single nucleotide variant
DTNA,18,34794250,na,na,Uncertain significance,Left ventricular noncompaction 1,GRCh38,single nucleotide variant
ATR,3,142556439,na,na,Likely benign,Seckel syndrome 1|Inborn genetic diseases,GRCh38,single nucleotide variant
SIX1,14,60648804,na,na,Pathogenic,Branchiootic syndrome 3|not provided|Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23;Branchiootorenal syndrome 1|SIX1-related disorder|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome,GRCh38,single nucleotide variant
SIX1,14,60648862,na,na,Pathogenic,Branchiootic syndrome 3|not provided|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23,GRCh38,single nucleotide variant
SIX1,14,60648826,na,na,Pathogenic,Branchiootic syndrome 3,GRCh38,single nucleotide variant
CASR,3,122284337,na,na,Pathogenic/Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Primary hyperparathyroidism,GRCh38,single nucleotide variant
CASR,3,122261924,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122261589,na,na,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia 1|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder",GRCh38,single nucleotide variant
CASR,3,122257275,na,na,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",GRCh38,single nucleotide variant
CASR,3,122261715,na,na,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|not provided,GRCh38,single nucleotide variant
CASR,3,122283699,na,na,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122283997,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122257241,na,na,Conflicting classifications of pathogenicity,Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122284371,na,na,Uncertain significance,Autosomal dominant hypocalcemia 1|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia,GRCh38,single nucleotide variant
CASR,3,122257347,na,na,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided,GRCh38,single nucleotide variant
CASR,3,122257249,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122257277,na,na,Pathogenic,Autosomal dominant hypocalcemia 1|CASR-related disorder,GRCh38,single nucleotide variant
CASR,3,122261606,na,na,Likely pathogenic,"Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",GRCh38,single nucleotide variant
CASR,3,122283789,na,na,Likely pathogenic,Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122284272,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122283963,na,na,Pathogenic,Neonatal severe primary hyperparathyroidism,GRCh38,single nucleotide variant
CASR,3,122254304,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1,GRCh38,single nucleotide variant
CASR,3,122261715,na,na,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",GRCh38,single nucleotide variant
CASR,3,122257308,na,na,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|CASR-related disorder|not provided|Familial hypocalciuric hypercalcemia|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia 1;Neonatal severe primary hyperparathyroidism;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia",GRCh38,single nucleotide variant
CASR,3,122257323,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia,GRCh38,single nucleotide variant
CASR,3,122254374,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1,GRCh38,single nucleotide variant
CASR,3,122257091,na,na,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",GRCh38,single nucleotide variant
CASR,3,122284317,na,na,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122254330,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122283800,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122284595,na,na,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122283896,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Nephrolithiasis/nephrocalcinosis|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122257080,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122284482,na,na,Likely pathogenic,Bartter syndrome with hypocalcemia|Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122257288,na,na,Uncertain significance,Bartter syndrome with hypocalcemia|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122261588,na,na,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",GRCh38,single nucleotide variant
CASR,3,122257269,na,na,Conflicting classifications of pathogenicity,"Autosomal dominant hypocalcemia 1|Bartter syndrome with hypocalcemia|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1",GRCh38,single nucleotide variant
CASR,3,122284413,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122284316,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122284910,na,na,Benign,Serum calcium level|Familial hypocalciuric hypercalcemia 1|Familial hypoparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not specified|Neonatal severe primary hyperparathyroidism|Autosomal dominant hypocalcemia 1|Malignant tumor of breast|not provided|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122283764,na,na,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Autosomal dominant hypocalcemia|Nephrolithiasis/nephrocalcinosis",GRCh38,single nucleotide variant
CASR,3,122257175,na,na,Pathogenic,Neonatal severe primary hyperparathyroidism,GRCh38,single nucleotide variant
CASR,3,122275828,na,na,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",GRCh38,single nucleotide variant
CASR,3,122254227,na,na,Uncertain significance,Familial hypocalciuric hypercalcemia 1|Nephrolithiasis/nephrocalcinosis,GRCh38,single nucleotide variant
CASR,3,122284134,na,na,Pathogenic,Autosomal dominant hypocalcemia 1,GRCh38,single nucleotide variant
CASR,3,122261574,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1,GRCh38,single nucleotide variant
CASR,3,122283699,na,na,Pathogenic,Familial hypocalciuric hypercalcemia 1,GRCh38,single nucleotide variant
CASR,3,122282161,na,na,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|not provided,GRCh38,single nucleotide variant
CASR,3,122284647,na,na,Uncertain significance,"Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",GRCh38,single nucleotide variant
TLR1,4,38797027,na,na,Conflicting classifications of pathogenicity; protective,"Leprosy, protection against|TLR1-related disorder|Leprosy, susceptibility to, 1",GRCh38,single nucleotide variant
TLR1,4,38798089,na,na,Benign; risk factor,"Leprosy, susceptibility to, 5|TLR1-related disorder",GRCh38,single nucleotide variant
RANBP2,2,108751993,na,na,Pathogenic/Likely pathogenic,Familial acute necrotizing encephalopathy|not provided|See cases,GRCh38,single nucleotide variant
RANBP2,2,108753466,na,na,risk factor,Familial acute necrotizing encephalopathy,GRCh38,single nucleotide variant
RANBP2,2,108753474,na,na,Conflicting classifications of pathogenicity,Familial acute necrotizing encephalopathy|not provided,GRCh38,single nucleotide variant
GCLM,1,93909753,na,na,risk factor,"Myocardial infarction, susceptibility to",GRCh38,single nucleotide variant
CCL11,17,34284427,na,na,protective,Susceptibility to HIV infection,GRCh38,single nucleotide variant
DDX11,12,31102313,na,na,Pathogenic,Warsaw breakage syndrome,GRCh38,single nucleotide variant
GDF6,8,96145185,na,na,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Isolated microphthalmia 4|Leber congenital amaurosis 17|Klippel-Feil syndrome|not specified|Congenital anomaly of kidney and urinary tract|not provided|Klippel-Feil syndrome 1, autosomal dominant;Congenital anomaly of kidney and urinary tract|Leber congenital amaurosis 17;Microphthalmia, isolated, with coloboma 6;Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4|GDF6-related disorder|Leber congenital amaurosis 17;Microphthalmia, isolated, with coloboma 6;Klippel-Feil syndrome 1, autosomal dominant;Multiple synostoses syndrome 4;Isolated microphthalmia 4|Retinal dystrophy",GRCh38,single nucleotide variant
GDF6,8,96145065,na,na,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|not provided|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|GDF6-related disorder|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",GRCh38,single nucleotide variant
GDF6,8,96144660,na,na,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome|Klippel-Feil syndrome 1, autosomal dominant;Autosomal dominant Parkinson disease 8|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|Leber congenital amaurosis 17|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",GRCh38,single nucleotide variant
GDF6,8,96160568,na,na,Likely benign,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",GRCh38,single nucleotide variant
GDF6,8,96145173,na,na,Uncertain significance,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",GRCh38,single nucleotide variant
GDF6,8,96144951,na,na,Benign,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",GRCh38,single nucleotide variant
GDF5,20,35434514,na,na,Pathogenic/Likely pathogenic,Brachydactyly type C|not provided|Multiple synostoses syndrome 2,GRCh38,single nucleotide variant
GDF5,20,35434216,na,na,Likely pathogenic,Grebe syndrome|Brachydactyly type A1C,GRCh38,single nucleotide variant
GDF5,20,35434093,na,na,Pathogenic,"Acromesomelic dysplasia 2B|Type A2 brachydactyly|not provided|Symphalangism, proximal, 1B",GRCh38,single nucleotide variant
GDF5,20,35437412,na,na,Pathogenic,Brachydactyly type C,GRCh38,single nucleotide variant
GDF5,20,35434102,na,na,Pathogenic,"Symphalangism, proximal, 1B|Multiple synostoses syndrome 2|not provided",GRCh38,single nucleotide variant
GDF5,20,35434100,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
GDF5,20,35433991,na,na,Pathogenic,Multiple synostoses syndrome 2,GRCh38,single nucleotide variant
GDF5,20,35433944,na,na,Pathogenic,"Symphalangism, proximal, 1B|not provided",GRCh38,single nucleotide variant
GDF5,20,35438203,na,na,Benign,"Acromesomelic dysplasia 2C, Hunter-Thompson type|Acromesomelic dysplasia 2B|Brachydactyly|Grebe syndrome|Multiple synostoses syndrome 2|not provided|Osteoarthritis susceptibility 5",GRCh38,single nucleotide variant
GDF5,20,35433954,na,na,Pathogenic,Brachydactyly type C,GRCh38,single nucleotide variant
GDF5,20,35434297,na,na,Pathogenic,"Symphalangism, proximal, 1B",GRCh38,single nucleotide variant
GDF5,20,35434282,na,na,Pathogenic,Acromesomelic dysplasia 2B,GRCh38,single nucleotide variant
GDF5,20,35434109,na,na,Pathogenic,Acromesomelic dysplasia 2B,GRCh38,single nucleotide variant
CSTB,21,43774760,na,na,Pathogenic,Unverricht-Lundborg syndrome|not provided|Inborn genetic diseases|Progressive myoclonic epilepsy|Chorea;Dyskinesia|Cerebral dysmyelination;Encephalopathy;Microcephaly,GRCh38,single nucleotide variant
CSTB,21,43774297,na,na,Pathogenic,Unverricht-Lundborg syndrome|8 conditions|Self-limited epilepsy with centrotemporal spikes|Progressive myoclonic epilepsy|not provided,GRCh38,single nucleotide variant
CSTB,21,43776260,na,na,Pathogenic,Unverricht-Lundborg syndrome,GRCh38,single nucleotide variant
CSTB,21,43774287,na,na,Pathogenic,Unverricht-Lundborg syndrome,GRCh38,single nucleotide variant
DCTN1,2,74378104,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 7B|Hereditary motor neuron disease|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Perry syndrome",GRCh38,single nucleotide variant
DCTN1,2,74361590,na,na,Benign/Likely benign,"Amyotrophic lateral sclerosis, susceptibility to|not provided|Perry syndrome|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1;Perry syndrome|Inborn genetic diseases",GRCh38,single nucleotide variant
DCTN1,2,74368870,na,na,Uncertain significance; risk factor,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome",GRCh38,single nucleotide variant
DCTN1,2,74366896,na,na,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|not provided|Charcot-Marie-Tooth disease|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Perry syndrome|Inborn genetic diseases|DCTN1-related disorder",GRCh38,single nucleotide variant
DCTN1,2,74363337,na,na,Uncertain significance,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Inborn genetic diseases|Perry syndrome|not specified",GRCh38,single nucleotide variant
DCTN1,2,74378068,na,na,Conflicting classifications of pathogenicity,"Perry syndrome|Neuronopathy, distal hereditary motor, type 7B",GRCh38,single nucleotide variant
DCTN1,2,74378058,na,na,Pathogenic,Perry syndrome|not provided,GRCh38,single nucleotide variant
CYP2C9,10,94981296,na,na,drug response; other,not provided|Tolbutamide response|Warfarin response|Phenytoin response|Glipizide response|Lesinurad response|Flurbiprofen response|Piroxicam response,GRCh38,single nucleotide variant
CYP2C9,10,94942290,na,na,Likely benign; drug response; other,Warfarin response|not provided|Piroxicam response|not specified|Flurbiprofen response|Lesinurad response|Phenytoin response,GRCh38,single nucleotide variant
CYP2C9,10,94947919,na,na,Pathogenic,Warfarin response,GRCh38,single nucleotide variant
ABCC2,10,99818820,na,na,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|not provided|ABCC2-related disorder,GRCh38,single nucleotide variant
ABCC2,10,99808231,na,na,Pathogenic,Dubin-Johnson syndrome,GRCh38,single nucleotide variant
ABCC2,10,99818959,na,na,Pathogenic,Dubin-Johnson syndrome|not provided,GRCh38,single nucleotide variant
ABCC2,10,99845781,na,na,Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder,GRCh38,single nucleotide variant
ABCC2,10,99811604,na,na,Pathogenic,Dubin-Johnson syndrome|not provided,GRCh38,single nucleotide variant
ABCC2,10,99836193,na,na,Pathogenic,Dubin-Johnson syndrome|not provided,GRCh38,single nucleotide variant
ABCC2,10,99836125,na,na,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder|not provided,GRCh38,single nucleotide variant
CTSK,1,150796799,na,na,Pathogenic,Pyknodysostosis,GRCh38,single nucleotide variant
CTSK,1,150804203,na,na,Pathogenic,not provided|Pyknodysostosis|Inborn genetic diseases,GRCh38,single nucleotide variant
CTSK,1,150799607,na,na,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,GRCh38,single nucleotide variant
CTSK,1,150799228,na,na,Pathogenic,Pyknodysostosis,GRCh38,single nucleotide variant
CTSK,1,150806109,na,na,Pathogenic,Pyknodysostosis,GRCh38,single nucleotide variant
CTSK,1,150806191,na,na,Pathogenic,Pyknodysostosis,GRCh38,single nucleotide variant
CTSK,1,150796863,na,na,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,GRCh38,single nucleotide variant
PMP22,17,15260681,na,na,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",GRCh38,single nucleotide variant
PMP22,17,15239554,na,na,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",GRCh38,single nucleotide variant
PMP22,17,15231047,na,na,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, type 1a, autosomal recessive|Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|not specified|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease|Tip-toe gait|6 conditions",GRCh38,single nucleotide variant
PMP22,17,15239584,na,na,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA",GRCh38,single nucleotide variant
PMP22,17,15239575,na,na,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease, type IA",GRCh38,single nucleotide variant
PMP22,17,15260692,na,na,Pathogenic/Likely pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|Inborn genetic diseases|Dejerine-Sottas disease|Roussy-Lévy syndrome",GRCh38,single nucleotide variant
PMP22,17,15239591,na,na,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|not provided|Charcot-Marie-Tooth disease, type I",GRCh38,single nucleotide variant
PMP22,17,15230952,na,na,Conflicting classifications of pathogenicity,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I",GRCh38,single nucleotide variant
PMP22,17,15259190,na,na,Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease, type I|not provided",GRCh38,single nucleotide variant
PMP22,17,15259162,na,na,Pathogenic,"Charcot-Marie-Tooth disease, type 1a, with focally folded myelin sheaths",GRCh38,single nucleotide variant
PMP22,17,15239591,na,na,Conflicting classifications of pathogenicity,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",GRCh38,single nucleotide variant
PMP22,17,15230931,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|Hereditary liability to pressure palsies",GRCh38,single nucleotide variant
PMP22,17,15260663,na,na,Pathogenic,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA",GRCh38,single nucleotide variant
FOXE3,1,47417035,na,na,Pathogenic,Congenital primary aphakia|not provided|Anterior segment dysgenesis,GRCh38,single nucleotide variant
FOXI1,5,170108247,na,na,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,GRCh38,single nucleotide variant
FOXI1,5,170108274,na,na,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,GRCh38,single nucleotide variant
FOXC1,6,1610837,na,na,Pathogenic,Anterior segment dysgenesis 3|Axenfeld-Rieger syndrome type 3,GRCh38,single nucleotide variant
FOXC1,6,1610823,na,na,Pathogenic,Anterior segment dysgenesis 3,GRCh38,single nucleotide variant
FOXC1,6,1610780,na,na,Pathogenic,Axenfeld-Rieger syndrome type 3,GRCh38,single nucleotide variant
FOXC1,6,1610512,na,na,Pathogenic,Axenfeld-Rieger syndrome type 3,GRCh38,single nucleotide variant
FOXC1,6,1610690,na,na,Pathogenic,Axenfeld-Rieger syndrome type 3,GRCh38,single nucleotide variant
FOXC1,6,1610706,na,na,Pathogenic,Anterior segment dysgenesis 3,GRCh38,single nucleotide variant
FOXC1,6,1610833,na,na,Conflicting classifications of pathogenicity,Axenfeld-Rieger syndrome type 3|not provided,GRCh38,single nucleotide variant
FOXC1,6,1610803,na,na,Pathogenic,Axenfeld-Rieger syndrome type 3,GRCh38,single nucleotide variant
FOXF1,16,86510794,na,na,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,GRCh38,single nucleotide variant
FOXF1,16,86513083,na,na,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,GRCh38,single nucleotide variant
AARS1,16,70268356,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2N|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|not provided|AARS1-related disorder,GRCh38,single nucleotide variant
CAV1,7,116526606,na,na,Pathogenic,"Congenital generalized lipodystrophy type 3|Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome",GRCh38,single nucleotide variant
VCP,9,35065363,na,na,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inborn genetic diseases,GRCh38,single nucleotide variant
VCP,9,35065364,na,na,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,GRCh38,single nucleotide variant
VCP,9,35064167,na,na,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided,GRCh38,single nucleotide variant
VCP,9,35067910,na,na,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,GRCh38,single nucleotide variant
VCP,9,35065363,na,na,Conflicting classifications of pathogenicity,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|not provided,GRCh38,single nucleotide variant
VCP,9,35065255,na,na,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Charcot-Marie-Tooth disease type 2Y;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1,GRCh38,single nucleotide variant
VCP,9,35065351,na,na,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|VCP-related disorder,GRCh38,single nucleotide variant
NFKBIL1,6,31547563,na,na,risk factor,Rheumatoid arthritis,GRCh38,single nucleotide variant
SNTA1,20,33410203,na,na,Conflicting classifications of pathogenicity,not provided|Long QT syndrome 12|Cardiovascular phenotype|Atrial fibrillation;Long QT syndrome|Long QT syndrome,GRCh38,single nucleotide variant
NPC2,14,74493217,na,na,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C|Inborn genetic diseases",GRCh38,single nucleotide variant
NPC2,14,74486324,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2",GRCh38,single nucleotide variant
NPC2,14,74484426,na,na,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC2,14,74484579,na,na,Pathogenic,"Niemann-Pick disease, type C2",GRCh38,single nucleotide variant
NPC2,14,74486404,na,na,Uncertain significance,"Niemann-Pick disease, type C2|NPC2-related disorder",GRCh38,single nucleotide variant
NPC2,14,74480707,na,na,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
NPC2,14,74484420,na,na,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C1|Niemann-Pick disease, type C",GRCh38,single nucleotide variant
CACNA1A,19,13371744,na,na,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",GRCh38,single nucleotide variant
CACNA1A,19,13303877,na,na,Pathogenic,"Migraine, familial hemiplegic, 1|Migraine, sporadic hemiplegic, with progressive cerebellar ataxia|not provided|Episodic ataxia type 2|Spinocerebellar ataxia type 6;Episodic ataxia type 2;Migraine, familial hemiplegic, 1|Inborn genetic diseases|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Developmental and epileptic encephalopathy, 42|Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42;Migraine, familial hemiplegic, 1",GRCh38,single nucleotide variant
CACNA1A,19,13303580,na,na,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",GRCh38,single nucleotide variant
CACNA1A,19,13230185,na,na,Pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",GRCh38,single nucleotide variant
CACNA1A,19,13275849,na,na,Pathogenic,Episodic ataxia type 2|not provided,GRCh38,single nucleotide variant
CACNA1A,19,13235702,na,na,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|not provided|Spinocerebellar ataxia type 6|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
CACNA1A,19,13359707,na,na,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia type 6|Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided",GRCh38,single nucleotide variant
CACNA1A,19,13303576,na,na,Pathogenic,"Migraine, familial hemiplegic, 1",GRCh38,single nucleotide variant
CACNA1A,19,13257474,na,na,Likely pathogenic,Episodic ataxia type 2,GRCh38,single nucleotide variant
CACNA1A,19,13261552,na,na,Pathogenic,"Migraine, familial hemiplegic, 1",GRCh38,single nucleotide variant
CACNA1A,19,13231847,na,na,Pathogenic,Episodic ataxia type 2,GRCh38,single nucleotide variant
CACNA1A,19,13259589,na,na,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",GRCh38,single nucleotide variant
CACNA1A,19,13365448,na,na,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2|not provided|Familial hemiplegic migraine|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
CACNA1A,19,13308452,na,na,Pathogenic,"Migraine, familial hemiplegic, 1|Sporadic hemiplegic migraine|Spinocerebellar ataxia type 6|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 52|Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
CACNA1A,19,13277122,na,na,Pathogenic,"Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided|CACNA1A-related complex neurodevelopmental disorder",GRCh38,single nucleotide variant
CACNA1A,19,13255217,na,na,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|Migraine, familial hemiplegic, 1;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42;Spinocerebellar ataxia type 6|Inborn genetic diseases|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
CACNA1A,19,13261495,na,na,Pathogenic,Episodic ataxia type 2,GRCh38,single nucleotide variant
CACNA1A,19,13230158,na,na,Pathogenic,"Episodic ataxia, type 2, and epilepsy|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
CACNA1A,19,13235219,na,na,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Spinocerebellar ataxia type 6|Episodic ataxia type 2|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Inborn genetic diseases|Neurodevelopmental delay",GRCh38,single nucleotide variant
CACNA1A,19,13359724,na,na,Pathogenic,Episodic ataxia type 2,GRCh38,single nucleotide variant
CACNA1A,19,13262789,na,na,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|not provided|Developmental and epileptic encephalopathy, 42|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",GRCh38,single nucleotide variant
LEPR,1,65592830,na,na,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not specified|Monogenic Non-Syndromic Obesity|not provided,GRCh38,single nucleotide variant
LEPR,1,65621459,na,na,Pathogenic,Obesity due to leptin receptor gene deficiency,GRCh38,single nucleotide variant
LEPR,1,65570758,na,na,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|Monogenic Non-Syndromic Obesity|not specified|not provided,GRCh38,single nucleotide variant
LEPR,1,65610269,na,na,Benign/Likely benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not provided|Monogenic Non-Syndromic Obesity|not specified,GRCh38,single nucleotide variant
GSS,20,34942488,na,na,Pathogenic,Inherited glutathione synthetase deficiency|not provided|Inborn genetic diseases|Glutathione synthetase deficiency with 5-oxoprolinuria,GRCh38,single nucleotide variant
GSS,20,34935611,na,na,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria,GRCh38,single nucleotide variant
GSS,20,34932121,na,na,Pathogenic/Likely pathogenic,Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria|not provided,GRCh38,single nucleotide variant
GSS,20,34942606,na,na,Pathogenic/Likely pathogenic,not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency without 5-oxoprolinuria;Glutathione synthetase deficiency with 5-oxoprolinuria,GRCh38,single nucleotide variant
GSS,20,34932027,na,na,Conflicting classifications of pathogenicity,Inherited glutathione synthetase deficiency|not specified|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,GRCh38,single nucleotide variant
GSS,20,34936976,na,na,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency without 5-oxoprolinuria|Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,GRCh38,single nucleotide variant
EPHB2,1,22907980,na,na,Pathogenic,Prostate cancer/brain cancer susceptibility,GRCh38,single nucleotide variant
EPHB2,1,22863060,na,na,Benign,Prostate cancer/brain cancer susceptibility|not provided,GRCh38,single nucleotide variant
EPHB2,1,22906853,na,na,Likely benign,Prostate cancer/brain cancer susceptibility|not provided|EPHB2-related disorder,GRCh38,single nucleotide variant
EPHB2,1,22913757,na,na,Pathogenic,Prostate cancer/brain cancer susceptibility,GRCh38,single nucleotide variant
SMAD4,18,51065539,na,na,Pathogenic,Carcinoma of pancreas,GRCh38,single nucleotide variant
SMAD4,18,51078285,na,na,Pathogenic,Carcinoma of pancreas,GRCh38,single nucleotide variant
SMAD4,18,51078351,na,na,Pathogenic,Carcinoma of pancreas,GRCh38,single nucleotide variant
SMAD4,18,51065548,na,na,Pathogenic/Likely pathogenic,Generalized juvenile polyposis/juvenile polyposis coli|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Juvenile polyposis syndrome|Familial thoracic aortic aneurysm and aortic dissection;Hereditary cancer-predisposing syndrome|SMAD4-related disorder|Neoplasm,GRCh38,single nucleotide variant
SMAD4,18,51067036,na,na,Pathogenic,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,GRCh38,single nucleotide variant
TNXB,6,32084536,na,na,Conflicting classifications of pathogenicity,not provided|Cardiovascular phenotype|TNXB-related disorder|Ehlers-Danlos syndrome|Ehlers-Danlos syndrome due to tenascin-X deficiency|See cases|not specified,GRCh38,single nucleotide variant
NR3C2,4,148435252,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Autism spectrum disorder,GRCh38,single nucleotide variant
NR3C2,4,148152550,na,na,Uncertain significance,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy|NR3C2-related disorder|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1",GRCh38,single nucleotide variant
NR3C2,4,148114132,na,na,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,GRCh38,single nucleotide variant
NR3C2,4,148194825,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148154589,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148259978,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148081363,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148436373,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148081460,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148435553,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148154899,na,na,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148154892,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
NR3C2,4,148152526,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,GRCh38,single nucleotide variant
NR3C2,4,148081384,na,na,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,GRCh38,single nucleotide variant
DMP1,4,87657031,na,na,Pathogenic/Likely pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1|not provided",GRCh38,single nucleotide variant
DMP1,4,87656493,na,na,Conflicting classifications of pathogenicity,"Hypophosphatemic rickets, autosomal recessive, 1|not provided|not specified",GRCh38,single nucleotide variant
MYO6,6,75857198,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,GRCh38,single nucleotide variant
MYO6,6,75914119,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 37|not provided,GRCh38,single nucleotide variant
MYO6,6,75840678,na,na,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 37|Autosomal dominant nonsyndromic hearing loss 22|not provided,GRCh38,single nucleotide variant
MYO6,6,75841299,na,na,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,GRCh38,single nucleotide variant
MYO6,6,75886881,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22|Rare genetic deafness|not provided,GRCh38,single nucleotide variant
MYO6,6,75884246,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,GRCh38,single nucleotide variant
SLC12A3,16,56894558,na,na,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|SLC12A3-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
SLC12A3,16,56879153,na,na,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,GRCh38,single nucleotide variant
SLC12A3,16,56870119,na,na,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,GRCh38,single nucleotide variant
SLC12A3,16,56886363,na,na,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,GRCh38,single nucleotide variant
SLC12A3,16,56886402,na,na,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|Familial hypokalemia-hypomagnesemia;Bartter syndrome,GRCh38,single nucleotide variant
SLC12A3,16,56886402,na,na,Likely pathogenic,Familial hypokalemia-hypomagnesemia,GRCh38,single nucleotide variant
SLC12A3,16,56899617,na,na,Pathogenic,Familial hypokalemia-hypomagnesemia,GRCh38,single nucleotide variant
SLC12A3,16,56884142,na,na,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,GRCh38,single nucleotide variant
SLC12A3,16,56872737,na,na,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,GRCh38,single nucleotide variant
SLC12A3,16,56885328,na,na,Pathogenic,Familial hypokalemia-hypomagnesemia,GRCh38,single nucleotide variant
SLC12A3,16,56885307,na,na,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,GRCh38,single nucleotide variant
SLC12A3,16,56868355,na,na,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,GRCh38,single nucleotide variant
SIX5,19,45768373,na,na,Uncertain significance,Branchiootorenal syndrome 2|not provided,GRCh38,single nucleotide variant
SIX5,19,45767073,na,na,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome 2|SIX5-related disorder,GRCh38,single nucleotide variant
SIX5,19,45766866,na,na,Pathogenic,Branchiootorenal syndrome 2,GRCh38,single nucleotide variant
SIX5,19,45766066,na,na,Uncertain significance,Branchiootorenal syndrome 2|not provided,GRCh38,single nucleotide variant
MYBPC3,11,47333189,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
MYBPC3,11,47332931,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided|Cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
MYBPC3,11,47342578,na,na,Pathogenic,not provided|Hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy 4;Left ventricular noncompaction 10|Cardiomyopathy|Left ventricular noncompaction 10|MYBPC3-related disorder,GRCh38,single nucleotide variant
MYBPC3,11,47337820,na,na,Pathogenic,Hypertrophic cardiomyopathy 4,GRCh38,single nucleotide variant
MYBPC3,11,47351356,na,na,Pathogenic,Hypertrophic cardiomyopathy 4,GRCh38,single nucleotide variant
MYBPC3,11,47335104,na,na,Uncertain significance,"Cardiomyopathy|Cardiomyopathy, dilated, 1MM",GRCh38,single nucleotide variant
MYBPC3,11,47333238,na,na,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiomyopathy,GRCh38,single nucleotide variant
MYBPC3,11,47337534,na,na,Pathogenic/Likely pathogenic,not provided|Hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|Cardiomyopathy|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|MYBPC3-related disorder,GRCh38,single nucleotide variant
MYBPC3,11,47347030,na,na,Pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,GRCh38,single nucleotide variant
MYBPC3,11,47333192,na,na,Pathogenic,Hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Cardiomyopathy|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|MYBPC3-related disorder,GRCh38,single nucleotide variant
AMH,19,2251418,na,na,Pathogenic,"Persistent mullerian duct syndrome, type I",GRCh38,single nucleotide variant
AMH,19,2250667,na,na,Pathogenic,"Persistent mullerian duct syndrome, type I|Persistent Mullerian duct syndrome",GRCh38,single nucleotide variant
AMHR2,12,53424471,na,na,Pathogenic,"Persistent mullerian duct syndrome, type II",GRCh38,single nucleotide variant
AMHR2,12,53429907,na,na,Likely pathogenic,"Persistent mullerian duct syndrome, type II|not provided",GRCh38,single nucleotide variant
AANAT,17,76469731,na,na,Uncertain significance,"Delayed sleep phase syndrome, susceptibility to",GRCh38,single nucleotide variant
GHR,5,42694991,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42688934,na,na,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Laron-type isolated somatotropin defect;Short stature due to partial GHR deficiency;Hypercholesterolemia, familial, 1",GRCh38,single nucleotide variant
GHR,5,42688921,na,na,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided|Growth hormone insensitivity syndrome,GRCh38,single nucleotide variant
GHR,5,42699978,na,na,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",GRCh38,single nucleotide variant
GHR,5,42688937,na,na,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|Growth hormone insensitivity syndrome|not provided,GRCh38,single nucleotide variant
GHR,5,42699919,na,na,Conflicting classifications of pathogenicity,"Short stature due to partial GHR deficiency|not provided|Laron-type isolated somatotropin defect;Short stature due to partial GHR deficiency|Short stature due to growth hormone secretagogue receptor deficiency;Laron-type isolated somatotropin defect;Short stature due to partial GHR deficiency;Hypercholesterolemia, familial, 1|Laron-type isolated somatotropin defect|not specified|GHR-related disorder",GRCh38,single nucleotide variant
GHR,5,42711314,na,na,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided,GRCh38,single nucleotide variant
GHR,5,42711291,na,na,Pathogenic,"not provided|Laron-type isolated somatotropin defect|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",GRCh38,single nucleotide variant
GHR,5,42689020,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42711206,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42713519,na,na,Pathogenic,Laron syndrome with elevated serum GH-binding protein,GRCh38,single nucleotide variant
GHR,5,42699899,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42718051,na,na,Pathogenic,Short stature due to partial GHR deficiency|not provided,GRCh38,single nucleotide variant
GHR,5,42711312,na,na,Pathogenic,Laron syndrome with undetectable serum GH-binding protein,GRCh38,single nucleotide variant
GHR,5,42699902,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42718122,na,na,Pathogenic,Laron syndrome with elevated serum GH-binding protein,GRCh38,single nucleotide variant
GHR,5,42699830,na,na,Likely pathogenic,Laron syndrome with undetectable serum GH-binding protein|Growth hormone insensitivity syndrome,GRCh38,single nucleotide variant
GHR,5,42699868,na,na,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided|Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42699892,na,na,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided,GRCh38,single nucleotide variant
GHR,5,42699896,na,na,Likely pathogenic,Laron-type isolated somatotropin defect|not provided,GRCh38,single nucleotide variant
GHR,5,42700794,na,na,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided,GRCh38,single nucleotide variant
GHR,5,42629069,na,na,Pathogenic,Laron-type isolated somatotropin defect|Growth hormone insensitivity syndrome,GRCh38,single nucleotide variant
GHR,5,42719137,na,na,Benign,"Hypercholesterolemia, familial, 1|not specified|Laron-type isolated somatotropin defect|Short stature due to partial GHR deficiency|not provided",GRCh38,single nucleotide variant
GHR,5,42694953,na,na,Pathogenic,Laron-type isolated somatotropin defect|not provided,GRCh38,single nucleotide variant
GHR,5,42694985,na,na,Pathogenic,Laron-type isolated somatotropin defect,GRCh38,single nucleotide variant
GHR,5,42699888,na,na,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided|not specified,GRCh38,single nucleotide variant
SERPINH1,11,75561608,na,na,Pathogenic,Preterm premature rupture of membranes,GRCh38,single nucleotide variant
KCNJ11,11,17387652,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided",GRCh38,single nucleotide variant
KCNJ11,11,17387490,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Neonatal insulin-dependent diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Neonatal diabetes mellitus|not provided|Hyperinsulinemia",GRCh38,single nucleotide variant
KCNJ11,11,17387917,na,na,Pathogenic,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal insulin-dependent diabetes mellitus|not provided|Neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",GRCh38,single nucleotide variant
KCNJ11,11,17387491,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus|Diabetes mellitus, permanent neonatal 2|not provided|Transitory neonatal diabetes mellitus|Neonatal diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Maturity onset diabetes mellitus in young|Diabetes mellitus, transient neonatal, 3;Diabetes mellitus, permanent neonatal 2",GRCh38,single nucleotide variant
KCNJ11,11,17387916,na,na,Likely benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",GRCh38,single nucleotide variant
KCNJ11,11,17387943,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|KCNJ11-related disorder",GRCh38,single nucleotide variant
KCNJ11,11,17387583,na,na,Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young",GRCh38,single nucleotide variant
KCNJ11,11,17387582,na,na,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young|Neonatal diabetes mellitus",GRCh38,single nucleotide variant
KCNJ11,11,17388056,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided",GRCh38,single nucleotide variant
KCNJ11,11,17388225,na,na,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|not specified",GRCh38,single nucleotide variant
KCNJ11,11,17387331,na,na,Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Type 2 diabetes mellitus|Maturity onset diabetes mellitus in young|not provided",GRCh38,single nucleotide variant
KCNJ11,11,17387968,na,na,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young type 13|Maturity onset diabetes mellitus in young|not provided",GRCh38,single nucleotide variant
KCNJ11,11,17387316,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 13;Hyperinsulinemic hypoglycemia, familial, 2;Diabetes mellitus, transient neonatal, 3;Diabetes mellitus, permanent neonatal 2|KCNJ11-related disorder",GRCh38,single nucleotide variant
ABCC8;KCNJ11,11,17388025,na,na,Benign/Likely benign,"Diabetes mellitus type 2, susceptibility to|Permanent neonatal diabetes mellitus|not specified|Maturity onset diabetes mellitus in young|Hyperinsulinemic hypoglycemia, familial, 2|Hyperinsulinism, Dominant/Recessive|Transient Neonatal Diabetes, Dominant|Diabetes mellitus, transient neonatal, 3|Maturity-onset diabetes of the young type 13|not provided|Type 2 diabetes mellitus|KCNJ11-related disorder",GRCh38,single nucleotide variant
KCNJ11,11,17387595,na,na,drug response,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Glibenclamide response",GRCh38,single nucleotide variant
KCNJ11,11,17387593,na,na,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",GRCh38,single nucleotide variant
KCNJ11,11,17387935,na,na,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|Transitory neonatal diabetes mellitus",GRCh38,single nucleotide variant
KCNJ11,11,17387935,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 3",GRCh38,single nucleotide variant
KCNJ11,11,17387190,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity-onset diabetes of the young type 13|not provided|Diabetes mellitus, transient neonatal, 3;Permanent neonatal diabetes mellitus 1;Hyperinsulinemic hypoglycemia, familial, 2|Diabetes mellitus, transient neonatal, 3|Maturity onset diabetes mellitus in young|Diabetes mellitus, permanent neonatal 2;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 13;Hyperinsulinemic hypoglycemia, familial, 2|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
KCNJ11,11,17387626,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Hypoglycemia|Hyperinsulinemia",GRCh38,single nucleotide variant
KCNJ11,11,17387934,na,na,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal hypoglycemia",GRCh38,single nucleotide variant
KCNJ11,11,17387248,na,na,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Type 2 diabetes mellitus;Permanent neonatal diabetes mellitus;Diabetes mellitus, transient neonatal, 3;Maturity-onset diabetes of the young type 13;Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|not provided|Type 2 diabetes mellitus;Diabetes mellitus, transient neonatal, 3;Maturity-onset diabetes of the young type 13;Diabetes mellitus, permanent neonatal 2;Hyperinsulinemic hypoglycemia, familial, 2|Familial hyperinsulinism",GRCh38,single nucleotide variant
CRYBB1,22,26599591,na,na,Pathogenic,Cataract 17 multiple types,GRCh38,single nucleotide variant
PTPRJ,11,48123636,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
PTPRJ,11,48123823,na,na,Benign,Carcinoma of colon|not specified|Colorectal cancer|not provided|PTPRJ-related disorder,GRCh38,single nucleotide variant
GFER,16,1985991,na,na,Pathogenic,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
PPOX,1,161169070,na,na,Pathogenic,Variegate porphyria|not provided,GRCh38,single nucleotide variant
PPOX,1,161168462,na,na,Pathogenic/Likely pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",GRCh38,single nucleotide variant
PPOX,1,161166906,na,na,Pathogenic,Variegate porphyria,GRCh38,single nucleotide variant
PPOX,1,161167187,na,na,Pathogenic,"Variegate porphyria|not provided|Variegate porphyria, childhood-onset",GRCh38,single nucleotide variant
PPOX,1,161168463,na,na,Pathogenic/Likely pathogenic,Variegate porphyria|not provided|See cases,GRCh38,single nucleotide variant
PPOX,1,161170467,na,na,Pathogenic,"Variegate porphyria, childhood-onset",GRCh38,single nucleotide variant
PPOX,1,161166882,na,na,Pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",GRCh38,single nucleotide variant
PPOX,1,161169143,na,na,Conflicting classifications of pathogenicity,"Variegate porphyria|not provided|Variegate porphyria, childhood-onset|PPOX-related disorder",GRCh38,single nucleotide variant
FGF9,13,21681060,na,na,Pathogenic,Multiple synostoses syndrome 3,GRCh38,single nucleotide variant
PPP1R3A,7,113878379,na,na,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Type 2 diabetes mellitus|not provided|PPP1R3A-related disorder",GRCh38,single nucleotide variant
FANCE,6,35455853,na,na,Pathogenic,Fanconi anemia complementation group E,GRCh38,single nucleotide variant
FANCE,6,35455919,na,na,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E,GRCh38,single nucleotide variant
FANCE,6,35459323,na,na,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E|not provided,GRCh38,single nucleotide variant
SGCB,4,52028899,na,na,Pathogenic,not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
SGCB,4,52028799,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,GRCh38,single nucleotide variant
SGCB,4,52029835,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,GRCh38,single nucleotide variant
SGCB,4,52029784,na,na,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,GRCh38,single nucleotide variant
SGCB,4,52029808,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,GRCh38,single nucleotide variant
SGCB,4,52029835,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided,GRCh38,single nucleotide variant
GJA8,1,147908217,na,na,Pathogenic/Likely pathogenic,Cataract 1 multiple types,GRCh38,single nucleotide variant
GJA8,1,147908097,na,na,Conflicting classifications of pathogenicity,Cataract 1 multiple types,GRCh38,single nucleotide variant
GJA8,1,147908696,na,na,Benign/Likely benign,Cataract 1 multiple types|not provided|GJA8-related disorder,GRCh38,single nucleotide variant
GJA8,1,147908023,na,na,Likely pathogenic,Cataract 1 multiple types,GRCh38,single nucleotide variant
GJA8,1,147908086,na,na,Uncertain significance,Cataract 1 multiple types,GRCh38,single nucleotide variant
GJA8,1,147908548,na,na,Conflicting classifications of pathogenicity,Cataract 1 multiple types|not provided,GRCh38,single nucleotide variant
GJA8,1,147908094,na,na,Pathogenic,Cataract 1 multiple types,GRCh38,single nucleotide variant
HADHA,2,26195184,na,na,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|LCHAD deficiency with maternal acute fatty liver of pregnancy|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|HADHA-related disorder|not specified|Inborn genetic diseases|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
HADHA,2,26204150,na,na,Pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
HADHA,2,26238933,na,na,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,GRCh38,single nucleotide variant
HADHA,2,26238931,na,na,Pathogenic/Likely pathogenic,not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,GRCh38,single nucleotide variant
HADHA,2,26194581,na,na,Pathogenic,Mitochondrial trifunctional protein deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
HADHA,2,26209840,na,na,Pathogenic,Mitochondrial trifunctional protein deficiency,GRCh38,single nucleotide variant
HADHA,2,26214516,na,na,Uncertain significance,not specified|Mitochondrial trifunctional protein deficiency 1,GRCh38,single nucleotide variant
HADHA,2,26214447,na,na,Pathogenic/Likely pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
HADHA,2,26214490,na,na,Pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Inborn genetic diseases,GRCh38,single nucleotide variant
GFI1,1,92476153,na,na,Pathogenic,"Neutropenia, severe congenital, 2, autosomal dominant|not provided",GRCh38,single nucleotide variant
GFI1,1,92476090,na,na,Conflicting classifications of pathogenicity,"Nonimmune chronic idiopathic neutropenia of adults|Neutropenia, severe congenital, 2, autosomal dominant",GRCh38,single nucleotide variant
CSNK1D,17,82265743,na,na,Pathogenic,Advanced sleep phase syndrome 2,GRCh38,single nucleotide variant
SDHA,5,251100,na,na,Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5;Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Leigh syndrome|not provided|Diffuse midline glioma, H3 K27-altered|Dilated cardiomyopathy 1GG|Paragangliomas 5;Mitochondrial complex II deficiency, nuclear type 1;Neurodegeneration with ataxia and late-onset optic atrophy;Dilated cardiomyopathy 1GG|SDHA-related disorder",GRCh38,single nucleotide variant
SDHA,5,251011,na,na,Pathogenic/Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome|Dilated cardiomyopathy 1GG",GRCh38,single nucleotide variant
SDHA,5,218356,na,na,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|Hereditary cancer-predisposing syndrome|Paragangliomas 5|Neurodegeneration with ataxia and late-onset optic atrophy",GRCh38,single nucleotide variant
SDHA,5,251338,na,na,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Dilated cardiomyopathy 1GG|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5",GRCh38,single nucleotide variant
CDKN1C,11,2885351,na,na,Pathogenic,Beckwith-Wiedemann syndrome,GRCh38,single nucleotide variant
CDKN1C,11,2884750,na,na,Pathogenic,Beckwith-Wiedemann syndrome,GRCh38,single nucleotide variant
GCKR,2,27508073,na,na,Benign,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5|not provided,GRCh38,single nucleotide variant
SLC12A1,15,48251770,na,na,Uncertain significance,Bartter disease type 1|Familial hypokalemia-hypomagnesemia;Bartter syndrome|not specified,GRCh38,single nucleotide variant
SLC12A1,15,48229278,na,na,Pathogenic,Bartter disease type 1,GRCh38,single nucleotide variant
SLC12A1,15,48251703,na,na,Pathogenic,Bartter disease type 1|not provided|SLC12A1-related disorder,GRCh38,single nucleotide variant
SLC12A1,15,48226575,na,na,Pathogenic,Bartter disease type 1,GRCh38,single nucleotide variant
FOXN1,17,28529157,na,na,Pathogenic,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
GDNF,5,37816010,na,na,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",GRCh38,single nucleotide variant
GDNF,5,37815839,na,na,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",GRCh38,single nucleotide variant
GDNF,5,37815827,na,na,risk factor,"Hirschsprung disease, susceptibility to, 3",GRCh38,single nucleotide variant
GDNF,5,37815654,na,na,Uncertain significance,"Hirschsprung disease, susceptibility to, 3|not specified",GRCh38,single nucleotide variant
CXCL12,10,44378102,na,na,protective,Susceptibility to HIV infection,GRCh38,single nucleotide variant
PDE6C,10,93612810,na,na,Pathogenic/Likely pathogenic,Cone dystrophy 4|Achromatopsia 5|not provided,GRCh38,single nucleotide variant
PDE6C,10,93626667,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93635590,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93620784,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93663028,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93620620,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93640068,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93640987,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93622034,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
PDE6C,10,93663117,na,na,Pathogenic,Achromatopsia 5,GRCh38,single nucleotide variant
CSRP3,11,19192439,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1M|not specified|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy 12|Sudden unexplained death;Hypertrophic cardiomyopathy|Cardiomyopathy|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Hypertrophic cardiomyopathy|CSRP3-related disorder,GRCh38,single nucleotide variant
CSRP3,11,19188245,na,na,Pathogenic,Hypertrophic cardiomyopathy 12|Cardiovascular phenotype,GRCh38,single nucleotide variant
CSRP3,11,19188286,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 12|Hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|See cases,GRCh38,single nucleotide variant
CSRP3,11,19188211,na,na,Uncertain significance,Dilated cardiomyopathy 1M|Hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
CSRP3,11,19188281,na,na,Uncertain significance,Hypertrophic cardiomyopathy 12|not specified|Hypertrophic cardiomyopathy 12;Dilated cardiomyopathy 1M|Cardiovascular phenotype|Cardiomyopathy|not provided,GRCh38,single nucleotide variant
MRE11,11,94437206,na,na,Pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,GRCh38,single nucleotide variant
MRE11,11,94479726,na,na,Conflicting classifications of pathogenicity,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,GRCh38,single nucleotide variant
MRE11,11,94447288,na,na,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,GRCh38,single nucleotide variant
MRE11,11,94459466,na,na,Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder,GRCh38,single nucleotide variant
MRE11,11,94476318,na,na,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|not provided,GRCh38,single nucleotide variant
DDB2,11,47234784,na,na,Pathogenic,"Xeroderma pigmentosum, group E",GRCh38,single nucleotide variant
DDB2,11,47234872,na,na,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group E|not provided",GRCh38,single nucleotide variant
DDB2,11,47235326,na,na,Pathogenic,"Xeroderma pigmentosum, group E",GRCh38,single nucleotide variant
DDB2,11,47235308,na,na,Pathogenic,"Xeroderma pigmentosum, group E",GRCh38,single nucleotide variant
LAMA3,18,23907639,na,na,Pathogenic,"Junctional epidermolysis bullosa gravis of Herlitz|not provided|Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate;Epidermolysis bullosa, junctional 2B, severe;Laryngo-onycho-cutaneous syndrome",GRCh38,single nucleotide variant
LAMA3,18,23939322,na,na,Uncertain significance,"Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate",GRCh38,single nucleotide variant
BMPR2,2,202556360,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|not provided|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202464950,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202467625,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202530866,na,na,Likely pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",GRCh38,single nucleotide variant
BMPR2,2,202552756,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202552773,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|BMPR2-related disorder|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",GRCh38,single nucleotide variant
BMPR2,2,202513807,na,na,Pathogenic,"Pulmonary hypertension, primary, 1",GRCh38,single nucleotide variant
BMPR2,2,202556282,na,na,Pathogenic/Likely pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|not provided|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",GRCh38,single nucleotide variant
BMPR2,2,202552774,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|not provided|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary venoocclusive disease 1",GRCh38,single nucleotide variant
BMPR2,2,202467638,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202467638,na,na,Pathogenic,"Pulmonary hypertension, primary, 1",GRCh38,single nucleotide variant
BMPR2,2,202530820,na,na,Pathogenic,"not provided|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension",GRCh38,single nucleotide variant
BMPR2,2,202556361,na,na,Pathogenic,"Pulmonary hypertension, primary, 1",GRCh38,single nucleotide variant
BMPR2,2,202518831,na,na,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, dexfenfluramine-associated|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Primary pulmonary hypertension",GRCh38,single nucleotide variant
BMPR2,2,202514903,na,na,Likely benign,"Pulmonary hypertension, primary, fenfluramine-associated|not provided|Primary pulmonary hypertension|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",GRCh38,single nucleotide variant
BMPR2,2,202464852,na,na,Pathogenic,Pulmonary venoocclusive disease 1,GRCh38,single nucleotide variant
BMPR2,2,202542331,na,na,Pathogenic,"Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia|Pulmonary hypertension, primary, 1",GRCh38,single nucleotide variant
IRS2,13,109782884,na,na,Benign; risk factor,Type 2 diabetes mellitus|IRS2-related disorder,GRCh38,single nucleotide variant
IRS2,13,109784115,na,na,risk factor,Type 2 diabetes mellitus,GRCh38,single nucleotide variant
PYY,17,43953299,na,na,Uncertain significance,Obesity,GRCh38,single nucleotide variant
CDKN1B,12,12718066,na,na,Pathogenic,Multiple endocrine neoplasia type 4,GRCh38,single nucleotide variant
SCNN1G,16,23215237,na,na,Pathogenic,Liddle syndrome 2,GRCh38,single nucleotide variant
SCNN1G,16,23215088,na,na,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",GRCh38,single nucleotide variant
SCNN1G,16,23189370,na,na,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",GRCh38,single nucleotide variant
SCNN1G,16,23189600,na,na,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|Liddle syndrome 2|not specified|SCNN1G-related disorder",GRCh38,single nucleotide variant
SCNN1G,16,23189642,na,na,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|Pseudohypoaldosteronism, type IB1, autosomal recessive|not specified|not provided|Liddle syndrome 2|Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 2;Bronchiectasis with or without elevated sweat chloride 3",GRCh38,single nucleotide variant
SCNN1B,16,23380574,na,na,Pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23380725,na,na,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23348708,na,na,Benign,"Liddle syndrome 1|Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive",GRCh38,single nucleotide variant
SCNN1B,16,23380736,na,na,Pathogenic,Liddle syndrome 1,GRCh38,single nucleotide variant
SCNN1B,16,23380727,na,na,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23380725,na,na,Pathogenic,Liddle syndrome 1,GRCh38,single nucleotide variant
SCNN1B,16,23367879,na,na,Likely pathogenic,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23380419,na,na,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
SCNN1B,16,23367959,na,na,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 1|not provided,GRCh38,single nucleotide variant
SCNN1B,16,23380493,na,na,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,GRCh38,single nucleotide variant
SCNN1B,16,23371836,na,na,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23367942,na,na,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",GRCh38,single nucleotide variant
SCNN1B,16,23348844,na,na,Conflicting classifications of pathogenicity,"Bronchiectasis with or without elevated sweat chloride 1|not specified|Liddle syndrome 1|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|SCNN1B-related disorder",GRCh38,single nucleotide variant
PSEN2,1,226885603,na,na,Pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226888977,na,na,Pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226895548,na,na,Uncertain significance,Alzheimer disease 4|not provided|Alzheimer disease,GRCh38,single nucleotide variant
PSEN2,1,226895521,na,na,Uncertain significance,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226885545,na,na,Pathogenic/Likely pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226888979,na,na,Pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226885546,na,na,Pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
PSEN2,1,226885570,na,na,Benign/Likely benign,Dilated cardiomyopathy 1V|Alzheimer disease 4|Alzheimer disease|not provided|PSEN2-related disorder|not specified,GRCh38,single nucleotide variant
PSEN2,1,226883817,na,na,Pathogenic,Alzheimer disease 4|not provided,GRCh38,single nucleotide variant
KCNJ5,11,128916630,na,na,Benign/Likely benign,Long QT syndrome 13|Andersen Tawil syndrome|Familial hyperaldosteronism type III|Long QT syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
PDX1,13,27924439,na,na,risk factor,"Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
PDX1,13,27920364,na,na,Conflicting classifications of pathogenicity,"Type 2 diabetes mellitus|Maturity-onset diabetes of the young type 4|not specified|Monogenic diabetes|Maturity onset diabetes mellitus in young|not provided|Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
PDX1,13,27920314,na,na,Uncertain significance,"Diabetes mellitus type 2, susceptibility to|PDX1-related disorder|not provided",GRCh38,single nucleotide variant
PDX1,13,27920190,na,na,Uncertain significance,"Type 2 diabetes mellitus|not provided|Diabetes mellitus type 2, susceptibility to|Pancreatic agenesis 1;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 4",GRCh38,single nucleotide variant
PDX1,13,27924519,na,na,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 4|Monogenic diabetes|not provided|Type 2 diabetes mellitus|not specified|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 4|Maturity onset diabetes mellitus in young,GRCh38,single nucleotide variant
PDX1,13,27924341,na,na,Pathogenic; risk factor,"Pancreatic agenesis 1|Diabetes mellitus type 2, susceptibility to",GRCh38,single nucleotide variant
PDX1,13,27924381,na,na,Pathogenic,Pancreatic agenesis 1,GRCh38,single nucleotide variant
IHH,2,219060185,na,na,Pathogenic,Brachydactyly type A1|not provided,GRCh38,single nucleotide variant
IHH,2,219057619,na,na,Likely pathogenic,Brachydactyly type A1|not provided,GRCh38,single nucleotide variant
IHH,2,219060168,na,na,Pathogenic,Brachydactyly type A1,GRCh38,single nucleotide variant
IHH,2,219060170,na,na,Pathogenic,Brachydactyly type A1|Brachydactyly type A1A|not provided,GRCh38,single nucleotide variant
IHH,2,219060331,na,na,Pathogenic,Acrocapitofemoral dysplasia,GRCh38,single nucleotide variant
IHH,2,219057441,na,na,Pathogenic,Acrocapitofemoral dysplasia|not provided,GRCh38,single nucleotide variant
IHH,2,219060184,na,na,Pathogenic,Brachydactyly type A1,GRCh38,single nucleotide variant
IHH,2,219057549,na,na,Pathogenic,Brachydactyly type A1,GRCh38,single nucleotide variant
IHH,2,219057627,na,na,Likely pathogenic,Brachydactyly type A1|not provided,GRCh38,single nucleotide variant
IHH,2,219057621,na,na,Pathogenic,Brachydactyly type A1,GRCh38,single nucleotide variant
SHH,7,155812032,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155811825,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155806545,na,na,Pathogenic,Holoprosencephaly 3|Inborn genetic diseases,GRCh38,single nucleotide variant
SHH,7,155806509,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155806509,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155803618,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155803613,na,na,Conflicting classifications of pathogenicity,Holoprosencephaly 3|not provided|Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies,GRCh38,single nucleotide variant
SHH,7,155803439,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155803142,na,na,Uncertain significance,"Holoprosencephaly 3|Schizencephaly|Microphthalmia, isolated, with coloboma 5|Solitary median maxillary central incisor syndrome|not provided",GRCh38,single nucleotide variant
SHH,7,155803420,na,na,Benign/Likely benign,"Holoprosencephaly 3|not specified|not provided|SHH-related disorder|Microphthalmia, isolated, with coloboma 5;Schizencephaly;Holoprosencephaly 3;Solitary median maxillary central incisor syndrome",GRCh38,single nucleotide variant
SHH,7,155803019,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155806527,na,na,Pathogenic,Solitary median maxillary central incisor syndrome,GRCh38,single nucleotide variant
SHH,7,155811860,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155803523,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
SHH,7,155803294,na,na,Likely pathogenic,Solitary median maxillary central incisor syndrome,GRCh38,single nucleotide variant
SHH,7,155806475,na,na,Pathogenic,Holoprosencephaly 3|Solitary median maxillary central incisor syndrome|not provided,GRCh38,single nucleotide variant
SHH,7,155806513,na,na,Pathogenic,Holoprosencephaly 3,GRCh38,single nucleotide variant
CNGB1,16,57897913,na,na,Pathogenic,Retinitis pigmentosa 45,GRCh38,single nucleotide variant
CNGB1,16,57887854,na,na,Pathogenic,Retinitis pigmentosa 45,GRCh38,single nucleotide variant
PPT1,1,40091398,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,GRCh38,single nucleotide variant
PPT1,1,40092409,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|PPT1-related disorder,GRCh38,single nucleotide variant
PPT1,1,40092171,na,na,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 1|not provided,GRCh38,single nucleotide variant
PPT1,1,40078630,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1,GRCh38,single nucleotide variant
PPT1,1,40097210,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,GRCh38,single nucleotide variant
PPT1,1,40089495,na,na,Pathogenic/Likely pathogenic,"Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Neuronal Ceroid-Lipofuscinosis, Recessive|PPT1-related disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
PPT1,1,40092085,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1,GRCh38,single nucleotide variant
PPT1,1,40092498,na,na,Pathogenic,Neuronal ceroid lipofuscinosis 1,GRCh38,single nucleotide variant
PTPN22,1,113834946,na,na,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to|not provided|chronic fatigue syndrome with infection-triggered onset",GRCh38,single nucleotide variant
PTPN22,1,113872746,na,na,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to",GRCh38,single nucleotide variant
TNNT3,11,1933737,na,na,Pathogenic/Likely pathogenic,"Arthrogryposis, distal, type 2B2|not provided|Arthyrgryposis, distal, type 2B",GRCh38,single nucleotide variant
SLC16A1,1,112917796,na,na,Uncertain significance,Metabolic myopathy due to lactate transporter defect|not provided,GRCh38,single nucleotide variant
SLC16A1,1,112913980,na,na,Conflicting classifications of pathogenicity,Metabolic myopathy due to lactate transporter defect|not specified|not provided,GRCh38,single nucleotide variant
SLC16A1,1,112956192,na,na,Pathogenic,Exercise-induced hyperinsulinism,GRCh38,single nucleotide variant
KCNJ2,17,70175251,na,na,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,GRCh38,single nucleotide variant
KCNJ2,17,70175691,na,na,Pathogenic/Likely pathogenic,"Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Andersen Tawil syndrome;Short QT syndrome type 3|Andersen Tawil syndrome;Atrial fibrillation, familial, 9;Short QT syndrome type 3|Cardiovascular phenotype",GRCh38,single nucleotide variant
KCNJ2,17,70175938,na,na,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNJ2,17,70175238,na,na,Pathogenic,"Andersen Tawil syndrome|not provided|Congenital long QT syndrome|Andersen Tawil syndrome;Atrial fibrillation, familial, 9;Short QT syndrome type 3|Andersen Tawil syndrome;Short QT syndrome type 3|not specified|Cardiovascular phenotype",GRCh38,single nucleotide variant
KCNJ2,17,70175596,na,na,Pathogenic,Congenital long QT syndrome|Andersen Tawil syndrome,GRCh38,single nucleotide variant
KCNJ2,17,70175943,na,na,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,GRCh38,single nucleotide variant
KCNJ2,17,70175685,na,na,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,GRCh38,single nucleotide variant
KCNJ2,17,70175553,na,na,Pathogenic,Short QT syndrome type 3|Short QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,GRCh38,single nucleotide variant
KCNJ2,17,70175263,na,na,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,GRCh38,single nucleotide variant
MSH6,2,47800616,na,na,Benign,Lynch syndrome 5|not provided|Lynch syndrome|not specified|Colorectal / endometrial cancer|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Carcinoma of colon|Hereditary nonpolyposis colorectal neoplasms|Breast and/or ovarian cancer|Endometrial carcinoma;Mismatch repair cancer syndrome 3;Lynch syndrome 5,GRCh38,single nucleotide variant
XRCC3,14,103699416,na,na,Benign,"Melanoma, cutaneous malignant, susceptibility to, 6|XRCC3-related disorder|not provided",GRCh38,single nucleotide variant
XRCC3,14,103699590,na,na,risk factor,"Breast cancer, susceptibility to",GRCh38,single nucleotide variant
CHUK,10,100205167,na,na,Pathogenic,Cocoon syndrome,GRCh38,single nucleotide variant
MEF2C,5,88731856,na,na,Pathogenic,"Intellectual disability, autosomal dominant 20",GRCh38,single nucleotide variant
MEF2A,15,99690400,na,na,Pathogenic,Coronary artery disease/myocardial infarction,GRCh38,single nucleotide variant
MEF2A,15,99690352,na,na,Benign/Likely benign,Coronary artery disease/myocardial infarction|not specified|not provided,GRCh38,single nucleotide variant
MEF2A,15,99690412,na,na,Pathogenic,Coronary artery disease/myocardial infarction,GRCh38,single nucleotide variant
CPT2,1,53213509,na,na,Pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4",GRCh38,single nucleotide variant
CPT2,1,53202427,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Inborn genetic diseases|Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|Rhabdomyolysis|Abnormality of the musculature|Encephalopathy, acute, infection-induced, susceptibility to, 4",GRCh38,single nucleotide variant
CPT2,1,53197092,na,na,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|Encephalopathy, acute, infection-induced, susceptibility to, 4",GRCh38,single nucleotide variant
CPT2,1,53213275,na,na,Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, severe infantile form",GRCh38,single nucleotide variant
CPT2,1,53213501,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",GRCh38,single nucleotide variant
CPT2,1,53210194,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Encephalopathy, acute, infection-induced, susceptibility to, 4",GRCh38,single nucleotide variant
CPT2,1,53210822,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Carnitine palmitoyl transferase II deficiency, myopathic form|Seizure;Abnormality of the nervous system|Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided",GRCh38,single nucleotide variant
CPT2,1,53211181,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|Carnitine palmitoyl transferase II deficiency, severe infantile form|CPT2-related disorder|Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided",GRCh38,single nucleotide variant
CPT2,1,53211016,na,na,Conflicting classifications of pathogenicity; other,"not specified|not provided|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form",GRCh38,single nucleotide variant
CPT2,1,53202322,na,na,Pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form",GRCh38,single nucleotide variant
CPT2,1,53210354,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|Encephalopathy, acute, infection-induced, susceptibility to, 4|CPT2-related disorder",GRCh38,single nucleotide variant
CPT2,1,53211034,na,na,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",GRCh38,single nucleotide variant
CPT2,1,53210312,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",GRCh38,single nucleotide variant
CPT2,1,53210033,na,na,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4",GRCh38,single nucleotide variant
NECTIN1,11,119677734,na,na,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7,GRCh38,single nucleotide variant
NKX2-1,14,36517757,na,na,Pathogenic,Benign hereditary chorea,GRCh38,single nucleotide variant
NKX2-1,14,36517771,na,na,Pathogenic/Likely pathogenic,Benign hereditary chorea|not provided|Brain-lung-thyroid syndrome,GRCh38,single nucleotide variant
NKX2-1,14,36517781,na,na,Pathogenic,Brain-lung-thyroid syndrome,GRCh38,single nucleotide variant
NKX2-1,14,36518022,na,na,Conflicting classifications of pathogenicity,Benign hereditary chorea|Brain-lung-thyroid syndrome|not provided,GRCh38,single nucleotide variant
NKX2-1,14,36517871,na,na,Pathogenic/Likely pathogenic,Brain-lung-thyroid syndrome|Benign hereditary chorea|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
NKX2-1,14,36517739,na,na,Pathogenic,Benign hereditary chorea|not provided,GRCh38,single nucleotide variant
NKX2-1,14,36518022,na,na,Pathogenic,Brain-lung-thyroid syndrome,GRCh38,single nucleotide variant
OPCML,11,132657203,na,na,Pathogenic,Ovarian neoplasm,GRCh38,single nucleotide variant
ETV6,12,11839202,na,na,Pathogenic,Acute myeloid leukemia,GRCh38,single nucleotide variant
STAR,8,38144359,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
STAR,8,38146068,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
STAR,8,38144382,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
STAR,8,38145963,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency,GRCh38,single nucleotide variant
STAR,8,38145313,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
STAR,8,38146068,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
STAR,8,38146054,na,na,Pathogenic/Likely pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided|Syndactyly-telecanthus-anogenital and renal malformations syndrome,GRCh38,single nucleotide variant
STAR,8,38146051,na,na,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,GRCh38,single nucleotide variant
KLF1,19,12885356,na,na,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,GRCh38,single nucleotide variant
KLF1,19,12885335,na,na,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,GRCh38,single nucleotide variant
KLF1,19,12885368,na,na,Affects,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6,GRCh38,single nucleotide variant
NKX2-5,5,173233011,na,na,Pathogenic,Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173233036,na,na,Pathogenic,Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173232952,na,na,Pathogenic,Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173235011,na,na,Conflicting classifications of pathogenicity,"Tetralogy of Fallot|Hypothyroidism, congenital, nongoitrous, 5|Hypoplastic left heart syndrome 2|Congenital heart disease|Aortic arch interruption|not specified|Atrial septal defect 7|Cardiovascular phenotype|not provided|Persistent truncus arteriosus",GRCh38,single nucleotide variant
NKX2-5,5,173235023,na,na,Conflicting classifications of pathogenicity,Tetralogy of Fallot|Congenital heart disease|not specified|not provided|Cardiovascular phenotype|Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173232898,na,na,Uncertain significance,Tetralogy of Fallot|not provided|6 conditions|Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173232888,na,na,Uncertain significance,Tetralogy of Fallot|Atrial septal defect 7|Cardiovascular phenotype|6 conditions,GRCh38,single nucleotide variant
NKX2-5,5,173232648,na,na,Pathogenic,"Atrial septal defect 7|Atrioventricular septal defect, somatic",GRCh38,single nucleotide variant
NKX2-5,5,173232976,na,na,Uncertain significance,Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173232776,na,na,Pathogenic,Atrial septal defect 7,GRCh38,single nucleotide variant
NKX2-5,5,173233189,na,na,Benign/Likely benign,"Hypothyroidism, congenital, nongoitrous, 5|not specified|Atrial septal defect 7|Cardiovascular phenotype|not provided|NKX2-5-related disorder",GRCh38,single nucleotide variant
NKX2-5,5,173233062,na,na,Uncertain significance,"Hypothyroidism, congenital, nongoitrous, 5|not provided|Atrial septal defect 7",GRCh38,single nucleotide variant
NKX2-5,5,173232997,na,na,Pathogenic,"Atrioventricular septal defect, somatic",GRCh38,single nucleotide variant
LHX3,9,136199800,na,na,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,GRCh38,single nucleotide variant
LHX3,9,136198798,na,na,Likely pathogenic,"Non-acquired combined pituitary hormone deficiency with spine abnormalities|Combined pituitary hormone deficiencies, genetic form",GRCh38,single nucleotide variant
LHX3,9,136198755,na,na,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,GRCh38,single nucleotide variant
LHX3,9,136200700,na,na,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,GRCh38,single nucleotide variant
GATA4,8,11750213,na,na,Pathogenic,Atrial septal defect 2|Transposition of the great arteries|Atrioventricular septal defect 4,GRCh38,single nucleotide variant
GATA4,8,11708467,na,na,Pathogenic,Atrial septal defect 2,GRCh38,single nucleotide variant
GATA4,8,11755082,na,na,Uncertain significance,Atrial septal defect 2|Atrioventricular septal defect 4,GRCh38,single nucleotide variant
GATA4,8,11758419,na,na,Conflicting classifications of pathogenicity,Atrial septal defect 2|Tetralogy of Fallot|Pulmonic stenosis;Tricuspid regurgitation;Pulmonary valve atresia|Inborn genetic diseases|not specified|not provided|Atrioventricular septal defect 4|GATA4-related disorder|Congenital heart disease|Ventricular septal defect 1;Atrioventricular septal defect 4;Testicular anomalies with or without congenital heart disease;Tetralogy of Fallot;Atrial septal defect 2,GRCh38,single nucleotide variant
CLCN2,3,184352810,na,na,Uncertain significance,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2|Leukoencephalopathy with mild cerebellar ataxia and white matter edema",GRCh38,single nucleotide variant
CLCN2,3,184357688,na,na,Conflicting classifications of pathogenicity,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11;Familial hyperaldosteronism type II|not specified",GRCh38,single nucleotide variant
CLCN2,3,184353787,na,na,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|not specified|Cerebral palsy|CLCN2-related disorder|Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11",GRCh38,single nucleotide variant
NRXN1,2,50496039,na,na,Pathogenic,Pitt-Hopkins-like syndrome 2,GRCh38,single nucleotide variant
ITIH4,3,52819385,na,na,Benign,"Hypercholesterolemia, susceptibility to",GRCh38,single nucleotide variant
STAT1,2,190975830,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,GRCh38,single nucleotide variant
STAT1,2,190978930,na,na,Pathogenic,Immunodeficiency 31B,GRCh38,single nucleotide variant
STAT1,2,190983699,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency|not provided,GRCh38,single nucleotide variant
STAT1,2,190991307,na,na,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,GRCh38,single nucleotide variant
ITGA7,12,55697279,na,na,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,GRCh38,single nucleotide variant
ITGA7,12,55693139,na,na,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,GRCh38,single nucleotide variant
VANGL2,1,160421171,na,na,risk factor,"Neural tube defects, susceptibility to",GRCh38,single nucleotide variant
VANGL2,1,160425122,na,na,risk factor,"Neural tube defects, susceptibility to",GRCh38,single nucleotide variant
NDUFV2,18,9117869,na,na,Benign,"not specified|not provided|Mitochondrial complex I deficiency, nuclear type 1|Parkinson disease, mitochondrial|Mitochondrial complex 1 deficiency, nuclear type 7",GRCh38,single nucleotide variant
AUH,9,91297993,na,na,Pathogenic,3-methylglutaconic aciduria type 1|not provided,GRCh38,single nucleotide variant
AUH,9,91216107,na,na,Pathogenic,3-methylglutaconic aciduria type 1,GRCh38,single nucleotide variant
AUH,9,91356157,na,na,Pathogenic,3-methylglutaconic aciduria type 1,GRCh38,single nucleotide variant
AUH,9,91214427,na,na,Pathogenic/Likely pathogenic,3-methylglutaconic aciduria type 1|AUH-related disorder,GRCh38,single nucleotide variant
CPT1A,11,68780737,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68784899,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68807622,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,GRCh38,single nucleotide variant
CPT1A,11,68781882,na,na,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68775398,na,na,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68761688,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68760241,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,GRCh38,single nucleotide variant
CPT1A,11,68760238,na,na,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,GRCh38,single nucleotide variant
SLC11A2,12,50992810,na,na,Pathogenic,Microcytic anemia with liver iron overload,GRCh38,single nucleotide variant
SLC11A2,12,50992291,na,na,Pathogenic,Microcytic anemia with liver iron overload,GRCh38,single nucleotide variant
SLC11A2,12,50999214,na,na,Pathogenic,Microcytic anemia with liver iron overload,GRCh38,single nucleotide variant
PLA2G4A,1,186894164,na,na,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,GRCh38,single nucleotide variant
PLA2G4A,1,186956219,na,na,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,GRCh38,single nucleotide variant
P2RY12,3,151338079,na,na,Uncertain significance,Platelet-type bleeding disorder 8|not provided|not specified,GRCh38,single nucleotide variant
P2RY12,3,151338053,na,na,Uncertain significance,Platelet-type bleeding disorder 8|not specified|not provided,GRCh38,single nucleotide variant
RELN,7,103558050,na,na,Pathogenic,Norman-Roberts syndrome,GRCh38,single nucleotide variant
ABCC8,11,17395610,na,na,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Hereditary hyperinsulinism|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17397055,na,na,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Inborn genetic diseases|Hereditary hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1;Diabetes mellitus, permanent neonatal 3|ABCC8-related disorder|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3|Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia",GRCh38,single nucleotide variant
ABCC8,11,17414611,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17430979,na,na,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|Familial hyperinsulinism",GRCh38,single nucleotide variant
ABCC8,11,17396980,na,na,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17395659,na,na,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1|Hereditary hyperinsulinism|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17394334,na,na,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Hereditary hyperinsulinism|Diabetes mellitus, permanent neonatal 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2|Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17394295,na,na,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided",GRCh38,single nucleotide variant
ABCC8,11,17396980,na,na,Conflicting classifications of pathogenicity,"Leucine-induced hypoglycemia|not provided|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17463457,na,na,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17476966,na,na,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 1|ABCC8-related disorder|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17470119,na,na,Pathogenic/Likely pathogenic,"Diabetes mellitus, permanent neonatal 3|Permanent neonatal diabetes mellitus|not provided|Neonatal diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17461767,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17395647,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17395915,na,na,Pathogenic/Likely pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Monogenic diabetes|not provided|ABCC8-related disorder",GRCh38,single nucleotide variant
ABCC8,11,17430887,na,na,Pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17474961,na,na,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Type 2 diabetes mellitus|not specified",GRCh38,single nucleotide variant
ABCC8,11,17453151,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
ABCC8,11,17404515,na,na,Uncertain significance,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus",GRCh38,single nucleotide variant
ABCC8,11,17476643,na,na,Uncertain significance,"Diabetes mellitus, permanent neonatal 3|not provided",GRCh38,single nucleotide variant
ABCC8,11,17474919,na,na,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",GRCh38,single nucleotide variant
IGHMBP2,11,68934466,na,na,Pathogenic,not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2S,GRCh38,single nucleotide variant
IGHMBP2,11,68911530,na,na,Pathogenic/Likely pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|not provided,GRCh38,single nucleotide variant
IGHMBP2,11,68935404,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Peripheral neuropathy|not provided,GRCh38,single nucleotide variant
IGHMBP2,11,68906103,na,na,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1,GRCh38,single nucleotide variant
IGHMBP2,11,68911599,na,na,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S,GRCh38,single nucleotide variant
IGHMBP2,11,68937092,na,na,Pathogenic/Likely pathogenic,"Autosomal recessive distal spinal muscular atrophy 1|not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Neuronopathy, distal hereditary motor, autosomal dominant",GRCh38,single nucleotide variant
IGHMBP2,11,68929229,na,na,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1,GRCh38,single nucleotide variant
FGF8,10,101775769,na,na,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,GRCh38,single nucleotide variant
FGF8,10,101775209,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|not specified|not provided,GRCh38,single nucleotide variant
FGF8,10,101775168,na,na,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,GRCh38,single nucleotide variant
FGF8,10,101774771,na,na,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,GRCh38,single nucleotide variant
FGF8,10,101771528,na,na,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,GRCh38,single nucleotide variant
FGF8,10,101770378,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|Holoprosencephaly 1|not provided,GRCh38,single nucleotide variant
NTRK2,9,84955510,na,na,Pathogenic,"Obesity, hyperphagia, and developmental delay",GRCh38,single nucleotide variant
GCNT2,6,10626447,na,na,Pathogenic,Cataract 13 with adult I phenotype,GRCh38,single nucleotide variant
GCNT2,6,10626552,na,na,Conflicting classifications of pathogenicity,Cataract 13 with adult I phenotype,GRCh38,single nucleotide variant
GCNT2,6,10529416,na,na,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,GRCh38,single nucleotide variant
GCNT2,6,10529594,na,na,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,GRCh38,single nucleotide variant
ECE1,1,21220008,na,na,Pathogenic,"Hirschsprung disease, cardiac defects, and autonomic dysfunction",GRCh38,single nucleotide variant
ECE1,1,21290752,na,na,risk factor,"Hypertension, essential, susceptibility to",GRCh38,single nucleotide variant
ECE1,1,21291253,na,na,risk factor,"Hypertension, essential, susceptibility to",GRCh38,single nucleotide variant
TTPA,8,63072990,na,na,Pathogenic/Likely pathogenic,Ataxia and retinitis pigmentosa with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E,GRCh38,single nucleotide variant
TTPA,8,63064294,na,na,Conflicting classifications of pathogenicity,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|not specified|TTPA-related disorder",GRCh38,single nucleotide variant
TTPA,8,63066056,na,na,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|TTPA-related disorder|Retinal dystrophy",GRCh38,single nucleotide variant
PEX5,12,7209700,na,na,Pathogenic/Likely pathogenic,not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger)|Rhizomelic chondrodysplasia punctata type 5,GRCh38,single nucleotide variant
PEX5,12,7208554,na,na,Pathogenic,Peroxisome biogenesis disorder 2A (Zellweger)|not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger);Peroxisome biogenesis disorder 2B;Rhizomelic chondrodysplasia punctata type 5,GRCh38,single nucleotide variant
BBS4,15,72731574,na,na,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
BBS4,15,72712242,na,na,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,GRCh38,single nucleotide variant
BBS4,15,72735167,na,na,Likely pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 1,GRCh38,single nucleotide variant
SLC25A3,12,98595490,na,na,Pathogenic,Cardiomyopathy-hypotonia-lactic acidosis syndrome,GRCh38,single nucleotide variant
GUCA1A;GUCA1ANB-GUCA1A,6,42178374,na,na,Pathogenic,Cone dystrophy 3|not provided|Retinitis pigmentosa|Macular dystrophy|Retinal dystrophy,GRCh38,single nucleotide variant
GUCA1A;GUCA1ANB-GUCA1A,6,42173762,na,na,Conflicting classifications of pathogenicity,Cone dystrophy 3|not provided|Macular dystrophy|Usher syndrome,GRCh38,single nucleotide variant
GUCA1A;GUCA1ANB-GUCA1A,6,42179248,na,na,Pathogenic,Retinal dystrophy|not provided|Cone-rod dystrophy 14,GRCh38,single nucleotide variant
KCNJ1,11,128840064,na,na,Pathogenic,Bartter disease type 2,GRCh38,single nucleotide variant
KCNJ1,11,128839644,na,na,Pathogenic,Bartter disease type 2|not provided,GRCh38,single nucleotide variant
KCNJ1,11,128839660,na,na,Conflicting classifications of pathogenicity,Bartter disease type 2|not provided|Bartter syndrome,GRCh38,single nucleotide variant
KCNJ1,11,128839231,na,na,Benign/Likely benign,Bartter disease type 2|not specified|not provided|KCNJ1-related disorder,GRCh38,single nucleotide variant
KCNJ1,11,128839709,na,na,Likely pathogenic,Bartter disease type 2|not provided|Bartter syndrome,GRCh38,single nucleotide variant
KCNJ1,11,128839801,na,na,Likely pathogenic,Bartter disease type 2|Bartter syndrome,GRCh38,single nucleotide variant
KCNJ1,11,128839979,na,na,Pathogenic,Bartter disease type 2,GRCh38,single nucleotide variant
KCNJ1,11,128839929,na,na,Pathogenic,Bartter disease type 2,GRCh38,single nucleotide variant
SMN1,5,70946163,na,na,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",GRCh38,single nucleotide variant
SMN1,5,70946127,na,na,Pathogenic/Likely pathogenic,Kugelberg-Welander disease|not provided,GRCh38,single nucleotide variant
SMN1,5,70946157,na,na,Pathogenic/Likely pathogenic,Werdnig-Hoffmann disease|not provided|Spinal muscular atrophy,GRCh38,single nucleotide variant
SMN1,5,70951942,na,na,Pathogenic,Werdnig-Hoffmann disease,GRCh38,single nucleotide variant
SMN1,5,70925108,na,na,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided|Spinal muscular atrophy",GRCh38,single nucleotide variant
SMN1,5,70946182,na,na,Pathogenic,Kugelberg-Welander disease,GRCh38,single nucleotide variant
SMN1,5,70938888,na,na,Pathogenic,Kugelberg-Welander disease,GRCh38,single nucleotide variant
SMN1,5,70942389,na,na,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",GRCh38,single nucleotide variant
SMN1,5,70938845,na,na,Pathogenic,"Spinal muscular atrophy, type II",GRCh38,single nucleotide variant
SMN1,5,70942367,na,na,Pathogenic,Kugelberg-Welander disease|not provided|Spinal muscular atrophy,GRCh38,single nucleotide variant
SMN1,5,70942416,na,na,Pathogenic,"Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|not provided",GRCh38,single nucleotide variant
SMN1,5,70946126,na,na,Pathogenic,Kugelberg-Welander disease,GRCh38,single nucleotide variant
SMN1,5,70942430,na,na,Pathogenic,Werdnig-Hoffmann disease|not provided,GRCh38,single nucleotide variant
SMN1,5,70942490,na,na,Pathogenic,Werdnig-Hoffmann disease,GRCh38,single nucleotide variant
RGR,10,84247707,na,na,Conflicting classifications of pathogenicity,Retinitis pigmentosa 44|Cone dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
COMP,19,18786040,na,na,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,GRCh38,single nucleotide variant
COMP,19,18786051,na,na,Uncertain significance,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|not specified,GRCh38,single nucleotide variant
COMP,19,18787602,na,na,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",GRCh38,single nucleotide variant
COMP,19,18787644,na,na,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,GRCh38,single nucleotide variant
COMP,19,18785772,na,na,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|Multiple epiphyseal dysplasia|not provided,GRCh38,single nucleotide variant
COMP,19,18786096,na,na,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",GRCh38,single nucleotide variant
COMP,19,18786036,na,na,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,GRCh38,single nucleotide variant
COMP,19,18783125,na,na,Pathogenic/Likely pathogenic,"Pseudoachondroplasia, severe|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|Multiple epiphyseal dysplasia type 1|not provided",GRCh38,single nucleotide variant
COMP,19,18787584,na,na,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided,GRCh38,single nucleotide variant
COMP,19,18783129,na,na,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|not provided|Multiple epiphyseal dysplasia|Carpal tunnel syndrome 2,GRCh38,single nucleotide variant
ACADSB,10,123053160,na,na,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACADSB,10,123043127,na,na,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,GRCh38,single nucleotide variant
ACADSB,10,123040605,na,na,Conflicting classifications of pathogenicity,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ACADSB,10,123053091,na,na,Pathogenic/Likely pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided,GRCh38,single nucleotide variant
GARS1,7,30609729,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|not provided|not specified|Charcot-Marie-Tooth disease type 2,GRCh38,single nucleotide variant
GARS1,7,30601179,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2D",GRCh38,single nucleotide variant
GARS1,7,30599996,na,na,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5A",GRCh38,single nucleotide variant
GARS1,7,30628598,na,na,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2",GRCh38,single nucleotide variant
GARS1,7,30626280,na,na,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2",GRCh38,single nucleotide variant
GARS1,7,30612107,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2D,GRCh38,single nucleotide variant
HNF4A,20,44419813,na,na,Pathogenic,Maturity-onset diabetes of the young type 1|not provided|Monogenic diabetes,GRCh38,single nucleotide variant
HNF4A,20,44413795,na,na,Pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes|not provided,GRCh38,single nucleotide variant
HNF4A,20,44413714,na,na,Likely pathogenic,Maturity-onset diabetes of the young type 1|not provided|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1;Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young|Maturity onset diabetes mellitus in young|Monogenic diabetes,GRCh38,single nucleotide variant
HNF4A,20,44428409,na,na,Uncertain significance,Type 2 diabetes mellitus|not provided|Monogenic diabetes|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1;Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young,GRCh38,single nucleotide variant
HNF4A,20,44424243,na,na,Likely pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes,GRCh38,single nucleotide variant
NOTCH3,19,15192504,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",GRCh38,single nucleotide variant
NOTCH3,19,15192134,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|Migraine without aura;Stroke disorder|Myofibromatosis, infantile, 2;Lateral meningocele syndrome;Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|NOTCH3-related disorder",GRCh38,single nucleotide variant
NOTCH3,19,15192095,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",GRCh38,single nucleotide variant
NOTCH3,19,15197510,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",GRCh38,single nucleotide variant
NOTCH3,19,15189004,na,na,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",GRCh38,single nucleotide variant
NOTCH3,19,15191466,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",GRCh38,single nucleotide variant
NOTCH3,19,15192242,na,na,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|Recurrent subcortical infarcts|not provided|Myofibromatosis, infantile, 2;Lateral meningocele syndrome;Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|NOTCH3-related disorder",GRCh38,single nucleotide variant
NOTCH3,19,15184451,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",GRCh38,single nucleotide variant
NOTCH3,19,15180765,na,na,Benign,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|not specified|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Myofibromatosis, infantile, 2;Lateral meningocele syndrome",GRCh38,single nucleotide variant
NOTCH3,19,15189085,na,na,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",GRCh38,single nucleotide variant
NOTCH2,1,119917763,na,na,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,GRCh38,single nucleotide variant
NOTCH2,1,119967555,na,na,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,GRCh38,single nucleotide variant
DSC3,18,31001724,na,na,Pathogenic,Hereditary hypotrichosis with recurrent skin vesicles,GRCh38,single nucleotide variant
SLC11A1,2,218384290,na,na,risk factor,"Mycobacterium tuberculosis, susceptibility to infection by",GRCh38,single nucleotide variant
SLC11A1,2,218395009,na,na,Uncertain significance,"Buruli ulcer, susceptibility to|Cystic fibrosis",GRCh38,single nucleotide variant
PMS2,7,6002590,na,na,Pathogenic,Lynch syndrome|Hereditary cancer-predisposing syndrome|Mismatch repair cancer syndrome 4|not provided|Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|Lynch syndrome 4|Lynch syndrome 1|Gastric cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4,GRCh38,single nucleotide variant
PMS2,7,5977629,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|Lynch syndrome 4|Mismatch repair cancer syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|not provided|Mismatch repair cancer syndrome 4|Rhabdomyosarcoma|Hereditary nonpolyposis colon cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4|PMS2-related disorder|Inherited MMR deficiency (Lynch syndrome),GRCh38,single nucleotide variant
PMS2,7,5986883,na,na,Pathogenic,Lynch syndrome 4|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer,GRCh38,single nucleotide variant
PMS2,7,6005918,na,na,Likely pathogenic,Lynch syndrome 4|Mismatch repair cancer syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Endometrial carcinoma|Lynch syndrome 1|PMS2-related disorder|Pituitary carcinoma|Mismatch repair cancer syndrome 4|Breast and/or ovarian cancer|Hypertrophic cardiomyopathy 9;Dilated cardiomyopathy 1G|Lynch syndrome 4;Mismatch repair cancer syndrome 4|PMS2-related cancer disorders|Inherited MMR deficiency (Lynch syndrome),GRCh38,single nucleotide variant
PMS2,7,6004003,na,na,Pathogenic,Mismatch repair cancer syndrome 4,GRCh38,single nucleotide variant
PDCD1,2,241851760,na,na,Benign,RECLASSIFIED - PDCD1 POLYMORPHISM,GRCh38,single nucleotide variant
SCN1B,19,35033654,na,na,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 1|Generalized epilepsy with febrile seizures plus|Atrial fibrillation, familial, 13|not provided|Brugada syndrome 5|Atrial fibrillation, familial, 13;Developmental and epileptic encephalopathy, 52;Brugada syndrome 5;Generalized epilepsy with febrile seizures plus, type 1|Cardiovascular phenotype|SCN1B-related disorder",GRCh38,single nucleotide variant
SCN1B,19,35033497,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 1",GRCh38,single nucleotide variant
SCN1B,19,35033827,na,na,Conflicting classifications of pathogenicity,"Brugada syndrome 5|not provided|Atrial fibrillation, familial, 13",GRCh38,single nucleotide variant
SCN1B,19,35033550,na,na,Uncertain significance,"Conduction system disorder|not provided|Developmental and epileptic encephalopathy, 52",GRCh38,single nucleotide variant
SCN1B,19,35033828,na,na,Pathogenic,Conduction system disorder,GRCh38,single nucleotide variant
HMGCS2,1,119764211,na,na,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,GRCh38,single nucleotide variant
HMGCS2,1,119753304,na,na,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|HMGCS2-related disorder,GRCh38,single nucleotide variant
HMGCS2,1,119759915,na,na,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|not provided,GRCh38,single nucleotide variant
HMGCS2,1,119750830,na,na,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,GRCh38,single nucleotide variant
HMGCS2,1,119764571,na,na,Conflicting classifications of pathogenicity,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,GRCh38,single nucleotide variant
HMGCS2,1,119764231,na,na,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,GRCh38,single nucleotide variant
SCNN1A,12,6348981,na,na,Conflicting classifications of pathogenicity,"Pseudohypoaldosteronism, type IB1, autosomal recessive|Bronchiectasis with or without elevated sweat chloride 2|Bronchiectasis with or without elevated sweat chloride 2;Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 3",GRCh38,single nucleotide variant
SCNN1A,12,6348198,na,na,Likely pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",GRCh38,single nucleotide variant
SCNN1A,12,6374444,na,na,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 2|not provided,GRCh38,single nucleotide variant
SCNN1A,12,6349184,na,na,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 2|not specified|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",GRCh38,single nucleotide variant
SCNN1A,12,6374543,na,na,Pathogenic,Bronchiectasis with or without elevated sweat chloride 2,GRCh38,single nucleotide variant
GCH1,14,54902402,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54865379,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54845792,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54865438,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54902661,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54865349,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54865326,na,na,Pathogenic,Dystonia 5|Dystonia 5;GTP cyclohydrolase I deficiency,GRCh38,single nucleotide variant
GCH1,14,54844108,na,na,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dystonia 5|Intellectual disability|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided|not specified",GRCh38,single nucleotide variant
GCH1,14,54902341,na,na,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|not provided|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",GRCh38,single nucleotide variant
GCH1,14,54844099,na,na,Conflicting classifications of pathogenicity,"Dystonia 5|GTP cyclohydrolase I deficiency;Dystonia 5|not provided|GTP cyclohydrolase I deficiency|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dopa-responsive dystonia|Inborn genetic diseases|GTP cyclohydrolase I deficiency with hyperphenylalaninemia|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia",GRCh38,single nucleotide variant
GCH1,14,54845808,na,na,Uncertain significance,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54865376,na,na,Pathogenic,Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54844023,na,na,Uncertain significance,"not specified|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",GRCh38,single nucleotide variant
GCH1,14,54844137,na,na,Pathogenic,GTP cyclohydrolase I deficiency with hyperphenylalaninemia,GRCh38,single nucleotide variant
GCH1,14,54902522,na,na,Pathogenic,Dystonia 5;GTP cyclohydrolase I deficiency|Dystonia 5,GRCh38,single nucleotide variant
GCH1,14,54845843,na,na,Pathogenic,GTP cyclohydrolase I deficiency|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided,GRCh38,single nucleotide variant
GCH1,14,54845799,na,na,Pathogenic,"Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",GRCh38,single nucleotide variant
TEK,9,27206762,na,na,Pathogenic,Multiple cutaneous and mucosal venous malformations|Segmental undergrowth associated with venous malformation without capillary component|Abnormal cardiovascular system morphology|not provided|TEK-related disorder,GRCh38,single nucleotide variant
TEK,9,27212710,na,na,Likely pathogenic,Multiple cutaneous and mucosal venous malformations|Blue rubber bleb nevus,GRCh38,single nucleotide variant
RUNX2,6,45512277,na,na,Pathogenic,Cleidocranial dysostosis,GRCh38,single nucleotide variant
RUNX2,6,45431963,na,na,Likely pathogenic,Cleidocranial dysostosis,GRCh38,single nucleotide variant
RUNX2,6,45432011,na,na,Likely pathogenic,Cleidocranial dysostosis|not provided,GRCh38,single nucleotide variant
RUNX2,6,45438040,na,na,Pathogenic,Cleidocranial dysostosis|not provided|Cleidocranial dysostosis;Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome|RUNX2-related disorder,GRCh38,single nucleotide variant
RUNX2,6,45438039,na,na,Pathogenic,Cleidocranial dysostosis|not provided,GRCh38,single nucleotide variant
RUNX2,6,45437964,na,na,Pathogenic,"Cleidocranial dysostosis|Cleidocranial dysplasia 1, forme fruste, dental anomalies only|not provided",GRCh38,single nucleotide variant
RUNX2,6,45547304,na,na,Pathogenic,Cleidocranial dysostosis,GRCh38,single nucleotide variant
RUNX2,6,45431945,na,na,Pathogenic,Cleidocranial dysostosis,GRCh38,single nucleotide variant
ASIP,20,34269192,na,na,association,"SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR",GRCh38,single nucleotide variant
KRT2,12,52646748,na,na,Pathogenic,Ichthyosis bullosa of Siemens|not provided,GRCh38,single nucleotide variant
KRT2,12,52646750,na,na,Pathogenic,Ichthyosis bullosa of Siemens|Exfoliative ichthyosis|not provided,GRCh38,single nucleotide variant
KRT2,12,52651601,na,na,Likely pathogenic,Ichthyosis bullosa of Siemens,GRCh38,single nucleotide variant
KRT2,12,52646774,na,na,Pathogenic,Ichthyosis bullosa of Siemens|not provided,GRCh38,single nucleotide variant
KRT2,12,52651587,na,na,Pathogenic,Ichthyosis bullosa of Siemens|not provided,GRCh38,single nucleotide variant
KRT2,12,52646783,na,na,Pathogenic,Ichthyosis bullosa of Siemens|not provided,GRCh38,single nucleotide variant
KRT2,12,52651587,na,na,Pathogenic,Ichthyosis bullosa of Siemens,GRCh38,single nucleotide variant
KRT2,12,52651585,na,na,Pathogenic,Ichthyosis bullosa of Siemens|not provided,GRCh38,single nucleotide variant
BRCA2,13,32332592,na,na,Benign,"not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|8 conditions|Breast ductal adenocarcinoma|Fanconi anemia complementation group D1|Familial cancer of breast|Breast carcinoma|BRCA2-related cancer predisposition",GRCh38,single nucleotide variant
BRCA2,13,32376769,na,na,Uncertain significance,Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome,GRCh38,single nucleotide variant
BRCA2,13,32363367,na,na,Pathogenic,"BRCA2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Familial cancer of breast",GRCh38,single nucleotide variant
BRCA2,13,32363421,na,na,Pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome",GRCh38,single nucleotide variant
BRCA2,13,32339003,na,na,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Fanconi anemia|Familial cancer of breast",GRCh38,single nucleotide variant
BRCA2,13,32356521,na,na,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
BRCA2,13,32340000,na,na,Pathogenic,"Wilms tumor 1|Glioma susceptibility 3|Medulloblastoma|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
BRCA2,13,32380085,na,na,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",GRCh38,single nucleotide variant
BRCA2,13,32326614,na,na,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Breast-ovarian cancer, familial, susceptibility to, 1",GRCh38,single nucleotide variant
BRCA2,13,32326615,na,na,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Fanconi anemia|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",GRCh38,single nucleotide variant
GUCY2D,17,8009531,na,na,Pathogenic,Leber congenital amaurosis 1|not provided|GUCY2D-related recessive retinopathy,GRCh38,single nucleotide variant
GUCY2D,17,8003201,na,na,Benign,"Leber congenital amaurosis 1|not provided|not specified|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Cone-rod dystrophy 6|GUCY2D-related recessive retinopathy|Night blindness, congenital stationary, type1i;Cone-rod dystrophy 6;Leber congenital amaurosis 1;Choroidal dystrophy, central areolar, 1",GRCh38,single nucleotide variant
GUCY2D,17,8014699,na,na,not provided,not provided,GRCh38,single nucleotide variant
GUCY2D,17,8014700,na,na,Pathogenic/Likely pathogenic,"Cone-rod dystrophy 6|not provided|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Retinal dystrophy|Choroidal dystrophy, central areolar, 1|Cone dystrophy|Leber congenital amaurosis 1",GRCh38,single nucleotide variant
GUCY2D,17,8014701,na,na,Pathogenic/Likely pathogenic,Cone-rod dystrophy 6|not provided|Cone dystrophy|Retinal dystrophy|Visual impairment;Macular dystrophy|Progressive cone dystrophy (without rod involvement)|Leber congenital amaurosis 1;Cone-rod dystrophy 6|Retinitis pigmentosa|Cone-rod dystrophy,GRCh38,single nucleotide variant
GUCY2D,17,8015404,na,na,Pathogenic,Cone-rod dystrophy 6,GRCh38,single nucleotide variant
JAK3,19,17843786,na,na,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,GRCh38,single nucleotide variant
JAK3,19,17837938,na,na,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,GRCh38,single nucleotide variant
JAK3,19,17839585,na,na,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,GRCh38,single nucleotide variant
JAK3,19,17843086,na,na,Uncertain significance,T-B+ severe combined immunodeficiency due to JAK3 deficiency,GRCh38,single nucleotide variant
AQP3,9,33442300,na,na,Affects,GIL BLOOD GROUP,GRCh38,single nucleotide variant
SCN5A,3,38551441,na,na,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia|SCN5A-related disorder,GRCh38,single nucleotide variant
SCN5A,3,38560418,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 3|Congenital long QT syndrome|Cardiovascular phenotype|not provided|Long QT syndrome,GRCh38,single nucleotide variant
SCN5A,3,38566555,na,na,Uncertain significance,Brugada syndrome|Brugada syndrome 1|not provided|Cardiovascular phenotype|Cardiac arrhythmia,GRCh38,single nucleotide variant
SCN5A,3,38551505,na,na,Pathogenic,Sick sinus syndrome 1|Familial isolated arrhythmogenic right ventricular dysplasia|not provided|Long QT syndrome 3|Cardiovascular phenotype|8 conditions|Cardiac arrhythmia|Brugada syndrome|SCN5A-related disorder,GRCh38,single nucleotide variant
SCN5A,3,38550988,na,na,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
SCN5A,3,38551504,na,na,Pathogenic,"Long QT syndrome 3|Long QT syndrome 3/6, digenic|Congenital long QT syndrome|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
SCN5A,3,38551022,na,na,Pathogenic/Likely pathogenic,Long QT syndrome 3|Brugada syndrome 1|Sinoatrial node disorder|Congenital long QT syndrome|not provided|Brugada syndrome|Cardiovascular phenotype|Long QT syndrome 1|Congenital long QT syndrome;Brugada syndrome|SCN5A-related disorder|Cardiac arrhythmia|8 conditions,GRCh38,single nucleotide variant
SCN5A,3,38562413,na,na,Pathogenic,"Progressive familial heart block, type 1A|not provided",GRCh38,single nucleotide variant
SCN5A,3,38555664,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 1|not provided|Primary familial hypertrophic cardiomyopathy|Cardiac arrhythmia|not specified|Cardiovascular phenotype|Brugada syndrome (shorter-than-normal QT interval),GRCh38,single nucleotide variant
SCN5A,3,38550602,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 1|Brugada syndrome|not provided|Brugada syndrome;Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype,GRCh38,single nucleotide variant
SCN5A,3,38551243,na,na,Pathogenic/Likely pathogenic,"not provided|Ventricular fibrillation, paroxysmal familial, type 1|Ventricular fibrillation|Cardiovascular phenotype|Brugada syndrome 1|8 conditions|Brugada syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3",GRCh38,single nucleotide variant
SCN5A,3,38554309,na,na,Pathogenic/Likely pathogenic,"Progressive familial heart block, type 1A|Atrioventricular block|not provided|Atrial fibrillation, familial, 10|SCN5A-related disorder",GRCh38,single nucleotide variant
SCN5A,3,38604062,na,na,Pathogenic,"Cardiac conduction defect, nonprogressive|Conduction system disorder",GRCh38,single nucleotide variant
SCN5A,3,38609776,na,na,Uncertain significance,"Progressive familial heart block, type 1A|Atrioventricular block|not specified|Migraine;Primary dilated cardiomyopathy;Hemiplegia|Cardiac arrhythmia|Dilated cardiomyopathy 1E|8 conditions|Long QT syndrome 3|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Brugada syndrome 1|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
SCN5A,3,38581170,na,na,Conflicting classifications of pathogenicity,"Congenital long QT syndrome|Long QT syndrome 3|not provided|8 conditions|Cardiac arrhythmia|SCN5A-related disorder|Dilated cardiomyopathy 1E;Atrial fibrillation, familial, 10;Brugada syndrome 1;Long QT syndrome 3",GRCh38,single nucleotide variant
SCN5A,3,38550895,na,na,Uncertain significance,Long QT syndrome 3|Congenital long QT syndrome|not specified|SUDDEN INFANT DEATH SYNDROME|not provided|Cardiovascular phenotype|Cardiac arrhythmia|8 conditions,GRCh38,single nucleotide variant
SCN5A,3,38606709,na,na,Pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiovascular phenotype|SCN5A-related disorder|Cardiac arrhythmia|not provided,GRCh38,single nucleotide variant
SCN5A,3,38597787,na,na,Pathogenic/Likely pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiac arrhythmia|not provided|Congenital long QT syndrome,GRCh38,single nucleotide variant
SCN5A,3,38575385,na,na,Benign/Likely benign,"Brugada syndrome 1|Primary familial hypertrophic cardiomyopathy|Brugada syndrome|Long QT syndrome 3, acquired, susceptibility to|not provided|not specified|Long QT syndrome 3|Cardiovascular phenotype|Sick sinus syndrome 1|Cardiac arrhythmia|Ventricular fibrillation, paroxysmal familial, type 1|Dilated cardiomyopathy 1E|Progressive familial heart block, type 1A|8 conditions|Cardiomyopathy",GRCh38,single nucleotide variant
SCN5A,3,38579416,na,na,Conflicting classifications of pathogenicity,"Long QT syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|not specified|not provided|Brugada syndrome|Dilated cardiomyopathy 1E|Long QT syndrome 3|Congenital long QT syndrome|Brugada syndrome 1|Cardiovascular phenotype|8 conditions|Cardiac arrhythmia|Primary dilated cardiomyopathy|Cardiomyopathy",GRCh38,single nucleotide variant
SCN5A,3,38562485,na,na,Conflicting classifications of pathogenicity,Sick sinus syndrome 1|Sick sinus syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3;Dilated cardiomyopathy 1E,GRCh38,single nucleotide variant
SCN5A,3,38560170,na,na,Pathogenic,Sick sinus syndrome 1|Brugada syndrome 1|Conduction system disorder|Brugada syndrome|not provided|Cardiovascular phenotype|Congenital long QT syndrome|8 conditions|Cardiac arrhythmia,GRCh38,single nucleotide variant
SCN5A,3,38613787,na,na,Conflicting classifications of pathogenicity,Brugada syndrome|AV junctional rhythm|Cardiovascular phenotype|Sick sinus syndrome 1|not specified|SCN5A-related disorder|Primary familial dilated cardiomyopathy|Long QT syndrome 3|Dilated cardiomyopathy 1E|Cardiac arrhythmia|not provided|Long QT syndrome 3;Brugada syndrome 1,GRCh38,single nucleotide variant
SCN5A,3,38550989,na,na,Pathogenic,Brugada syndrome 1|Brugada syndrome,GRCh38,single nucleotide variant
SCN5A,3,38604067,na,na,Uncertain significance,Conduction system disorder|Brugada syndrome 1|not provided|Cardiac arrhythmia|8 conditions,GRCh38,single nucleotide variant
SCN5A,3,38566465,na,na,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Brugada syndrome|Long QT syndrome 3|not provided|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",GRCh38,single nucleotide variant
SCN5A,3,38581002,na,na,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Congenital long QT syndrome|Long QT syndrome 3|Atrial fibrillation, familial, 10|not specified|Cardiovascular phenotype|not provided|Cardiac arrhythmia|Dilated cardiomyopathy 1E",GRCh38,single nucleotide variant
SCN5A,3,38566426,na,na,Pathogenic,"Atrial fibrillation, familial, 10|Dilated cardiomyopathy 1E|not provided|Brugada syndrome|Atrial standstill 1, digenic|Cardiovascular phenotype|Long QT syndrome 3|Cardiac arrhythmia|SCN5A-related disorder",GRCh38,single nucleotide variant
SCN5A,3,38550917,na,na,Conflicting classifications of pathogenicity,"Long QT syndrome 2/3, digenic|Long QT syndrome|Congenital long QT syndrome|Brugada syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype|Atrial fibrillation|not provided",GRCh38,single nucleotide variant
SCN5A,3,38557268,na,na,Pathogenic,Brugada syndrome 1,GRCh38,single nucleotide variant
SCN5A,3,38554309,na,na,Pathogenic/Likely pathogenic,Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|Brugada syndrome 1;Long QT syndrome 3|8 conditions|not provided,GRCh38,single nucleotide variant
SCN5A,3,38613752,na,na,Conflicting classifications of pathogenicity,"Brugada syndrome|Brugada syndrome, lidocaine-induced|not provided|Brugada syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia|not specified",GRCh38,single nucleotide variant
CDKN2A,9,21971094,na,na,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
CDKN2A,9,21971121,na,na,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Hereditary cancer-predisposing syndrome|Lip and oral cavity carcinoma|Neoplasm|Familial melanoma",GRCh38,single nucleotide variant
CDKN2A,9,21971058,na,na,Pathogenic,"Hereditary cancer-predisposing syndrome|Familial melanoma|Melanoma-pancreatic cancer syndrome|Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Melanoma|CDKN2A-related disorder|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma and neural system tumor syndrome",GRCh38,single nucleotide variant
CDKN2A,9,21971200,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|CDKN2A-related disorder|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome",GRCh38,single nucleotide variant
CDKN2A,9,21974757,na,na,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome|Melanoma and neural system tumor syndrome",GRCh38,single nucleotide variant
CDKN2A,9,21971054,na,na,Conflicting classifications of pathogenicity,Familial melanoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
CDKN2A,9,21970982,na,na,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome|not provided|Familial melanoma|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2",GRCh38,single nucleotide variant
CDKN2A,9,21970995,na,na,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|Familial melanoma",GRCh38,single nucleotide variant
CDKN2A,9,21971183,na,na,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome|Familial melanoma|Melanoma and neural system tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2",GRCh38,single nucleotide variant
CDKN2A,9,21971192,na,na,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome",GRCh38,single nucleotide variant
CDKN2A,9,21971093,na,na,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma-pancreatic cancer syndrome",GRCh38,single nucleotide variant
KCNMA1,10,77090433,na,na,Pathogenic,Generalized epilepsy-paroxysmal dyskinesia syndrome|not provided,GRCh38,single nucleotide variant
CREBBP,16,3850689,na,na,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,GRCh38,single nucleotide variant
CREBBP,16,3793533,na,na,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,GRCh38,single nucleotide variant
CREBBP,16,3740399,na,na,Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|CREBBP-related disorder,GRCh38,single nucleotide variant
CREBBP,16,3757894,na,na,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|Inborn genetic diseases,GRCh38,single nucleotide variant
CREBBP,16,3749631,na,na,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|not provided|Inborn genetic diseases|Abnormality of the nervous system|Intellectual disability|CREBBP-related disorder|Menke-Hennekam syndrome 1;Rubinstein-Taybi syndrome due to CREBBP mutations,GRCh38,single nucleotide variant
CREBBP,16,3745356,na,na,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,GRCh38,single nucleotide variant
SGCA,17,50167717,na,na,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
SGCA,17,50168512,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,GRCh38,single nucleotide variant
SGCA,17,50167653,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Abnormality of the musculature|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
SGCA,17,50168398,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,GRCh38,single nucleotide variant
SGCA,17,50170245,na,na,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Autosomal recessive limb-girdle muscular dystrophy,GRCh38,single nucleotide variant
SLC1A3,5,36679635,na,na,Pathogenic,Episodic ataxia type 6,GRCh38,single nucleotide variant
SLC1A3,5,36674080,na,na,Pathogenic,Episodic ataxia type 6,GRCh38,single nucleotide variant
MMP13,11,102955390,na,na,Pathogenic,"Spondyloepimetaphyseal dysplasia, Missouri type|not provided",GRCh38,single nucleotide variant
MMP13,11,102955393,na,na,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant",GRCh38,single nucleotide variant
MMP13,11,102955342,na,na,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant|not provided|Spondyloepimetaphyseal dysplasia, Missouri type|Spondyloepimetaphyseal dysplasia, Missouri type;Metaphyseal chondrodysplasia, Spahr type",GRCh38,single nucleotide variant
MMP13,11,102952117,na,na,Pathogenic,"Metaphyseal chondrodysplasia, Spahr type",GRCh38,single nucleotide variant
RRAS2,11,14294844,na,na,Pathogenic,Noonan syndrome 12|Ovarian neoplasm|Noonan syndrome,GRCh38,single nucleotide variant
PTPN12,7,77571160,na,na,Pathogenic,Carcinoma of colon,GRCh38,single nucleotide variant
LRP2,2,169205630,na,na,Pathogenic/Likely pathogenic,Donnai-Barrow syndrome|not provided,GRCh38,single nucleotide variant
LRP2,2,169256237,na,na,Pathogenic,Donnai-Barrow syndrome,GRCh38,single nucleotide variant
LRP2,2,169201627,na,na,Pathogenic,Donnai-Barrow syndrome|not provided,GRCh38,single nucleotide variant
LRP2,2,169178001,na,na,Pathogenic,Donnai-Barrow syndrome|not provided,GRCh38,single nucleotide variant
LRP2,2,169280348,na,na,Pathogenic,Donnai-Barrow syndrome,GRCh38,single nucleotide variant
LRP2,2,169282951,na,na,Pathogenic,Donnai-Barrow syndrome|not provided,GRCh38,single nucleotide variant
ITGB2,21,44889376,na,na,Pathogenic,Leukocyte adhesion deficiency 1|ITGB2-related disorder|not provided,GRCh38,single nucleotide variant
ITGB2,21,44901646,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44903418,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44901728,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44910781,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44889397,na,na,Benign/Likely benign,Leukocyte adhesion deficiency 1|not specified|not provided|ITGB2-related disorder,GRCh38,single nucleotide variant
ITGB2,21,44895002,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44901700,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44903482,na,na,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|not provided,GRCh38,single nucleotide variant
ITGB2,21,44900367,na,na,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
ITGB2,21,44903452,na,na,Pathogenic,Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
ITGB2,21,44900400,na,na,Pathogenic/Likely pathogenic,not provided|Leukocyte adhesion deficiency 1,GRCh38,single nucleotide variant
CNGA3,2,98389696,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|Retinal dystrophy|Achromatopsia,GRCh38,single nucleotide variant
CNGA3,2,98396017,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CNGA3,2,98396018,na,na,Pathogenic,Achromatopsia 2|Achromatopsia|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CNGA3,2,98396839,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|not specified|Retinal dystrophy|Inborn genetic diseases,GRCh38,single nucleotide variant
CNGA3,2,98396042,na,na,Pathogenic,Achromatopsia 2|Retinal dystrophy,GRCh38,single nucleotide variant
CNGA3,2,98396811,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|Retinal dystrophy|Achromatopsia|not provided,GRCh38,single nucleotide variant
CNGA3,2,98396398,na,na,Pathogenic,Achromatopsia 2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CNGA3,2,98396755,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|CNGA3-related disorder|Retinal dystrophy|CNGA3-related retinopathy|Achromatopsia 3,GRCh38,single nucleotide variant
CNGA3,2,98395999,na,na,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|Macular degeneration;Color vision defect;Photophobia|Optic atrophy|Retinal dystrophy,GRCh38,single nucleotide variant
CNGA3,2,98396476,na,na,Pathogenic,Achromatopsia 2|Achromatopsia|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
ABCA1,9,104806276,na,na,Pathogenic,Tangier disease|ABCA1-related disorder,GRCh38,single nucleotide variant
ABCA1,9,104816142,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104831027,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104822520,na,na,Pathogenic,Tangier disease|not provided,GRCh38,single nucleotide variant
ABCA1,9,104822514,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104831048,na,na,Uncertain significance,Tangier disease|not provided,GRCh38,single nucleotide variant
ABCA1,9,104786940,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104804668,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104822521,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104798504,na,na,Pathogenic,"Tangier disease, variant",GRCh38,single nucleotide variant
ABCA1,9,104818830,na,na,Uncertain significance,"Hypoalphalipoproteinemia, primary, 1|not provided",GRCh38,single nucleotide variant
ABCA1,9,104788469,na,na,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",GRCh38,single nucleotide variant
ABCA1,9,104814154,na,na,Benign,"Tangier disease|Hypoalphalipoproteinemia, primary, 1",GRCh38,single nucleotide variant
ABCA1,9,104831098,na,na,Pathogenic,Tangier disease,GRCh38,single nucleotide variant
ABCA1,9,104858586,na,na,Benign,"|Tangier disease|Hypoalphalipoproteinemia, primary, 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
ABCA1,9,104885374,na,na,Benign,ABCA1 polymorphism,GRCh38,single nucleotide variant
THPO,3,184376246,na,na,Pathogenic/Likely pathogenic,Thrombocythemia 1|not provided,GRCh38,single nucleotide variant
THPO,3,184376290,na,na,Likely pathogenic,Thrombocythemia 1|not provided,GRCh38,single nucleotide variant
BAX,19,48955799,na,na,Pathogenic,T-cell acute lymphoblastic leukemia,GRCh38,single nucleotide variant
OTX2,14,56802340,na,na,Pathogenic,Syndromic microphthalmia type 5,GRCh38,single nucleotide variant
OTX2,14,56802068,na,na,Pathogenic,Syndromic microphthalmia type 5,GRCh38,single nucleotide variant
EMX2,10,117545631,na,na,Pathogenic,Schizencephaly,GRCh38,single nucleotide variant
EMX2,10,117545628,na,na,Pathogenic,Schizencephaly,GRCh38,single nucleotide variant
EMX2,10,117545632,na,na,Pathogenic,Schizencephaly,GRCh38,single nucleotide variant
CHIT1,1,203225706,na,na,Conflicting classifications of pathogenicity,Chitotriosidase deficiency,GRCh38,single nucleotide variant
CHIT1,1,203225058,na,na,Benign,Chitotriosidase deficiency|not provided,GRCh38,single nucleotide variant
LBR,1,225422279,na,na,Pathogenic,Pelger-Huët anomaly,GRCh38,single nucleotide variant
LBR,1,225422087,na,na,Conflicting classifications of pathogenicity,Pelger-Huët anomaly|not provided,GRCh38,single nucleotide variant
LBR,1,225404715,na,na,Pathogenic,Pelger-Huët anomaly,GRCh38,single nucleotide variant
LBR,1,225403445,na,na,Pathogenic,Pelger-Huët anomaly,GRCh38,single nucleotide variant
LBR,1,225411411,na,na,Conflicting classifications of pathogenicity,Reynolds syndrome|Greenberg dysplasia|Greenberg dysplasia;Regressive spondylometaphyseal dysplasia|not provided,GRCh38,single nucleotide variant
MXI1,10,110279296,na,na,Pathogenic,Prostate cancer,GRCh38,single nucleotide variant
MXI1,10,110280017,na,na,Pathogenic,Prostate cancer,GRCh38,single nucleotide variant
MXI1,10,110228276,na,na,Pathogenic,Neurofibrosarcoma,GRCh38,single nucleotide variant
OPRM1,6,154039662,na,na,Uncertain significance; drug response,"Opioid dependence, susceptibility to, 1|Tramadol response",GRCh38,single nucleotide variant
CIITA,16,10906633,na,na,Pathogenic,MHC class II deficiency 1,GRCh38,single nucleotide variant
CIITA,16,10922491,na,na,Pathogenic,MHC class II deficiency 1,GRCh38,single nucleotide variant
CIITA,16,10907555,na,na,Pathogenic,MHC class II deficiency|MHC class II deficiency 1,GRCh38,single nucleotide variant
CIITA,16,10877045,na,na,risk factor,Rheumatoid arthritis,GRCh38,single nucleotide variant
CACNB2,10,18539345,na,na,Conflicting classifications of pathogenicity,Brugada syndrome 4|Cardiovascular phenotype,GRCh38,single nucleotide variant
MT-TV,MT,1606,na,na,Uncertain significance,"Ataxia, progressive seizures, mental deterioration, and hearing loss|MELAS syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TV,MT,1624,na,na,Likely pathogenic,"Leigh syndrome|MELAS syndrome|Leigh syndrome, mitochondrial|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TY,MT,5874,na,na,Uncertain significance,"Exercise intolerance and complex III deficiency, somatic|not provided|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TY,MT,5877,na,na,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TY,MT,5843,na,na,Benign,Focal segmental glomerulosclerosis and dilated cardiomyopathy|MELAS syndrome,GRCh38,single nucleotide variant
MT-TW,MT,5549,na,na,Pathogenic,Mitochondrial encephalopathy,GRCh38,single nucleotide variant
MT-TW,MT,5521,na,na,Likely pathogenic,Inborn mitochondrial myopathy|MELAS syndrome|not provided|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TW,MT,5532,na,na,Uncertain significance,"Neurogastrointestinal syndrome, mitochondrial|MELAS syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TW,MT,5545,na,na,Uncertain significance,"Encephalocardiomyopathy, mitochondrial|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TT,MT,15950,na,na,Uncertain significance,"Parkinson disease, mitochondrial|MELAS syndrome",GRCh38,single nucleotide variant
MT-TS2,MT,12258,na,na,Likely pathogenic,"Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TS2,MT,12207,na,na,Uncertain significance,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TS1,MT,7512,na,na,Likely pathogenic,"Mitochondrial cytochrome c oxidase deficiency|MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TS1;MT-CO1,MT,7445,na,na,Pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Palmoplantar keratoderma-deafness syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TS1,MT,7510,na,na,Likely pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TS1,MT,7511,na,na,Likely pathogenic,"Mitochondrial non-syndromic sensorineural hearing loss|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO1;MT-TS1,MT,7445,na,na,Uncertain significance,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TS1,MT,7497,na,na,Likely pathogenic,"Exercise intolerance, muscle pain, and lactic acidemia|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TP,MT,15990,na,na,Likely pathogenic,Myopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TP,MT,15965,na,na,Benign,"Parkinson disease, mitochondrial|MELAS syndrome",GRCh38,single nucleotide variant
MT-TP,MT,15967,na,na,Uncertain significance,MERFF syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TF,MT,583,na,na,Uncertain significance,MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TF,MT,611,na,na,Pathogenic,MERRF syndrome,GRCh38,single nucleotide variant
MT-TF,MT,622,na,na,Uncertain significance,"Myopathy, mitochondrial, late-onset|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TF,MT,616,na,na,Likely pathogenic,"Epilepsy, mitochondrial|MELAS syndrome|Interstitial nephritis|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TF,MT,616,na,na,Pathogenic,"Epilepsy, mitochondrial",GRCh38,single nucleotide variant
MT-TM,MT,4409,na,na,Pathogenic,Inborn mitochondrial myopathy,GRCh38,single nucleotide variant
MT-TK,MT,8344,na,na,Pathogenic,"Leigh syndrome|MERRF syndrome|Parkinson disease, mitochondrial|not provided|Mitochondrial disease|MELAS syndrome|MT-TK-related mitochondrial disorder|MT-TK-related disorder|Complex hereditary spastic paraplegia",GRCh38,single nucleotide variant
MT-TK,MT,8356,na,na,Likely pathogenic,MERRF syndrome|MERRF/MELAS overlap syndrome|Mitochondrial disease|MELAS syndrome,GRCh38,single nucleotide variant
MT-TK,MT,8363,na,na,Likely pathogenic,Cardiomyopathy and Deafness|Leigh syndrome|MERRF syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TK,MT,8342,na,na,Uncertain significance,Progressive external ophthalmoplegia with myoclonus|not specified,GRCh38,single nucleotide variant
MT-TK,MT,8313,na,na,Likely pathogenic,Mitochondrial DNA depletion syndrome 1|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TK,MT,8296,na,na,Uncertain significance,Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TK,MT,8361,na,na,Pathogenic,MERRF syndrome,GRCh38,single nucleotide variant
MT-TL2,MT,12315,na,na,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TL2,MT,12320,na,na,Uncertain significance,Inborn mitochondrial myopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TL2,MT,12297,na,na,Benign,"Cardiomyopathy, mitochondrial|MELAS syndrome|not provided",GRCh38,single nucleotide variant
MT-TL1,MT,3243,na,na,Pathogenic/Likely pathogenic,"MELAS syndrome|Age related macular degeneration 2|Mitochondrial complex IV deficiency, nuclear type 1|Cyclical vomiting syndrome|MERRF/MELAS overlap syndrome|3-methylglutaconic aciduria type 1|Diabetes-deafness syndrome maternally transmitted|Leigh syndrome|Sensorineural hearing loss disorder;Stroke disorder;Glucose intolerance;Short stature|not provided|Mitochondrial disease|MELAS syndrome;MERRF syndrome|not specified|See cases|Cerebral palsy|Charcot-Marie-Tooth disease, axonal, mitochondrial form, 1|MELAS syndrome;Diabetes-deafness syndrome maternally transmitted;Leigh Syndrome (mtDNA mutation);Hypertrophic cardiomyopathy|Auditory neuropathy spectrum disorder|Leigh syndrome, mitochondrial|Maternally-inherited mitochondrial myopathy",GRCh38,single nucleotide variant
MT-TL1,MT,3271,na,na,Pathogenic,MELAS syndrome|MERRF syndrome;MELAS syndrome|not specified|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TL1,MT,3256,na,na,Likely pathogenic,"MERRF syndrome|Diabetes mellitus, noninsulin-dependent, maternally transmitted|MELAS syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TL1,MT,3303,na,na,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,GRCh38,single nucleotide variant
MT-TL1,MT,3250,na,na,Uncertain significance,"MELAS syndrome|Mitochondrial skeletal myopathy, responsive to riboflavin",GRCh38,single nucleotide variant
MT-TL1,MT,3252,na,na,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TL1,MT,3251,na,na,Likely pathogenic,"Progressive external ophthalmoplegia, proximal myopathy, and sudden death|MELAS syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TL1,MT,3260,na,na,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,GRCh38,single nucleotide variant
MT-TL1,MT,3290,na,na,Benign,SUDDEN INFANT DEATH SYNDROME|MELAS syndrome,GRCh38,single nucleotide variant
MT-TL1,MT,3274,na,na,Uncertain significance,Neuropsychiatric disorder and early-onset cataract|MELAS syndrome|Mitochondrial disease|MERRF syndrome,GRCh38,single nucleotide variant
MT-TL1,MT,3249,na,na,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TL1,MT,3242,na,na,Likely pathogenic,Myelodysplastic syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TI,MT,4317,na,na,Benign,"Cardiomyopathy, fatal infantile|MELAS syndrome",GRCh38,single nucleotide variant
MT-TI,MT,4269,na,na,Pathogenic,"Cardiomyopathy, fatal|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TI,MT,4295,na,na,Uncertain significance,Primary familial hypertrophic cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss|not specified|not provided|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TI,MT,4284,na,na,Uncertain significance,Multisystem disorder|MERRF syndrome|MELAS syndrome|Mitochondrial disease|not provided,GRCh38,single nucleotide variant
MT-TI,MT,4290,na,na,Uncertain significance,"Encephalopathy, familial progressive necrotizing|MELAS syndrome",GRCh38,single nucleotide variant
MT-TI,MT,4300,na,na,Likely pathogenic,"Primary familial hypertrophic cardiomyopathy|MERRF syndrome|Mitochondrial disease|Primary dilated cardiomyopathy;Asymmetric septal hypertrophy|Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial",GRCh38,single nucleotide variant
MT-TI,MT,4291,na,na,Pathogenic,"Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial",GRCh38,single nucleotide variant
MT-TH,MT,12192,na,na,Benign,"CARDIOMYOPATHY, IDIOPATHIC DILATED, MITOCHONDRIAL|CARDIOMYOPATHY, HYPERTROPHIC, MITOCHONDRIAL|MELAS syndrome",GRCh38,single nucleotide variant
MT-TH,MT,12183,na,na,Uncertain significance,PIGMENTARY RETINOPATHY AND SENSORINEURAL DEAFNESS|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TH,MT,12147,na,na,Likely pathogenic,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TG,MT,9997,na,na,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not specified|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TG,MT,10010,na,na,Uncertain significance,Exercise intolerance|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TG,MT,10044,na,na,Benign,Sudden death|MELAS syndrome,GRCh38,single nucleotide variant
MT-CO1;MT-TQ,MT,4336,na,na,Benign,Sensorineural deafness and migraine|not provided|MELAS syndrome|not specified|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TQ,MT,4332,na,na,Uncertain significance,MELAS syndrome|MT-TQ-related myopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TE,MT,14709,na,na,Likely pathogenic,"Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Inborn mitochondrial myopathy|Mitochondrial disease",GRCh38,single nucleotide variant
MT-TE,MT,14674,na,na,Likely pathogenic,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|not provided|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TD,MT,7526,na,na,Pathogenic,"Mitochondrial myopathy, isolated",GRCh38,single nucleotide variant
MT-TN,MT,5703,na,na,Pathogenic,"Ophthalmoplegia, isolated|Mitochondrial disease|Mitochondrial complex IV deficiency, nuclear type 1",GRCh38,single nucleotide variant
MT-TN,MT,5692,na,na,Pathogenic,"Ophthalmoplegia, isolated",GRCh38,single nucleotide variant
MT-TN,MT,5728,na,na,Likely pathogenic,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 2|Mitochondrial complex IV deficiency, nuclear type 1|MELAS syndrome|Mitochondrial disease|not provided",GRCh38,single nucleotide variant
MT-TR,MT,10438,na,na,Pathogenic,Mitochondrial encephalomyopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TA,MT,5650,na,na,Likely pathogenic,Myotonic dystrophy-like myopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-TA,MT,5591,na,na,Uncertain significance,Inborn mitochondrial myopathy|MELAS syndrome|Mitochondrial disease|not provided,GRCh38,single nucleotide variant
MT-RNR2,MT,2991,na,na,Pathogenic,Chloramphenicol resistance,GRCh38,single nucleotide variant
MT-RNR2,MT,2939,na,na,Pathogenic,Chloramphenicol resistance,GRCh38,single nucleotide variant
MT-ND1;MT-RNR1,MT,1555,na,na,Pathogenic; drug response,"Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Restrictive cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss;Aminoglycoside-induced deafness|not provided|amikacin response - Toxicity|streptomycin response - Toxicity|Gentamicin response|Rare genetic deafness|Mitochondrial disease|tobramycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|gentamicin response - Toxicity|kanamycin response - Toxicity|Hearing loss, sensorineural, autosomal-mitochondrial type|Aminoglycoside induced ototoxicity",GRCh38,single nucleotide variant
MT-RNR1,MT,1291,na,na,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not provided,GRCh38,single nucleotide variant
MT-RNR1,MT,1095,na,na,drug response,Aminoglycoside-induced deafness|Auditory neuropathy|not specified|Mitochondrial non-syndromic sensorineural hearing loss|gentamicin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity|streptomycin response - Toxicity|not provided,GRCh38,single nucleotide variant
MT-RNR1;MT-TS1,MT,1494,na,na,Likely pathogenic; drug response,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Gentamicin response|Mitochondrial disease|Rare genetic deafness|Aminoglycoside Ototoxicity|gentamicin response - Toxicity|streptomycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity|tobramycin response - Toxicity,GRCh38,single nucleotide variant
MT-RNR1,MT,961,na,na,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not specified,GRCh38,single nucleotide variant
MT-RNR1,MT,827,na,na,drug response,Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Gentamicin response,GRCh38,single nucleotide variant
MT-ATP8,MT,8393,na,na,Benign,"Brain pseudoatrophy, reversible, valproate-induced, susceptibility to|Leigh syndrome",GRCh38,single nucleotide variant
MT-ATP6;MT-ATP8,MT,8529,na,na,Uncertain significance,"Cardiomyopathy, apical hypertrophic, and neuropathy|Mitochondrial disease",GRCh38,single nucleotide variant
MT-ATP8;MT-ATP6,MT,8528,na,na,Likely pathogenic,"Cardiomyopathy, infantile hypertrophic|Histiocytoid cardiomyopathy|Mitochondrial disease",GRCh38,single nucleotide variant
"covers 26 genes, none of which curated to show dosage sensitivity",MT,8993,na,na,Pathogenic,"Leigh syndrome|NARP syndrome|Cerebellar ataxia|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|8 conditions|Mitochondrial disease|Rod-cone dystrophy|Leber optic atrophy|not specified|Striatonigral degeneration, infantile, mitochondrial",GRCh38,single nucleotide variant
MT-ATP6,MT,8993,na,na,Pathogenic,"Ataxia and polyneuropathy, adult-onset|Leigh syndrome|Mitochondrial disease|NARP syndrome|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|Leber optic atrophy",GRCh38,single nucleotide variant
MT-ATP6,MT,9101,na,na,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-ATP6,MT,9176,na,na,Pathogenic,"Striatonigral degeneration, infantile, mitochondrial|Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Leigh syndrome, mitochondrial|Maternally-inherited spastic paraplegia|Mitochondrial disease|NARP syndrome",GRCh38,single nucleotide variant
MT-ATP6,MT,8851,na,na,Uncertain significance,"Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial|not provided|Leber optic atrophy|Mitochondrial disease|NARP syndrome",GRCh38,single nucleotide variant
MT-ATP6,MT,9185,na,na,Pathogenic,"Leigh syndrome|Charcot-Marie-Tooth disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leber optic atrophy|Mitochondrial DNA-Associated Leigh Syndrome and NARP|NARP syndrome|Charcot-Marie-Tooth disease, type IA",GRCh38,single nucleotide variant
MT-ATP6,MT,9176,na,na,Likely pathogenic,"Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO3,MT,9438,na,na,Benign,Leber optic atrophy|Leigh syndrome,GRCh38,single nucleotide variant
MT-CO3,MT,9804,na,na,Conflicting classifications of pathogenicity,Leber optic atrophy|Leigh syndrome|not provided|See cases|not specified,GRCh38,single nucleotide variant
MT-CO3,MT,9952,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",GRCh38,single nucleotide variant
MT-CO3,MT,9379,na,na,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO2,MT,7587,na,na,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO2,MT,8009,na,na,Benign,Familial colorectal cancer|not specified,GRCh38,single nucleotide variant
MT-CO2,MT,7671,na,na,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO2,MT,7896,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO1;MT-TS1,MT,7444,na,na,Likely benign,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|not specified,GRCh38,single nucleotide variant
MT-CO1,MT,6742,na,na,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|not specified|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CO1,MT,6721,na,na,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CO1,MT,6480,na,na,Conflicting classifications of pathogenicity,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO1,MT,6264,na,na,Uncertain significance,Familial colorectal cancer|Leigh syndrome,GRCh38,single nucleotide variant
MT-CO1,MT,6930,na,na,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO1,MT,5920,na,na,Likely pathogenic,"Myoglobinuria, recurrent|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CO1,MT,6489,na,na,Benign/Likely benign,Cytochrome c oxidase I deficiency|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-CO1,MT,6328,na,na,Uncertain significance,Cytochrome c oxidase I deficiency|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CO1,MT,6277,na,na,Pathogenic,Familial colorectal cancer,GRCh38,single nucleotide variant
MT-CO1,MT,7275,na,na,Pathogenic,Familial colorectal cancer,GRCh38,single nucleotide variant
MT-CYB,MT,15257,na,na,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-CYB,MT,15812,na,na,Benign,Leber optic atrophy|Leigh syndrome,GRCh38,single nucleotide variant
MT-CYB,MT,14985,na,na,Uncertain significance,Familial colorectal cancer|Leigh syndrome,GRCh38,single nucleotide variant
MT-CYB,MT,15572,na,na,Benign,Familial colorectal cancer|not specified,GRCh38,single nucleotide variant
MT-CYB,MT,15615,na,na,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,GRCh38,single nucleotide variant
MT-CYB,MT,14846,na,na,Uncertain significance,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|MT-CYB associated Exercise intolerance;MT-CYB associated Mitochondrial myopathy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CYB,MT,15242,na,na,Likely pathogenic,Mitochondrial encephalomyopathy|Leigh syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CYB,MT,15150,na,na,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CYB,MT,15197,na,na,Uncertain significance,Exercise intolerance|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CYB,MT,15579,na,na,Uncertain significance,Multisystem disorder|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-CYB,MT,15498,na,na,Uncertain significance,Histiocytoid cardiomyopathy|Leigh syndrome,GRCh38,single nucleotide variant
MT-CYB,MT,14849,na,na,Uncertain significance,"Exercise intolerance, cardiomyopathy, and septooptic dysplasia|Leigh syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
MT-CYB,MT,15497,na,na,Benign/Likely benign,Obesity|Leigh syndrome|not provided,GRCh38,single nucleotide variant
MT-ND6,MT,14484,na,na,Pathogenic,Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|Retinal dystrophy|Optic atrophy,GRCh38,single nucleotide variant
MT-ND5;MT-ND6,MT,14459,na,na,Pathogenic,Leber optic atrophy|Leigh syndrome|Leber optic atrophy and dystonia|Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease|not provided,GRCh38,single nucleotide variant
MT-ND6,MT,14596,na,na,Uncertain significance,Leber optic atrophy|Leber optic atrophy and dystonia|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND6,MT,14495,na,na,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND6,MT,14453,na,na,Likely pathogenic,MELAS syndrome|Leigh syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND6,MT,14482,na,na,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND6,MT,14487,na,na,Pathogenic,"Striatal necrosis, bilateral, with dystonia|Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease|MELAS syndrome|Leber optic atrophy",GRCh38,single nucleotide variant
MT-ND6,MT,14319,na,na,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND5,MT,13708,na,na,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-ND5,MT,13730,na,na,Uncertain significance,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,12706,na,na,Likely pathogenic,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,12770,na,na,Pathogenic,MELAS syndrome,GRCh38,single nucleotide variant
MT-ND5,MT,13045,na,na,Uncertain significance,MELAS syndrome|Leber optic atrophy|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,13084,na,na,Uncertain significance,Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,13513,na,na,Pathogenic,MELAS syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|not provided|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,13042,na,na,Likely pathogenic,MELAS syndrome|MERRF syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND5,MT,12848,na,na,Pathogenic,Leber optic atrophy,GRCh38,single nucleotide variant
MT-ND5,MT,12397,na,na,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND4L,MT,10563,na,na,Uncertain significance,Familial colorectal cancer|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND4L,MT,10663,na,na,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND4,MT,11778,na,na,Pathogenic,"Leber optic atrophy|not provided|Mitochondrial disease|not specified|Leber optic atrophy and dystonia|Leber optic atrophy, susceptibility to|Optic atrophy|Retinal dystrophy",GRCh38,single nucleotide variant
MT-ND4,MT,11084,na,na,Benign,MELAS syndrome|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND4,MT,11696,na,na,Benign,Leber optic atrophy and dystonia|Leber optic atrophy|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND4,MT,11777,na,na,Likely pathogenic,Mitochondrial complex I deficiency|Leber optic atrophy|Leigh syndrome|Mitochondrial disease|Leber optic atrophy and dystonia,GRCh38,single nucleotide variant
MT-ND3,MT,10191,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leigh syndrome|Mitochondrial disease|Mitochondrial complex I deficiency",GRCh38,single nucleotide variant
MT-ND3,MT,10398,na,na,Benign,"Parkinson disease, resistance to|Leigh syndrome|not provided|not specified",GRCh38,single nucleotide variant
MT-ND3,MT,10158,na,na,Pathogenic,"not provided|Leigh syndrome|Mitochondrial complex 1 deficiency, mitochondrial type 1|Mitochondrial disease",GRCh38,single nucleotide variant
MT-ND3,MT,10197,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leber optic atrophy and dystonia|Leigh syndrome|Mitochondrial DNA-Associated Leigh Syndrome and NARP|not provided|not specified|Mitochondrial disease|See cases|Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy",GRCh38,single nucleotide variant
MT-ND2,MT,4917,na,na,Benign,Leber optic atrophy|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-ND2,MT,5244,na,na,Uncertain significance,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND2,MT,4640,na,na,Benign,Leber optic atrophy|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND2,MT,4810,na,na,Likely pathogenic,Mitochondrial complex I deficiency|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND2,MT,4681,na,na,Pathogenic,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND1,MT,3460,na,na,Pathogenic,"Leber optic atrophy|Leigh syndrome|not provided|MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Optic atrophy|Mitochondrial disease|MELAS syndrome",GRCh38,single nucleotide variant
MT-ND1,MT,4160,na,na,Uncertain significance,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND1,MT,4216,na,na,Benign,Leber optic atrophy|not provided|Leigh syndrome|not specified,GRCh38,single nucleotide variant
MT-ND1,MT,3394,na,na,Uncertain significance,Leber optic atrophy|not provided|Leigh syndrome|Optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND1,MT,3397,na,na,Benign,"Alzheimer disease|Parkinson disease, late-onset|Leigh syndrome",GRCh38,single nucleotide variant
MT-ND1,MT,4136,na,na,Benign,Leber optic atrophy|Leigh syndrome|not provided,GRCh38,single nucleotide variant
MT-ND1,MT,3308,na,na,Benign/Likely benign,Carcinoma of colon|SUDDEN INFANT DEATH SYNDROME|not specified|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND1,MT,3308,na,na,Likely benign,SUDDEN INFANT DEATH SYNDROME|Leigh syndrome,GRCh38,single nucleotide variant
MT-ND1,MT,3796,na,na,Benign,"Dystonia, adult-onset|not provided|Leigh syndrome|not specified",GRCh38,single nucleotide variant
MT-ND1,MT,4171,na,na,Uncertain significance,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND1,MT,3697,na,na,Likely pathogenic,Leber optic atrophy and dystonia|Leber optic atrophy|MELAS syndrome|Mitochondrial disease|7 conditions,GRCh38,single nucleotide variant
"covers 22 genes, none of which curated to show dosage sensitivity",MT,3946,na,na,Likely pathogenic,MELAS syndrome|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND1,MT,3949,na,na,Uncertain significance,MELAS syndrome|Mitochondrial disease,GRCh38,single nucleotide variant
MT-ND1,MT,3733,na,na,Uncertain significance,Leber optic atrophy|Mitochondrial disease,GRCh38,single nucleotide variant
SRY,Y,2787278,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787426,na,na,Pathogenic,"46,XY sex reversal 1|not provided",GRCh38,single nucleotide variant
SRY,Y,2787327,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787334,na,na,Pathogenic,"46,XY sex reversal 1|46,XY TRUE HERMAPHRODITISM",GRCh38,single nucleotide variant
SRY,Y,2787287,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787267,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787284,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787401,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787412,na,na,Likely pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787395,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787330,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787321,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787592,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787207,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787600,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787551,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787320,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
SRY,Y,2787224,na,na,Pathogenic,"46,XY sex reversal 1",GRCh38,single nucleotide variant
ZNF81,X,47915182,na,na,Uncertain significance,"Intellectual disability, X-linked 45",GRCh38,single nucleotide variant
ZNF41,X,47449438,na,na,Likely benign,not provided,GRCh38,single nucleotide variant
ZNF41,X,47456440,na,na,Likely benign,not provided|ZNF41-related disorder,GRCh38,single nucleotide variant
ZNF711,X,85271115,na,na,Pathogenic,"Intellectual disability, X-linked 97",GRCh38,single nucleotide variant
XK,X,37694549,na,na,Pathogenic,McLeod neuroacanthocytosis syndrome,GRCh38,single nucleotide variant
XK,X,37727635,na,na,Pathogenic,McLeod neuroacanthocytosis syndrome,GRCh38,single nucleotide variant
XK,X,37728007,na,na,Pathogenic,McLeod neuroacanthocytosis syndrome,GRCh38,single nucleotide variant
XK,X,37728068,na,na,Pathogenic,McLeod neuroacanthocytosis syndrome,GRCh38,single nucleotide variant
XK,X,37728022,na,na,Pathogenic,McLeod neuroacanthocytosis syndrome,GRCh38,single nucleotide variant
KDM5C,X,53199029,na,na,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,GRCh38,single nucleotide variant
KDM5C,X,53211867,na,na,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,GRCh38,single nucleotide variant
KDM5C,X,53199140,na,na,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|not provided,GRCh38,single nucleotide variant
KDM5C,X,53211545,na,na,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,GRCh38,single nucleotide variant
KDM5C,X,53198836,na,na,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,GRCh38,single nucleotide variant
KDM5C,X,53218398,na,na,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,GRCh38,single nucleotide variant
XIST,X,73852757,na,na,Pathogenic,"X inactivation, familial skewed, 1",GRCh38,single nucleotide variant
UBA1,X,47205989,na,na,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,GRCh38,single nucleotide variant
UBA1,X,47206011,na,na,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,GRCh38,single nucleotide variant
UBA1,X,47206103,na,na,Conflicting classifications of pathogenicity,Infantile-onset X-linked spinal muscular atrophy|Inborn genetic diseases,GRCh38,single nucleotide variant
SERPINA7,X,106035268,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
SERPINA7,X,106035377,na,na,Conflicting classifications of pathogenicity,"Thyroxine-binding globulin, variant A|not provided|Thyroxine-binding globulin deficiency|SERPINA7-related disorder",GRCh38,single nucleotide variant
SERPINA7,X,106034370,na,na,Benign,"Thyroxine-binding globulin, variant P|not provided|not specified|Thyroxine-binding globulin quantitative trait locus|SERPINA7-related disorder",GRCh38,single nucleotide variant
SERPINA7,X,106036488,na,na,Pathogenic,"Thyroxine-binding globulin, slow",GRCh38,single nucleotide variant
SERPINA7,X,106033697,na,na,association,"Thyroxine-binding globulin deficiency, partial",GRCh38,single nucleotide variant
SERPINA7,X,106036662,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
SERPINA7,X,106036712,na,na,Pathogenic,"Thyroxine-binding globulin deficiency, partial",GRCh38,single nucleotide variant
SERPINA7,X,106034293,na,na,Pathogenic,"Thyroxine-binding globulin, Chicago",GRCh38,single nucleotide variant
SERPINA7,X,106033600,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
SERPINA7,X,106034380,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
SERPINA7,X,106035387,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
SERPINA7,X,106034230,na,na,association,Thyroxine-binding globulin quantitative trait locus,GRCh38,single nucleotide variant
AR,X,67721837,na,na,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,GRCh38,single nucleotide variant
AR,X,67711673,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67722976,na,na,Pathogenic,"Androgen resistance syndrome|Prostate cancer;Hypospadias 1, X-linked;Kennedy disease;Androgen resistance syndrome;Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|AR-related disorder",GRCh38,single nucleotide variant
AR,X,67721905,na,na,Pathogenic,Kennedy disease;Androgen resistance syndrome|Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67686012,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67711459,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
AR,X,67717595,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67723728,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67686030,na,na,Pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided|Disorder of sexual differentiation,GRCh38,single nucleotide variant
AR,X,67721876,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67722948,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67717495,na,na,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|Prostate cancer|Kennedy disease;Androgen resistance syndrome",GRCh38,single nucleotide variant
AR,X,67721838,na,na,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,GRCh38,single nucleotide variant
AR,X,67686064,na,na,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|not provided|Kennedy disease;Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67722976,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67722944,na,na,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Androgen resistance syndrome;Kennedy disease|Male infertility,GRCh38,single nucleotide variant
AR,X,67723688,na,na,Pathogenic,"Hypospadias 1, X-linked",GRCh38,single nucleotide variant
AR,X,67545324,na,na,Pathogenic,Androgen resistance syndrome|not provided,GRCh38,single nucleotide variant
AR,X,67686067,na,na,Pathogenic,"Androgen insensitivity, partial, with breast cancer",GRCh38,single nucleotide variant
AR,X,67722899,na,na,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Androgen resistance syndrome;Kennedy disease|not provided,GRCh38,single nucleotide variant
AR,X,67722898,na,na,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,GRCh38,single nucleotide variant
AR,X,67723710,na,na,Pathogenic,"Prostate cancer, somatic|Neoplasm",GRCh38,single nucleotide variant
AR,X,67711549,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67723711,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
AR,X,67723701,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
AR,X,67723786,na,na,Pathogenic,"Prostate cancer, somatic",GRCh38,single nucleotide variant
AR,X,67711680,na,na,Uncertain significance,"Prostate cancer, somatic|Kennedy disease;Androgen resistance syndrome|not specified",GRCh38,single nucleotide variant
AR,X,67711639,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67643378,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67643387,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67643284,na,na,Uncertain significance,"Hypospadias 1, X-linked|not specified",GRCh38,single nucleotide variant
AR,X,67545150,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67721857,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67685999,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67545667,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67721909,na,na,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not provided|Prostate cancer|not specified|Androgen resistance syndrome;Kennedy disease|Male infertility,GRCh38,single nucleotide variant
AR,X,67721937,na,na,Likely pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided,GRCh38,single nucleotide variant
AR,X,67717484,na,na,Conflicting classifications of pathogenicity,Prostate cancer susceptibility|Prostate cancer|Kennedy disease;Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67723745,na,na,Pathogenic,Androgen resistance syndrome|not provided|Kennedy disease;Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67721968,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67711653,na,na,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67643371,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67722973,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67711585,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67717535,na,na,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67717535,na,na,Pathogenic,Androgen resistance syndrome,GRCh38,single nucleotide variant
AR,X,67717526,na,na,Pathogenic,Partial androgen insensitivity syndrome,GRCh38,single nucleotide variant
AR,X,67711453,na,na,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not specified|not provided|Castleman-Kojima disease|Kennedy disease;Androgen resistance syndrome|Male infertility|AR-related disorder,GRCh38,single nucleotide variant
SYP,X,49191730,na,na,Pathogenic,"Intellectual disability, X-linked 96",GRCh38,single nucleotide variant
SYN1,X,47576222,na,na,Pathogenic,"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders",GRCh38,single nucleotide variant
SHOX,X,641037,na,na,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,GRCh38,single nucleotide variant
SHOX,Y,641037,na,na,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,GRCh38,single nucleotide variant
SHOX,X,641051,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,Y,641051,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,X,634734,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,Y,634734,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,X,634798,na,na,Likely pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,Y,634798,na,na,Likely pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,X,640851,na,na,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,GRCh38,single nucleotide variant
SHOX,Y,640851,na,na,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,GRCh38,single nucleotide variant
SHOX,X,640836,na,na,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,GRCh38,single nucleotide variant
SHOX,Y,640836,na,na,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,GRCh38,single nucleotide variant
SHOX,X,634644,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,Y,634644,na,na,Pathogenic,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,X,644634,na,na,Uncertain significance,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
SHOX,Y,644634,na,na,Uncertain significance,Leri-Weill dyschondrosteosis,GRCh38,single nucleotide variant
HTR2C,X,114731326,na,na,Benign,HTR2C POLYMORPHISM|not provided|HTR2C-related disorder,GRCh38,single nucleotide variant
RS1,X,18647231,na,na,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RS1,X,18647213,na,na,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Retinoschisis,GRCh38,single nucleotide variant
CDKL5;RS1,X,18647303,na,na,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Inborn genetic diseases,GRCh38,single nucleotide variant
RS1,X,18647301,na,na,Pathogenic,Juvenile retinoschisis|not provided,GRCh38,single nucleotide variant
RS1,X,18647296,na,na,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RS1,X,18647192,na,na,Pathogenic,Juvenile retinoschisis|not provided,GRCh38,single nucleotide variant
RS1,X,18672031,na,na,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided,GRCh38,single nucleotide variant
RS1,X,18642012,na,na,Pathogenic,Juvenile retinoschisis|not provided,GRCh38,single nucleotide variant
RS1,X,18642071,na,na,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided|Retinoschisis|Retinal dystrophy,GRCh38,single nucleotide variant
RS1,X,18647212,na,na,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|RS1-related disorder,GRCh38,single nucleotide variant
RPGR,X,38318909,na,na,Uncertain significance,Retinitis pigmentosa 3|not provided|RPGR-related retinopathy,GRCh38,single nucleotide variant
RPGR,X,38310690,na,na,Pathogenic,not provided|Retinitis pigmentosa 3,GRCh38,single nucleotide variant
RPGR,X,38304746,na,na,Pathogenic,Retinitis pigmentosa 3|not provided|Retinitis pigmentosa|Primary ciliary dyskinesia|RPGR-related retinopathy,GRCh38,single nucleotide variant
RPGR,X,38322921,na,na,Likely pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia|Retinal dystrophy|RPGR-related retinopathy|RPGR-related disorder,GRCh38,single nucleotide variant
RPGR,X,38321041,na,na,Pathogenic,Retinitis pigmentosa 3|not provided,GRCh38,single nucleotide variant
RPGR,X,38286349,na,na,Pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia,GRCh38,single nucleotide variant
RPGR,X,38318828,na,na,Pathogenic,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness|not provided",GRCh38,single nucleotide variant
RPGR,X,38317418,na,na,Pathogenic,"not provided|RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS",GRCh38,single nucleotide variant
RPGR,X,38286070,na,na,Pathogenic,X-linked cone-rod dystrophy 1,GRCh38,single nucleotide variant
RPGR,X,38300884,na,na,Uncertain significance,Retinitis pigmentosa 3|Primary ciliary dyskinesia|not specified,GRCh38,single nucleotide variant
UBE2A,X,119583178,na,na,Pathogenic,Syndromic X-linked intellectual disability Nascimento type,GRCh38,single nucleotide variant
PHKA1,X,72582562,na,na,Pathogenic,Glycogen storage disease IXd,GRCh38,single nucleotide variant
PHKA1,X,72582397,na,na,Pathogenic,Glycogen storage disease IXd,GRCh38,single nucleotide variant
PHKA1,X,72657610,na,na,Pathogenic,Glycogen storage disease IXd,GRCh38,single nucleotide variant
PHKA1,X,72667425,na,na,Pathogenic,Glycogen storage disease IXd,GRCh38,single nucleotide variant
PRPS1,X,107640936,na,na,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
PRPS1,X,107645193,na,na,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome,GRCh38,single nucleotide variant
PRPS1,X,107639326,na,na,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,GRCh38,single nucleotide variant
PRPS1,X,107640980,na,na,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,GRCh38,single nucleotide variant
PRPS1,X,107645215,na,na,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,GRCh38,single nucleotide variant
PRPS1,X,107645225,na,na,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,GRCh38,single nucleotide variant
PRPS1,X,107639301,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5,GRCh38,single nucleotide variant
PRPS1,X,107640939,na,na,Likely pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5|Charcot-Marie-Tooth Neuropathy X,GRCh38,single nucleotide variant
PRPS1,X,107642415,na,na,Uncertain significance,not provided|Arts syndrome,GRCh38,single nucleotide variant
PRPS1,X,107640993,na,na,Pathogenic,Arts syndrome,GRCh38,single nucleotide variant
PRPS1,X,107639365,na,na,Pathogenic,"Hearing loss, X-linked 1",GRCh38,single nucleotide variant
PRPS1,X,107639431,na,na,Uncertain significance,"Hearing loss, X-linked 1|Charcot-Marie-Tooth Neuropathy X",GRCh38,single nucleotide variant
PRPS1,X,107649991,na,na,Pathogenic/Likely pathogenic,"Hearing loss, X-linked 1|PRPS1-related disorder",GRCh38,single nucleotide variant
PRPS1,X,107649944,na,na,Pathogenic,"Hearing loss, X-linked 1",GRCh38,single nucleotide variant
PGK1,X,78123240,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78118146,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78124992,na,na,other,Phosphoglycerate kinase electrophoretic variant PGK II,GRCh38,single nucleotide variant
PGK1,X,78113890,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78117367,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78124883,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78123196,na,na,Uncertain significance,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,GRCh38,single nucleotide variant
PGK1,X,78123292,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78113767,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78124896,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PGK1,X,78117385,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,GRCh38,single nucleotide variant
PGK1,X,78122954,na,na,Likely pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,GRCh38,single nucleotide variant
PGK1,X,78125344,na,na,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,GRCh38,single nucleotide variant
PIGA,X,15331637,na,na,Likely pathogenic,Paroxysmal nocturnal hemoglobinuria|not provided,GRCh38,single nucleotide variant
PIGA,X,15331768,na,na,Pathogenic,Paroxysmal nocturnal hemoglobinuria,GRCh38,single nucleotide variant
PIGA,X,15324664,na,na,Pathogenic,Paroxysmal nocturnal hemoglobinuria,GRCh38,single nucleotide variant
MAOA,X,43731784,na,na,Pathogenic,Brunner syndrome,GRCh38,single nucleotide variant
FMR1,X,147936534,na,na,Pathogenic,Fragile X syndrome,GRCh38,single nucleotide variant
LAMP2,X,120449086,na,na,Pathogenic,Danon disease,GRCh38,single nucleotide variant
LAMP2,X,120446300,na,na,Pathogenic,Danon disease,GRCh38,single nucleotide variant
LAMP2,X,120447840,na,na,Pathogenic/Likely pathogenic,Danon disease|Cardiovascular phenotype,GRCh38,single nucleotide variant
LAMP2,X,120449006,na,na,Pathogenic,Danon disease,GRCh38,single nucleotide variant
LAMP2,X,120442599,na,na,Pathogenic,Danon disease|not provided|Danon disease;Hypertrophic cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
LAMP2,X,120441862,na,na,Uncertain significance,Danon disease,GRCh38,single nucleotide variant
L1CAM,X,153865838,na,na,Pathogenic,X-linked hydrocephalus syndrome,GRCh38,single nucleotide variant
L1CAM,X,153870403,na,na,Pathogenic,X-linked hydrocephalus syndrome,GRCh38,single nucleotide variant
L1CAM,X,153870854,na,na,Pathogenic,MASA syndrome,GRCh38,single nucleotide variant
L1CAM,X,153868034,na,na,Pathogenic,MASA syndrome,GRCh38,single nucleotide variant
L1CAM,X,153868866,na,na,Pathogenic,X-linked hydrocephalus syndrome|not provided|Hydrocephalus due to aqueductal stenosis|Spastic paraplegia|L1 syndrome,GRCh38,single nucleotide variant
L1CAM,X,153870933,na,na,Pathogenic,X-linked hydrocephalus syndrome|L1 syndrome|Inborn genetic diseases|Spastic paraplegia,GRCh38,single nucleotide variant
L1CAM,X,153862856,na,na,Pathogenic/Likely pathogenic,X-linked hydrocephalus syndrome|MASA syndrome|not provided|Hydrops fetalis;Severe hydrocephalus|Inborn genetic diseases,GRCh38,single nucleotide variant
L1CAM,X,153870948,na,na,Pathogenic,MASA syndrome,GRCh38,single nucleotide variant
L1CAM,X,153869818,na,na,Pathogenic,MASA syndrome|not provided|X-linked hydrocephalus syndrome|Spastic paraplegia|L1CAM-related disorders,GRCh38,single nucleotide variant
L1CAM,X,153866826,na,na,Pathogenic,Spastic paraplegia|not provided|X-linked hydrocephalus syndrome,GRCh38,single nucleotide variant
L1CAM,X,153867795,na,na,Likely pathogenic,Spastic paraplegia|X-linked hydrocephalus syndrome,GRCh38,single nucleotide variant
L1CAM,X,153864893,na,na,Pathogenic,"Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction|not provided",GRCh38,single nucleotide variant
L1CAM,X,153870475,na,na,Pathogenic/Likely pathogenic,X-linked complicated corpus callosum dysgenesis|X-linked hydrocephalus syndrome|not provided|Congenital cerebellar hypoplasia|Spastic paraplegia|MASA syndrome|L1 syndrome|MASA syndrome;X-linked complicated corpus callosum dysgenesis;X-linked hydrocephalus syndrome,GRCh38,single nucleotide variant
ANOS1,X,8587809,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,GRCh38,single nucleotide variant
ANOS1,X,8585354,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,GRCh38,single nucleotide variant
ANOS1,X,8585349,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,GRCh38,single nucleotide variant
ANOS1,X,8536852,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,GRCh38,single nucleotide variant
ANOS1,X,8585339,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia|not provided,GRCh38,single nucleotide variant
ANOS1,X,8568252,na,na,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 1 with or without anosmia|not specified|not provided,GRCh38,single nucleotide variant
ANOS1,X,8570498,na,na,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,GRCh38,single nucleotide variant
IL2RG,X,71110603,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71108278,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71110980,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71110617,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71110503,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71110292,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71108323,na,na,Pathogenic,"Combined immunodeficiency, X-linked|X-linked severe combined immunodeficiency",GRCh38,single nucleotide variant
IL2RG,X,71110615,na,na,Pathogenic,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
IL2RG,X,71108599,na,na,Pathogenic,X-linked severe combined immunodeficiency|not provided,GRCh38,single nucleotide variant
IL2RG,X,71109321,na,na,Pathogenic,"Combined immunodeficiency, X-linked|Inborn genetic diseases|X-linked severe combined immunodeficiency",GRCh38,single nucleotide variant
IL2RG,X,71110506,na,na,Uncertain significance,X-linked severe combined immunodeficiency,GRCh38,single nucleotide variant
HPRT1,X,134490199,na,na,Pathogenic; other,HPRT ANN ARBOR|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475285,na,na,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ARLINGTON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134498677,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ASHVILLE,GRCh38,single nucleotide variant
HPRT1,X,134473453,na,na,Pathogenic; other,Lesch-Nyhan syndrome|HPRT DETROIT,GRCh38,single nucleotide variant
HPRT1,X,134475268,na,na,Pathogenic; other,HPRT FLINT|Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134498655,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134486475,na,na,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT LONDON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134490192,na,na,Pathogenic; other,HPRT MIDLAND|Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134493586,na,na,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MILWAUKEE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475358,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MUNICH,GRCh38,single nucleotide variant
HPRT1,X,134498670,na,na,Pathogenic; other,Lesch-Nyhan syndrome|HPRT NEW BRITON,GRCh38,single nucleotide variant
HPRT1,X,134475255,na,na,Pathogenic,Lesch-Nyhan syndrome|HPRT NEW HAVEN|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475257,na,na,Likely pathogenic,HPRT YALE|Lesch-Nyhan syndrome|not provided,GRCh38,single nucleotide variant
HPRT1,X,134486471,na,na,Pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|not provided,GRCh38,single nucleotide variant
HPRT1,X,134500030,na,na,Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134473465,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134498433,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134498689,na,na,Likely pathogenic,Lesch-Nyhan syndrome|not provided|HPRT1-related disorder,GRCh38,single nucleotide variant
HPRT1,X,134498441,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134473357,na,na,Pathogenic,Lesch-Nyhan syndrome|HPRT1-related disorder,GRCh38,single nucleotide variant
HPRT1,X,134498431,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134475197,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT TORONTO,GRCh38,single nucleotide variant
HPRT1,X,134475197,na,na,Pathogenic,Lesch-Nyhan syndrome|not provided|HPRT FUJIMI|Microcephaly|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475216,na,na,Pathogenic; other,"HPRT MONTREAL|Lesch-nyhan syndrome, neurologic variant|HPRT1-related disorder",GRCh38,single nucleotide variant
HPRT1,X,134493533,na,na,Pathogenic,Lesch-Nyhan syndrome,GRCh38,single nucleotide variant
HPRT1,X,134498412,na,na,Pathogenic/Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134498407,na,na,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134473377,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT URANGAN,GRCh38,single nucleotide variant
HPRT1,X,134475218,na,na,Pathogenic; other,HPRT TOOWONG|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475278,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT SWAN,GRCh38,single nucleotide variant
HPRT1,X,134493591,na,na,Pathogenic,Lesch-Nyhan syndrome|HPRT CHERMSIDE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134475201,na,na,Uncertain significance,HPRT EDINBURGH|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134493524,na,na,Uncertain significance,Lesch-Nyhan syndrome|HPRT TOKYO|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
HPRT1,X,134498657,na,na,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MOOSE JAW,GRCh38,single nucleotide variant
HPRT1,X,134493564,na,na,Pathogenic; other,Lesch-Nyhan syndrome|HPRT PARIS,GRCh38,single nucleotide variant
HPRT1,X,134475239,na,na,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,GRCh38,single nucleotide variant
F8,X,154837677,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154861759,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154896103,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154863161,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154991304,na,na,Uncertain significance,Hereditary factor VIII deficiency disease|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154861758,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F8,X,154969468,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154837676,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904025,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154966525,na,na,Pathogenic,FACTOR VIII (OKAYAMA)|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154928677,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154928668,na,na,Pathogenic,Hereditary factor VIII deficiency disease|FACTOR VIII (EAST HARTFORD)|not provided,GRCh38,single nucleotide variant
F8,X,154928694,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
F8,X,154928607,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904026,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966526,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154837676,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154863103,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154896102,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154992971,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154966634,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154904083,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969355,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966664,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966077,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",GRCh38,single nucleotide variant
F8,X,154928623,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154837698,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154906421,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154954041,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,155022510,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,155022476,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,155022464,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,155022432,na,na,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect|not specified",GRCh38,single nucleotide variant
F8,X,154987307,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997095,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997086,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997065,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997050,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997038,na,na,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect",GRCh38,single nucleotide variant
F8,X,154997033,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154997011,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154996973,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154993141,na,na,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|Hemorrhage|not provided|Thrombophilia, X-linked, due to factor 8 defect|F8-related disorder|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",GRCh38,single nucleotide variant
F8,X,154993139,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154993133,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154993127,na,na,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,GRCh38,single nucleotide variant
F8,X,154993046,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154993044,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154992996,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154992983,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154987242,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154987237,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154984805,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154984684,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154969543,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969518,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969508,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969486,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969459,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969444,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969438,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154969438,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969417,na,na,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,GRCh38,single nucleotide variant
F8,X,154969405,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154969400,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154969360,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966671,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154969354,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966654,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966522,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966522,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154966523,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966483,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966471,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966120,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966082,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154966065,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154965996,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154965995,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154961131,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154961120,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154957172,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154957079,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154957073,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154957061,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Mild hemophilia A|not provided,GRCh38,single nucleotide variant
F8,X,154957061,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154957060,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",GRCh38,single nucleotide variant
F8,X,154957049,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154957027,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154956983,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154956979,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154956959,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154956980,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154953991,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F8,X,154953987,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154953983,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154953981,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154953961,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Familial aortopathy|Thrombophilia, X-linked, due to factor 8 defect",GRCh38,single nucleotide variant
F8,X,154953903,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154953887,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154947853,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154947854,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154947846,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154947823,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154947782,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154931641,na,na,Pathogenic/Likely pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided|Abnormality of coagulation|Thrombophilia, X-linked, due to factor 8 defect|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect",GRCh38,single nucleotide variant
F8,X,154931623,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",GRCh38,single nucleotide variant
F8,X,154931575,na,na,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,GRCh38,single nucleotide variant
F8,X,154931407,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154930621,na,na,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect|not provided",GRCh38,single nucleotide variant
F8,X,154928890,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154928667,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided|Abnormality of coagulation,GRCh38,single nucleotide variant
F8,X,154928647,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154928647,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154906575,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154906488,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154906470,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154906468,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154906457,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904998,na,na,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,GRCh38,single nucleotide variant
F8,X,154904999,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904999,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904989,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904975,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904954,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904871,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904867,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F8,X,154904864,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904918,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904839,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904811,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904518,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904518,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904511,na,na,Uncertain significance,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154904493,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904434,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904401,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904082,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154904025,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904022,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154904004,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154903968,na,na,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,GRCh38,single nucleotide variant
F8,X,154903966,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154903951,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154902150,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154902120,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154902053,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154899946,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154899876,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154896228,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154896146,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154896135,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154896093,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154863124,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154863151,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",GRCh38,single nucleotide variant
F8,X,154863142,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154863139,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154863125,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154863124,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154863112,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154863113,na,na,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",GRCh38,single nucleotide variant
F8,X,154861810,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154861758,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154861759,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154860588,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154860538,na,na,Pathogenic,Hereditary factor VIII deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154860467,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154837697,na,na,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F8,X,154837686,na,na,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154837685,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,154992945,na,na,Likely pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F8,X,155022449,na,na,Pathogenic,Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
CSF2RA,X,1290449,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",GRCh38,single nucleotide variant
CSF2RA,Y,1290449,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",GRCh38,single nucleotide variant
GRIA3,X,123482856,na,na,Pathogenic,Syndromic X-linked intellectual disability 94|not provided,GRCh38,single nucleotide variant
GRIA3,X,123427954,na,na,Pathogenic,Syndromic X-linked intellectual disability 94,GRCh38,single nucleotide variant
GRIA3,X,123464905,na,na,Pathogenic,Syndromic X-linked intellectual disability 94,GRCh38,single nucleotide variant
G6PD,X,154535277,na,na,Conflicting classifications of pathogenicity,"G6PD A+|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|G6PD deficiency|Inborn genetic diseases|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154536002,na,na,Pathogenic/Likely pathogenic,"G6PD ASAHI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Inborn genetic diseases|G6PD deficiency|G6PD deficiency;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154533586,na,na,Pathogenic/Likely pathogenic,"G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided",GRCh38,single nucleotide variant
G6PD,X,154532990,na,na,Conflicting classifications of pathogenicity,"G6PD CHATHAM|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Inborn genetic diseases|G6PD-related disorder|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154535187,na,na,Conflicting classifications of pathogenicity,"G6PD ILESHA|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154532738,na,na,Benign/Likely benign,"G6PD deficiency|not specified|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532439,na,na,Benign/Likely benign,"G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154534495,na,na,Pathogenic/Likely pathogenic,"G6PD MAHIDOL|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|G6PD deficiency|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154534419,na,na,Pathogenic/Likely pathogenic,"not provided|G6PD SASSARI|G6PD MEDITERRANEAN|G6PD CAGLIARI|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Inborn genetic diseases|Hemolytic anemia, G6PD deficient (favism)|Malaria, susceptibility to|See cases|G6PD deficient hemolytic anemia|G6PD-related disorder",GRCh38,single nucleotide variant
G6PD,X,154536032,na,na,Conflicting classifications of pathogenicity,"G6PD METAPONTO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",GRCh38,single nucleotide variant
G6PD,X,154532676,na,na,Pathogenic,"G6PD PORTICI|G6PD NASHVILLE|G6PD ANAHEIM|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided",GRCh38,single nucleotide variant
G6PD,X,154532411,na,na,Pathogenic/Likely pathogenic,"G6PD SANTIAGO DE CUBA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154533596,na,na,Pathogenic,"G6PD SEATTLE-LIKE|G6PD MODENA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|not provided|G6PD deficiency|G6PD-related disorder|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154534157,na,na,Likely pathogenic,"G6PD HARILAOU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154534556,na,na,Benign,"G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532698,na,na,Pathogenic/Likely pathogenic,"G6PD IOWA CITY|G6PD IOWA|G6PD SPRINGFIELD|G6PD WALTER REED|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD-related disorder",GRCh38,single nucleotide variant
G6PD,X,154532694,na,na,Pathogenic,"G6PD BEVERLY HILLS|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532701,na,na,Pathogenic,"G6PD TOMAH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532626,na,na,Pathogenic/Likely pathogenic,"G6PD RIVERSIDE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532389,na,na,Pathogenic/Likely pathogenic,"G6PD ANDALUS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532269,na,na,Pathogenic,"G6PD AGRIGENTO|G6PD TAIWAN-HAKKA|G6PD GIFU|G6PD CANTON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD-related disorder",GRCh38,single nucleotide variant
G6PD,X,154532752,na,na,Pathogenic/Likely pathogenic,"G6PD PUERTO LIMON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154534440,na,na,Pathogenic/Likely pathogenic,"G6PD MALAGA|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154534345,na,na,Pathogenic/Likely pathogenic,"G6PD MARION|G6PD GASTONIA|G6PD MINNESOTA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|See cases",GRCh38,single nucleotide variant
G6PD,X,154532797,na,na,Pathogenic,"G6PD IERAPETRA|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154533122,na,na,Pathogenic/Likely pathogenic,"G6PD VIANGCHAN|G6PD JAMMU|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Inborn genetic diseases|G6PD deficient hemolytic anemia|G6PD-related disorder|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154534125,na,na,Pathogenic,G6PD deficiency,GRCh38,single nucleotide variant
G6PD,X,154533025,na,na,Conflicting classifications of pathogenicity,"G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|G6PD-related disorder|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154532257,na,na,Conflicting classifications of pathogenicity,"G6PD PETRICH-LIKE|G6PD SAPPORO-LIKE|G6PD ANANT|G6PD KAIPING|G6PD DHON|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Inborn genetic diseases|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154532765,na,na,Likely pathogenic,"G6PD LOMA LINDA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154534390,na,na,Pathogenic,"G6PD COIMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154535336,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
G6PD,X,154534489,na,na,Pathogenic/Likely pathogenic,"G6PD TAIWAN-HAKKA 2|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154534389,na,na,Likely pathogenic,"G6PD SANTIAGO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154534125,na,na,Conflicting classifications of pathogenicity,"G6PD MEXICO CITY|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",GRCh38,single nucleotide variant
G6PD,X,154532695,na,na,Pathogenic,"G6PD GUADALAJARA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154532674,na,na,Likely pathogenic,"G6PD ALHAMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532625,na,na,Pathogenic,"G6PD JAPAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532434,na,na,Conflicting classifications of pathogenicity,"G6PD PAWNEE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154533044,na,na,Pathogenic/Likely pathogenic,"G6PD KERALA-KALYAN|G6PD KERALA|G6PD KALYAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Congenital nonspherocytic hemolytic anemia",GRCh38,single nucleotide variant
G6PD,X,154536156,na,na,Pathogenic/Likely pathogenic,"G6PD AURES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder",GRCh38,single nucleotide variant
G6PD,X,154546061,na,na,Pathogenic,"G6PD GAOHE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Inborn genetic diseases|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|Early-onset coronary artery disease|G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154535261,na,na,Pathogenic/Likely pathogenic,"G6PD QUING YUAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154532969,na,na,Conflicting classifications of pathogenicity,"G6PD MAHIDOL-LIKE|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154536168,na,na,Pathogenic/Likely pathogenic,"G6PD ORISSA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154534465,na,na,Pathogenic,"G6PD NANKANG|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154532245,na,na,Likely pathogenic,"G6PD NEAPOLIS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532772,na,na,Likely pathogenic,"G6PD SERRES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154533634,na,na,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD AVEIRO",GRCh38,single nucleotide variant
G6PD,X,154533029,na,na,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD REHOVOT",GRCh38,single nucleotide variant
G6PD,X,154532203,na,na,Conflicting classifications of pathogenicity,"G6PD SPLIT|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154535996,na,na,Pathogenic/Likely pathogenic,"G6PD NAMORU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",GRCh38,single nucleotide variant
G6PD,X,154534389,na,na,Pathogenic/Likely pathogenic,"G6PD NILGIRI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",GRCh38,single nucleotide variant
G6PD,X,154532464,na,na,Pathogenic,"G6PD ZURICH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
G6PD,X,154532269,na,na,Pathogenic,"G6PD COSENZA|not provided|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",GRCh38,single nucleotide variant
GATA1,X,48792337,na,na,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",GRCh38,single nucleotide variant
GATA1,X,48792377,na,na,Pathogenic/Likely pathogenic,"Thrombocytopenia, X-linked, without dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Thrombocytopenia",GRCh38,single nucleotide variant
GATA1,X,48792376,na,na,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",GRCh38,single nucleotide variant
GATA1,X,48792371,na,na,Pathogenic,"Beta-thalassemia-X-linked thrombocytopenia syndrome|Diamond-Blackfan anemia;GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|X-linked dyserythropoetic anemia with abnormal platelets and neutropenia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|not provided",GRCh38,single nucleotide variant
GJB1,X,71224131,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth Neuropathy X,GRCh38,single nucleotide variant
GJB1,X,71224221,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,GRCh38,single nucleotide variant
GJB1,X,71224122,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
GJB1,X,71224104,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,GRCh38,single nucleotide variant
GJB1,X,71224365,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
GJB1,X,71223796,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,GRCh38,single nucleotide variant
GJB1,X,71224174,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
GJB1,X,71223901,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,GRCh38,single nucleotide variant
GJB1,X,71223744,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,GRCh38,single nucleotide variant
GJB1,X,71223990,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases,GRCh38,single nucleotide variant
GJB1,X,71224321,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,GRCh38,single nucleotide variant
GJB1,X,71223961,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth disease|not provided,GRCh38,single nucleotide variant
GJB1,X,71223179,na,na,Uncertain significance,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X,GRCh38,single nucleotide variant
GJB1,X,71223871,na,na,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X,GRCh38,single nucleotide variant
GJB1,X,71223181,na,na,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,GRCh38,single nucleotide variant
GJB1,X,71224411,na,na,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease X-linked dominant 1|not specified|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
GJB1,X,71224114,na,na,Pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease X-linked dominant 1,GRCh38,single nucleotide variant
COL4A5,X,108665561,na,na,Pathogenic,X-linked Alport syndrome,GRCh38,single nucleotide variant
COL4A5,X,108597042,na,na,Pathogenic,X-linked Alport syndrome,GRCh38,single nucleotide variant
COL4A5,X,108582921,na,na,Pathogenic,X-linked Alport syndrome,GRCh38,single nucleotide variant
COL4A5,X,108559083,na,na,Pathogenic,X-linked Alport syndrome,GRCh38,single nucleotide variant
COL4A5,X,108695409,na,na,Pathogenic,X-linked Alport syndrome|Alport syndrome|not provided|COL4A5-related disorder,GRCh38,single nucleotide variant
COL4A5,X,108696350,na,na,Pathogenic/Likely pathogenic,X-linked Alport syndrome|Hematuria|not provided|COL4A5-related disorder,GRCh38,single nucleotide variant
ALAS2,X,55014757,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55015583,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55021195,na,na,Pathogenic,X-linked sideroblastic anemia 1|not provided,GRCh38,single nucleotide variant
ALAS2,X,55017618,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55017594,na,na,Pathogenic,"Sideroblastic anemia 1, late-onset",GRCh38,single nucleotide variant
ALAS2,X,55021176,na,na,Likely pathogenic,"Sideroblastic anemia 1, late-onset|X-linked sideroblastic anemia 1",GRCh38,single nucleotide variant
ALAS2,X,55021121,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55014953,na,na,Pathogenic,X-linked sideroblastic anemia 1|not provided,GRCh38,single nucleotide variant
ALAS2,X,55009242,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55015000,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55021215,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55021215,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55031184,na,na,Benign/Likely benign,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,GRCh38,single nucleotide variant
ALAS2,X,55013516,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55021095,na,na,Pathogenic,X-linked sideroblastic anemia 1,GRCh38,single nucleotide variant
ALAS2,X,55014830,na,na,Pathogenic,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,GRCh38,single nucleotide variant
IDS,X,149483072,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II|Mucopolysaccharidosis, MPS-III-A|See cases|not provided",GRCh38,single nucleotide variant
IDS,X,149490322,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",GRCh38,single nucleotide variant
IDS,X,149482894,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149500977,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149498301,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided|Inborn genetic diseases",GRCh38,single nucleotide variant
IDS,X,149486983,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",GRCh38,single nucleotide variant
IDS,X,149483135,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149503326,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149482974,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149482997,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II|not provided",GRCh38,single nucleotide variant
IDS,X,149482996,na,na,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II|not provided",GRCh38,single nucleotide variant
IDS,X,149487231,na,na,Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149482996,na,na,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
IDS,X,149482933,na,na,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-II",GRCh38,single nucleotide variant
OPN1LW,X,154154734,na,na,Pathogenic,Cone monochromatism,GRCh38,single nucleotide variant
OPN1LW,X,154153068,na,na,Benign,RED CONE POLYMORPHISM|not provided|not specified,GRCh38,single nucleotide variant
OPN1LW,X,154154602,na,na,Pathogenic,Cone monochromatism|not provided|Protan defect,GRCh38,single nucleotide variant
OPN1LW,X,154158844,na,na,Pathogenic,Protan defect,GRCh38,single nucleotide variant
OPN1MW,X,154191716,na,na,Pathogenic,Cone monochromatism|Deuteranomaly,GRCh38,single nucleotide variant
OPN1MW,X,154195934,na,na,Pathogenic,Deuteranomaly,GRCh38,single nucleotide variant
OPN1MW,X,154182566,na,na,Pathogenic,Deuteranomaly,GRCh38,single nucleotide variant
OPN1MW,X,154187939,na,na,Pathogenic,Deuteranomaly,GRCh38,single nucleotide variant
OPN1MW,X,154190173,na,na,Pathogenic,"Cone dystrophy 5, X-linked",GRCh38,single nucleotide variant
GPR143,X,9759390,na,na,Pathogenic,"Ocular albinism, type I|not provided",GRCh38,single nucleotide variant
GPR143,X,9759332,na,na,Uncertain significance,"Ocular albinism, type I|not provided",GRCh38,single nucleotide variant
GPR143,X,9743637,na,na,Pathogenic,"Ocular albinism, type I|not provided",GRCh38,single nucleotide variant
GPR143,X,9759390,na,na,Pathogenic,"Ocular albinism, type I|not provided",GRCh38,single nucleotide variant
GPR143,X,9765714,na,na,Pathogenic,"Ocular albinism, type I|not provided",GRCh38,single nucleotide variant
GPR143,X,9760811,na,na,Pathogenic,"Nystagmus 6, congenital, X-linked",GRCh38,single nucleotide variant
PHKA2,X,18901487,na,na,Pathogenic,Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18908865,na,na,Pathogenic,Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18943709,na,na,Pathogenic,Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18897299,na,na,Pathogenic,Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18893579,na,na,Pathogenic,Glycogen storage disease IXa1|not provided,GRCh38,single nucleotide variant
PHKA2,X,18894400,na,na,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18940017,na,na,Pathogenic,Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18945139,na,na,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18951163,na,na,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18951164,na,na,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,GRCh38,single nucleotide variant
PHKA2,X,18945140,na,na,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1|not provided,GRCh38,single nucleotide variant
PHKA2,X,18945131,na,na,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,GRCh38,single nucleotide variant
RAB39B,X,155264073,na,na,Pathogenic,"Intellectual disability, X-linked 72",GRCh38,single nucleotide variant
RAB39B,X,155264268,na,na,Pathogenic,"Intellectual disability, X-linked 72",GRCh38,single nucleotide variant
RP2,X,46837176,na,na,Pathogenic,Retinitis pigmentosa 2|not provided,GRCh38,single nucleotide variant
RP2,X,46853726,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RP2,X,46853826,na,na,Pathogenic,Retinitis pigmentosa 2,GRCh38,single nucleotide variant
RP2,X,46853726,na,na,Pathogenic,Retinitis pigmentosa 2,GRCh38,single nucleotide variant
RP2,X,46853731,na,na,Pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
STS,X,7325356,na,na,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,GRCh38,single nucleotide variant
STS,X,7334066,na,na,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,GRCh38,single nucleotide variant
STS,X,7305109,na,na,Conflicting classifications of pathogenicity,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,GRCh38,single nucleotide variant
STS,X,7325357,na,na,Uncertain significance,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,GRCh38,single nucleotide variant
STS,X,7334060,na,na,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,GRCh38,single nucleotide variant
STS,X,7325499,na,na,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,GRCh38,single nucleotide variant
F9,X,139530716,na,na,Pathogenic,Hemophilia B leyden,GRCh38,single nucleotide variant
F9,X,139537059,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139537090,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139530816,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139530843,na,na,Uncertain significance,Hereditary factor IX deficiency disease|not specified,GRCh38,single nucleotide variant
F9,X,139537139,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139537144,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139537145,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",GRCh38,single nucleotide variant
F9,X,139537158,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139541076,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139541085,na,na,Likely pathogenic,Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F9,X,139541099,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139541114,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder|Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139541127,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139548450,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139548467,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551112,na,na,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",GRCh38,single nucleotide variant
F9,X,139551113,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139561565,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139551121,na,na,Benign,"Deep venous thrombosis, protection against|not specified|not provided|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139551196,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551217,na,na,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",GRCh38,single nucleotide variant
F9,X,139551218,na,na,Pathogenic,Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided,GRCh38,single nucleotide variant
F9,X,139551082,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551223,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551223,na,na,Pathogenic,Hemophilia b(m),GRCh38,single nucleotide variant
F9,X,139551250,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551251,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139551265,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139560821,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139560836,na,na,Benign/Likely benign,"Hereditary factor IX deficiency disease|FACTOR IX, DNA POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder|not provided",GRCh38,single nucleotide variant
F9,X,139551238,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561566,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor VIII deficiency disease|not provided",GRCh38,single nucleotide variant
F9,X,139561577,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561602,na,na,Likely pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561683,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561694,na,na,Likely pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561710,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",GRCh38,single nucleotide variant
F9,X,139561743,na,na,Pathogenic,"Hereditary factor IX deficiency disease|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561749,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561753,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561754,na,na,Pathogenic/Likely pathogenic,Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease,GRCh38,single nucleotide variant
F9,X,139561820,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139561821,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139561829,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561835,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",GRCh38,single nucleotide variant
F9,X,139561865,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561902,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561773,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561925,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561992,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561992,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139562009,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139562013,na,na,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139562042,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139562054,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561805,na,na,Pathogenic,Hereditary factor IX deficiency disease|not specified,GRCh38,single nucleotide variant
F9,X,139548455,na,na,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561592,na,na,Benign/Likely benign,"FACTOR IX POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|F9-related disorder",GRCh38,single nucleotide variant
F9,X,139561872,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139541126,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139530743,na,na,Pathogenic,Hemophilia B leyden,GRCh38,single nucleotide variant
F9,X,139530731,na,na,Pathogenic,Hemophilia B leyden,GRCh38,single nucleotide variant
F9,X,139530748,na,na,Likely pathogenic,"Hemophilia B leyden|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",GRCh38,single nucleotide variant
F9,X,139561755,na,na,Pathogenic,Hereditary factor IX deficiency disease|not provided,GRCh38,single nucleotide variant
F9,X,139561917,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561916,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561913,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561557,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139530710,na,na,Pathogenic,HEMOPHILIA B BRANDENBURG,GRCh38,single nucleotide variant
F9,X,139530795,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139530846,na,na,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",GRCh38,single nucleotide variant
F9,X,139561941,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561836,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139537031,na,na,Pathogenic,"Warfarin sensitivity, X-linked",GRCh38,single nucleotide variant
F9,X,139561874,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139537388,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561716,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139560772,na,na,Pathogenic,Hereditary factor IX deficiency disease,GRCh38,single nucleotide variant
F9,X,139561836,na,na,Pathogenic,"Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease",GRCh38,single nucleotide variant
MAGT1,X,77841311,na,na,Uncertain significance,not provided,GRCh38,single nucleotide variant
CCNQ,X,153592505,na,na,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,GRCh38,single nucleotide variant
CCNQ,X,153588455,na,na,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,GRCh38,single nucleotide variant
HUWE1,X,53537656,na,na,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",GRCh38,single nucleotide variant
HUWE1,X,53551420,na,na,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",GRCh38,single nucleotide variant
HUWE1,X,53535474,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked syndromic, Turner type|not provided|Non-syndromic X-linked intellectual disability",GRCh38,single nucleotide variant
NDP,X,43949932,na,na,Uncertain significance,Atrophia bulborum hereditaria|not provided,GRCh38,single nucleotide variant
NDP,X,43949977,na,na,Likely pathogenic,"Atrophia bulborum hereditaria|Exudative vitreoretinopathy 2, X-linked",GRCh38,single nucleotide variant
NDP,X,43950022,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43958515,na,na,Likely pathogenic,Atrophia bulborum hereditaria|not provided,GRCh38,single nucleotide variant
NDP,X,43949914,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43949831,na,na,Pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided",GRCh38,single nucleotide variant
NDP,X,43949995,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43949817,na,na,Pathogenic,Atrophia bulborum hereditaria|not provided,GRCh38,single nucleotide variant
NDP,X,43958645,na,na,Pathogenic,Atrophia bulborum hereditaria|not provided,GRCh38,single nucleotide variant
NDP,X,43949840,na,na,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided|Atrophia bulborum hereditaria|Retinal dystrophy",GRCh38,single nucleotide variant
NDP,X,43958608,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43950020,na,na,Pathogenic,Atrophia bulborum hereditaria|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
NDP,X,43958521,na,na,Pathogenic,"Exudative vitreoretinopathy, X-linked|not provided|Atrophia bulborum hereditaria|Atrophia bulborum hereditaria;Exudative vitreoretinopathy 2, X-linked",GRCh38,single nucleotide variant
NDP,X,43949888,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43949873,na,na,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",GRCh38,single nucleotide variant
NDP,X,43949839,na,na,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",GRCh38,single nucleotide variant
NDP,X,43949913,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43958512,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43949983,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
NDP,X,43949899,na,na,Pathogenic,Atrophia bulborum hereditaria,GRCh38,single nucleotide variant
PORCN,X,48511336,na,na,Pathogenic,Focal dermal hypoplasia|not provided|Focal dermal hypoplasia;Anophthalmia-microphthalmia syndrome,GRCh38,single nucleotide variant
PORCN,X,48511932,na,na,Pathogenic,Focal dermal hypoplasia|not provided,GRCh38,single nucleotide variant
PORCN,X,48511380,na,na,Pathogenic,Focal dermal hypoplasia|not provided,GRCh38,single nucleotide variant
AMER1,X,64192230,na,na,Pathogenic,Osteopathia striata with cranial sclerosis|not provided|Neoplasm|Inborn genetic diseases,GRCh38,single nucleotide variant
AMER1,X,64192215,na,na,Pathogenic,Osteopathia striata with cranial sclerosis|Inborn genetic diseases|not provided|AMER1-related disorder,GRCh38,single nucleotide variant
ZDHHC9,X,129841774,na,na,Pathogenic,Syndromic X-linked intellectual disability Raymond type,GRCh38,single nucleotide variant
ZDHHC9,X,129823724,na,na,Pathogenic/Likely pathogenic,Syndromic X-linked intellectual disability Raymond type|not provided|Intellectual disability,GRCh38,single nucleotide variant
ZDHHC9,X,129823718,na,na,Pathogenic,Syndromic X-linked intellectual disability Raymond type,GRCh38,single nucleotide variant
GLA,X,101398033,na,na,Pathogenic,Fabry disease|not provided|GLA-related disorder,GRCh38,single nucleotide variant
GLA,X,101398467,na,na,Pathogenic,"Fabry disease, cardiac variant|Fabry disease|Cardiovascular phenotype|not provided|Primary familial hypertrophic cardiomyopathy",GRCh38,single nucleotide variant
GLA,X,101407773,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398483,na,na,Pathogenic/Likely pathogenic,"not provided|Fabry disease, cardiac variant|Fabry disease",GRCh38,single nucleotide variant
GLA,X,101407786,na,na,Pathogenic,not provided|Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398369,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398534,na,na,Likely pathogenic,"Fabry disease, cardiac variant|not provided",GRCh38,single nucleotide variant
GLA,X,101398387,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101403984,na,na,Conflicting classifications of pathogenicity,not specified|not provided|Fabry disease|Cardiovascular phenotype|GLA-related disorder,GRCh38,single nucleotide variant
GLA,X,101407803,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101407738,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101401743,na,na,Uncertain significance,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101401713,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101401695,na,na,Pathogenic/Likely pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101400699,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398942,na,na,Pathogenic,Fabry disease|not provided|Cardiovascular phenotype|Fabry disease;Hypertrophic cardiomyopathy|Cardiomyopathy,GRCh38,single nucleotide variant
GLA,X,101398563,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398906,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398907,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398795,na,na,Pathogenic/Likely pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398789,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398508,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398479,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA;RPL36A-HNRNPH2,X,101398432,na,na,Conflicting classifications of pathogenicity; other,Fabry disease|not specified|Hypertrophic cardiomyopathy|Sudden unexplained death|Cardiovascular phenotype|Cardiomyopathy|not provided,GRCh38,single nucleotide variant
GLA,X,101398390,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398386,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398079,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398074,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398075,na,na,Pathogenic,Fabry disease|not provided|GLA-related disorder,GRCh38,single nucleotide variant
GLA,X,101398018,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101397907,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101403809,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA;RPL36A-HNRNPH2,X,101401752,na,na,Conflicting classifications of pathogenicity,Fabry disease|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype|GLA-related disorder,GRCh38,single nucleotide variant
GLA,X,101398481,na,na,Pathogenic,"Fabry disease, cardiac variant",GRCh38,single nucleotide variant
GLA,X,101407846,na,na,Pathogenic,"Fabry disease, cardiac variant",GRCh38,single nucleotide variant
GLA,X,101407710,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398004,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101399747,na,na,Pathogenic,"Fabry disease, cardiac variant|not provided|Fabry disease|Cardiomyopathy|Fabry disease;Hypertrophic cardiomyopathy|Cardiovascular phenotype|GLA-related disorder",GRCh38,single nucleotide variant
GLA,X,101401752,na,na,Pathogenic/Likely pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101398920,na,na,Pathogenic,Fabry disease|not provided,GRCh38,single nucleotide variant
GLA,X,101397871,na,na,Pathogenic,Fabry disease,GRCh38,single nucleotide variant
GLA,X,101398554,na,na,Pathogenic/Likely pathogenic,Fabry disease,GRCh38,single nucleotide variant
SRPX2,X,100667292,na,na,Conflicting classifications of pathogenicity,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked|not provided|not specified",GRCh38,single nucleotide variant
SRPX2,X,100662227,na,na,Uncertain significance,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked",GRCh38,single nucleotide variant
AP1S2,X,15852419,na,na,Pathogenic,Pettigrew syndrome,GRCh38,single nucleotide variant
AP1S2,X,15852371,na,na,Pathogenic,Pettigrew syndrome|not provided,GRCh38,single nucleotide variant
AP1S2,X,15845898,na,na,Likely pathogenic,Pettigrew syndrome|not provided,GRCh38,single nucleotide variant
AP1S2,X,15845965,na,na,Pathogenic,Pettigrew syndrome,GRCh38,single nucleotide variant
FRMD7,X,132085625,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked",GRCh38,single nucleotide variant
FRMD7,X,132080053,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",GRCh38,single nucleotide variant
FRMD7,X,132099466,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked",GRCh38,single nucleotide variant
FRMD7,X,132097298,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked",GRCh38,single nucleotide variant
FRMD7,X,132100704,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",GRCh38,single nucleotide variant
FRMD7,X,132085992,na,na,Pathogenic/Likely pathogenic,"Nystagmus 1, congenital, X-linked|not provided",GRCh38,single nucleotide variant
FRMD7,X,132084546,na,na,Pathogenic,"Nystagmus 1, congenital, X-linked",GRCh38,single nucleotide variant
C1GALT1C1,X,120626965,na,na,Pathogenic,Polyagglutinable erythrocyte syndrome,GRCh38,single nucleotide variant
C1GALT1C1,X,120626774,na,na,Benign/Likely benign,"Polyagglutinable erythrocyte syndrome|Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature|C1GALT1C1-related disorder|not provided",GRCh38,single nucleotide variant
C1GALT1C1,X,120626713,na,na,Pathogenic,Polyagglutinable erythrocyte syndrome,GRCh38,single nucleotide variant
POF1B,X,85308188,na,na,Conflicting classifications of pathogenicity,Premature ovarian failure 2B|not provided|Premature ovarian insufficiency,GRCh38,single nucleotide variant
SHROOM4,X,50607876,na,na,Uncertain significance,"X-linked intellectual disability, Stocco dos Santos type",GRCh38,single nucleotide variant
ZNF674,X,46501237,na,na,Uncertain significance,not provided,GRCh38,single nucleotide variant
PHF8,X,54014529,na,na,Pathogenic,Syndromic X-linked intellectual disability Siderius type,GRCh38,single nucleotide variant
PHF8,X,54016662,na,na,Pathogenic,Syndromic X-linked intellectual disability Siderius type,GRCh38,single nucleotide variant
PHF8,X,54011232,na,na,Pathogenic,Syndromic X-linked intellectual disability Siderius type,GRCh38,single nucleotide variant
ATP6AP2,X,40597269,na,na,Pathogenic,Syndromic X-linked intellectual disability Hedera type,GRCh38,single nucleotide variant
BRWD3,X,80692088,na,na,Pathogenic,"Intellectual disability, X-linked 93",GRCh38,single nucleotide variant
BRWD3,X,80677232,na,na,Pathogenic,"Intellectual disability, X-linked 93",GRCh38,single nucleotide variant
MID1,X,10449495,na,na,Pathogenic,X-linked Opitz G/BBB syndrome,GRCh38,single nucleotide variant
MID1,X,10567205,na,na,Pathogenic,X-linked Opitz G/BBB syndrome,GRCh38,single nucleotide variant
MID1,X,10482609,na,na,Pathogenic,X-linked Opitz G/BBB syndrome,GRCh38,single nucleotide variant
PHEX,X,22038468,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,GRCh38,single nucleotide variant
PHEX,X,22038468,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,GRCh38,single nucleotide variant
PHEX,X,22094080,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,GRCh38,single nucleotide variant
PHEX,X,22047116,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,GRCh38,single nucleotide variant
PHEX,X,22094005,na,na,Pathogenic,not provided,GRCh38,single nucleotide variant
PHEX,X,22212922,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,GRCh38,single nucleotide variant
PHEX,X,22095367,na,na,Uncertain significance,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,GRCh38,single nucleotide variant
PHEX,X,22212957,na,na,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,GRCh38,single nucleotide variant
FGD1,X,54456233,na,na,Pathogenic,Aarskog syndrome|not provided,GRCh38,single nucleotide variant
FGD1,X,54465522,na,na,Conflicting classifications of pathogenicity,Aarskog syndrome|not provided,GRCh38,single nucleotide variant
FGD1,X,54470182,na,na,Conflicting classifications of pathogenicity,not provided|Aarskog syndrome|Intellectual disability|FGD1-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
FGD1,X,54467901,na,na,Uncertain significance,Aarskog syndrome|not provided,GRCh38,single nucleotide variant
FGD1,X,54467796,na,na,Pathogenic,Aarskog syndrome,GRCh38,single nucleotide variant
FGD1,X,54465797,na,na,Pathogenic,Aarskog syndrome,GRCh38,single nucleotide variant
AVPR2,X,153905901,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153906059,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153906120,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus",GRCh38,single nucleotide variant
AVPR2,X,153906113,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153905843,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",GRCh38,single nucleotide variant
AVPR2,X,153905719,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153906345,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",GRCh38,single nucleotide variant
AVPR2,X,153906621,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided|Diabetes insipidus, nephrogenic, X-linked;Nephrogenic syndrome of inappropriate antidiuresis",GRCh38,single nucleotide variant
AVPR2,X,153905759,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",GRCh38,single nucleotide variant
AVPR2,X,153906108,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153905916,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|Nephrogenic syndrome of inappropriate antidiuresis|not provided",GRCh38,single nucleotide variant
AVPR2,X,153906047,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",GRCh38,single nucleotide variant
AVPR2,X,153905819,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153905643,na,na,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153905816,na,na,Likely pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|not provided|Nephrogenic syndrome of inappropriate antidiuresis;Diabetes insipidus, nephrogenic, X-linked",GRCh38,single nucleotide variant
AVPR2,X,153905915,na,na,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis|not provided,GRCh38,single nucleotide variant
AVPR2,X,153905916,na,na,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis,GRCh38,single nucleotide variant
OCRL,X,129589905,na,na,Pathogenic,Lowe syndrome|not provided|Dent disease type 2;Lowe syndrome,GRCh38,single nucleotide variant
OCRL,X,129569296,na,na,Pathogenic,Lowe syndrome|not provided,GRCh38,single nucleotide variant
OCRL,X,129569369,na,na,Pathogenic,Lowe syndrome,GRCh38,single nucleotide variant
OCRL,X,129567333,na,na,Pathogenic,Dent disease type 2,GRCh38,single nucleotide variant
OCRL,X,129562396,na,na,Pathogenic/Likely pathogenic,Dent disease type 2|Lowe syndrome|not provided|OCRL-related disorder,GRCh38,single nucleotide variant
IQSEC2,X,53247131,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 1|not provided|Intellectual disability",GRCh38,single nucleotide variant
IQSEC2,X,53248778,na,na,Pathogenic,"Intellectual disability, X-linked 1",GRCh38,single nucleotide variant
IQSEC2,X,53250303,na,na,Pathogenic,"Intellectual disability, X-linked 1",GRCh38,single nucleotide variant
IQSEC2,X,53254856,na,na,Pathogenic,"Intellectual disability, X-linked 1",GRCh38,single nucleotide variant
FANCB,X,14850500,na,na,Pathogenic,Fanconi anemia complementation group B,GRCh38,single nucleotide variant
PDHA1,X,19359613,na,na,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|See cases|Inborn genetic diseases,GRCh38,single nucleotide variant
PDHA1,X,19355713,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,GRCh38,single nucleotide variant
PDHA1,X,19358920,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|Inborn genetic diseases|PDHA1-related disorder,GRCh38,single nucleotide variant
PDHA1,X,19355699,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,GRCh38,single nucleotide variant
PDHA1,X,19355360,na,na,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,GRCh38,single nucleotide variant
PDHA1,X,19355472,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,GRCh38,single nucleotide variant
PDHA1,X,19358959,na,na,Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,GRCh38,single nucleotide variant
PDHA1,X,19357664,na,na,Benign,not specified|Pyruvate dehydrogenase E1-alpha deficiency|not provided|Pyruvate dehydrogenase complex deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
PDHA1,X,19344066,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,GRCh38,single nucleotide variant
PDHA1,X,19357683,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|PDHA1-related disorder,GRCh38,single nucleotide variant
PDHA1,X,19355393,na,na,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,GRCh38,single nucleotide variant
FTSJ1,X,48481715,na,na,Pathogenic,"Intellectual disability, X-linked 9|not provided",GRCh38,single nucleotide variant
FTSJ1,X,48478621,na,na,Pathogenic,"Intellectual disability, X-linked 9",GRCh38,single nucleotide variant
FTSJ1,X,48478615,na,na,Pathogenic,"Intellectual disability, X-linked 9",GRCh38,single nucleotide variant
SH2D1A,X,124365786,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency|X-linked lymphoproliferative syndrome|not provided,GRCh38,single nucleotide variant
SH2D1A,X,124365795,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124346737,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124365760,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124371389,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124370276,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124370177,na,na,Uncertain significance,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124346633,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124346645,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
SH2D1A,X,124365787,na,na,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,GRCh38,single nucleotide variant
BCOR,X,40075092,na,na,Pathogenic,Oculofaciocardiodental syndrome|not provided,GRCh38,single nucleotide variant
BCOR,X,40062394,na,na,Pathogenic,Oculofaciocardiodental syndrome,GRCh38,single nucleotide variant
BCOR,X,40072420,na,na,Pathogenic,Oculofaciocardiodental syndrome,GRCh38,single nucleotide variant
CYBB,X,37805098,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided|Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37805020,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",GRCh38,single nucleotide variant
CYBB,X,37796092,na,na,Uncertain significance,"Granulomatous disease, chronic, X-linked|not provided",GRCh38,single nucleotide variant
CYBB,X,37783565,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|CYBB-related disorder",GRCh38,single nucleotide variant
CYBB,X,37799011,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",GRCh38,single nucleotide variant
CYBB,X,37793793,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided|Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37792024,na,na,Pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37803890,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",GRCh38,single nucleotide variant
CYBB,X,37809565,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37798956,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|Chronic granulomatous disease",GRCh38,single nucleotide variant
CYBB,X,37783605,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37809604,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",GRCh38,single nucleotide variant
CYBB,X,37792023,na,na,Likely pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37783600,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|Granulomatous disease, chronic, X-linked;X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency",GRCh38,single nucleotide variant
CYBB,X,37803886,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",GRCh38,single nucleotide variant
CYBB,X,37794789,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
CYBB,X,37780128,na,na,Pathogenic,"Granulomatous disease, chronic, X-linked",GRCh38,single nucleotide variant
GK,X,30696041,na,na,Pathogenic,Inborn glycerol kinase deficiency,GRCh38,single nucleotide variant
GK,X,30720721,na,na,Pathogenic,Inborn glycerol kinase deficiency,GRCh38,single nucleotide variant
GK,X,30720639,na,na,Pathogenic,Inborn glycerol kinase deficiency,GRCh38,single nucleotide variant
GK,X,30724124,na,na,Pathogenic,Inborn glycerol kinase deficiency,GRCh38,single nucleotide variant
GK,X,30707584,na,na,Pathogenic,Inborn glycerol kinase deficiency,GRCh38,single nucleotide variant
NR0B1,X,30308517,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308257,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308576,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308564,na,na,Pathogenic/Likely pathogenic,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308660,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308851,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30309091,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",GRCh38,single nucleotide variant
NR0B1,X,30304673,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30304809,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",GRCh38,single nucleotide variant
NR0B1,X,30308551,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308218,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308491,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308773,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30304676,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308222,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308226,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30304795,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30308474,na,na,Uncertain significance,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30309255,na,na,Pathogenic,"Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
NR0B1,X,30309049,na,na,Conflicting classifications of pathogenicity,"Mineralocorticoid deficiency, isolated|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",GRCh38,single nucleotide variant
PQBP1,X,48901944,na,na,Pathogenic,Renpenning syndrome,GRCh38,single nucleotide variant
OTC,X,38401310,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38401309,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38381375,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency,GRCh38,single nucleotide variant
OTC,X,38403723,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38401348,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38367347,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38352773,na,na,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
OTC,X,38367350,na,na,Benign,ORNITHINE TRANSCARBAMYLASE POLYMORPHISM|not specified|Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
OTC,X,38408797,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38401273,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38408987,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38408752,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38369838,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38367361,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38401372,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38369815,na,na,Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38369860,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38411906,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38421050,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38381429,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38401332,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38403694,na,na,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38367331,na,na,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
OTC,X,38367332,na,na,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,GRCh38,single nucleotide variant
PCDH19,X,100407276,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 9",GRCh38,single nucleotide variant
PCDH19,X,100408345,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 9",GRCh38,single nucleotide variant
PCDH19,X,100406586,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 9",GRCh38,single nucleotide variant
PCDH19,X,100408456,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 9",GRCh38,single nucleotide variant
PCDH19,X,100406927,na,na,Likely pathogenic,"Developmental and epileptic encephalopathy, 9",GRCh38,single nucleotide variant
NHS,X,17724370,na,na,Pathogenic,not provided|Nance-Horan syndrome|Cataract 40,GRCh38,single nucleotide variant
NHS,X,17375872,na,na,Pathogenic,Nance-Horan syndrome,GRCh38,single nucleotide variant
NHS,X,17721439,na,na,Pathogenic,Nance-Horan syndrome,GRCh38,single nucleotide variant
EDA,X,69616489,na,na,Pathogenic/Likely pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|Tooth agenesis, selective, X-linked, 1;Hypohidrotic X-linked ectodermal dysplasia",GRCh38,single nucleotide variant
EDA,X,69616514,na,na,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not provided|not specified|EDA-related disorder,GRCh38,single nucleotide variant
EDA,X,69616375,na,na,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,GRCh38,single nucleotide variant
EDA,X,69616495,na,na,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,GRCh38,single nucleotide variant
EDA,X,69957093,na,na,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",GRCh38,single nucleotide variant
EDA,X,69957096,na,na,Pathogenic/Likely pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided|EDA-related disorder,GRCh38,single nucleotide variant
EDA,X,69957097,na,na,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",GRCh38,single nucleotide variant
EDA,X,70027956,na,na,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not specified,GRCh38,single nucleotide variant
EDA,X,70028001,na,na,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,GRCh38,single nucleotide variant
EDA,X,70035478,na,na,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,GRCh38,single nucleotide variant
EDA,X,69616491,na,na,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,GRCh38,single nucleotide variant
EDA,X,69616501,na,na,Pathogenic,"Tooth agenesis, selective, X-linked, 1",GRCh38,single nucleotide variant
EDA,X,70035505,na,na,Pathogenic,"Tooth agenesis, selective, X-linked, 1",GRCh38,single nucleotide variant
EDA,X,70035446,na,na,Pathogenic,"Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",GRCh38,single nucleotide variant
ARHGEF9,X,63724557,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 8",GRCh38,single nucleotide variant
MTM1,X,150641306,na,na,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided,GRCh38,single nucleotide variant
MTM1,X,150657957,na,na,Pathogenic,Severe X-linked myotubular myopathy,GRCh38,single nucleotide variant
MTM1,X,150598660,na,na,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|not provided,GRCh38,single nucleotide variant
MTM1,X,150645682,na,na,Likely pathogenic,Severe X-linked myotubular myopathy,GRCh38,single nucleotide variant
MTM1,X,150659654,na,na,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy|MTM1-related disorder,GRCh38,single nucleotide variant
MTM1,X,150645725,na,na,Pathogenic,Severe X-linked myotubular myopathy|not provided,GRCh38,single nucleotide variant
MTM1,X,150641410,na,na,Pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy,GRCh38,single nucleotide variant
MTM1,X,150638967,na,na,Likely pathogenic,Severe X-linked myotubular myopathy|not provided,GRCh38,single nucleotide variant
PHF6,X,134425256,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided|Intellectual disability,GRCh38,single nucleotide variant
PHF6,X,134393556,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome,GRCh38,single nucleotide variant
PHF6,X,134413937,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome,GRCh38,single nucleotide variant
PHF6,X,134377751,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,GRCh38,single nucleotide variant
PHF6,X,134413923,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome,GRCh38,single nucleotide variant
PHF6,X,134377619,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome|Hereditary spastic paraplegia 4|not provided,GRCh38,single nucleotide variant
PHF6,X,134415055,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,GRCh38,single nucleotide variant
PHF6,X,134377639,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome,GRCh38,single nucleotide variant
PHF6,X,134377997,na,na,Pathogenic,Borjeson-Forssman-Lehmann syndrome,GRCh38,single nucleotide variant
PLP1,X,103788460,na,na,Pathogenic,Pelizaeus-Merzbacher disease|not provided,GRCh38,single nucleotide variant
PLP1,X,103787831,na,na,Likely pathogenic,Pelizaeus-Merzbacher disease|not provided,GRCh38,single nucleotide variant
PLP1,X,103785621,na,na,Pathogenic/Likely pathogenic,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2|not provided,GRCh38,single nucleotide variant
PLP1,X,103787811,na,na,Pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103788469,na,na,Likely pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103787888,na,na,Pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103788485,na,na,Uncertain significance,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2,GRCh38,single nucleotide variant
PLP1,X,103787951,na,na,Pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103786493,na,na,Pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103788475,na,na,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",GRCh38,single nucleotide variant
PLP1,X,103786691,na,na,Uncertain significance,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease|not provided,GRCh38,single nucleotide variant
PLP1,X,103787904,na,na,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103785705,na,na,Likely pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103776998,na,na,Pathogenic,"Pelizaeus-Merzbacher disease, mild|Hereditary spastic paraplegia 2",GRCh38,single nucleotide variant
PLP1,X,103789346,na,na,Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103786707,na,na,Pathogenic/Likely pathogenic,"Pelizaeus-Merzbacher disease, atypical|Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease",GRCh38,single nucleotide variant
PLP1,X,103789361,na,na,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",GRCh38,single nucleotide variant
PLP1,X,103787853,na,na,Likely pathogenic,Hereditary spastic paraplegia 2|not provided,GRCh38,single nucleotide variant
PLP1,X,103789401,na,na,Likely pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103786730,na,na,Likely pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103786682,na,na,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
PLP1,X,103785746,na,na,Pathogenic,Pelizaeus-Merzbacher disease,GRCh38,single nucleotide variant
TAFAZZIN,X,154413206,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154412129,na,na,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|not provided,GRCh38,single nucleotide variant
TAFAZZIN,X,154413206,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154420037,na,na,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|TAFAZZIN-related disorder|not provided,GRCh38,single nucleotide variant
TAFAZZIN,X,154411957,na,na,Likely pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154413362,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154413549,na,na,Uncertain significance,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154412084,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154413248,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
TAFAZZIN,X,154420211,na,na,Pathogenic,3-Methylglutaconic aciduria type 2,GRCh38,single nucleotide variant
WAS,X,48684407,na,na,Pathogenic,Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
WAS,X,48684407,na,na,Pathogenic,Wiskott-Aldrich syndrome|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,GRCh38,single nucleotide variant
WAS,X,48684317,na,na,Pathogenic,Thrombocytopenia 1|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1|Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
WAS,X,48686928,na,na,Pathogenic,Thrombocytopenia 1,GRCh38,single nucleotide variant
WAS,X,48683953,na,na,Pathogenic,Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,GRCh38,single nucleotide variant
WAS,X,48683854,na,na,Pathogenic,Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
WAS,X,48684394,na,na,Likely pathogenic,"WISKOTT-ALDRICH SYNDROME, ATTENUATED|not provided",GRCh38,single nucleotide variant
WAS,X,48684284,na,na,Pathogenic,Thrombocytopenia 1|Thrombocytopenia|Thrombocytopenia 1;Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia|not provided|WAS-related disorder|Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
WAS,X,48688331,na,na,Pathogenic/Likely pathogenic,X-linked severe congenital neutropenia|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,GRCh38,single nucleotide variant
WAS,X,48684323,na,na,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",GRCh38,single nucleotide variant
WAS,X,48689423,na,na,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",GRCh38,single nucleotide variant
WAS,X,48686780,na,na,Pathogenic,Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
WAS,X,48686136,na,na,Pathogenic,Wiskott-Aldrich syndrome,GRCh38,single nucleotide variant
AMELX,X,11298243,na,na,Pathogenic,Amelogenesis imperfecta type 1E,GRCh38,single nucleotide variant
AMELX,X,11298932,na,na,Pathogenic,Amelogenesis imperfecta type 1E,GRCh38,single nucleotide variant
AMELX,X,11298569,na,na,Pathogenic,Amelogenesis imperfecta type 1E|not provided|AMELX-related disorder,GRCh38,single nucleotide variant
AMELX,X,11294790,na,na,Pathogenic,Amelogenesis imperfecta type 1E,GRCh38,single nucleotide variant
AMELX,X,11294799,na,na,Pathogenic,Amelogenesis imperfecta type 1E,GRCh38,single nucleotide variant
CHM,X,85894214,na,na,Pathogenic,Choroideremia|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CHM,X,85894227,na,na,Pathogenic,Choroideremia,GRCh38,single nucleotide variant
CHM,X,85894201,na,na,Pathogenic,Choroideremia|not provided,GRCh38,single nucleotide variant
CHM,X,85957918,na,na,Pathogenic,Choroideremia|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
CD40LG,X,136659332,na,na,Pathogenic,Hyper-IgM syndrome type 1,GRCh38,single nucleotide variant
CD40LG,X,136656393,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
CD40LG,X,136659309,na,na,Pathogenic,Hyper-IgM syndrome type 1,GRCh38,single nucleotide variant
CD40LG,X,136659093,na,na,Pathogenic,Hyper-IgM syndrome type 1|not provided,GRCh38,single nucleotide variant
CD40LG,X,136648355,na,na,Pathogenic/Likely pathogenic,Hyper-IgM syndrome type 1,GRCh38,single nucleotide variant
CD40LG,X,136659048,na,na,Pathogenic,Hyper-IgM syndrome type 1,GRCh38,single nucleotide variant
CD40LG,X,136659047,na,na,Likely pathogenic,Hyper-IgM syndrome type 1|not provided,GRCh38,single nucleotide variant
CD40LG,X,136656377,na,na,Pathogenic,Hyper-IgM syndrome type 1,GRCh38,single nucleotide variant
EMD,X,154379485,na,na,Pathogenic,not provided|X-linked Emery-Dreifuss muscular dystrophy,GRCh38,single nucleotide variant
EMD,X,154379737,na,na,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
EMD,X,154380980,na,na,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,GRCh38,single nucleotide variant
EMD,X,154380979,na,na,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,GRCh38,single nucleotide variant
CFP,X,47627564,na,na,Pathogenic,"Properdin deficiency, X-linked|not provided",GRCh38,single nucleotide variant
CFP,X,47628207,na,na,Uncertain significance,"Properdin deficiency, type II|not provided",GRCh38,single nucleotide variant
CFP,X,47626820,na,na,Pathogenic,"Properdin deficiency, X-linked",GRCh38,single nucleotide variant
CFP,X,47627290,na,na,Pathogenic,"Properdin deficiency, X-linked",GRCh38,single nucleotide variant
CFP,X,47626062,na,na,Pathogenic,"Properdin deficiency, type III",GRCh38,single nucleotide variant
ARX,X,25012937,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 1|Corpus callosum agenesis-abnormal genitalia syndrome;X-linked lissencephaly with abnormal genitalia;Developmental and epileptic encephalopathy, 1;Partington syndrome;Intellectual disability, X-linked, with or without seizures, ARX-related|Inborn genetic diseases",GRCh38,single nucleotide variant
ARX,X,25013000,na,na,Pathogenic,"X-linked lissencephaly with abnormal genitalia|not provided|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related",GRCh38,single nucleotide variant
ARX,X,25010262,na,na,Pathogenic,X-linked lissencephaly with abnormal genitalia,GRCh38,single nucleotide variant
ARX,X,25012967,na,na,Pathogenic,X-linked lissencephaly with abnormal genitalia,GRCh38,single nucleotide variant
ARX,X,25015640,na,na,Pathogenic,"Intellectual disability, X-linked, with or without seizures, ARX-related",GRCh38,single nucleotide variant
ARX,X,25013139,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked, with or without seizures, ARX-related|not provided|Intellectual disability, X-linked, with or without seizures, ARX-related;Developmental and epileptic encephalopathy, 1|not specified|Inborn genetic diseases",GRCh38,single nucleotide variant
ARX,X,25012997,na,na,Pathogenic,Corpus callosum agenesis-abnormal genitalia syndrome|not provided,GRCh38,single nucleotide variant
ARX,X,25010274,na,na,Pathogenic,Hydranencephaly with abnormal genitalia,GRCh38,single nucleotide variant
ARX,X,25013763,na,na,Pathogenic,X-linked lissencephaly with abnormal genitalia,GRCh38,single nucleotide variant
DMD,X,32454796,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32484931,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32345978,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31444621,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Cardiomyopathy;Duchenne muscular dystrophy;Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31182736,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31178784,na,na,Pathogenic,Duchenne muscular dystrophy|Becker muscular dystrophy|Dystrophin deficiency;Cardiomyopathy;Duchenne muscular dystrophy;Becker muscular dystrophy|not provided|Dilated cardiomyopathy 3B;Duchenne muscular dystrophy;Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31875331,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32844794,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32501833,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32501821,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32816565,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|Dilated cardiomyopathy 3B;Duchenne muscular dystrophy;Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32501752,na,na,Pathogenic,Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31479104,na,na,Pathogenic,Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32849753,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32454660,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32816495,na,na,Pathogenic,Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32545310,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31180437,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32849821,na,na,Conflicting classifications of pathogenicity,Becker muscular dystrophy|Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32849736,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Cardiomyopathy;Duchenne muscular dystrophy;Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32699252,na,na,Pathogenic,Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32699219,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32699195,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32614347,na,na,Pathogenic,Intermediate muscular dystrophy|Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32595870,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32595757,na,na,Pathogenic,Becker muscular dystrophy|Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32565742,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32501827,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32501818,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32468539,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32464674,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32411772,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32389605,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32342123,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
DMD,X,32217062,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,32216981,na,na,Pathogenic,Duchenne muscular dystrophy|not provided,GRCh38,single nucleotide variant
DMD,X,31929718,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31774100,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31478314,na,na,Benign/Likely benign,Duchenne muscular dystrophy|Cardiovascular phenotype|not specified|not provided|Dilated cardiomyopathy 3B|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31478309,na,na,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 3B|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31478281,na,na,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Becker muscular dystrophy|Dilated cardiomyopathy 3B|not provided|Cardiovascular phenotype|DMD-related disorder|Duchenne muscular dystrophy;Becker muscular dystrophy;Dystrophin deficiency;Cardiomyopathy,GRCh38,single nucleotide variant
DMD,X,31323625,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31178751,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|X-linked DMD-related dystrophinopathy|Abnormality of the musculature|Dystrophin deficiency;Cardiomyopathy;Duchenne muscular dystrophy;Becker muscular dystrophy|See cases,GRCh38,single nucleotide variant
DMD,X,31178664,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31177932,na,na,Uncertain significance,Becker muscular dystrophy|not provided|not specified|Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,32697995,na,na,Uncertain significance,Dilated cardiomyopathy 3B|not provided,GRCh38,single nucleotide variant
DMD,X,32448611,na,na,Pathogenic,Becker muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31206663,na,na,Pathogenic,Dilated cardiomyopathy 3B|Duchenne muscular dystrophy|not provided|Duchenne muscular dystrophy;Becker muscular dystrophy;Dystrophin deficiency;Cardiomyopathy|Qualitative or quantitative defects of dystrophin,GRCh38,single nucleotide variant
DMD,X,32438372,na,na,Pathogenic,Becker muscular dystrophy|not provided|Duchenne muscular dystrophy|Qualitative or quantitative defects of dystrophin|Cardiovascular phenotype,GRCh38,single nucleotide variant
DMD,X,31261301,na,na,Pathogenic/Likely pathogenic,Becker muscular dystrophy|not provided|Duchenne muscular dystrophy,GRCh38,single nucleotide variant
DMD,X,31478330,na,na,Pathogenic,Duchenne muscular dystrophy|not provided|Becker muscular dystrophy;Duchenne muscular dystrophy;Dilated cardiomyopathy 3B,GRCh38,single nucleotide variant
DMD,X,32310214,na,na,Pathogenic,Duchenne muscular dystrophy,GRCh38,single nucleotide variant
ABCD1,X,153726137,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153737214,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153740572,na,na,Pathogenic,Adrenoleukodystrophy|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
ABCD1,X,153736195,na,na,Pathogenic,Adrenoleukodystrophy|not provided,GRCh38,single nucleotide variant
ABCD1,X,153725709,na,na,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,GRCh38,single nucleotide variant
ABCD1,X,153725786,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153726062,na,na,Pathogenic,Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
ABCD1,X,153736232,na,na,Pathogenic,Adrenoleukodystrophy|not specified|not provided,GRCh38,single nucleotide variant
ABCD1,X,153736372,na,na,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,GRCh38,single nucleotide variant
ABCD1,X,153736510,na,na,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided|ABCD1-related disorder,GRCh38,single nucleotide variant
ABCD1,X,153737192,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153740147,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153740155,na,na,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided,GRCh38,single nucleotide variant
ABCD1,X,153740238,na,na,Pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153743023,na,na,Pathogenic,Primary adrenocortical insufficiency|not provided|Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153743056,na,na,Pathogenic,Adrenoleukodystrophy|not provided,GRCh38,single nucleotide variant
ABCD1,X,153743055,na,na,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,GRCh38,single nucleotide variant
ABCD1,X,153743072,na,na,Likely pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
ABCD1,X,153726166,na,na,Likely pathogenic,Adrenoleukodystrophy,GRCh38,single nucleotide variant
TIMM8A,X,101348595,na,na,Pathogenic,Deafness dystonia syndrome,GRCh38,single nucleotide variant
TIMM8A,X,101346595,na,na,Likely pathogenic,Deafness dystonia syndrome,GRCh38,single nucleotide variant
TIMM8A,X,101346555,na,na,Pathogenic,Deafness dystonia syndrome,GRCh38,single nucleotide variant
TIMM8A,X,101346683,na,na,Pathogenic,Deafness dystonia syndrome,GRCh38,single nucleotide variant
NLGN3,X,71167508,na,na,risk factor,"Autism, susceptibility to, X-linked 1",GRCh38,single nucleotide variant
TBX22,X,80027321,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80026849,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80023236,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80025778,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80022435,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80026711,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
TBX22,X,80026860,na,na,Pathogenic,Cleft palate with ankyloglossia,GRCh38,single nucleotide variant
CUL4B,X,120539349,na,na,Pathogenic,X-linked intellectual disability Cabezas type|not provided,GRCh38,single nucleotide variant
CUL4B,X,120544179,na,na,Pathogenic,X-linked intellectual disability Cabezas type|Global developmental delay;Abnormal facial shape;Seizure;Short stature;Intellectual disability|not provided,GRCh38,single nucleotide variant
CUL4B,X,120545519,na,na,Pathogenic,X-linked intellectual disability Cabezas type,GRCh38,single nucleotide variant
BTK,X,101354687,na,na,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency|not provided,GRCh38,single nucleotide variant
BTK,X,101356845,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101375248,na,na,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101375242,na,na,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Inherited Immunodeficiency Diseases|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101358330,na,na,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101353865,na,na,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101375202,na,na,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101375283,na,na,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101375188,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101370080,na,na,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101370081,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101370051,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101360626,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101360589,na,na,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101360581,na,na,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101360087,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101359325,na,na,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia;X-linked agammaglobulinemia with growth hormone deficiency|not provided,GRCh38,single nucleotide variant
BTK,X,101358672,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101358411,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101357561,na,na,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101356910,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101356858,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101356112,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101356102,na,na,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101356060,na,na,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|not provided|Autosomal recessive agammaglobulinemia 1,GRCh38,single nucleotide variant
BTK,X,101356059,na,na,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia with growth hormone deficiency;X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101354636,na,na,Conflicting classifications of pathogenicity,X-linked agammaglobulinemia with growth hormone deficiency|not provided,GRCh38,single nucleotide variant
BTK,X,101354629,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353936,na,na,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101353879,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353336,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353329,na,na,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353282,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353264,na,na,Likely pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353213,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353196,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101349910,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
BTK,X,101353935,na,na,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|not provided|X-linked agammaglobulinemia with growth hormone deficiency,GRCh38,single nucleotide variant
BTK,X,101386057,na,na,Pathogenic,X-linked agammaglobulinemia,GRCh38,single nucleotide variant
UPF3B,X,119837771,na,na,Pathogenic,Syndromic X-linked intellectual disability 14|not provided,GRCh38,single nucleotide variant
UPF3B,X,119843293,na,na,Pathogenic,Syndromic X-linked intellectual disability 14,GRCh38,single nucleotide variant
MBTPS2,X,21868476,na,na,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",GRCh38,single nucleotide variant
MBTPS2,X,21845207,na,na,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",GRCh38,single nucleotide variant
MBTPS2,X,21880921,na,na,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome|not provided",GRCh38,single nucleotide variant
MBTPS2,X,21882519,na,na,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",GRCh38,single nucleotide variant
MBTPS2,X,21868473,na,na,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",GRCh38,single nucleotide variant
FOXP3,X,49251441,na,na,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis,GRCh38,single nucleotide variant
FOXP3,X,49251698,na,na,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
FOXP3,X,49251480,na,na,Pathogenic/Likely pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
FOXP3,X,49253913,na,na,Uncertain significance,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
FOXP3,X,49253200,na,na,Conflicting classifications of pathogenicity,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
FOXP3,X,49258503,na,na,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
FOXP3,X,49251711,na,na,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,GRCh38,single nucleotide variant
NYX,X,41474502,na,na,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1A|not provided|not specified,GRCh38,single nucleotide variant
NYX,X,41473558,na,na,Pathogenic,not provided|Congenital stationary night blindness 1A,GRCh38,single nucleotide variant
NYX,X,41473734,na,na,Pathogenic,Congenital stationary night blindness 1A,GRCh38,single nucleotide variant
NYX,X,41473755,na,na,Pathogenic,Congenital stationary night blindness 1A,GRCh38,single nucleotide variant
NSDHL,X,152858816,na,na,Likely pathogenic,Child syndrome|not provided,GRCh38,single nucleotide variant
NSDHL,X,152865888,na,na,Pathogenic,Child syndrome,GRCh38,single nucleotide variant
NSDHL,X,152865903,na,na,Pathogenic,Child syndrome,GRCh38,single nucleotide variant
NSDHL,X,152850418,na,na,Pathogenic,Child syndrome,GRCh38,single nucleotide variant
NSDHL,X,152865819,na,na,Pathogenic,Child syndrome,GRCh38,single nucleotide variant
NSDHL,X,152862632,na,na,Pathogenic,Child syndrome,GRCh38,single nucleotide variant
ZIC3,X,137567659,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137567495,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137569063,na,na,Pathogenic,"Congenital heart defects, multiple types, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137567436,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137567449,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137569054,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137567340,na,na,Benign/Likely benign,"not specified|Congenital heart defects, multiple types, 1, X-linked|VACTERL association, X-linked, with or without hydrocephalus|Congenital heart defects 1, nonsyndromic, 1|not provided|Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
ZIC3,X,137567454,na,na,Pathogenic,"Heterotaxy, visceral, 1, X-linked",GRCh38,single nucleotide variant
HSD17B10,X,53432086,na,na,Pathogenic,HSD10 mitochondrial disease|not provided,GRCh38,single nucleotide variant
HSD17B10,X,53432110,na,na,Uncertain significance,HSD10 mitochondrial disease|not specified,GRCh38,single nucleotide variant
HSD17B10,X,53431450,na,na,Pathogenic,HSD10 mitochondrial disease,GRCh38,single nucleotide variant
HSD17B10,X,53431819,na,na,Pathogenic,HSD10 mitochondrial disease,GRCh38,single nucleotide variant
HSD17B10,X,53431445,na,na,Uncertain significance,HSD10 mitochondrial disease,GRCh38,single nucleotide variant
IKBKG,X,154564420,na,na,Conflicting classifications of pathogenicity,Incontinentia pigmenti syndrome|not provided,GRCh38,single nucleotide variant
IKBKG,X,154564460,na,na,Pathogenic,"Incontinentia pigmenti syndrome|ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED",GRCh38,single nucleotide variant
IKBKG,X,154552186,na,na,Pathogenic,Incontinentia pigmenti syndrome|not provided,GRCh38,single nucleotide variant
IKBKG,X,154564372,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,GRCh38,single nucleotide variant
IKBKG,X,154564450,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,GRCh38,single nucleotide variant
IKBKG,X,154564451,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,GRCh38,single nucleotide variant
IKBKG,X,154564418,na,na,Likely pathogenic,"ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED|Incontinentia pigmenti syndrome|Ectodermal dysplasia and immunodeficiency 1",GRCh38,single nucleotide variant
IKBKG,X,154558590,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,GRCh38,single nucleotide variant
IKBKG,X,154564408,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,GRCh38,single nucleotide variant
IKBKG,X,154561789,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,GRCh38,single nucleotide variant
IKBKG,X,154563958,na,na,Pathogenic,Immunodeficiency 33,GRCh38,single nucleotide variant
IKBKG,X,154562904,na,na,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,GRCh38,single nucleotide variant
IKBKG,X,154563590,na,na,Likely pathogenic,Immunodeficiency 33|not provided,GRCh38,single nucleotide variant
IKBKG,X,154563602,na,na,Pathogenic,Immunodeficiency 33,GRCh38,single nucleotide variant
IKBKG,X,154558649,na,na,Pathogenic,not provided|Immunodeficiency 33,GRCh38,single nucleotide variant
BMP15,X,50916132,na,na,Pathogenic,Ovarian dysgenesis 2,GRCh38,single nucleotide variant
BMP15,X,50911009,na,na,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,GRCh38,single nucleotide variant
BMP15,X,50915966,na,na,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,GRCh38,single nucleotide variant
BMP15,X,50916059,na,na,Pathogenic,Premature ovarian failure 4,GRCh38,single nucleotide variant
BMP15,X,50910985,na,na,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2|not provided|BMP15-related disorder,GRCh38,single nucleotide variant
SLC9A6,X,136024365,na,na,Pathogenic,Christianson syndrome|not provided,GRCh38,single nucleotide variant
IL1RAPL1,X,29955106,na,na,Pathogenic,"Intellectual disability, X-linked 21",GRCh38,single nucleotide variant
IL1RAPL1,X,29955189,na,na,Likely pathogenic,"Intellectual disability, X-linked 21",GRCh38,single nucleotide variant
EBP,X,48523858,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,GRCh38,single nucleotide variant
EBP,X,48523958,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided,GRCh38,single nucleotide variant
EBP,X,48524009,na,na,Pathogenic/Likely pathogenic,Chondrodysplasia punctata 2 X-linked dominant|Connective tissue disorder|not provided,GRCh38,single nucleotide variant
EBP,X,48527026,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,GRCh38,single nucleotide variant
EBP,X,48527202,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,GRCh38,single nucleotide variant
EBP,X,48528287,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,GRCh38,single nucleotide variant
EBP,X,48528351,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,GRCh38,single nucleotide variant
EBP,X,48527256,na,na,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided|Chondrodysplasia punctata 2 X-linked dominant;MEND syndrome,GRCh38,single nucleotide variant
EBP,X,48523824,na,na,Pathogenic,MEND syndrome,GRCh38,single nucleotide variant
CDKL5,X,18581942,na,na,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",GRCh38,single nucleotide variant
CDKL5,X,18584324,na,na,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",GRCh38,single nucleotide variant
CDKL5,X,18628374,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 2|Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",GRCh38,single nucleotide variant
CDKL5,X,18564496,na,na,Pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder|not provided",GRCh38,single nucleotide variant
CDKL5,X,18575423,na,na,Pathogenic,"Developmental and epileptic encephalopathy, 2|not provided|Rett syndrome|CDKL5 disorder|Angelman syndrome-like;Developmental and epileptic encephalopathy, 2",GRCh38,single nucleotide variant
CDKL5,X,18598499,na,na,Conflicting classifications of pathogenicity,"Developmental and epileptic encephalopathy, 2|CDKL5 disorder|not provided",GRCh38,single nucleotide variant
CDKL5,X,18598508,na,na,Uncertain significance,"Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",GRCh38,single nucleotide variant
TRAPPC2,X,13719866,na,na,Pathogenic,"Spondyloepiphyseal dysplasia tarda|not provided|Spondyloepiphyseal dysplasia tarda, X-linked|Inborn genetic diseases",GRCh38,single nucleotide variant
TRAPPC2,X,13716080,na,na,Likely pathogenic,Spondyloepiphyseal dysplasia tarda|Connective tissue disorder,GRCh38,single nucleotide variant
TRAPPC2,X,13714439,na,na,Pathogenic,Spondyloepiphyseal dysplasia tarda,GRCh38,single nucleotide variant
TRAPPC2,X,13714501,na,na,Pathogenic,Spondyloepiphyseal dysplasia tarda,GRCh38,single nucleotide variant
TRAPPC2,X,13716530,na,na,Pathogenic,Spondyloepiphyseal dysplasia tarda,GRCh38,single nucleotide variant
DLG3,X,70450788,na,na,Likely pathogenic,"Intellectual disability, X-linked 90|not provided",GRCh38,single nucleotide variant
DLG3,X,70453794,na,na,Pathogenic,"Intellectual disability, X-linked 90",GRCh38,single nucleotide variant
MED12,X,71127367,na,na,Pathogenic/Likely pathogenic,"FG syndrome 1|6 conditions|FG syndrome 1;Blepharophimosis - intellectual disability syndrome, MKB type;X-linked intellectual disability with marfanoid habitus|Intellectual disability|not provided|Blepharophimosis - intellectual disability syndrome, MKB type|FG syndrome|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
MED12,X,71127931,na,na,Pathogenic/Likely pathogenic,X-linked intellectual disability with marfanoid habitus|not provided|FG syndrome 1|FG syndrome,GRCh38,single nucleotide variant
ARSL,X,2958423,na,na,Uncertain significance,"X-linked chondrodysplasia punctata 1|Chondrodysplasia punctata, brachytelephalangic, autosomal",GRCh38,single nucleotide variant
ARSL,X,2953224,na,na,Pathogenic/Likely pathogenic,X-linked chondrodysplasia punctata 1|not provided,GRCh38,single nucleotide variant
ARSL,X,2953241,na,na,Pathogenic,X-linked chondrodysplasia punctata 1,GRCh38,single nucleotide variant
ARSL,X,2953163,na,na,Pathogenic,X-linked chondrodysplasia punctata 1,GRCh38,single nucleotide variant
ARSL,X,2949425,na,na,Pathogenic,X-linked chondrodysplasia punctata 1,GRCh38,single nucleotide variant
ARSL,X,2935127,na,na,Pathogenic,X-linked chondrodysplasia punctata 1,GRCh38,single nucleotide variant
ARSL,X,2934870,na,na,Pathogenic,X-linked chondrodysplasia punctata 1,GRCh38,single nucleotide variant
ARSL,X,2934859,na,na,Pathogenic/Likely pathogenic,"X-linked chondrodysplasia punctata 1|not provided|See cases|Chondrodysplasia punctata, brachytelephalangic, autosomal|Inborn genetic diseases",GRCh38,single nucleotide variant
CASK,X,41553843,na,na,Pathogenic,Syndromic X-linked intellectual disability Najm type|not provided|Intellectual disability,GRCh38,single nucleotide variant
CASK,X,41636578,na,na,Pathogenic,Syndromic X-linked intellectual disability Najm type,GRCh38,single nucleotide variant
CASK,X,41853204,na,na,Pathogenic,FG syndrome 4,GRCh38,single nucleotide variant
CASK,X,41660468,na,na,Conflicting classifications of pathogenicity,"FG syndrome 4|Intellectual disability, CASK-related, X-linked|not provided",GRCh38,single nucleotide variant
CASK,X,41542717,na,na,Likely pathogenic,FG syndrome 4|FG syndrome 4;Syndromic X-linked intellectual disability Najm type,GRCh38,single nucleotide variant
CASK,X,41520446,na,na,Pathogenic,FG syndrome 4,GRCh38,single nucleotide variant
CASK,X,41589562,na,na,Conflicting classifications of pathogenicity,"FG syndrome 4|not provided|Syndromic X-linked intellectual disability Najm type|Intellectual disability, CASK-related, X-linked|Inborn genetic diseases",GRCh38,single nucleotide variant
OFD1,X,13756659,na,na,Pathogenic,Orofaciodigital syndrome I,GRCh38,single nucleotide variant
OFD1,X,13744405,na,na,Pathogenic,Orofaciodigital syndrome I,GRCh38,single nucleotide variant
FHL1,X,136207825,na,na,Pathogenic,X-linked scapuloperoneal muscular dystrophy|not provided,GRCh38,single nucleotide variant
FHL1,X,136208625,na,na,Pathogenic/Likely pathogenic,not provided|X-linked myopathy with postural muscle atrophy,GRCh38,single nucleotide variant
FHL1,X,136207827,na,na,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",GRCh38,single nucleotide variant
FHL1,X,136207855,na,na,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|Centronuclear myopathy",GRCh38,single nucleotide variant
FHL1,X,136207917,na,na,Pathogenic/Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy|Abnormality of the musculature",GRCh38,single nucleotide variant
FHL1,X,136207918,na,na,Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy",GRCh38,single nucleotide variant
FHL1,X,136207909,na,na,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",GRCh38,single nucleotide variant
FHL1,X,136207169,na,na,Pathogenic,"Myopathy, reducing body, X-linked, childhood-onset",GRCh38,single nucleotide variant
FHL1,X,136210023,na,na,Pathogenic,Emery-Dreifuss muscular dystrophy 6,GRCh38,single nucleotide variant
FHL1,X,136208578,na,na,Pathogenic,Emery-Dreifuss muscular dystrophy 6|X-linked myopathy with postural muscle atrophy,GRCh38,single nucleotide variant
FHL1,X,136209392,na,na,Pathogenic,X-linked myopathy with postural muscle atrophy,GRCh38,single nucleotide variant
FHL1,X,136208642,na,na,Pathogenic,X-linked myopathy with postural muscle atrophy,GRCh38,single nucleotide variant
FHL1,X,136207828,na,na,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",GRCh38,single nucleotide variant
FHL1,X,136207829,na,na,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",GRCh38,single nucleotide variant
ACSL4,X,109661643,na,na,Pathogenic,"Intellectual disability, X-linked 63",GRCh38,single nucleotide variant
ACSL4,X,109669175,na,na,Pathogenic,"Intellectual disability, X-linked 63",GRCh38,single nucleotide variant
ACSL4,X,109674403,na,na,Likely pathogenic,"Intellectual disability, X-linked 63|not provided",GRCh38,single nucleotide variant
XPNPEP2,X,129736814,na,na,risk factor,Susceptibility to angioedema induced by ACE inhibitors,GRCh38,single nucleotide variant
PAK3,X,111196488,na,na,Pathogenic,"Intellectual disability, X-linked 30|not provided",GRCh38,single nucleotide variant
PAK3,X,111142119,na,na,Pathogenic,"Intellectual disability, X-linked 30",GRCh38,single nucleotide variant
PAK3,X,111194402,na,na,Pathogenic,"Intellectual disability, X-linked 30|not provided",GRCh38,single nucleotide variant
PAK3,X,111196570,na,na,Pathogenic,"Intellectual disability, X-linked 30",GRCh38,single nucleotide variant
PAK3,X,111142200,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 30|not provided|Intellectual disability",GRCh38,single nucleotide variant
ABCB7,X,75071516,na,na,Pathogenic,X-linked sideroblastic anemia with ataxia|not provided,GRCh38,single nucleotide variant
ABCB7,X,75070433,na,na,Pathogenic,X-linked sideroblastic anemia with ataxia,GRCh38,single nucleotide variant
ABCB7,X,75070499,na,na,Pathogenic,X-linked sideroblastic anemia with ataxia,GRCh38,single nucleotide variant
OPHN1,X,68299067,na,na,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,GRCh38,single nucleotide variant
DKC1,X,154765465,na,na,Pathogenic,"Dyskeratosis congenita, X-linked",GRCh38,single nucleotide variant
DKC1,X,154765478,na,na,Pathogenic,"Dyskeratosis congenita, X-linked",GRCh38,single nucleotide variant
DKC1,X,154774651,na,na,Pathogenic,"Dyskeratosis congenita, X-linked",GRCh38,single nucleotide variant
DKC1,X,154773152,na,na,Pathogenic,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",GRCh38,single nucleotide variant
DKC1,X,154763573,na,na,Pathogenic,"Dyskeratosis congenita, X-linked|DKC1-related disorder",GRCh38,single nucleotide variant
DKC1,X,154765505,na,na,Pathogenic,"Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",GRCh38,single nucleotide variant
DKC1,X,154766313,na,na,Conflicting classifications of pathogenicity,"Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",GRCh38,single nucleotide variant
DKC1,X,154765472,na,na,Pathogenic,"Dyskeratosis congenita, X-linked|Hoyeraal-Hreidarsson syndrome",GRCh38,single nucleotide variant
DKC1,X,154765450,na,na,Pathogenic,"Dyskeratosis congenita, X-linked",GRCh38,single nucleotide variant
DKC1,X,154773163,na,na,Uncertain significance,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",GRCh38,single nucleotide variant
DKC1,X,154774706,na,na,Pathogenic,"Dyskeratosis congenita, X-linked",GRCh38,single nucleotide variant
DCX,X,111410215,na,na,Pathogenic/Likely pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",GRCh38,single nucleotide variant
DCX,X,111401121,na,na,Pathogenic,"Ectopic tissue|Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",GRCh38,single nucleotide variant
DCX,X,111401322,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",GRCh38,single nucleotide variant
DCX,X,111410223,na,na,Pathogenic,"Lissencephaly type 1 due to doublecortin gene mutation|Subcortical laminar heterotopia, X-linked",GRCh38,single nucleotide variant
DCX,X,111401087,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|Neurodevelopmental disorder",GRCh38,single nucleotide variant
DCX,X,111410260,na,na,Uncertain significance,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",GRCh38,single nucleotide variant
DCX,X,111410166,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked|not provided",GRCh38,single nucleotide variant
DCX,X,111410134,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked",GRCh38,single nucleotide variant
DCX,X,111401108,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided|Ectopic tissue|Abnormal cerebral morphology|Inborn genetic diseases",GRCh38,single nucleotide variant
DCX,X,111410188,na,na,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",GRCh38,single nucleotide variant
MAMLD1,X,150470162,na,na,Pathogenic,"Hypospadias 2, X-linked",GRCh38,single nucleotide variant
MAMLD1,X,150470381,na,na,Pathogenic,"Hypospadias 2, X-linked",GRCh38,single nucleotide variant
MAMLD1,X,150503409,na,na,Pathogenic,"Hypospadias 2, X-linked|46,XY ovotesticular disorder of sex development",GRCh38,single nucleotide variant
CACNA1F,X,49228048,na,na,Pathogenic,Congenital stationary night blindness 2A,GRCh38,single nucleotide variant
CACNA1F,X,49218511,na,na,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|Retinal dystrophy|not provided|CACNA1F-related disorder,GRCh38,single nucleotide variant
CACNA1F,X,49219344,na,na,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|not provided,GRCh38,single nucleotide variant
CACNA1F,X,49222576,na,na,Pathogenic,"Congenital stationary night blindness, type 2A, severe|not provided",GRCh38,single nucleotide variant
SMS,X,21972576,na,na,Pathogenic,Syndromic X-linked intellectual disability Snyder type,GRCh38,single nucleotide variant
SMS,X,21967312,na,na,Pathogenic,Syndromic X-linked intellectual disability Snyder type|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
SMS,X,21977126,na,na,Pathogenic,Syndromic X-linked intellectual disability Snyder type,GRCh38,single nucleotide variant
GDI1,X,154439027,na,na,Uncertain significance,"Intellectual disability, X-linked 41|not specified",GRCh38,single nucleotide variant
GDI1,X,154438819,na,na,Pathogenic,"Intellectual disability, X-linked 41",GRCh38,single nucleotide variant
GDI1,X,154442596,na,na,Pathogenic,"Intellectual disability, X-linked 41",GRCh38,single nucleotide variant
TSPAN7,X,38681258,na,na,Pathogenic,"Intellectual disability, X-linked 58",GRCh38,single nucleotide variant
TSPAN7,X,38675778,na,na,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 58|not provided|History of neurodevelopmental disorder",GRCh38,single nucleotide variant
SLC16A2,X,74529355,na,na,Pathogenic,Allan-Herndon-Dudley syndrome,GRCh38,single nucleotide variant
SLC16A2,X,74521008,na,na,Pathogenic/Likely pathogenic,Allan-Herndon-Dudley syndrome|not provided,GRCh38,single nucleotide variant
SLC16A2,X,74529232,na,na,Pathogenic,Allan-Herndon-Dudley syndrome|Intellectual disability,GRCh38,single nucleotide variant
SLC16A2,X,74531414,na,na,Pathogenic,Allan-Herndon-Dudley syndrome,GRCh38,single nucleotide variant
SLC16A2,X,74525802,na,na,Pathogenic,Allan-Herndon-Dudley syndrome,GRCh38,single nucleotide variant
SLC16A2,X,74525844,na,na,Pathogenic,Allan-Herndon-Dudley syndrome,GRCh38,single nucleotide variant
RBM10,X,47180493,na,na,Pathogenic,TARP syndrome,GRCh38,single nucleotide variant
XIAP,X,123886014,na,na,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,GRCh38,single nucleotide variant
NDUFA1,X,119871933,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",GRCh38,single nucleotide variant
NDUFA1,X,119873312,na,na,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",GRCh38,single nucleotide variant
RPS6KA3,X,20209307,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20187923,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20204103,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20195146,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20195131,na,na,Likely pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20156144,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20155435,na,na,Pathogenic/Likely pathogenic,Coffin-Lowry syndrome|not provided|Intellectual disability|Inborn genetic diseases,GRCh38,single nucleotide variant
RPS6KA3,X,20175244,na,na,Pathogenic,"Intellectual disability, X-linked 19",GRCh38,single nucleotide variant
RPS6KA3,X,20193514,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20194186,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20176354,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
RPS6KA3,X,20186338,na,na,Pathogenic,Coffin-Lowry syndrome,GRCh38,single nucleotide variant
HCCS,X,11120974,na,na,Pathogenic,Linear skin defects with multiple congenital anomalies 1,GRCh38,single nucleotide variant
HCCS,X,11121652,na,na,Likely pathogenic,Linear skin defects with multiple congenital anomalies 1|HCCS-related disorder,GRCh38,single nucleotide variant
SMC1A,X,53409129,na,na,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,GRCh38,single nucleotide variant
SMC1A,X,53409120,na,na,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome|not provided,GRCh38,single nucleotide variant
POU3F4,X,83508928,na,na,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
POU3F4,X,83509274,na,na,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
POU3F4,X,83509324,na,na,Likely pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
POU3F4,X,83509259,na,na,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
POU3F4,X,83509314,na,na,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
POU3F4,X,83509291,na,na,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,GRCh38,single nucleotide variant
GPC3,X,133753628,na,na,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,GRCh38,single nucleotide variant
GPC3,X,133692368,na,na,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,GRCh38,single nucleotide variant
GPC3,X,133753919,na,na,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|not provided|Wilms tumor 1,GRCh38,single nucleotide variant
GPC3,X,133754153,na,na,Pathogenic,Wilms tumor 1,GRCh38,single nucleotide variant
GPC3,X,133536162,na,na,Uncertain significance,Wilms tumor 1,GRCh38,single nucleotide variant
GPC3,X,133953049,na,na,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,GRCh38,single nucleotide variant
GPC3,X,133699902,na,na,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|Wilms tumor 1|not provided,GRCh38,single nucleotide variant
GPC3,X,133536201,na,na,Pathogenic/Likely pathogenic,Simpson-Golabi-Behmel syndrome type 1|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
SLC6A8,X,153694577,na,na,Pathogenic,Creatine transporter deficiency|Inborn genetic diseases|not provided|Intellectual disability,GRCh38,single nucleotide variant
SLC6A8,X,153693586,na,na,Pathogenic,Creatine transporter deficiency,GRCh38,single nucleotide variant
SLC6A8,X,153688833,na,na,Uncertain significance,Creatine transporter deficiency|not provided,GRCh38,single nucleotide variant
SLC6A8,X,153690373,na,na,Pathogenic,Creatine transporter deficiency,GRCh38,single nucleotide variant
SLC6A8,X,153693361,na,na,Pathogenic,Creatine transporter deficiency,GRCh38,single nucleotide variant
SLC6A8,X,153691304,na,na,Likely pathogenic,Creatine transporter deficiency,GRCh38,single nucleotide variant
SLC6A8,X,153694424,na,na,Likely pathogenic,Creatine transporter deficiency,GRCh38,single nucleotide variant
EFNB1,X,68838820,na,na,Pathogenic,Craniofrontonasal syndrome|not provided,GRCh38,single nucleotide variant
EFNB1,X,68838649,na,na,Pathogenic/Likely pathogenic,Craniofrontonasal syndrome|not provided,GRCh38,single nucleotide variant
EFNB1,X,68839708,na,na,Pathogenic,Craniofrontonasal syndrome|not provided,GRCh38,single nucleotide variant
EFNB1,X,68839709,na,na,Pathogenic,Craniofrontonasal syndrome,GRCh38,single nucleotide variant
EFNB1,X,68839729,na,na,Pathogenic,Craniofrontonasal syndrome|not provided,GRCh38,single nucleotide variant
EFNB1,X,68839731,na,na,Pathogenic,Craniofrontonasal syndrome,GRCh38,single nucleotide variant
EFNB1,X,68829885,na,na,Pathogenic,Craniofrontonasal syndrome,GRCh38,single nucleotide variant
EFNB1,X,68829886,na,na,Pathogenic,Craniofrontonasal syndrome,GRCh38,single nucleotide variant
EFNB1,X,68838684,na,na,Pathogenic,Craniofrontonasal syndrome|not provided,GRCh38,single nucleotide variant
AGTR2,X,116172342,na,na,Benign/Likely benign,"not provided|not specified|Intellectual disability, X-linked 88",GRCh38,single nucleotide variant
AGTR2,X,116173251,na,na,Conflicting classifications of pathogenicity,not provided|AGTR2-related disorder,GRCh38,single nucleotide variant
AGTR2,X,116173289,na,na,Uncertain significance,not provided,GRCh38,single nucleotide variant
AGTR2,X,116172437,na,na,Uncertain significance,not provided,GRCh38,single nucleotide variant
ATRX,X,77633696,na,na,Likely pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome|not provided,GRCh38,single nucleotide variant
ATRX,X,77633682,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77633572,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77600552,na,na,Benign/Likely benign,"Alpha thalassemia-X-linked intellectual disability syndrome|not specified|not provided|Atypical teratoid rhabdoid tumor|Astrocytoma, anaplastic|Inborn genetic diseases|Intellectual disability-hypotonic facies syndrome, X-linked, 1",GRCh38,single nucleotide variant
ATRX,X,77593702,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77574326,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77558685,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77520832,na,na,Pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder",GRCh38,single nucleotide variant
ATRX,X,77520826,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77618991,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77558781,na,na,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder|not provided",GRCh38,single nucleotide variant
ATRX,X,77633210,na,na,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",GRCh38,single nucleotide variant
ATRX,X,77684505,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77688844,na,na,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1",GRCh38,single nucleotide variant
ATRX,X,77684520,na,na,Pathogenic/Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Inborn genetic diseases|Acquired hemoglobin H disease;Intellectual disability-hypotonic facies syndrome, X-linked, 1;Alpha thalassemia-X-linked intellectual disability syndrome|Renier-Gabreels-Jasper syndrome|Intellectual disability-hypotonic facies syndrome, X-linked, 1",GRCh38,single nucleotide variant
ATRX,X,77620442,na,na,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,GRCh38,single nucleotide variant
ATRX,X,77508631,na,na,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",GRCh38,single nucleotide variant
ATRX,X,77633660,na,na,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder|not provided",GRCh38,single nucleotide variant
ATRX,X,77785981,na,na,Pathogenic,Acquired hemoglobin H disease,GRCh38,single nucleotide variant
ATRX,X,77697589,na,na,Pathogenic,Acquired hemoglobin H disease,GRCh38,single nucleotide variant
ATRX,X,77717155,na,na,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Inborn genetic diseases|not provided|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1;Acquired hemoglobin H disease",GRCh38,single nucleotide variant
ATRX,X,77684030,na,na,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",GRCh38,single nucleotide variant
ATRX,X,77589902,na,na,Conflicting classifications of pathogenicity,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|History of neurodevelopmental disorder|not provided",GRCh38,single nucleotide variant
ATRX,X,77684942,na,na,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|Alpha thalassemia-X-linked intellectual disability syndrome",GRCh38,single nucleotide variant
ATRX,X,77523290,na,na,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",GRCh38,single nucleotide variant
FLNA,X,154367920,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154367639,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154367741,na,na,Uncertain significance,"Heterotopia, periventricular, X-linked dominant|not provided",GRCh38,single nucleotide variant
FLNA,X,154370872,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154364582,na,na,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|not provided|Neurodevelopmental delay",GRCh38,single nucleotide variant
FLNA,X,154351689,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154371001,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154367844,na,na,Pathogenic/Likely pathogenic,"Oto-palato-digital syndrome, type I|Familial thoracic aortic aneurysm and aortic dissection|Conductive hearing impairment;Short stature;Cleft palate|not provided|not specified|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|FLNA-related disorder",GRCh38,single nucleotide variant
FLNA,X,154367505,na,na,Pathogenic,"Oto-palato-digital syndrome, type II|not provided|Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome;Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154360319,na,na,Pathogenic,Frontometaphyseal dysplasia 1,GRCh38,single nucleotide variant
FLNA,X,154360233,na,na,Pathogenic/Likely pathogenic,Melnick-Needles syndrome|not provided,GRCh38,single nucleotide variant
FLNA,X,154360199,na,na,Pathogenic/Likely pathogenic,"Melnick-Needles syndrome|Melnick-Needles syndrome;Oto-palato-digital syndrome, type I;Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154350049,na,na,Pathogenic,"Heterotopia, periventricular, with frontometaphyseal dysplasia",GRCh38,single nucleotide variant
FLNA,X,154360238,na,na,Pathogenic/Likely pathogenic,"Frontometaphyseal dysplasia 1|not provided|Oto-palato-digital syndrome, type II|9 conditions|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154371130,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154367857,na,na,Pathogenic,"Oto-palato-digital syndrome, type I",GRCh38,single nucleotide variant
FLNA,X,154368081,na,na,Pathogenic,"Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154354860,na,na,Pathogenic,Otopalatodigital syndrome spectrum disorder,GRCh38,single nucleotide variant
FLNA,X,154364625,na,na,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Cardiac valvular dysplasia, X-linked|FLNA-related periventricular nodular heterotopia|not provided|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|FLNA-related disorder",GRCh38,single nucleotide variant
FLNA,X,154367878,na,na,Conflicting classifications of pathogenicity,"Oto-palato-digital syndrome, type II|Oto-palato-digital syndrome, type I|not provided|Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome;Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154367732,na,na,Pathogenic,"Oto-palato-digital syndrome, type II",GRCh38,single nucleotide variant
FLNA,X,154359839,na,na,Benign/Likely benign,"FG syndrome 2|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|not provided|Familial thoracic aortic aneurysm and aortic dissection|FLNA-related disorder",GRCh38,single nucleotide variant
FLNA,X,154354825,na,na,Pathogenic,"Terminal osseous dysplasia-pigmentary defects syndrome|not provided|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154364638,na,na,Pathogenic,"Cardiac valvular dysplasia, X-linked",GRCh38,single nucleotide variant
FLNA,X,154367403,na,na,Pathogenic/Likely pathogenic,"Cardiac valvular dysplasia, X-linked|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant",GRCh38,single nucleotide variant
FLNA,X,154364263,na,na,Pathogenic,"Cardiac valvular dysplasia, X-linked",GRCh38,single nucleotide variant
ATP7A,X,78043437,na,na,Conflicting classifications of pathogenicity,"Menkes disease, mild|Menkes kinky-hair syndrome",GRCh38,single nucleotide variant
ATP7A,X,78014752,na,na,Conflicting classifications of pathogenicity,"Cutis laxa, X-linked",GRCh38,single nucleotide variant
ATP7A,X,78011216,na,na,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome",GRCh38,single nucleotide variant
ATP7A,X,78029271,na,na,Pathogenic,"Menkes kinky-hair syndrome|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",GRCh38,single nucleotide variant
ATP7A,X,78003237,na,na,Conflicting classifications of pathogenicity,Menkes kinky-hair syndrome,GRCh38,single nucleotide variant
ATP7A,X,78029389,na,na,Pathogenic,Menkes kinky-hair syndrome,GRCh38,single nucleotide variant
ATP7A,X,78042694,na,na,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome|not provided",GRCh38,single nucleotide variant
ATP7A,X,77988722,na,na,Pathogenic,"Menkes kinky-hair syndrome|not provided|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",GRCh38,single nucleotide variant
ATP7A,X,78029314,na,na,Conflicting classifications of pathogenicity,X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome,GRCh38,single nucleotide variant
ATP7A,X,78045502,na,na,Pathogenic,"X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3|Menkes kinky-hair syndrome",GRCh38,single nucleotide variant
CLCN5,X,50086360,na,na,Pathogenic,"Dent disease type 1|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",GRCh38,single nucleotide variant
CLCN5,X,50090678,na,na,Pathogenic,Dent disease type 1|not provided,GRCh38,single nucleotide variant
CLCN5,X,50081723,na,na,Pathogenic,Dent disease type 1,GRCh38,single nucleotide variant
CLCN5,X,50090139,na,na,Pathogenic,Dent disease type 1,GRCh38,single nucleotide variant
CLCN5,X,50090846,na,na,Conflicting classifications of pathogenicity,"X-linked recessive nephrolithiasis with renal failure|CLCN5-related disorder|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Dent disease type 1",GRCh38,single nucleotide variant
CLCN5,X,50088867,na,na,Pathogenic,Dent disease type 1|X-linked recessive nephrolithiasis with renal failure,GRCh38,single nucleotide variant
CLCN5,X,50085987,na,na,Pathogenic,"Hypophosphatemic rickets, X-linked recessive|Dent disease type 1|not provided|X-linked recessive nephrolithiasis with renal failure;Dent disease type 1;Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Hypophosphatemic rickets, X-linked recessive|CLCN5-related disorder",GRCh38,single nucleotide variant
CLCN5,X,50086551,na,na,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",GRCh38,single nucleotide variant
CLCN5,X,50086362,na,na,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",GRCh38,single nucleotide variant
CLCN5,X,50072553,na,na,Pathogenic,X-linked recessive nephrolithiasis with renal failure,GRCh38,single nucleotide variant
CLCN5,X,50086035,na,na,Pathogenic,Dent disease type 1,GRCh38,single nucleotide variant
MECP2,X,154031431,na,na,Pathogenic,"Rett syndrome, zappella variant|not provided|Rett syndrome|Angelman syndrome|X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|not specified|Severe neonatal-onset encephalopathy with microcephaly|Neurodevelopmental delay|Intellectual disability|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154031364,na,na,Likely pathogenic,Rett syndrome,GRCh38,single nucleotide variant
MECP2,X,154031355,na,na,Pathogenic/Likely pathogenic,"Rett syndrome|Angelman syndrome|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome|not provided|Autism, susceptibility to, X-linked 3|Abnormality of the nervous system|Inborn genetic diseases|X-linked intellectual disability-psychosis-macroorchidism syndrome|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154032268,na,na,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3|not specified|X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;Severe neonatal-onset encephalopathy with microcephaly;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154031020,na,na,Pathogenic,"Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome|not provided|Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154030648,na,na,Pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome,GRCh38,single nucleotide variant
MECP2,X,154030948,na,na,Pathogenic,"not provided|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|See cases|Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154031409,na,na,Pathogenic/Likely pathogenic,"X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|8 conditions|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Atypical behavior|Intellectual disability|Autism, susceptibility to, X-linked 3|MECP2-related disorder|Syndromic X-linked intellectual disability Lubs type|Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome|Neurodevelopmental disorder|Inborn genetic diseases",GRCh38,single nucleotide variant
MECP2,X,154030912,na,na,Pathogenic,"Rett syndrome|not provided|Angelman syndrome|Severe neonatal-onset encephalopathy with microcephaly|Intellectual disability|Autism, susceptibility to, X-linked 3|Neurodevelopmental delay|Inborn genetic diseases|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly|See cases|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154031418,na,na,Pathogenic/Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided,GRCh38,single nucleotide variant
MECP2,X,154031326,na,na,Pathogenic,Rett syndrome|not provided|Intellectual disability|Global developmental delay;Developmental regression|Severe neonatal-onset encephalopathy with microcephaly|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder|Inborn genetic diseases,GRCh38,single nucleotide variant
MECP2,X,154031065,na,na,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Neurodevelopmental delay|Abnormality of the nervous system|Syndromic X-linked intellectual disability Lubs type|Autism|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154030546,na,na,Benign,Severe neonatal-onset encephalopathy with microcephaly|not specified|not provided|MECP2-related disorder|Inborn genetic diseases|Rett syndrome,GRCh38,single nucleotide variant
MECP2,X,154031405,na,na,Pathogenic,Atypical Rett syndrome|Angelman syndrome|Rett syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|not provided,GRCh38,single nucleotide variant
MECP2,X,154030465,na,na,Pathogenic,Rett syndrome|not provided,GRCh38,single nucleotide variant
MECP2,X,154032286,na,na,Pathogenic,Rett syndrome|not provided,GRCh38,single nucleotide variant
MECP2,X,154031154,na,na,Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly,GRCh38,single nucleotide variant
MECP2,X,154030864,na,na,Conflicting classifications of pathogenicity,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,GRCh38,single nucleotide variant
MECP2,X,154031374,na,na,Likely pathogenic,"Rett syndrome, zappella variant|X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|MECP2-related disorder",GRCh38,single nucleotide variant
MECP2,X,154097661,na,na,Pathogenic/Likely pathogenic,Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,GRCh38,single nucleotide variant
MYO7A,11,77156069,na,na,Pathogenic,Usher syndrome type 1B|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2,GRCh38,single nucleotide variant
MYO7A,11,77156969,na,na,Pathogenic,Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 2,GRCh38,single nucleotide variant
MYO7A,11,77156904,na,na,Pathogenic/Likely pathogenic,Rare genetic deafness|Usher syndrome type 1B|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|not provided|Usher syndrome|Retinal dystrophy|Autosomal recessive nonsyndromic hearing loss 2,GRCh38,single nucleotide variant
MYO7A,11,77156903,na,na,Pathogenic/Likely pathogenic,Usher syndrome type 1B|not provided|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11,GRCh38,single nucleotide variant
MYO7A,11,77158332,na,na,Likely benign,Usher syndrome type 1B|not specified|Autosomal dominant nonsyndromic hearing loss 11|Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1|Retinal dystrophy,GRCh38,single nucleotide variant
MYO7A,11,77157000,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome,GRCh38,single nucleotide variant
MYO7A,11,77166162,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1B,GRCh38,single nucleotide variant
MYO7A,11,77172834,na,na,Pathogenic,Usher syndrome type 1B|not provided,GRCh38,single nucleotide variant
MYO7A,11,77142783,na,na,Pathogenic,"Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Retinitis pigmentosa|Hearing loss, autosomal recessive|not provided",GRCh38,single nucleotide variant
MYO7A,11,77174816,na,na,Pathogenic,Usher syndrome type 1B|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Rare genetic deafness|not provided|Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2,GRCh38,single nucleotide variant
MYO7A,11,77182575,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
MYO7A,11,77162149,na,na,Pathogenic,Autosomal dominant nonsyndromic hearing loss 11|not provided,GRCh38,single nucleotide variant
FAH,15,80153101,na,na,Pathogenic/Likely pathogenic,Tyrosinemia type I,GRCh38,single nucleotide variant
FAH,15,80162282,na,na,Pathogenic/Likely pathogenic,Tyrosinemia type I,GRCh38,single nucleotide variant
FAH,15,80181069,na,na,Pathogenic,Tyrosinemia type I|not provided,GRCh38,single nucleotide variant
FAH,15,80180184,na,na,Benign/Likely benign; other,Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I|not provided|not specified,GRCh38,single nucleotide variant
FAH,15,80180172,na,na,Pathogenic,Tyrosinemia type I|not provided,GRCh38,single nucleotide variant
FAH,15,80180230,na,na,Pathogenic,Tyrosinemia type I|not provided|Tyrosinemia|FAH-related disorder,GRCh38,single nucleotide variant
FAH,15,80181048,na,na,Pathogenic,Tyrosinemia type I|FAH-related disorder|not provided,GRCh38,single nucleotide variant
FAH,15,80181120,na,na,Pathogenic/Likely pathogenic,Tyrosinemia type I,GRCh38,single nucleotide variant
FAH,15,80173093,na,na,Pathogenic,Tyrosinemia type I,GRCh38,single nucleotide variant
FAH,15,80168263,na,na,Pathogenic,Tyrosinemia type I|not provided|FAH-related disorder,GRCh38,single nucleotide variant
FAH,15,80173143,na,na,Pathogenic/Likely pathogenic,Tyrosinemia type I,GRCh38,single nucleotide variant
PRSS1,7,142751938,na,na,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,GRCh38,single nucleotide variant
PRSS1,7,142750600,na,na,Pathogenic,Hereditary pancreatitis|Trypsinogen deficiency;Hereditary pancreatitis|Myoepithelial tumor|not provided|Vitamin D-dependent rickets type II with alopecia|PRSS1-related disorder,GRCh38,single nucleotide variant
PRSS1,7,142750582,na,na,Likely pathogenic,Hereditary pancreatitis,GRCh38,single nucleotide variant
PRSS1,7,142751808,na,na,Uncertain significance,not provided|Hereditary pancreatitis|not specified,GRCh38,single nucleotide variant
PRSS1,7,142750675,na,na,Conflicting classifications of pathogenicity,Hereditary pancreatitis,GRCh38,single nucleotide variant
PRSS1,7,142751937,na,na,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,GRCh38,single nucleotide variant
PRSS1,7,142751934,na,na,Uncertain significance,Hereditary pancreatitis|not provided|not specified,GRCh38,single nucleotide variant
TBXAS1,7,140017766,na,na,Pathogenic,Ghosal hematodiaphyseal dysplasia,GRCh38,single nucleotide variant
TBXAS1,7,139911233,na,na,Conflicting classifications of pathogenicity,not provided|Ghosal hematodiaphyseal dysplasia,GRCh38,single nucleotide variant
TBXAS1,7,140017747,na,na,Pathogenic,Ghosal hematodiaphyseal dysplasia,GRCh38,single nucleotide variant
TBXAS1,7,140015731,na,na,Conflicting classifications of pathogenicity,not provided|Ghosal hematodiaphyseal dysplasia,GRCh38,single nucleotide variant
F11,4,186287824,na,na,Pathogenic,Hereditary factor XI deficiency disease|not provided|Plasma factor XI deficiency,GRCh38,single nucleotide variant
F11,4,186274193,na,na,Pathogenic,Hereditary factor XI deficiency disease|not provided|F11-related disorder|Abnormal bleeding;Thrombocytopenia|Inborn genetic diseases|Plasma factor XI deficiency,GRCh38,single nucleotide variant
F11,4,186280258,na,na,Pathogenic,Hereditary factor XI deficiency disease|Factor XI|Plasma factor XI deficiency|not provided|F11-related disorder,GRCh38,single nucleotide variant
F11,4,186280472,na,na,Pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
F11,4,186274280,na,na,Pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
F11,4,186285711,na,na,Pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
F11,4,186274228,na,na,Pathogenic/Likely pathogenic,not provided|Hereditary factor XI deficiency disease|Plasma factor XI deficiency,GRCh38,single nucleotide variant
F11,4,186284167,na,na,Uncertain significance,Hereditary factor XI deficiency disease|not specified,GRCh38,single nucleotide variant
F11,4,186280333,na,na,Likely pathogenic,Hereditary factor XI deficiency disease|not provided,GRCh38,single nucleotide variant
F11,4,186284245,na,na,Uncertain significance,Hereditary factor XI deficiency disease|not specified,GRCh38,single nucleotide variant
F11,4,186288518,na,na,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
F11,4,186271719,na,na,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease|not provided|Factor XI deficiency|Plasma factor XI deficiency,GRCh38,single nucleotide variant
F11,4,186280065,na,na,Conflicting classifications of pathogenicity,Hereditary factor XI deficiency disease|not provided,GRCh38,single nucleotide variant
F11,4,186284209,na,na,Likely pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
F11,4,186288496,na,na,Pathogenic,Hereditary factor XI deficiency disease,GRCh38,single nucleotide variant
UMPS,3,124735222,na,na,Likely benign,not provided,GRCh38,single nucleotide variant
UMPS,3,124737583,na,na,Pathogenic,Oroticaciduria,GRCh38,single nucleotide variant
IDUA,4,1002747,na,na,Pathogenic,"Hurler syndrome|not provided|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis, MPS-I-H/S|Inborn genetic diseases|See cases|Mucopolysaccharidosis type 1;Hurler syndrome|IDUA-related disorder",GRCh38,single nucleotide variant
IDUA;SLC26A1,4,987858,na,na,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|Interstitial pneumonitis|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|IDUA-related disorder|Mucopolysaccharidosis",GRCh38,single nucleotide variant
IDUA,4,1003418,na,na,Pathogenic,"Hurler syndrome|not provided|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Inborn genetic diseases|Mucopolysaccharidosis, MPS-I-S",GRCh38,single nucleotide variant
IDUA,4,1002767,na,na,Conflicting classifications of pathogenicity,not specified|Mucopolysaccharidosis type 1|Hurler syndrome|not provided,GRCh38,single nucleotide variant
IDUA,4,987842,na,na,Pathogenic,Hurler syndrome|not provided|Mucopolysaccharidosis type 1,GRCh38,single nucleotide variant
IDUA,4,1002117,na,na,Likely pathogenic,Hurler syndrome|Mucopolysaccharidosis type 1,GRCh38,single nucleotide variant
IDUA,4,1002392,na,na,Pathogenic,Hurler syndrome,GRCh38,single nucleotide variant
IDUA,4,1004292,na,na,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",GRCh38,single nucleotide variant
IDUA,4,1003108,na,na,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|not provided|Mucopolysaccharidosis, MPS-I-S;Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S",GRCh38,single nucleotide variant
IDUA,4,1003102,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|not provided|Mucopolysaccharidosis type 1",GRCh38,single nucleotide variant
IDUA,4,1004391,na,na,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1",GRCh38,single nucleotide variant
IDUA,4,987916,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",GRCh38,single nucleotide variant
IDUA,4,1002087,na,na,Conflicting classifications of pathogenicity,|Hurler syndrome|Mucopolysaccharidosis type 1|not provided,GRCh38,single nucleotide variant
IDUA,4,1004286,na,na,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|Hurler syndrome",GRCh38,single nucleotide variant
IDUA,4,1002387,na,na,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",GRCh38,single nucleotide variant
IDUA,4,1002333,na,na,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",GRCh38,single nucleotide variant
MVK,12,109595044,na,na,Pathogenic,Mevalonic aciduria,GRCh38,single nucleotide variant
MVK,12,109596515,na,na,Pathogenic/Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|Autoinflammatory syndrome|MVK-related disorder|Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Retinal dystrophy|not specified|Inborn genetic diseases",GRCh38,single nucleotide variant
MVK,12,109595142,na,na,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|Retinal dystrophy",GRCh38,single nucleotide variant
MVK,12,109574881,na,na,Pathogenic,"Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|not provided",GRCh38,single nucleotide variant
MVK,12,109591275,na,na,Pathogenic,"Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not specified|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|MVK-related disorder|Autoinflammatory syndrome|Inborn genetic diseases|Retinal dystrophy",GRCh38,single nucleotide variant
MVK,12,109581517,na,na,Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever",GRCh38,single nucleotide variant
MVK,12,109595070,na,na,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|Autoinflammatory syndrome",GRCh38,single nucleotide variant
BCKDHB,6,80168945,na,na,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1B|Maple syrup urine disease type 1A|Inborn genetic diseases,GRCh38,single nucleotide variant
BCKDHB,6,80169013,na,na,Likely pathogenic,Maple syrup urine disease type 1B|Maple syrup urine disease,GRCh38,single nucleotide variant
BCKDHB,6,80167690,na,na,Pathogenic,Maple syrup urine disease type 1B,GRCh38,single nucleotide variant
DBT,1,100214929,na,na,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|See cases|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
DBT,1,100207186,na,na,Pathogenic/Likely pathogenic,Maple syrup urine disease|DBT-related disorder|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,GRCh38,single nucleotide variant
DBT,1,100196256,na,na,Pathogenic,Maple syrup urine disease type 2,GRCh38,single nucleotide variant
DBT,1,100230872,na,na,Pathogenic,Maple syrup urine disease type 2,GRCh38,single nucleotide variant
DBT,1,100206504,na,na,Benign,Maple syrup urine disease|Maple syrup urine disease type 2,GRCh38,single nucleotide variant
DBT,1,100196349,na,na,Pathogenic,Maple syrup urine disease type 2,GRCh38,single nucleotide variant
DBT,1,100216174,na,na,Pathogenic,Maple syrup urine disease type 2,GRCh38,single nucleotide variant
HMGCL,1,23817520,na,na,Uncertain significance,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,GRCh38,single nucleotide variant
HMGCL,1,23820532,na,na,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
HMGCL,1,23804441,na,na,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase,GRCh38,single nucleotide variant
INVS,9,100284342,na,na,Pathogenic/Likely pathogenic,Infantile nephronophthisis|not provided|Nephronophthisis,GRCh38,single nucleotide variant
INVS,9,100264835,na,na,Uncertain significance,Infantile nephronophthisis|Nephronophthisis|not specified,GRCh38,single nucleotide variant
INVS,9,100292976,na,na,Pathogenic,Infantile nephronophthisis|Nephronophthisis|INVS-related disorder,GRCh38,single nucleotide variant
INVS,9,100292952,na,na,Pathogenic/Likely pathogenic,Infantile nephronophthisis|Nephronophthisis|not provided|INVS-related disorder,GRCh38,single nucleotide variant
DLD,7,107902340,na,na,Pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
DLD,7,107919098,na,na,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
DLD,7,107915506,na,na,Pathogenic,Pyruvate dehydrogenase E3 deficiency|Inborn genetic diseases|not provided|DLD-related disorder,GRCh38,single nucleotide variant
DLD,7,107919212,na,na,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
DLD,7,107917404,na,na,Pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
DLD,7,107915697,na,na,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
DLD,7,107917349,na,na,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency|not provided|Inborn genetic diseases|See cases|DLD-related disorder,GRCh38,single nucleotide variant
DLD,7,107917307,na,na,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,GRCh38,single nucleotide variant
AMT,3,49419042,na,na,Conflicting classifications of pathogenicity,Glycine encephalopathy|Glycine encephalopathy 2,GRCh38,single nucleotide variant
AMT,3,49422223,na,na,Conflicting classifications of pathogenicity,Glycine encephalopathy|Inborn genetic diseases|Glycine encephalopathy 2|Glycine encephalopathy 1,GRCh38,single nucleotide variant
AMT,3,49422237,na,na,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,GRCh38,single nucleotide variant
AMT,3,49419022,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,GRCh38,single nucleotide variant
AMT,3,49417892,na,na,Pathogenic,Glycine encephalopathy|not provided|Inborn genetic diseases|Glycine encephalopathy 2|Glycine encephalopathy 1,GRCh38,single nucleotide variant
AMT,3,49419382,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,GRCh38,single nucleotide variant
AMT,3,49417974,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|not provided|Glycine encephalopathy 1,GRCh38,single nucleotide variant
GLDC,9,6588417,na,na,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,GRCh38,single nucleotide variant
GLDC,9,6589230,na,na,Pathogenic,Glycine encephalopathy|Generalized epilepsy;Obesity;Global developmental delay|Glycine encephalopathy 1|GLDC-related disorder|not provided,GRCh38,single nucleotide variant
GLDC,9,6554703,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,GRCh38,single nucleotide variant
GLDC,9,6553420,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1|not provided,GRCh38,single nucleotide variant
GLDC,9,6645498,na,na,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,GRCh38,single nucleotide variant
GLDC,9,6595109,na,na,Pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1|Inborn genetic diseases,GRCh38,single nucleotide variant
GLDC,9,6554768,na,na,Pathogenic/Likely pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1,GRCh38,single nucleotide variant
PYGL,14,50912155,na,na,Pathogenic,"Glycogen storage disease, type VI",GRCh38,single nucleotide variant
PYGL,14,50924101,na,na,Pathogenic,"Glycogen storage disease, type VI",GRCh38,single nucleotide variant
PYGL,14,50921064,na,na,Benign,"not specified|Glycogen storage disease, type VI|not provided",GRCh38,single nucleotide variant
PYGL,14,50915933,na,na,Pathogenic,"Glycogen storage disease, type VI",GRCh38,single nucleotide variant
PYGL,14,50913028,na,na,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VI",GRCh38,single nucleotide variant
G6PC1,17,42903947,na,na,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|Glycogen storage disease|not provided|Hypoglycemia;Short stature|Glycogen storage disease, type I|not specified",GRCh38,single nucleotide variant
G6PC1,17,42911235,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,GRCh38,single nucleotide variant
G6PC1,17,42911391,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease|G6PC1-related disorder|not specified,GRCh38,single nucleotide variant
G6PC1,17,42901105,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,GRCh38,single nucleotide variant
G6PC1,17,42901110,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,GRCh38,single nucleotide variant
G6PC1,17,42911000,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,GRCh38,single nucleotide variant
G6PC1,17,42900989,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not specified|not provided,GRCh38,single nucleotide variant
G6PC1,17,42904028,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,GRCh38,single nucleotide variant
G6PC1,17,42907552,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,GRCh38,single nucleotide variant
G6PC1,17,42909407,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,GRCh38,single nucleotide variant
G6PC1,17,42909418,na,na,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease, type I",GRCh38,single nucleotide variant
G6PC1,17,42903948,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,GRCh38,single nucleotide variant
G6PC1,17,42909353,na,na,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,GRCh38,single nucleotide variant
PCCB,3,136327184,na,na,Pathogenic/Likely pathogenic,Propionic acidemia|not provided,GRCh38,single nucleotide variant
PCCB,3,136262024,na,na,Pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCB,3,136327239,na,na,Pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCB,3,136327638,na,na,Pathogenic/Likely pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCB,3,136284409,na,na,Pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCA,13,100268731,na,na,Pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCA,13,100301512,na,na,Pathogenic/Likely pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
PCCA,13,100305776,na,na,Pathogenic,Propionic acidemia,GRCh38,single nucleotide variant
ETFDH,4,158672458,na,na,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ETFDH,4,158682269,na,na,Pathogenic,Multiple acyl-CoA dehydrogenase deficiency|Glutaric acidemia IIc|not provided|See cases,GRCh38,single nucleotide variant
ETFDH,4,158685137,na,na,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
ETFDH,4,158682399,na,na,Pathogenic/Likely pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,GRCh38,single nucleotide variant
KHK,2,27092357,na,na,Uncertain significance,Essential fructosuria,GRCh38,single nucleotide variant
KHK,2,27092366,na,na,Pathogenic,Essential fructosuria,GRCh38,single nucleotide variant
KLKB1,4,186236789,na,na,Pathogenic,Prekallikrein deficiency,GRCh38,single nucleotide variant
KLKB1,4,186252077,na,na,Pathogenic,Prekallikrein deficiency,GRCh38,single nucleotide variant
KLKB1,4,186257283,na,na,Conflicting classifications of pathogenicity,Prekallikrein deficiency|not provided|Inherited prekallikrein deficiency,GRCh38,single nucleotide variant
KLKB1,4,186236819,na,na,Pathogenic,Prekallikrein deficiency,GRCh38,single nucleotide variant
KLKB1,4,186236880,na,na,Benign,Prekallikrein deficiency|not specified|not provided|Inherited prekallikrein deficiency,GRCh38,single nucleotide variant
FANCD2,3,10090315,na,na,Pathogenic/Likely pathogenic,Fanconi anemia complementation group D2|Inborn genetic diseases|Fanconi anemia,GRCh38,single nucleotide variant
FANCD2,3,10043065,na,na,Pathogenic/Likely pathogenic,Fanconi anemia|Fanconi anemia complementation group D2,GRCh38,single nucleotide variant
FANCD2,3,10043119,na,na,Pathogenic,Fanconi anemia complementation group D2|Fanconi anemia,GRCh38,single nucleotide variant
FANCC,9,95101723,na,na,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,GRCh38,single nucleotide variant
FANCC,9,95150056,na,na,Pathogenic,Fanconi anemia complementation group C|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia|Malignant tumor of breast|FANCC-related disorder,GRCh38,single nucleotide variant
FANCC,9,95172033,na,na,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|FANCC-related disorder,GRCh38,single nucleotide variant
FANCC,9,95249255,na,na,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,GRCh38,single nucleotide variant
FANCC,9,95101742,na,na,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
FANCC,9,95107112,na,na,Pathogenic,Fanconi anemia complementation group C,GRCh38,single nucleotide variant
FANCC,9,95249126,na,na,Pathogenic,Fanconi anemia complementation group C|Fanconi anemia|not provided,GRCh38,single nucleotide variant
F10,13,113149146,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113149062,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113149197,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113122916,na,na,Pathogenic,Factor X deficiency|not provided,GRCh38,single nucleotide variant
F10,13,113147490,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113149170,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113140972,na,na,Conflicting classifications of pathogenicity,Factor X deficiency|Abnormal bleeding|not specified|not provided|Hereditary factor X deficiency disease|F10-related disorder,GRCh38,single nucleotide variant
F10,13,113149014,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113129521,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113129595,na,na,Pathogenic,Factor X deficiency,GRCh38,single nucleotide variant
F10,13,113147496,na,na,Pathogenic,"Factor x deficiency, autosomal dominant",GRCh38,single nucleotide variant
F7,13,113117504,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118863,na,na,Pathogenic,Factor VII deficiency|not provided,GRCh38,single nucleotide variant
F7,13,113113879,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113113961,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113105879,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118668,na,na,Pathogenic/Likely pathogenic,"Factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to|not provided|Abnormal bleeding|Congenital factor VII deficiency|F7-related disorder",GRCh38,single nucleotide variant
F10;F7,13,113118845,na,na,Conflicting classifications of pathogenicity,"Myocardial infarction, decreased susceptibility to|Factor X deficiency|Factor VII deficiency|not specified|not provided",GRCh38,single nucleotide variant
F7,13,113105748,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113113893,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118772,na,na,Pathogenic/Likely pathogenic,"Factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to|Congenital factor VII deficiency",GRCh38,single nucleotide variant
F7,13,113116822,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113110812,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118831,na,na,Likely pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118847,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
F7,13,113118590,na,na,Pathogenic,Factor VII deficiency,GRCh38,single nucleotide variant
BPGM,7,134661775,na,na,Pathogenic,Deficiency of bisphosphoglycerate mutase|not provided,GRCh38,single nucleotide variant
HSD11B2,16,67436100,na,na,Likely pathogenic,Apparent mineralocorticoid excess,GRCh38,single nucleotide variant
HSD11B2,16,67436115,na,na,Pathogenic,Apparent mineralocorticoid excess,GRCh38,single nucleotide variant
HSD11B2,16,67436794,na,na,Pathogenic,Apparent mineralocorticoid excess,GRCh38,single nucleotide variant
HSD11B2,16,67436101,na,na,Pathogenic/Likely pathogenic,Apparent mineralocorticoid excess|not provided,GRCh38,single nucleotide variant
HSD11B2,16,67436620,na,na,Pathogenic,Apparent mineralocorticoid excess,GRCh38,single nucleotide variant
HSD11B2,16,67436264,na,na,Pathogenic,"Apparent mineralocorticoid excess, mild",GRCh38,single nucleotide variant
HSD11B2,16,67436251,na,na,Uncertain significance,Apparent mineralocorticoid excess|not provided,GRCh38,single nucleotide variant
C7,5,40979743,na,na,Pathogenic,Complement component 7 deficiency,GRCh38,single nucleotide variant
C7,5,40959520,na,na,Conflicting classifications of pathogenicity,"Complement component 7 deficiency|C7 and C6 deficiency, combined subtotal|not provided|C7-related disorder|not specified",GRCh38,single nucleotide variant
C7,5,40931063,na,na,Pathogenic,Complement component 7 deficiency|not provided,GRCh38,single nucleotide variant
C7,5,40955428,na,na,Conflicting classifications of pathogenicity,Complement component 7 deficiency|not provided|C7-related disorder,GRCh38,single nucleotide variant
C7,5,40958230,na,na,Pathogenic,Complement component 7 deficiency,GRCh38,single nucleotide variant
CFI,4,109746398,na,na,Conflicting classifications of pathogenicity,Factor I deficiency|not provided,GRCh38,single nucleotide variant
CFI,4,109746231,na,na,Pathogenic/Likely pathogenic,Atypical hemolytic-uremic syndrome with I factor anomaly|CFI-related disorder|not provided,GRCh38,single nucleotide variant
CFI,4,109741074,na,na,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,GRCh38,single nucleotide variant
CFI,4,109741008,na,na,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,GRCh38,single nucleotide variant
CFI,4,109760567,na,na,Pathogenic,Factor I deficiency,GRCh38,single nucleotide variant
CFI,4,109749594,na,na,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided|Factor I deficiency;Atypical hemolytic-uremic syndrome with I factor anomaly;Age related macular degeneration 13,GRCh38,single nucleotide variant
CFI,4,109741090,na,na,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided,GRCh38,single nucleotide variant
C2,6,31933876,na,na,Pathogenic,"C2 deficiency, type II",GRCh38,single nucleotide variant
C2,6,31943254,na,na,Uncertain significance,"C2 deficiency, type II|not provided",GRCh38,single nucleotide variant
C2,6,31936027,na,na,Benign/Likely benign,Age related macular degeneration 14|Complement component 2 deficiency|not specified|not provided|Complement component 2 deficiency;Age related macular degeneration 14,GRCh38,single nucleotide variant
C2,6,31943161,na,na,protective,Age related macular degeneration 14,GRCh38,single nucleotide variant
SLC25A20,3,48862581,na,na,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,GRCh38,single nucleotide variant
SLC25A20,3,48884134,na,na,Pathogenic,not provided|Carnitine acylcarnitine translocase deficiency|SLC25A20-related disorder,GRCh38,single nucleotide variant
SLC25A20,3,48859097,na,na,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,GRCh38,single nucleotide variant
FUT1,19,48750334,na,na,Affects,Bombay phenotype,GRCh38,single nucleotide variant
FUT1,19,48750791,na,na,Pathogenic,Para-Bombay phenotype,GRCh38,single nucleotide variant
FUT1,19,48750456,na,na,Pathogenic,Para-Bombay phenotype,GRCh38,single nucleotide variant
FUT1,19,48750557,na,na,Pathogenic; Affects,"BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype",GRCh38,single nucleotide variant
BBS1,11,66526181,na,na,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Retinitis pigmentosa|not provided|Retinal dystrophy|Usher syndrome|BBS1-related disorder|See cases|Inborn genetic diseases,GRCh38,single nucleotide variant
BBS1,11,66531692,na,na,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|Inborn genetic diseases|Retinitis pigmentosa|BBS1-related disorder,GRCh38,single nucleotide variant
BBS1,11,66514679,na,na,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|BBS1-related disorder,GRCh38,single nucleotide variant
BBS1,11,66530973,na,na,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
BBS1,11,66519725,na,na,Benign/Likely benign,"Bardet-Biedl syndrome|not provided|not specified|BBS1-related ciliopathy|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 1/7, digenic",GRCh38,single nucleotide variant
CYP21A2,6,32039426,na,na,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases|not provided|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
CYP21A2,6,32040110,na,na,Pathogenic/Likely pathogenic,"Carcinoma, adrenocortical, androgen-secreting|Inborn genetic diseases|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Adenoma, cortisol-producing|not provided|CYP21A2-related disorder|Congenital adrenal hyperplasia",GRCh38,single nucleotide variant
CYP21A2;LOC106780800;TNXB,6,32040535,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder,GRCh38,single nucleotide variant
CYP21A2,6,32038514,na,na,Pathogenic/Likely pathogenic,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,GRCh38,single nucleotide variant
CYP21A2;LOC106780800;TNXB,6,32040072,na,na,Benign,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Congenital adrenal hyperplasia|21-HYDROXYLASE POLYMORPHISM|not specified|not provided,GRCh38,single nucleotide variant
CYP21A2,6,32039081,na,na,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Inborn genetic diseases|See cases|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
CYP21A2,6,32040140,na,na,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,GRCh38,single nucleotide variant
CYP21A2,6,32039118,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
CYP21A2,6,32041006,na,na,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder|Congenital lipoid adrenal hyperplasia due to STAR deficency|See cases,GRCh38,single nucleotide variant
CYP21A2,6,32040206,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,GRCh38,single nucleotide variant
CYP21A2;LOC106780800;TNXB,6,32040421,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
CYP21A2,6,32040485,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,GRCh38,single nucleotide variant
CYP21A2,6,32040766,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,GRCh38,single nucleotide variant
CYP21A2,6,32040692,na,na,Uncertain significance,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified,GRCh38,single nucleotide variant
CYP21A2,6,32039810,na,na,Conflicting classifications of pathogenicity,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
CYP21A2,6,32040926,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|CYP21A2-related disorder|not provided,GRCh38,single nucleotide variant
CYP21A2,6,32039092,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,GRCh38,single nucleotide variant
CYP21A2,6,32040871,na,na,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,GRCh38,single nucleotide variant
CYP21A2,6,32040675,na,na,Pathogenic,"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency",GRCh38,single nucleotide variant
CYP21A2,6,32038610,na,na,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified|Congenital adrenal hyperplasia|not provided,GRCh38,single nucleotide variant
HSD3B2,1,119422013,na,na,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HSD3B2,1,119422246,na,na,Pathogenic,not provided|3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
HSD3B2,1,119415448,na,na,Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,GRCh38,single nucleotide variant
HSD3B2,1,119422620,na,na,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,GRCh38,single nucleotide variant
HSD3B2,1,119421925,na,na,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,GRCh38,single nucleotide variant
HSD3B2,1,119422165,na,na,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
HSD3B2,1,119422277,na,na,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided|Congenital adrenal hyperplasia,GRCh38,single nucleotide variant
HSD3B2,1,119422523,na,na,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,GRCh38,single nucleotide variant
XBP1,22,28800769,na,na,risk factor,-,GRCh38,single nucleotide variant
VCL,10,74112086,na,na,Uncertain significance,Dilated cardiomyopathy 1W|Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Dilated cardiomyopathy 1W;Hypertrophic cardiomyopathy 15|Primary familial hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
VCL,10,74082499,na,na,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1W|not provided|Dilated cardiomyopathy 1W;Hypertrophic cardiomyopathy 15|not specified|Cardiomyopathy,GRCh38,single nucleotide variant
VIM,10,17229873,na,na,Pathogenic,Cataract 30|not provided,GRCh38,single nucleotide variant
VLDLR,9,2643480,na,na,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",GRCh38,single nucleotide variant
AVP,20,3083037,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3083156,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3084620,na,na,Pathogenic,Neurohypophyseal diabetes insipidus|not provided|AVP-related disorder,GRCh38,single nucleotide variant
AVP,20,3083005,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3083022,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3083012,na,na,Conflicting classifications of pathogenicity,Neurohypophyseal diabetes insipidus|not provided,GRCh38,single nucleotide variant
AVP,20,3084619,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3083138,na,na,Likely pathogenic,Neurohypophyseal diabetes insipidus|not provided,GRCh38,single nucleotide variant
AVP,20,3083139,na,na,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,GRCh38,single nucleotide variant
AVP,20,3082788,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3083039,na,na,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,GRCh38,single nucleotide variant
AVP,20,3083024,na,na,Likely pathogenic,Neurohypophyseal diabetes insipidus|AVP-related disorder,GRCh38,single nucleotide variant
AVP,20,3083099,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
AVP,20,3084655,na,na,Pathogenic,"Diabetes insipidus, neurohypophyseal, autosomal recessive",GRCh38,single nucleotide variant
AVP,20,3082779,na,na,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,GRCh38,single nucleotide variant
AVP,20,3084614,na,na,Pathogenic,Neurohypophyseal diabetes insipidus,GRCh38,single nucleotide variant
VEGFA,6,43770613,na,na,Benign,"Microvascular complications of diabetes, susceptibility to, 1|not provided",GRCh38,single nucleotide variant
VEGFA,6,43768652,na,na,Benign,"Atherosclerosis, susceptibility to",GRCh38,single nucleotide variant
ATP6V1B1,2,70936045,na,na,Pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,GRCh38,single nucleotide variant
ATP6V1B1,2,70960079,na,na,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,GRCh38,single nucleotide variant
ATP6V1B1,2,70958113,na,na,Pathogenic,Renal tubular acidosis with progressive nerve deafness|Nephrolithiasis;Nephrocalcinosis|Distal renal tubular acidosis|not provided,GRCh38,single nucleotide variant
ATP6V1B1,2,70958103,na,na,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
CDH1,16,68823593,na,na,Likely benign,Hereditary diffuse gastric adenocarcinoma|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|CDH1-related diffuse gastric and lobular breast cancer syndrome|not specified|not provided,GRCh38,single nucleotide variant
CDH1,16,68822138,na,na,Benign,Endometrial carcinoma|Hereditary diffuse gastric adenocarcinoma|not provided|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast|6 conditions|Breast and/or ovarian cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome,GRCh38,single nucleotide variant
CDH1,16,68833362,na,na,Likely benign,Ovarian neoplasm|not specified|Hereditary cancer-predisposing syndrome|Hereditary diffuse gastric adenocarcinoma|Familial cancer of breast|6 conditions|not provided|Familial cancer of breast;Ovarian cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome|CDH1-related disorder,GRCh38,single nucleotide variant
CDH1,16,68810290,na,na,Pathogenic,Breast lobular carcinoma|Hereditary diffuse gastric adenocarcinoma|Gastric cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
CDH1,16,68823557,na,na,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Familial cancer of breast;Ovarian cancer|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
CDH1,16,68738307,na,na,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome,GRCh38,single nucleotide variant
CDH1,16,68738318,na,na,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome,GRCh38,single nucleotide variant
CDH1,16,68822081,na,na,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|CDH1-related diffuse gastric and lobular breast cancer syndrome|Familial cancer of breast,GRCh38,single nucleotide variant
CDH1,16,68822190,na,na,Pathogenic/Likely pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|not provided,GRCh38,single nucleotide variant
CDH1,16,68812144,na,na,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not specified|Gastric adenocarcinoma|not provided|CDH1-related disorder|Breast and/or ovarian cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome,GRCh38,single nucleotide variant
CDH1,16,68833344,na,na,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of stomach|not specified|not provided|Hereditary breast ovarian cancer syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome|CDH1-related disorder|Familial cancer of breast;Ovarian cancer,GRCh38,single nucleotide variant
CDH1,16,68737131,na,na,Benign,not provided|Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Prostate cancer susceptibility,GRCh38,single nucleotide variant
CDH1,16,68808569,na,na,Pathogenic,Diffuse gastric and lobular breast cancer syndrome with cleft lip and with or without cleft palate,GRCh38,single nucleotide variant
SCGB1A1,11,62419058,na,na,Uncertain significance,Inherited susceptibility to asthma,GRCh38,single nucleotide variant
UMOD,16,20348858,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,GRCh38,single nucleotide variant
UMOD,16,20348652,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348994,na,na,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|UMOD-related disorder,GRCh38,single nucleotide variant
UMOD,16,20349071,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348925,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348918,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348537,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348298,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348253,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,GRCh38,single nucleotide variant
UMOD,16,20348484,na,na,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,GRCh38,single nucleotide variant
PLAU,10,73913343,na,na,Benign,"Alzheimer disease, late-onset, susceptibility to|not provided",GRCh38,single nucleotide variant
UGT1A1,2,233768259,na,na,Pathogenic,Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome,GRCh38,single nucleotide variant
UGT1A1,2,233767160,na,na,Pathogenic,Crigler-Najjar syndrome type 1,GRCh38,single nucleotide variant
UGT1A1,2,233767873,na,na,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|UGT1A1-related disorder",GRCh38,single nucleotide variant
"covers 10 genes, none of which curated to show dosage sensitivity",2,233767161,na,na,Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",GRCh38,single nucleotide variant
UGT1A1,2,233767092,na,na,Pathogenic/Likely pathogenic,Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|UGT1A1-related disorder,GRCh38,single nucleotide variant
UGT1A1,2,233761127,na,na,Pathogenic,Crigler-Najjar syndrome type 1,GRCh38,single nucleotide variant
UGT1A1,2,233760973,na,na,Conflicting classifications of pathogenicity; other,"Gilbert syndrome|Crigler-Najjar syndrome, type II|not specified|not provided|UGT1A1-related disorder|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome",GRCh38,single nucleotide variant
UGT1A1,2,233761152,na,na,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",GRCh38,single nucleotide variant
UGT1A1,2,233760432,na,na,Likely pathogenic,"Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",GRCh38,single nucleotide variant
UGT1A1,2,233768218,na,na,Pathogenic,Crigler-Najjar syndrome type 1,GRCh38,single nucleotide variant
"covers 10 genes, none of which curated to show dosage sensitivity",2,233760498,na,na,Conflicting classifications of pathogenicity; drug response,"Gilbert syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Lucey-Driscoll syndrome|not specified|Irinotecan response|Crigler-Najjar syndrome, type II|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome|UGT1A1-related disorder|Gilbert syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome|Crigler-Najjar syndrome type 1",GRCh38,single nucleotide variant
UGT1A1,2,233772413,na,na,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|Hyperbilirubinemia|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome|Gilbert syndrome|Crigler-Najjar syndrome type 1|UGT1A1-related disorder",GRCh38,single nucleotide variant
UGT1A1,2,233758936,na,na,Pathogenic,Lucey-Driscoll syndrome,GRCh38,single nucleotide variant
"covers 10 genes, none of which curated to show dosage sensitivity",2,233767922,na,na,Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",GRCh38,single nucleotide variant
UGT1A1,2,233760811,na,na,Likely pathogenic; other,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|UGT1A1-related disorder",GRCh38,single nucleotide variant
UGT1A1,2,233768333,na,na,Uncertain significance,"Crigler-Najjar syndrome, type II|Gilbert syndrome|not specified",GRCh38,single nucleotide variant
UGT1A1,2,233760331,na,na,Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",GRCh38,single nucleotide variant
"covers 10 genes, none of which curated to show dosage sensitivity",2,233757013,na,na,Conflicting classifications of pathogenicity,"Gilbert syndrome, susceptibility to|Gilbert syndrome|not provided|Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome|UGT1A9-related disorder|UGT1A8-related condition",GRCh38,single nucleotide variant
UGT1A1,2,233763993,na,na,Benign; association,"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",GRCh38,single nucleotide variant
UNG,12,109103562,na,na,Pathogenic,Hyper-IgM syndrome type 5,GRCh38,single nucleotide variant
USF1,1,161039733,na,na,risk factor,"Hyperlipidemia, familial combined, susceptibility to",GRCh38,single nucleotide variant
USF1,1,161040972,na,na,risk factor,"Hyperlipidemia, familial combined, susceptibility to",GRCh38,single nucleotide variant
DPAGT1,11,119100396,na,na,Conflicting classifications of pathogenicity,DPAGT1-congenital disorder of glycosylation|DPAGT1-congenital disorder of glycosylation;Congenital myasthenic syndrome 13|not provided|Congenital disorder of glycosylation,GRCh38,single nucleotide variant
UCHL1,4,41260751,na,na,risk factor,"Parkinson disease 5, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
UCHL1,4,41257616,na,na,Benign,"Parkinson disease 5, autosomal dominant, susceptibility to|not provided|Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome",GRCh38,single nucleotide variant
NTRK1,1,156879365,na,na,Pathogenic,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
NTRK1,1,156876496,na,na,Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
NTRK1,1,156881590,na,na,Pathogenic,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
NTRK1,1,156860959,na,na,not provided,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
NTRK1,1,156879154,na,na,Benign/Likely benign,Familial medullary thyroid carcinoma|Hereditary insensitivity to pain with anhidrosis|not specified|not provided,GRCh38,single nucleotide variant
NTRK1,1,156880036,na,na,Pathogenic/Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
NTRK1,1,156873858,na,na,Conflicting classifications of pathogenicity,Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease,GRCh38,single nucleotide variant
NTRK1,1,156876526,na,na,Pathogenic,Hereditary insensitivity to pain with anhidrosis,GRCh38,single nucleotide variant
DDR2,1,162776341,na,na,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,GRCh38,single nucleotide variant
DDR2,1,162776264,na,na,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,GRCh38,single nucleotide variant
DDR2,1,162776225,na,na,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,GRCh38,single nucleotide variant
DDR2,1,162776371,na,na,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,GRCh38,single nucleotide variant
KDR,4,55088939,na,na,Pathogenic,not specified|Capillary infantile hemangioma,GRCh38,single nucleotide variant
KDR,4,55106779,na,na,Likely benign,Capillary infantile hemangioma|not specified|not provided,GRCh38,single nucleotide variant
BLK,8,11548067,na,na,Benign/Likely benign,Maturity-onset diabetes of the young type 11|not specified|Monogenic diabetes|not provided,GRCh38,single nucleotide variant
BLK,8,11564446,na,na,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 11|not specified,GRCh38,single nucleotide variant
BLK,8,11573132,na,na,Benign,Maturity-onset diabetes of the young type 11|not specified|BLK-related disorder,GRCh38,single nucleotide variant
BLK,8,11474238,na,na,Pathogenic,Maturity-onset diabetes of the young type 11,GRCh38,single nucleotide variant
BLK,8,11564613,na,na,Pathogenic,Maturity-onset diabetes of the young type 11,GRCh38,single nucleotide variant
TH,11,2165727,na,na,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,GRCh38,single nucleotide variant
TH,11,2167896,na,na,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,GRCh38,single nucleotide variant
TH,11,2164339,na,na,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia|Inborn genetic diseases,GRCh38,single nucleotide variant
TH,11,2167905,na,na,Pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,GRCh38,single nucleotide variant
TH,11,2166693,na,na,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,GRCh38,single nucleotide variant
TH,11,2166995,na,na,Uncertain significance,Autosomal recessive DOPA responsive dystonia|not specified,GRCh38,single nucleotide variant
TH,11,2166762,na,na,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia,GRCh38,single nucleotide variant
TH,11,2165787,na,na,Pathogenic,Autosomal recessive DOPA responsive dystonia,GRCh38,single nucleotide variant
TH,11,2166544,na,na,Likely pathogenic,Autosomal recessive DOPA responsive dystonia,GRCh38,single nucleotide variant
TNFRSF1A,12,6334099,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),GRCh38,single nucleotide variant
TNFRSF1A,12,6333823,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided|Multiple sclerosis,GRCh38,single nucleotide variant
TNFRSF1A,12,6334109,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,GRCh38,single nucleotide variant
TNFRSF1A,12,6333817,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,GRCh38,single nucleotide variant
TNFRSF1A,12,6333490,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),GRCh38,single nucleotide variant
TNFRSF1A,12,6333489,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),GRCh38,single nucleotide variant
TNFRSF1A,12,6333477,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),GRCh38,single nucleotide variant
TNFRSF1A,12,6334108,na,na,Pathogenic/Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,GRCh38,single nucleotide variant
TNFRSF1A,12,6334100,na,na,Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|Inborn genetic diseases,GRCh38,single nucleotide variant
TNFRSF1A,12,6333764,na,na,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),GRCh38,single nucleotide variant
TP53,17,7674221,na,na,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm|Ovarian neoplasm|not provided|Li-Fraumeni syndrome|Lip and oral cavity carcinoma|Breast and/or ovarian cancer|Choroid plexus carcinoma|Gallbladder cancer|Familial pancreatic carcinoma|Malignant lymphoma, large B-cell, diffuse|Adrenocortical carcinoma, hereditary|Congenital fibrosarcoma|TP53-related disorder|Gastric cancer",GRCh38,single nucleotide variant
TP53,17,7674191,na,na,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome,GRCh38,single nucleotide variant
TP53,17,7674230,na,na,Pathogenic,Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Neoplasm,GRCh38,single nucleotide variant
TP53,17,7674208,na,na,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided,GRCh38,single nucleotide variant
TP53,17,7676154,na,na,Benign,TP53 POLYMORPHISM|Li-Fraumeni syndrome 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Lip and oral cavity carcinoma|Hereditary breast ovarian cancer syndrome|Acute myeloid leukemia|12 conditions|Neoplasm,GRCh38,single nucleotide variant
TP53,17,7674216,na,na,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Cervical cancer|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Squamous cell carcinoma of the head and neck|not provided|Li-Fraumeni syndrome 1|Adrenal cortex carcinoma|Neoplasm,GRCh38,single nucleotide variant
TP53,17,7675143,na,na,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Neoplasm|Li-Fraumeni syndrome 1|Squamous cell carcinoma|not provided,GRCh38,single nucleotide variant
TP53,17,7674238,na,na,Pathogenic/Likely pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Li-Fraumeni syndrome 1|not provided|Familial cancer of breast,GRCh38,single nucleotide variant
TP53,17,7674229,na,na,Pathogenic/Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|not provided|Adrenocortical carcinoma, hereditary",GRCh38,single nucleotide variant
TP53,17,7674220,na,na,Pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm|Familial cancer of breast|Ductal carcinoma in situ|Breast carcinoma|Hereditary cancer-predisposing syndrome|Sarcoma|not provided|Multiple myeloma|Hereditary breast ovarian cancer syndrome|Ovarian neoplasm|11 conditions|Lymphoma|Lip and oral cavity carcinoma|Rhabdomyosarcoma|Adrenal cortex carcinoma|Gastric cancer|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|TP53-related disorder|Colorectal cancer|12 conditions",GRCh38,single nucleotide variant
TP53,17,7675214,na,na,Pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided,GRCh38,single nucleotide variant
TP53,17,7673806,na,na,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome,GRCh38,single nucleotide variant
TP53,17,7674241,na,na,Pathogenic/Likely pathogenic,Bone osteosarcoma|Hepatoblastoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|not provided|12 conditions|Neoplasm,GRCh38,single nucleotide variant
TP53,17,7676011,na,na,Pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TP53,17,7673776,na,na,Pathogenic/Likely pathogenic,"Li-fraumeni-like syndrome|Li-Fraumeni syndrome 1|not provided|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome|Colorectal cancer|Pleomorphic xanthoastrocytoma;Astrocytoma, anaplastic|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Adrenocortical carcinoma, hereditary|Neoplasm|TP53-related disorder",GRCh38,single nucleotide variant
TP53,17,7674230,na,na,Pathogenic,"Li-fraumeni-like syndrome|Adenocarcinoma|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Familial ovarian cancer|Astrocytoma, anaplastic|Breast carcinoma|Atypical teratoid rhabdoid tumor|Colorectal cancer|Ovarian neoplasm|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|12 conditions|Gastric cancer|TP53-related disorder|See cases",GRCh38,single nucleotide variant
TP53,17,7673802,na,na,Pathogenic,"Li-Fraumeni syndrome 1|Thyroid gland undifferentiated (anaplastic) carcinoma|not provided|Lung adenocarcinoma|Neoplasm|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Ovarian neoplasm|Malignant tumor of breast|Familial cancer of breast|Multiple myeloma;Colorectal cancer|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma|Gastric cancer|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|12 conditions|TP53-related disorder",GRCh38,single nucleotide variant
TP53,17,7673554,na,na,Conflicting classifications of pathogenicity,Familial colorectal cancer|Non-Hodgkin lymphoma|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
TP53,17,7673781,na,na,Pathogenic/Likely pathogenic,Nasopharyngeal carcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|Malignant tumor of urinary bladder|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TP53,17,7675161,na,na,Pathogenic/Likely pathogenic,"Breast adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Rhabdomyosarcoma",GRCh38,single nucleotide variant
TP53,17,7675161,na,na,Pathogenic/Likely pathogenic,Breast adenocarcinoma|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Ovarian neoplasm|Rhabdomyosarcoma,GRCh38,single nucleotide variant
TP53,17,7676264,na,na,Uncertain significance,Carcinoma of pancreas|Li-Fraumeni syndrome,GRCh38,single nucleotide variant
TP53,17,7674193,na,na,Conflicting classifications of pathogenicity,Li-fraumeni-like syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TP53,17,7675088,na,na,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm|not provided|Malignant tumor of esophagus|Gastric cancer|Ovarian neoplasm|Lip and oral cavity carcinoma|Squamous cell carcinoma of the head and neck|Familial cancer of breast|Colorectal cancer|TP53-related disorder|12 conditions|Adrenocortical carcinoma, hereditary",GRCh38,single nucleotide variant
TP53,17,7670678,na,na,Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenal cortex carcinoma|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary",GRCh38,single nucleotide variant
TP53,17,7675200,na,na,Pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
TP53,17,7673745,na,na,Uncertain significance,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TP53,17,7670699,na,na,Pathogenic/Likely pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Breast neoplasm|Squamous cell carcinoma of the head and neck|Hereditary breast ovarian cancer syndrome|12 conditions|Gastric cancer|TP53-related disorder",GRCh38,single nucleotide variant
TP53,17,7674965,na,na,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1;Familial cancer of breast,GRCh38,single nucleotide variant
TP53,17,7674872,na,na,Pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome|not provided,GRCh38,single nucleotide variant
TP53,17,7673766,na,na,Pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|Choroid plexus carcinoma|Li-Fraumeni syndrome|Neoplasm",GRCh38,single nucleotide variant
TNF,6,31577157,na,na,Pathogenic,"TNF receptor binding, altered",GRCh38,single nucleotide variant
TNF,6,31575186,na,na,risk factor,"Malaria, cerebral, susceptibility to",GRCh38,single nucleotide variant
TNF,6,31574705,na,na,risk factor,|,GRCh38,single nucleotide variant
TNF,6,31574699,na,na,protective,"Alzheimer disease, protection against",GRCh38,single nucleotide variant
TSC2,16,2087897,na,na,Pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|TSC2-related disorder,GRCh38,single nucleotide variant
TSC2,16,2048649,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
TSC2,16,2064341,na,na,Pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TSC2,16,2070571,na,na,Pathogenic/Likely pathogenic,Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|not provided|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TSC2,16,2072293,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
TSC2,16,2063042,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,GRCh38,single nucleotide variant
TSC2,16,2060790,na,na,Pathogenic,Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2,GRCh38,single nucleotide variant
TSC2,16,2084965,na,na,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,GRCh38,single nucleotide variant
TSC2,16,2076142,na,na,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis;Tuberous sclerosis 2;Isolated focal cortical dysplasia type II|TSC2-related disorder,GRCh38,single nucleotide variant
TSC2,16,2076141,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
TSC2,16,2076141,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,GRCh38,single nucleotide variant
TSC2,16,2062561,na,na,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,GRCh38,single nucleotide variant
TNNT2,1,201365638,na,na,Pathogenic,"Dilated cardiomyopathy 1D|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiomyopathy",GRCh38,single nucleotide variant
TNNT2,1,201365297,na,na,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Dilated cardiomyopathy 1D|Cardiomyopathy, familial restrictive, 3",GRCh38,single nucleotide variant
TNNT2,1,201359245,na,na,Conflicting classifications of pathogenicity,"Hypertrophic cardiomyopathy 2|not specified|not provided|Hypertrophic cardiomyopathy 1|Cardiovascular phenotype|Costello syndrome|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Dilated cardiomyopathy 1D|Cardiomyopathy|Hypertrophic cardiomyopathy",GRCh38,single nucleotide variant
TNNT2,1,201365244,na,na,Pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Dilated cardiomyopathy 1D|Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiomyopathy, familial restrictive, 3",GRCh38,single nucleotide variant
TNNT2,1,201364336,na,na,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Primary dilated cardiomyopathy;Hypertrophic cardiomyopathy|Familial isolated dilated cardiomyopathy|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3",GRCh38,single nucleotide variant
TNNT2,1,201364366,na,na,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiomyopathy, familial restrictive, 3|Hypertrophic cardiomyopathy 2",GRCh38,single nucleotide variant
TNNT2,1,201361988,na,na,Pathogenic,Dilated cardiomyopathy 1D,GRCh38,single nucleotide variant
TNNT2,1,201359636,na,na,Uncertain significance,"Dilated cardiomyopathy 1D|Cardiomyopathy, familial restrictive, 3|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiovascular phenotype|Hypertrophic cardiomyopathy 2|Cardiomyopathy",GRCh38,single nucleotide variant
TNNI3,19,55154146,na,na,Pathogenic,Hypertrophic cardiomyopathy 7|not provided|Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
TNNI3,19,55151851,na,na,Pathogenic,Hypertrophic cardiomyopathy 7,GRCh38,single nucleotide variant
TNNI3,19,55156239,na,na,Benign/Likely benign,"Hypertrophic cardiomyopathy 7|Cardiomyopathy|Cardiovascular phenotype|not provided|not specified|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Amyloidosis, hereditary systemic 1;Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated cardiomyopathy 2A|Cardiomyopathy, familial restrictive, 1|Dilated cardiomyopathy 1FF;Cardiomyopathy, familial restrictive, 1;Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A",GRCh38,single nucleotide variant
TNNI3,19,55151881,na,na,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 7|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 2A;Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 1FF",GRCh38,single nucleotide variant
TNNI3,19,55151898,na,na,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",GRCh38,single nucleotide variant
TNNI3,19,55151892,na,na,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Primary familial hypertrophic cardiomyopathy|not provided|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy|Dilated cardiomyopathy 2A|SUDDEN INFANT DEATH SYNDROME",GRCh38,single nucleotide variant
TNNI3,19,55154047,na,na,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",GRCh38,single nucleotide variant
TNNI3,19,55154146,na,na,Pathogenic,"Cardiomyopathy, familial restrictive, 1|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|SUDDEN INFANT DEATH SYNDROME|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|TNNI3-related disorder|Cardiomyopathy, familial restrictive, 1;Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 1FF;Dilated cardiomyopathy 2A",GRCh38,single nucleotide variant
TNNI3,19,55154148,na,na,Pathogenic,"Cardiomyopathy, familial restrictive, 1",GRCh38,single nucleotide variant
TNNI3,19,55154068,na,na,Conflicting classifications of pathogenicity,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype",GRCh38,single nucleotide variant
TNNI3,19,55157052,na,na,Pathogenic,Dilated cardiomyopathy 1FF,GRCh38,single nucleotide variant
TNNI3,19,55151912,na,na,Pathogenic,Dilated cardiomyopathy 1FF,GRCh38,single nucleotide variant
TNNI3,19,55151860,na,na,Pathogenic,Hypertrophic cardiomyopathy 7,GRCh38,single nucleotide variant
TNNI3,19,55157097,na,na,Pathogenic,Hypertrophic cardiomyopathy 7|Cardiovascular phenotype|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
TNNI2,11,1841523,na,na,Pathogenic,not provided|Distal arthrogryposis type 2B1,GRCh38,single nucleotide variant
TNNI2,11,1841468,na,na,Pathogenic,Distal arthrogryposis type 2B1|not provided|Ulnar deviation of the wrist;Congenital finger flexion contractures;Calcaneovalgus deformity;Distal arthrogryposis,GRCh38,single nucleotide variant
TNNT1,19,55137176,na,na,Pathogenic,Nemaline myopathy 5|not provided,GRCh38,single nucleotide variant
TNNC1,3,52451285,na,na,Likely pathogenic,Dilated cardiomyopathy 1Z|not provided,GRCh38,single nucleotide variant
TNNC1,3,52452222,na,na,Uncertain significance,Hypertrophic cardiomyopathy 13|not specified|Dilated cardiomyopathy 1Z;Hypertrophic cardiomyopathy 13|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
TNNC1,3,52453993,na,na,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 13|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1Z;Hypertrophic cardiomyopathy 13|Dilated cardiomyopathy 1Z|Cardiomyopathy,GRCh38,single nucleotide variant
TNNC1,3,52451810,na,na,Uncertain significance,Hypertrophic cardiomyopathy 13|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z,GRCh38,single nucleotide variant
TNNC1,3,52451410,na,na,Uncertain significance,Hypertrophic cardiomyopathy 13|Dilated cardiomyopathy 1Z;Hypertrophic cardiomyopathy 13|Dilated cardiomyopathy 1S|not specified|Cardiovascular phenotype|not provided|Cardiomyopathy,GRCh38,single nucleotide variant
TPM3,1,154191993,na,na,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant",GRCh38,single nucleotide variant
TPM3,1,154167938,na,na,Likely pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",GRCh38,single nucleotide variant
TPM3,1,154167941,na,na,Uncertain significance,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",GRCh38,single nucleotide variant
TPM3,1,154191925,na,na,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",GRCh38,single nucleotide variant
TPM3,1,154172971,na,na,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|See cases",GRCh38,single nucleotide variant
TPM3,1,154176194,na,na,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant",GRCh38,single nucleotide variant
TPM3,1,154172972,na,na,Pathogenic/Likely pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4B, autosomal recessive|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive|Congenital myopathy 4A, autosomal dominant|TPM3-related core myopathy",GRCh38,single nucleotide variant
TPM3,1,154172972,na,na,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant|Inborn genetic diseases|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|Nemaline myopathy",GRCh38,single nucleotide variant
TPM1,15,63060915,na,na,Pathogenic,Hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
TPM1,15,63060899,na,na,Pathogenic,Hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1Y|Cardiomyopathy|Primary dilated cardiomyopathy,GRCh38,single nucleotide variant
TPM1,15,63057028,na,na,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 3|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
TPM1,15,63044072,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1Y|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
TPM1,15,63044030,na,na,Uncertain significance,Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy,GRCh38,single nucleotide variant
TPM2,9,35685750,na,na,Pathogenic,"Arthrogryposis, distal, type 1A|not provided",GRCh38,single nucleotide variant
TPM2,9,35685486,na,na,Uncertain significance,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A",GRCh38,single nucleotide variant
TPM2,9,35685672,na,na,Pathogenic/Likely pathogenic,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A",GRCh38,single nucleotide variant
TPM2,9,35685529,na,na,Pathogenic,"Arthrogryposis, distal, type 2B4|not provided|Arthrogryposis, distal, type 1A|TPM2-related disorder|Arthrogryposis",GRCh38,single nucleotide variant
TPM2,9,35689265,na,na,Pathogenic,"not provided|Congenital myopathy 23|Arthrogryposis, distal, type 1A",GRCh38,single nucleotide variant
TPM2,9,35684765,na,na,Pathogenic,not provided|Congenital myopathy 23,GRCh38,single nucleotide variant
TPI1,12,6869174,na,na,Pathogenic/Likely pathogenic,Triosephosphate isomerase deficiency|not provided,GRCh38,single nucleotide variant
TPI1,12,6869300,na,na,Uncertain significance,Triosephosphate isomerase manchester|not provided,GRCh38,single nucleotide variant
TPI1,12,6870354,na,na,Pathogenic,Triosephosphate isomerase deficiency,GRCh38,single nucleotide variant
TPI1,12,6868873,na,na,Pathogenic,Triosephosphate isomerase deficiency,GRCh38,single nucleotide variant
TPI1,12,6869741,na,na,Pathogenic,Triosephosphate isomerase deficiency,GRCh38,single nucleotide variant
TPI1,12,6869369,na,na,Pathogenic,Triosephosphate isomerase deficiency,GRCh38,single nucleotide variant
TGFB3,14,75980923,na,na,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|not provided|TGFB3-related disorder|Rienhoff syndrome|Arrhythmogenic right ventricular dysplasia 1;Rienhoff syndrome,GRCh38,single nucleotide variant
TGFB3,14,75958692,na,na,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|Rienhoff syndrome|TGFB3-related disorder,GRCh38,single nucleotide variant
NOTCH1,9,136508238,na,na,Pathogenic,Aortic valve disease 1|Adams-Oliver syndrome 5|not provided,GRCh38,single nucleotide variant
TGM1,14,24262228,na,na,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,GRCh38,single nucleotide variant
TGM1,14,24261775,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|Abnormality of the skin|not provided,GRCh38,single nucleotide variant
TGM1,14,24261724,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1,GRCh38,single nucleotide variant
TGM1,14,24261779,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24259720,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24261778,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24259099,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24258646,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided,GRCh38,single nucleotide variant
TGM1,14,24259087,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis|TGM1-related disorder|Abnormality of the skin,GRCh38,single nucleotide variant
TGM1,14,24258667,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24256011,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|Lamellar ichthyosis|not provided,GRCh38,single nucleotide variant
TGM1,14,24259984,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24258658,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1,GRCh38,single nucleotide variant
TGM1,14,24261778,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1,GRCh38,single nucleotide variant
TGM1,14,24259959,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|TGM1-related disorder,GRCh38,single nucleotide variant
TGM1,14,24255457,na,na,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,GRCh38,single nucleotide variant
TGM1,14,24262072,na,na,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not provided,GRCh38,single nucleotide variant
TGM1,14,24259950,na,na,Pathogenic,Autosomal recessive congenital ichthyosis 1,GRCh38,single nucleotide variant
TGM1,14,24259769,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGM1,14,24260555,na,na,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Congenital ichthyosiform erythroderma|Lamellar ichthyosis,GRCh38,single nucleotide variant
TGFBR2,3,30672127,na,na,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Loeys-Dietz syndrome 2|Familial colorectal cancer|not provided|not specified|Ehlers-Danlos syndrome",GRCh38,single nucleotide variant
TGFBR2,3,30691471,na,na,Pathogenic,Malignant tumor of esophagus|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
TGFBR2,3,30688511,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30672106,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30674196,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30691504,na,na,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
TGFBR2,3,30672189,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30672246,na,na,Conflicting classifications of pathogenicity,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Colorectal cancer, hereditary nonpolyposis, type 6|Familial thoracic aortic aneurysm and aortic dissection",GRCh38,single nucleotide variant
TGFBR2,3,30672252,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30691478,na,na,Pathogenic,"Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome",GRCh38,single nucleotide variant
TGFBR2,3,30691477,na,na,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|Neoplasm|TGFBR2-related disorder,GRCh38,single nucleotide variant
TGFBR2,3,30644745,na,na,Conflicting classifications of pathogenicity,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection|Isolated thoracic aortic aneurysm|not provided,GRCh38,single nucleotide variant
TGFBR2,3,30674228,na,na,Pathogenic,Loeys-Dietz syndrome 2|not provided|Cardiovascular phenotype|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
TGFBR2,3,30674229,na,na,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
TGFBR2,3,30688382,na,na,Likely pathogenic,Loeys-Dietz syndrome 2|not provided,GRCh38,single nucleotide variant
TGFBR2,3,30674123,na,na,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection,GRCh38,single nucleotide variant
TGFBR2,3,30674130,na,na,Pathogenic,Loeys-Dietz syndrome 2,GRCh38,single nucleotide variant
TGFBR2,3,30688470,na,na,Pathogenic,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Loeys-Dietz syndrome 2;Malignant tumor of esophagus;Colorectal cancer, hereditary nonpolyposis, type 6|Cardiovascular phenotype",GRCh38,single nucleotide variant
TGFBR1,9,99142683,na,na,Pathogenic,Loeys-Dietz syndrome 1,GRCh38,single nucleotide variant
TGFBR1,9,99146553,na,na,Pathogenic,Loeys-Dietz syndrome 1,GRCh38,single nucleotide variant
TGFBR1,9,99137883,na,na,Pathogenic,Loeys-Dietz syndrome 1,GRCh38,single nucleotide variant
TGFBR1,9,99149253,na,na,Pathogenic,Loeys-Dietz syndrome 1|Cardiovascular phenotype,GRCh38,single nucleotide variant
TGFBR1,9,99138006,na,na,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|Marfan syndrome;Loeys-Dietz syndrome 1|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1,GRCh38,single nucleotide variant
TGFBR1,9,99149253,na,na,Pathogenic,Loeys-Dietz syndrome 1|Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|TGFBR1-related disorder,GRCh38,single nucleotide variant
TGFBR1,9,99149252,na,na,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection|not provided|Familial thoracic aortic aneurysm and aortic dissection|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1|Loeys-Dietz syndrome,GRCh38,single nucleotide variant
TGFBR1,9,99132686,na,na,Uncertain significance,Loeys-Dietz syndrome 1|not provided,GRCh38,single nucleotide variant
TGFB1,19,41342209,na,na,Pathogenic,Diaphyseal dysplasia,GRCh38,single nucleotide variant
TGFB1,19,41342229,na,na,Pathogenic,Diaphyseal dysplasia|not provided|Inborn genetic diseases,GRCh38,single nucleotide variant
TGFB1,19,41342215,na,na,Uncertain significance,Diaphyseal dysplasia|not provided,GRCh38,single nucleotide variant
TGFB1,19,41342230,na,na,Pathogenic,Diaphyseal dysplasia|not provided|See cases,GRCh38,single nucleotide variant
TGFB1,19,41352804,na,na,Pathogenic,Diaphyseal dysplasia,GRCh38,single nucleotide variant
TGFB1,19,41342215,na,na,Pathogenic,Diaphyseal dysplasia,GRCh38,single nucleotide variant
TGFB1,19,41353016,na,na,Benign,"Breast cancer, invasive, susceptibility to|Cystic fibrosis|not specified|not provided|Inflammatory bowel disease, immunodeficiency, and encephalopathy|Diaphyseal dysplasia|Meckel syndrome, type 10",GRCh38,single nucleotide variant
THRB,3,24127610,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24127623,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24122912,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24127714,na,na,Uncertain significance,Generalized resistance to thyroid hormone|not specified,GRCh38,single nucleotide variant
THRB,3,24127679,na,na,Pathogenic,Generalized resistance to thyroid hormone,GRCh38,single nucleotide variant
THRB,3,24127694,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|Thyroid hormone resistance syndrome",GRCh38,single nucleotide variant
THRB,3,24127649,na,na,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",GRCh38,single nucleotide variant
THRB,3,24127609,na,na,Pathogenic,Generalized resistance to thyroid hormone,GRCh38,single nucleotide variant
THRB,3,24127609,na,na,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",GRCh38,single nucleotide variant
THRB,3,24127603,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24122946,na,na,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",GRCh38,single nucleotide variant
THRB,3,24122921,na,na,Pathogenic,Generalized resistance to thyroid hormone,GRCh38,single nucleotide variant
THRB,3,24122913,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",GRCh38,single nucleotide variant
THRB,3,24122943,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24127610,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",GRCh38,single nucleotide variant
THRB,3,24127684,na,na,Pathogenic/Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Inborn genetic diseases|not provided|THRB-related disorder",GRCh38,single nucleotide variant
THRB,3,24143539,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Thyroid hormone resistance syndrome|not provided",GRCh38,single nucleotide variant
THRB,3,24127696,na,na,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided",GRCh38,single nucleotide variant
THRB,3,24127685,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",GRCh38,single nucleotide variant
THRB,3,24127631,na,na,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24122957,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not specified|not provided",GRCh38,single nucleotide variant
THRB,3,24122894,na,na,Pathogenic,Generalized resistance to thyroid hormone,GRCh38,single nucleotide variant
THRB,3,24127684,na,na,Pathogenic,Selective pituitary resistance to thyroid hormone,GRCh38,single nucleotide variant
THRB,3,24122934,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",GRCh38,single nucleotide variant
THRB,3,24122897,na,na,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",GRCh38,single nucleotide variant
THRB,3,24122968,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",GRCh38,single nucleotide variant
THRB,3,24143511,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24143512,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|THRB-related disorder|not provided",GRCh38,single nucleotide variant
THRB,3,24123122,na,na,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",GRCh38,single nucleotide variant
THRB,3,24127634,na,na,Pathogenic,Selective pituitary resistance to thyroid hormone,GRCh38,single nucleotide variant
ERBB3,12,56092977,na,na,Pathogenic,Lethal congenital contracture syndrome 2,GRCh38,single nucleotide variant
SRC,20,37403359,na,na,Pathogenic,"Colon cancer, advanced",GRCh38,single nucleotide variant
MYC,8,127738431,na,na,Pathogenic,Burkitt lymphoma,GRCh38,single nucleotide variant
MYC,8,127738519,na,na,Pathogenic,Burkitt lymphoma,GRCh38,single nucleotide variant
MYC,8,127738379,na,na,Pathogenic,Burkitt lymphoma,GRCh38,single nucleotide variant
MYC,8,127738437,na,na,other,Burkitt lymphoma|Cholesteatoma of middle ear|Neoplasm,GRCh38,single nucleotide variant
KRAS,12,25245351,na,na,Likely pathogenic,Lung carcinoma|Non-small cell lung carcinoma|Endometrial carcinoma|Lung adenocarcinoma|Gallbladder cancer|not provided|RASopathy|Lung cancer|Neoplasm,GRCh38,single nucleotide variant
KRAS,12,25245351,na,na,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Squamous cell lung carcinoma|Non-small cell lung carcinoma|not provided|RASopathy|Neoplasm|Adenoid cystic carcinoma,GRCh38,single nucleotide variant
KRAS,12,25245347,na,na,Pathogenic,"Breast adenocarcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Nevus sebaceous|OCULOECTODERMAL SYNDROME, SOMATIC|not provided|Neoplasm|Inborn genetic diseases|RASopathy|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis|KRAS-related disorder|Familial pancreatic carcinoma",GRCh38,single nucleotide variant
KRAS,12,25227349,na,na,Pathogenic,"Bladder cancer, transitional cell, somatic",GRCh38,single nucleotide variant
KRAS,12,25245350,na,na,Pathogenic/Likely pathogenic,Carcinoma of pancreas|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|not provided|Acute myeloid leukemia|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Encephalocraniocutaneous lipomatosis|Cardiovascular phenotype|12 conditions|KRAS-related overgrowth|Congenital Pulmonary Airway Malformations|Neoplasm,GRCh38,single nucleotide variant
KRAS,12,25245350,na,na,Pathogenic,"Carcinoma of pancreas|Nevus sebaceous|not provided|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Linear nevus sebaceous syndrome|Chronic myelogenous leukemia, BCR-ABL1 positive|Neoplasm",GRCh38,single nucleotide variant
KRAS,12,25245351,na,na,Pathogenic,Gastric cancer|Non-small cell lung carcinoma|Ovarian neoplasm|Juvenile myelomonocytic leukemia|not provided|RASopathy|Neoplasm|Vascular malformation|Cardiofaciocutaneous syndrome 2,GRCh38,single nucleotide variant
KRAS,12,25227346,na,na,Pathogenic,Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome 3|Noonan syndrome;Cardio-facio-cutaneous syndrome|Inborn genetic diseases|Toriello-Lacassie-Droste syndrome;Noonan syndrome 3,GRCh38,single nucleotide variant
KRAS,12,25209904,na,na,Pathogenic,Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|not specified|11 conditions|Noonan syndrome 1|Cardiovascular phenotype,GRCh38,single nucleotide variant
KRAS,12,25227351,na,na,Pathogenic,Noonan syndrome 3|not provided|Noonan syndrome|RASopathy,GRCh38,single nucleotide variant
KRAS,12,25245345,na,na,Pathogenic,Noonan syndrome 3|Endometrial carcinoma|RASopathy|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome and Noonan-related syndrome,GRCh38,single nucleotide variant
KRAS,12,25245284,na,na,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Autoimmune lymphoproliferative syndrome type 4;Acute myeloid leukemia;Noonan syndrome 3;Cardiofaciocutaneous syndrome 2|RASopathy|Noonan syndrome 3,GRCh38,single nucleotide variant
KRAS,12,25209907,na,na,Pathogenic,Noonan syndrome 3,GRCh38,single nucleotide variant
KRAS,12,25245348,na,na,Pathogenic,Non-small cell lung carcinoma|Pilocytic astrocytoma|not provided,GRCh38,single nucleotide variant
KRAS,12,25245370,na,na,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Inborn genetic diseases|RASopathy,GRCh38,single nucleotide variant
KRAS,12,25209894,na,na,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder,GRCh38,single nucleotide variant
KRAS,12,25245372,na,na,Pathogenic/Likely pathogenic,"Noonan syndrome 3|RASopathy|not provided|Noonan syndrome|Prostate cancer, hereditary, 1|KRAS-related disorder",GRCh38,single nucleotide variant
KRAS,12,25227346,na,na,Pathogenic,Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2,GRCh38,single nucleotide variant
HRAS,11,534288,na,na,Pathogenic,"Malignant tumor of urinary bladder|Costello syndrome|Myopathy, congenital, with excess of muscle spindles|Epidermal nevus|not provided|HRAS-related disorder|Cardiovascular phenotype",GRCh38,single nucleotide variant
HRAS,11,533875,na,na,Pathogenic/Likely pathogenic,"Thyroid cancer, nonmedullary, 2|Spermatocytic seminoma|Noonan syndrome 3|not provided|Lip and oral cavity carcinoma|Epidermal nevus",GRCh38,single nucleotide variant
HRAS,11,534289,na,na,Pathogenic,"Costello syndrome|Myopathy, congenital, with excess of muscle spindles|Nevus sebaceous|not provided|Epidermal nevus with urothelial cancer, somatic|RASopathy|Wooly hair nevus|Lip and oral cavity carcinoma|Cardiovascular phenotype|Rhabdomyosarcoma|Noonan syndrome and Noonan-related syndrome|See cases|Noonan syndrome 1|Epidermal nevus|HRAS-related disorder|6 conditions",GRCh38,single nucleotide variant
HRAS,11,534288,na,na,Pathogenic,Costello syndrome|not provided|Inborn genetic diseases|6 conditions|Rhabdomyosarcoma|Noonan syndrome and Noonan-related syndrome,GRCh38,single nucleotide variant
HRAS,11,534285,na,na,Pathogenic/Likely pathogenic,Costello syndrome|not provided|Noonan syndrome and Noonan-related syndrome|RASopathy|6 conditions|Non-immune hydrops fetalis|HRAS-related disorder,GRCh38,single nucleotide variant
HRAS,11,533553,na,na,Pathogenic,Costello syndrome|not provided|RASopathy,GRCh38,single nucleotide variant
HRAS,11,534286,na,na,Pathogenic,Costello syndrome|RASopathy|not provided|Noonan syndrome|6 conditions|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder|Linear nevus sebaceous syndrome,GRCh38,single nucleotide variant
HRAS,11,533467,na,na,Pathogenic,Costello syndrome,GRCh38,single nucleotide variant
HRAS,11,533869,na,na,Pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",GRCh38,single nucleotide variant
HRAS,11,534259,na,na,Likely pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",GRCh38,single nucleotide variant
HRAS,11,533883,na,na,Pathogenic,Costello syndrome|RASopathy|not provided|HRAS-related disorder,GRCh38,single nucleotide variant
HRAS,11,533466,na,na,Likely pathogenic,Costello syndrome,GRCh38,single nucleotide variant
HRAS;LRRC56,11,534288,na,na,Pathogenic/Likely pathogenic,"Costello syndrome, severe|Costello syndrome|Nevus sebaceous|RASopathy|not provided|Lip and oral cavity carcinoma|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder",GRCh38,single nucleotide variant
HRAS,11,534289,na,na,Pathogenic,Costello syndrome|Nevus sebaceous|Epidermal nevus|RASopathy|not provided|6 conditions,GRCh38,single nucleotide variant
TF,3,133756969,na,na,Pathogenic,Transferrin variant D1,GRCh38,single nucleotide variant
TF,3,133757854,na,na,Benign,Transferrin variant D(Chi)|Atransferrinemia|not provided,GRCh38,single nucleotide variant
TF,3,133777188,na,na,Likely benign,Transferrin variant B2|Atransferrinemia|not provided|not specified|TF-related disorder,GRCh38,single nucleotide variant
TF,3,133775510,na,na,Benign,TF*C2|Atransferrinemia|not provided,GRCh38,single nucleotide variant
TF,3,133777112,na,na,Pathogenic,Transferrin variant Bv,GRCh38,single nucleotide variant
TF,3,133766376,na,na,Pathogenic,Atransferrinemia,GRCh38,single nucleotide variant
TF,3,133753607,na,na,Pathogenic,Atransferrinemia,GRCh38,single nucleotide variant
TF,3,133756968,na,na,Benign,Iron deficiency anemia|Atransferrinemia|not provided|TF-related disorder,GRCh38,single nucleotide variant
TF,3,133759306,na,na,Uncertain significance,Atransferrinemia|not specified,GRCh38,single nucleotide variant
ABL1,9,130872896,na,na,Likely pathogenic; association,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Chronic myelogenous leukemia, BCR-ABL1 positive",GRCh38,single nucleotide variant
ABL1,9,130862920,na,na,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",GRCh38,single nucleotide variant
ABL1,9,130862919,na,na,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",GRCh38,single nucleotide variant
ABL1,9,130862970,na,na,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",GRCh38,single nucleotide variant
ABL1,9,130872883,na,na,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",GRCh38,single nucleotide variant
ABL1,9,130873004,na,na,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",GRCh38,single nucleotide variant
TEAD1,11,12937202,na,na,Pathogenic,Helicoid peripapillary chorioretinal degeneration,GRCh38,single nucleotide variant
ZEB1,10,31520683,na,na,Pathogenic,Posterior polymorphous corneal dystrophy 3,GRCh38,single nucleotide variant
ZEB1,10,31461211,na,na,Benign,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified|ZEB1-related disorder",GRCh38,single nucleotide variant
ZEB1,10,31521854,na,na,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified",GRCh38,single nucleotide variant
HNF1B,17,37739455,na,na,Pathogenic,Renal cysts and diabetes syndrome|not provided|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus,GRCh38,single nucleotide variant
HNF1B,17,37744584,na,na,Pathogenic,Renal cysts and diabetes syndrome|not provided,GRCh38,single nucleotide variant
HNF1B,17,37731814,na,na,Pathogenic,Renal cysts and diabetes syndrome|Autosomal dominant medullary cystic kidney disease with or without hyperuricemia|not provided|Maturity onset diabetes mellitus in young|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus,GRCh38,single nucleotide variant
HNF1B,17,37701122,na,na,Conflicting classifications of pathogenicity,Type 2 diabetes mellitus|Renal cysts and diabetes syndrome|Ovarian cancer,GRCh38,single nucleotide variant
HNF1B,17,37739439,na,na,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus|not provided,GRCh38,single nucleotide variant
HNF1B,17,37739439,na,na,Pathogenic,Renal cysts and diabetes syndrome|not provided|HNF1B-related disorder,GRCh38,single nucleotide variant
HNF1B,17,37739541,na,na,Pathogenic,Renal cysts and diabetes syndrome|not provided,GRCh38,single nucleotide variant
HNF1B,17,37739490,na,na,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|not provided|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus,GRCh38,single nucleotide variant
TTN,2,178785999,na,na,Pathogenic,Hypertrophic cardiomyopathy 9,GRCh38,single nucleotide variant
TTN,2,178782980,na,na,Likely pathogenic,Dilated cardiomyopathy 1G|Primary dilated cardiomyopathy,GRCh38,single nucleotide variant
TTN,2,178527121,na,na,Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|not provided|Primary familial dilated cardiomyopathy,GRCh38,single nucleotide variant
TTN,2,178527148,na,na,Pathogenic/Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J,GRCh38,single nucleotide variant
TTN,2,178785990,na,na,Uncertain significance,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,GRCh38,single nucleotide variant
TTN,2,178802273,na,na,Uncertain significance,Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,GRCh38,single nucleotide variant
TTN,2,178740125,na,na,Pathogenic,Dilated cardiomyopathy 1G,GRCh38,single nucleotide variant
TTN,2,178738114,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|TTN-related disorder,GRCh38,single nucleotide variant
TTN,2,178799566,na,na,Conflicting classifications of pathogenicity,"Myopathy, myofibrillar, 9, with early respiratory failure|not specified|not provided|Dilated cardiomyopathy 1G;Autosomal recessive limb-girdle muscular dystrophy type 2J|Early-onset myopathy with fatal cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|Tibial muscular dystrophy|Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J",GRCh38,single nucleotide variant
PRKAR1A,17,68528994,na,na,Likely pathogenic,"Carney complex, type 1|not provided|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
PRKAR1A,17,68515400,na,na,Pathogenic,"Carney complex, type 1|not provided",GRCh38,single nucleotide variant
PRKAR1A,17,68512549,na,na,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1",GRCh38,single nucleotide variant
PRKAR1A,17,68525913,na,na,Pathogenic,"Carney complex, type 1",GRCh38,single nucleotide variant
PRKAR1A,17,68529919,na,na,Pathogenic,"Adrenocortical tumor, somatic",GRCh38,single nucleotide variant
PRKAR1A,17,68522798,na,na,Uncertain significance,"Carney complex, type 1|Carney complex|Hereditary cancer-predisposing syndrome|PRKAR1A-related disorder|not provided|Acrodysostosis 1 with or without hormone resistance",GRCh38,single nucleotide variant
TIMP3,22,32859351,na,na,Pathogenic,Sorsby fundus dystrophy|not provided,GRCh38,single nucleotide variant
TIMP3,22,32859313,na,na,Pathogenic,Sorsby fundus dystrophy|not provided,GRCh38,single nucleotide variant
TIMP3,22,32859277,na,na,Pathogenic,Sorsby fundus dystrophy|Retinal dystrophy,GRCh38,single nucleotide variant
TIMP3,22,32859306,na,na,Pathogenic,Sorsby fundus dystrophy,GRCh38,single nucleotide variant
TIMP3,22,32859225,na,na,Uncertain significance,Sorsby fundus dystrophy|not provided,GRCh38,single nucleotide variant
TRHR,8,109087561,na,na,Pathogenic,"Hypothyroidism, congenital, nongoitrous, 7",GRCh38,single nucleotide variant
TSHB,1,115033507,na,na,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency,GRCh38,single nucleotide variant
TSHB,1,115033456,na,na,Pathogenic,Isolated thyroid-stimulating hormone deficiency,GRCh38,single nucleotide variant
TSHB,1,115034015,na,na,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided|TSHB-related disorder,GRCh38,single nucleotide variant
TSHB,1,115033529,na,na,Pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided,GRCh38,single nucleotide variant
TG,8,132871345,na,na,Pathogenic,Iodotyrosyl coupling defect,GRCh38,single nucleotide variant
TG,8,132888417,na,na,Conflicting classifications of pathogenicity,Iodotyrosyl coupling defect|not provided|Premature ovarian failure,GRCh38,single nucleotide variant
TG,8,132923397,na,na,Pathogenic,"Iodotyrosyl coupling defect|not provided|Congenital hypothyroidism|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",GRCh38,single nucleotide variant
TG,8,132906786,na,na,Pathogenic,Iodotyrosyl coupling defect,GRCh38,single nucleotide variant
TG,8,132971804,na,na,Pathogenic,Iodotyrosyl coupling defect,GRCh38,single nucleotide variant
TG,8,132882609,na,na,Pathogenic,"Iodotyrosyl coupling defect|not provided|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|TG-related disorder|Congenital hypothyroidism",GRCh38,single nucleotide variant
TG,8,132971813,na,na,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",GRCh38,single nucleotide variant
TG,8,132888007,na,na,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",GRCh38,single nucleotide variant
TG,8,132897729,na,na,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",GRCh38,single nucleotide variant
TG,8,133017940,na,na,Pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3|not provided",GRCh38,single nucleotide variant
TG,8,132983349,na,na,Pathogenic,Iodotyrosyl coupling defect,GRCh38,single nucleotide variant
TG,8,132898809,na,na,Pathogenic,Iodotyrosyl coupling defect,GRCh38,single nucleotide variant
TG,8,133029907,na,na,Pathogenic/Likely pathogenic,"Iodotyrosyl coupling defect|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",GRCh38,single nucleotide variant
TG,8,132967797,na,na,Uncertain significance,Iodotyrosyl coupling defect|not provided,GRCh38,single nucleotide variant
TG,8,133022121,na,na,Likely pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|not provided",GRCh38,single nucleotide variant
TG,8,132873222,na,na,Pathogenic,Iodotyrosyl coupling defect|Congenital hypothyroidism,GRCh38,single nucleotide variant
TMPO,12,98534325,na,na,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1T|not specified|Loeys-Dietz syndrome 2|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 25|not provided|TMPO-related disorder,GRCh38,single nucleotide variant
TK2,16,66531394,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial DNA depletion syndrome|not provided|Mitochondrial disease",GRCh38,single nucleotide variant
TK2,16,66513795,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Mitochondrial disease",GRCh38,single nucleotide variant
TK2,16,66531432,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3|TK2-related disorder|Mitochondrial DNA depletion syndrome|Mitochondrial disease",GRCh38,single nucleotide variant
TK2,16,66541951,na,na,Likely pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial disease",GRCh38,single nucleotide variant
TBXA2R,19,3600456,na,na,Benign,"Bleeding disorder, platelet-type, 13, susceptibility to|Asthma",GRCh38,single nucleotide variant
THBS2,6,169234915,na,na,Benign; risk factor,"Lumbar disk herniation, susceptibility to|THBS2-related disorder",GRCh38,single nucleotide variant
THBD,20,23048049,na,na,Benign,Thrombomodulin-related bleeding disorder|Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|THBD-related disorder|not specified|Kidney disorder,GRCh38,single nucleotide variant
THBD,20,23049363,na,na,Pathogenic,Thrombomodulin-related bleeding disorder,GRCh38,single nucleotide variant
THBD,20,23049378,na,na,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not specified|not provided|Atypical hemolytic-uremic syndrome|THBD-related disorder,GRCh38,single nucleotide variant
THBD,20,23049347,na,na,risk factor,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly,GRCh38,single nucleotide variant
THBD,20,23048022,na,na,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|Atypical hemolytic-uremic syndrome|not provided|Thrombomodulin-related bleeding disorder|THBD-related disorder,GRCh38,single nucleotide variant
TPMT,6,18143724,na,na,drug response,Thiopurine S-methyltransferase deficiency,GRCh38,single nucleotide variant
TPMT,6,18138997,na,na,Benign/Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided|TPMT-related disorder,GRCh38,single nucleotide variant
TPMT,6,18130781,na,na,drug response,Thiopurine S-methyltransferase deficiency,GRCh38,single nucleotide variant
TPMT,6,18130687,na,na,Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided,GRCh38,single nucleotide variant
TPMT,6,18130762,na,na,drug response,Thiopurine S-methyltransferase deficiency,GRCh38,single nucleotide variant
TPMT,6,18133884,na,na,drug response,Thiopurine S-methyltransferase deficiency,GRCh38,single nucleotide variant
CRIPTO,3,46579986,na,na,Uncertain significance,Forebrain defects,GRCh38,single nucleotide variant
TERT,5,1294282,na,na,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|not provided|Dyskeratosis congenita, autosomal dominant 2|not specified|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder",GRCh38,single nucleotide variant
TERT,5,1293652,na,na,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|not specified|not provided|Dyskeratosis congenita, autosomal dominant 2|Autosomal recessive dyskeratosis congenita 4|Idiopathic Pulmonary Fibrosis;Dyskeratosis congenita, autosomal dominant 2|Acute myeloid leukemia;Melanoma, cutaneous malignant, susceptibility to, 9;Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita",GRCh38,single nucleotide variant
TERT,5,1279341,na,na,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita|Pulmonary fibrosis|not provided",GRCh38,single nucleotide variant
TERT,5,1272252,na,na,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis",GRCh38,single nucleotide variant
TERT,5,1254395,na,na,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Interstitial lung disease 2|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2|7 conditions|not provided|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita",GRCh38,single nucleotide variant
TERT,5,1264541,na,na,Pathogenic,"Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 1",GRCh38,single nucleotide variant
TERT,5,1266524,na,na,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|not provided|Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|Pulmonary fibrosis",GRCh38,single nucleotide variant
TERT,5,1294770,na,na,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|not provided",GRCh38,single nucleotide variant
CCL5,17,35880401,na,na,Likely benign,"Human immunodeficiency virus type 1, delayed disease progression with infection by|CCL5-related condition",GRCh38,single nucleotide variant
CCL5,17,35879999,na,na,Pathogenic,"Human immunodeficiency virus type 1, rapid disease progression with infection by",GRCh38,single nucleotide variant
ITK,5,157241663,na,na,Likely pathogenic,Lymphoproliferative syndrome 1,GRCh38,single nucleotide variant
CD8A,2,86790400,na,na,Pathogenic,Susceptibility to respiratory infections associated with CD8alpha chain mutation,GRCh38,single nucleotide variant
CD81,11,2395971,na,na,Pathogenic,"Immunodeficiency, common variable, 6",GRCh38,single nucleotide variant
CD3E,11,118313876,na,na,Likely pathogenic,Immunodeficiency 18,GRCh38,single nucleotide variant
CD3E,11,118312690,na,na,Pathogenic,Immunodeficiency 18,GRCh38,single nucleotide variant
CD3D,11,118340447,na,na,Pathogenic,Immunodeficiency 19|not provided,GRCh38,single nucleotide variant
CD3D,11,118339902,na,na,Pathogenic,Immunodeficiency 19,GRCh38,single nucleotide variant
CD247,1,167439355,na,na,Pathogenic,Immunodeficiency 25,GRCh38,single nucleotide variant
CD247,1,167439354,na,na,Pathogenic,Immunodeficiency 25,GRCh38,single nucleotide variant
CD3G,11,118344424,na,na,Pathogenic/Likely pathogenic,Combined immunodeficiency due to CD3gamma deficiency,GRCh38,single nucleotide variant
SDC3,1,30874473,na,na,association,"Obesity, association with",GRCh38,single nucleotide variant
SDC3,1,30876800,na,na,association,"Obesity, association with",GRCh38,single nucleotide variant
SURF1,9,133354657,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",GRCh38,single nucleotide variant
SURF1,9,133352446,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|not provided|Mitochondrial disease|Charcot-Marie-Tooth disease type 4K;Mitochondrial complex IV deficiency, nuclear type 1",GRCh38,single nucleotide variant
SURF1,9,133353747,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",GRCh38,single nucleotide variant
SURF1,9,133352074,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|not provided",GRCh38,single nucleotide variant
SURF1,9,133353893,na,na,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome",GRCh38,single nucleotide variant
EPCAM,2,47375300,na,na,Pathogenic,Congenital diarrhea 5 with tufting enteropathy|Hereditary cancer-predisposing syndrome|not provided|Gastric cancer,GRCh38,single nucleotide variant
EPCAM,2,47375233,na,na,Uncertain significance,Congenital diarrhea 5 with tufting enteropathy|not provided,GRCh38,single nucleotide variant
EPCAM,2,47373820,na,na,Pathogenic,Congenital diarrhea 5 with tufting enteropathy,GRCh38,single nucleotide variant
SOD3,4,24800212,na,na,Benign,"Superoxide dismutase, elevated extracellular|SOD3-related disorder",GRCh38,single nucleotide variant
SDHB,1,17033078,na,na,Pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 4;Pheochromocytoma|Von Hippel-Lindau syndrome,GRCh38,single nucleotide variant
SDHB,1,17024025,na,na,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|not provided,GRCh38,single nucleotide variant
SDHB,1,17022648,na,na,Pathogenic/Likely pathogenic,"Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma|Pheochromocytoma;Gastrointestinal stromal tumor;Paragangliomas 4|SDHB-related disorder|Mitochondrial complex 2 deficiency, nuclear type 4",GRCh38,single nucleotide variant
SDHB,1,17044882,na,na,Pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|not provided|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor,GRCh38,single nucleotide variant
SDHB,1,17044825,na,na,Pathogenic,Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|SDHB-related disorder|Paragangliomas 4,GRCh38,single nucleotide variant
SDHB,1,17028721,na,na,Pathogenic,Paragangliomas 4,GRCh38,single nucleotide variant
SDHB,1,17028628,na,na,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma,GRCh38,single nucleotide variant
SDHB,1,17028724,na,na,Conflicting classifications of pathogenicity,Pheochromocytoma|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
SDHB,1,17028599,na,na,Pathogenic,Carney-Stratakis syndrome,GRCh38,single nucleotide variant
SDHB,1,17054012,na,na,Benign/Likely benign,"Cowden syndrome|not provided|not specified|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor|Paragangliomas 4;Pheochromocytoma;Gastrointestinal stromal tumor|Carney-Stratakis syndrome;Paragangliomas 4;Pheochromocytoma;Gastrointestinal stromal tumor;Mitochondrial complex 2 deficiency, nuclear type 4|SDHB-related disorder",GRCh38,single nucleotide variant
SDHB,1,17027802,na,na,Conflicting classifications of pathogenicity,Cowden syndrome|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Paragangliomas 4;Gastrointestinal stromal tumor|Paragangliomas 4|not provided|not specified|Gastrointestinal stromal tumor|Hereditary pheochromocytoma-paraganglioma|Carney-Stratakis syndrome|Malignant tumor of breast,GRCh38,single nucleotide variant
NR5A1,9,124500196,na,na,Pathogenic,"ADRENAL INSUFFICIENCY, NR5A1-RELATED",GRCh38,single nucleotide variant
NR5A1,9,124500685,na,na,Pathogenic,"46,XY sex reversal 3|ADRENAL INSUFFICIENCY, NR5A1-RELATED|46,XX sex reversal 4",GRCh38,single nucleotide variant
NR5A1,9,124503348,na,na,Pathogenic,"46,XY sex reversal 3",GRCh38,single nucleotide variant
NR5A1,9,124503353,na,na,Pathogenic,"46,XY sex reversal 3",GRCh38,single nucleotide variant
NR5A1,9,124503089,na,na,Pathogenic,"46,XY sex reversal 3",GRCh38,single nucleotide variant
NR5A1,9,124500689,na,na,Likely pathogenic,"46,XY sex reversal 3|not provided",GRCh38,single nucleotide variant
NR5A1,9,124482834,na,na,Pathogenic,"46,XY sex reversal 3",GRCh38,single nucleotide variant
NR5A1,9,124493143,na,na,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",GRCh38,single nucleotide variant
NR5A1,9,124503393,na,na,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",GRCh38,single nucleotide variant
NR5A1,9,124500592,na,na,Conflicting classifications of pathogenicity,"not provided|not specified|Oligosynaptic infertility;46,XY disorder of sex development|Spermatogenic failure 8|NR5A1-related disorder",GRCh38,single nucleotide variant
KITLG,12,88934558,na,na,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",GRCh38,single nucleotide variant
KITLG,12,88905969,na,na,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",GRCh38,single nucleotide variant
KITLG,12,88545774,na,na,Pathogenic,"Hyperpigmentation with or without hypopigmentation, familial progressive",GRCh38,single nucleotide variant
SOX2,3,181712889,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome|not provided,GRCh38,single nucleotide variant
SOX2,3,181712637,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712608,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712650,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712823,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712523,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712581,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712498,na,na,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712749,na,na,Conflicting classifications of pathogenicity,Optic nerve hypoplasia and abnormalities of the central nervous system|Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SOX2,3,181712931,na,na,Uncertain significance,Optic nerve hypoplasia and abnormalities of the central nervous system|Inborn genetic diseases|Anophthalmia/microphthalmia-esophageal atresia syndrome,GRCh38,single nucleotide variant
SPTB,14,64767725,na,na,Likely pathogenic,Elliptocytosis 3|not provided,GRCh38,single nucleotide variant
SPTB,14,64767300,na,na,Pathogenic,Elliptocytosis 3,GRCh38,single nucleotide variant
SPTB,14,64801797,na,na,Pathogenic,Hereditary spherocytosis type 2,GRCh38,single nucleotide variant
SPTB,14,64767829,na,na,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 3",GRCh38,single nucleotide variant
SPTB,14,64767827,na,na,Pathogenic/Likely pathogenic,Elliptocytosis 3|Hereditary spherocytosis type 2|not provided|SPTB-related disorder,GRCh38,single nucleotide variant
SPTB,14,64767808,na,na,Conflicting classifications of pathogenicity,"ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL|Hereditary spherocytosis type 2|not provided|SPTB-related disorder",GRCh38,single nucleotide variant
SPTB,14,64767691,na,na,Pathogenic,Elliptocytosis 3,GRCh38,single nucleotide variant
SPTB,14,64823094,na,na,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 2|not specified|not provided,GRCh38,single nucleotide variant
SPTB,14,64772867,na,na,Pathogenic,Hereditary spherocytosis type 2|not provided|Elliptocytosis 3;Hereditary spherocytosis type 2,GRCh38,single nucleotide variant
SPTA1,1,158678434,na,na,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided|Spherocytosis,GRCh38,single nucleotide variant
SPTA1,1,158672135,na,na,Uncertain significance,Elliptocytosis 2|not provided,GRCh38,single nucleotide variant
SPTA1,1,158654738,na,na,Benign/Likely benign,"SPHEROCYTOSIS, TYPE 3, AUTOSOMAL RECESSIVE|not specified|Hereditary spherocytosis type 3|Pyropoikilocytosis, hereditary|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not provided",GRCh38,single nucleotide variant
SPTA1,1,158678432,na,na,Conflicting classifications of pathogenicity,Elliptocytosis 2|not provided,GRCh38,single nucleotide variant
SPTA1,1,158685237,na,na,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2",GRCh38,single nucleotide variant
SPTA1,1,158685235,na,na,Likely pathogenic,Elliptocytosis 2,GRCh38,single nucleotide variant
SPTA1,1,158685227,na,na,Uncertain significance,Elliptocytosis 2|Hereditary spherocytosis type 2;Elliptocytosis 2,GRCh38,single nucleotide variant
SPTA1,1,158685251,na,na,Pathogenic,Elliptocytosis 2,GRCh38,single nucleotide variant
SPTA1,1,158685289,na,na,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided,GRCh38,single nucleotide variant
SPTA1,1,158685290,na,na,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|not provided",GRCh38,single nucleotide variant
SPTA1,1,158685290,na,na,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|SPTA1-related disorder|not provided",GRCh38,single nucleotide variant
SPTA1,1,158685289,na,na,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|Prenatal anemia|not provided|SPTA1-related disorder",GRCh38,single nucleotide variant
SPTA1,1,158680641,na,na,Conflicting classifications of pathogenicity,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|not provided",GRCh38,single nucleotide variant
SPTA1,1,158685229,na,na,Uncertain significance,"Pyropoikilocytosis, hereditary|not provided",GRCh38,single nucleotide variant
SPTA1,1,158662793,na,na,Conflicting classifications of pathogenicity,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|Hereditary spherocytosis type 3|not provided|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not specified",GRCh38,single nucleotide variant
SPTA1,1,158661410,na,na,Pathogenic,Elliptocytosis 2,GRCh38,single nucleotide variant
SPTA1,1,158656669,na,na,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|not provided",GRCh38,single nucleotide variant
SPTA1,1,158636763,na,na,Pathogenic,Hereditary spherocytosis type 3,GRCh38,single nucleotide variant
SPTA1,1,158653269,na,na,Pathogenic,"Pyropoikilocytosis, hereditary",GRCh38,single nucleotide variant
SOS1,2,39051211,na,na,Pathogenic,"Noonan syndrome 4|Noonan syndrome|RASopathy|not provided|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome 1",GRCh38,single nucleotide variant
SOS1,2,39051202,na,na,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy|Noonan syndrome 1|Cardiovascular phenotype,GRCh38,single nucleotide variant
SOS1,2,39022774,na,na,Pathogenic,"Noonan syndrome 4|Noonan syndrome|not provided|RASopathy|Noonan syndrome 4;Fibromatosis, gingival, 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
SOS1,2,39022772,na,na,Pathogenic,"RASopathy|Noonan syndrome 4|Noonan syndrome 1|not provided|Noonan syndrome|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome and Noonan-related syndrome",GRCh38,single nucleotide variant
SOS1,2,39023134,na,na,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy,GRCh38,single nucleotide variant
SSTR5,16,1079586,na,na,Benign/Likely benign,not provided,GRCh38,single nucleotide variant
SCN2A,2,165308751,na,na,Uncertain significance,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided|Inborn genetic diseases|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
SCN2A,2,165374700,na,na,Pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
SCN2A,2,165386881,na,na,Pathogenic,"Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided",GRCh38,single nucleotide variant
SCN2A,2,165344666,na,na,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|not provided|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3;Episodic ataxia, type 9|Developmental and epileptic encephalopathy, 11",GRCh38,single nucleotide variant
SCN2A,2,165309414,na,na,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11|Benign familial infantile epilepsy|Seizure",GRCh38,single nucleotide variant
SCN2A,2,165373331,na,na,Pathogenic,"Seizures, benign familial infantile, 3|not provided|Seizures, benign familial infantile, 3;Developmental and epileptic encephalopathy, 11|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11|Benign familial infantile epilepsy|benign sporadic infantile epilepsy",GRCh38,single nucleotide variant
SCN2A,2,165354279,na,na,Uncertain significance,"Seizures, benign familial infantile, 3|Seizures, benign familial infantile, 3;Developmental and epileptic encephalopathy, 11|Complex neurodevelopmental disorder",GRCh38,single nucleotide variant
SCN1A,2,165992332,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy|not provided|Autosomal dominant epilepsy",GRCh38,single nucleotide variant
SCN1A,2,166038098,na,na,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy|not provided|Inborn genetic diseases|Seizure|SCN1A-related disorder",GRCh38,single nucleotide variant
SCN1A,2,166054677,na,na,Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 1|Generalized epilepsy with febrile seizures plus, type 2|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
SCN1A,2,166002699,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy",GRCh38,single nucleotide variant
SCN1A,2,165992307,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
SCN1A,2,166013839,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|not provided",GRCh38,single nucleotide variant
SCN1A,2,166052882,na,na,Pathogenic/Likely pathogenic,"Severe myoclonic epilepsy in infancy|not provided|Developmental and epileptic encephalopathy|Generalized epilepsy with febrile seizures plus, type 2;Severe myoclonic epilepsy in infancy;Migraine, familial hemiplegic, 3|Intellectual disability|Generalized epilepsy with febrile seizures plus, type 2|Febrile seizures, familial, 3a;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Severe myoclonic epilepsy in infancy|Inborn genetic diseases",GRCh38,single nucleotide variant
SCN1A,2,166036521,na,na,Pathogenic,Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy,GRCh38,single nucleotide variant
SCN1A,2,166012179,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Inborn genetic diseases|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
SCN1A,2,166002473,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1",GRCh38,single nucleotide variant
SCN1A,2,165998049,na,na,Pathogenic,"Migraine, familial hemiplegic, 3|Severe myoclonic epilepsy in infancy",GRCh38,single nucleotide variant
SCN1A,2,165992149,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
SCN1A,2,165994167,na,na,Pathogenic,"Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2",GRCh38,single nucleotide variant
SCN1A,2,166056450,na,na,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|not provided|Febrile seizures, familial, 3a|Migraine, familial hemiplegic, 3;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Severe myoclonic epilepsy in infancy|Severe myoclonic epilepsy in infancy",GRCh38,single nucleotide variant
SCN1A,2,166053034,na,na,drug response,"Febrile seizures, familial, 3a|carbamazepine response - Dosage|Developmental and epileptic encephalopathy",GRCh38,single nucleotide variant
SCN1A,2,165996099,na,na,Pathogenic,"Migraine, familial hemiplegic, 3|not provided|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy",GRCh38,single nucleotide variant
SCN1A,2,165998047,na,na,Pathogenic,"Migraine, familial hemiplegic, 3",GRCh38,single nucleotide variant
SLC5A2,16,31488919,na,na,Pathogenic,Familial renal glucosuria,GRCh38,single nucleotide variant
SLC5A2,16,31490477,na,na,Conflicting classifications of pathogenicity,Familial renal glucosuria|not provided|not specified|SLC5A2-related disorder,GRCh38,single nucleotide variant
SLC5A1,22,32043363,na,na,Likely pathogenic,Congenital glucose-galactose malabsorption,GRCh38,single nucleotide variant
SLC5A1,22,32043364,na,na,Uncertain significance,Congenital glucose-galactose malabsorption,GRCh38,single nucleotide variant
ATP1A3,19,41978041,na,na,Pathogenic,Dystonia 12|not provided|Alternating hemiplegia of childhood 2,GRCh38,single nucleotide variant
ATP1A3,19,41985090,na,na,Pathogenic,Dystonia 12,GRCh38,single nucleotide variant
ATP1A3,19,41985082,na,na,Pathogenic/Likely pathogenic,Dystonia 12|not provided,GRCh38,single nucleotide variant
ATP1A3,19,41970533,na,na,Likely pathogenic,Dystonia 12|not provided,GRCh38,single nucleotide variant
ATP1A3,19,41970468,na,na,Pathogenic,Dystonia 12,GRCh38,single nucleotide variant
ATP1A3,19,41970405,na,na,Pathogenic,Dystonia 12,GRCh38,single nucleotide variant
ATP1A3,19,41968837,na,na,Pathogenic,Dystonia 12|Alternating hemiplegia of childhood 2|Dystonia 12;Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;Alternating hemiplegia of childhood 2|not provided|Seizure|ATP1A3-associated neurological disorder,GRCh38,single nucleotide variant
ATP1A2,1,160135845,na,na,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",GRCh38,single nucleotide variant
ATP1A2,1,160136665,na,na,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",GRCh38,single nucleotide variant
ATP1A2,1,160135510,na,na,Likely pathogenic,"Migraine, familial hemiplegic, 2",GRCh38,single nucleotide variant
ATP1A2,1,160135246,na,na,Likely pathogenic,"Migraine, familial hemiplegic, 2|not provided",GRCh38,single nucleotide variant
ATP1A2,1,160128767,na,na,Pathogenic/Likely pathogenic,Alternating hemiplegia of childhood 1|Familial hemiplegic migraine|ATP1A2-related disorder,GRCh38,single nucleotide variant
ATP1A2,1,160127704,na,na,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",GRCh38,single nucleotide variant
ATP1A2,1,160128667,na,na,Pathogenic,"Migraine, familial hemiplegic, 2",GRCh38,single nucleotide variant
ATP1A2,1,160135470,na,na,Conflicting classifications of pathogenicity,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|not provided",GRCh38,single nucleotide variant
ATP1A2,1,160139735,na,na,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Migraine, familial hemiplegic, 2;Alternating hemiplegia of childhood 1|not provided",GRCh38,single nucleotide variant
ATP1A2,1,160130283,na,na,Pathogenic,"Migraine, familial basilar|not provided|Familial hemiplegic migraine|Developmental and epileptic encephalopathy 98|Migraine, familial hemiplegic, 2|ATP1A2-related disorder",GRCh38,single nucleotide variant
ATP1A2,1,160127660,na,na,Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",GRCh38,single nucleotide variant
ATP1A2,1,160129007,na,na,Uncertain significance,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Alternating hemiplegia of childhood 1|ATP1A2-related disorder",GRCh38,single nucleotide variant
ATP1A2,1,160123228,na,na,Uncertain significance,"Migraine, familial hemiplegic, 2|not provided|Familial hemiplegic migraine",GRCh38,single nucleotide variant
ATP1A2,1,160128761,na,na,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Inborn genetic diseases|not provided",GRCh38,single nucleotide variant
SLC34A1,5,177386473,na,na,Uncertain significance,Hypophosphatemic nephrolithiasis/osteoporosis 1|not provided,GRCh38,single nucleotide variant
SLC6A4,17,30211356,na,na,Uncertain significance,"Obsessive-compulsive disorder, susceptibility to|Behavior disorder",GRCh38,single nucleotide variant
SPR,2,72888364,na,na,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,GRCh38,single nucleotide variant
SPR,2,72888457,na,na,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder|SPR-related disorder,GRCh38,single nucleotide variant
SPR,2,72887420,na,na,Uncertain significance,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided,GRCh38,single nucleotide variant
SPR,2,72888497,na,na,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,GRCh38,single nucleotide variant
SPR,2,72891502,na,na,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder,GRCh38,single nucleotide variant
FUT2,19,48703417,na,na,Benign,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1|SECRETOR/NONSECRETOR POLYMORPHISM|Familial Otitis Media|VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1;Bombay phenotype|not provided,GRCh38,single nucleotide variant
FUT2,19,48703374,na,na,Benign,"SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE|Familial Otitis Media|not provided",GRCh38,single nucleotide variant
STIL,1,47251285,na,na,Pathogenic,"Microcephaly 7, primary, autosomal recessive",GRCh38,single nucleotide variant
STIL,1,47262902,na,na,Pathogenic,"Microcephaly 7, primary, autosomal recessive",GRCh38,single nucleotide variant
AHCY,20,34292467,na,na,Pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,GRCh38,single nucleotide variant
AHCY,20,34292375,na,na,Pathogenic/Likely pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase|not provided|Inborn genetic diseases|Rhabdomyolysis,GRCh38,single nucleotide variant
RYR2,1,237634937,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiomyopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
RYR2,1,237648523,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237784024,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237791441,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiovascular phenotype|Cardiomyopathy,GRCh38,single nucleotide variant
RYR2,1,237640938,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237454396,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia|Long QT syndrome|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237639068,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237798037,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237784314,na,na,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR2,1,237819181,na,na,Uncertain significance,Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome|Catecholaminergic polymorphic ventricular tachycardia 1,GRCh38,single nucleotide variant
RYR1,19,38457545,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Inborn genetic diseases|Malignant hyperthermia of anesthesia|enflurane response - Toxicity|succinylcholine response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity|Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;King Denborough syndrome;Congenital myopathy with fiber type disproportion;Central core myopathy",GRCh38,single nucleotide variant
RYR1,19,38446710,na,na,Likely pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia",GRCh38,single nucleotide variant
RYR1,19,38499997,na,na,Pathogenic; drug response,"Central core myopathy|not provided|RYR1-related disorder|enflurane response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1;Central core myopathy|Malignant hyperthermia, susceptibility to, 1",GRCh38,single nucleotide variant
RYR1,19,38444211,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|RYR1-related disorder|desflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia",GRCh38,single nucleotide variant
RYR1,19,38451850,na,na,Uncertain significance; drug response,"Central core myopathy|not provided|succinylcholine response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|enflurane response - Toxicity|RYR1-related disorder|halothane response - Toxicity|methoxyflurane response - Toxicity|not specified",GRCh38,single nucleotide variant
RYR1,19,38448712,na,na,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder",GRCh38,single nucleotide variant
RYR1,19,38499993,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|Central core myopathy|Inborn genetic diseases|Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;King Denborough syndrome;Central core myopathy",GRCh38,single nucleotide variant
RYR1,19,38500654,na,na,Likely pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|Malignant hyperthermia of anesthesia|RYR1-related disorder|sevoflurane response - Toxicity|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity",GRCh38,single nucleotide variant
RYR1,19,38500655,na,na,drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|enflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity",GRCh38,single nucleotide variant
RYR1,19,38494564,na,na,Pathogenic; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|enflurane response - Toxicity",GRCh38,single nucleotide variant
RYR1,19,38494565,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|RYR1-related disorder|enflurane response - Toxicity|isoflurane response - Toxicity",GRCh38,single nucleotide variant
RYR1,19,38584989,na,na,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|Congenital myopathy|RYR1-related myopathy",GRCh38,single nucleotide variant
RYR1,19,38494579,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Congenital multicore myopathy with external ophthalmoplegia|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|Central core myopathy|isoflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia of anesthesia",GRCh38,single nucleotide variant
RYR1,19,38496283,na,na,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|History of neonatal hypotonia;Absence of the sacrum;Ptosis|Malignant hyperthermia of anesthesia|RYR1-related disorder|King Denborough syndrome|Malignant hyperthermia, susceptibility to|Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;King Denborough syndrome;Central core myopathy|Inborn genetic diseases",GRCh38,single nucleotide variant
RYR1,19,38580094,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|RYR1-related disorder",GRCh38,single nucleotide variant
RYR1,19,38580004,na,na,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity",GRCh38,single nucleotide variant
RYR1,19,38580440,na,na,Conflicting classifications of pathogenicity; drug response,"Central core myopathy|not provided|RYR1-related disorder|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia, susceptibility to, 1|enflurane response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia of anesthesia|RYR1-related myopathy",GRCh38,single nucleotide variant
RYR1,19,38525455,na,na,Pathogenic,not provided|Congenital multicore myopathy with external ophthalmoplegia,GRCh38,single nucleotide variant
RYR1,19,38580403,na,na,drug response,"Congenital multicore myopathy with external ophthalmoplegia|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|Malignant hyperthermia of anesthesia|succinylcholine response - Toxicity|Centronuclear myopathy|Inborn genetic diseases|RYR1-related myopathy",GRCh38,single nucleotide variant
RYR1,19,38504319,na,na,Likely pathogenic,"not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1",GRCh38,single nucleotide variant
RYR1,19,38583494,na,na,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,GRCh38,single nucleotide variant
RYR1,19,38443612,na,na,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Congenital myopathy with fiber type disproportion|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Centronuclear myopathy|Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;King Denborough syndrome;Central core myopathy",GRCh38,single nucleotide variant
RYR1,19,38499961,na,na,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Lower limb amyotrophy;EMG abnormality;Clubfoot|Congenital myopathy with fiber type disproportion|Congenital multicore myopathy with external ophthalmoplegia;Malignant hyperthermia, susceptibility to, 1;King Denborough syndrome;Congenital myopathy with fiber type disproportion;Central core myopathy|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease|Central core myopathy",GRCh38,single nucleotide variant
RYR1,19,38579980,na,na,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,GRCh38,single nucleotide variant
RYR1,19,38523111,na,na,Uncertain significance,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Malignant hyperthermia, susceptibility to, 1",GRCh38,single nucleotide variant
RYR1,19,38572181,na,na,Pathogenic/Likely pathogenic,Central core myopathy|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia,GRCh38,single nucleotide variant
RYR1,19,38455359,na,na,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|desflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity",GRCh38,single nucleotide variant
RPS17,15,82540427,na,na,Pathogenic,Diamond-Blackfan anemia 4|Diamond-Blackfan anemia,GRCh38,single nucleotide variant
RPL35A,3,197951244,na,na,Pathogenic,Diamond-Blackfan anemia 5,GRCh38,single nucleotide variant
RPL35A,3,197954142,na,na,Pathogenic,Diamond-Blackfan anemia 5,GRCh38,single nucleotide variant
RNASEL,1,182586014,na,na,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 1|not provided|Prostate cancer|RNASEL-related disorder",GRCh38,single nucleotide variant
RNASEL,1,182586804,na,na,Pathogenic,"Prostate cancer, hereditary, 1",GRCh38,single nucleotide variant
RNASEL,1,182585422,na,na,Likely benign,"Prostate cancer, hereditary, 1|Prostate cancer susceptibility|Hereditary cancer",GRCh38,single nucleotide variant
RPIA,2,88729279,na,na,Pathogenic,Deficiency of ribose-5-phosphate isomerase,GRCh38,single nucleotide variant
GRK1,13,113731288,na,na,Pathogenic/Likely pathogenic,Oguchi disease-2|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
GRK1,13,113731321,na,na,Pathogenic/Likely pathogenic,Oguchi disease-2,GRCh38,single nucleotide variant
RHO,3,129528801,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy|Pigmentary retinal dystrophy;Retinitis pigmentosa 4;Congenital stationary night blindness autosomal dominant 1|RHO-related disorder,GRCh38,single nucleotide variant
RHO,3,129533711,na,na,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4|not provided|Retinal dystrophy|Retinitis pigmentosa|Peripheral visual field loss;Night blindness;Blurred vision|RHO-related disorder|Microcephaly 17, primary, autosomal recessive",GRCh38,single nucleotide variant
RHO,3,129533710,na,na,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129528906,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided|RHO-related disorder,GRCh38,single nucleotide variant
RHO,3,129528783,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not specified|not provided,GRCh38,single nucleotide variant
RHO,3,129528866,na,na,Uncertain significance,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129528993,na,na,Likely pathogenic,Retinitis pigmentosa 4|Pigmentary retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129528999,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Pigmentary retinal dystrophy|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129529049,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RHO,3,129532288,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129530918,na,na,Pathogenic,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129532253,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129532289,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129532352,na,na,Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129530917,na,na,Pathogenic,Retinitis pigmentosa|Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinal dystrophy|RHO-related disorder,GRCh38,single nucleotide variant
RHO,3,129533701,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129532722,na,na,Pathogenic,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129533711,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
RHO,3,129532264,na,na,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RHO,3,129532636,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
RHO,3,129529062,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129532581,na,na,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinal dystrophy",GRCh38,single nucleotide variant
RHO,3,129528891,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
RHO,3,129529049,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RHO,3,129532288,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
RHO,3,129528777,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129532340,na,na,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RHO,3,129532711,na,na,Pathogenic,Congenital stationary night blindness autosomal dominant 1,GRCh38,single nucleotide variant
RHO,3,129529002,na,na,Pathogenic,Congenital stationary night blindness autosomal dominant 1|Pigmentary retinal dystrophy|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129530962,na,na,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinitis pigmentosa 4|Autosomal recessive retinitis pigmentosa|Retinal dystrophy",GRCh38,single nucleotide variant
RHO,3,129528884,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|RHO-related disorder,GRCh38,single nucleotide variant
RHO,3,129529074,na,na,Pathogenic,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129531005,na,na,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHO,3,129531025,na,na,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
RHO,3,129533704,na,na,Pathogenic,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129533711,na,na,Pathogenic,Retinitis pigmentosa 4|not provided,GRCh38,single nucleotide variant
RHO,3,129529014,na,na,Likely pathogenic,Congenital stationary night blindness autosomal dominant 1,GRCh38,single nucleotide variant
RHO,3,129528800,na,na,Pathogenic,Retinitis pigmentosa 4,GRCh38,single nucleotide variant
RHO,3,129533704,na,na,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
RHAG,6,49619284,na,na,Pathogenic,Rh mod blood group phenotype,GRCh38,single nucleotide variant
RHAG,6,49612506,na,na,Likely pathogenic,"Rh-null, regulator type|Overhydrated hereditary stomatocytosis",GRCh38,single nucleotide variant
RHAG,6,49636655,na,na,Pathogenic,"Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis|RHAG-related disorder",GRCh38,single nucleotide variant
RHAG,6,49611146,na,na,Pathogenic,"Rh-null, regulator type",GRCh38,single nucleotide variant
RHAG,6,49636810,na,na,Pathogenic,Rh mod blood group phenotype,GRCh38,single nucleotide variant
RHAG,6,49611023,na,na,Pathogenic,"Rh-null, regulator type|Rh deficiency syndrome",GRCh38,single nucleotide variant
RHAG,6,49612534,na,na,Benign/Likely benign,"not provided|Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis",GRCh38,single nucleotide variant
RHAG,6,49606921,na,na,Pathogenic,"Rh-null, regulator type",GRCh38,single nucleotide variant
FFAR4;RBP4,10,93600739,na,na,Conflicting classifications of pathogenicity,Progressive retinal dystrophy due to retinol transport defect|not provided,GRCh38,single nucleotide variant
RBP4;FFAR4,10,93600470,na,na,Likely pathogenic,Progressive retinal dystrophy due to retinol transport defect,GRCh38,single nucleotide variant
RB1,13,48456351,na,na,Pathogenic,Retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48379594,na,na,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma|not provided,GRCh38,single nucleotide variant
RB1,13,48452997,na,na,Likely pathogenic,Retinoblastoma|not provided,GRCh38,single nucleotide variant
RB1,13,48465238,na,na,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,GRCh38,single nucleotide variant
RB1,13,48367604,na,na,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48368549,na,na,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm,GRCh38,single nucleotide variant
RB1,13,48463729,na,na,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48465028,na,na,Pathogenic,Small cell lung carcinoma|Retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48464997,na,na,Pathogenic,Retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48303724,na,na,Likely pathogenic,Retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48303715,na,na,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48459708,na,na,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Bone osteosarcoma;Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma|not provided|Vulvar adenocarcinoma of mammary gland type,GRCh38,single nucleotide variant
RB1,13,48459750,na,na,Pathogenic,Retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48463835,na,na,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48381414,na,na,Pathogenic,Trilateral retinoblastoma|Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48463758,na,na,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Hereditary retinoblastoma,GRCh38,single nucleotide variant
RB1,13,48349024,na,na,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,GRCh38,single nucleotide variant
RB1,13,48456207,na,na,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,GRCh38,single nucleotide variant
RB1,13,48471962,na,na,Pathogenic/Likely pathogenic,Retinoblastoma|not provided,GRCh38,single nucleotide variant
RLBP1,15,89215133,na,na,Pathogenic/Likely pathogenic,Pigmentary retinal dystrophy|Retinitis punctata albescens|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy|Bothnia retinal dystrophy,GRCh38,single nucleotide variant
RLBP1,15,89218565,na,na,Pathogenic,Retinitis punctata albescens|Newfoundland cone-rod dystrophy|not provided|Retinitis pigmentosa,GRCh38,single nucleotide variant
RLBP1,15,89210794,na,na,Pathogenic/Likely pathogenic,Bothnia retinal dystrophy|Retinitis punctata albescens|RLBP1-related disorder|not provided|Retinitis pigmentosa|Retinal dystrophy,GRCh38,single nucleotide variant
RLBP1,15,89211750,na,na,Pathogenic/Likely pathogenic,Retinitis punctata albescens|Retinitis pigmentosa|RLBP1-related disorder|not provided|Retinal dystrophy|Bothnia retinal dystrophy;Retinitis punctata albescens|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy,GRCh38,single nucleotide variant
PDE6G,17,81651644,na,na,Pathogenic,Retinitis pigmentosa 57|Retinitis pigmentosa,GRCh38,single nucleotide variant
PDE6B,4,654119,na,na,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|Retinal dystrophy|not provided,GRCh38,single nucleotide variant
PDE6B,4,660590,na,na,Pathogenic,Retinitis pigmentosa 40|not provided,GRCh38,single nucleotide variant
PDE6B,4,662188,na,na,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
PDE6B,4,653912,na,na,Pathogenic,Congenital stationary night blindness autosomal dominant 2|not provided,GRCh38,single nucleotide variant
PDE6B,4,667922,na,na,Pathogenic,Retinitis pigmentosa 40|Autosomal recessive retinitis pigmentosa,GRCh38,single nucleotide variant
PDE6A,5,149886354,na,na,Pathogenic,Retinitis pigmentosa 43|Retinitis pigmentosa|not provided,GRCh38,single nucleotide variant
PDE6A,5,149907345,na,na,Pathogenic,Retinitis pigmentosa 43,GRCh38,single nucleotide variant
PDE6A,5,149895228,na,na,Pathogenic,Retinitis pigmentosa 43,GRCh38,single nucleotide variant
RPE65,1,68439586,na,na,Pathogenic,Leber congenital amaurosis 2|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinitis pigmentosa 20|RPE65-related recessive retinopathy|Retinal dystrophy,GRCh38,single nucleotide variant
RPE65,1,68444858,na,na,Pathogenic,Retinitis pigmentosa 20|Retinitis pigmentosa 20;Leber congenital amaurosis 2|not provided|Leber congenital amaurosis 2|Retinitis pigmentosa 20;RPE65-related disorder;Leber congenital amaurosis|Abnormality of the eye|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis|RPE65-related recessive retinopathy|Retinitis pigmentosa 87 with choroidal involvement;Retinitis pigmentosa 20;Leber congenital amaurosis 2,GRCh38,single nucleotide variant
RPE65,1,68431160,na,na,Likely pathogenic,Retinitis pigmentosa 20|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|not specified|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2|RPE65-related recessive retinopathy,GRCh38,single nucleotide variant
RPE65,1,68438228,na,na,Pathogenic,Retinitis pigmentosa 20|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Leber congenital amaurosis|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2,GRCh38,single nucleotide variant
RPE65,1,68438293,na,na,Pathogenic,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinal dystrophy|Retinitis pigmentosa 87 with choroidal involvement;Retinitis pigmentosa 20;Leber congenital amaurosis 2,GRCh38,single nucleotide variant
RPE65,1,68444632,na,na,Benign,not provided|Retinitis pigmentosa 20|Leber congenital amaurosis 2|Leber congenital amaurosis|not specified|RPE65-related recessive retinopathy|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Retinal dystrophy|RPE65-related disorder,GRCh38,single nucleotide variant
RPE65,1,68429835,na,na,Pathogenic,Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided|Retinitis pigmentosa|Leber congenital amaurosis|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Retinal dystrophy|RPE65-related recessive retinopathy,GRCh38,single nucleotide variant
RD3,1,211481119,na,na,Pathogenic,Leber congenital amaurosis 12,GRCh38,single nucleotide variant
REN,1,204155078,na,na,Pathogenic,"HYPERPRORENINEMIA, FAMILIAL",GRCh38,single nucleotide variant
REN,1,204162117,na,na,Pathogenic/Likely pathogenic,Renal tubular dysgenesis|Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided,GRCh38,single nucleotide variant
REN,1,204159399,na,na,Pathogenic,Renal tubular dysgenesis,GRCh38,single nucleotide variant
REN,1,204166247,na,na,Pathogenic,Familial juvenile hyperuricemic nephropathy type 2,GRCh38,single nucleotide variant
RAD51,15,40718818,na,na,Conflicting classifications of pathogenicity,Familial cancer of breast|RAD51-related disorder|not specified|not provided|Hereditary cancer,GRCh38,single nucleotide variant
RAD51,15,40695330,na,na,Benign,"Breast cancer, susceptibility to, in BRCA1 and BRCA2 carriers|not provided",GRCh38,single nucleotide variant
RAG2,11,36592736,na,na,Conflicting classifications of pathogenicity,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG2,11,36593483,na,na,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG2,11,36594046,na,na,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG2,11,36593315,na,na,Likely pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency disease|Inborn error of immunity;Recombinase activating gene 2 deficiency;Histiocytic medullary reticulosis,GRCh38,single nucleotide variant
RAG2,11,36593886,na,na,Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided",GRCh38,single nucleotide variant
RAG2,11,36593525,na,na,Benign,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|not provided|not specified|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Histiocytic medullary reticulosis|Recombinase activating gene 2 deficiency",GRCh38,single nucleotide variant
RAG2,11,36594054,na,na,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Recombinase activating gene 2 deficiency",GRCh38,single nucleotide variant
RAG2,11,36593939,na,na,Likely pathogenic,Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Recombinase activating gene 2 deficiency;Inborn error of immunity,GRCh38,single nucleotide variant
RAG2,11,36592817,na,na,Pathogenic,"Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency;Inborn error of immunity;Combined immunodeficiency with skin granulomas|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Common variable immunodeficiency|Severe combined immunodeficiency disease|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency",GRCh38,single nucleotide variant
RAG1,11,36575468,na,na,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency disease|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36575624,na,na,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG1,11,36576118,na,na,Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Recombinase activating gene 1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36573771,na,na,Uncertain significance,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG1,11,36574986,na,na,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",GRCh38,single nucleotide variant
RAG1,11,36574490,na,na,Pathogenic,"Histiocytic medullary reticulosis|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36576039,na,na,Pathogenic,Histiocytic medullary reticulosis,GRCh38,single nucleotide variant
RAG1,11,36574491,na,na,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas",GRCh38,single nucleotide variant
RAG1,11,36574590,na,na,Pathogenic,Histiocytic medullary reticulosis,GRCh38,single nucleotide variant
RAG1,11,36574985,na,na,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Histiocytic medullary reticulosis|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",GRCh38,single nucleotide variant
RAG1,11,36575514,na,na,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Inherited Immunodeficiency Diseases|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36575825,na,na,Pathogenic,"Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|not provided",GRCh38,single nucleotide variant
RAG1,11,36576246,na,na,Pathogenic,Combined immunodeficiency due to partial RAG1 deficiency,GRCh38,single nucleotide variant
RAG1,11,36574244,na,na,Pathogenic/Likely pathogenic,"Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36574823,na,na,Conflicting classifications of pathogenicity,"Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|not specified",GRCh38,single nucleotide variant
RAG1,11,36575637,na,na,Pathogenic,"Combined immunodeficiency with skin granulomas|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36576227,na,na,Pathogenic,"Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
RAG1,11,36574287,na,na,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency disease",GRCh38,single nucleotide variant
RAG1,11,36575630,na,na,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency;Histiocytic medullary reticulosis;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency",GRCh38,single nucleotide variant
PRPH2,6,42704546,na,na,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder|Retinal dystrophy|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium,GRCh38,single nucleotide variant
PRPH2,6,42721781,na,na,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7, digenic|not provided|Leber congenital amaurosis 18|Patterned macular dystrophy 1|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Retinitis pigmentosa",GRCh38,single nucleotide variant
PRPH2,6,42721820,na,na,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Retinitis pigmentosa|Macular dystrophy|PRPH2-related disorder|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|Stargardt disease|Vitelliform macular dystrophy 3|Retinitis pigmentosa 7",GRCh38,single nucleotide variant
PRPH2,6,42704419,na,na,Pathogenic,not provided|Vitelliform macular dystrophy 3,GRCh38,single nucleotide variant
PRPH2,6,42721835,na,na,Pathogenic,Patterned macular dystrophy 1|not provided|PRPH2-related disorder,GRCh38,single nucleotide variant
PRPH2,6,42721821,na,na,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium|maculopathy|Cone-rod dystrophy|Stargardt disease|Patterned macular dystrophy 1|Vitelliform macular dystrophy 2|Retinitis pigmentosa 7|Retinal dystrophy",GRCh38,single nucleotide variant
PRPH2,6,42704461,na,na,Pathogenic,Retinitis pigmentosa 7|not provided|Retinal dystrophy,GRCh38,single nucleotide variant
PRPH2,6,42704564,na,na,Pathogenic/Likely pathogenic,not provided|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Vitelliform macular dystrophy 3,GRCh38,single nucleotide variant
PRPH2,6,42722333,na,na,Pathogenic/Likely pathogenic,not provided|Retinal dystrophy|Vitelliform macular dystrophy 3|PRPH2-related disorder,GRCh38,single nucleotide variant
PRPH2,6,42698389,na,na,Pathogenic,not provided|Vitelliform macular dystrophy 3,GRCh38,single nucleotide variant
PRPH2,6,42722199,na,na,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7|not provided|Patterned dystrophy of the retinal pigment epithelium|Patterned macular dystrophy 1|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Choroidal dystrophy, central areolar 2",GRCh38,single nucleotide variant
PRPH2,6,42721817,na,na,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder,GRCh38,single nucleotide variant
PRPH2,6,42704609,na,na,Pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|Retinal dystrophy",GRCh38,single nucleotide variant
PRPH2,6,42721911,na,na,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Cone dystrophy|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|maculopathy|Progressive cone dystrophy (without rod involvement)|Stargardt disease|Retinitis pigmentosa|PRPH2-related disorder|Patterned macular dystrophy 1",GRCh38,single nucleotide variant
RDX,11,110231889,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,GRCh38,single nucleotide variant
RDX,11,110263964,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,GRCh38,single nucleotide variant
RDX,11,110257766,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,GRCh38,single nucleotide variant
PDHB,3,58430851,na,na,Likely pathogenic,Pyruvate dehydrogenase E1-beta deficiency,GRCh38,single nucleotide variant
PDHB,3,58428084,na,na,Pathogenic,Pyruvate dehydrogenase E1-beta deficiency,GRCh38,single nucleotide variant
PYCR1,17,81934326,na,na,Pathogenic,Autosomal recessive cutis laxa type 2B|not provided|Inborn genetic diseases|Cutis laxa,GRCh38,single nucleotide variant
PYCR1,17,81934670,na,na,Pathogenic,Autosomal recessive cutis laxa type 2B,GRCh38,single nucleotide variant
PYCR1,17,81935111,na,na,Pathogenic,Autosomal recessive cutis laxa type 2B,GRCh38,single nucleotide variant
PYCR1,17,81935110,na,na,Pathogenic/Likely pathogenic,Autosomal recessive cutis laxa type 2B|PYCR1-related de Barsy syndrome|Wiedemann-Rautenstrauch-like progeroid syndrome|not provided|Cutis laxa,GRCh38,single nucleotide variant
PYCR1,17,81934371,na,na,Pathogenic/Likely pathogenic,PYCR1-related de Barsy syndrome|not provided|Inborn genetic diseases|Cutis laxa,GRCh38,single nucleotide variant
SFTPA2,10,79557264,na,na,Pathogenic/Likely risk allele,Interstitial lung disease 2|Pulmonary fibrosis,GRCh38,single nucleotide variant
SFTPA2,10,79557363,na,na,Pathogenic,Interstitial lung disease 2,GRCh38,single nucleotide variant
SFTPB,2,85663814,na,na,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 1|not provided|Hereditary pulmonary alveolar proteinosis",GRCh38,single nucleotide variant
SFTPB,2,85665723,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1",GRCh38,single nucleotide variant
SFTPA1,10,79614021,na,na,Benign,"Pulmonary fibrosis, idiopathic, susceptibility to|not specified|not provided|SFTPA1-related disorder",GRCh38,single nucleotide variant
SFTPC,8,22163547,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided",GRCh38,single nucleotide variant
SFTPC,8,22163096,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided|Pulmonary fibrosis|Hereditary pulmonary alveolar proteinosis",GRCh38,single nucleotide variant
SFTPC,8,22163947,na,na,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 2|Interstitial lung disease 2|Hereditary pulmonary alveolar proteinosis|not provided|not specified|SFTPC-related disorder",GRCh38,single nucleotide variant
SFTPC,8,22164010,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",GRCh38,single nucleotide variant
SFTPC,8,22163547,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",GRCh38,single nucleotide variant
SFTPC,8,22163458,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",GRCh38,single nucleotide variant
SFTPC,8,22162727,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",GRCh38,single nucleotide variant
SFTPC,8,22164028,na,na,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",GRCh38,single nucleotide variant
BCHE,3,165830741,na,na,Conflicting classifications of pathogenicity,Deficiency of butyrylcholinesterase|Postanesthetic apnea|BCHE-related disorder|not provided,GRCh38,single nucleotide variant
BCHE,3,165830526,na,na,Likely pathogenic,"BCHE, H variant|not provided",GRCh38,single nucleotide variant
BCHE,3,165830222,na,na,Conflicting classifications of pathogenicity,"BCHE, flouride 1|not provided|Deficiency of butyrylcholinesterase",GRCh38,single nucleotide variant
BCHE,3,165829781,na,na,Conflicting classifications of pathogenicity,"BCHE, fluoride 2|Deficiency of butyrylcholinesterase|BCHE-related disorder",GRCh38,single nucleotide variant
BCHE,3,165773492,na,na,Conflicting classifications of pathogenicity,Butyrylcholinesterase activity|Deficiency of butyrylcholinesterase|not specified|not provided,GRCh38,single nucleotide variant
BCHE,3,165786255,na,na,Uncertain significance,"BCHE, J variant|not specified",GRCh38,single nucleotide variant
BCHE,3,165829962,na,na,Pathogenic/Likely pathogenic,"Butyrylcholinesterase deficiency, fluoride-resistant, Japanese type|Deficiency of butyrylcholinesterase",GRCh38,single nucleotide variant
BCHE,3,165830567,na,na,Pathogenic,Deficiency of butyrylcholinesterase,GRCh38,single nucleotide variant
BCHE,3,165830030,na,na,Pathogenic/Likely pathogenic,Deficiency of butyrylcholinesterase,GRCh38,single nucleotide variant
BCHE,3,165773520,na,na,no classification for the single variant,-,GRCh38,single nucleotide variant
MAF,16,79599040,na,na,Pathogenic,Cataract 21 multiple types,GRCh38,single nucleotide variant
MAF,16,79599013,na,na,Pathogenic,Cataract 21 multiple types,GRCh38,single nucleotide variant
EPB42,15,43215191,na,na,Conflicting classifications of pathogenicity,Hereditary spherocytosis type 5|EPB42-related disorder,GRCh38,single nucleotide variant
EPB42,15,43208769,na,na,Likely pathogenic,Hereditary spherocytosis type 5,GRCh38,single nucleotide variant
EPB42,15,43209273,na,na,Pathogenic,Hereditary spherocytosis type 5,GRCh38,single nucleotide variant
EPB42,15,43203237,na,na,Pathogenic,Hereditary spherocytosis type 5,GRCh38,single nucleotide variant
PRKCSH,19,11449074,na,na,Pathogenic,Polycystic liver disease 1,GRCh38,single nucleotide variant
PRKCSH,19,11437972,na,na,Pathogenic,Polycystic liver disease 1,GRCh38,single nucleotide variant
PRKCSH,19,11448604,na,na,Pathogenic,Polycystic liver disease 1,GRCh38,single nucleotide variant
PRKCSH,19,11448917,na,na,Pathogenic/Likely pathogenic,Polycystic liver disease 1|not provided,GRCh38,single nucleotide variant
PRKCG,19,53889653,na,na,Pathogenic,Spinocerebellar ataxia type 14|not provided,GRCh38,single nucleotide variant
PRKCG,19,53889707,na,na,Pathogenic,Spinocerebellar ataxia type 14,GRCh38,single nucleotide variant
PRKCG,19,53889735,na,na,Pathogenic,Spinocerebellar ataxia type 14|not provided,GRCh38,single nucleotide variant
PRKCG,19,53889705,na,na,Pathogenic,Spinocerebellar ataxia type 14|not provided,GRCh38,single nucleotide variant
PRKCG,19,53889732,na,na,Pathogenic,Spinocerebellar ataxia type 14|not provided,GRCh38,single nucleotide variant
PRKCG,19,53906728,na,na,Pathogenic,Spinocerebellar ataxia type 14,GRCh38,single nucleotide variant
PRKCG,19,53898100,na,na,Likely pathogenic,Spinocerebellar ataxia type 14|not provided,GRCh38,single nucleotide variant
PRKCG,19,53889655,na,na,Pathogenic,Spinocerebellar ataxia type 14,GRCh38,single nucleotide variant
ZAP70,2,97737984,na,na,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency|not provided|ZAP70-Related Severe Combined Immunodeficiency|ZAP70-related disorder|Severe combined immunodeficiency disease,GRCh38,single nucleotide variant
ZAP70,2,97737828,na,na,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency,GRCh38,single nucleotide variant
ZAP70,2,97737577,na,na,Uncertain significance,Combined immunodeficiency due to ZAP70 deficiency|ZAP70-Related Severe Combined Immunodeficiency,GRCh38,single nucleotide variant
EPHA2,1,16125304,na,na,Pathogenic,Cataract 6 multiple types,GRCh38,single nucleotide variant
EPHA2,1,16129440,na,na,Pathogenic,Cataract 6 multiple types,GRCh38,single nucleotide variant
EPHA2,1,16132227,na,na,Conflicting classifications of pathogenicity,"Cataract 6, age-related cortical|Cataract 6 multiple types|not specified|EPHA2-related disorder|Meniere disease",GRCh38,single nucleotide variant
FGFR2,10,121517378,na,na,Pathogenic/Likely pathogenic,Crouzon syndrome|Pfeiffer syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Craniosynostosis syndrome|11 conditions,GRCh38,single nucleotide variant
FGFR2,10,121517385,na,na,Pathogenic,Crouzon syndrome|not provided|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121517342,na,na,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|Inborn genetic diseases|See cases|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517379,na,na,Pathogenic,Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Jackson-Weiss syndrome|FGFR2-related craniosynostosis|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517379,na,na,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121517371,na,na,Pathogenic,"Crouzon syndrome|Craniosynostosis, nonclassifiable autosomal dominant|Scaphocephaly and axenfeld-rieger anomaly|Craniosynostosis syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|Acrocephalosyndactyly type I|FGFR2-related disorder|11 conditions",GRCh38,single nucleotide variant
FGFR2,10,121517372,na,na,Pathogenic,Jackson-Weiss syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|Pfeiffer syndrome|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121517420,na,na,Pathogenic/Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517363,na,na,Pathogenic/Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided|22 conditions|Meier-Gorlin syndrome 1|Pfeiffer syndrome,GRCh38,single nucleotide variant
FGFR2,10,121520163,na,na,Pathogenic,Acrocephalosyndactyly type I|Endometrial carcinoma|not provided|FGFR2-related craniosynostosis|FGFR2-related disorder|11 conditions|Pfeiffer syndrome|11 conditions|Neoplasm,GRCh38,single nucleotide variant
FGFR2,10,121520160,na,na,Pathogenic/Likely pathogenic,Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis|not provided|11 conditions|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121517382,na,na,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517377,na,na,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,GRCh38,single nucleotide variant
FGFR2,10,121520052,na,na,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121515280,na,na,Pathogenic/Likely pathogenic,Beare-Stevenson cutis gyrata syndrome|Endometrial carcinoma|FGFR2-related craniosynostosis|not provided|11 conditions|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121515289,na,na,Pathogenic,Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121520048,na,na,Pathogenic,"Pfeiffer syndrome|Aural atresia, congenital|FGFR2-related disorder|not provided",GRCh38,single nucleotide variant
FGFR2,10,121520044,na,na,Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121520050,na,na,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,GRCh38,single nucleotide variant
FGFR2,10,121520050,na,na,Pathogenic,Crouzon syndrome|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121517351,na,na,Pathogenic,Pfeiffer syndrome type 3|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided|FGFR2-related craniosynostosis|Pfeiffer syndrome|Crouzon syndrome|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121517460,na,na,Pathogenic,"Craniosynostosis, nonsyndromic unicoronal|FGFR2-related craniosynostosis|not provided|Crouzon syndrome|11 conditions",GRCh38,single nucleotide variant
FGFR2,10,121520119,na,na,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided|Gastric cancer,GRCh38,single nucleotide variant
FGFR2,10,121517464,na,na,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
FGFR2,10,121520048,na,na,Pathogenic,Pfeiffer syndrome|Craniofacial-skeletal-dermatologic dysplasia|FGFR2-related craniosynostosis|not provided|11 conditions,GRCh38,single nucleotide variant
FGFR2,10,121496701,na,na,Pathogenic/Likely pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided|FGFR2-related disorder,GRCh38,single nucleotide variant
FGFR2,10,121498591,na,na,Pathogenic/Likely pathogenic,"Familial scaphocephaly syndrome, McGillivray type|Crouzon syndrome|not provided|Pfeiffer syndrome|FGFR2-related craniosynostosis",GRCh38,single nucleotide variant
FGFR2,10,121488035,na,na,Pathogenic,"Levy-Hollister syndrome|FGFR2-related craniosynostosis|not provided|Familial scaphocephaly syndrome, McGillivray type",GRCh38,single nucleotide variant
FGFR2,10,121488095,na,na,Pathogenic,Levy-Hollister syndrome|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517316,na,na,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|Crouzon syndrome;Pfeiffer syndrome;Acrocephalosyndactyly type I|not provided,GRCh38,single nucleotide variant
FGFR2,10,121517441,na,na,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,GRCh38,single nucleotide variant
F2,11,46725897,na,na,Conflicting classifications of pathogenicity; risk factor,"PROTHROMBIN TYPE 3|not provided|Congenital prothrombin deficiency|Cerebral palsy|Thrombophilia due to thrombin defect;Congenital prothrombin deficiency;Pregnancy loss, recurrent, susceptibility to, 2;Ischemic stroke|not specified|Thrombophilia due to thrombin defect",GRCh38,single nucleotide variant
F2,11,46726563,na,na,Pathogenic,Congenital prothrombin deficiency|Thrombophilia due to thrombin defect,GRCh38,single nucleotide variant
F2,11,46728746,na,na,Pathogenic/Likely pathogenic,not provided|Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46728138,na,na,Likely pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46739341,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46728004,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46728157,na,na,Pathogenic,DYSPROTHROMBINEMIA PROTHROMBIN HIMI-II,GRCh38,single nucleotide variant
F2,11,46739505,na,na,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance; risk factor","Congenital prothrombin deficiency|Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 2|Venous thromboembolism|Thrombophilia caused by F2 prothrombin deficiency|Congenital prothrombin deficiency;Ischemic stroke;Thrombophilia due to thrombin defect;Pregnancy loss, recurrent, susceptibility to, 2|not provided|Cerebral palsy|Thrombophilia due to thrombin defect",GRCh38,single nucleotide variant
F2,11,46726734,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46726761,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46728139,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
F2,11,46739324,na,na,Pathogenic,Congenital prothrombin deficiency,GRCh38,single nucleotide variant
PROS1,3,93879306,na,na,Conflicting classifications of pathogenicity,"Protein S Heerlen|Thrombophilia due to protein S deficiency, autosomal recessive|not specified|not provided|Thrombophilia due to protein S deficiency, autosomal dominant|Hereditary thrombophilia due to congenital protein S deficiency|Retinal dystrophy|Optic atrophy",GRCh38,single nucleotide variant
PROS1,3,93898524,na,na,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROS1,3,93905799,na,na,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive|PROS1-related disorder",GRCh38,single nucleotide variant
PROS1,3,93874245,na,na,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROS1,3,93884905,na,na,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",GRCh38,single nucleotide variant
PROS1,3,93898462,na,na,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive",GRCh38,single nucleotide variant
PROS1,3,93877155,na,na,Uncertain significance,"Thrombophilia due to protein S deficiency, autosomal dominant|Protein S deficiency disease",GRCh38,single nucleotide variant
PTPN11,12,112450394,na,na,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|Noonan syndrome 1;LEOPARD syndrome 1|Noonan syndrome 1;LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia|Noonan syndrome and Noonan-related syndrome,GRCh38,single nucleotide variant
PTPN11,12,112450395,na,na,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|not provided|Noonan syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|RASopathy|Cardiovascular phenotype,GRCh38,single nucleotide variant
PTPN11,12,112477719,na,na,Pathogenic,Noonan syndrome 1|not provided|RASopathy|Noonan syndrome|LEOPARD syndrome 1;Noonan syndrome 1|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype|LEOPARD syndrome 1|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1|Abnormal bleeding;Thrombocytopenia|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|PTPN11-related disorder|Male infertility with azoospermia or oligozoospermia due to single gene mutation,GRCh38,single nucleotide variant
PTPN11,12,112477720,na,na,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|not provided|Noonan syndrome 3|LEOPARD syndrome 1;Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|Neoplasm,GRCh38,single nucleotide variant
PTPN11,12,112473023,na,na,Pathogenic/Likely pathogenic,RASopathy|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Noonan syndrome with multiple lentigines;Noonan syndrome|CBL-related disorder|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome 1|Cardiovascular phenotype|not specified|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112450364,na,na,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome;Juvenile myelomonocytic leukemia|Noonan syndrome and Noonan-related syndrome|6 conditions|Cardiovascular phenotype|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112450362,na,na,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Short stature;Abnormal cardiovascular system morphology|Noonan syndrome;Juvenile myelomonocytic leukemia|Non-immune hydrops fetalis|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia,GRCh38,single nucleotide variant
PTPN11,12,112488466,na,na,Pathogenic,LEOPARD syndrome 1|RASopathy|not provided|Noonan syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome|PTPN11-related disorder|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Hypertrophic cardiomyopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype,GRCh38,single nucleotide variant
PTPN11,12,112489080,na,na,Pathogenic,Noonan syndrome 1|Juvenile myelomonocytic leukemia;Noonan syndrome|Noonan syndrome|not provided|RASopathy|Noonan syndrome 1;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;Metachondromatosis|PTPN11-related disorder|Cardiovascular phenotype,GRCh38,single nucleotide variant
PTPN11,12,112450368,na,na,Pathogenic,"Noonan syndrome 1|RASopathy|not provided|Noonan syndrome 3|Noonan syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1|B lymphoblastic leukemia lymphoma, no ICD-O subtype;Lymphoma|Noonan syndrome and Noonan-related syndrome|LEOPARD syndrome 1|Metachondromatosis|PTPN11-related disorder|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
PTPN11,12,112450398,na,na,Pathogenic,RASopathy|Noonan syndrome|not provided|Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|Metachondromatosis;Noonan syndrome 1;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis,GRCh38,single nucleotide variant
PTPN11,12,112477651,na,na,Pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|RASopathy|Early T cell progenitor acute lymphoblastic leukemia|Non-immune hydrops fetalis|Metachondromatosis|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|LEOPARD syndrome 1,GRCh38,single nucleotide variant
PTPN11,12,112450406,na,na,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|RASopathy|not provided|Noonan syndrome|Malignant neoplastic disease|PTPN11-related disorder|Neoplasm|Noonan syndrome 1,GRCh38,single nucleotide variant
PTPN11,12,112450407,na,na,Pathogenic,Juvenile myelomonocytic leukemia|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome,GRCh38,single nucleotide variant
PTPN11,12,112450407,na,na,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|not provided|RASopathy,GRCh38,single nucleotide variant
PTPN11,12,112450407,na,na,Pathogenic,Juvenile myelomonocytic leukemia|not provided,GRCh38,single nucleotide variant
PTPN11,12,112450416,na,na,Pathogenic,Noonan syndrome 1|Noonan syndrome|RASopathy|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|not provided|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 3|PTPN11-related disorder|Cardiovascular phenotype,GRCh38,single nucleotide variant
PTPN11,12,112486482,na,na,Uncertain significance,Noonan syndrome 1|RASopathy|Acute megakaryoblastic leukemia in down syndrome|Cardiovascular phenotype|not provided,GRCh38,single nucleotide variant
PTPN11,12,112488444,na,na,Pathogenic,Noonan syndrome with multiple lentigines|not provided|LEOPARD syndrome 1|RASopathy|Noonan syndrome 1|not specified|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112488454,na,na,Pathogenic,not provided|RASopathy|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome with multiple lentigines;Noonan syndrome|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112489105,na,na,Pathogenic,LEOPARD syndrome 1|RASopathy|not provided|Noonan syndrome 3|Noonan syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome with multiple lentigines;Noonan syndrome|LEOPARD syndrome 1;Noonan syndrome 1|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112489105,na,na,Pathogenic/Likely pathogenic,Noonan syndrome 1|LEOPARD syndrome 1|not provided|RASopathy|Cardiovascular phenotype|PTPN11-related disorder,GRCh38,single nucleotide variant
PTPN11,12,112453274,na,na,Pathogenic,Metachondromatosis|RASopathy,GRCh38,single nucleotide variant
PTPN11,12,112419116,na,na,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|Metachondromatosis|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|RASopathy|LEOPARD syndrome 1|See cases,GRCh38,single nucleotide variant
MAP2K1,15,66435104,na,na,Likely pathogenic,Cardiofaciocutaneous syndrome 3|not provided|Cardio-facio-cutaneous syndrome|RASopathy,GRCh38,single nucleotide variant
MAP2K1,15,66436843,na,na,Pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|RASopathy|Cardiofaciocutaneous syndrome 3;Noonan syndrome 1|Melorheostosis|MAP2K1-related disorder|Noonan syndrome 1|Cardiovascular phenotype|Neoplasm,GRCh38,single nucleotide variant
MAP2K1,15,66436837,na,na,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|RASopathy,GRCh38,single nucleotide variant
POMC,2,25161572,na,na,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,GRCh38,single nucleotide variant
POMC,2,25164783,na,na,Pathogenic,Obesity due to pro-opiomelanocortin deficiency|Obesity;Obesity due to pro-opiomelanocortin deficiency|not provided,GRCh38,single nucleotide variant
POMC,2,25161179,na,na,Conflicting classifications of pathogenicity,"Obesity, early-onset, susceptibility to|not provided|Obesity due to pro-opiomelanocortin deficiency|POMC-related disorder|Obesity due to pro-opiomelanocortin deficiency;Inherited obesity",GRCh38,single nucleotide variant
POMC,2,25161734,na,na,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,GRCh38,single nucleotide variant
PTGER2,14,52300623,na,na,risk factor,"Asthma, aspirin-induced, susceptibility to",GRCh38,single nucleotide variant
PSAP,10,71828084,na,na,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Inborn genetic diseases|not provided|Combined PSAP deficiency;Gaucher disease due to saposin C deficiency;Krabbe disease due to saposin A deficiency;Sphingolipid activator protein 1 deficiency;Parkinson disease 24, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
PSAP,10,71823922,na,na,Likely pathogenic,Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy,GRCh38,single nucleotide variant
PSAP,10,71825892,na,na,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Combined PSAP deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
PSAP,10,71819761,na,na,Pathogenic,Gaucher disease due to saposin C deficiency,GRCh38,single nucleotide variant
PSAP,10,71851221,na,na,Pathogenic,Combined PSAP deficiency|Gaucher disease due to saposin C deficiency|Sphingolipid activator protein 1 deficiency,GRCh38,single nucleotide variant
PSAP,10,71828158,na,na,Pathogenic,"Sphingolipid activator protein 1 deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",GRCh38,single nucleotide variant
PSAP,10,71828091,na,na,Pathogenic/Likely pathogenic,Sphingolipid activator protein 1 deficiency|PSAP-related disorder,GRCh38,single nucleotide variant
PSAP,10,71819762,na,na,Pathogenic,Gaucher disease due to saposin C deficiency,GRCh38,single nucleotide variant
PSAP,10,71819527,na,na,Pathogenic,Gaucher disease due to saposin C deficiency,GRCh38,single nucleotide variant
PSAP,10,71819860,na,na,Likely pathogenic,Gaucher disease due to saposin C deficiency|Metachromatic leukodystrophy,GRCh38,single nucleotide variant
PSAP,10,71819902,na,na,Likely pathogenic,Combined PSAP deficiency|Sphingolipid activator protein 1 deficiency,GRCh38,single nucleotide variant
PSAP,10,71828159,na,na,Pathogenic,Sphingolipid activator protein 1 deficiency,GRCh38,single nucleotide variant
ZBTB16,11,114250382,na,na,Uncertain significance,"Skeletal defects, genital hypoplasia, and intellectual disability",GRCh38,single nucleotide variant
INS,11,2160825,na,na,Pathogenic,Hyperproinsulinemia,GRCh38,single nucleotide variant
INS,11,2160829,na,na,Pathogenic,Hyperproinsulinemia,GRCh38,single nucleotide variant
INS,11,2160872,na,na,Uncertain significance,Hyperproinsulinemia,GRCh38,single nucleotide variant
INS,11,2159919,na,na,Pathogenic/Likely pathogenic,"Hyperproinsulinemia|not provided|INS-related disorder|Type 1 diabetes mellitus 2;Hyperproinsulinemia;Diabetes mellitus, permanent neonatal 4;Maturity-onset diabetes of the young type 10",GRCh38,single nucleotide variant
INS,11,2159911,na,na,Uncertain significance,"Hyperproinsulinemia|Diabetes mellitus, permanent neonatal 4",GRCh38,single nucleotide variant
INS,11,2159919,na,na,Pathogenic,Hyperproinsulinemia,GRCh38,single nucleotide variant
INS,11,2159919,na,na,Pathogenic,Hyperproinsulinemia,GRCh38,single nucleotide variant
INS,11,2159898,na,na,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|not provided|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",GRCh38,single nucleotide variant
INS,11,2160901,na,na,Pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|not provided",GRCh38,single nucleotide variant
INS,11,2160829,na,na,Likely pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",GRCh38,single nucleotide variant
INS,11,2160956,na,na,Likely risk allele,Maturity-onset diabetes of the young type 10,GRCh38,single nucleotide variant
INS,11,2160835,na,na,Conflicting classifications of pathogenicity,"Maturity-onset diabetes of the young type 10|not provided|Diabetes mellitus, permanent neonatal 4",GRCh38,single nucleotide variant
INS,11,2160809,na,na,Pathogenic/Likely pathogenic/Likely risk allele,Type 1 diabetes mellitus 2|not provided|Diabetes mellitus type 1|Monogenic diabetes|INS-related disorder,GRCh38,single nucleotide variant
PHB1,17,49404263,na,na,risk factor,"Breast cancer, susceptibility to",GRCh38,single nucleotide variant
PRNP,20,4699525,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|not provided|Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|Spongiform encephalopathy with neuropsychiatric features,GRCh38,single nucleotide variant
PRNP,20,4699570,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases|not provided,GRCh38,single nucleotide variant
PRNP,20,4699605,na,na,Benign/Likely benign,||Inherited prion disease||not specified|Autism spectrum disorder|not provided|Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions|Fatal familial insomnia,GRCh38,single nucleotide variant
PRNP,20,4699818,na,na,Pathogenic,Inherited Creutzfeldt-Jakob disease|Fatal familial insomnia|Huntington disease-like 1|not provided|6 conditions,GRCh38,single nucleotide variant
PRNP,20,4699752,na,na,Pathogenic/Likely pathogenic,Fatal familial insomnia|Huntington disease-like 1|Huntington disease-like 1;Spongiform encephalopathy with neuropsychiatric features;Gerstmann-Straussler-Scheinker syndrome|not provided,GRCh38,single nucleotide variant
PRNP,20,4699813,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|not provided,GRCh38,single nucleotide variant
PRNP,20,4699870,na,na,Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|PRNP-related disorder,GRCh38,single nucleotide variant
PRNP,20,4699848,na,na,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions|Inborn genetic diseases,GRCh38,single nucleotide variant
PRNP,20,4699534,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases,GRCh38,single nucleotide variant
PRNP,20,4699758,na,na,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Inherited prion disease|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome|6 conditions,GRCh38,single nucleotide variant
PRNP,20,4699915,na,na,Uncertain significance,Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions,GRCh38,single nucleotide variant
PRNP,20,4699767,na,na,Pathogenic,Spongiform encephalopathy with neuropsychiatric features|Huntington disease-like 1,GRCh38,single nucleotide variant
PRNP,20,4699732,na,na,Benign,Spongiform encephalopathy with neuropsychiatric features|Inherited prion disease|Huntington disease-like 1|not provided|not specified,GRCh38,single nucleotide variant
PRNP,20,4699875,na,na,Benign,Inherited prion disease|Huntington disease-like 1|not provided|Reclassified - variant of unknown significance,GRCh38,single nucleotide variant
PRNP,20,4699612,na,na,Pathogenic/Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1,GRCh38,single nucleotide variant
PRNP,20,4699843,na,na,Pathogenic/Likely pathogenic,Inherited Creutzfeldt-Jakob disease|not provided|PRNP-related disorder|Huntington disease-like 1,GRCh38,single nucleotide variant
PRNP,20,4699780,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Spongiform encephalopathy with neuropsychiatric features,GRCh38,single nucleotide variant
PRNP,20,4699533,na,na,Pathogenic,Spongiform encephalopathy with neuropsychiatric features,GRCh38,single nucleotide variant
PRNP,20,4699618,na,na,Pathogenic,Gerstmann-Straussler-Scheinker syndrome,GRCh38,single nucleotide variant
PRNP,20,4699533,na,na,Uncertain significance,Gerstmann-Straussler-Scheinker syndrome|not provided,GRCh38,single nucleotide variant
PRNP,20,4699600,na,na,protective,"Kuru, protection against",GRCh38,single nucleotide variant
TTR,18,31592974,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Charcot-Marie-Tooth disease|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|TTR-related disorder",GRCh38,single nucleotide variant
TTR,18,31592983,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31598632,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595152,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595157,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Charcot-Marie-Tooth disease|Cardiomyopathy|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595209,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Charcot-Marie-Tooth disease|not specified|Amyloidosis, hereditary systemic 1;Hyperthyroxinemia, dystransthyretinemic;Carpal tunnel syndrome 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595230,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
TTR,18,31598622,na,na,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31598655,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease|ATTRV122I amyloidosis|Amyloidosis|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic|Tip-toe gait|TTR-related disorder",GRCh38,single nucleotide variant
TTR,18,31595247,na,na,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|Cardiovascular phenotype|Cardiomyopathy|Heart failure|not provided|Charcot-Marie-Tooth disease",GRCh38,single nucleotide variant
TTR,18,31593011,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595129,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
TTR,18,31592975,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592992,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31598647,na,na,Benign/Likely benign,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 1, MODIFIER OF|not specified|not provided|Cardiomyopathy|Cardiovascular phenotype|Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Hyperthyroxinemia, dystransthyretinemic",GRCh38,single nucleotide variant
TTR,18,31595152,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31593025,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592959,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595143,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595128,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592974,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595124,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595244,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595189,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592914,na,na,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595191,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595181,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|Hyperthyroxinemia, dystransthyretinemic;Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1|not provided",GRCh38,single nucleotide variant
TTR,18,31595160,na,na,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31598581,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31598631,na,na,Pathogenic,Carpal tunnel syndrome 1,GRCh38,single nucleotide variant
TTR,18,31598610,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Hereditary amyloidosis|Cardiovascular phenotype|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31593026,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31592902,na,na,Benign/Likely benign,"TRANSTHYRETIN POLYMORPHISM|Cardiovascular phenotype|not specified|Amyloidosis, hereditary systemic 1|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic|Charcot-Marie-Tooth disease|Hypertrophic cardiomyopathy|not provided",GRCh38,single nucleotide variant
TTR,18,31595169,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Carpal tunnel syndrome;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31598617,na,na,Uncertain significance,"Hyperthyroxinemia, dystransthyretinemic|not provided|Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31592944,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31592983,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",GRCh38,single nucleotide variant
TTR,18,31592921,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1|not specified",GRCh38,single nucleotide variant
TTR,18,31598602,na,na,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|Cardiovascular phenotype|not provided|Charcot-Marie-Tooth disease|Cardiomyopathy",GRCh38,single nucleotide variant
TTR,18,31593025,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31593017,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31595137,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592939,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31592975,na,na,Pathogenic,"Amyloidosis, hereditary systemic 1",GRCh38,single nucleotide variant
TTR,18,31595184,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",GRCh38,single nucleotide variant
TTR,18,31598580,na,na,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",GRCh38,single nucleotide variant
KCNA5,12,5045270,na,na,Pathogenic,"Atrial fibrillation, familial, 7",GRCh38,single nucleotide variant
KCNA5,12,5045727,na,na,Uncertain significance,"Atrial fibrillation, familial, 7|not provided",GRCh38,single nucleotide variant
KCNA5,12,5045874,na,na,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 7",GRCh38,single nucleotide variant
KCNA5,12,5045975,na,na,Pathogenic,"Atrial fibrillation, familial, 7",GRCh38,single nucleotide variant
KCNC3,19,50323694,na,na,Pathogenic,Spinocerebellar ataxia type 13|not provided,GRCh38,single nucleotide variant
KCNC3,19,50323609,na,na,Pathogenic,Spinocerebellar ataxia type 13,GRCh38,single nucleotide variant
KCNE1,21,34449615,na,na,Pathogenic,Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5,GRCh38,single nucleotide variant
KCNE1,21,34449409,na,na,Conflicting classifications of pathogenicity,Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1|not provided|Cardiovascular phenotype|Long QT syndrome|Jervell and Lange-Nielsen syndrome|not specified|Arrhythmogenic right ventricular cardiomyopathy,GRCh38,single nucleotide variant
KCNE1,21,34449414,na,na,Conflicting classifications of pathogenicity,Long QT syndrome 5|Congenital long QT syndrome|Long QT syndrome|not specified|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2|not provided|Cardiovascular phenotype,GRCh38,single nucleotide variant
KCNE1,21,34449382,na,na,Conflicting classifications of pathogenicity; other; risk factor,"Long QT syndrome 2/5, digenic|Long QT syndrome 5, acquired, susceptibility to|not provided|Long QT syndrome|not specified|Jervell and Lange-Nielsen syndrome 2|Cardiovascular phenotype|Congenital long QT syndrome|Long QT syndrome 5|Cardiomyopathy|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2",GRCh38,single nucleotide variant
KCNA1,12,4912601,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4912093,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4911898,na,na,Pathogenic,Episodic ataxia type 1|Inborn genetic diseases,GRCh38,single nucleotide variant
KCNA1,12,4912123,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4911929,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4912353,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4912054,na,na,Pathogenic,Episodic ataxia type 1|not provided,GRCh38,single nucleotide variant
KCNA1,12,4912588,na,na,Pathogenic,Episodic ataxia type 1|not provided,GRCh38,single nucleotide variant
KCNA1,12,4911908,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4912102,na,na,Pathogenic,Myokymia 1|not provided,GRCh38,single nucleotide variant
KCNA1,12,4912109,na,na,Pathogenic,Myokymia 1,GRCh38,single nucleotide variant
KCNA1,12,4912627,na,na,Pathogenic,Episodic ataxia type 1,GRCh38,single nucleotide variant
KCNA1,12,4912055,na,na,Pathogenic,Episodic ataxia type 1|not provided,GRCh38,single nucleotide variant
KCNA1,12,4912055,na,na,Pathogenic,Myokymia 1,GRCh38,single nucleotide variant
KCNA1,12,4912141,na,na,Pathogenic,Myokymia 1 with hypomagnesemia,GRCh38,single nucleotide variant
POLG,15,89320883,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive sclerosing poliodystrophy|Mitochondrial disease|not provided|Mitochondrial DNA depletion syndrome",GRCh38,single nucleotide variant
POLG,15,89327201,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|POLG-Related Spectrum Disorders|Mitochondrial disease|Neurodevelopmental delay|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|POLG-related disorder|not provided|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Inborn genetic diseases|Mitochondrial DNA depletion syndrome 4b|Tip-toe gait|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",GRCh38,single nucleotide variant
POLG,15,89329055,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not provided|Progressive sclerosing poliodystrophy|6 conditions|Inborn genetic diseases|POLG-related disorder|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",GRCh38,single nucleotide variant
POLG,15,89333747,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1",GRCh38,single nucleotide variant
POLG,15,89325520,na,na,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",GRCh38,single nucleotide variant
POLG,15,89320953,na,na,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Mitochondrial disease|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",GRCh38,single nucleotide variant
POLG,15,89319053,na,na,Pathogenic/Likely pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|not provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|See cases|Autosomal dominant non-syndromic intellectual disability|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",GRCh38,single nucleotide variant
POLG,15,89321792,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|POLG-Related Spectrum Disorders|not provided|Hereditary spastic paraplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Mitochondrial disease|Inborn genetic diseases|POLG-related disorder|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome|6 conditions",GRCh38,single nucleotide variant
POLG,15,89330184,na,na,Conflicting classifications of pathogenicity,"Mitochondrial DNA depletion syndrome 1|POLG-Related Spectrum Disorders|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 4b|Global developmental delay|Progressive sclerosing poliodystrophy|not provided|not specified|Tip-toe gait|POLG-related disorder|Inborn genetic diseases|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Abnormality of the nervous system|Mitochondrial disease|Hypertrophic cardiomyopathy|See cases|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|6 conditions|Mitochondrial DNA depletion syndrome",GRCh38,single nucleotide variant
POLG,15,89321242,na,na,Pathogenic,Progressive sclerosing poliodystrophy,GRCh38,single nucleotide variant
POLG,15,89325639,na,na,Conflicting classifications of pathogenicity,"Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided|Mitochondrial DNA depletion syndrome 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not specified|Mitochondrial disease|Tip-toe gait|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Abnormality of the nervous system|Inborn genetic diseases|Global developmental delay|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|POLG-related disorder|Hereditary spastic paraplegia|Hypertrophic cardiomyopathy|See cases|6 conditions",GRCh38,single nucleotide variant
POLG,15,89321743,na,na,Pathogenic,"Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Progressive sclerosing poliodystrophy",GRCh38,single nucleotide variant
POLG,15,89323426,na,na,Pathogenic/Likely pathogenic,"Progressive sclerosing poliodystrophy|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|not provided|not specified|POLG-Related Spectrum Disorders|Mitochondrial disease|Mitochondrial DNA depletion syndrome 4b|Inborn genetic diseases|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy|POLG-related disorder|6 conditions",GRCh38,single nucleotide variant
POLG,15,89320878,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive sclerosing poliodystrophy",GRCh38,single nucleotide variant
POLG,15,89321842,na,na,Benign/Likely benign,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|not provided|not specified|Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|POLG-related disorder|Hereditary spastic paraplegia|Inborn genetic diseases",GRCh38,single nucleotide variant
POLG,15,89327006,na,na,Uncertain significance,Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|not provided|not specified|6 conditions,GRCh38,single nucleotide variant
POLG,15,89319275,na,na,Pathogenic,Progressive sclerosing poliodystrophy,GRCh38,single nucleotide variant
POLG,15,89321777,na,na,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|not specified|Mitochondrial DNA depletion syndrome|not provided|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy",GRCh38,single nucleotide variant
POLG,15,89323460,na,na,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|Mitochondrial disease|not provided|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|Hereditary spastic paraplegia|POLG-related disorder|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Inborn genetic diseases|Tip-toe gait",GRCh38,single nucleotide variant
POLG,15,89326965,na,na,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1",GRCh38,single nucleotide variant
POLG,15,89330257,na,na,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 4b|not provided|Progressive sclerosing poliodystrophy|Abnormality of corpus callosum|Inborn genetic diseases|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome",GRCh38,single nucleotide variant
POLG,15,89318986,na,na,Pathogenic,Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided,GRCh38,single nucleotide variant
PKD2,4,88043277,na,na,Pathogenic,Polycystic kidney disease 2,GRCh38,single nucleotide variant
PKD2,4,88065479,na,na,Pathogenic,Polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|not provided,GRCh38,single nucleotide variant
PKD2,4,88043351,na,na,Pathogenic,Polycystic kidney disease 2,GRCh38,single nucleotide variant
PKD2,4,88046712,na,na,Pathogenic,Polycystic kidney disease 2|Polycystic kidney disease|not provided|Autosomal dominant polycystic kidney disease,GRCh38,single nucleotide variant
PKD2,4,88046854,na,na,Pathogenic,Polycystic kidney disease 2,GRCh38,single nucleotide variant
PIGR,1,206933133,na,na,Uncertain significance,IgA glomerulonephritis,GRCh38,single nucleotide variant
SELP,1,169594713,na,na,Benign,SELECTIN P POLYMORPHISM|not provided|SELP-related disorder,GRCh38,single nucleotide variant
SELP,1,169596108,na,na,Benign,SELECTIN P POLYMORPHISM,GRCh38,single nucleotide variant
GP9,3,129061921,na,na,Pathogenic,Bernard-Soulier syndrome type C|Bernard Soulier syndrome|Thrombocytopenia|Macrothrombocytopenia|not provided|GP9-related disorder,GRCh38,single nucleotide variant
GP9,3,129061849,na,na,Pathogenic,Bernard-Soulier syndrome type C,GRCh38,single nucleotide variant
GP9,3,129061951,na,na,Pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome|Macrothrombocytopenia,GRCh38,single nucleotide variant
GP9,3,129061906,na,na,Pathogenic,Bernard-Soulier syndrome type C,GRCh38,single nucleotide variant
GP9,3,129061809,na,na,Likely pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome,GRCh38,single nucleotide variant
GP9,3,129061759,na,na,Uncertain significance,Bernard-Soulier syndrome type C|not provided,GRCh38,single nucleotide variant
CD36,7,80656687,na,na,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Inherited bleeding disorder, platelet-type|not specified",GRCh38,single nucleotide variant
CD36,7,80671133,na,na,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Malaria, cerebral, susceptibility to|not specified",GRCh38,single nucleotide variant
CD36,7,80669964,na,na,Pathogenic,Platelet-type bleeding disorder 10,GRCh38,single nucleotide variant
CD36,7,80673392,na,na,Pathogenic,Platelet-type bleeding disorder 10,GRCh38,single nucleotide variant
PDGFRA,4,54285926,na,na,Conflicting classifications of pathogenicity,Gastrointestinal stromal tumor|not provided,GRCh38,single nucleotide variant
PDGFRA,4,54274869,na,na,Conflicting classifications of pathogenicity,"Gastrointestinal stromal tumor|Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|not provided",GRCh38,single nucleotide variant
PDGFRA,4,54278380,na,na,Uncertain significance,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib|Gastrointestinal stromal tumor",GRCh38,single nucleotide variant
PDGFRA,4,54285937,na,na,Conflicting classifications of pathogenicity,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome",GRCh38,single nucleotide variant
PDGFRA,4,54274851,na,na,Likely pathogenic,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor",GRCh38,single nucleotide variant
ITGB3,17,47286364,na,na,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24|not provided|Platelet-type bleeding disorder 16|Bleeding disorder, platelet-type, 24",GRCh38,single nucleotide variant
ITGB3,17,47284514,na,na,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 2,GRCh38,single nucleotide variant
ITGB3,17,47286363,na,na,Likely pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia|not provided,GRCh38,single nucleotide variant
ITGB3,17,47310169,na,na,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,GRCh38,single nucleotide variant
ITGB3,17,47284587,na,na,Benign,PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM|not provided|Glanzmann thrombasthenia|not specified,GRCh38,single nucleotide variant
ITGB3,17,47283364,na,na,Benign,"PL(A1)/(A2) ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not specified|Myocardial infarction, susceptibility to|not provided",GRCh38,single nucleotide variant
ITGB3,17,47292175,na,na,Uncertain significance,Mo ALLOANTIGEN POLYMORPHISM|not specified|not provided,GRCh38,single nucleotide variant
ITGB3,17,47274505,na,na,Pathogenic,Glanzmann thrombasthenia 2,GRCh38,single nucleotide variant
ITGB3,17,47292422,na,na,Benign,Ca/Tu ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not provided,GRCh38,single nucleotide variant
ITGB3,17,47291027,na,na,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,GRCh38,single nucleotide variant
ITGB3,17,47307584,na,na,Pathogenic,"Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Platelet-type bleeding disorder 16|Glanzmann thrombasthenia 2|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",GRCh38,single nucleotide variant
ITGB3,17,47300488,na,na,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,GRCh38,single nucleotide variant
ITGB3,17,47284509,na,na,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",GRCh38,single nucleotide variant
ITGB3,17,47287128,na,na,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,GRCh38,single nucleotide variant
ITGB3,17,47286385,na,na,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,GRCh38,single nucleotide variant
SERPINE1,7,101128436,na,na,Benign/Likely benign,Congenital plasminogen activator inhibitor type 1 deficiency|not provided|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|not specified|SERPINE1-related disorder,GRCh38,single nucleotide variant
PLG,6,160738593,na,na,Conflicting classifications of pathogenicity,"Dysplasminogenemia|Plasminogen deficiency, type I|not specified|not provided",GRCh38,single nucleotide variant
PLG,6,160722431,na,na,Pathogenic,Dysplasminogenemia,GRCh38,single nucleotide variant
PLG,6,160736976,na,na,Pathogenic,Dysplasminogenemia,GRCh38,single nucleotide variant
PLG,6,160716680,na,na,Pathogenic,"Plasminogen deficiency, type I",GRCh38,single nucleotide variant
PLG,6,160738583,na,na,Pathogenic,"Plasminogen deficiency, type I",GRCh38,single nucleotide variant
PLG,6,160731229,na,na,Pathogenic,"Plasminogen deficiency, type I",GRCh38,single nucleotide variant
PLG,6,160752240,na,na,Uncertain significance,Dysplasminogenemia|PLG-related disorder|not provided,GRCh38,single nucleotide variant
PLG,6,160706469,na,na,Pathogenic/Likely pathogenic,"Plasminogen deficiency, type I|not provided|Otitis media, susceptibility to|Deep venous thrombosis|Angioedema, hereditary, 4;Plasminogen deficiency, type I",GRCh38,single nucleotide variant
ENPP1,6,131890410,na,na,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided",GRCh38,single nucleotide variant
ENPP1,6,131884939,na,na,Conflicting classifications of pathogenicity,"Arterial calcification, generalized, of infancy, 1|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Type 2 diabetes mellitus|not provided",GRCh38,single nucleotide variant
ENPP1,6,131877005,na,na,Pathogenic,"Arterial calcification, generalized, of infancy, 1",GRCh38,single nucleotide variant
ENPP1,6,131851228,na,na,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Obesity|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1|Hypopigmentation-punctate palmoplantar keratoderma syndrome|Diabetes mellitus type 2, susceptibility to|not provided|Hypophosphatemic rickets|Type 2 diabetes mellitus|ENPP1-related disorder|Hypopigmentation-punctate palmoplantar keratoderma syndrome;Type 2 diabetes mellitus;Arterial calcification, generalized, of infancy, 1;Inherited obesity;Hypophosphatemic rickets, autosomal recessive, 2",GRCh38,single nucleotide variant
ENPP1,6,131891554,na,na,Benign,"Obesity|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",GRCh38,single nucleotide variant
ENPP1,6,131861704,na,na,Pathogenic/Likely pathogenic,"Arterial calcification, generalized, of infancy, 1|Coronary sclerosis, medial, of infancy|not provided",GRCh38,single nucleotide variant
ENPP1,6,131864886,na,na,Pathogenic,"Arterial calcification, generalized, of infancy, 1",GRCh38,single nucleotide variant
ENPP1,6,131860388,na,na,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",GRCh38,single nucleotide variant
ENPP1,6,131890435,na,na,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",GRCh38,single nucleotide variant
ENPP1,6,131858735,na,na,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided|ENPP1-related disorder",GRCh38,single nucleotide variant
SERPINB6,6,2948696,na,na,Pathogenic,Autosomal recessive nonsyndromic hearing loss 91,GRCh38,single nucleotide variant
POU1F1,3,87262161,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",GRCh38,single nucleotide variant
POU1F1,3,87259959,na,na,Conflicting classifications of pathogenicity,"Pituitary hormone deficiency, combined, 1|not provided",GRCh38,single nucleotide variant
POU1F1,3,87262203,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",GRCh38,single nucleotide variant
POU1F1,3,87276392,na,na,Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",GRCh38,single nucleotide variant
POU1F1,3,87264299,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1|Combined pituitary hormone deficiencies, genetic form",GRCh38,single nucleotide variant
POU1F1,3,87260022,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
POU1F1,3,87264323,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
POU1F1,3,87260055,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
POU1F1,3,87262098,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
POU1F1,3,87264294,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
POU1F1,3,87260082,na,na,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|POU1F1-related disorder|not provided|Combined pituitary hormone deficiencies, genetic form",GRCh38,single nucleotide variant
POU1F1,3,87262160,na,na,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided|Combined pituitary hormone deficiencies, genetic form|POU1F1-related disorder",GRCh38,single nucleotide variant
POU1F1,3,87262138,na,na,Pathogenic,"Pituitary hormone deficiency, combined, 1",GRCh38,single nucleotide variant
PHKB,16,47650919,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|not provided,GRCh38,single nucleotide variant
PHKB,16,47502989,na,na,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency,GRCh38,single nucleotide variant
PHKB,16,47596425,na,na,Pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency|PHKB-related disorder,GRCh38,single nucleotide variant
PHKB,16,47696408,na,na,Uncertain significance,Glycogen storage disease IXb,GRCh38,single nucleotide variant
PHKB,16,47503037,na,na,Conflicting classifications of pathogenicity,Glycogen storage disease IXb|not specified|not provided,GRCh38,single nucleotide variant
PSPH,7,56021119,na,na,Uncertain significance,Deficiency of phosphoserine phosphatase|not provided,GRCh38,single nucleotide variant
PSPH,7,56019720,na,na,Pathogenic,Deficiency of phosphoserine phosphatase,GRCh38,single nucleotide variant
PHKG2,16,30756191,na,na,Pathogenic,Glycogen storage disease IXc,GRCh38,single nucleotide variant
PHKG2,16,30751594,na,na,Pathogenic,Glycogen storage disease IXc,GRCh38,single nucleotide variant
PHKG2,16,30751140,na,na,Pathogenic,Glycogen storage disease IXc|not provided,GRCh38,single nucleotide variant
PHKG2,16,30753434,na,na,Pathogenic,Glycogen storage disease IXc,GRCh38,single nucleotide variant
PHKG2,16,30756396,na,na,Pathogenic,Glycogen storage disease IXc,GRCh38,single nucleotide variant
MTHFD1,14,64425752,na,na,Conflicting classifications of pathogenicity,"Spina bifida, folate-sensitive, susceptibility to|not provided|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not specified",GRCh38,single nucleotide variant
MTHFD1,14,64442127,na,na,Benign/Likely benign,"Neural tube defects, folate-sensitive, susceptibility to|not specified|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not provided",GRCh38,single nucleotide variant
PLTP,20,45919554,na,na,Benign,RECLASSIFIED - PLTP POLYMORPHISM,GRCh38,single nucleotide variant
PLN,6,118558946,na,na,Pathogenic,Dilated cardiomyopathy 1P|not provided|Primary dilated cardiomyopathy|Cardiomyopathy,GRCh38,single nucleotide variant
PLN,6,118559037,na,na,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1P|Hypertrophic cardiomyopathy 18|Hypertrophic cardiomyopathy|Sudden cardiac death|Cardiac arrest|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy 18;Dilated cardiomyopathy 1P|Intrinsic cardiomyopathy,GRCh38,single nucleotide variant
GPI,19,34377575,na,na,Uncertain significance,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34394044,na,na,Pathogenic/Likely pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34399933,na,na,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|Inborn genetic diseases,GRCh38,single nucleotide variant
GPI,19,34399974,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,GRCh38,single nucleotide variant
GPI,19,34378971,na,na,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,GRCh38,single nucleotide variant
GPI,19,34365325,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34394020,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34394032,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34365280,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
GPI,19,34396362,na,na,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,GRCh38,single nucleotide variant
PGM1,1,63629521,na,na,Pathogenic,PGM1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PGM1,1,63648516,na,na,Pathogenic,PGM1-congenital disorder of glycosylation,GRCh38,single nucleotide variant
PIK3CA,3,179234297,na,na,Pathogenic,"OVARIAN CANCER, EPITHELIAL, SOMATIC|Carcinoma of colon|Hepatocellular carcinoma|Breast adenocarcinoma|Non-small cell lung carcinoma|Seborrheic keratosis|CLOVES syndrome|Ovarian neoplasm|PIK3CA related overgrowth syndrome|Neoplasm|Rosette-forming glioneuronal tumor|not provided|Lip and oral cavity carcinoma|Abnormal cardiovascular system morphology|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|CLAPO syndrome|Cerebrofacial Vascular Metameric Syndrome (CVMS)|Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes|MACRODACTYLY, SOMATIC|Megalencephaly-capillary malformation-polymicrogyria syndrome|Gastric cancer|Congenital macrodactylia|Rare venous malformation|Segmental undergrowth associated with mainly venous malformation with capillary component|Segmental undergrowth associated with lymphatic malformation|PIK3CA-related disorder|PIK3CA-Related Overgrowth Spectrum Disorders|Breast carcinoma|Klippel-Trenaunay-like-Syndrome|Rare combined vascular malformation",GRCh38,single nucleotide variant
PIK3CA,3,179234297,na,na,Pathogenic,"Breast adenocarcinoma|CLOVES syndrome|PIK3CA related overgrowth syndrome|Ovarian neoplasm|CLAPO syndrome|Macrodactyly of toe;Stroke disorder|Hemihypertrophy|Cowden syndrome 1|Megalencephaly-capillary malformation-polymicrogyria syndrome|Colorectal cancer|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|not provided|Inborn genetic diseases|Cavernous lymphangioma|Neoplasm",GRCh38,single nucleotide variant
PIK3CA,3,179218306,na,na,Likely pathogenic,Breast adenocarcinoma|PIK3CA related overgrowth syndrome,GRCh38,single nucleotide variant
PIK3CA,3,179218303,na,na,Pathogenic/Likely pathogenic,"OVARIAN CANCER, EPITHELIAL, SOMATIC|Carcinoma of colon|Seborrheic keratosis|Breast adenocarcinoma|Non-small cell lung carcinoma|Megalencephaly-capillary malformation-polymicrogyria syndrome|Sarcoma|Ovarian neoplasm|not provided|Abnormal cardiovascular system morphology|Cerebrofacial Vascular Metameric Syndrome (CVMS)|Segmental undergrowth associated with lymphatic malformation|Gastric cancer|CLOVES syndrome|PIK3CA related overgrowth syndrome|Gallbladder cancer|Eccrine angiomatous hamartoma|HEMIFACIAL MYOHYPERPLASIA, SOMATIC|Neoplasm|Angioosteohypertrophic syndrome|Rare venous malformation|Rare combined vascular malformation|PIK3CA overgrowth syndrome",GRCh38,single nucleotide variant
PIK3CA,3,179218304,na,na,Pathogenic,Epidermal nevus|Carcinoma of colon|PIK3CA related overgrowth syndrome,GRCh38,single nucleotide variant
PIK3CA,3,179218306,na,na,Conflicting classifications of pathogenicity,"Carcinoma of colon|OVARIAN CANCER, EPITHELIAL, SOMATIC|Prostate cancer|PIK3CA related overgrowth syndrome|Ovarian neoplasm|Segmental undergrowth associated with mainly venous malformation with capillary component|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome",GRCh38,single nucleotide variant
PIK3CA,3,179218304,na,na,Pathogenic,Hepatocellular carcinoma|Ovarian neoplasm|Abnormal cardiovascular system morphology,GRCh38,single nucleotide variant
ALPP,2,232378876,na,na,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-1 POLYMORPHISM",GRCh38,single nucleotide variant
ALPP,2,232378876,na,na,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM|not provided",GRCh38,single nucleotide variant
ALPL,1,21564103,na,na,Pathogenic,Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|not provided,GRCh38,single nucleotide variant
ALPL,1,21561126,na,na,Pathogenic,Infantile hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21573683,na,na,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder|Osteogenesis imperfecta,GRCh38,single nucleotide variant
ALPL,1,21561127,na,na,Likely pathogenic,Infantile hypophosphatasia|not provided|Adult hypophosphatasia|Hypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21564188,na,na,Conflicting classifications of pathogenicity,Infantile hypophosphatasia|not provided|not specified,GRCh38,single nucleotide variant
ALPL,1,21560662,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21576638,na,na,Pathogenic,Infantile hypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21573694,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21564139,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|Hypophosphatasia|not provided|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Osteogenesis imperfecta|Odontohypophosphatasia|Inborn genetic diseases|ALPL-related disorder|See cases,GRCh38,single nucleotide variant
ALPL,1,21575868,na,na,Pathogenic,Adult hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Childhood hypophosphatasia|Inborn genetic diseases|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21575736,na,na,Pathogenic,Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|not provided|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21573781,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|not provided|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21563219,na,na,Pathogenic/Likely pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|not provided|Adult hypophosphatasia|Osteogenesis imperfecta|Odontohypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21564053,na,na,Pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|not provided,GRCh38,single nucleotide variant
ALPL,1,21563158,na,na,Pathogenic,Childhood hypophosphatasia|Adult hypophosphatasia|Odontohypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21564217,na,na,Pathogenic,Perinatal lethal hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder|Adult hypophosphatasia;Childhood hypophosphatasia;Infantile hypophosphatasia|Inborn genetic diseases,GRCh38,single nucleotide variant
ALPL,1,21576582,na,na,Pathogenic/Likely pathogenic,Perinatal lethal hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|not provided|Childhood hypophosphatasia|ALPL-related disorder|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21563135,na,na,Pathogenic,Odontohypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21577439,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia,GRCh38,single nucleotide variant
ALPL,1,21568201,na,na,Pathogenic,Childhood hypophosphatasia|Odontohypophosphatasia|not provided|Hypophosphatasia|Infantile hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21564094,na,na,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Adult hypophosphatasia;Childhood hypophosphatasia;Infantile hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,GRCh38,single nucleotide variant
ALPL,1,21570326,na,na,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|not provided|ALPL-related disorder|Hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia|Adult hypophosphatasia,GRCh38,single nucleotide variant
ACP1,2,277003,na,na,Benign,ACP1 A/B POLYMORPHISM|not provided,GRCh38,single nucleotide variant
ABCB4,7,87411948,na,na,Pathogenic/Likely pathogenic,"Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|not provided",GRCh38,single nucleotide variant
ABCB4,7,87439761,na,na,Uncertain significance,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|not specified|ABCB4-related disorder",GRCh38,single nucleotide variant
ABCB4,7,87447080,na,na,Pathogenic/Likely pathogenic,"Low phospholipid associated cholelithiasis|Cholestasis, intrahepatic, of pregnancy, 3|Progressive familial intrahepatic cholestasis type 3|not provided|Progressive familial intrahepatic cholestasis|ABCB4-related disorder|Progressive familial intrahepatic cholestasis type 3;Low phospholipid associated cholelithiasis;Cholestasis, intrahepatic, of pregnancy, 3",GRCh38,single nucleotide variant
ABCB4,7,87452957,na,na,Benign/Likely benign,"Low phospholipid associated cholelithiasis|not provided|not specified|Cholestasis, intrahepatic, of pregnancy, 3|Progressive familial intrahepatic cholestasis type 3",GRCh38,single nucleotide variant
ABCB4,7,87406293,na,na,Conflicting classifications of pathogenicity,Low phospholipid associated cholelithiasis|not provided|not specified,GRCh38,single nucleotide variant
ABCB4,7,87443686,na,na,Pathogenic,Progressive familial intrahepatic cholestasis type 3,GRCh38,single nucleotide variant
ABCB4,7,87453050,na,na,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|ABCB4-related disorder|Progressive familial intrahepatic cholestasis type 3",GRCh38,single nucleotide variant
ABCB4,7,87431528,na,na,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|not specified|Progressive familial intrahepatic cholestasis type 3|not provided|Progressive familial intrahepatic cholestasis type 1|ABCB4-related disorder|Progressive familial intrahepatic cholestasis type 3;Low phospholipid associated cholelithiasis;Cholestasis, intrahepatic, of pregnancy, 3",GRCh38,single nucleotide variant
ABCB1,7,87566218,na,na,Pathogenic,COLCHICINE RESISTANCE,GRCh38,single nucleotide variant
PPARA,22,46218377,na,na,Benign,"Hyperapobetalipoproteinemia, susceptibility to",GRCh38,single nucleotide variant
ABCD3,1,94515203,na,na,Uncertain significance,not specified,GRCh38,single nucleotide variant
ABCD3,1,94418528,na,na,Uncertain significance,not specified,GRCh38,single nucleotide variant
PEX2,8,76983824,na,na,Pathogenic,Peroxisome biogenesis disorder 5A (Zellweger)|Peroxisome biogenesis disorder 5B|Zellweger spectrum disorders|Peroxisome biogenesis disorder 5A (Zellweger);Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder|PEX2-related disorder|not provided,GRCh38,single nucleotide variant
PEX2,8,76984016,na,na,Likely pathogenic,Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder,GRCh38,single nucleotide variant
PRPH,12,49295621,na,na,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|not provided|not specified|PRPH-related disorder",GRCh38,single nucleotide variant
PRF1,10,70598599,na,na,Pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|not provided|Inborn genetic diseases|Aplastic anemia|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2|Autoinflammatory syndrome",GRCh38,single nucleotide variant
PRF1,10,70600713,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,GRCh38,single nucleotide variant
PRF1,10,70599048,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Inborn genetic diseases|Familial hemophagocytic lymphohistiocytosis type 1|Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,GRCh38,single nucleotide variant
PRF1,10,70598435,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,GRCh38,single nucleotide variant
PRF1,10,70598687,na,na,Uncertain significance,Familial hemophagocytic lymphohistiocytosis 2|not specified,GRCh38,single nucleotide variant
PRF1,10,70598885,na,na,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,GRCh38,single nucleotide variant
PRF1,10,70599173,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,GRCh38,single nucleotide variant
PRF1,10,70598966,na,na,Conflicting classifications of pathogenicity,Familial hemophagocytic lymphohistiocytosis 2|not specified|not provided|Autoinflammatory syndrome,GRCh38,single nucleotide variant
PRF1,10,70598417,na,na,Pathogenic/Likely pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia|Autoinflammatory syndrome|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2",GRCh38,single nucleotide variant
PRF1,10,70600631,na,na,Conflicting classifications of pathogenicity; risk factor,"Hemophagocytic lymphohistiocytosis, familial, 2, susceptibility to|not provided|not specified|Familial hemophagocytic lymphohistiocytosis 2|Autoinflammatory syndrome|PRF1-related disorder",GRCh38,single nucleotide variant
PRF1,10,70598558,na,na,Uncertain significance,Aplastic anemia|not specified,GRCh38,single nucleotide variant
PRF1,10,70600892,na,na,Benign/Likely benign,Aplastic anemia|not specified|Familial hemophagocytic lymphohistiocytosis 2|not provided|Autoinflammatory syndrome,GRCh38,single nucleotide variant
PRF1,10,70598475,na,na,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,GRCh38,single nucleotide variant
TAP2,6,32832635,na,na,Benign,not specified|MHC class I deficiency|not provided|TAP2 POLYMORPHISM,GRCh38,single nucleotide variant
TAP2,6,32828974,na,na,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,GRCh38,single nucleotide variant
TAP2,6,32828908,na,na,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,GRCh38,single nucleotide variant
TAP2,6,32835282,na,na,Pathogenic,MHC class I deficiency 2,GRCh38,single nucleotide variant
TAP1,6,32850997,na,na,Benign/Likely benign,PEPTIDE TRANSPORTER PSF1 POLYMORPHISM|not specified|MHC class I deficiency,GRCh38,single nucleotide variant
TAP1,6,32847198,na,na,Benign/Likely benign,PEPTIDE TRANSPORTER PSF1 POLYMORPHISM|not specified|MHC class I deficiency,GRCh38,single nucleotide variant
TAP1,6,32847132,na,na,Likely benign,"TAP1 deficiency, somatic|MHC class I deficiency|not provided",GRCh38,single nucleotide variant
TAP1,6,32852503,na,na,Pathogenic,MHC class I deficiency,GRCh38,single nucleotide variant
PRB3,12,11268104,na,na,Pathogenic,PRB3S(CYS),GRCh38,single nucleotide variant
PON1,7,95308134,na,na,Benign,Enzyme activity finding|not provided|PON1-related disorder,GRCh38,single nucleotide variant
PON1,7,95316772,na,na,Benign,Enzyme activity finding|not provided|PON1-related disorder,GRCh38,single nucleotide variant
PON1,7,95324583,na,na,Benign,Enzyme activity finding|not provided,GRCh38,single nucleotide variant
PTHLH,12,27963693,na,na,Pathogenic,Brachydactyly type E2,GRCh38,single nucleotide variant
PTHLH,12,27963741,na,na,Pathogenic,Brachydactyly type E2,GRCh38,single nucleotide variant
PTHLH,12,27958559,na,na,Pathogenic,Brachydactyly type E2,GRCh38,single nucleotide variant
PTHLH,12,27963514,na,na,Pathogenic,Brachydactyly type E2,GRCh38,single nucleotide variant
PTH1R,3,46898691,na,na,Pathogenic,"Metaphyseal chondrodysplasia, Jansen type|Primary failure of tooth eruption|not provided",GRCh38,single nucleotide variant
PTH1R,3,46902542,na,na,Pathogenic,"Metaphyseal chondrodysplasia, Jansen type",GRCh38,single nucleotide variant
PTH1R,3,46901797,na,na,Pathogenic,Chondrodysplasia Blomstrand type|not provided,GRCh38,single nucleotide variant
PTH1R,3,46897936,na,na,Pathogenic,"Chondrodysplasia Blomstrand type|Metaphyseal chondrodysplasia, Jansen type;Eiken syndrome;Chondrodysplasia Blomstrand type;Primary failure of tooth eruption",GRCh38,single nucleotide variant
PTH1R,3,46902768,na,na,Pathogenic,"Metaphyseal chondrodysplasia, Jansen type",GRCh38,single nucleotide variant
PTH1R,3,46902543,na,na,Pathogenic,"Metaphyseal chondrodysplasia, Jansen type",GRCh38,single nucleotide variant
PTH1R,3,46903327,na,na,Pathogenic,Eiken syndrome,GRCh38,single nucleotide variant
PTH1R,3,46895866,na,na,Pathogenic,Chondrodysplasia Blomstrand type|not provided,GRCh38,single nucleotide variant
PTH1R,3,46901114,na,na,Pathogenic,Chondrodysplasia Blomstrand type,GRCh38,single nucleotide variant
PTH1R,3,46901411,na,na,Pathogenic,Primary failure of tooth eruption,GRCh38,single nucleotide variant
PTH1R,3,46898193,na,na,Pathogenic,Primary failure of tooth eruption,GRCh38,single nucleotide variant
PTH1R,3,46898112,na,na,Pathogenic,Primary failure of tooth eruption,GRCh38,single nucleotide variant
CCND1,11,69648142,na,na,Benign,"Colorectal cancer, susceptibility to|not provided|MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO|CCND1-related disorder|VON HIPPEL-LINDAU SYNDROME, MODIFIER OF",GRCh38,single nucleotide variant
PTH,11,13492804,na,na,Pathogenic,"Hypoparathyroidism, familial isolated 1",GRCh38,single nucleotide variant
PTH,11,13492769,na,na,Pathogenic,"Hypoparathyroidism, familial isolated 1",GRCh38,single nucleotide variant
PTH,11,13492789,na,na,Pathogenic,"Hypoparathyroidism, familial isolated 1",GRCh38,single nucleotide variant
PTH,11,13492506,na,na,Likely pathogenic,Primary hyperparathyroidism|Familial hypoparathyroidism,GRCh38,single nucleotide variant
SPINK1,5,147828115,na,na,Conflicting classifications of pathogenicity; association; risk factor,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis|not provided|Finnish congenital nephrotic syndrome|Pancreatitis|Tropical pancreatitis",GRCh38,single nucleotide variant
SPINK1,5,147831576,na,na,Pathogenic,Hereditary pancreatitis,GRCh38,single nucleotide variant
SPINK1,5,147831792,na,na,Pathogenic,Tropical pancreatitis,GRCh38,single nucleotide variant
SPINK1,5,147831537,na,na,Pathogenic,Hereditary pancreatitis,GRCh38,single nucleotide variant
SPINK1,5,147831537,na,na,Uncertain significance,Hereditary pancreatitis,GRCh38,single nucleotide variant
PAX9,14,36663232,na,na,Pathogenic,"Tooth agenesis, selective, 3",GRCh38,single nucleotide variant
